Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,positive regulation of nervous system development (GO:0051962),-0.6065120756626707,-2.364239462236204,0.0,0.0036148909541181794,0.004,12/42,6.10%,CX3CR1;NUMB;IL1RAPL1;NRXN1;NLGN1;PTPRD;CLSTN2;TGM2;GRID2;CLSTN3;RGS14;EPHB1
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.5760527790690646,-2.016974887987759,0.0,0.2638870396506271,0.399,20/26,24.55%,NRXN1;NLGN1;RIMS1;SLC8A3;LRRK2;SHANK3;RIMS2;APP;SLC8A2;GRIN1;PRKCZ;CUX2;CHRNA7;TMEM25;SHANK1;NLGN2;NLGN3;RELN;CBLN1;MTMR2
prerank,positive regulation of synapse assembly (GO:0051965),-0.5843947045330358,-1.9969446793341306,0.0,0.22111083002689536,0.463,16/27,21.68%,IL1RAPL1;NRXN1;NLGN1;PTPRD;CLSTN2;GRID2;CLSTN3;EPHB1;CUX2;DLG5;CLSTN1;IL1RAP;NLGN2;NLGN3;SYNDIG1;SEMA4A
prerank,regulation of synapse assembly (GO:0051963),-0.5130245339519609,-1.982984270628687,0.0,0.19249294330679306,0.513,24/46,19.67%,MEF2C;IL1RAPL1;NRXN1;NLGN1;LRFN5;PTPRD;CLSTN2;GRID2;IL1RAPL2;CLSTN3;PDLIM5;EPHB1;APP;ROBO2;TLR2;MDGA1;CUX2;DLG5;CLSTN1;GPC4;IL1RAP;NLGN2;NLGN3;SYNDIG1
prerank,T cell activation (GO:0042110),0.6818429866737284,1.9702766115169217,0.0,0.00610983269159205,0.006,26/69,11.73%,LCP1;LCK;CD3E;NLRC3;ITK;CD8B;PTPRC;CD4;MSN;KIF13B;LAT;CD8A;CD44;CD2;CD7;CD3G;CD28;NCK2;PTPN22;GATA3;NCK1;RASGRP1;PTPN2;JAML;CRTAM;DLL4
prerank,regulation of sequestering of triglyceride (GO:0010889),0.8525930052415582,1.9522613766759631,0.0,0.005600679967292713,0.011,7/15,9.02%,OSBPL8;PLIN2;LPL;APOC4;PPARG;TREM2;ABHD5
prerank,potassium ion export across plasma membrane (GO:0097623),-0.669910745058949,-1.9113626136659625,0.007662835249042145,0.30581977471839794,0.77,9/13,31.95%,KCND3;KCNK5;KCNH2;KCNQ1;KCNIP2;KCNE3;KCNE4;KCNA5;KCNE2
prerank,glutamate receptor signaling pathway (GO:0007215),-0.5030967408913269,-1.901614490944175,0.007751937984496124,0.2774428807285703,0.801,18/37,11.50%,GRIA4;GRM7;GRIK2;GRIK3;GRIN2A;PLCB1;GRIA3;GRIK4;KCNB1;GRM1;GRID2;GRIN2B;GRM5;GRM3;APP;HOMER3;GRM8;GRIN1
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.7862115005655149,1.8768152374094562,0.0,0.0529518833271311,0.12,7/18,8.97%,GPR137B;LTF;FSTL3;FBXW7;TCTA;LILRB1;LILRB3
prerank,regulation of cation transmembrane transport (GO:1904062),-0.5379832500240302,-1.8560282102858967,0.00684931506849315,0.35606675898064066,0.904,12/29,13.31%,KCNIP4;DPP10;FGF12;KCNIP3;SNTA1;DPP6;WNK1;WNK3;KCNN2;KCNAB2;KCNIP1;KCNH2
prerank,amino acid transmembrane transport (GO:0003333),0.6715310704646602,1.853196174952976,0.0,0.06975392322900925,0.206,20/45,19.43%,MFSD12;SLC3A2;SLC38A1;SLC6A6;SLC38A6;SLC7A1;SLC7A11;SLC6A14;SLC36A4;SLC36A3;SFXN1;SLC7A6;SLC38A11;SLC7A8;SFXN2;SLC38A7;SLC38A10;SLC25A18;SLC16A2;SLC38A2
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.5951659342719389,-1.8505650691463227,0.0091324200913242,0.32782542340159243,0.92,10/18,17.71%,GRIK2;GRIK3;GRIK4;GRID2;UNC13B;GRID1;CDH8;NAPB;GRIA2;UNC13C
prerank,cytoplasmic translation (GO:0002181),0.6252195695229913,1.8502034923544766,0.0,0.060080021467321824,0.224,53/91,22.02%,RPS12;EIF4A1;UBA52;RPS27A;RPS6;RPS14;RPL10A;RPL18;RPS24;RPS7;RPL41;RPL36A;RPS20;RPS26;RPL23;RPL17;ETF1;RPS25;RPL35A;RPS28;RPL28;RPL27A;RPL11;RPS2;TMA7;RPL32;DRG1;RWDD1;RPL21;RPL9;RPL36;RPL37;RPL38;RPS18;RPS19;RPS27;RPS23;EIF3M;RPL14;RPS16;RPL30;RPL31;RPL12;GSPT1;DRG2;RPL13A;RPS9;RPL4;RPS3;RPS13;RPSA;EIF4A2;RPL15
prerank,regulation of T cell activation (GO:0050863),0.6756948012435735,1.8379094002598564,0.0,0.06364409053741718,0.285,22/42,16.92%,LGALS3;GPNMB;LCK;LAX1;SIRPA;PRKCQ;CD4;LAT;TBX21;CD2;IL27;PTPN22;METTL3;CRTAM;CCR2;CCL5;TNFRSF1B;TNFSF8;HSPD1;DUSP3;TNFSF9;SPINK5
prerank,reverse cholesterol transport (GO:0043691),0.8116918504633013,1.8366791107037852,0.0,0.057025105121525796,0.295,4/13,3.58%,APOE;ABCG1;ABCA1;APOA2
prerank,innate immune response in mucosa (GO:0002227),0.8740960283888376,1.8270414719415409,0.0,0.061734767821294674,0.342,3/10,4.43%,CAMP;LTF;RNASE3
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.6217218191926249,1.8218138136606907,0.0,0.06155090711529769,0.375,49/87,22.02%,RPS12;UBA52;RPS27A;RPS6;RPS14;RPL10A;RPL18;RPS24;RPS7;RPL41;RPL36A;RPS20;RPS26;RPL23;RPL17;RPS25;RPL35A;RPS28;RPLP2;RPL28;RPL27A;RPL11;RPS2;SEC61B;RPL32;SRP14;RPL21;SEC63;RPL9;RPL36;RPL37;RPL38;RPS18;RPS19;RPS27;RPS23;RPL14;RPS16;SRP9;RPL30;RPL31;RPL12;RPL13A;RPS9;RPL4;RPS3;RPS13;RPSA;RPL15
prerank,cotranslational protein targeting to membrane (GO:0006613),0.6150288773409583,1.8170897331962113,0.0,0.05977452983274222,0.396,56/91,27.03%,RPS12;UBA52;RPS27A;RPS6;RPS14;RPL10A;RPL18;RPS24;RPS7;RPL41;RPL36A;RPS20;RPS26;RPL23;RPL17;RPS25;RPL35A;RPS28;RPLP2;RPL28;SIL1;RPL27A;RPL11;RPS2;RPL32;SRP14;RPL21;SEC63;RPL9;RPL36;RPL37;RPL38;RPS18;RPS19;RPS27;RPS23;RPL14;RPS16;SRP9;RPL30;RPL31;RPL12;RPL13A;RPS9;RPL4;RPS3;RPS13;RPSA;RPL15;RPL7A;RPL23A;RPL8;RPLP1;RPL29;SSR1;RPL37A
prerank,detection of visible light (GO:0009584),0.7709251498827832,1.8164794654694258,0.0,0.05489592100172857,0.399,6/16,14.16%,GNAQ;ABCA4;PDE6B;CNGB1;CEP250;GNA11
prerank,regulation of microglial cell activation (GO:1903978),0.7811023237636208,1.8157844443957383,0.0013003901170351106,0.05074555485516731,0.402,6/15,7.29%,STAP1;MMP8;PTPRC;CST7;SPHK1;TREM2
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.6872250964884286,-1.8083956189122212,0.0070921985815602835,0.41029012329241343,0.964,6/10,15.71%,PRKCE;HECW1;COMMD1;HECW2;OSR1;NEDD4L
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.6023923507376845,1.8079649975855367,0.0,0.056790111556464566,0.473,58/110,22.15%,RPS12;UBA52;RPS27A;RPS6;EIF4G1;RPS14;RPL10A;RPL18;RPS24;PPP2R1A;RPS7;RPL41;RPL36A;RPS20;RPS26;RPL23;RPL17;ETF1;RPS25;RPL35A;RPS28;RPLP2;RPL28;RPL27A;RPL11;RPS2;PABPC1;DHX34;SMG9;RPL32;RPL21;RPL9;RPL36;RPL37;DCP1A;RPL38;EIF4A3;RPS18;RPS19;RPS27;HELZ2;RPS23;RPL14;RPS16;RPL30;RPL31;RPL12;GSPT1;EIF3E;RPL13A;RPS9;UPF3A;RPL4;RPS3;RPS13;RPSA;RPL15;UPF3B
prerank,protein targeting to ER (GO:0045047),0.6099203801464654,1.8069758784579688,0.0,0.05375198046531577,0.477,54/99,22.02%,RPS12;UBA52;RPS27A;RPS6;RPS14;RPL10A;RPL18;EDEM1;RPS24;RPS7;RPL41;RPL36A;RPS20;ZFAND2A;RPS26;RPL23;RPL17;RPS25;RPL35A;CHMP4A;CHMP4B;RPS28;RPLP2;RPL28;RPL27A;RPL11;RPS2;RPL32;SRP14;RPL21;SPCS3;SEC63;RPL9;RPL36;RPL37;RPL38;RPS18;RPS19;RPS27;RPS23;RPL14;RPS16;SRP9;RPL30;RPL31;RPL12;RPL13A;RPS9;RPL4;GET3;RPS3;RPS13;RPSA;RPL15
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.4871558539246491,-1.801118931508242,0.0,0.38896226666311606,0.965,15/34,19.58%,MEF2C;GRIN2A;LRRK2;GABRG3;GRID2;GABRA2;GRIN2B;GABRA1;GRIN1;MPP2;GLRA1;ARRB2;GABRE;GABRG2;NLGN3
prerank,positive chemotaxis (GO:0050918),0.7633958644615088,1.789965848668933,0.0,0.07134926843181383,0.585,7/17,10.20%,LGALS3;GPNMB;FPR2;NRP1;VEGFA;ANGPT1;FGF7
prerank,granulocyte chemotaxis (GO:0071621),0.6366940188316108,1.7897337687812915,0.0,0.06746273596966222,0.588,17/55,19.39%,LGALS3;S100A8;S100A9;ANXA1;CXCR2;CCL4;CCL13;PIP5K1C;JAML;CCL7;CCL5;CCL14;PPIA;ITGB2;SYK;FCER1G;PIKFYVE
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.7904559186942931,1.7861638009022476,0.0013404825737265416,0.06762746185105319,0.617,6/14,11.70%,IGF1;PTPRC;CST7;CD200R1;TREM2;TNFRSF1B
prerank,cholesterol efflux (GO:0033344),0.7230676721708031,1.782597492850129,0.0012690355329949238,0.06845275515579982,0.634,9/20,13.76%,APOE;ABCG1;ABCA1;APOA2;SOAT1;APOC1;SOAT2;ABCA7;NPC1
prerank,regulation of platelet activation (GO:0010543),0.7246507811392267,1.7771723378660635,0.0011737089201877935,0.0733179922991046,0.681,7/21,7.55%,APOE;PLEK;PRKCQ;TEC;PDGFA;HRG;TXK
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.6257482835500293,-1.7740316514081922,0.01838235294117647,0.4341976975571495,0.984,5/13,10.44%,SCAMP5;SYT10;KCNB1;SYT1;STX1A
prerank,regulation of T cell proliferation (GO:0042129),0.6255340394797614,1.7706089158593614,0.0,0.07856226535938778,0.72,21/61,18.40%,LGALS3;GPNMB;CD3E;PTPRC;ANXA1;SLC7A1;SPN;CD6;CD28;NCK2;IL27;CD274;NCK1;LILRB1;CCL5;TNFRSF1B;TNFSF8;TFRC;TNFSF9;RIPK3;IL6
prerank,"wound healing, spreading of cells (GO:0044319)",0.7057367104802927,1.7694175822215197,0.0012300123001230013,0.07642139938054818,0.724,8/24,2.96%,LCP1;MMP12;ARHGAP24;FLNA;MRTFA;ITGA5;PDPN;CD44
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.6273548427924576,-1.767069511354842,0.013100436681222707,0.41925204044949804,0.988,8/15,13.34%,GRM7;GRIK3;GRM1;GRM5;GRM3;HOMER3;GRM8;DAGLB
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.5756282681044287,-1.7637481268861432,0.009523809523809525,0.39735993641806755,0.989,10/17,26.28%,CACNA2D1;NOS1AP;SNTA1;KCNH2;KCNQ1;ANK2;SCN4B;KCNE3;KCNE4;GJA5
prerank,negative regulation of lipid storage (GO:0010888),0.7289583402978914,1.7621184059939998,0.0,0.08350104678509136,0.764,8/19,9.58%,OSBPL8;ABCG1;ABCA1;PPARG;TREM2;PPARD;ABHD5;PTPN2
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.7045560662667694,1.7605450783030698,0.003708281829419036,0.08208427398704102,0.774,8/21,10.78%,IGF1;NR4A3;MEF2D;MMP9;FGF2;ERN1;DNMT1;JUN
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.7257196553599,1.7599037077423658,0.0024125452352231603,0.07985211892761276,0.779,9/21,8.10%,LCK;STAP1;PRKCH;PTPRC;KCNN4;CD226;TESPA1;TRAT1;PRKCB
prerank,neuron projection regeneration (GO:0031102),-0.6924451735587963,-1.759540506564278,0.04,0.3810482375385646,0.991,3/10,4.25%,GAP43;RTN4RL1;NREP
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.6616035037694086,1.7557503969985684,0.0,0.08240127690060478,0.805,12/37,9.98%,BCL2;S100A8;S100A9;LCK;BCL2L1;CAV1;BID;RPS7;NCK1;BCL2L11;RACK1;BAX
prerank,proteoglycan biosynthetic process (GO:0030166),0.6717703438585505,1.7552790208020053,0.0,0.08021113687423409,0.807,5/31,2.58%,IGF1;XYLT1;CHST11;HS3ST3B1;B4GALT7
prerank,neutrophil chemotaxis (GO:0030593),0.6267218638808737,1.7550141649457005,0.0,0.07765521920980266,0.809,16/53,19.39%,LGALS3;S100A8;S100A9;CXCR2;CCL4;CCL13;PIP5K1C;JAML;CCL7;CCL5;CCL14;PPIA;ITGB2;SYK;FCER1G;PIKFYVE
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.6293626304385073,1.7405931650874102,0.0,0.0972118022894378,0.87,16/49,9.98%,BCL2;S100A8;S100A9;LCK;BCL2L1;PLAUR;MCL1;SGMS1;MMP9;CAV1;BID;NOC2L;BCL2L11;P4HB;RACK1;BAX
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.6579987197711805,1.7380182094821774,0.0011325028312570782,0.09779243704645896,0.883,15/33,15.86%,LGALS3;LCK;DGKZ;KCNN4;CD226;SH2D1A;TESPA1;PTPN22;TRAT1;CD300A;PTPN2;PHPT1;PRKD2;UBASH3A;DUSP3
prerank,regulation of cell-matrix adhesion (GO:0001952),0.6076355572076614,1.7360863808645859,0.0,0.09724817034117346,0.888,26/64,16.42%,PLAU;PEAK1;CDK6;SKAP1;CD3E;CORO1C;CSF1;SLC9A1;PTPRA;MACF1;PIK3CB;PTK2B;JAG1;ACTG1;HOXA7;JUP;MYOC;RHOA;CCL28;UTRN;ROCK1;ADAM15;DUSP3;NF1;RASA1;MINK1
prerank,high-density lipoprotein particle assembly (GO:0034380),0.8165007508641059,1.735198081624882,0.0,0.09535937797683722,0.894,4/10,3.99%,APOE;ABCA1;APOA2;BMP1
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.7429741548669426,1.7339672048247137,0.0,0.0940341437690339,0.896,9/16,19.60%,LYST;PLEKHM2;GZMB;ARL8B;KLRK1;CEBPG;VAMP2;TUBB;SLAMF7
prerank,defense response to bacterium (GO:0042742),0.5798901817494255,1.7333772509305199,0.0,0.0920486410051469,0.897,39/105,21.73%,LYST;COLEC12;S100A8;S100A9;CAMP;LCN2;FPR2;LTF;FGR;SPN;OPTN;RNASE3;PRKCD;ADGRB1;TREM2;DMBT1;ADAM17;DEFB130A;SERPINE1;MPEG1;MBL2;RPS19;SYK;TIRAP;GBP2;RAB1A;ANXA3;RNASE7;RPL30;CFP;PGLYRP2;IL6;JCHAIN;RNASE6;FCER1G;SLC11A1;EPX;LBP;LYZL4
prerank,myotube cell development (GO:0014904),0.8187843060991209,1.7326964404114993,0.0,0.09023983284199436,0.901,2/10,2.79%,IGF1;SELENON
prerank,natural killer cell mediated immunity (GO:0002228),0.7478229335216194,1.731866050379848,0.0,0.08926174618002099,0.905,9/15,19.60%,LYST;PLEKHM2;KLRC2;GZMB;ARL8B;KLRK1;CEBPG;TUBB;SLAMF7
prerank,primary alcohol metabolic process (GO:0034308),0.6806480534346177,1.7305198392729957,0.0,0.08847942897824043,0.908,9/25,14.76%,IGF1;GPD2;RDH12;DHRS3;GDPD3;DHRS9;NAPEPLD;RBP4;CYP1B1
prerank,amino acid transport (GO:0006865),0.622393085372826,1.7295174876105048,0.0010869565217391304,0.08773939919277232,0.913,21/49,20.39%,SLC3A2;SLC38A1;SLC6A6;SLC38A6;SLC7A1;PDPN;SLC7A11;SLC6A19;SLC6A14;SLC36A4;SLC36A3;SLC16A10;SLC7A6;SLC1A5;SLC38A11;SLC7A8;SLC43A2;SLC38A7;SLC38A10;SLC38A2;SLC25A44
prerank,regulation of postsynapse organization (GO:0099175),-0.49678213522497267,-1.725017601372118,0.019736842105263157,0.45300608473357656,0.999,13/28,10.20%,TANC2;IL1RAPL1;CDKL5;ABI3;EPHA4;ARHGAP44;LRRK2;SIPA1L1;PDLIM5;SHANK3;PPFIA2;FCGR2B;WNT5A
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.7942083533344448,1.7245468295352795,0.0013020833333333333,0.09239782070442713,0.921,4/12,2.96%,LCK;SKAP1;GCNT2;CD44
prerank,T cell differentiation (GO:0030217),0.6207656535052634,1.7239285087205196,0.0,0.09094250967869706,0.922,17/40,20.52%,LCK;TCF7;PTPRC;ANXA1;CD4;CD8A;CD28;PTPN22;GATA3;ADAM17;PTPN2;DLL4;RIPK3;FCER1G;IL2;GPR89A;GPR89B
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.5758747577808969,-1.721624634012405,0.004545454545454545,0.43440822387692063,0.999,8/17,17.22%,NLGN1;SCAMP5;SYT10;KCNB1;RAB3A;STX1A;RAB15;CACNA1G
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.6623656381025261,1.716958035255325,0.002325581395348837,0.09936115414701571,0.942,11/32,18.75%,S100A9;CAMP;LTF;HRG;RNASE3;CXCL14;CCL13;RPS19;RNASE7;RPL30;RNASE6
prerank,negative regulation of blood coagulation (GO:0030195),0.6395425439427762,1.7148210116269804,0.0,0.10029066832784024,0.945,14/38,19.36%,PLAU;APOE;PLAUR;PDGFA;HRG;A2M;TFPI;F11;SERPINE2;SERPINE1;KLKB1;APOH;SERPINF2;F8
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.6993764725187576,1.713284958794414,0.00245398773006135,0.1004970496295597,0.95,4/20,6.39%,IGF1;NIBAN2;TRIM6;GATA3
prerank,regulation of immune response (GO:0050776),0.5647486308071549,1.7130826639288943,0.0,0.09856249481552756,0.951,44/135,17.46%,COLEC12;CD3E;CD96;CD247;CD300LF;CD8B;ITGAL;PDCD1;CD226;FGR;CD300LB;CD8A;KLRC1;SPN;SH2D1A;GPR151;CD3G;ADCY7;NCR1;ITGA4;TRAF3;CD22;BCL6;PTPN22;CD200R1;SELL;TREM2;IFITM1;LILRB1;CD300A;KLRK1;B2M;C3;FCRLB;JAML;CRTAM;TREML4;RSAD2;ITGB2;SYK;APPL2;TIRAP;SPINK5;RIPK3
prerank,mucosal immune response (GO:0002385),0.7486620119639069,1.7115887536580765,0.0025477707006369425,0.09847476554062186,0.955,3/15,4.43%,CAMP;LTF;RNASE3
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.6738134264136666,1.7094203683269429,0.0011695906432748538,0.09913769267357322,0.96,7/26,9.58%,GPR137B;CDK6;FSTL3;TCTA;LILRB3;HOXA7;PTPN2
prerank,regulation of smooth muscle cell migration (GO:0014910),0.7064998226397571,1.7082186663040242,0.0012690355329949238,0.09919623293849267,0.967,8/20,11.65%,PLAU;IGF1;LRP1;PDGFA;NRP1;S100A11;SERPINE1;CCL5
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.5410704305732037,-1.7066646253075841,0.014634146341463415,0.4553167797356206,1.0,12/18,19.58%,NRXN1;NLGN1;RIMS1;SHANK3;RIMS2;GRIN1;PRKCZ;CUX2;CHRNA7;SHANK1;NLGN2;NLGN3
prerank,acylglycerol metabolic process (GO:0006639),0.6259580020931278,1.7057282529088604,0.0,0.10144055553912758,0.97,16/37,17.10%,LPL;APOE;DGKZ;PLAAT3;GK;APOA2;ABHD12;CAV1;MGLL;APOBR;APOC1;LYPLA2;DGKA;DGKH;APOH;DGKD
prerank,fibrinolysis (GO:0042730),0.7746908346737478,1.704937895406608,0.002621231979030144,0.10062130713965659,0.971,4/13,11.33%,PLAU;PLAUR;HRG;SERPINE1
prerank,ganglion development (GO:0061548),0.7857399344334378,1.7040362278113346,0.0013297872340425532,0.10000175140115967,0.973,3/11,4.62%,CTNNB1;NRP2;NRP1
prerank,positive regulation of monooxygenase activity (GO:0032770),0.6677249329389598,1.7016668766211447,0.0011682242990654205,0.10203420594958723,0.977,7/26,5.53%,APOE;HIF1A;ATP7A;PIK3CB;CYP27B1;VDR;POR
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.44380056575132637,-1.700880243415777,0.0,0.4484473055858831,1.0,18/46,11.48%,OPHN1;MEF2C;GRM7;NRXN1;NLGN1;TSHZ3;GRIK3;CACNG3;LRRK2;GRM1;GRM5;SYT1;GRM3;CDH2;SHANK3;CACNG8;CCL2;GRM8
prerank,cellular response to oxygen levels (GO:0071453),0.8088471968488233,1.6986364671688747,0.0013908205841446453,0.1053247302227061,0.979,6/10,9.19%,ATP6V1A;ATP6V0D1;CPEB4;ATP6V1G1;TMEM199;ATP6AP1
prerank,natural killer cell activation (GO:0030101),0.675257364042179,1.6986277529142584,0.0,0.10329925464150021,0.979,14/23,21.36%,ELF4;PTPRC;CD2;AXL;NFIL3;NCR1;PRDX1;RASGRP1;KLRK1;TOX;KAT7;SLAMF7;IL2;PBX1
prerank,neurotransmitter transport (GO:0006836),-0.3931001335329878,-1.6981211939337657,0.015625,0.43274049869167364,1.0,25/73,11.67%,SNAP25;NRXN1;SYN2;CASK;PPFIA4;SLC1A3;CPLX1;RIMS1;LIN7A;RAB3A;GABRA2;SNAPIN;GAD2;UNC13B;SYT1;APBA1;STXBP3;PPFIA2;GLUL;TSPOAP1;SLC32A1;STXBP1;STX1A;BRSK1;GAD1
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.5734966060152888,-1.6921946108652102,0.023255813953488372,0.4288616255691955,1.0,5/17,8.98%,FCHSD2;WASF2;CTNNA2;NCKAP1;ARF1
prerank,steroid catabolic process (GO:0006706),0.7908384191636723,1.6909885412031593,0.005390835579514825,0.11468424948463189,0.991,3/10,4.08%,SPP1;CYP19A1;CYP27B1
prerank,neurotransmitter secretion (GO:0007269),-0.4410975343052097,-1.6905281496199438,0.011904761904761904,0.41282915384352026,1.0,19/44,13.03%,SNAP25;NRXN1;SYN2;CPLX1;SYT10;RIMS1;LIN7A;RAB3A;SNAPIN;GAD2;SYT1;STXBP3;RIMS2;SLC32A1;STXBP1;STX1A;BRSK1;GAD1;SYN1
prerank,negative regulation of anoikis (GO:2000811),0.7393176290757019,1.6901816170821617,0.003947368421052632,0.114069067751359,0.992,4/14,5.32%,BCL2;ITGA5;MCL1;CAV1
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.6736112429085315,1.6894934885563608,0.0024154589371980675,0.11306893408349288,0.992,5/25,6.39%,IGF1;NIBAN2;TRIM6;DOT1L;GATA3
prerank,eosinophil migration (GO:0072677),0.7586702595204134,1.6892936947415225,0.0,0.1094231732046822,0.992,5/14,11.65%,LGALS3;CCL4;CCL13;CCL7;CCL5
prerank,eosinophil chemotaxis (GO:0048245),0.7586702595204134,1.6892936947415225,0.0,0.1094231732046822,0.992,5/14,11.65%,LGALS3;CCL4;CCL13;CCL7;CCL5
prerank,cellular response to increased oxygen levels (GO:0036295),0.7738155800348312,1.688131180289238,0.0,0.10911669591449595,0.992,7/11,9.19%,ATG7;ATP6V1A;ATP6V0D1;ATP6V1G1;CAV1;TMEM199;ATP6AP1
prerank,neutrophil activation involved in immune response (GO:0002283),0.5413678927695719,1.6879190736817558,0.0,0.1076642269213311,0.993,176/428,20.31%,LGALS3;PLAU;IQGAP1;S100A8;CTSB;S100A9;FTL;CYBA;CAMP;ITGAX;LCN2;CTSD;GALNS;ANPEP;TBC1D10C;MMP8;CTSZ;TCIRG1;SDCBP;IGF2R;ATG7;FPR2;SIRPA;FABP5;OLR1;PLAUR;DOCK2;PTPRC;PSMD1;ITGAL;LTF;PKM;CTSA;FGR;COTL1;CYBB;CXCR2;GNS;ALDOA;ATP6V0A1;ADAM8;ARPC5;CCT2;CD44;PRDX6;RETN;TARM1;PKP1;ATP8B4;DNAJC5;MMP9;RNASE3;PSAP;PRKCD;C3AR1;MAGT1;TOM1;EEF2;DYNC1H1;S100A11;CAP1;DERA;GLB1;GYG1;SYNGR1;GAA;EEF1A1;CRACR2A;SELL;UBR4;LRG1;RAB5C;VAT1;HP;CAPN1;PDXK;MOSPD2;DPP7;CD53;PLEKHO2;CSTB;PSMD6;LILRB3;PFKL;ABCA13;MVP;CD300A;LAMP2;CDK13;VCP;B2M;NHLRC3;PSMC3;JUP;ARSA;NRAS;GLA;C3;ERP44;RHOG;RAB7A;CD63;HRNR;DIAPH1;HUWE1;FUCA1;TNFRSF1B;GUSB;ADGRE5;GSN;RHOA;SRP14;TMBIM1;IQGAP2;HSPA8;ALDOC;ROCK1;PSMD14;NEU1;CPNE3;PRG2;PSMD2;CAB39;CCT8;PPIA;MGAM;GCA;NFKB1;APRT;MCEMP1;ACP3;APAF1;ITGB2;TIMP2;ARL8A;CAT;QPCT;SYK;PLAC8;CKAP4;ANXA3;GGH;C5AR1;PPIE;VAMP2;CLEC12A;ARHGAP9;HK3;TUBB;CFP;GPI;RAB37;GPR84;ATP6V0C;PSMA5;ANO6;ORMDL3;ASAH1;ALDH3B1;DDOST;NPC2;FCER1G;BST2;AGA;GLIPR1;SLC11A1;CLEC4D;VPS35L;OSTF1;B4GALT1;CYB5R3;FTH1;HMGB1;TMC6;AGPAT2;CYSTM1
prerank,secretory granule organization (GO:0033363),0.8046802379932831,1.6873907996119717,0.004081632653061225,0.10666749574071119,0.993,4/10,8.41%,LYST;ABCA1;BLOC1S3;DTNBP1
prerank,neutrophil degranulation (GO:0043312),0.5411137558811404,1.6872320647067194,0.0,0.10518594478065987,0.993,175/425,20.31%,LGALS3;PLAU;IQGAP1;S100A8;CTSB;S100A9;FTL;CYBA;CAMP;ITGAX;LCN2;CTSD;GALNS;ANPEP;TBC1D10C;MMP8;CTSZ;TCIRG1;SDCBP;IGF2R;ATG7;FPR2;SIRPA;FABP5;OLR1;PLAUR;DOCK2;PTPRC;PSMD1;ITGAL;LTF;PKM;CTSA;FGR;COTL1;CYBB;CXCR2;GNS;ALDOA;ATP6V0A1;ADAM8;ARPC5;CCT2;CD44;PRDX6;RETN;TARM1;PKP1;ATP8B4;DNAJC5;MMP9;RNASE3;PSAP;PRKCD;C3AR1;MAGT1;TOM1;EEF2;DYNC1H1;S100A11;CAP1;DERA;GLB1;GYG1;SYNGR1;GAA;EEF1A1;CRACR2A;SELL;UBR4;LRG1;RAB5C;VAT1;HP;CAPN1;PDXK;MOSPD2;DPP7;CD53;PLEKHO2;CSTB;PSMD6;LILRB3;PFKL;ABCA13;MVP;CD300A;LAMP2;CDK13;VCP;B2M;NHLRC3;PSMC3;JUP;ARSA;NRAS;GLA;C3;ERP44;RHOG;RAB7A;CD63;HRNR;DIAPH1;HUWE1;FUCA1;TNFRSF1B;GUSB;ADGRE5;GSN;RHOA;SRP14;TMBIM1;IQGAP2;HSPA8;ALDOC;ROCK1;PSMD14;NEU1;CPNE3;PRG2;PSMD2;CAB39;CCT8;PPIA;MGAM;GCA;NFKB1;APRT;MCEMP1;ACP3;APAF1;ITGB2;TIMP2;ARL8A;CAT;QPCT;PLAC8;CKAP4;ANXA3;GGH;C5AR1;PPIE;VAMP2;CLEC12A;ARHGAP9;HK3;TUBB;CFP;GPI;RAB37;GPR84;ATP6V0C;PSMA5;ANO6;ORMDL3;ASAH1;ALDH3B1;DDOST;NPC2;FCER1G;BST2;AGA;GLIPR1;SLC11A1;CLEC4D;VPS35L;OSTF1;B4GALT1;CYB5R3;FTH1;HMGB1;TMC6;AGPAT2;CYSTM1
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.4586280443172698,-1.6862920068309366,0.0,0.40614121435643685,1.0,14/31,12.97%,TANC2;NLGN1;ABI3;EPHA4;ARHGAP44;LRRK2;SIPA1L1;PDLIM5;SHANK3;PPFIA2;LRP8;DBN1;CUX2;CAMK2B
prerank,leukotriene biosynthetic process (GO:0019370),-0.5931677780035237,-1.6857101111921953,0.017241379310344827,0.3903689307517838,1.0,3/14,3.78%,LTC4S;ALOX5;GGT5
prerank,proteoglycan metabolic process (GO:0006029),0.6628864093507616,1.6851237756773787,0.003575685339690107,0.10670855644428373,0.994,4/26,2.58%,IGF1;XYLT1;CHST11;B4GALT7
prerank,neutrophil mediated immunity (GO:0002446),0.5399704360874134,1.6848017758812446,0.0,0.10566131297602441,0.994,177/432,20.31%,LGALS3;PLAU;IQGAP1;S100A8;CTSB;S100A9;FTL;CYBA;CAMP;ITGAX;LCN2;CTSD;GALNS;ANPEP;TBC1D10C;MMP8;CTSZ;TCIRG1;SDCBP;IGF2R;ATG7;FPR2;SIRPA;FABP5;OLR1;PLAUR;DOCK2;PTPRC;PSMD1;ITGAL;LTF;PKM;CTSA;FGR;COTL1;CYBB;CXCR2;GNS;ALDOA;ATP6V0A1;ADAM8;ARPC5;CCT2;CD44;PRDX6;RETN;TARM1;PKP1;ATP8B4;DNAJC5;MMP9;RNASE3;PSAP;PRKCD;C3AR1;MAGT1;TOM1;EEF2;DYNC1H1;S100A11;CAP1;DERA;GLB1;GYG1;SYNGR1;GAA;EEF1A1;CRACR2A;SELL;UBR4;LRG1;RAB5C;VAT1;HP;CAPN1;PDXK;MOSPD2;DPP7;CD53;PLEKHO2;CSTB;PSMD6;LILRB3;ADAM17;PFKL;ABCA13;MVP;CD300A;LAMP2;CDK13;VCP;B2M;NHLRC3;PSMC3;JUP;ARSA;NRAS;GLA;C3;ERP44;RHOG;RAB7A;CD63;HRNR;DIAPH1;HUWE1;FUCA1;TNFRSF1B;GUSB;ADGRE5;GSN;RHOA;SRP14;TMBIM1;IQGAP2;HSPA8;ALDOC;ROCK1;PSMD14;NEU1;CPNE3;PRG2;PSMD2;CAB39;CCT8;PPIA;MGAM;GCA;NFKB1;APRT;MCEMP1;ACP3;APAF1;ITGB2;TIMP2;ARL8A;CAT;QPCT;PLAC8;CKAP4;ANXA3;GGH;C5AR1;PPIE;VAMP2;CLEC12A;ARHGAP9;HK3;TUBB;CFP;GPI;RAB37;GPR84;ATP6V0C;PSMA5;ANO6;IL6;ORMDL3;ASAH1;ALDH3B1;DDOST;NPC2;FCER1G;BST2;AGA;GLIPR1;SLC11A1;CLEC4D;VPS35L;OSTF1;B4GALT1;CYB5R3;FTH1;HMGB1;TMC6;AGPAT2;CYSTM1
prerank,positive regulation of calcium ion import (GO:0090280),0.7772488367690116,1.6840171335321217,0.003978779840848806,0.10515594859044755,0.994,2/12,2.90%,LGALS3;SPHK2
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.5731865617387955,1.683708467426868,0.0,0.10411781555979682,0.994,50/86,32.79%,HIF1A;ATF3;PSMD8;NFE2L2;PSMD1;UBA52;RPS27A;MUC1;VEGFA;PSMD6;PSMA1;PSMC3;HMOX1;PSMA8;PSMD14;PSMD2;STOX1;DDIT3;INO80;PSMC6;PSMA6;DNAJB1;PSMD5;ELOB;PSMA5;EGLN1;UBC;EPO;VHL;EGLN3;CUL2;MAPK7;BAG3;PSMA3;ATF4;PSMB8;PSMB10;PSMD7;PSMB6;PSMD10;PSMB5;PSMB7;PSMC4;EP300;PSMD12;CREBBP;PSMD3;UBB;ARNT;EPAS1
prerank,regulation of fibroblast proliferation (GO:0048145),0.6087801618716527,1.6829286358183686,0.001122334455667789,0.10363572270056515,0.994,22/45,25.22%,IGF1;CTNNB1;FN1;CDK6;NLRC3;B4GALT7;PDGFA;SPHK1;S100A6;PEX2;CD300A;GAS6;NF1;DDR2;BMI1;DHX9;FTH1;CD74;MIF;PDGFRA;CDK4;SFRP1
prerank,Rac protein signal transduction (GO:0016601),-0.5406733636089408,-1.6815490884393076,0.014925373134328358,0.3849482314994807,1.0,7/18,11.54%,ELMO1;EPS8;NCKAP1;FARP2;AIF1;TIAM1;CDH13
prerank,neutral amino acid transport (GO:0015804),0.6450615928145816,1.6785872873062548,0.0035460992907801418,0.10946023642996502,0.995,13/28,19.43%,SLC3A2;SLC38A1;SLC6A6;SLC38A6;SLC6A14;SLC36A4;SLC36A3;SLC6A7;SLC1A5;LLGL2;SLC7A8;SLC43A2;SLC38A2
prerank,regulation of amyloid-beta clearance (GO:1900221),0.7280532039366604,1.6779914051837939,0.002570694087403599,0.10886883251929953,0.996,9/16,15.51%,APOE;LRP1;TREM2;HDAC1;LRPAP1;ABCA7;ROCK1;CLU;SRF
prerank,neuron cell-cell adhesion (GO:0007158),-0.6003863740381229,-1.6776346809290703,0.01680672268907563,0.3794189545442441,1.0,7/14,10.31%,NRXN3;NRXN1;NLGN1;ASTN2;CNTN4;NCAM2;RET
prerank,intracellular pH reduction (GO:0051452),0.6452771896013462,1.6767104642373778,0.0011325028312570782,0.1090029571499973,0.996,19/33,20.52%,TCIRG1;ATP6V1C1;ATP6V0D2;DMXL2;ATP6V1A;ATP6V0A1;ATP6V1B2;ATP6V0D1;ATP6V0B;ATP6V1G1;RAB7A;ATP6V1F;DMXL1;ATP6V0C;SLC11A1;ATP6V0A4;ATP6V1E1;GPR89A;GPR89B
prerank,integrin-mediated signaling pathway (GO:0007229),0.5792086443519086,1.6759683551429108,0.0,0.10888594689658689,0.996,33/73,21.74%,FN1;PLEK;PTPRA;FGR;LAT;ITGA5;TEC;ADAMTS13;PTK2B;NRP1;NEDD9;DAB2;PLPP3;ERBIN;TXK;ILK;PRAM1;FBLN1;CDC42;ADAM15;ITGB2;LAMA5;SYK;ITGA11;ZYX;ITGB1BP1;FERMT2;CUL3;COL16A1;DST;ITGA2B;LAMA3;CD47
prerank,regulation of mast cell activation (GO:0033003),0.7865521185348913,1.6759422879335184,0.006793478260869565,0.10739536900150533,0.996,4/10,5.10%,CD84;CD300LF;CD226;MILR1
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.6159749105295201,1.6753896687114502,0.0022123893805309734,0.10659678008455853,0.996,24/42,27.54%,CDK6;SKAP1;CD3E;CSF1;HRG;PTK2B;NRP1;VEGFA;RIN2;JUP;MYOC;CCL28;UTRN;ROCK1;EFEMP2;KDR;FERMT2;COL16A1;GSK3B;GFUS;SFRP1;CX3CL1;LIMS1;S100A10
prerank,regulation of cytoplasmic translation (GO:2000765),0.7369560647752469,1.6732346273001137,0.001282051282051282,0.10883313849269674,0.996,9/14,18.62%,PKM;UNK;CPEB4;CPEB2;CPEB3;YBX3;DHX36;CNBP;DHX9
prerank,vesicle transport along actin filament (GO:0030050),0.6869398126416414,1.6730027068534135,0.008816120906801008,0.1076651598626491,0.996,4/19,3.44%,MYO1E;MYO5A;MYO1F;MYO1A
prerank,androgen metabolic process (GO:0008209),0.690134719125564,1.6726046018133869,0.0075,0.10686776247893562,0.996,4/18,7.89%,SPP1;CYP19A1;DHRS9;SRD5A3
prerank,maturation of 5.8S rRNA (GO:0000460),0.7136729897079918,1.6722286743232888,0.0012903225806451613,0.10617174177231449,0.996,8/17,12.33%,C1D;EIF6;NSA2;EXOSC4;WDR12;MAK16;EXOSC10;FTSJ3
prerank,endosome organization (GO:0007032),0.606679905031427,1.6694091542101304,0.0033112582781456954,0.10959347081217168,0.996,22/41,26.88%,CORO1C;EEA1;ALS2;SQSTM1;WASHC5;PI4K2A;SNX33;HOOK1;VPS18;SNX10;ARFGEF2;PLEKHF1;VPS11;ALS2CL;RAB22A;HOOK3;LAPTM4B;USP50;USP8;PLEKHJ1;RILP;PI4K2B
prerank,sympathetic nervous system development (GO:0048485),0.7286893991855544,1.6687256304783347,0.002617801047120419,0.1094547805262986,0.996,4/15,6.39%,CTNNB1;NRP2;NRP1;GATA3
prerank,neutrophil migration (GO:1990266),0.5898292086975686,1.6680704208415784,0.0010695187165775401,0.10903602265438217,0.996,16/58,19.39%,LGALS3;S100A8;S100A9;CXCR2;CCL4;CCL13;PIP5K1C;JAML;CCL7;CCL5;CCL14;PPIA;ITGB2;SYK;FCER1G;PIKFYVE
prerank,carboxylic acid transmembrane transport (GO:1905039),0.6177345758555978,1.667076357930011,0.002224694104560623,0.10926417463463782,0.996,19/40,19.43%,SLC27A1;SLC38A1;SLC38A6;SLC7A11;SLC23A1;SLC23A2;SLC6A14;SLC36A4;SLC36A3;SLC7A6;SLC38A11;SLC25A14;SLC7A8;SLC25A21;SLC38A7;SLC19A1;SLC13A3;SLC38A10;SLC38A2
prerank,ribosomal small subunit biogenesis (GO:0042274),0.6191445082205239,1.6665941590176692,0.002277904328018223,0.10873239290036964,0.998,22/39,23.44%,RPS6;RPS14;RRP7A;RPS24;METTL17;RPS7;RPS25;RIOK2;RPS28;RIOK3;LSM6;MRPS7;RPS19;RPS27;DDX52;RPS16;UTP4;SRFBP1;NPM1;RPSA;WDR3;SNU13
prerank,positive regulation of DNA binding (GO:0043388),0.6407719485574891,1.6639234135005991,0.0011614401858304297,0.11154170169894267,0.999,8/31,6.39%,IGF1;MMP8;NIBAN2;PLAUR;TRIM6;MMP9;PPARG;GATA3
prerank,transferrin transport (GO:0033572),0.6326623736497342,1.6637512292711025,0.0,0.11055361924485134,0.999,18/33,21.03%,TCIRG1;ATP6V1C1;ATP6V0D2;ATP6V1A;ATP6V0A1;ATP6V1B2;ATP6V0D1;ATP6V0B;ATP6V1G1;REP15;ATP6AP1;DNM2;ATP6V1F;TFRC;ATP6V0C;ATP6V0A4;ATP6V1E1;LMTK2
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.6977816634859434,1.6635224099474908,0.005037783375314861,0.10958906256347643,0.999,8/17,15.86%,LGALS3;DGKZ;SH2D1A;PTPN22;PTPN2;PHPT1;UBASH3A;DUSP3
prerank,positive regulation of phospholipase activity (GO:0010518),0.673840716128406,1.6631111804928083,0.008526187576126675,0.10889878267955243,0.999,8/22,11.65%,FLT1;ABL2;GNA13;FGF2;PDPK1;ARL1;PLAA;CCL5
prerank,wound healing (GO:0042060),0.5791279728710905,1.6597894755381195,0.0021645021645021645,0.11304374555548315,0.999,17/62,11.10%,IGF1;MYOF;AHNAK2;MMP12;MACF1;PDGFA;NRG1;FER1L5;RAF1;FGF2;ARL8B;DCBLD2;ANXA6;EVPL;HMOX1;PLEC;JAML
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.7495062869318179,1.6589448512857474,0.008207934336525308,0.11335963528365708,0.999,6/12,12.95%,APOC4;SOAT1;P4HB;APOC1;SOAT2;LPCAT3
prerank,negative regulation of platelet activation (GO:0010544),0.7159627318894133,1.6588423877906815,0.006418485237483954,0.11221031744387899,0.999,5/16,10.39%,CD9;APOE;PDGFA;PRKCD;SERPINE2
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.6678763999979271,1.6587780353641066,0.0012091898428053204,0.11110971023979475,0.999,10/22,16.32%,RAB7B;LTF;WDFY1;MFHAS1;PTPN22;TREM2;ACOD1;APPL2;TIRAP;NINJ1
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.706933187140516,1.6581898038895877,0.008974358974358974,0.11062191523276939,0.999,4/15,11.04%,APOE;ABCG1;APOA2;APOC1
prerank,positive regulation of lipid transport (GO:0032370),0.7543846502783131,1.656983603349762,0.006596306068601583,0.11123028746231681,0.999,5/12,10.98%,SPP1;APOE;LRP1;CYP19A1;TRIAP1
prerank,cellular potassium ion homeostasis (GO:0030007),0.7357466337952776,1.6562530264036095,0.0039164490861618795,0.11136055563425294,0.999,6/13,7.31%,ATP1B3;KCNJ2;KCNMA1;ATP1A4;ATP1A3;ATP1A1
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.6644795716081611,1.6525535332759902,0.004860267314702308,0.11622916491263371,0.999,10/22,15.86%,LGALS3;DGKZ;SH2D1A;CD22;PTPN22;CD300A;PTPN2;PHPT1;UBASH3A;DUSP3
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.668731997509142,1.652239120462074,0.0012531328320802004,0.11556683537926239,0.999,8/21,11.05%,STAP1;PRKCH;CD22;RUNX1;PTPN22;PRKCB;CD300A;ELF2
prerank,regulation of cholesterol storage (GO:0010885),0.7170935065480958,1.6517790376709778,0.006493506493506494,0.11527217678137001,0.999,6/15,8.86%,LPL;ABCG1;ABCA1;PPARG;TREM2;PPARD
prerank,translation (GO:0006412),0.5328285104066709,1.6504682323395294,0.0,0.11610803583709475,1.0,95/208,23.77%,EPRS1;RPS12;MRPS12;AARS1;UBA52;AGO2;RPS27A;TNIP1;RPS6;EIF4G1;MRPL47;RPS14;MRPL51;RPL10A;RPL18;EEF2;VARS1;RPS24;IGHMBP2;RPS7;RPL41;RPL36A;RPS20;CARS1;RPS26;EEF1A1;RPL23;RPL17;MRPL23;ETF1;RPS25;RPL35A;RPS28;RPLP2;RPL28;LARS2;GARS1;RPL27A;EEF1D;RPL11;RPS2;TMA7;GTPBP2;MRPL52;RARS1;RPL32;DRG1;RWDD1;MRPS15;RPL21;MRPL24;RPL9;RPL36;RPL37;MRPS33;MRPS16;RPL38;RPS18;MRPS7;RPS19;RPS27;FARSA;RPS23;RPL14;RPS16;SARS2;SARS1;MRPL11;GATB;RPL30;RPL31;RPL12;GSPT1;DRG2;FARSB;RPL13A;FARS2;RPS9;RPL4;NARS1;RRBP1;RPS3;MRPS28;RPS13;PABPC4;YARS1;RPSA;RPL15;GFM2;MRPS14;LARS1;TARS1;TRMT112;MRPL37;AIMP2
prerank,rRNA processing (GO:0006364),0.5344518162623252,1.6504326529884619,0.0,0.11500552772575758,1.0,86/172,27.03%,C1D;UBA52;ESF1;EIF6;RPS6;RPS14;RPL10A;RPL18;NSA2;RRP7A;RPS24;EXOSC4;RPS7;RPL41;RPL36A;RPL23;RPL17;RPS25;WDR12;RIOK2;MAK16;RPL35A;RPS28;RRP12;RPLP2;RPL28;NOL8;XRN2;RPL27A;RPL11;RPS2;DDX49;BMS1;NOLC1;WDR43;MRM2;NOL6;UTP11;UTP20;NVL;RIOK3;RPL32;EXOSC9;RPL21;EXOSC10;RPL9;RPL36;RPL37;RPL38;LSM6;SART1;RPS19;RPS27;MDN1;DDX52;RPL14;RPS16;UTP4;RPL30;RPL31;UTP14A;RPL12;RPL13A;KRR1;RPS9;LYAR;NOC4L;RPL4;EXOSC5;SRFBP1;RRP9;DKC1;RPL15;WDR3;MRPL1;SNU13;RPL7A;RRP1B;RRP1;RPL23A;RPL8;RPLP1;NAT10;RPL29;PIH1D1;RPL37A
prerank,regulation of ATP metabolic process (GO:1903578),0.5834418741470434,1.6502663356649372,0.001092896174863388,0.11412294634652294,1.0,33/54,30.91%,HIF1A;NUP205;ATP7A;EIF6;GCK;SPHK2;GCKR;COX7A1;SLC25A33;AK4;NUP188;OGT;RANBP2;TPR;PRKAG1;RAE1;NUP93;AAAS;SLC2A6;COX7A2L;NUP54;JMJD8;NUP50;COX7A2;NUP98;NUP42;NUP133;NUP210;NUP35;NUP214;FIS1;SHMT2;EP300
prerank,chemical synaptic transmission (GO:0007268),-0.31545964368154,-1.6463090553683724,0.0,0.4471689627377921,1.0,73/284,11.76%,CACNB2;FCHSD2;SNAP25;GRIA4;GABRB2;GRM7;NRXN1;GABRB3;SYNJ2BP;NLGN1;SYN2;RPS6KA1;GRIK2;CHRM2;GLRA3;KCND2;DLGAP1;AMPH;DLG2;GRIK3;SLC1A3;GRIN2A;CPLX1;SYT10;RIMS1;LIN7A;GRIA3;PLP1;GRIK4;GABRG3;KCNQ3;RIT2;GRM1;GRID2;RAB3A;GABRA2;HTR2A;GRIN2B;SNAPIN;APBA2;GAD2;UNC13B;GRM5;HTR2C;SYT1;GRID1;GRM3;APBA1;CHRM3;CAMKK2;STXBP3;PENK;HRH2;SLC12A6;HTR1F;HAP1;SLC6A1;TSPOAP1;CDH8;SHISA6;CAMK1;SLC32A1;GABRA1;BSN;PRKAR2A;STXBP1;STX1A;CBLN2;GRIN1;PRKAR2B;BRSK1;GAD1;GABRB1
prerank,lymphocyte migration (GO:0072676),0.6228011617087936,1.6448632406076509,0.0011507479861910242,0.12236122844979634,1.0,10/32,13.90%,MSN;TBX21;CCL4;ADAM8;GATA3;CCL13;CRTAM;CCL7;CCL5;CCL14
prerank,signal release from synapse (GO:0099643),-0.4313473583874367,-1.6443629464424419,0.011627906976744186,0.43666543877246083,1.0,18/43,13.03%,SNAP25;NRXN1;SYN2;CPLX1;SYT10;RIMS1;LIN7A;RAB3A;SNAPIN;GAD2;SYT1;STXBP3;SLC32A1;STXBP1;STX1A;BRSK1;GAD1;SYN1
prerank,actin filament-based transport (GO:0099515),0.6644328736987261,1.6398382618462786,0.009962640099626401,0.13024126687577053,1.0,4/21,3.44%,MYO1E;MYO5A;MYO1F;MYO1A
prerank,"phototransduction, visible light (GO:0007603)",0.7166064213210999,1.6395085797743691,0.008032128514056224,0.12943569652583953,1.0,7/14,18.99%,GNAQ;ABCA4;SAG;PDE6B;CNGB1;GNA11;GNB1
prerank,plasma membrane repair (GO:0001778),0.7412568211833286,1.6373191708640238,0.004076086956521739,0.13211015687555164,1.0,5/13,7.35%,MYOF;AHNAK2;FER1L5;ARL8B;ANXA6
prerank,myoblast differentiation (GO:0045445),0.7211488780090932,1.637111814515878,0.005128205128205128,0.13114390073457693,1.0,5/14,8.76%,IGF1;NRG1;PLEKHM3;JAG1;DDX17
prerank,regulation of NMDA receptor activity (GO:2000310),-0.46159339750680867,-1.63694463724421,0.006756756756756757,0.4407584899056952,1.0,15/32,13.79%,MEF2C;GRIA4;NLGN1;NEFL;DLG2;GRIN2A;GRIA3;LRRC7;GRIN2B;APP;CCL2;GRIN1;SLC6A9;CAMK2B;CAMK2A
prerank,sodium ion export across plasma membrane (GO:0036376),0.7302799855197155,1.6355252774572113,0.009079118028534372,0.13293781803484817,1.0,5/13,7.31%,SLC9A1;ATP1B3;ATP1A4;ATP1A3;ATP1A1
prerank,positive regulation of transport (GO:0051050),0.5524564041771204,1.6348278062491033,0.0,0.133029484175505,1.0,36/85,22.50%,CYBA;APOE;LRP1;IL2RB;FPR2;KMT2A;SIRPA;DOCK2;ANXA1;SGK1;SGK2;SCIN;APOA2;PON1;DYNC1H1;BID;DAB2;TREM2;PLAA;BAX;KCTD7;GAS6;ABCA7;ACTB;NUMA1;SMPD1;CHP1;HIP1R;LMAN2;LYAR;FCER1G;SLC11A1;MLC1;GSK3B;CD47;CALR
prerank,carboxylic acid transport (GO:0046942),0.5799052909982988,1.632647402929023,0.0010893246187363835,0.13633765025011693,1.0,23/55,19.43%,SLC3A2;SLC38A1;SLC6A6;SLC38A6;SLC7A1;SLC23A1;SLC23A2;SLC6A14;SLC36A4;SLC17A5;PSAP;SLC36A3;SLC6A7;SLC7A6;SLC16A9;CLN3;SLC1A5;SLC16A3;LLGL2;SLC7A8;SLC13A3;SLC16A2;SLC38A2
prerank,iron ion transport (GO:0006826),0.5929265788429142,1.631521437523244,0.0010799136069114472,0.13717621248692807,1.0,24/47,21.21%,TCIRG1;ATP6V1C1;ATP6V0D2;LTF;ATP6V1A;ATP6V0A1;ATP6V1B2;ATP6V0D1;ATP6V0B;ATP6V1G1;HEPH;REP15;ATP6AP1;DNM2;ATP6V1F;MELTF;TFRC;ATP6V0C;SLC11A1;FTH1;ATP6V0A4;ATP6V1E1;LMTK2;ABCB7
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.7376088732596736,1.6284189195632264,0.006578947368421052,0.14196875129213196,1.0,5/13,10.12%,PLXNC1;NRP2;PLXNA2;NRP1;PLXND1
prerank,regulation of neuroinflammatory response (GO:0150077),0.6800446500226128,1.6283524252051085,0.00625,0.14085313072038738,1.0,7/19,11.70%,IGF1;MMP8;SPHK1;MMP9;CD200R1;TREM2;TNFRSF1B
prerank,antibacterial humoral response (GO:0019731),0.7012541083452805,1.6255719854443726,0.005208333333333333,0.1453214448372909,1.0,7/16,18.75%,CAMP;LTF;RNASE3;DMBT1;RNASE7;JCHAIN;RNASE6
prerank,rRNA metabolic process (GO:0016072),0.5287280277667422,1.6248906432094399,0.0,0.14531493969191903,1.0,82/160,28.15%,C1D;DEDD2;UBA52;ESF1;RPS6;RPS14;RPL10A;RPL18;RRP7A;RPS24;EXOSC4;RPS7;RPL41;RPL36A;ERN2;RPL23;RPL17;RPS25;WDR12;RPL35A;RPS28;RRP12;RPLP2;RPL28;NOL8;XRN2;RPL27A;RPL11;RPS2;DDX49;BMS1;NOLC1;WDR43;MRM2;NOL6;UTP11;UTP20;NVL;RPL32;EXOSC9;RPL21;EXOSC10;RPL9;RPL36;RPL37;RPL38;RPS19;RPS27;MDN1;DDX52;RPL14;RPS16;UTP4;RPL30;RPL31;UTP14A;RPL12;RPL13A;KRR1;RPS9;LYAR;NOC4L;RPL4;EXOSC5;RRP9;DKC1;RPL15;WDR3;XRN1;SNU13;RPL7A;RRP1B;RRP1;RPL23A;RPL8;RPLP1;RPL29;PIH1D1;RPL37A;BYSL;TRIR;NOP14
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.5929092025221141,1.6229859230989347,0.005574136008918618,0.14802706257709847,1.0,26/42,30.65%,EPRS1;AARS1;VARS1;VARS2;CARS1;LARS2;GARS1;RARS1;EARS2;FARSA;SARS2;SARS1;FARSB;FARS2;NARS1;YARS1;LARS1;TARS1;AIMP2;AIMP1;TARS2;RARS2;MARS2;NARS2;PPA1;QARS1
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.5663081752425011,1.6213251072230224,0.0010660980810234541,0.14995223597063673,1.0,32/67,25.39%,FN1;CDK6;SKAP1;CD3E;CSF1;FLNA;PTK2B;NRP1;NEDD9;CRKL;LIMS2;P4HB;ILK;JUP;MYOC;CCL28;UTRN;CDC42;DOCK5;C1QBP;MYADM;TESK1;ECM2;FERMT2;GSK3B;TRIOBP;CALR;CSPG5;JAK2;SFRP1;CX3CL1;MDK
prerank,cell differentiation in spinal cord (GO:0021515),-0.6401530303338812,-1.619524389015801,0.04332129963898917,0.4728962950753739,1.0,6/10,30.47%,MDGA2;MDGA1;SOX13;ZC4H2;ISL1;SOX4
prerank,lipid droplet formation (GO:0140042),-0.6378401390587217,-1.6192268324765724,0.02247191011235955,0.45788618752163607,1.0,3/10,15.73%,CDS1;PLA2G4C;SQLE
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.5439515583510792,1.618859069825311,0.0,0.1540767603761276,1.0,36/88,22.50%,APOE;EPRS1;RGP1;GZMB;NCL;CDK5;NELL1;LSM14A;PUS7;RIC1;PATL2;CSTB;RACK1;CPEB3;SERPINE2;CNOT10;SHMT1;CLN3;ENC1;LARP1;DNAJC1;ILF3;SYNCRIP;EIF4A3;NFKB1;EIF4ENIF1;DAPK1;DHX36;EIF4E2;FXR2;DAPK3;RPL13A;RPS3;SAMD4A;GIGYF2;CALR
prerank,negative regulation of lymphocyte activation (GO:0051250),0.6476791064058112,1.6179786723082716,0.010948905109489052,0.15474700886704734,1.0,6/21,8.41%,LGALS3;GPNMB;LAX1;FOXJ1;PTPN22;SAMSN1
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.7524354090513876,1.6172582580920873,0.00903225806451613,0.1550457830443948,1.0,5/12,8.95%,MYO1E;IQGAP1;CD24;JAG1;BASP1
prerank,negative regulation of T cell activation (GO:0050868),0.6052059903051817,1.6154966243624285,0.0022497187851518562,0.1574456885910259,1.0,8/35,8.96%,LGALS3;GPNMB;LAX1;SPN;RIPOR2;CD274;PTPN22;LILRB1
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.6390312677422985,-1.6132399511171733,0.02909090909090909,0.4607236825716428,1.0,6/10,18.40%,GABRB2;GABRG3;GABRA2;GABRA1;GABRE;GABRG2
prerank,calcium ion import across plasma membrane (GO:0098703),-0.5900777397007351,-1.6129576100441505,0.05365853658536585,0.44694737687401803,1.0,8/14,29.26%,CACNA2D1;SLC8A3;SLC8A2;TRPV4;TRPM2;SLC24A1;SLC24A2;SLC8A1
prerank,calcium ion import into cytosol (GO:1902656),-0.5736232544438383,-1.6125104427551913,0.03940886699507389,0.4348275649203671,1.0,8/15,29.26%,CACNA2D1;SLC8A3;SLC8A2;TRPV4;TRPM2;SLC24A1;SLC24A2;SLC8A1
prerank,positive regulation of lipid localization (GO:1905954),0.7443204503399777,1.6122693482349357,0.005291005291005291,0.16290298265421346,1.0,5/11,14.42%,LPL;LRP1;IKBKE;C3;NFKB1
prerank,macrophage chemotaxis (GO:0048246),0.7467916758706772,1.6121257324987497,0.01366120218579235,0.16182499444075246,1.0,3/10,11.65%,LGALS3;TAFA4;CCL5
prerank,positive regulation of cholesterol efflux (GO:0010875),0.6616433471694442,1.6117836213974883,0.006119951040391677,0.16116380899821697,1.0,7/21,7.29%,APOE;LRP1;EEPD1;PON1;CAV1;PPARG;TREM2
prerank,T cell mediated immunity (GO:0002456),0.727752991120731,1.6104944562747276,0.0039011703511053317,0.16260907337044297,1.0,7/13,21.23%,CD8A;JAG1;CADM1;BTN3A3;CRTAM;MYO1G;CD55
prerank,amino sugar biosynthetic process (GO:0046349),0.7382166759886479,1.6097537026041637,0.006657789613848202,0.16299564590356497,1.0,9/12,23.52%,RENBP;GNPNAT1;GNPDA1;NAGK;UAP1L1;GNPDA2;NANP;UAP1;AMDHD2
prerank,neuron projection extension (GO:1990138),0.6172293666136139,1.6071618550240685,0.004555808656036446,0.16727529747102626,1.0,7/32,4.97%,ALCAM;IQGAP1;CTNNB1;NRP2;CDK5;NRP1;LLPH
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.7482429549639232,1.6064294085862048,0.0106951871657754,0.16751945843519653,1.0,5/11,15.54%,PRKCQ;MALT1;IL12RB1;NFKBIZ;CLEC6A
prerank,acylglycerol homeostasis (GO:0055090),0.654039935879002,1.605956436105869,0.015834348355663823,0.16710799733683696,1.0,4/20,5.01%,LPL;APOE;GCKR;APOC4
prerank,positive regulation of cholesterol transport (GO:0032376),0.6308648356894739,1.6048576414366722,0.007177033492822967,0.1681820348042732,1.0,10/27,13.05%,APOE;LRP1;EEPD1;PON1;CAV1;PPARG;TREM2;ABCA13;LPCAT3;ABCA7
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.6155838264628659,1.6046318143585194,0.007100591715976331,0.1672907470831713,1.0,14/27,24.98%,IGF1;FN1;CDK6;PDGFA;SPHK1;S100A6;GAS6;DDR2;BMI1;DHX9;CD74;MIF;PDGFRA;CDK4
prerank,cholesterol transport (GO:0030301),0.5734763572534817,1.6044144253675519,0.004484304932735426,0.16649294084588337,1.0,16/45,20.81%,APOE;ABCG1;ABCA1;CEL;APOA2;SOAT1;CAV1;APOC1;SOAT2;OSBPL2;ABCA7;NPC1;CLU;NPC2;STARD4;SERAC1
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.6473601781235528,1.6035332082818117,0.007151370679380214,0.16711260733979807,1.0,10/23,12.27%,UBA52;RPS27A;COPS3;COPS4;COPS8;DDB2;DDB1;COPS2;XPA;COPS6
prerank,excitatory postsynaptic potential (GO:0060079),-0.5191120066432241,-1.602308727249498,0.028901734104046242,0.4497615429017185,1.0,8/19,14.95%,MEF2C;GRIN2A;LRRK2;GRID2;GRIN2B;GRIN1;MPP2;ARRB2
prerank,negative regulation of DNA metabolic process (GO:0051053),0.6415805277944211,1.6019049627707485,0.00853658536585366,0.16895254016019093,1.0,11/24,21.83%,NIBAN2;KMT2A;ERCC1;ZRANB3;BLM;H1-0;ERCC4;RTEL1;DACH1;RPS3;DFFA
prerank,heterotypic cell-cell adhesion (GO:0034113),0.632965382424033,1.601300575191057,0.012077294685990338,0.16896874455106412,1.0,10/25,16.83%,ITGAX;ITGA5;CD2;ITGA4;CD200R1;JUP;PARVA;ITGB2;NINJ1;PKP2
prerank,canonical glycolysis (GO:0061621),0.6398642385894376,1.6012096604970298,0.008264462809917356,0.16659630267713207,1.0,12/24,17.78%,PKM;ALDOA;GCK;HK1;PFKL;PGK1;ENO1;ALDOC;PFKP;ENO2;HK3;GPI
prerank,glucose catabolic process to pyruvate (GO:0061718),0.6398642385894376,1.6012096604970298,0.008264462809917356,0.16659630267713207,1.0,12/24,17.78%,PKM;ALDOA;GCK;HK1;PFKL;PGK1;ENO1;ALDOC;PFKP;ENO2;HK3;GPI
prerank,superoxide metabolic process (GO:0006801),0.6190550379642351,1.6002510117468103,0.00589622641509434,0.16734406181784642,1.0,9/29,12.75%,SH3PXD2B;CYBA;CYBB;ATP7A;PRDX1;TAFA4;CYB5R4;NCF4;NRROS
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.652584369566162,1.5987064083087201,0.00850546780072904,0.16919710753716208,1.0,8/20,9.19%,SLC9A1;ATP1B3;KCNJ2;KCNMA1;ATP1A4;ATP1A3;ATP1A1;ATP6AP1
prerank,glycolytic process (GO:0006096),0.6227262780611166,1.5979262956593487,0.005787037037037037,0.16998213451534647,1.0,12/28,17.78%,PKM;ALDOA;GCK;HK1;PFKL;PGK1;LDHA;ENO1;ALDOC;ENO2;HK3;GPI
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.5912763401632283,1.5976536217420694,0.002188183807439825,0.169462378997089,1.0,14/41,13.09%,LCK;SKAP1;CD3E;PLAUR;GCNT2;CD44;FSTL3;PTPN23;PIEZO1;PLPP3;JAK1;MAGI1;CCL5;SMAD7
prerank,B cell receptor signaling pathway (GO:0050853),0.6115374648574483,1.5957846668613076,0.004618937644341801,0.17262491061244495,1.0,10/32,9.98%,BCL2;RFTN1;LCK;ITK;PTPRC;TEC;BLNK;PRKCB;PLEKHA1;BAX
prerank,acylglycerol catabolic process (GO:0046464),0.5954145135381607,1.5951946033402895,0.010452961672473868,0.17276028121477666,1.0,5/30,5.96%,LPL;FABP5;APOA2;ABHD12;MGLL
prerank,positive regulation of T cell proliferation (GO:0042102),0.5678625597405601,1.5950224383052163,0.00425531914893617,0.17189723333380347,1.0,22/55,20.16%,IGF1;CD3E;PTPRC;ANXA1;SLC7A1;CD24;CD6;CD28;NCK2;IL12RB1;CD274;NCK1;IL27RA;CCR2;CCL5;SYK;TFRC;TNFSF9;IL6;IL2;HMGB1;RPS3
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.612282956148288,1.5947812202020613,0.007927519818799546,0.17109698143795185,1.0,8/30,9.55%,CD300LF;UBA52;TANK;RPS27A;TRAF3;IKBKE;TNIP3;TICAM1
prerank,negative regulation of endocytosis (GO:0045806),0.623112370300923,1.5946928738377226,0.0097442143727162,0.1700641810811097,1.0,8/24,13.05%,LGALS3;MCTP1;CAV1;SNX33;LILRB1;CD300A;APOC1;ABCA7
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",-0.479526089585085,-1.5944448248589829,0.006944444444444444,0.45751609154300016,1.0,9/25,14.95%,MEF2C;GRIN2A;LRRK2;GRID2;GRIN2B;GRIN1;MPP2;GLRA1;ARRB2
prerank,cellular component disassembly (GO:0022411),0.5671777774774217,1.593968937642179,0.004366812227074236,0.1706551753543164,1.0,20/53,17.39%,SH3PXD2B;LCP1;MMP8;MMP12;CAPG;ADAM8;CD44;BMP1;A2M;MMP9;CAPN1;SCUBE3;GSN;KLKB1;ADAM15;MMP19;LAMC1;TIMP2;FURIN;CAPNS1
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.7354878275956048,1.5938705884494377,0.006702412868632708,0.16963978754467787,1.0,6/12,18.49%,APOE;TREM2;IAPP;PFDN1;CLU;PFDN2
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.5221614344816988,1.5923055558264907,0.0,0.17185484574247017,1.0,53/163,18.08%,BCL2;THEMIS;RFTN1;LCK;LAX1;SKAP1;CD3E;CD247;PSMD8;ITK;GRAP2;PTPRC;PSMD1;PRKCQ;CD4;MALT1;LAT;TEC;PIK3CB;CD3G;CD28;PTPN22;BLNK;PDPK1;TRAT1;GATA3;NCK1;TXK;PRKCB;BTN3A3;SPG21;PSMD6;PLEKHA1;PSMA1;NFKBIZ;PSMC3;FYN;PRAM1;PSMA8;PAK2;PSMD14;PSMD2;NFKB1;PRKD2;SPPL3;PSMC6;PSMA6;SYK;LAT2;PIK3R2;PSMD5;EIF2B2;PSMA5
prerank,regulation of hemopoiesis (GO:1903706),0.7427298707653599,1.5911781573843535,0.02054794520547945,0.17316772382060205,1.0,4/10,11.96%,LGALS3;RUNX1;PRKCB;MYSM1
prerank,regulation of integrin activation (GO:0033623),0.6917230595544182,1.5911107293441786,0.007741935483870968,0.17214211154882364,1.0,4/15,4.51%,FBLIM1;SKAP1;PLEK;PIEZO1
prerank,regulation of hippo signaling (GO:0035330),-0.5258092483690286,-1.5910421415809766,0.0380952380952381,0.45397005565467474,1.0,10/17,23.65%,MAPK14;SCHIP1;WWC1;MOB3B;VGLL4;AJUBA;DLG5;NEK8;CIT;WWC2
prerank,regulation of lymphocyte proliferation (GO:0050670),0.6768580002579185,1.5905200274098732,0.018252933507170794,0.17213490346649765,1.0,8/16,16.52%,LGALS3;IKZF3;CD22;IL27;PTPN22;TNFRSF1B;TNFSF8;TNFSF9
prerank,response to muscle stretch (GO:0035994),0.6968892300299134,1.5902874361302208,0.016581632653061226,0.17155371389747615,1.0,5/15,11.96%,CTNNB1;SLC9A1;NPPA;CSRP3;GSN
prerank,epithelial cell differentiation (GO:0030855),0.5324925743234448,1.5899350105470944,0.0,0.1712586103453252,1.0,36/88,24.87%,LGALS3;CTSB;ANXA1;TAGLN2;ANXA4;TAGLN;IRF6;OVOL1;GSTA2;PPARG;JAG1;DAB2;GATA3;DHRS9;VEGFA;HDAC1;DMBT1;BASP1;PGK1;PCK2;ALDOC;FSTL1;EHF;KDR;PTER;SPINK5;TST;CBR1;ANXA7;TPP1;BMP4;LATS1;FGFR2;EDF1;HDAC2;CPT1A
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.6342724350553729,1.5889267400783977,0.014423076923076924,0.17239034557965516,1.0,9/23,11.17%,KLRC2;CD226;KLRC1;NCR1;CADM1;RASGRP1;LILRB1;KLRK1;CRTAM
prerank,relaxation of cardiac muscle (GO:0055119),0.7043002768830808,1.5885836462614917,0.009174311926605505,0.1719060382305395,1.0,5/13,15.42%,P2RX4;KCNJ2;ATP1A1;GSN;ATP1A2
prerank,epiboly involved in wound healing (GO:0090505),0.6807778027325019,1.5878960219148153,0.013020833333333334,0.17229994413936275,1.0,5/16,2.96%,LCP1;FLNA;MRTFA;PDPN;CD44
prerank,tRNA aminoacylation (GO:0043039),0.5897465270027618,1.5877913420327399,0.006772009029345372,0.17142577113584836,1.0,23/37,30.65%,EPRS1;AARS1;VARS1;CARS1;LARS2;GARS1;RARS1;FARSA;SARS2;SARS1;GATB;FARSB;FARS2;NARS1;YARS1;LARS1;TARS1;AIMP2;AIMP1;RARS2;MARS2;PPA1;QARS1
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.6485805346445701,1.587714690083842,0.013349514563106795,0.1704774715205614,1.0,10/21,24.48%,CILP;VEPH1;DAB2;RBPMS;SH2B1;BMP6;FAM89B;NUP93;BMP4;JAK2
prerank,T cell receptor signaling pathway (GO:0050852),0.523595722154555,1.586975935352421,0.0,0.17097087378010575,1.0,45/138,18.08%,THEMIS;RFTN1;LCK;SKAP1;CD3E;CD247;PSMD8;ITK;GRAP2;PTPRC;PSMD1;PRKCQ;CD4;MALT1;LAT;TEC;PIK3CB;CD3G;CD28;PTPN22;PDPK1;TRAT1;GATA3;NCK1;TXK;BTN3A3;PSMD6;PSMA1;NFKBIZ;PSMC3;FYN;PRAM1;PSMA8;PAK2;PSMD14;PSMD2;NFKB1;PRKD2;SPPL3;PSMC6;PSMA6;PIK3R2;PSMD5;EIF2B2;PSMA5
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.6483575215266508,1.5865632305133226,0.014669926650366748,0.1698185459818132,1.0,4/21,2.66%,BCL2;BCL2L1;EYA4;MCL1
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.6483575215266508,1.5865632305133226,0.014669926650366748,0.1698185459818132,1.0,4/21,2.66%,BCL2;BCL2L1;EYA4;MCL1
prerank,extracellular matrix disassembly (GO:0022617),0.5619635744922382,1.586338913597109,0.004343105320304018,0.16930769081229288,1.0,20/53,17.39%,SH3PXD2B;LCP1;MMP8;MMP12;CAPG;ADAM8;CD44;BMP1;A2M;MMP9;CAPN1;SCUBE3;GSN;KLKB1;ADAM15;MMP19;LAMC1;TIMP2;FURIN;CAPNS1
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.6800496363146442,1.5860080371504768,0.009913258983890954,0.16899415360400385,1.0,8/16,17.17%,SIRPA;NLRC3;CHID1;ADCY7;TREM2;ABCD2;APPL2;PDCD4
prerank,peptide biosynthetic process (GO:0043043),0.5175503807526178,1.584347143153466,0.0,0.17113856415020465,1.0,77/153,27.77%,RPS12;MRPS12;AGO2;RPS27A;TNIP1;RPS6;EIF4G1;RPS14;MRPL51;RPL10A;RPL18;RPS24;IGHMBP2;RPS7;RPL41;RPL36A;RPS20;RPS26;EEF1A1;RPL23;RPL17;MRPL23;RPS25;RPL35A;RPS28;RPLP2;RPL28;RPL27A;RPL11;RPS2;MRPL52;RPL32;MRPS15;RPL21;MRPL24;RPL9;RPL36;RPL37;MRPS33;MRPS16;RPL38;RPS18;MRPS7;RPS19;RPS27;RPS23;FURIN;RPL14;RPS16;SARS1;MRPL11;RPL30;RPL31;RPL12;GSPT1;FARSB;RPL13A;RPS9;RPL4;RRBP1;RPS3;RPS13;PABPC4;RPSA;RPL15;MRPS14;MRPL37;RPL7A;MRPL18;RPL23A;RPL8;RPLP1;RPL29;RPL37A;GGTA1;MRPL41;MRPL27
prerank,fatty acid transport (GO:0015908),0.6731189360597929,1.5842880574101617,0.00749063670411985,0.1702267274907452,1.0,6/17,8.86%,APOE;FABP5;SLC27A1;PPARG;ACSL1;PPARD
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.6165932305190822,1.5837308113037492,0.013142174432497013,0.1703006535509195,1.0,6/27,5.42%,LPL;ABCG1;PRKCH;ABCA1;CSF1;PPARG
prerank,lipid catabolic process (GO:0016042),0.6553646978431483,1.583611010184318,0.015247776365946633,0.16949818375516237,1.0,3/18,2.30%,LPL;PLAAT3;CEL
prerank,regulation of calcium ion import (GO:0090279),0.6481072818290824,1.583522919679895,0.00834326579261025,0.16864372538428724,1.0,5/21,10.28%,LGALS3;CTNNB1;SPHK2;PSEN2;FYN
prerank,lymphocyte differentiation (GO:0030098),0.538600375566028,1.58307772525948,0.0010672358591248667,0.16848047678170244,1.0,24/68,21.36%,LCK;PTPRC;CD4;HDAC9;AXL;NFIL3;ITGA4;HDAC4;KLF6;PTPN22;BLNK;GATA3;TPD52;ADAM17;PTPN2;DLL4;DNAJB9;CEBPG;TOX;KAT7;IL2;GPR89A;GPR89B;PBX1
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.5746164342934462,1.5819294013088012,0.005599104143337066,0.16991066661797652,1.0,23/41,29.50%,HIF1A;NUP205;EIF6;GCK;GCKR;NUP188;OGT;RANBP2;TPR;PRKAG1;RAE1;NUP93;AAAS;SLC2A6;NUP54;JMJD8;NUP50;NUP98;NUP42;NUP133;NUP210;NUP35;NUP214
prerank,regulation of translational initiation (GO:0006446),0.5505752601175117,1.5814229973948704,0.003188097768331562,0.16992366039294796,1.0,30/63,24.63%,ATF3;EIF1;AGO2;EIF4G1;HSPB1;NCK2;NCK1;EIF4G2;MIF4GD;ALKBH1;DDX1;YTHDF3;CCL5;LARP1;EIF4G3;POLR2D;EIF5B;TPR;PPP1R15B;YTHDF2;KLHL25;EIF2B2;EIF3E;NPM1;EIF4A2;CDC123;EIF4B;EIF3B;ATF4;EIF3H
prerank,negative regulation of mitochondrion organization (GO:0010823),0.605094307664641,1.5811482294918102,0.007050528789659225,0.16952074254955696,1.0,17/33,26.99%,IGF1;BCL2L1;VAT1;IAPP;SLC35F6;TRIAP1;HUWE1;MPV17L;GHITM;CLU;TFRC;PRELID1;BNIP3;ACAA2;GPX1;PSMD10;NOL3
prerank,negative regulation of translation (GO:0017148),0.5338891039171365,1.579802976039613,0.002105263157894737,0.1713867970312076,1.0,38/87,22.50%,EPRS1;AGO2;UNK;GZMB;NCL;CPEB4;CPEB2;LSM14A;CELF1;PUS7;PATL2;RACK1;METTL3;CPEB3;CNOT10;SHMT1;YTHDF3;ENC1;LARP1;ILF3;ROCK1;SYNCRIP;EIF4A3;EIF4ENIF1;DAPK1;TPR;YTHDF2;DHX36;EIF4E2;FXR2;PUM1;DAPK3;EIF3E;RPL13A;RPS3;SAMD4A;GIGYF2;CALR
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),-0.44428346839551297,-1.5791222074726883,0.036231884057971016,0.4718898191456975,1.0,10/31,13.86%,SCAMP5;SYT10;KCNB1;SYT1;SYT2;STXBP3;REST;STXBP1;STX1A;SYT9
prerank,monocyte chemotaxis (GO:0002548),0.6049440628767457,1.5788902549367974,0.008158508158508158,0.17240328094959206,1.0,9/32,14.98%,LGALS3;FLT1;ANXA1;CCL4;CCL13;CCL7;CCL5;CCL14;RPS19
prerank,regulation of AMPA receptor activity (GO:2000311),-0.47437096022365605,-1.5780650208098477,0.045714285714285714,0.46206392333922447,1.0,14/25,23.78%,MEF2C;NLGN1;CACNG3;SHANK3;CACNG8;SHISA6;CNIH3;SHISA7;SHANK1;NLGN2;NLGN3;CACNG2;MAPK8IP2;RELN
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.5412999468878068,1.577806449498861,0.0020942408376963353,0.17378092925998204,1.0,42/74,32.79%,HIF1A;PSMD8;NFE2L2;PSMD1;UBA52;RPS27A;VEGFA;PSMD6;PSMA1;PSMC3;PSMA8;PSMD14;PSMD2;STOX1;PSMC6;PSMA6;PSMD5;ELOB;PSMA5;EGLN1;UBC;EPO;VHL;EGLN3;CUL2;PSMA3;PSMB8;PSMB10;PSMD7;PSMB6;PSMD10;PSMB5;PSMB7;PSMC4;EP300;PSMD12;SIRT2;CREBBP;PSMD3;UBB;ARNT;EPAS1
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.7154738747439895,1.57635897981981,0.012,0.17577835613585102,1.0,3/12,5.42%,ABCG1;ABCA1;PPARG
prerank,cellular response to interleukin-4 (GO:0071353),0.75185737142783,1.5763139254540328,0.014388489208633094,0.17484421599042535,1.0,4/10,6.39%,TCF7;LEF1;RUFY4;GATA3
prerank,cellular response to copper ion (GO:0071280),0.6806516084686826,1.5759235839210108,0.01808785529715762,0.1747237583146995,1.0,11/16,26.26%,DAXX;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;HSF1;MT2A
prerank,response to interleukin-4 (GO:0070670),0.7552236953231584,1.5749049084613234,0.01440922190201729,0.17581390719640874,1.0,4/10,6.39%,TCF7;LEF1;RUFY4;GATA3
prerank,monosaccharide transmembrane transport (GO:0015749),0.6753297826294687,1.5744611393643682,0.015604681404421327,0.17574111038612275,1.0,8/16,21.90%,SLC23A1;SLC23A2;SLC5A1;SLC2A8;SLC45A3;SLC50A1;SLC5A3;SLC2A6
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.6828628830774184,1.5724752174058894,0.010282776349614395,0.17898148463403452,1.0,5/15,10.58%,SLC27A1;FBXW7;CTDNEP1;SIK1;C3
prerank,positive regulation of phagocytosis (GO:0050766),0.5573442224151763,1.5721109599031664,0.00755939524838013,0.1787666503729875,1.0,24/47,25.24%,CYBA;STAP1;IL2RB;FPR2;CD300LF;SIRPA;DOCK2;PTPRC;APOA2;TREM2;C3;GAS6;ABCA7;APPL2;ANO6;LMAN2;LYAR;FCER1G;SLC11A1;CD47;CALR;TNF;NCKAP1L;PLA2G5
prerank,platelet degranulation (GO:0002576),0.52012167347749,1.5721025750423963,0.0,0.17783007484028193,1.0,43/118,22.60%,IGF1;CD9;FN1;TLN1;PLEK;FLNA;ANXA5;TMSB4X;ALDOA;TAGLN2;CHID1;PDGFA;CTSW;HRG;A2M;LHFPL2;PSAP;APLP2;ACTN1;TOR4A;VEGFA;LAMP2;GTPBP2;CYB5R1;CD63;SERPINE1;F5;ECM1;LY6G6F;GAS6;PROS1;CLU;FAM3C;APOH;SERPINF2;OLA1;F8;ACTN2;CDC37L1;TIMP1;ITGA2B;SRGN;ACTN4
prerank,vacuolar acidification (GO:0007035),0.638237380424324,1.569075082675506,0.012077294685990338,0.183531272619812,1.0,10/21,20.02%,TCIRG1;ATP6V0D2;DMXL2;ATP6V0A1;ATP6V0D1;TMEM199;CLN3;DMXL1;SLC11A1;ATP6V0A4
prerank,ribosome biogenesis (GO:0042254),0.5089437769873388,1.5684690089484314,0.0,0.18377056296276637,1.0,70/187,19.23%,DDX31;C1D;UBA52;ESF1;EIF6;RPS6;RPS14;RPL10A;RPL18;RRP7A;RPS24;EXOSC4;METTL17;RPS7;RPL41;NOC2L;RPL36A;RPL23;RPL17;RPS25;WDR12;RIOK2;RPL35A;RPS28;RRP12;RPLP2;EIF2A;RPL28;NOL8;XRN2;RPL27A;RPL11;RPS2;DDX49;BMS1;NOLC1;WDR43;MRM2;NOL6;UTP11;UTP20;NVL;RPL32;EXOSC9;RPL21;EXOSC10;DHX29;XPO1;RPL9;RPL36;RPL37;RPL38;RPS19;RPS27;MDN1;DDX52;RPL14;RPS16;UTP4;RPL30;RPL31;UTP14A;RPL12;RPL13A;KRR1;RPS9;LYAR;NOC4L;RPL4;EXOSC5
prerank,negative regulation of cellular metabolic process (GO:0031324),0.5809408180200385,1.5683907066934655,0.012528473804100227,0.182911029513044,1.0,11/37,15.21%,APOE;SDCBP;OPTN;TRAT1;BRCA1;ANKRD13B;LRPAP1;SIRT5;TRAP1;NFKB1;ANKRD13A
prerank,ncRNA processing (GO:0034470),0.5045905808981421,1.5683273334210088,0.0,0.18205530454946744,1.0,74/200,19.31%,C1D;AARS1;UBA52;AGO2;ESF1;THG1L;RPS6;RPS14;RPL10A;RPL18;RRP7A;RPS24;EXOSC4;RPS7;RPL41;RPL36A;RPL23;RPL17;RPS25;WDR12;RPL35A;RPS28;RRP12;RPLP2;RPL28;NOL8;XRN2;RPL27A;RPL11;RPS2;DDX49;BMS1;NOLC1;WDR43;MRM2;NOL6;METTL3;UTP11;UTP20;NVL;RPL32;EXOSC9;RPL21;EXOSC10;RPL9;RPL36;SMAD1;RPL37;RPL38;HNRNPA2B1;RPS19;RPS27;MDN1;INTS2;DDX52;INTS6;RPL14;RPS16;SARS1;UTP4;RPL30;RPL31;UTP14A;RPL12;RPL13A;FARS2;KRR1;RPS9;LYAR;NOC4L;RPL4;ADAR;EXOSC5;AGO3
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.6285446057032095,1.567269423741472,0.013064133016627079,0.18350414619125743,1.0,13/24,29.00%,NFE2L2;PDPK1;GATA3;ANGPT1;SERPINE1;TNIP2;GAS6;KDR;KRIT1;MAPK7;PAK4;TNFAIP3;NDNF
prerank,regulation of epithelial cell differentiation (GO:0030856),0.6514419713560938,1.567162969618537,0.019777503090234856,0.18272560565822246,1.0,7/17,12.66%,FOXN1;MAFF;CD24;CAV1;GATA3;SOX9;MAFG
prerank,regulation of neuron differentiation (GO:0045664),-0.35519031924558575,-1.566894680941732,0.0,0.48024753220576455,1.0,20/76,13.77%,ZFHX3;MEF2C;BIN1;NLGN1;ZEB1;MMD;CNTN4;BEND6;LRRK2;NREP;BRINP1;TIAM1;PCP4;REST;ECT2;DISP3;YWHAH;DTX1;SIN3A;VWC2
prerank,phagosome acidification (GO:0090383),0.6284913135778082,1.5657845240654584,0.012910798122065728,0.18474347940726552,1.0,11/26,12.00%,TCIRG1;ATP6V1C1;ATP6V0D2;ATP6V1A;ATP6V0A1;ATP6V1B2;ATP6V0D1;ATP6V0B;ATP6V1G1;RAB7A;ATP6V1F
prerank,retinol metabolic process (GO:0042572),0.6850859853870231,1.5650102336667613,0.011612903225806452,0.185412839420113,1.0,6/14,22.05%,RDH12;DHRS3;DHRS9;RBP4;CYP1B1;RDH10
prerank,homotypic cell-cell adhesion (GO:0034109),0.5827503830374008,1.5649923562440693,0.012318029115341545,0.18445875840330284,1.0,12/39,8.86%,FN1;TLN1;PLEK;FLNA;PIK3CB;TJP2;MYL9;HSPB1;PLPP3;ACTN1;ACTG1;ILK
prerank,alanine transport (GO:0032328),0.7397145884144822,1.5645465909165643,0.023004059539918808,0.18444727375538633,1.0,4/10,5.05%,SLC6A6;SLC6A14;SLC36A4;SLC36A3
prerank,negative regulation of protein polymerization (GO:0032272),-0.4687540404115544,-1.5642263326199557,0.006756756756756757,0.47461258920725374,1.0,7/27,7.72%,SSH2;CYRIB;TUBB4A;KANK1;TWF2;STMN1;MAP2
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.7360009616490674,1.5633049484307933,0.012211668928086838,0.18622727392435456,1.0,8/11,23.52%,RENBP;GNPNAT1;GNPDA1;NAGK;UAP1L1;GNPDA2;UAP1;AMDHD2
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.7092708847119036,1.5628300265609436,0.021505376344086023,0.1862650383061743,1.0,3/12,4.15%,IGF1;GCK;DYRK2
prerank,regulation of oxidoreductase activity (GO:0051341),0.6933531945616068,1.5623368264626096,0.026385224274406333,0.1863498970935575,1.0,4/13,7.59%,ABL2;ATP7A;GZMA;HP
prerank,positive regulation of lipid storage (GO:0010884),0.6362355870507467,1.5576891403785005,0.014492753623188406,0.19618126876997669,1.0,6/21,14.42%,PLIN2;LPL;APOC4;IKBKE;C3;NFKB1
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.5511736671962109,-1.557609584514347,0.05439330543933055,0.4806041607536145,1.0,6/13,19.90%,CACNB2;KCNJ3;KCNN2;CACNA1C;KCNQ1;ANK2
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.6729088410107346,1.5570910470424566,0.01859229747675963,0.19647028662886126,1.0,6/15,16.79%,APOE;ADAM8;SNX33;TNFRSF1B;FURIN;SH3D19
prerank,relaxation of muscle (GO:0090075),0.6923379217965566,1.5561994660692267,0.012903225806451613,0.19767075205527443,1.0,5/13,15.42%,P2RX4;KCNJ2;ATP1A1;GSN;ATP1A2
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.617021130669158,1.5541571623090158,0.01410105757931845,0.2016554932016828,1.0,12/25,17.78%,PKM;ALDOA;GCK;HK1;PFKL;PGK1;ENO1;ALDOC;PFKP;ENO2;HK3;GPI
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.5034289940455038,1.5531106831897459,0.0,0.20291021802531378,1.0,84/168,27.10%,RPS12;UBA52;RPS27A;RPS6;EIF4G1;CNOT4;RPS14;RPL10A;RPL18;RPS24;PPP2R1A;EXOSC4;RPS7;RPL41;RPL36A;RPS20;RPS26;RPL23;RPL17;ETF1;RPS25;PATL1;RPL35A;RPS28;RPLP2;RPL28;XRN2;PATL2;RPL27A;RPL11;RPS2;PABPC1;CNOT10;DHX34;SMG9;RPL32;EXOSC9;DXO;RPL21;EXOSC10;RPL9;RPL36;RPL37;DCP1A;RPL38;EIF4A3;POLR2D;RPS18;RPS19;RPS27;HELZ2;RPS23;RPL14;RPS16;RPL30;RPL31;RPL12;GSPT1;EIF3E;ATM;RPL13A;RPS9;UPF3A;RPL4;EXOSC5;RPS3;CNOT6;RPS13;RPSA;SAMD4A;RPL15;UPF3B;PAN2;XRN1;RPL7A;PYM1;RPL23A;RPL8;RPLP1;CNOT6L;RPL29;MTPAP;RPL37A;RC3H1
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.5982890909436404,-1.5520895006933093,0.035856573705179286,0.4833195274488247,1.0,4/11,1.63%,CACNB2;CACNA2D1;BIN1;NOS1AP
prerank,inorganic anion transport (GO:0015698),0.5488085155786829,1.5513476036356362,0.0054466230936819175,0.20597914182131893,1.0,19/53,23.02%,PACC1;SLC26A1;ANO9;ANO8;CLIC4;SLC13A4;SLC26A11;CLCN1;SLC25A14;SLC26A4;RACGAP1;ANO5;XPR1;ANO6;CLCN4;SLC11A1;SLC26A6;FXYD1;CLIC5
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.6994570934476223,1.5512363380506378,0.021534320323014805,0.205208914001605,1.0,3/13,4.15%,IGF1;GCK;DYRK2
prerank,regulation of lymphocyte activation (GO:0051249),0.7046869883717557,1.5477312219924817,0.02766798418972332,0.2122533585795527,1.0,6/12,11.65%,LCK;IKZF3;CD4;LAT;CRTAM;CCL5
prerank,carbohydrate catabolic process (GO:0016052),0.5735330776520692,1.547352353081788,0.010033444816053512,0.21196380790707173,1.0,14/38,17.78%,PKM;ALDOA;GCK;DERA;HK1;PFKL;PGK1;LDHA;ENO1;ALDOC;NEU1;ENO2;HK3;GPI
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.3772387859595115,-1.547234298411813,0.0,0.4853831778218567,1.0,20/57,13.79%,MEF2C;GRIA4;NLGN1;NEFL;DLGAP1;DLG2;GRIN2A;GRIA3;CACNG3;NETO1;LRRC7;GRIN2B;APP;CACNG8;SHISA6;BEGAIN;GRIN1;CAMK2B;CNIH3;CAMK2A
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.7008961114097501,1.5459474567224436,0.017711171662125342,0.2144210167504944,1.0,5/12,11.05%,PTPRC;RUNX1;PTPN22;CD300A;ELF2
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.4381888079274922,-1.5444280190212645,0.011834319526627219,0.481766376248841,1.0,8/29,10.44%,SSH2;CYRIB;KANK1;TWF2;TJP1;SHANK3;PRKN;FKBP4
prerank,endoderm formation (GO:0001706),0.5741505050210178,1.5442643778950906,0.014755959137343927,0.21751803053007776,1.0,8/35,9.79%,FN1;MMP8;ITGA5;EOMES;MMP9;ITGA4;COL12A1;SOX7
prerank,positive regulation of cell development (GO:0010720),-0.4360461052813917,-1.5441093210044747,0.026490066225165563,0.47172318678489955,1.0,5/31,5.51%,CX3CR1;NUMB;TGM2;BAD;RGS14
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.5353865254635725,1.543850687763164,0.005291005291005291,0.2175001091333736,1.0,30/67,28.23%,CYBA;PSMD8;PSMD1;CYBB;SEC22B;TAPBP;PSMD6;PSMA1;NCF4;B2M;PSMC3;PSMA8;PSMD14;PSMD2;PSMC6;PSMA6;PSMD5;PSMA5;CALR;PSMA3;PSMB8;PSMB10;NCF2;PSMD7;PSMB6;NCF1;PSMD10;PSMB5;VAMP3;PSMB7
prerank,cellular sodium ion homeostasis (GO:0006883),0.6687582530733556,1.542441305137028,0.015132408575031526,0.2199589201276468,1.0,5/15,7.31%,SLC9A1;ATP1B3;ATP1A4;ATP1A3;ATP1A1
prerank,regulation of vasculature development (GO:1901342),0.6086193106528902,1.542365143268586,0.016412661195779603,0.21906849389853233,1.0,11/26,19.73%,GPNMB;CTNNB1;FGF2;PLXND1;HMOX1;RNH1;SP100;NF1;HTATIP2;IL6;EGLN1
prerank,water transport (GO:0006833),0.709294629684315,1.54224222630322,0.021534320323014805,0.2182698563477083,1.0,3/12,17.26%,PDPN;SLC5A1;AQP4
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.713403905430193,1.5411612638270693,0.03050397877984085,0.21985653139984024,1.0,5/11,16.11%,CYBA;MFHAS1;TREM2;ACOD1;TIRAP
prerank,response to exogenous dsRNA (GO:0043330),0.6392065623137585,1.5408447353458794,0.02608695652173913,0.21951271120292104,1.0,5/18,9.55%,COLEC12;RFTN1;SLC3A2;CAV1;TICAM1
prerank,P-body assembly (GO:0033962),0.7130657231751375,1.54060196762093,0.013386880856760375,0.2190611498452249,1.0,10/12,27.10%,DYNC1H1;PATL1;LSM14A;PATL2;EIF4ENIF1;ATXN2;LSM4;EDC3;LSM3;RC3H1
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.5210149955181056,1.5390326633535734,0.0031982942430703624,0.2217552247427124,1.0,35/84,22.50%,IGF1;APOE;EPRS1;GZMB;SPHK1;NCL;ORMDL1;LSM14A;PUS7;PATL2;RACK1;CPEB3;CNOT10;SHMT1;ENC1;LARP1;ABCA7;ILF3;ROCK1;SYNCRIP;EIF4A3;EIF4ENIF1;CLU;DAPK1;DHX36;EIF4E2;FXR2;DAPK3;PIN1;RPL13A;ORMDL3;RPS3;SAMD4A;GIGYF2;CALR
prerank,positive regulation of bone resorption (GO:0045780),0.7209771506235277,1.5390084540324835,0.022911051212938006,0.22076192816873716,1.0,5/11,16.00%,SPP1;ADAM8;PLEKHM1;ATP6AP1;SYK
prerank,membrane raft organization (GO:0031579),0.6629492959777322,1.5389942786006807,0.022486772486772486,0.21977315630363742,1.0,6/15,16.47%,RFTN1;FLOT2;CLN3;ABCA7;NPC1;MYADM
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.5556319659299049,1.5389063937529577,0.011982570806100218,0.2189498803619514,1.0,12/48,11.70%,FNIP2;BCL2;BCL2L1;MCL1;DYRK2;IKBKE;BCL2L11;BRCA1;AEN;BAX;HIPK1;TNFRSF1B
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.5131710571733973,1.5363519705631932,0.0010141987829614604,0.22419691626647498,1.0,43/113,25.42%,LGALS3;FNIP2;LCP1;SKAP1;ABCA1;PLEK;ASAP1;CAPG;EIF4G1;NRG1;PIEZO1;ERCC1;BID;VEGFA;BCL2L11;DDB2;RACK1;VCP;DDB1;BAX;PSMC3;XPA;CLU;ERCC4;PSMC6;SYK;TFRC;TIRAP;DHX33;GTF2H1;ATM;FERMT2;IL5;TERF1;RPS3;BIK;GSK3B;TRABD2B;USP50;TNF;SUMO1;GTF2H5;CUL4A
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.6219978903268369,1.5359061630091864,0.0161090458488228,0.22424775332804095,1.0,11/22,24.29%,APOE;ADAM8;SNX33;TNFRSF1B;TIMP4;ROCK1;TIMP2;FURIN;SH3D19;TIMP1;TNF
prerank,response to amyloid-beta (GO:1904645),0.5612977515926044,1.5353265096624933,0.006644518272425249,0.22474655208200298,1.0,12/44,10.28%,CACNA1A;IGF1;LRP1;MMP12;FPR2;MMP9;CDK5;ITGA4;TREM2;ATP1A3;IGF1R;FYN
prerank,amyloid precursor protein metabolic process (GO:0042982),0.6384795866047426,1.534463166848902,0.012903225806451613,0.22593361528497544,1.0,6/18,10.88%,APOE;ABCG1;KLK6;PSEN2;ADAM17;CLN3
prerank,positive regulation of histone methylation (GO:0031062),0.601703223415057,1.5344038468473973,0.022304832713754646,0.2250223608346572,1.0,12/24,18.73%,CTNNB1;KMT2A;FAM47E;DNMT1;MTF2;BRCA1;WDR5;OGT;PHF1;CHTOP;PAF1;DNMT3B
prerank,folic acid-containing compound metabolic process (GO:0006760),0.6429596798309584,1.5340298130192096,0.019753086419753086,0.2249072726314476,1.0,10/19,19.45%,MTHFD2;SLC46A1;MTHFS;SHMT1;MTHFD1;FPGS;GGH;MTRR;SLC19A1;ALDH1L2
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.5464225845390643,1.5334212478462743,0.008771929824561403,0.22556841774904704,1.0,19/48,17.73%,HIF1A;P2RX4;ANXA1;TMSB4X;HDAC9;HDAC7;FGF2;HSPB1;ANGPT4;PDPK1;VEGFA;ANGPT1;ADAM17;HMOX1;FGF18;PRKD2;KDR;MAP2K3;SP1
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.5923206495747232,1.5322017573512603,0.015909090909090907,0.2276255157029002,1.0,7/29,9.55%,CD300LF;UBA52;TANK;RPS27A;TRAF3;IKBKE;TICAM1
prerank,regulation of anoikis (GO:2000209),0.6336670475901119,1.531837791672826,0.027848101265822784,0.22751398565186554,1.0,7/19,17.00%,BCL2;ITGA5;MCL1;CAV1;SIK1;TLE5;MYBBP1A
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.7288615668397715,1.531615548503418,0.026027397260273973,0.22703685701756676,1.0,6/10,21.40%,FN1;CD24;LILRB1;FURIN;LAPTM4B;HSP90AB1
prerank,cellular response to peptide (GO:1901653),0.5395788733796621,1.531400971842139,0.0010822510822510823,0.22650988144470788,1.0,13/56,8.00%,CACNA1A;IGF1;LRP1;FPR2;VIM;CDK5;ITGA4;CAV1;PTPN22;RPL23;TREM2;ATP1A3;IGF1R
prerank,positive regulation of organelle assembly (GO:1902117),0.5545138214005435,1.5308994688920843,0.010857763300760043,0.2267546423602019,1.0,22/44,26.22%,LCP1;SDCBP;ASAP1;CAPG;KCTD17;DYNC1H1;HTT;PDCD6IP;NUMA1;PLK4;RALB;RAB3GAP2;IL5;CNOT6;MARK4;CEP120;G3BP1;CCDC88A;TNF;SDC4;RAB3GAP1;CNOT6L
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.5491453652803635,1.5304086557018612,0.0067039106145251395,0.22701065500602394,1.0,26/48,24.54%,ERCC6;ZMIZ1;SPHK2;CDCA4;TAF1D;DDX21;ZMIZ2;POLR1G;POLR2H;H1-0;ACTB;ELOF1;DEK;POLR1A;MYBBP1A;TBP;WBP2;BAZ1B;ARID1B;TAF1A;SERTAD1;ATAD2B;TAF1C;POLR1F;SF3B1;POLR2F
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.5192553536768153,1.5300929519999646,0.0031120331950207467,0.22672637514279756,1.0,34/88,25.33%,LGALS3;FNIP2;PLEK;SDCBP;ATP13A2;NRG1;CLDN19;ERCC1;BID;VEGFA;BCL2L11;PDCD6IP;RACK1;VCP;BAX;RAB7A;VPS4B;LIMK1;CLU;TPR;SLX4;SYK;TFRC;TIRAP;RPS3;EMILIN1;BIK;GSK3B;PFN1;TRABD2B;TNF;SUMO1;SDC4;CX3CL1
prerank,positive regulation of ATP metabolic process (GO:1903580),0.5818025569552652,1.5296507080805064,0.012557077625570776,0.22690944585274217,1.0,8/32,13.57%,IGF1;HIF1A;TMSB4X;PFKFB3;TREM2;VCP;ENO1;ENTPD5
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.7087200170010847,1.5295021650930378,0.02368421052631579,0.2262225065419342,1.0,5/11,16.00%,PLAUR;PRKCQ;JAK1;CCL5;SYK
prerank,response to lipid (GO:0033993),0.5104236613181377,1.5282191202374455,0.004056795131845842,0.22836377534349941,1.0,26/105,16.11%,S100A8;CTNNB1;SPP1;S100A9;ABCG1;ANXA1;TRIM6;CD6;CYP19A1;CYP27B1;PPARG;PTPN22;SOX9;ERBIN;NOCT;TRIM16;MAPKAPK3;PPARD;ADAM17;MAPKAPK2;VPS4B;PCK2;RBP4;ASXL1;FOXO1;TIRAP
prerank,regulation of T cell differentiation (GO:0045580),0.5709795584811598,1.5264948329829127,0.010380622837370242,0.2316885268092771,1.0,14/33,19.64%,ZMIZ1;TCF7;TBX21;CD2;RUNX1;GATA3;METTL3;CRTAM;CCR2;CLPTM1;SPINK5;CAMK4;FANCA;IL2
prerank,T cell activation involved in immune response (GO:0002286),0.6923440070858252,1.5257116554501056,0.0324254215304799,0.23280464352001418,1.0,7/12,25.39%,LCP1;ITGAL;LILRB1;FCER1G;SLC11A1;CD74;MDK
prerank,regulation of phagocytosis (GO:0050764),0.5334074684229557,1.5249607020669111,0.00866738894907909,0.233794264568906,1.0,19/53,19.58%,CYBA;IL2RB;FPR2;SIRPA;DOCK2;PTPRC;FGR;FER1L5;APOA2;SPHK1;TREM2;RACK1;GAS6;ABCA7;SYK;LMAN2;LYAR;FCER1G;SLC11A1
prerank,mitochondrion distribution (GO:0048311),-0.5509978622497481,-1.5232856627615432,0.06349206349206349,0.5170079910248587,1.0,8/12,20.91%,MEF2A;LRRK2;ATCAY;HAP1;MSTO1;ARMC1;DNM1L;TRAK2
prerank,cellular response to interleukin-6 (GO:0071354),-0.4640809094558579,-1.5227403710606406,0.04216867469879518,0.5076998976198746,1.0,7/26,5.98%,SELPLG;IL6R;ST3GAL6;FER;RELA;STAT3;ST18
prerank,glycolipid metabolic process (GO:0006664),0.5447062078544679,1.5224491985733863,0.009922822491730982,0.2392111684951777,1.0,20/47,18.92%,CTSA;CERK;ESYT1;PSAP;HEXA;GLB1;GLTP;UGCG;GALC;PGAP1;SMPD4;ST8SIA6;ARSA;GLA;FUCA1;NEU1;B4GALNT1;SMPD1;ASAH1;GBA2
prerank,epidermal cell differentiation (GO:0009913),0.5571122406303928,1.5223467872403738,0.015384615384615385,0.2385154939350618,1.0,9/41,9.67%,CTNNB1;ANXA1;ST14;OVOL1;JAG1;CLIC4;HDAC1;UGCG;EVPL
prerank,platelet aggregation (GO:0070527),0.5807899733052141,1.522057312817031,0.02054794520547945,0.2382107388686186,1.0,12/33,14.16%,FN1;TLN1;PLEK;FLNA;PIK3CB;MYL9;HSPB1;ACTN1;ACTG1;ILK;ACTB;PPIA
prerank,triglyceride metabolic process (GO:0006641),0.5411689140593556,1.5217522841980295,0.003289473684210526,0.237998008591102,1.0,11/48,11.04%,LPL;APOE;FABP5;PLAAT3;GK;APOA2;SLC27A5;CAV1;APOBR;LPGAT1;APOC1
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.7265766359972431,1.5197749892870112,0.02886002886002886,0.2422166797673023,1.0,5/10,26.12%,SAG;PDE6B;CNGB1;GNB1;PDE6G
prerank,positive regulation of telomere maintenance (GO:0032206),0.5807985553764686,1.519725402239926,0.0178359096313912,0.24135106731932082,1.0,13/31,18.50%,PRKCQ;TNKS2;ERCC1;RAD50;PKIB;HNRNPA2B1;SLX4;DHX36;PPP1R10;ATRX;ATM;GNL3;RTEL1
prerank,AMP metabolic process (GO:0046033),0.6808650475726259,1.5191597732336006,0.028314028314028315,0.24162031885944016,1.0,7/13,24.99%,XDH;AK4;AK3;AMPD2;ADSS1;NUDT2;ADSL
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.5985469743448706,1.5183168266710236,0.022592152199762187,0.24271289414562414,1.0,4/26,2.66%,BCL2;BCL2L1;EYA4;MCL1
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.7244019483396016,1.518237107149627,0.024657534246575342,0.24193101170190653,1.0,4/10,8.96%,FPR2;FGR;CD24;LILRB1
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.6635365354676566,1.5166663218073446,0.031578947368421054,0.24485466237712875,1.0,8/15,16.15%,P2RX4;TMSB4X;FGF2;HSPB1;VEGFA;FGF18;PRKD2;KDR
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.578881731933623,1.5160558897960803,0.015855039637599093,0.24535780022272058,1.0,16/33,29.00%,NFE2L2;PDPK1;GATA3;ANGPT1;CAST;SERPINE1;TNIP2;GAS6;KDR;WFS1;KRIT1;MAPK7;MDK;PAK4;TNFAIP3;NDNF
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.5223383882531184,1.515670778678495,0.007368421052631579,0.24534152731217468,1.0,31/70,28.23%,CYBA;PSMD8;PSMD1;CYBB;SEC22B;TAPBP;PSMD6;PSMA1;NCF4;B2M;PSMC3;PSMA8;PSMD14;PSMD2;PSMC6;PSMA6;PSMD5;PSMA5;FCER1G;CALR;PSMA3;PSMB8;PSMB10;NCF2;PSMD7;PSMB6;NCF1;PSMD10;PSMB5;VAMP3;PSMB7
prerank,phospholipid homeostasis (GO:0055091),0.7104004333791654,1.515071889747476,0.03163686382393398,0.24572367445943188,1.0,5/11,14.60%,ABCG1;ABCA1;TLCD1;TLCD2;RCN3
prerank,fatty acid transmembrane transport (GO:1902001),0.6324375308146756,1.514949669852146,0.025798525798525797,0.24508853628320723,1.0,10/19,18.63%,SLC27A1;ACACA;SLC27A5;SLC2A1;ABCD4;ABCD2;MID1IP1;ABCD3;CPT2;ACACB
prerank,intestinal lipid absorption (GO:0098856),0.6947418738356353,1.5146044407572978,0.03576341127922971,0.24500836415463562,1.0,3/11,11.34%,CEL;UGCG;SOAT2
prerank,triglyceride catabolic process (GO:0019433),0.6193789415452923,1.513268168737761,0.02111801242236025,0.24755370584877512,1.0,2/19,1.30%,LPL;FABP5
prerank,regulation of stem cell differentiation (GO:2000736),0.5071676157794155,1.513048200984127,0.00510204081632653,0.24706433901893485,1.0,39/89,29.34%,KMT2A;PSMD8;PSMD1;TCF15;JAG1;RUNX1;GATA3;PUS7;PSMD6;PSMA1;PSMC3;METTL3;PSMA8;PSMD14;PSMD2;SETD1A;SP7;YTHDF2;PSMC6;PSMA6;PSMD5;TCF12;HNRNPU;PSMA5;NSUN2;HOXB4;PSMA3;SMYD5;PSMB8;PDGFRA;PSMB10;PSMD7;PSMB6;PSMD10;HES1;PSMB5;PSMB7;NUDT21;PSMC4
prerank,regulation of calcium-mediated signaling (GO:0050848),0.5920623312164034,1.512777311193132,0.035629453681710214,0.24680021145127884,1.0,7/25,7.45%,PLEK;P2RX4;CCL4;CD22;TRAT1;TREM2;HTT
prerank,pre-replicative complex assembly (GO:0036388),0.5321275088625061,1.5103945079718586,0.004232804232804233,0.2520225803750335,1.0,29/64,28.23%,PSMD8;PSMD1;ORC3;UBA52;RPS27A;MCM7;MCM2;GMNN;PSMD6;PSMA1;PSMC3;PSMA8;PSMD14;PSMD2;PSMC6;PSMA6;PSMD5;PSMA5;UBC;MCM6;MCM8;PSMA3;PSMB8;PSMB10;PSMD7;PSMB6;PSMD10;PSMB5;PSMB7
prerank,lymphocyte proliferation (GO:0046651),0.6132789699717793,1.5101005203608113,0.01707317073170732,0.2517171201841917,1.0,5/22,7.88%,BCL2;ELF4;PTPRC;MSN;RASGRP1
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.5955139683821244,1.5093781401546071,0.024504084014002333,0.2525795288090573,1.0,12/26,21.65%,CYBA;LTF;WDFY1;MFHAS1;CAV1;PTPN22;TREML4;RSAD2;TIRAP;NINJ1;HMGB1;LBP
prerank,sodium ion homeostasis (GO:0055078),0.6072741518684328,1.509111481593333,0.030303030303030304,0.25229409001584446,1.0,5/21,7.31%,SLC9A1;ATP1B3;ATP1A4;ATP1A3;ATP1A1
prerank,positive regulation of macrophage activation (GO:0043032),0.636308865358056,1.509100589246536,0.034610630407911,0.25135567514944973,1.0,6/17,14.90%,STAP1;MMP8;TREM2;CEBPA;TNIP2;HSPD1
prerank,B cell activation (GO:0042113),0.5160893300968118,1.5087212107700225,0.008438818565400843,0.2514113587283485,1.0,20/68,16.60%,BCL2;LAX1;PTPRC;MALT1;HDAC9;CHRNB2;ITGA4;HDAC4;CD22;KLF6;BLNK;TPD52;RASGRP1;PRKCB;ADAM17;PTPN2;DNAJB9;HSPD1;CEBPG;LAT2
prerank,regulation of DNA binding (GO:0051101),0.5483276124589955,1.50850928209156,0.013377926421404682,0.2510162096389911,1.0,13/44,12.89%,IGF1;MMP8;PLAUR;LEF1;GZMA;DOT1L;MMP9;PPARG;MDFI;JUN;ILRUN;TFAP4;SP100
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.33189409020899363,-1.5084239293934867,0.0,0.5391647513181371,1.0,33/107,9.72%,CX3CR1;OPHN1;MEF2C;GRM7;SNCAIP;NLGN1;LRRC4C;GRIK2;DLGAP1;GRIK3;CPLX1;NRG3;RIMS1;CLSTN2;CNTNAP4;SLC8A3;GRIK4;LRRK2;GRM1;GRID2;CLSTN3;GRM5;SYT1;GRID1;SLC12A2;GRM3;CDH2;PXK;RIMS2;APP;SLC8A2;LRP8;IQSEC2
prerank,response to peptide (GO:1901652),0.5669656208685441,1.5077311001795042,0.020833333333333332,0.2520871710530942,1.0,8/33,11.69%,CACNA1A;MMP12;ANXA1;STAT4;MMP9;ERBIN;FYN;IRF5
prerank,B cell homeostasis (GO:0001782),-0.5849897770529472,-1.5074849806852528,0.078125,0.5306143507652041,1.0,4/10,7.94%,MEF2C;TNFRSF13B;DOCK10;CAMLG
prerank,intracellular sterol transport (GO:0032366),0.6679984334095741,1.5069559747413175,0.03412073490813648,0.2531499571892271,1.0,9/13,23.40%,ABCG1;ABCA1;ARV1;OSBPL2;NPC1;NPC2;STARD4;SERAC1;OSBP
prerank,actomyosin structure organization (GO:0031032),-0.35022182730251245,-1.5067887478665218,0.0,0.5218095092269592,1.0,17/75,9.40%,CAPN3;F11R;ROCK2;EPB41L4B;EPB41L2;EPB41L5;MYH10;EPB41L3;EPB41L4A;TJP1;PDCD10;MYH14;FRMD3;PGM5;CDC42BPB;PHACTR1;EPB41L1
prerank,positive regulation of synaptic transmission (GO:0050806),-0.34438330387448085,-1.5067358532067046,0.0196078431372549,0.5117728708131722,1.0,32/72,20.25%,NRXN1;NLGN1;LGMN;GRIK2;TSHZ3;GRIN2A;RIMS1;CLSTN2;SLC8A3;CACNG3;GRIN2B;CLSTN3;SYT1;RGS14;SHANK3;RIMS2;APP;HAP1;SLC8A2;CACNG8;CCL2;PRKCZ;MPP2;CLSTN1;FLOT1;SHISA7;CHRNA7;ADRA1A;NLGN2;NLGN3;KCTD13;NMU
prerank,cellular response to zinc ion (GO:0071294),0.6455566636189531,1.5066619801253893,0.03655352480417755,0.25298888977732864,1.0,10/15,19.88%,P2RX4;ATP13A2;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X
prerank,detection of mechanical stimulus (GO:0050982),0.6403303477294915,1.5063529009969299,0.032846715328467155,0.25290618692526257,1.0,5/19,10.08%,CTNNB1;PIEZO1;CSRP3;PIEZO2;JUP
prerank,mRNA stabilization (GO:0048255),0.5608719996749375,1.5061083687637202,0.01362088535754824,0.252593548521454,1.0,16/40,19.58%,TENT5C;NOCT;HNRNPC;MAPKAPK2;PABPC1;TAF15;LARP1;YBX3;SYNCRIP;EIF4ENIF1;VIP;TIRAP;HNRNPU;DHX9;TARDBP;SLC11A1
prerank,regulation of cholesterol esterification (GO:0010872),0.7098582464413713,1.5058115220464638,0.034532374100719423,0.2524823280128887,1.0,4/10,11.04%,APOE;ABCG1;APOA2;APOC1
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.43245984617491967,-1.505482818068579,0.05421686746987952,0.5050593558539828,1.0,13/27,14.02%,F11R;WASF2;PIK3R1;TMEFF2;TJP1;STMN1;SHANK3;PRKN;CLASP2;CGNL1;INPP5K;PHLDB2;ARHGAP28
prerank,glycosphingolipid metabolic process (GO:0006687),0.5501289084488626,1.5054571105948216,0.014705882352941176,0.25253593737438673,1.0,18/42,18.92%,CTSA;CERK;ESYT1;LARGE1;PSAP;HEXA;GLB1;GLTP;UGCG;GALC;SMPD4;ARSA;GLA;NEU1;B4GALNT1;SMPD1;ASAH1;GBA2
prerank,regulation of melanin biosynthetic process (GO:0048021),0.7034377483424169,1.5052104790509258,0.03783783783783784,0.2522737759487329,1.0,3/10,3.46%,MFSD12;ATP7A;TYRP1
prerank,regulation of lipid storage (GO:0010883),0.602976122397865,1.5050588757800023,0.028151774785801713,0.25177507578549396,1.0,8/22,18.40%,LPL;FBXW7;IKBKE;ALKBH7;PTPN2;C3;NFKB1;IL6
prerank,regulation of phospholipase C activity (GO:1900274),0.662578627257502,1.5046817067761777,0.03201024327784891,0.25173642139857694,1.0,4/15,7.88%,FLT1;ABL2;FGF2;RASGRP1
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.5292634481872074,1.504557863223735,0.015233949945593036,0.251078050811494,1.0,13/52,11.77%,CXXC1;TLN1;GOSR2;ATP6V0D1;EDEM1;MYDGF;ERN2;ERN1;TATDN2;LMNA;EXTL2;DCTN1;DNAJB9
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.5931211508011319,1.504447649517042,0.027348394768133173,0.2504170336445469,1.0,3/27,0.19%,XYLT1;CHST11;CSPG4
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.5888554736708794,1.5035783259186066,0.025670945157526253,0.2517079486332864,1.0,11/29,19.58%,TENT5C;PKP1;NOCT;PABPC1;DHX34;TAF15;LARP1;EIF4ENIF1;VIP;HNRNPU;SLC11A1
prerank,superoxide anion generation (GO:0042554),0.6793114620060414,1.5030307000503778,0.037283621837549935,0.2521532411551931,1.0,4/13,9.47%,CYBA;CYBB;TAFA4;NCF4
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.6760453765496697,1.5022171479853577,0.03129074315514994,0.253598788919014,1.0,8/13,23.52%,RENBP;GNPNAT1;GNPDA1;NAGK;UAP1L1;GNPDA2;UAP1;AMDHD2
prerank,positive regulation of T cell activation (GO:0050870),0.5230706860283522,1.5020098536313378,0.00946372239747634,0.253178036914093,1.0,17/62,11.65%,LCK;CD3E;ZMIZ1;SIRPA;PTPRC;ANXA1;PRKCQ;SLC7A1;CD6;CD28;NCK2;CD274;GATA3;NCK1;FLOT2;CCR2;CCL5
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.5881273282501923,1.500841676426379,0.022673031026252982,0.2553336578984461,1.0,5/26,10.58%,IGF1;OSBPL8;NR4A3;RHOQ;C3
prerank,regulation of cellular amine metabolic process (GO:0033238),0.540997884077963,1.5007636773884117,0.013114754098360656,0.2546166548113039,1.0,25/50,29.34%,PSMD8;PSMD1;AZIN1;PSMD6;PSMA1;OAZ3;PSMC3;PSMA8;PSMD14;PSMD2;PSMC6;PSMA6;ODC1;PSMD5;PSMA5;PSMA3;PSMB8;PSMB10;PSMD7;PSMB6;PSMD10;PSMB5;NQO1;PSMB7;PSMC4
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.7154376209765141,1.4984231112067843,0.029535864978902954,0.260197116238708,1.0,4/10,14.57%,HIF1A;ITGA5;PRKCB;PRKD2
prerank,cellular zinc ion homeostasis (GO:0006882),0.5932318518296783,1.4978055805048005,0.018867924528301886,0.2609662288396254,1.0,13/26,19.88%,LCK;ATP13A2;SLC39A6;SLC39A7;SLC30A9;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X
prerank,positive regulation of growth (GO:0045927),0.5211400252265288,1.497542591719909,0.006362672322375398,0.260660827801616,1.0,18/64,17.22%,BCL2;RFTN1;S100A8;S100A9;SDCBP;EIF4G1;SPHK1;EXOSC4;SLC25A33;EIF4G2;ADAM17;DDX49;EXOSC9;CDC42;CXCL16;INO80;USP47;WFS1
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.5912633682332452,1.4969243183087724,0.030952380952380953,0.2612675678101416,1.0,12/25,20.96%,LYST;CHMP4A;CHMP4B;VCP;VPS4B;VTA1;CHMP7;MVB12A;TMEM50B;CHMP6;LAPTM4B;UBXN6
prerank,regulation of mRNA stability (GO:0043488),0.49053189402822744,1.4964429428095478,0.0,0.2615209894139636,1.0,73/145,32.39%,PSMD8;PSMD1;UBA52;TENT5C;RPS27A;VIM;EIF4G1;PRKCD;HSPB1;EXOSC4;NOCT;CELF1;PSMD6;PSMA1;MAPKAPK2;PABPC1;PSMC3;METTL3;TAF15;YTHDF3;PSMA8;EXOSC9;LARP1;XPO1;HSPA8;PCBP4;DCP1A;ROCK1;PSMD14;PSMD2;EIF4ENIF1;YTHDF2;VIP;PSMC6;PSMA6;DHX36;FXR2;PUM1;PSMD5;HNRNPU;YWHAB;PSMA5;EXOSC5;SLC11A1;UBC;FASTKD3;NPM1;SAMD4A;GIGYF2;XRN1;PSMA3;PSMB8;TNPO1;KHSRP;PSMB10;YWHAZ;PSMD7;PSMB6;PSMD10;RC3H1;FUS;PSMB5;PSMB7;RIDA;PSMC4;NUP214;SAMD4B;PSMD12;SET;DCP2;CIRBP;PSMD3;UBB
prerank,positive regulation of endocytosis (GO:0045807),0.5401795172583304,1.4961998625112432,0.00972972972972973,0.2612706447994354,1.0,18/45,16.05%,APOE;STAP1;LRP1;AXL;DAB2;TREM2;ABCA13;B2M;HIP1;C3;CLN3;SERPINE1;HNRNPK;CDC42;CLU;CBL;SMPD1;APPL2
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.5736560706387968,1.4957435179228684,0.03481392557022809,0.2614972661985657,1.0,9/30,9.62%,PTPRC;PRKCD;CAV1;PPP2R1A;SAMSN1;MVP;CD300A;PTPN2;CADM4
prerank,muscle contraction (GO:0006936),0.4961530854572156,1.4951605773012595,0.003048780487804878,0.26208903521450516,1.0,26/126,15.17%,MYOF;MYOM3;TLN1;ASPH;TNNT3;CHRNB2;ALDOA;SNTB1;VIM;EDNRA;TPM2;SGCA;SCN4A;MYL9;SLC6A8;TPCN2;PABPN1;LTB4R;TPM4;UTRN;DTNA;ROCK1;CLCN1;ACTA2;SORBS1;ARHGEF11
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.5437137137147903,1.494687491685056,0.013452914798206279,0.2624318613245728,1.0,23/41,29.50%,HIF1A;NUP205;EIF6;GCK;GCKR;NUP188;OGT;RANBP2;TPR;PRKAG1;RAE1;NUP93;AAAS;SLC2A6;NUP54;JMJD8;NUP50;NUP98;NUP42;NUP133;NUP210;NUP35;NUP214
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.5210825346442403,1.494238770701636,0.012671594508975714,0.26268037634476654,1.0,29/61,29.44%,PSMD8;PSMD1;NCOR2;AZIN1;CAV1;PSMD6;PSMA1;OAZ3;PSMC3;SIRT5;PSMA8;PSMD14;PSMD2;PSMC6;PSMA6;ODC1;PSMD5;PSMA5;PSMA3;PSMB8;PSMB10;PSMD7;PSMB6;PSMD10;PSMB5;NQO1;PSMB7;PSMC4;SIRT1
prerank,phospholipid transport (GO:0015914),0.5315292103554695,1.494110399096595,0.017391304347826087,0.2620815199542196,1.0,14/52,13.05%,OSBPL8;APOE;ABCG1;ABCA1;APOA2;ATP8B4;ABCA4;ATP9B;TRIAP1;APOC1;PITPNC1;OSBPL2;PRELID2;ABCA7
prerank,proton transmembrane transport (GO:1902600),0.5599745790243502,1.493270335318695,0.01380897583429229,0.26348126772775926,1.0,17/36,25.91%,SLC9A1;ATP6V1A;ATP6V0D1;UCP2;SLC36A3;SLC46A1;ATP1A4;ATP1A3;ATP1A1;ATP6V1F;SLC25A14;ATP1A2;ATP6V0C;ATP6V0A4;ATP5F1B;ATP6V0E1;ATP5MF
prerank,positive regulation of ruffle assembly (GO:1900029),-0.5267749809216039,-1.492919723692532,0.07509881422924901,0.5312184565311215,1.0,3/13,1.82%,P2RY12;NLGN1;EPS8
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.6501484709071207,1.49193176291879,0.02987012987012987,0.26626412915420333,1.0,6/14,11.65%,CCL4;PTK2B;ADAM17;CCR2;CCL7;CCL5
prerank,dendrite morphogenesis (GO:0048813),-0.4101556333518137,-1.4915499595916863,0.0,0.5249624974480512,1.0,13/35,12.73%,CTNNA2;CTNND2;BTBD3;MEF2A;EPHB1;DOCK10;SHANK3;MAP2;MAP6;PHACTR1;DCDC2;KLF7;PAK3
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.5310869696757105,1.4914006078123736,0.007462686567164179,0.26668443241519824,1.0,12/55,9.98%,BCL2;S100A8;S100A9;LCK;BCL2L1;DEDD2;TRAF2;CAV1;BID;BCL2L11;RACK1;BAX
prerank,androgen receptor signaling pathway (GO:0030521),0.689872603041025,1.49134078915766,0.0492676431424767,0.26592021533815363,1.0,5/11,8.77%,ZMIZ1;RNF14;DAXX;DDX17;KDM3A
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.5144120295629694,1.4912748875845392,0.007423117709437964,0.2651819787605842,1.0,30/70,28.23%,KMT2A;PSMD8;PSMD1;TCF15;RUNX1;GATA3;PUS7;PSMD6;PSMA1;PSMC3;METTL3;PSMA8;PSMD14;PSMD2;SETD1A;YTHDF2;PSMC6;PSMA6;PSMD5;TCF12;PSMA5;PSMA3;PSMB8;PSMB10;PSMD7;PSMB6;PSMD10;PSMB5;N4BP2L2;PSMB7
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.5492916521607831,-1.490735374838444,0.08695652173913043,0.5176030906621671,1.0,5/12,7.80%,RIMS1;UNC13B;SYT1;SYT2;RIMS2
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.5576316901524296,1.4905378750548826,0.02531645569620253,0.266295504515745,1.0,10/34,15.38%,RAB7B;CD300LF;GRAMD4;MFHAS1;TREM2;OTUD4;CD300A;TICAM1;SARM1;ACOD1
prerank,cell projection assembly (GO:0030031),0.6092786844995044,1.489779010198051,0.019559902200488997,0.2675459957348614,1.0,9/22,12.86%,CAPG;PDGFA;SCIN;RHOQ;RHOG;PARVA;GSN;RHOU;CDC42
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.5178648560903447,1.489316943245299,0.0041753653444676405,0.2677731893269627,1.0,31/73,24.48%,S100A8;S100A9;LCK;TRAF2;XDH;TNFSF15;MTCH1;PPARG;BID;DLC1;DIABLO;RACK1;VCP;BAX;HIP1;DAP;HSPD1;APAF1;CASP4;HIP1R;CASP9;CRADD;LAPTM5;TNFSF10;SENP1;EGLN3;F2R;HSPE1;ANP32B;TNF;JAK2
prerank,aminoglycan metabolic process (GO:0006022),0.71576858281241,1.4892885363654038,0.0326975476839237,0.26694296422510033,1.0,3/10,10.43%,XYLT1;B4GALT7;B3GALT6
prerank,regulation of viral genome replication (GO:0045069),0.5302037524957487,1.4892682744322594,0.011752136752136752,0.2661080753568765,1.0,24/56,19.32%,LTF;ADARB1;SHFL;SRPK1;TNIP1;TRIM6;CD28;IFITM2;IFITM1;RNASEL;PABPC1;DDB1;CCL5;LARP1;PKN2;ILF3;RSAD2;PPIA;VAPB;ZC3HAV1;PPIE;ISG20;ADAR;BST2
prerank,endomembrane system organization (GO:0010256),0.4818342061335253,1.4890117133405973,0.0010070493454179255,0.2659236791985533,1.0,63/178,25.50%,MYOF;PLEKHM2;ARHGAP21;SYNE1;OPTN;ALS2;FER1L5;ATP8B4;SQSTM1;GOLGB1;SYNGR1;TLCD1;CTDNEP1;TOR1AIP2;WASHC5;ARL1;PI4K2A;TRAPPC8;SNX33;HTT;HOOK1;SMPD4;TLCD2;VPS18;SNX10;COG4;LEMD2;GAK;ARFGEF2;REEP3;DOP1B;HUWE1;LMAN1;OSBPL2;CDC42;PLEKHF1;VPS11;ALS2CL;VAPB;CSNK1D;AP3D1;RAB22A;RAB1A;TRAPPC11;HOOK3;VPS51;TBC1D20;ARFGEF1;LMAN2;SUN1;LAPTM4B;NUP93;SRGN;TMED3;TOR1B;USP50;GOLPH3;SYNGR2;USP8;MAPK15;TRAPPC12;GOLGA2;PLEKHJ1
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.5377194023241542,-1.488670704549248,0.08943089430894309,0.5133790671089622,1.0,5/13,7.13%,TMEM30A;SORL1;CD81;INSIG1;SAR1B
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.661196263361629,1.4882364300468869,0.05660377358490566,0.26711741961795876,1.0,11/13,30.52%,NCK1;RACK1;DNAJB9;ABCA7;BFAR;PPP1R15B;WFS1;PPP1R15A;HSPA5;UFL1;PTPN1
prerank,positive regulation of glucose import (GO:0046326),0.605625164897373,1.4875154191835844,0.035108958837772396,0.2682493045141311,1.0,2/21,0.09%,IGF1;OSBPL8
prerank,positive regulation of viral process (GO:0048524),0.522239678628092,1.4871445437496076,0.010638297872340425,0.2683957417029287,1.0,28/60,27.98%,MDFIC;ADARB1;SRPK1;AXL;CD28;POLR2H;PABPC1;DDB1;KPNA6;RAB7A;CCL5;LARP1;PKN2;GTF2F1;PPIA;POLR2D;VAPB;PPIE;TBC1D20;DHX9;ADAR;SRPK2;POLR2F;TMEM39A;TARBP2;PPIH;SUPT4H1;RSF1
prerank,regulation of keratinocyte proliferation (GO:0010837),-0.4625941287067894,-1.486976364091373,0.043010752688172046,0.5088910305014527,1.0,8/22,10.53%,CASK;FGF10;EPB41L4B;PTPRK;NOTCH2;KLF9;STXBP4;PRKD1
prerank,triglyceride homeostasis (GO:0070328),0.5772975910822252,1.4869745593215458,0.03150525087514586,0.2679952161861368,1.0,4/26,5.01%,LPL;APOE;GCKR;APOC4
prerank,morphogenesis of an epithelium (GO:0002009),0.5939861490621833,1.4868178735091189,0.022565320665083134,0.2675205268192329,1.0,13/25,26.04%,DAG1;TBX18;SOX9;ACTG1;ACTB;ARHGAP12;LRP6;LAMA5;RIPK4;LAMA3;FGFR2;SOX10;TRAF3IP1
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.5125236987002446,1.486256046818983,0.007246376811594203,0.26809054001489496,1.0,14/74,12.36%,LGALS3;IGF1;BCL2;BCL2L1;EYA4;TRAF2;MCL1;SIAH2;HTT;BRCA1;HMOX1;SERPINE1;BIRC6;TMBIM1
prerank,lipoxygenase pathway (GO:0019372),-0.5080014268713576,-1.4858767256723762,0.0603448275862069,0.5027347268733753,1.0,4/14,4.19%,HPGD;LTC4S;ALOX5;PON3
prerank,regulation of cellular component movement (GO:0051270),0.5345382886413189,1.48531248773566,0.015217391304347827,0.269894064304811,1.0,18/49,15.07%,CD9;CDK6;ABL2;PDPN;NRG1;RAF1;ACTN1;VEGFA;ADAM17;CADM4;DIAPH1;RHOA;MEMO1;SP100;PKN2;ROCK1;RPS19;ZSWIM8
prerank,phosphatidylserine metabolic process (GO:0006658),0.5606978126608236,1.4849284144331303,0.03541912632821724,0.27005262125645574,1.0,4/32,4.27%,OSBPL8;SLC27A1;PLAAT3;ABHD12
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.6920916024366754,1.4846741718286418,0.037283621837549935,0.2698278754704282,1.0,4/11,7.29%,P2RX4;CCL4;TRAT1;TREM2
prerank,cellular response to interleukin-12 (GO:0071349),0.5352641618167665,1.484432622767811,0.01,0.2696144342260711,1.0,21/48,24.48%,LCP1;SIRPA;MSN;STAT4;GSTA2;IL12RB1;P4HB;JAK1;CDC42;PAK2;HNRNPA2B1;PPIA;HSPA9;PDCD4;HNRNPF;CFL1;SOD2;CD47;TALDO1;MIF;JAK2
prerank,cellular response to insulin stimulus (GO:0032869),0.4902605330206081,1.4840335375372844,0.0010193679918450561,0.2698214752322264,1.0,31/124,12.39%,BCAR3;MYO5A;TCIRG1;EPRS1;ATP6V1C1;ATP6V0D2;SLC27A1;ATP6V1A;PKM;HDAC9;ATP6V0A1;GCK;ATP6V1B2;ATP6V0D1;ATP6V0B;ATP6V1G1;PPARG;SLC25A33;PDPK1;CPEB2;GRB2;DENND4C;IGF1R;RHOQ;ATP6AP1;PTPN2;RAB8A;RAB8B;PCK2;ATP6V1F;NAMPT
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.5540729539914562,1.4826930004051608,0.0234375,0.27265781146132473,1.0,9/40,9.77%,CTNNB1;SDCBP;LEF1;GCNT2;PDPN;GLIPR2;JAG1;DAB2;BAMBI
prerank,DNA geometric change (GO:0032392),0.5953898160206522,1.480734172619769,0.024793388429752067,0.2770246292274031,1.0,12/24,20.52%,ANXA1;ASCC3;ZRANB3;RAD50;DDX1;BLM;HNRNPA2B1;DHX36;RTEL1;DHX9;HMGB1;RECQL5
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.5267082295800655,-1.4791418335311697,0.06072874493927125,0.5127018221027275,1.0,4/12,11.22%,TUBB4A;STMN1;MAP2;DYRK1A
prerank,retinoid metabolic process (GO:0001523),0.49924821972,1.4782462871822892,0.008385744234800839,0.2828878480294982,1.0,15/71,16.13%,LPL;APOE;LRP1;RDH12;DHRS3;APOA2;ABCA4;DHRS9;AKR1B10;NAPEPLD;SCPEP1;RBP4;CYP1B1;RDH13;HSPG2
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.598007308419443,1.4779644364929767,0.033047735618115054,0.2827591777080283,1.0,5/22,10.82%,GPNMB;RAP2A;PDGFA;VEGFA;RAD50
prerank,long-chain fatty acid import into cell (GO:0044539),0.7005535950127797,1.4766742127172923,0.049247606019151846,0.2855218913360392,1.0,4/10,7.03%,SLC27A1;SLC27A5;SLC2A1;ACSL1
prerank,positive regulation of cellular component organization (GO:0051130),0.48960377684484274,1.475818650404457,0.0010214504596527069,0.2870657669040126,1.0,27/107,16.11%,LGALS3;FNIP2;PLEKHM2;APOE;LRP1;ASAP1;NRG1;CLDN19;PTPN23;BID;LRP4;RUNX1;DAB2;VEGFA;TREM2;BCL2L11;IGF1R;RACK1;VCP;BAX;DCTN1;LMAN1;CLU;SMPD1;SYK;TFRC;TIRAP
prerank,response to interferon-gamma (GO:0034341),0.5105261580390733,1.4755374089483544,0.01818181818181818,0.28699562114845173,1.0,30/67,25.33%,EPRS1;SIRPA;SHFL;CCL4;CYP27B1;IL12RB1;IFITM2;IFITM1;CCL13;IRF8;CCL7;CCL5;SP100;CCL14;CXCL16;SYNCRIP;DAPK1;ACOD1;GBP2;AQP4;DAPK3;RPL13A;BST2;SLC11A1;CD47;SLC26A6;TRIM21;CD74;KYNU;CX3CL1
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.6130406512718053,1.4738230225263937,0.05867665418227216,0.2911140554558143,1.0,8/18,20.65%,COLGALT1;PDPN;RUNX1;EFEMP2;MELTF;DDR2;IL6;EMILIN1
prerank,regulation of protein transport (GO:0051223),0.5695613104051119,1.4736741389142807,0.03456495828367104,0.29058937078026625,1.0,14/27,24.29%,LCP1;ATP13A2;RHBDF2;P3H1;RHBDF1;DNAJC1;HSPA8;LLGL2;CHP1;DISP1;SNX12;LLGL1;DNAJA1;TNF
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.6360540717611677,1.4727906849810735,0.04336734693877551,0.29216801188765723,1.0,6/15,13.52%,NR4A3;PPARG;PPARD;LPGAT1;MID1IP1;SLC45A3
prerank,phagosome maturation (GO:0090382),0.5602237583456746,1.4727813570576285,0.030269058295964126,0.2912733075705974,1.0,16/35,20.44%,TCIRG1;ATP6V1C1;ATP6V0D2;ATP6V1A;ATP6V0A1;ATP6V1B2;ATP6V0D1;ATP6V0B;ATP6V1G1;RAB32;RAB7A;ATP6V1F;ATP6V0C;PIKFYVE;ATP6V0A4;ATP6V1E1
prerank,gliogenesis (GO:0042063),0.6468641713470823,1.4723853026859006,0.04225352112676056,0.29161052346449423,1.0,3/15,1.53%,CD9;CDK6;ANXA1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.591907724064268,1.471545206557725,0.0471584038694075,0.2930833941133446,1.0,13/24,26.37%,HIF1A;ATF3;NFE2L2;MUC1;VEGFA;DDIT3;CHD6;MBTPS2;HSF1;MAPK7;ATF4;HSPA5;SESN2
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.5587888642132302,-1.4711676604932438,0.0842911877394636,0.5256051447287834,1.0,7/11,15.49%,SYNJ2BP;EPN2;ALOX5;SEMA6A;THBS1;E2F2;CREB3L1
prerank,diterpenoid metabolic process (GO:0016101),0.5117627508225109,1.4687686717593893,0.018338727076591153,0.30002725088004534,1.0,9/55,7.21%,LPL;APOE;LRP1;RDH12;DHRS3;APOA2;ABCA4;AKR1B10;NAPEPLD
prerank,defense response to Gram-positive bacterium (GO:0050830),0.536423351557084,1.4685661442419518,0.015555555555555555,0.2997285255223493,1.0,13/40,18.75%,CAMP;FGR;RNASE3;DMBT1;ADAM17;MPEG1;MBL2;TIRAP;GBP2;RNASE7;PGLYRP2;IL6;RNASE6
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.5776948139564545,1.4684837064959,0.033816425120772944,0.2990330244866556,1.0,4/23,4.51%,IGF1;NIBAN2;NRG1;PIEZO1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.6934578533902995,1.4684683021204485,0.04971590909090909,0.29725543154397616,1.0,2/10,13.66%,CNGB1;CEP250
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.6934578533902995,1.4684683021204485,0.04971590909090909,0.29725543154397616,1.0,2/10,13.66%,CNGB1;CEP250
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.6090742745459667,1.4682951795309438,0.048407643312101914,0.2968267809442538,1.0,11/19,32.16%,ZMIZ1;AXL;GATA3;GAS6;SYK;BTK;NCKAP1L;MDK;ZBTB1;XBP1;IL7
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.5985338792436928,1.4682224637828976,0.043942992874109264,0.2961453749033403,1.0,10/22,24.29%,LCK;SKAP1;GCNT2;CD44;FLOT2;MBP;MYADM;MAPK7;MAP2K5;TNF
prerank,intracellular cholesterol transport (GO:0032367),0.6329982778183025,1.4681614457869785,0.04949238578680203,0.29541593157163065,1.0,9/15,23.40%,ABCG1;ABCA1;OSBPL2;NPC1;LRP6;NPC2;STARD4;SERAC1;OSBP
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.652086981814207,1.467684175565665,0.03929024081115336,0.29591405900899875,1.0,5/14,6.35%,LCK;KCNN4;CD226;TESPA1;TRAT1
prerank,cellular transition metal ion homeostasis (GO:0046916),0.49453794714289373,1.4667706689973126,0.001037344398340249,0.2975189736571907,1.0,35/91,21.21%,LCK;FTL;LCN2;SLC31A2;ATP6V1A;ATP7A;ATP13A2;ATP6V0D1;ATP6V1G1;ATOX1;SLC46A1;HEPH;CYBRD1;TMEM199;ATP6AP1;HMOX1;FRRS1;SLC39A6;SLC39A7;SLC30A9;TFRC;BMP6;SLC11A1;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;FTH1;CAND1;CUL1;ABCB7
prerank,defense response to Gram-negative bacterium (GO:0050829),0.5361981741535196,1.466217728418373,0.020134228187919462,0.2983786950281968,1.0,16/42,21.65%,CAMP;LTF;OPTN;RNASE3;ADGRB1;TREM2;DMBT1;SERPINE1;MPEG1;RPS19;RNASE7;RPL30;IL6;RNASE6;SLC11A1;LBP
prerank,lipoprotein transport (GO:0042953),0.6925614298677891,1.4656690970272295,0.041251778093883355,0.29898781466087404,1.0,3/10,8.10%,LRP1;PPARG;PRKCB
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.5959043582982202,1.4650731084113529,0.03878787878787879,0.2997836850472497,1.0,12/22,28.23%,NFE2L2;PSMA1;PSMA8;ENC1;PSMA6;PSMA5;PSMA3;PSMB8;PSMB10;PSMB6;PSMB5;PSMB7
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.6016738952190556,1.464943621643519,0.0477326968973747,0.29924321593938463,1.0,11/20,24.50%,CCT2;HSPA4;BBS10;LONP1;CLU;HSPD1;NDUFAF1;MKKS;PTGES3;HSP90AB1;PSMG3
prerank,neurotrophin signaling pathway (GO:0038179),-0.43955234330630644,-1.4645422744710064,0.043478260869565216,0.5349742309557683,1.0,7/21,10.27%,ZFYVE27;CASP3;RAPGEF2;HAP1;NTRK2;SORT1;DDIT4
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.681095594350478,1.4644472428972535,0.05555555555555555,0.29974526784458994,1.0,2/11,3.58%,ABCG1;APOA2
prerank,response to copper ion (GO:0046688),0.6063249743001964,1.4639816853038805,0.039850560398505604,0.30020243627894,1.0,12/20,30.19%,DAXX;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;HSF1;MT2A;ATP7B
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.5537077388065187,1.4631541098877712,0.03968253968253968,0.3016692563561236,1.0,10/33,17.90%,BCAR3;PLAUR;MMP9;FBXW7;ADAM17;HIP1;DOK1;CBL;DGKD;HIP1R
prerank,actin crosslink formation (GO:0051764),0.676125376893264,1.4631259608809517,0.04582210242587601,0.3008645975412331,1.0,3/12,1.00%,GAS2L3;LCP1;FLNA
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.502036727578162,1.462486983123626,0.008421052631578947,0.30179842181558864,1.0,30/73,28.23%,KMT2A;PSMD8;PSMD1;RUNX1;GATA3;PUS7;KITLG;PSMD6;PSMA1;PSMC3;METTL3;PSMA8;PSMD14;PSMD2;SETD1A;YTHDF2;PSMC6;PSMA6;DHX36;PSMD5;TCF12;PSMA5;PSMA3;PSMB8;PSMB10;PSMD7;PSMB6;PSMD10;PSMB5;PSMB7
prerank,folic acid metabolic process (GO:0046655),0.6186414255977698,1.462282721956476,0.040740740740740744,0.3016463474350395,1.0,13/18,32.69%,MTHFD2;SLC46A1;MTHFS;SHMT1;MTHFD1;FPGS;MTRR;SLC19A1;ALDH1L2;MTHFR;SHMT2;MTHFD1L;SLC25A32
prerank,pinocytosis (GO:0006907),0.6933542832327296,1.4621686879269475,0.04172461752433936,0.301123251785614,1.0,4/10,9.25%,DOCK2;SNX33;MAPKAPK3;MAPKAPK2
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.6298043530104427,1.4619527194952895,0.03974358974358974,0.30092397545756455,1.0,7/16,15.68%,KLRC2;CD226;CADM1;RASGRP1;KLRK1;CRTAM;AP1G1
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.7013047597240584,1.461643746178542,0.043055555555555555,0.3009518117295098,1.0,3/10,10.39%,CD9;PRKCD;SERPINE2
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.694023754116597,1.4615878721544198,0.03765690376569038,0.30024209442217137,1.0,3/10,7.59%,GZMA;ETFBKMT;HP
prerank,cellular protein metabolic process (GO:0044267),0.46565698606697953,1.4604783913577706,0.0,0.3024688138210116,1.0,132/396,22.07%,IGF1;FAM20C;SPP1;APOE;FN1;ABL2;CSF1;IGFBP7;RPS12;MRPS12;LGALS1;MSRA;UBL4A;CSF2RA;UBA52;AGO2;PARP4;B4GALT7;RPS27A;TNIP1;RPS6;EIF4G1;SERPINA10;APOA2;MATN3;ENAM;FSTL3;RPS14;SFTPA1;SFTPA2;MRPL51;RPL10A;RPL18;RPS24;ANO8;IGHMBP2;SIAH2;MSRB1;RPS7;RPL41;RPL36A;RPS20;RPS26;EEF1A1;RPL23;RPL17;MRPL23;APLP2;RPS25;GNMT;DMBT1;RPL35A;LMCD1;NAPSA;RPS28;RPLP2;RPL28;P4HB;UBE2L3;PSEN2;ADAM17;RPL27A;RPL11;RPS2;ERO1A;TTF1;MRPL52;C3;RABGGTB;RPL32;BAP1;F5;MRPS15;RPL21;SPCS3;MRPL24;AFG3L2;TGM5;GAS6;RPL9;FSTL1;RPL36;RPL37;MRPS33;MRPS16;RPL38;RPS18;UBE2L6;LAMC1;MRPS7;SPPL3;RPS19;ADORA2A;RPS27;STK38;RPS23;QPCT;FURIN;MELTF;CKAP4;RPL14;RPS16;SARS1;MRPL11;WFS1;RIPK3;KLK3;RPL30;RPL31;RPL12;GSPT1;UBL5;FARSB;IL6;RPL13A;RPS9;SPARCL1;RPL4;STOML2;RRBP1;RPS3;SHISA5;TIMP1;DUSP12;RPS13;CALU;PABPC4;RPSA;CDC34;BMP4;RPL15;FBXO11
prerank,response to axon injury (GO:0048678),-0.4895343977067951,-1.4604449920351092,0.07537688442211055,0.5368404590329539,1.0,8/18,11.70%,P2RY12;GAP43;RTN4RL1;NREP;FLRT3;MORN4;APOD;SOD1
prerank,regulation of dephosphorylation (GO:0035303),-0.4955531068002891,-1.4595818405942391,0.07883817427385892,0.5306573851813247,1.0,12/15,35.21%,MTMR9;SMG6;INPP5K;SMG5;SRC;MTMR4;MTMR2;SMG7;PPP1R17;MTMR3;PPP1R16A;IGBP1
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.613620546073055,1.4591887568581758,0.04326328800988875,0.30514541072707896,1.0,9/17,21.85%,MGARP;TFPI;ATP1A3;ATP1A1;UBE2L3;ACOD1;ATP1A2;NR3C1;BMP4
prerank,neutrophil activation (GO:0042119),0.6604702826299554,1.4588505593986858,0.03664921465968586,0.3051318913442001,1.0,5/12,19.24%,CXCR2;PRKCD;CCL5;SYK;FCER1G
prerank,histone H4 deacetylation (GO:0070933),0.6960479069351964,1.4587964261449453,0.056164383561643834,0.3044386141725289,1.0,4/10,7.38%,HDAC9;RCOR1;HDAC4;HDAC1
prerank,protein-containing complex disassembly (GO:0032984),0.5139754572737919,1.4583256696147462,0.0196078431372549,0.30489161323878516,1.0,21/54,24.60%,CTNNB1;TECPR1;CAV1;RPL23;LIX1;LAMP2;LIX1L;VCP;CLN3;MAP1LC3B;FRAT1;FZD1;HSPA8;UBQLN1;LRP6;VIPAS39;GSK3B;MAP1LC3A;GABARAP;VPS16;PYM1
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.6281097383690939,1.4582555443131626,0.050913838120104436,0.30422306762244994,1.0,6/14,12.46%,CTNNB1;KMT2A;DNMT1;BRCA1;PRDM9;WDR5
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.6981065676959979,1.4580036472124207,0.03961748633879782,0.3039942953002546,1.0,8/10,27.46%,STAP1;TREM2;CD300A;C3;APPL2;ANO6;NCKAP1L;RAB31
prerank,insulin receptor signaling pathway (GO:0008286),0.5029912484217126,1.4563153707380174,0.012671594508975714,0.3081089084151861,1.0,25/69,21.45%,BCAR3;TCIRG1;ATP6V1C1;ATP6V0D2;ATP6V1A;ATP6V0A1;ATP6V1B2;ATP6V0D1;ATP6V0B;ATP6V1G1;GRB2;IGF1R;RHOQ;ATP6AP1;PTPN2;ATP6V1F;NAMPT;SORBS1;FOXO1;PIK3R2;ATP6V0C;ATP6V0A4;ATP6V1E1;BAIAP2;GSK3B
prerank,regulation of plasminogen activation (GO:0010755),0.6628800144552198,1.4557566160508257,0.043824701195219126,0.30875762824527614,1.0,7/12,17.58%,CTSZ;RUNX1;SERPINE2;ENO1;SERPINE1;MELTF;SERPINF2
prerank,protein deneddylation (GO:0000338),0.696160769527355,1.4556869611047816,0.05631868131868132,0.3080715313446276,1.0,5/10,12.27%,COPS3;COPS4;COPS8;COPS2;COPS6
prerank,cellular response to hypoxia (GO:0071456),0.4807030403615583,1.453137428821166,0.007077856420626896,0.31463369157356774,1.0,65/126,32.79%,HIF1A;PSMD8;PSMD1;UBA52;RPS27A;ADAM8;MGARP;ANGPT4;CPEB2;AK4;VEGFA;P4HB;LMNA;PSMD6;PSMA1;PGK1;PSMC3;HMOX1;HP1BP3;NDRG1;PSMA8;PSMD14;PSMD2;STOX1;UBQLN1;PSMC6;PSMA6;PSMD5;ELOB;PSMA5;PTGIS;EGLN1;UBC;EPO;VHL;EGLN3;CUL2;TERT;BNIP3;CPEB1;PSMA3;MDM2;PLK3;PSMB8;PSMB10;SFRP1;PSMD7;ACAA2;PSMB6;PSMD10;PSMB5;BNIP3L;PSMB7;NDNF;PSMC4;SIRT1;SUV39H2;EP300;PSMD12;SIRT2;CREBBP;PSMD3;UBB;ARNT;EPAS1
prerank,thyroid hormone generation (GO:0006590),-0.559760349202087,-1.451913943627115,0.08928571428571429,0.5426572631514127,1.0,7/10,34.69%,TG;CTSK;FOXE1;SLC5A5;CPQ;DUOX1;DIO2
prerank,retina homeostasis (GO:0001895),0.5794431919612023,1.4512465136357018,0.037383177570093455,0.31932927417556006,1.0,10/23,18.60%,LTF;HSPB1;PRDX1;ACTG1;B2M;CNGB1;ACTB;POTEF;SLC28A2;JCHAIN
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.6799214339098337,1.4509392314843195,0.05756358768406961,0.31932479225253296,1.0,4/11,12.06%,COLEC12;RFTN1;TICAM1;TNIP2
prerank,regulation of vacuole organization (GO:0044088),0.5975530843003038,1.4506858244830358,0.04539877300613497,0.31918249816614874,1.0,9/20,20.62%,NPRL2;ENO1;RAB5A;ENO2;IFT88;TBC1D12;PIKFYVE;NPRL3;LAPTM4B
prerank,regulation of mRNA catabolic process (GO:0061013),0.4800897194908527,1.4504555230845753,0.0030581039755351682,0.31897366208914857,1.0,60/121,32.39%,PSMD8;PSMD1;UBA52;RPS27A;VIM;EIF4G1;PKP1;PRKCD;HSPB1;EXOSC4;PSMD6;PSMA1;MAPKAPK2;PABPC1;PSMC3;YTHDF3;PSMA8;EXOSC9;XPO1;HSPA8;PCBP4;DCP1A;PSMD14;PSMD2;YTHDF2;PSMC6;ZC3HAV1;PSMA6;DHX36;FXR2;PUM1;PSMD5;YWHAB;PSMA5;EXOSC5;UBC;SAMD4A;XRN1;PSMA3;PRR5L;PSMB8;TNPO1;KHSRP;PSMB10;YWHAZ;PSMD7;PSMB6;PSMD10;RC3H1;PSMB5;PSMB7;PSMC4;NUP214;SAMD4B;PSMD12;SET;DCP2;PSMD3;ZC3H12A;UBB
prerank,cellular response to cadmium ion (GO:0071276),0.5820645141264912,1.4493462187885442,0.04,0.3213313198817061,1.0,18/24,30.69%,MMP9;DAXX;JUN;MAPK9;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;HSF1;SUMO1;MT2A;NCF1;MAPK3;MAPK1
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.6764582966496291,1.4491932278248685,0.044444444444444446,0.32090571020565095,1.0,5/10,14.19%,XDH;PIK3CB;HRG;CADM4;DCN
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.619040694042867,1.4491749955287994,0.03689567430025445,0.3200734347328966,1.0,7/17,15.68%,KLRC2;CD226;CADM1;RASGRP1;KLRK1;CRTAM;AP1G1
prerank,membrane depolarization (GO:0051899),0.547486101825407,1.4491663359707445,0.03263403263403263,0.3192429201470549,1.0,5/32,5.32%,CACNA1A;P2RX4;CHRNB2;SCN4A;CAV1
prerank,cellular response to alcohol (GO:0097306),0.5300961721626813,1.4491192966811213,0.030033370411568408,0.3185193031991747,1.0,20/42,25.22%,CTNNB1;ADCY8;ADCY3;PTGFR;SPHK2;ADCY7;CDH1;BRCA1;JUP;LARP1;BLM;ADAM15;LRP6;GRAMD1B;GNB1;MLC1;PTGER4;AHR;GOLPH3;SFRP1
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.4770778763341301,-1.4490980483559177,0.06989247311827956,0.5418999608758083,1.0,5/18,5.78%,GNA15;CHRM2;RGS10;PLCB1;CHRM3
prerank,regulation of lymphocyte differentiation (GO:0045619),0.6114586393943308,1.4490779979580533,0.053217821782178217,0.3177637330346657,1.0,10/18,25.90%,IKZF3;TBX21;CD2;METTL3;CRTAM;CCR2;SPINK5;PRELID1;NCKAP1L;TLR9
prerank,regulation of cholesterol efflux (GO:0010874),0.5587979261468408,1.44888569934931,0.041666666666666664,0.3175158954037312,1.0,7/30,7.29%,APOE;LRP1;EEPD1;PON1;CAV1;PPARG;TREM2
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.5817246209641096,1.4488181741096788,0.050970873786407765,0.3168521905142384,1.0,5/23,14.17%,PLEK;GCK;HDAC4;SIK1;GIT1
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.48367303451192944,1.448732709147624,0.006122448979591836,0.3162687005772718,1.0,53/109,29.43%,PSMD8;ITK;GRAP2;PSMD1;PRKCQ;MALT1;LAT;TEC;PIK3CB;MS4A2;NR4A3;PDPK1;GRB2;TAB1;PSMD6;PSMA1;PSMC3;JUN;PSMA8;PAK2;PSMD14;PSMD2;MAP3K1;NFKB1;MAPK9;PSMC6;PSMA6;SYK;LAT2;PIK3R2;PSMD5;PSMA5;FCER1G;GAB2;NFATC3;FBXW11;CUL1;VAV3;PSMA3;PPP3R1;PSMB8;BTK;VAV1;PSMB10;PSMD7;PSMB6;BTRC;PSMD10;PSMB5;PSMB7;MAPK3;PSMC4;TAB2
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.6760645747089152,1.4486676464213335,0.06613756613756613,0.3156064380301604,1.0,4/11,16.00%,CTNNB1;FZD1;LRP6;NR4A2
prerank,regulation of leukocyte activation (GO:0002694),0.6462160742502747,1.4476413758221114,0.048162230671736375,0.3176187267401867,1.0,3/14,4.80%,GPR137B;LCK;MFHAS1
prerank,lymphocyte mediated immunity (GO:0002449),0.6645023509985533,1.4474197583565238,0.06460296096904442,0.3173935886628238,1.0,6/12,21.23%,KLRC2;CD8A;JAG1;BTN3A3;MYO1G;CD55
prerank,peptide cross-linking (GO:0018149),0.5739353211654493,1.447274507138649,0.05017921146953405,0.31693132132130675,1.0,7/25,13.05%,FN1;CD247;ANXA1;CD3G;EVPL;TGM5;ABCA7
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.6892177181860659,1.4472421732902097,0.06198347107438017,0.31620409985584214,1.0,3/10,14.85%,CTNNB1;FZD1;LRP6
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.5668098338188555,1.4470360520794072,0.04161979752530934,0.31599526670681477,1.0,6/28,9.98%,BCL2;DEDD2;DAXX;BID;DIABLO;BAX
prerank,cellular response to amyloid-beta (GO:1904646),0.5485533993208059,1.4468922249924054,0.03903559127439724,0.3155779634820812,1.0,10/35,10.28%,CACNA1A;IGF1;LRP1;FPR2;CDK5;ITGA4;TREM2;ATP1A3;IGF1R;FYN
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.6552932978182384,1.4468770564406275,0.042723631508678236,0.314822528190183,1.0,6/13,16.43%,RGPD1;IPO5;KPNA4;KPNA6;RANBP2;CBLB
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.48638034747463993,1.446704086196206,0.0030241935483870967,0.3145441294730506,1.0,41/108,24.48%,S100A8;S100A9;LCK;CTSD;GRAMD4;MALT1;TRAF2;XDH;TNFSF15;MTCH1;PPARG;BID;DLC1;DIABLO;RACK1;SOX7;VCP;BAX;HIP1;DAP;GSN;DAPK1;HSPD1;APAF1;CASP4;SYK;HIP1R;ARL6IP5;CASP9;HMGB1;RPS3;CRADD;LAPTM5;TNFSF10;SENP1;EGLN3;F2R;HSPE1;ANP32B;TNF;JAK2
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.6321559079902401,1.4464078440346937,0.04725415070242656,0.3145790777059713,1.0,7/15,13.40%,PKM;ITGA5;FGF2;PDPK1;VEGFA;JAK1;SMAD1
prerank,regulation of extracellular matrix organization (GO:1903053),0.6364997770217449,1.4461114620762179,0.048366013071895426,0.3145899145929306,1.0,6/15,17.04%,LRP1;RUNX1;RIC1;AEBP1;EFEMP2;DDR2
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.6700829432228401,1.445462695506998,0.05444887118193891,0.31548640863108274,1.0,4/11,16.40%,PCBP4;PCBP1;NOVA2;RASA1
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.6801385580626914,1.4454227759787266,0.053763440860215055,0.31478334117941326,1.0,6/10,21.65%,LTF;WDFY1;PTPN22;TIRAP;NINJ1;LBP
prerank,positive regulation of interleukin-17 production (GO:0032740),0.5791040540612579,1.4454224368005657,0.039240506329113925,0.31396784029552877,1.0,5/22,8.94%,RFTN1;PRKCQ;SPHK1;ZBTB7B;LY9
prerank,cellular response to tumor necrosis factor (GO:0071356),0.4687258576837709,1.4448075924152814,0.0,0.31491424907942644,1.0,68/175,29.44%,PSMD8;NFE2L2;PSMD1;TMSB4X;TANK;TRAF2;CCL4;LTB;TNFSF15;PTK2B;TRAF3;GATA3;ERBIN;SMPD4;ILK;PSMD6;PSMA1;ADAM17;CCL13;BRCA1;TRAF1;PSMC3;CCL7;CCL5;TNFRSF1B;PSMA8;TNFRSF9;YBX3;PSMD14;CCL14;PSMD2;TNFSF8;ACOD1;PSMC6;PSMA6;GBP2;TNFSF9;PSMD5;PSMA5;DHX9;ASAH1;ARHGEF2;RPS3;EIF5A;TNFRSF11B;CDIP1;ACTN4;PSMA3;TNF;JAK2;BIRC2;PSMB8;PSMB10;SFRP1;CX3CL1;PSMD7;AIM2;PSMB6;PSMD10;LIMS1;PSMB5;RIPK1;PSMB7;ZFAND6;PYDC1;PSMC4;TNFRSF8;SIRT1
prerank,negative regulation of cell development (GO:0010721),0.5671117375170234,1.443921955719229,0.04693140794223827,0.31678222746586926,1.0,12/25,27.44%,IGF1;LTF;FBXW7;LILRB1;B2M;APPL2;HOOK3;IL6;GSK3B;TNF;RFLNA;GSK3A
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.5804759786419209,1.4437567093036323,0.046875,0.3163919530576613,1.0,11/22,29.29%,LGALS3;MGAT5;PTPA;BOD1L1;ROCK1;GSK3B;PPP1R15A;TNF;NCKAP1L;FKBP1B;FKBP1A
prerank,response to histamine (GO:0034776),-0.5596161161799983,-1.4433830436871224,0.09655172413793103,0.5496140454823849,1.0,2/10,0.56%,GABRB2;GABRB3
prerank,negative regulation of histone modification (GO:0031057),0.643776196764487,1.4430924359965145,0.06084656084656084,0.31746847327889,1.0,6/14,19.06%,SPHK2;NOC2L;THAP7;BRCA1;PRMT6;TAF7
prerank,zinc ion homeostasis (GO:0055069),0.5620798164980121,1.4427141694981143,0.04498269896193772,0.3177139043245477,1.0,13/28,19.88%,LCK;ATP13A2;SLC39A6;SLC39A7;SLC30A9;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X
prerank,regulation of monocyte differentiation (GO:0045655),0.6454035876404807,1.4423103477408172,0.04677623261694058,0.3180645896082188,1.0,7/14,23.08%,CDK6;CSF1;CD4;HOXA7;ACIN1;IL34;CD74
prerank,keratan sulfate metabolic process (GO:0042339),0.5529353555715453,1.4420755588275664,0.04903078677309008,0.3180248240322025,1.0,8/31,5.87%,B4GALT5;GALNS;GNS;B4GAT1;B3GNT3;HEXA;GLB1;SLC35D2
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.49355644523280473,1.4418943124508021,0.018947368421052633,0.31776040606309974,1.0,31/73,24.54%,ERCC6;DNMT3A;SPHK2;TAF1D;HDAC4;DDX21;DNMT1;POLR1G;POLR2H;MTF2;PRMT7;PHF1;EED;ACTB;DEK;POLR1A;MYBBP1A;TBP;WBP2;BAZ1B;BMI1;DNMT3B;ZFP57;TAF1A;TAF1C;CREBZF;RBBP7;SMYD5;POLR1F;SF3B1;POLR2F
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.5357578863989718,1.4405936334152813,0.03551609322974473,0.3207636383201052,1.0,17/38,28.03%,LGALS3;BCL2L1;TRAF2;BRCA1;HMOX1;SERPINE1;TMBIM1;SP100;BMP5;ARHGEF2;GSK3B;TNFSF10;SFRP1;GPX1;STX4;TNFAIP3;RIPK1
prerank,negative regulation of hemostasis (GO:1900047),0.6480985932867056,1.4405794684731985,0.05366492146596859,0.3199844868732948,1.0,5/12,16.20%,APOE;TFPI;SERPINE2;SERPINE1;APOH
prerank,regulation of protein-containing complex assembly (GO:0043254),0.4807660170187968,1.4400431591812868,0.0040609137055837565,0.32083290633796185,1.0,41/110,26.04%,LGALS3;FNIP2;FBLIM1;APOE;ABCA1;TRAF2;HRG;NRG1;RAF1;BBS10;BID;VEGFA;NAPA;BCL2L11;RACK1;VCP;BAX;IAPP;RIOK3;GSN;CDC42;HSPA8;CLU;SYK;TFRC;TIRAP;SAR1A;RALB;GFAP;RPS3;BIK;HSF1;GSK3B;LATS1;TRABD2B;TNF;SUMO1;HSPA5;MAPK15;HCFC1;TRAF3IP1
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.6309559989054898,1.4396183713891118,0.05784061696658098,0.32121396367919763,1.0,9/15,26.99%,IGF1;BCL2L1;TRIAP1;GHITM;CLU;PRELID1;GPX1;PSMD10;NOL3
prerank,regulation of glycolytic process (GO:0006110),0.4929423040106205,1.4395196311954952,0.02092050209205021,0.32066157840534315,1.0,26/68,26.78%,IGF1;HIF1A;NUP205;EIF6;GCK;GCKR;HDAC4;PFKFB3;NUP188;OGT;ENTPD5;GIT1;RANBP2;TPR;PRKAG1;RAE1;NUP93;AAAS;SLC2A6;NUP54;JMJD8;NUP50;NUP98;NUP42;NUP133;NUP210
prerank,lipoprotein localization (GO:0044872),0.6662201736670699,1.4395059234113312,0.053445850914205346,0.31988283633192327,1.0,3/11,8.10%,LRP1;PPARG;PRKCB
prerank,vesicle organization (GO:0016050),0.518899043583505,1.4386034064970283,0.019823788546255508,0.3216042232862324,1.0,24/46,28.35%,ALS2;SQSTM1;CAV1;WASHC5;PI4K2A;SNX33;HOOK1;VPS18;SNX10;ARFGEF2;PLEKHF1;VPS11;ALS2CL;RAB22A;SAR1A;HOOK3;LAPTM4B;SRGN;SNX11;USP50;USP8;PLEKHJ1;PI4K2B;LAMTOR1
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.532918239267678,-1.4385167796517102,0.06437768240343347,0.5472174082199119,1.0,3/14,3.76%,SLCO2B1;HMOX2;SLCO1B1
prerank,heme catabolic process (GO:0042167),-0.532918239267678,-1.4385167796517102,0.06437768240343347,0.5472174082199119,1.0,3/14,3.76%,SLCO2B1;HMOX2;SLCO1B1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.5770159503473932,1.4384748961402412,0.037575757575757575,0.32112085004690055,1.0,11/24,23.58%,BCL2;BCL2L1;MUC1;CD44;TPT1;TRIAP1;CLU;ING2;CCAR2;CD74;MIF
prerank,positive regulation of cell growth (GO:0030307),0.48166247213830016,1.438008429787025,0.015306122448979591,0.3217415659442131,1.0,25/96,15.76%,IGF1;BCL2;S100A8;S100A9;SDCBP;MACF1;EIF4G1;GOLGA4;SPHK1;EXOSC4;SLC25A33;ITSN2;EIF4G2;ADAM17;DDX49;PLAA;RUFY3;RASAL1;EXOSC9;LIMK1;CDC42;CXCL16;INO80;RNF157;USP47
prerank,plasma membrane organization (GO:0007009),0.5017141529287762,1.4378468585549755,0.02748414376321353,0.32140895860905955,1.0,18/61,16.22%,MYOF;AHNAK2;PLSCR2;FER1L5;ARL8B;TLCD1;ANXA6;SNX33;CHMP4A;UGCG;TLCD2;ARV1;CLN3;ABCD2;OSBPL2;ABCA7;SMPD1;CAVIN2
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.5183104119014478,1.4373544081029324,0.03711790393013101,0.3220887562245404,1.0,24/47,22.78%,CORO1C;FLNA;PDPN;NRP1;NEDD9;CRKL;LIMS2;P4HB;ILK;MYOC;FBLN1;CDC42;DOCK5;SPRY4;C1QBP;MELTF;MYADM;TESK1;ITGB1BP1;FERMT2;TRIOBP;CALR;ACTN4;CSPG5
prerank,response to unfolded protein (GO:0006986),0.522481295104137,1.4373428328490632,0.024471635150166853,0.3213556295608504,1.0,24/48,26.92%,OPTN;HSPA4;HSPB1;DAXX;STT3B;ERN1;BAX;ERP44;HSPA8;DDIT3;HSPD1;DERL1;DNAJC4;HSPA9;DNAJB1;HSP90AB1;HSF1;TOR1B;BAG3;DNAJA1;HSPE1;HSPA5;HSPA2;PACRG
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.45787557375291166,1.4373405389777014,0.0,0.3205735639264153,1.0,115/306,24.54%,B4GALT5;APOE;RPS12;MRPS12;ORC3;AGO2;LARGE1;RPS27A;TNIP1;RPS6;EIF4G1;RPS14;MCM7;MCM2;MRPL51;RPL10A;RPL18;EEF2;GRWD1;RPS24;IGHMBP2;RPS7;RPL41;RPL36A;RPS20;RPS26;EEF1A1;RPL23;RPL17;MRPL23;RPS25;ING4;RPL35A;EIF4G2;RPS28;PTMS;RPLP2;RPL28;POLR2H;RMI1;POLE;RNASEH2A;RPL27A;EEF1D;RPL11;RPS2;BRCA1;GTPBP2;MRPL52;RAD50;ALAS1;RPL32;DRG1;MRPS15;RPL21;MRPL24;PWP1;BLM;CDK2;RPL9;RPL36;RPL37;MRPS33;MRPS16;RPL38;POLR2D;RPS18;MRPS7;RPS19;RPS27;RPS23;CDC7;BARD1;NR4A2;ING5;RPL14;RPS16;SARS1;MRPL11;RPL30;RPL31;RPL12;GSPT1;KAT7;FARSB;ATM;KIN;RPL13A;RAD1;RPS9;RPL4;TOP1;RRBP1;RPS3;MCM6;DUT;RECQL5;TBRG1;DBF4;MCM8;RPS13;PABPC4;RPSA;RPL15;TERT;TOPBP1;ST3GAL2;MRPS14;POLA2;MRPL37;REV1;GOLPH3;RFC2;RPL7A;POLR2F
prerank,keratan sulfate catabolic process (GO:0042340),0.6788653901031008,1.4364483171714038,0.04993252361673414,0.3224633920562471,1.0,4/11,5.37%,GALNS;GNS;HEXA;GLB1
prerank,sphingolipid metabolic process (GO:0006665),0.4754036099274842,1.436328382432857,0.006122448979591836,0.3220733321044611,1.0,42/108,24.31%,CTSA;CERK;ESYT1;SGMS1;SPHK2;TEX2;SPHK1;HACD2;PSAP;HEXA;GLB1;PPP2R1A;CERS6;ORMDL1;SPTSSA;PLPP3;GLTP;UGCG;GALC;SMPD4;ARV1;ARSA;GLA;HACD1;KDSR;NEU1;B4GALNT1;PRKD2;VAPB;SMPD1;ALDH3A2;ORMDL3;ASAH1;GBA2;ALDH3B1;ELOVL2;SAMD8;CERKL;ELOVL1;SPTLC3;PDXDC1;PRKD3
prerank,histone H3-K4 methylation (GO:0051568),0.5692999307591794,1.4362212254343114,0.047619047619047616,0.32159576269841667,1.0,9/26,14.28%,CXXC1;KMT2A;DYDC1;TET3;RBBP5;PRDM9;WDR5;OGT;SETD1A
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.5834174760678069,1.434857150006866,0.05218446601941747,0.32485925913360697,1.0,5/22,7.43%,IGF1;P2RX4;SLC9A1;NR4A3;LMCD1
prerank,regulation of translation (GO:0006417),0.46345245712167915,1.4347106745623817,0.0050200803212851405,0.32455025912849667,1.0,72/173,24.75%,EPRS1;EIF1;SHFL;EIF6;VIM;EIF4G1;GZMB;NCL;CD28;EEF2;HSPB1;PIWIL2;ETF1;RBM4B;EIF4G2;LSM14A;PUS7;EIF2A;PATL2;NOLC1;RACK1;LARP4;MIF4GD;METTL3;CPEB3;CNOT10;SHMT1;ALKBH1;DDX1;YTHDF3;OGFOD1;TRAP1;ENC1;LARP1;ILF3;EIF4G3;YBX2;SYNCRIP;EIF4A3;EIF4ENIF1;DAPK1;EIF5B;DHX36;EIF4E2;FXR2;KLHL25;TCOF1;MTRF1;EIF2B2;GSPT1;DAPK3;EIF3E;IL6;NSUN3;RPL13A;DHX9;UPF3A;ATXN2;RPS3;NPM1;EIF4A2;SAMD4A;UPF3B;GIGYF2;CALR;EIF4B;EIF3B;POLDIP3;EIF2B4;PYM1;EIF3H;MALSU1
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.5400954010690613,1.4346684218695742,0.04550625711035267,0.3238704452669016,1.0,20/34,27.54%,FLNA;NRP1;NEDD9;CRKL;LIMS2;P4HB;ILK;MYOC;CDC42;DOCK5;C1QBP;MYADM;TESK1;FERMT2;TRIOBP;CALR;CSPG5;MDK;LIMS1;S100A10
prerank,protein-containing complex subunit organization (GO:0043933),0.47867602884870075,1.4338238605136846,0.011270491803278689,0.32544697782714127,1.0,51/109,28.39%,MITF;CD3E;CD247;IL2RB;EPRS1;KMT2A;NUP205;CAPG;TRAF2;TUBGCP4;CD3G;PTK2B;SLC2A1;PPP2R1A;SOX9;WIPF1;TAPBP;SKAP2;RANBP9;TRAF1;CARD10;MAGI1;AFG3L2;TFAP4;GPAA1;TSPAN4;LAMC1;NDUFAF1;TPR;MDN1;VAMP2;ELOB;JCHAIN;FANCA;TEAD1;WAS;LLGL1;CD74;PEX14;NUP54;MDM2;NUP98;ST13;NCKAP1L;NUP133;GEMIN5;PPIH;HES1;VAMP3;MNAT1;NUP35
prerank,regulation of endocytosis (GO:0030100),0.4995359160189455,1.432850943256424,0.016025641025641024,0.3274674022847826,1.0,17/61,13.60%,LGALS3;APOE;LRP1;ABL2;MCTP1;SPHK1;CD22;DAB2;RAB5C;SNX33;LILRB1;LRPAP1;HIP1;RAB5A;ABCA7;RUFY2;ROCK1
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.6354674266998047,1.4327634823313573,0.06040268456375839,0.3269274538425318,1.0,7/13,21.85%,ADAM8;TESPA1;FOXJ1;CLPTM1;CAMK4;TOX;BMP4
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.5137034702039514,1.4324272934853803,0.03863134657836645,0.32708361725708335,1.0,13/47,14.42%,PLEK;SIRPA;SLC27A1;GCK;FBXW7;CAV1;SIK1;BRCA1;FYN;GLA;APOC1;MPV17L;NFKB1
prerank,cellular response to arsenic-containing substance (GO:0071243),0.6206137200358202,1.4302227970050971,0.060991105463786534,0.33244993145566215,1.0,8/15,21.41%,ATF3;MAPK13;DAXX;CPEB2;VCP;DHX36;GSTO2;HSF1
prerank,regulation of myeloid cell differentiation (GO:0045637),0.49328075142568234,1.4296384699140867,0.024442082890541977,0.33335529082825127,1.0,21/62,19.31%,LGALS3;CDK6;KMT2A;PRKCQ;EIF6;CNOT4;NR4A3;PTK2B;MYL9;RUNX1;HDAC1;PRKCB;RBBP5;WDR5;ZBTB16;SETD1A;RBM15;HSPA9;PRMT6;PAF1;AGO3
prerank,cholesterol homeostasis (GO:0042632),0.49530426780090997,1.4294373296855418,0.0255863539445629,0.33316772195044503,1.0,10/64,5.32%,LPL;APOE;ABCG1;ABCA1;HDAC9;CD24;APOA2;MALL;SOAT1;CAV1
prerank,positive regulation of transporter activity (GO:0032411),0.6380364872418275,1.428906083560975,0.06760204081632654,0.33385664169531903,1.0,4/13,3.68%,KMT2A;SGK1;SGK2;PON1
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.3206614581386952,-1.4286677902609153,0.0,0.5660447726633314,1.0,60/224,13.03%,CACNB2;SNAP25;GRIA4;GABRB2;GRM7;NRXN1;GABRB3;SYNJ2BP;NLGN1;SYN2;RPS6KA1;GRIK2;CHRM2;GLRA3;KCND2;DLGAP1;AMPH;DLG2;SLC1A3;GRIN2A;CPLX1;SYT10;GRIA3;PLP1;GRIK4;GABRG3;KCNQ3;RIT2;GRM1;GABRA2;HTR2A;GRIN2B;APBA2;GAD2;UNC13B;GRM5;HTR2C;SYT1;GRM3;APBA1;CHRM3;CAMKK2;PENK;HRH2;SLC12A6;HTR1F;HAP1;SLC6A1;CAMK1;GABRA1;BSN;PRKAR2A;GRIN1;PRKAR2B;GAD1;GABRB1;GLRA2;PDE7B;GABRR2;SYN1
prerank,epithelial cell morphogenesis (GO:0003382),0.6119336582692484,1.4284125721834724,0.05082592121982211,0.33454229641770544,1.0,4/17,8.73%,CCDC88C;POF1B;RILPL2;COL18A1
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.6083876864362687,1.42839669587695,0.0599250936329588,0.33380197045553733,1.0,3/16,3.09%,APOE;HIF1A;PIK3CB
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.5072308269413102,1.4278560525703712,0.030204962243797196,0.3346286197267702,1.0,21/54,17.73%,APOE;HIF1A;P2RX4;TMSB4X;HRG;FGF2;HSPB1;PPARG;ANGPT4;PDPK1;VEGFA;ANGPT1;ADAM17;JUP;ANGPT2;FGF18;PRKD2;NF1;KDR;MAP2K3;SP1
prerank,positive regulation of viral genome replication (GO:0045070),0.5558697223682253,1.427538652000009,0.04953917050691244,0.3347421590889969,1.0,16/29,27.29%,ADARB1;SRPK1;CD28;PABPC1;DDB1;CCL5;LARP1;PKN2;PPIA;VAPB;PPIE;ADAR;SRPK2;TMEM39A;TARBP2;PPIH
prerank,"phagocytosis, engulfment (GO:0006911)",-0.3832495450309679,-1.426937110359341,0.03636363636363636,0.562593225384314,1.0,12/36,9.85%,ELMO1;ITGAM;RHOBTB1;BIN2;XKR4;MEGF10;AIF1;FCGR1A;THBS1;XKR6;FCGR2B;RHOBTB2
prerank,DNA double-strand break processing (GO:0000729),0.5902996165366413,1.426855664772322,0.06823821339950373,0.3358208823068794,1.0,8/18,21.92%,BRCA1;RAD50;BLM;SLX4;BARD1;UBE2V2;ATM;SETMAR
prerank,regulation of ATP biosynthetic process (GO:2001169),0.6215122571074857,1.4261369771013939,0.0449438202247191,0.3372236540153261,1.0,6/16,11.11%,TMSB4X;SPHK2;AK4;TREM2;VCP;ENO1
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.5087170597130146,1.4257205162144462,0.02516411378555799,0.3375920483938393,1.0,25/55,29.34%,PSMD8;PSMD1;PSMD6;PSMA1;PSMC3;ATF5;PSMA8;PSMD14;PSMD2;USP47;PSMC6;PSMA6;PSMD5;PSMA5;CUL1;AVEN;PSMA3;PSMB8;PSMB10;PSMD7;PSMB6;PSMD10;PSMB5;PSMB7;PSMC4
prerank,long-chain fatty acid transport (GO:0015909),0.5543594373450348,1.4255921304325798,0.04566744730679157,0.33723238156948937,1.0,12/30,18.63%,APOE;FABP5;SLC27A1;ACACA;ABCD4;PPARG;ACSL1;ABCD2;MID1IP1;ABCD3;CPT2;ACACB
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.6793052830709786,1.4249760925560315,0.07317073170731707,0.3383023833943342,1.0,4/10,11.65%,SKAP1;CD3E;PIEZO1;CCL5
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.5411714573862261,1.4247665060209607,0.037209302325581395,0.3381199367725206,1.0,8/32,12.77%,CDK14;CDK18;ID2;CDK5;BRD4;FBXO5;CDK17;NPAT
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.5864854989620625,1.4246746140972044,0.0630952380952381,0.3375776849646145,1.0,10/21,18.05%,PEAK1;CORO1C;SLC9A1;PTPRA;MACF1;ACTG1;RHOA;ROCK1;DUSP3;DAPK3
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.5339370381686214,1.4245221824009777,0.04195011337868481,0.3364865999620645,1.0,17/32,29.50%,NUP205;XPOT;NUP188;NOL6;RANBP2;TPR;RAE1;NUP93;AAAS;NUP54;NUP50;NUP98;NUP42;NUP133;NUP210;NUP35;NUP214
prerank,tRNA export from nucleus (GO:0006409),0.5339370381686214,1.4245221824009777,0.04195011337868481,0.3364865999620645,1.0,17/32,29.50%,NUP205;XPOT;NUP188;NOL6;RANBP2;TPR;RAE1;NUP93;AAAS;NUP54;NUP50;NUP98;NUP42;NUP133;NUP210;NUP35;NUP214
prerank,regulation of synapse maturation (GO:0090128),-0.5534494168613322,-1.4241459420708704,0.12811387900355872,0.5628028817862304,1.0,6/10,27.39%,NRXN1;CAMK2B;ADGRL1;ARHGEF15;RELN;CDC20
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.49133413079819227,1.4238834964285128,0.029473684210526315,0.3375951769292168,1.0,26/67,16.66%,FLT1;CYBA;NRP2;CYBB;PIK3CB;AXL;SH2D2A;PTK2B;NRP1;HSPB1;NCK2;NCK1;VEGFA;MAPKAPK3;CYFIP2;MAPKAPK2;NCF4;FYN;RHOA;CDC42;PAK2;ROCK1;AAMP;PRKD2;KDR;PIK3R2
prerank,regulation of fatty acid metabolic process (GO:0019217),0.6064851900466808,1.4238715041783936,0.06415094339622641,0.3368745940126768,1.0,5/17,16.85%,EIF6;CAV1;PPARG;PPARD;ADIPOR1
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.6432134410116718,1.4236851530740315,0.068,0.336641994389367,1.0,4/13,16.30%,IGF1;SOAT1;ALG10B;CHP1
prerank,regulation of acute inflammatory response (GO:0002673),0.5971552104518476,1.4236629070270557,0.0546583850931677,0.33592687802162363,1.0,5/18,18.40%,PTGES;ADAM8;OSMR;KLKB1;IL6
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.5672576687389175,1.4236576622535109,0.05489260143198091,0.33517094714183493,1.0,8/25,17.90%,BCAR3;PLAUR;MMP9;HIP1;DOK1;CBL;DGKD;HIP1R
prerank,Fc receptor signaling pathway (GO:0038093),0.476316187798051,1.4235747468163986,0.007150153217568948,0.3346267420623496,1.0,52/110,29.43%,PSMD8;ITK;GRAP2;PSMD1;PRKCQ;MALT1;LAT;TEC;PIK3CB;MS4A2;PDPK1;GRB2;TAB1;PSMD6;PSMA1;PSMC3;JUN;PSMA8;PAK2;PSMD14;PSMD2;MAP3K1;NFKB1;MAPK9;PSMC6;PSMA6;SYK;LAT2;PIK3R2;PSMD5;PSMA5;FCER1G;GAB2;NFATC3;FBXW11;CUL1;VAV3;PSMA3;PPP3R1;PSMB8;BTK;VAV1;PSMB10;PSMD7;PSMB6;BTRC;PSMD10;PSMB5;PSMB7;MAPK3;PSMC4;TAB2
prerank,lamellipodium organization (GO:0097581),-0.4014593612400784,-1.4230918530098247,0.044444444444444446,0.5579483774043796,1.0,9/29,14.14%,P2RY12;SNX2;PTPRO;CARMIL1;ABLIM3;DMTN;CDH13;ARHGEF4;SPATA13
prerank,positive regulation of leukocyte migration (GO:0002687),0.5602143607641824,1.4229358162621926,0.056778679026651215,0.3357683262848765,1.0,5/27,9.01%,LGALS3;CSF1;ADAM8;VEGFA;ADAM17
prerank,base conversion or substitution editing (GO:0016553),0.6622155427031876,1.4221820125794022,0.05103448275862069,0.3372848816172987,1.0,3/11,10.17%,APOBEC1;ADARB1;METTL3
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.5070010336454142,1.4215202333343167,0.03373231773667029,0.33855782843534055,1.0,25/53,29.34%,PSMD8;PSMD1;AZIN1;PSMD6;PSMA1;OAZ3;PSMC3;PSMA8;PSMD14;PSMD2;PSMC6;PSMA6;ODC1;PSMD5;PSMA5;PSMA3;PSMB8;PSMB10;PSMD7;PSMB6;PSMD10;PSMB5;NQO1;PSMB7;PSMC4
prerank,glucose import (GO:0046323),0.635170486255842,1.4213729883119368,0.07445442875481387,0.3382241917021257,1.0,3/13,4.52%,SLC27A1;SLC5A1;SLC2A1
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.5292082435165705,1.4211093498808034,0.04421768707482993,0.3381712303356423,1.0,10/37,13.71%,IGF1;NR4A3;MEF2D;MMP9;FGF2;PPARG;ERN1;DNMT1;JUN;EFEMP2
prerank,response to cAMP (GO:0051591),-0.3749734217514675,-1.4208361518946737,0.059322033898305086,0.5567055866977413,1.0,17/37,28.49%,RAPGEF2;HCN1;NDUFS4;IGFBP5;AKAP6;DMTN;INPP5K;EZR;PDE2A;STAT1;RAPGEF3;KCNQ1;VGF;AQP1;SLC5A5;WT1;HCN2
prerank,positive regulation of calcium ion transport (GO:0051928),0.5296340200293399,1.4206560598263112,0.04703247480403135,0.3386733231098369,1.0,9/36,12.47%,LGALS3;P2RX4;ATP2B1;CCL4;SPHK2;CAV1;CRACR2A;CCL5;CACNA1D
prerank,sterol homeostasis (GO:0055092),0.492059141489382,1.4206489818105528,0.031982942430703626,0.3379407236396462,1.0,10/65,5.32%,LPL;APOE;ABCG1;ABCA1;HDAC9;CD24;APOA2;MALL;SOAT1;CAV1
prerank,positive regulation of myelination (GO:0031643),0.6648448753836588,1.420327732633476,0.07055630936227951,0.33815469104469836,1.0,5/11,15.75%,ITGAX;CST7;EGR2;TNFRSF1B;NCMAP
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.6349242870941003,1.4200915451651024,0.06758448060075094,0.3380887486390875,1.0,5/15,8.00%,ITK;TEC;PTK2B;TXK;IGF1R
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.6330290833200819,1.419975604696472,0.08718626155878467,0.33766103515133306,1.0,7/13,19.24%,LPL;CD9;ABCA1;PPARG;ITGB2;SYK;FCER1G
prerank,glycoprotein biosynthetic process (GO:0009101),0.4811165133877971,1.4196724288340223,0.023784901758014478,0.3377861419660922,1.0,11/79,5.70%,IGF1;XYLT1;CHST11;B4GALT5;ATP7A;LARGE1;B4GALT7;GCNT2;TNIP1;B3GNT3;B3GALNT2
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.512473123439596,1.4181255130636368,0.038802660753880266,0.3415063047152184,1.0,19/46,24.48%,LCP1;MSN;STAT4;GSTA2;IL12RB1;P4HB;JAK1;CDC42;PAK2;HNRNPA2B1;PPIA;HSPA9;PDCD4;HNRNPF;CFL1;SOD2;TALDO1;MIF;JAK2
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.666017964810936,1.417852460657692,0.08743169398907104,0.34149873540885983,1.0,8/10,23.52%,RENBP;GNPDA1;NAGK;NPL;ST6GAL1;GNPDA2;NANP;AMDHD2
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.5039876663263203,1.4172705622240742,0.025613660618996798,0.3424332441355941,1.0,18/57,16.80%,DDX31;RPS6;RPS24;METTL17;RPS7;NOC2L;RPS25;WDR12;RIOK2;RPL35A;RPS28;RPL11;NVL;XPO1;RPL38;RPS19;RPL14;RPS16
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.5934016468241028,1.4171448157659052,0.0648854961832061,0.3420566333031303,1.0,6/18,10.16%,ANXA1;HDAC9;HDAC7;FGF2;VEGFA;HMOX1
prerank,lipid oxidation (GO:0034440),-0.5304797595803277,-1.4166936488145507,0.07792207792207792,0.5599905736828884,1.0,2/12,4.80%,ALOX5;PPARGC1A
prerank,sodium ion transport (GO:0006814),0.4795638213434916,1.4164707366906428,0.0189873417721519,0.3433118562407147,1.0,15/85,7.45%,FGF13;SLC6A6;SLC24A4;SGK1;ATP1B3;SLC23A1;SLC5A1;SLC6A19;SLC6A14;SCN4A;ASIC3;SLC6A8;SLC6A7;ATP1A4;SLC6A4
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.6270119689967268,1.4162883452069321,0.05740987983978638,0.3431421973038296,1.0,5/15,5.38%,P2RX4;TMSB4X;HRG;FGF2;HSPB1
prerank,positive regulation of viral life cycle (GO:1903902),0.5700759819851553,1.4161842791604808,0.06082725060827251,0.3426998041916087,1.0,7/22,10.70%,LGALS1;CD4;AXL;TMPRSS2;P4HB;DDB1;KPNA6
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.5664059639356813,1.416180135198194,0.045774647887323945,0.34196205564608095,1.0,12/26,21.21%,CYBA;MMP8;SPHK2;SLC25A33;ADGRB1;ABCD2;TRAP1;CCN6;SLC18A2;SLC5A3;PIKFYVE;ABCB7
prerank,regulation of protein autophosphorylation (GO:0031952),0.5330223567158001,1.4159111835074258,0.041237113402061855,0.34197574783689544,1.0,7/36,10.82%,GPNMB;RAP2A;PDGFA;PPP2R5C;VEGFA;MVP;RAD50
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.5406643557588969,-1.415707310899129,0.10583941605839416,0.5552954490986073,1.0,5/10,15.71%,PRKCE;HECW1;HECW2;OSR1;NEDD4L
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.6416456764753828,1.4153406709779341,0.0801068090787717,0.34298117920783827,1.0,4/13,10.53%,TSR1;KRI1;BMS1;UTP20
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.649910043620077,1.415209280800543,0.05503355704697987,0.3426421504586732,1.0,7/12,24.29%,LPL;MBP;TIRAP;HMGB1;CD74;MAP2K5;TNF
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.504178098340247,1.414714081636159,0.028602860286028604,0.34330529673458526,1.0,25/48,30.91%,HIF1A;NUP205;EIF6;GCK;GCKR;NUP188;OGT;RANBP2;TPR;PRKAG1;RAE1;NUP93;AAAS;SLC2A6;NUP54;JMJD8;NUP50;NUP98;NUP42;NUP133;NUP210;NUP35;NUP214;NOA1;EP300
prerank,negative regulation of cell activation (GO:0050866),0.6303043790502351,1.4140919030377872,0.06380208333333333,0.344386952393211,1.0,3/14,7.29%,APOE;PDGFA;TREM2
prerank,positive regulation of glycolytic process (GO:0045821),0.5809793091052994,1.4137670676608203,0.05752753977968176,0.34390972061353664,1.0,3/20,7.01%,IGF1;HIF1A;PFKFB3
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.5809793091052994,1.4137670676608203,0.05752753977968176,0.34390972061353664,1.0,3/20,7.01%,IGF1;HIF1A;PFKFB3
prerank,positive regulation of angiogenesis (GO:0045766),0.4652286327586157,1.4128606983633694,0.015368852459016393,0.3457572200481745,1.0,30/108,16.52%,FLT1;HIF1A;ITGAX;PKM;SASH1;ITGA5;AGO2;SPHK1;FGF2;HSPB1;ANGPT4;MYDGF;RUNX1;PDPK1;VEGFA;PRKCB;BRCA1;JUP;HMOX1;HIPK1;SERPINE1;JAK1;ECM1;SMAD1;FGF18;PRKD2;CYP1B1;KDR;NINJ1;ANXA3
prerank,negative regulation of protein metabolic process (GO:0051248),0.5123044397274084,1.4123468733893774,0.039779005524861875,0.34646319782129703,1.0,15/48,18.49%,CD84;APOE;FLNA;AZIN1;ADGRB1;SF3B3;TREM2;FLOT2;IAPP;ROCK1;PFDN1;NFKB1;CLU;PIN1;PFDN2
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.6215030654382897,1.4118296119143845,0.0625,0.34718136361700797,1.0,3/15,3.93%,IGF1;SLC9A1;NR4A3
prerank,ncRNA export from nucleus (GO:0097064),0.5203547951801624,1.4116073763452033,0.04411764705882353,0.3471684933226751,1.0,18/36,29.50%,NUP205;XPOT;NUP188;NOL6;RANBP2;TPR;RAE1;NUP93;AAAS;NPM1;NUP54;NUP50;NUP98;NUP42;NUP133;NUP210;NUP35;NUP214
prerank,response to cadmium ion (GO:0046686),0.5576418016970083,1.411584228020279,0.061004784688995214,0.3464811313948515,1.0,17/26,28.29%,MMP9;DAXX;JUN;MAPK9;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;HSF1;SUMO1;MT2A;NCF1;MAPK3
prerank,regulation of store-operated calcium entry (GO:2001256),0.6711783683506677,1.4115052742579253,0.07210884353741497,0.3459520167470168,1.0,4/10,14.58%,CD84;SARAF;HOMER2;SLC8B1
prerank,cellular response to chemical stress (GO:0062197),0.47299941546011687,1.4111247267790865,0.013457556935817806,0.3463013556866564,1.0,43/96,28.45%,CYBA;ATG7;NFE2L2;MSRA;SLC25A24;CYBB;ATP13A2;PRDX5;PRDX6;CAV1;PRDX1;CPEB2;SRXN1;EIF2S1;NCF4;ERO1A;GSR;LONP1;TXNRD1;CHCHD2;RBM11;PPIA;STOX1;CAT;FOXO1;SOD3;ATM;ALDH3B1;SOD2;NUDT2;PRR5L;ATF4;PYCR2;NCF2;NOX4;GPX1;SESN2;KEAP1;NCF1;STX4;ZFAND1;CYCS;PRDX3
prerank,positive regulation of vasculature development (GO:1904018),0.46558316447643694,1.4107288892584904,0.0196078431372549,0.3467201153054615,1.0,26/94,16.52%,FLT1;HIF1A;ITGAX;SASH1;AGO2;SPHK1;FGF2;HSPB1;ANGPT4;MYDGF;RUNX1;PDPK1;VEGFA;PRKCB;BRCA1;JUP;HMOX1;HIPK1;SERPINE1;ECM1;FGF18;PRKD2;CYP1B1;KDR;NINJ1;ANXA3
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.4710005682667066,1.4098669166697944,0.012282497441146366,0.34860775917374265,1.0,43/105,29.43%,KLRC2;PSMD8;PSMD1;MALT1;MUC1;MUC16;RAF1;PRKCD;PDPK1;TAB1;PSMD6;PSMA1;PSMC3;NRAS;KRAS;FYN;PSMA8;PAK2;PSMD14;PSMD2;NFKB1;CLEC6A;PSMC6;PSMA6;SYK;CLEC4E;PSMD5;PSMA5;FCER1G;CLEC4D;FBXW11;CUL1;PSMA3;PSMB8;PSMB10;PSMD7;PSMB6;BTRC;PSMD10;PSMB5;PSMB7;PSMC4;TAB2
prerank,response to iron ion (GO:0010039),0.6350291682178408,1.4092452231652106,0.08236808236808237,0.34970876759869074,1.0,2/12,0.52%,BCL2;HIF1A
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.5506754029822993,1.4089891228820828,0.06511627906976744,0.34965663063958025,1.0,9/26,16.30%,IGF1;SLC9A1;DYRK2;LMCD1;RCAN1;CHERP;HOMER2;SPPL3;CHP1
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.6163515941662693,1.4085269431106056,0.06608478802992519,0.3502672494721693,1.0,6/15,13.09%,RPS7;RPL23;FBXO5;RPL11;LIMK1;SMAD7
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.6311155578950682,1.4081676651811648,0.07863695937090433,0.35051604187787255,1.0,7/13,24.48%,DAB2;RBPMS;SH2B1;BMP6;NUP93;BMP4;JAK2
prerank,negative regulation of binding (GO:0051100),0.48499777447394493,1.4077354071911228,0.013612565445026177,0.3509929163744866,1.0,38/81,29.55%,CTSZ;LEF1;NES;GZMA;GTPBP4;PRKCD;CAV1;DAB2;WAPL;MDFI;RACK1;LRPAP1;BAX;JUN;ILRUN;TLE5;TFAP4;SP100;GTF2F1;ROCK1;ACTB;PSME3IP1;SYMPK;RALB;PIN1;ITGB1BP1;IFIT2;GSK3B;USP33;PEX14;SUMO1;JAK2;GOLGA2;KDM1A;DACT1;RSF1;CSNK1E;PEX19
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.4710190990110336,1.4068190098101938,0.011293634496919919,0.3523717132194461,1.0,43/104,29.43%,KLRC2;PSMD8;PSMD1;MALT1;MUC1;MUC16;RAF1;PRKCD;PDPK1;TAB1;PSMD6;PSMA1;PSMC3;NRAS;KRAS;FYN;PSMA8;PAK2;PSMD14;PSMD2;NFKB1;CLEC6A;PSMC6;PSMA6;SYK;CLEC4E;PSMD5;PSMA5;FCER1G;CLEC4D;FBXW11;CUL1;PSMA3;PSMB8;PSMB10;PSMD7;PSMB6;BTRC;PSMD10;PSMB5;PSMB7;PSMC4;TAB2
prerank,cellular response to lectin (GO:1990858),0.4710190990110336,1.4068190098101938,0.011293634496919919,0.3523717132194461,1.0,43/104,29.43%,KLRC2;PSMD8;PSMD1;MALT1;MUC1;MUC16;RAF1;PRKCD;PDPK1;TAB1;PSMD6;PSMA1;PSMC3;NRAS;KRAS;FYN;PSMA8;PAK2;PSMD14;PSMD2;NFKB1;CLEC6A;PSMC6;PSMA6;SYK;CLEC4E;PSMD5;PSMA5;FCER1G;CLEC4D;FBXW11;CUL1;PSMA3;PSMB8;PSMB10;PSMD7;PSMB6;BTRC;PSMD10;PSMB5;PSMB7;PSMC4;TAB2
prerank,sterol transport (GO:0015918),0.5793233788549514,1.4064041774679739,0.07351077313054499,0.35286075842870196,1.0,8/19,26.21%,APOA2;CAV1;ARV1;OSBPL2;NPC1;NPC2;OSBP;MSR1
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.47592796846745733,1.406162964820954,0.024261603375527425,0.3528281103813,1.0,20/71,12.24%,CTSB;CTSZ;MALT1;FBXL17;UBA52;RPS27A;CTSW;GZMB;GZMA;CLPP;CHMP4B;ATXN3;PDCD6IP;USP9X;VCP;DDB1;LONP1;VPS4B;PSMA8;DDI2
prerank,cytoplasmic translational initiation (GO:0002183),0.586253929333255,1.4060202435584375,0.06956521739130435,0.35245546194920074,1.0,12/17,29.88%,EIF4A1;EIF3A;EIF4G1;DENR;DHX29;EIF3M;EIF2S2;EIF4A2;EIF4B;EIF3I;EIF2D;EIF5
prerank,negative regulation of gluconeogenesis (GO:0045721),0.6443223490102118,1.4058503914510856,0.07702523240371846,0.3522561599032112,1.0,2/11,6.73%,GCK;SIK1
prerank,positive regulation of protein processing (GO:0010954),0.5772332233433619,1.4057480575109114,0.06115107913669065,0.35184021481294586,1.0,6/19,15.97%,ADAM8;ENO1;GSN;LPCAT3;KLKB1;MELTF
prerank,negative regulation of interferon-beta production (GO:0032688),0.6703052887059358,1.4055488539488388,0.07832167832167833,0.35170350438424647,1.0,4/10,13.57%,SIRPA;NLRC3;LILRB1;YY1
prerank,negative regulation of catalytic activity (GO:0043086),0.5613310170752002,1.4053135255677602,0.06279620853080568,0.3516464852191547,1.0,10/24,20.95%,NES;GZMA;PPP1R12A;HP;CLN3;PHPT1;TMBIM1;CCAR2;TIMP1;CAND1
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.5822604105239754,1.4050143115068028,0.07458912768647281,0.35177049995683496,1.0,3/18,6.11%,GPNMB;LAX1;PTPN22
prerank,homocysteine metabolic process (GO:0050667),0.6580252338208522,1.4046366070407121,0.08519553072625698,0.3522528014829718,1.0,9/11,34.23%,MMUT;BLMH;MTRR;TST;MPST;MTHFR;NOX4;CBS;CTH
prerank,pseudouridine synthesis (GO:0001522),0.6283232187038031,1.4044939456164163,0.0650730411686587,0.35197976197995784,1.0,4/13,12.95%,PUS1;TRUB2;PUS7;GAR1
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.652145452689989,1.4042433129182468,0.0723055934515689,0.35200733174479953,1.0,4/11,13.09%,ANXA1;TBX21;SOCS5;SMAD7
prerank,positive regulation of stem cell differentiation (GO:2000738),0.6012173632004688,1.4033993893800076,0.06297229219143577,0.35373540121726116,1.0,6/16,19.80%,TCF15;SOX9;SP7;DHX36;HOXB4;LTBP3
prerank,regulation of peptidase activity (GO:0052547),0.5815809153358372,1.4030008792264677,0.07575757575757576,0.3542098358598324,1.0,11/19,25.35%,ATP13A2;CST7;CAV1;HDAC1;CSTB;ECM1;RCN3;FURIN;PSMA3;PSMB8;MAPK12
prerank,lipoprotein biosynthetic process (GO:0042158),0.6501142337711676,1.4017571764254408,0.08367626886145405,0.3571583178849135,1.0,4/11,8.76%,APOE;ATG7;UGCG;WDR45
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.5370963534680117,1.401741725044318,0.06462984723854288,0.3564991077040774,1.0,14/29,24.90%,ACACA;ACSBG1;ACSBG2;HACD2;SLC25A1;ACSL1;SCD5;HSD17B8;HACD1;GCDH;ELOVL2;ELOVL1;FASN;HSD17B12
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.6344137412727311,1.4015300369497747,0.0701058201058201,0.3563782799487323,1.0,6/13,16.15%,CTNNB1;NRP1;COL4A1;VEGFA;DLL4;KDR
prerank,negative regulation of telomere maintenance (GO:0032205),0.6064811531708844,1.4014230285677263,0.07279693486590039,0.3560232568605652,1.0,8/15,20.13%,TNKS2;ERCC1;RAD50;ERCC4;SLX4;ATM;RTEL1;TERF1
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.5460006257224078,1.4005592922069068,0.0564042303172738,0.35781420513949963,1.0,5/26,8.84%,B4GALT5;LARGE1;TNIP1;GK;ST8SIA6
prerank,regulation of phosphorylation (GO:0042325),0.4632586014777884,1.400289417529887,0.009174311926605505,0.3578947305392254,1.0,47/120,26.78%,FNIP2;STAP1;HIF1A;FN1;CORO1C;SDCBP;CCDC88C;NUP205;EIF6;GCK;CD24;GCKR;MCM7;NRP1;HSPB1;ILK;CADM4;NUP188;CCL5;OGT;ROCK1;RANBP2;TPR;BARD1;KDM4D;PRKAG1;RAE1;PIN1;TESK1;PTGES3;DSCAM;NUP93;NLRC5;AAAS;BMP4;SLC2A6;MIF;NUP54;JMJD8;NUP50;CCDC88A;NUP98;NCKAP1L;SESN2;NUP42;NUP133;NUP210
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.474412382853062,1.3999111658431163,0.019689119170984457,0.3583339790736174,1.0,29/86,20.12%,IGF1;CSPG4;PTPRC;ITGA5;TEC;PDGFA;CD44;HRG;PTK2B;NRP1;PRKCD;ANGPT4;VEGFA;ANGPT1;TREM2;SAMSN1;CADM4;FGF7;FYN;PAK2;EFNA1;GHR;ITGB2;CLEC6A;BMP6;HAX1;IL6;ARHGEF2;IL5
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.4655490845539506,1.3996409251494453,0.01634320735444331,0.35840910201682075,1.0,46/114,29.34%,PSMD8;PSMD1;TMSB4X;TRAF2;LTB;TNFSF15;PTK2B;TRAF3;ILK;PSMD6;PSMA1;ADAM17;TRAF1;PSMC3;TNFRSF1B;PSMA8;TNFRSF9;PSMD14;PSMD2;TNFSF8;PSMC6;PSMA6;TNFSF9;PSMD5;PSMA5;EIF5A;TNFRSF11B;CDIP1;ACTN4;PSMA3;TNF;JAK2;BIRC2;PSMB8;PSMB10;PSMD7;AIM2;PSMB6;PSMD10;LIMS1;PSMB5;RIPK1;PSMB7;PYDC1;PSMC4;TNFRSF8
prerank,leukocyte cell-cell adhesion (GO:0007159),0.560700562150553,1.3996104305961503,0.06793802145411204,0.35778687252817293,1.0,9/24,16.00%,OLR1;ITGAL;MSN;TNIP1;ITGA4;CCL5;ROCK1;ITGB2;SYK
prerank,response to estrogen (GO:0043627),0.5329351614534791,1.399244365720576,0.05828571428571429,0.3581672647454306,1.0,11/31,25.22%,CD24;CYP27B1;CAV1;SERPINB9;GATA3;BRCA1;RBBP5;WBP2;TRIM24;KMT2D;SFRP1
prerank,anion transmembrane transport (GO:0098656),0.4858205636802721,1.3992026701381695,0.03404255319148936,0.35756407229203474,1.0,21/67,18.98%,MFSD12;LRRC8C;SLC3A2;SLC27A1;SLC7A1;SLC23A1;SLC23A2;SLC36A4;SLC25A1;SLC6A8;SFXN1;SLC13A4;SLC25A14;SLC35B1;SLC7A8;SFXN2;SLC25A21;SLC19A1;ARL6IP5;SLC13A3;SLC25A18
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.5816827311177815,1.3983732874765833,0.08542713567839195,0.3591605495539717,1.0,8/18,20.16%,IGF1;CD24;IL12RB1;IL27RA;TNFSF9;IL2;HMGB1;RPS3
prerank,acyl-CoA biosynthetic process (GO:0071616),0.6030257282328555,1.3981463360938549,0.0696774193548387,0.3590909837726733,1.0,8/16,19.09%,ACACA;SLC25A1;SCD5;DIP2A;HSD17B8;PPCS;ACAT1;GCDH
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.5596959326613672,1.3971872905814826,0.08700980392156862,0.36120034483830327,1.0,2/21,1.78%,OSBPL8;PLAAT3
prerank,negative regulation of reproductive process (GO:2000242),0.5817585886660944,1.3962555123764542,0.07556675062972293,0.36319960335489454,1.0,5/17,22.50%,IGF1;NPPC;TIMP1;ARHGDIB;CALR
prerank,early endosome to late endosome transport (GO:0045022),0.5705345285487593,1.3961861918182408,0.0859277708592777,0.36271203115702394,1.0,12/20,29.95%,EEA1;WDR91;PTPN23;HOOK1;RAB7A;RAB5A;HOOK3;LMTK2;RILP;KIF16B;SNF8;BECN1
prerank,macrophage migration (GO:1905517),0.6164242348213642,1.396175025042313,0.0821566110397946,0.3620334423886098,1.0,5/13,11.65%,LGALS3;P2RX4;TAFA4;CCR2;CCL5
prerank,cytoplasmic microtubule organization (GO:0031122),0.4947149858989267,1.3956183836192333,0.03796095444685466,0.362941529888263,1.0,18/54,20.41%,CCDC88C;MAP10;FIGNL1;TUBGCP4;DYNC1H1;CLIP2;HOOK1;DCTN1;WDR73;VPS4B;RHOA;CRIPT;NUMA1;CHP1;HOOK3;RAB11A;DST;SLAIN2
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.6253652818587562,1.3954284089697353,0.0778688524590164,0.36283372194193725,1.0,5/12,14.19%,XDH;PIK3CB;HRG;CADM4;DCN
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.6202450932303902,1.3949100846463607,0.07702349869451697,0.36366159184625185,1.0,6/14,15.36%,AK8;DCTPP1;AK4;AK3;ITPA;AK5
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.559165870717213,1.3947542554197805,0.07425742574257425,0.36344229252165694,1.0,9/22,19.18%,ERCC6;BRD4;THOC1;EAPP;HMGN1;CDK13;DDX39B;KAT7;CCNT2
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.5059068852789645,1.3945999704508052,0.048044692737430165,0.3631568736871913,1.0,10/43,12.81%,IGF1;SIRPA;NLRC3;LTF;POMC;CD274;PTPN22;LILRB1;ILRUN;GAS6
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.6348628750626788,1.3944578385994448,0.08575197889182058,0.3629217028718066,1.0,5/12,19.58%,PRKCQ;IL12RB1;CCR2;CLEC6A;SLC11A1
prerank,cellular protein catabolic process (GO:0044257),0.49175617580277187,1.394212075351581,0.038419319429198684,0.3630013667643342,1.0,13/59,11.12%,CTSB;CTSZ;TCIRG1;MYLIP;MALT1;CTSW;GZMB;GZMA;SIAH2;CLPP;AFG1L;LONP1;RAB7A
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.4718673824632968,1.3941743197121454,0.024896265560165973,0.3624129508765596,1.0,35/84,28.23%,PSMD8;PSMD1;UBA52;RPS27A;ANAPC15;FZR1;FBXO5;FBXO31;PSMD6;PSMA1;CCNB1;PSMC3;PSMA8;CDK2;ANAPC1;PSMD14;PSMD2;PSMC6;PSMA6;PSMD5;PSMA5;CDC26;CUL3;BUB1B;UBC;ANAPC7;PSMA3;PSMB8;PSMB10;PSMD7;UBE2C;PSMB6;PSMD10;PSMB5;PSMB7
prerank,NIK/NF-kappaB signaling (GO:0038061),0.48498817608978256,1.394156119749944,0.029535864978902954,0.36175056746341105,1.0,31/72,28.23%,PSMD8;PSMD1;MALT1;TRAF2;TNFSF15;COPS8;PSMD6;PSMA1;CARD10;PSMC3;PSMA8;PSMD14;PSMD2;PSMC6;PSMA6;TIRAP;PSMD5;PSMA5;FBXW11;CUL1;REL;PSMA3;BIRC2;PSMB8;PSMB10;PSMD7;PSMB6;BTRC;PSMD10;PSMB5;PSMB7
prerank,synapse organization (GO:0050808),-0.29181939478593305,-1.3941402495707285,0.0,0.6088118485522916,1.0,26/125,9.71%,CX3CR1;CACNB2;NRXN1;NLGN1;LRRC4C;LRFN5;ADGRL3;CTNND2;PTPRD;PPFIA4;SLC8A3;LRRK2;SDK1;UNC13B;GRM5;ARHGAP39;PSEN1;CDH2;FLRT3;SHANK3;PPFIA2;APP;SLC6A1;SLC8A2;DNER;REST
prerank,regulation of aerobic respiration (GO:1903715),0.6114949054213958,1.3940024817798067,0.08,0.36145161561121475,1.0,5/15,9.82%,ATP7A;COX7A1;SLC25A33;AK4;VCP
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.6140578617443153,1.393626428863551,0.0741687979539642,0.3618703201811766,1.0,8/15,21.85%,PRKCH;CYP27B1;VDR;TRIM16;NUMA1;SULT2B1;ETV4;BMP4
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.6587422806785428,1.3934470289563732,0.08310626702997276,0.3617607839387144,1.0,9/11,29.44%,BCL2;MUC1;CD44;TRIAP1;ING2;CD74;MIF;KDM1A;SIRT1
prerank,zymogen activation (GO:0031638),0.510213259539597,1.3932794414472949,0.07048458149779736,0.36159735535325066,1.0,13/39,17.48%,PLAU;ASPH;KLK1;HPR;HP;F11;CYFIP2;PGK1;CD5L;KLKB1;FURIN;APOH;KLK3
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.5787756407818017,1.3931579763163209,0.06551297898640297,0.3612893525254409,1.0,9/19,23.52%,RENBP;GNPNAT1;GNPDA1;NANS;NAGK;UAP1L1;GNPDA2;UAP1;AMDHD2
prerank,membrane fusion (GO:0061025),0.5317910187524048,1.3928255835158174,0.0657439446366782,0.36160470901471736,1.0,9/33,17.36%,MYOF;RABEP1;FER1L5;NAPA;DNM2;HUWE1;GCA;CHP1;VAMP2
prerank,B cell differentiation (GO:0030183),0.5001030781552565,1.392749489583364,0.05849268841394826,0.3611165697093051,1.0,10/46,11.77%,PTPRC;HDAC9;ITGA4;HDAC4;KLF6;BLNK;TPD52;ADAM17;PTPN2;DNAJB9
prerank,regulation of mitochondrial depolarization (GO:0051900),0.6584543559710622,1.3917380783886921,0.08192090395480225,0.3635485198910128,1.0,5/10,16.15%,BCL2;RACK1;MYOC;DCN;KDR
prerank,DNA replication initiation (GO:0006270),0.5177336151990847,1.3913904426863635,0.054764512595837894,0.36388280606707857,1.0,16/37,23.62%,ORC3;MCM7;MCM2;NOC3L;POLE;GMNN;CDK2;CDC7;PURA;MCM6;DBF4;MCM8;CDC34;POLE4;TOPBP1;POLA2
prerank,response to amino acid starvation (GO:1990928),0.47951087302620804,1.3913860454573952,0.03412616339193381,0.36320711627644947,1.0,16/72,12.42%,TCIRG1;RRAGD;ATP6V1C1;ATP6V0D2;ATP6V1A;ATP6V1B2;ATP6V0D1;ATP6V0B;ATP6V1G1;TFEB;EIF2S1;DAPL1;DAP;NPRL2;ATP6V1F;LARP1
prerank,regulation of osteoclast differentiation (GO:0045670),0.5334064319512368,1.391181504741483,0.06455266138165346,0.36314073890459286,1.0,5/33,8.97%,GPR137B;CSF1;FSTL3;TCTA;LILRB3
prerank,cortical actin cytoskeleton organization (GO:0030866),0.5709961725630507,1.3904778955464379,0.0705596107055961,0.36453806646401277,1.0,8/20,14.50%,LCP1;PLEK;FMNL2;STRIP1;FMNL3;RHOQ;ROCK1;LLGL2
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.6165412306196368,1.3901308842914002,0.08192457737321196,0.36486799554030835,1.0,10/15,25.54%,RENBP;LARGE1;GNPDA1;OGA;EXTL2;NAGK;GNPDA2;AMDHD2;CHST2;CHST3
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.47113805262266467,1.3898844111081725,0.02151639344262295,0.3648902479149648,1.0,34/94,23.50%,FNIP2;BCL2;BCL2L1;TRAF2;MCL1;CD24;PRKCD;ERN2;STK24;ERN1;IKBKE;BCL2L11;DIABLO;BRCA1;ERO1A;BAX;TNFRSF1B;DDIT3;CYP1B1;APAF1;CASP4;C1QBP;MYBBP1A;GSKIP;STK11;ATM;ARL6IP5;CUL3;CASP9;CUL1;CUL2;PPP1R15A;BNIP3;DNAJC10
prerank,axon extension (GO:0048675),0.5590706932346139,1.3894427272230632,0.07065868263473053,0.3655127615153822,1.0,5/23,8.91%,ALCAM;NRP2;CDK5;NRP1;USP9X
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.6750041044425636,1.389068841984186,0.08194444444444444,0.3659983203410299,1.0,5/10,14.57%,PRKCH;CYP27B1;VDR;TRIM16;NUMA1
prerank,actin nucleation (GO:0045010),0.5627113913475954,1.3888069183399745,0.08834355828220859,0.366135698841873,1.0,7/21,15.24%,ARPC2;ARPC3;ARPC5;SCIN;IQGAP2;ACTR3;ARPC1B
prerank,response to interleukin-1 (GO:0070555),0.47660823618818354,1.3877341448615472,0.02774813233724653,0.3685831196555816,1.0,18/73,16.38%,HIF1A;SIRPA;ANXA1;IRAK2;TANK;CCL4;MAPK13;HDAC4;SOX9;CCL13;CCL7;CCL5;TLE5;CCL14;NFKB1;ACOD1;SMPD1;GBP2
prerank,negative regulation of phagocytosis (GO:0050765),0.5902916528248032,1.3874783139781102,0.07558859975216853,0.36867937341598106,1.0,5/17,9.53%,CD300LF;SIRPA;FER1L5;CD300A;RACK1
prerank,positive regulation of immune response (GO:0050778),0.4847339135352027,1.3873275752081649,0.03488372093023256,0.3684515217333494,1.0,16/64,15.37%,CYBA;SKAP1;FPR2;PTPRC;CD226;ADAM8;SPHK2;HRG;GPR151;IL12RB1;LILRB1;POLR3D;RIOK3;CCL5;RSAD2;ITGB2
prerank,innate immune response (GO:0045087),0.448954121560612,1.3868532661033417,0.002004008016032064,0.36917517975617203,1.0,64/217,22.44%,COLEC12;LCK;CYBA;CAMP;LCN2;KLRC2;LTF;MALT1;FGR;CD300LB;CYBB;SHFL;SRPK1;TRIM6;TRIM43;CYP27B1;PTK2B;RNASE3;MFHAS1;OTULIN;PPARG;MSRB1;IFITM2;TRIM28;AKAP1;TREM2;DMBT1;PPP1R14B;IFITM1;B2M;FYN;C3;MASP1;IRF5;ATAD3A;NRROS;SP100;ZDHHC1;MBL2;ADAM15;CXCL16;CLEC6A;SMPD1;SYK;CLEC4E;RNASE7;CFP;PGLYRP2;S100B;JCHAIN;RNASE6;ADAR;FCER1G;BST2;CYBC1;SLC11A1;CLEC4D;HMGB1;MASP2;NLRC5;SRPK2;LBP;TRIM21;IRAK4
prerank,dopaminergic neuron differentiation (GO:0071542),0.593517595753248,1.3867467359337406,0.07035175879396985,0.36884786160622796,1.0,4/19,16.00%,CTNNB1;VEGFA;LRP6;NR4A2
prerank,regulation of activated T cell proliferation (GO:0046006),0.5288116862280728,1.3865654058315915,0.06395348837209303,0.3687033196783684,1.0,12/30,21.57%,IGF1;CD24;IL12RB1;CD274;IL27RA;CRTAM;TNFSF9;RIPK3;IL2;HMGB1;RPS3;PRKAR1A
prerank,regulation of embryonic development (GO:0045995),0.5212015757035333,1.3864533832281867,0.05190311418685121,0.36836312089133977,1.0,13/34,23.05%,B4GALT5;NIBAN2;DAG1;TRIP12;PHLDB1;RBM19;RACGAP1;DHX36;CCSAP;EHMT1;CFL1;NIPBL;ZBED3
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.6378064650615696,1.3855464373006219,0.07827260458839407,0.37051771108297504,1.0,2/12,0.64%,LCK;SKAP1
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.5179146484756149,1.385114759462166,0.05145413870246085,0.3711211414989767,1.0,17/40,26.99%,IGF1;BCL2L1;PLAUR;MMP9;BID;BCL2L11;BAX;TRIAP1;GHITM;CLU;BIK;TNFSF10;PRELID1;BNIP3;GPX1;PSMD10;NOL3
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.5117111005785393,1.384882267203845,0.06492027334851937,0.37107385026827594,1.0,14/34,19.85%,FLT1;ANXA1;SPHK1;NRP1;HSPB1;ERN1;VEGFA;MAPKAPK2;DLL4;PRKD2;KDR;MAP2K3;ITGB1BP1;MT1G
prerank,DNA duplex unwinding (GO:0032508),0.5048246103908094,1.3844484591877426,0.048298572996706916,0.3716258436320356,1.0,24/50,25.49%,ANXA1;UBA52;RPS27A;MCM7;MCM2;ASCC3;DDB2;DDB1;RAD50;DDX1;XPA;BLM;TWNK;PURA;GTF2H1;RTEL1;DHX9;UBC;MCM6;RECQL5;XPC;GTF2H5;CUL4A;CETN2
prerank,keratinocyte differentiation (GO:0030216),0.5314373466798834,1.3843700787759996,0.07043879907621248,0.371179741872025,1.0,6/29,9.67%,ANXA1;ST14;JAG1;CLIC4;UGCG;EVPL
prerank,toll-like receptor signaling pathway (GO:0002224),0.4766464863324465,1.3838961847181908,0.022727272727272728,0.3720104512972288,1.0,22/84,16.11%,COLEC12;RFTN1;S100A8;CTSB;S100A9;UBA52;IRAK2;RPS27A;TNIP1;SFTPA1;SFTPA2;TRAF3;TAB1;TNIP3;MAPKAPK3;MAPKAPK2;TICAM1;TNIP2;MAP3K1;HSPD1;ITGB2;TIRAP
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.45079020264559516,-1.3838689324314006,0.10232558139534884,0.6311270979439968,1.0,7/18,10.58%,NRXN1;NLGN1;TSHZ3;CACNG3;SHANK3;CACNG8;CCL2
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.6228269065673271,1.382721117802871,0.09778357235984354,0.37491534644031616,1.0,5/13,10.75%,RENBP;LARGE1;OGA;EXTL2;NAGK
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.602449628190523,1.3822331447452287,0.08974358974358974,0.37562581110903787,1.0,6/15,15.24%,ARPC2;ARPC3;ARPC5;IQGAP2;ACTR3;ARPC1B
prerank,aerobic respiration (GO:0009060),0.5722895802642232,1.3815470259285523,0.072992700729927,0.3770358637778087,1.0,11/20,24.53%,NDUFS7;SDHB;SLC25A14;SURF1;UQCRH;MTFR2;MTFR1;SDHC;UQCR10;UQCRB;SIRT3
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.5215548291835926,1.38128557275929,0.05895691609977324,0.37715648596125234,1.0,11/33,24.29%,CSF1;CD4;LEF1;ID2;RUNX1;HAX1;ACIN1;HSF1;IL34;CD74;TNF
prerank,DNA methylation or demethylation (GO:0044728),0.5799294196931961,1.380810763923364,0.07088607594936709,0.3773178185374925,1.0,7/19,19.45%,DNMT3A;DNMT1;GATAD2A;MTRR;ATRX;DNMT3B;EHMT1
prerank,DNA alkylation (GO:0006305),0.5799294196931961,1.380810763923364,0.07088607594936709,0.3773178185374925,1.0,7/19,19.45%,DNMT3A;DNMT1;GATAD2A;MTRR;ATRX;DNMT3B;EHMT1
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.5991225115990381,1.3805354791595876,0.09346991037131883,0.37745553612089305,1.0,3/15,0.83%,LPL;PRKCH;CSF1
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.49432955315252247,1.3804846035629026,0.038461538461538464,0.3768987102139844,1.0,12/56,9.25%,S100A8;CTSB;S100A9;UBA52;IRAK2;RPS27A;SFTPA1;SFTPA2;TRAF3;TAB1;MAPKAPK3;MAPKAPK2
prerank,regulation of cell communication (GO:0010646),0.5216057160300018,1.3790628857508465,0.05096262740656852,0.38038618192144824,1.0,9/35,11.65%,IGFBP7;ANXA1;TBX18;MTCH1;VEPH1;MGLL;UGCG;SRI;YWHAG
prerank,negative regulation of programmed cell death (GO:0043069),0.44191125155783473,1.378968954585714,0.0,0.3800058181275957,1.0,120/355,25.41%,IGF1;BCL2;CTNNB1;ARHGAP10;BCL2L1;NIBAN2;FLNA;IL2RB;ANXA5;PLAUR;ANXA1;LTF;MALT1;LEF1;UBA52;RPS27A;MCL1;PDPN;FIGNL1;CD44;ANXA4;PRDX5;AXL;SPHK1;PTK2B;SQSTM1;MMP9;RAF1;CD28;HYPK;SERPINB9;HSPB1;ANGPT4;BID;SIAH2;MYDGF;DAB2;TPT1;SOX9;APIP;VEGFA;ANGPT1;TREM2;HDAC1;PLK2;IGF1R;PSEN2;NAA16;SON;UFM1;MGMT;NAT8;ATF5;CLN3;TRIAP1;PIM1;RAB7A;WDR73;BIRC6;ATAD3A;PRDM9;HNRNPK;GAS6;FSTL1;PAK2;BIRC5;IL31RA;NFKB1;BFAR;HSPD1;CIAPIN1;CBL;HSPA9;VIP;RNF157;CAT;USP47;FOXO1;BARD1;TFRC;HTATIP2;CCND2;KDR;RASA1;WFS1;RIPK3;HAX1;IL6;HIGD2A;BNIP2;AIFM2;IL2;UBC;MTDH;CFL1;LAPTM5;VHL;GSK3B;NPM1;BMP4;HTR2B;CD74;PRELID1;BAG3;BNIP3;AVEN;MIF;DNAJA1;SOCS2;GOLPH3;TCIM;PLK3;BIRC2;HDAC2;HSPA5;NCKAP1L;SFRP1;KANK2;CX3CL1;YWHAZ
prerank,regulation of synapse organization (GO:0050807),-0.41009009003152086,-1.3789164445981674,0.04938271604938271,0.6373562544424394,1.0,10/26,12.97%,MEF2C;IL1RAPL1;CTNNA2;CDKL5;EPHA4;PDLIM5;SLITRK4;WNT5A;MDGA1;CAMK2B
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.5426605733624867,1.3782101756656742,0.07701283547257877,0.38161812055366784,1.0,10/27,15.37%,LCK;SKAP1;SIRPA;PRKCQ;CD44;NR4A3;CCR2;RHOA;HSPD1;ITGB2
prerank,response to interleukin-6 (GO:0070741),-0.5650600622164283,-1.3779618825666784,0.13059701492537312,0.6321483358372488,1.0,3/10,4.86%,SELPLG;ST3GAL6;RELA
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.5149073742218521,1.3778829350683444,0.06797235023041474,0.381873586789766,1.0,18/35,30.69%,CTNNB1;PRKCQ;CCT2;TNKS2;PKIB;CCT8;HNRNPA2B1;DHX36;ATM;RTEL1;CCT5;ACD;MAPK15;ATR;MAPK3;XRCC5;PNKP;MAPK1
prerank,cellular response to amino acid starvation (GO:0034198),0.47483784952990626,1.376785952630653,0.04033092037228542,0.38442294538880156,1.0,15/71,12.00%,TCIRG1;RRAGD;ATP6V1C1;ATP6V0D2;ATP6V1A;ATP6V1B2;ATP6V0D1;ATP6V0B;ATP6V1G1;TFEB;EIF2S1;DAPL1;DAP;NPRL2;ATP6V1F
prerank,positive regulation of protein sumoylation (GO:0033235),0.6469399755892739,1.3765074747051531,0.09431345353675451,0.3845283581856161,1.0,8/10,32.10%,HDAC4;GNL3;PIAS1;SAE1;RWDD3;PIAS4;MUL1;PIAS3
prerank,organelle fusion (GO:0048284),0.5606678244544405,1.375895614756437,0.08292079207920793,0.3857002803559738,1.0,13/22,32.17%,EEA1;THG1L;VPS18;BAX;AFG3L2;VPS11;STX4;USP30;SPG7;FIS1;MFF;MIGA2;MFN1
prerank,cellular response to superoxide (GO:0071451),0.6603543808183998,1.3756724987827327,0.0821917808219178,0.3856486165581846,1.0,5/10,20.57%,ATP7A;PRDX1;ADPRS;SOD3;SOD2
prerank,tRNA transport (GO:0051031),0.5100717269270707,1.375561580290198,0.0519774011299435,0.38529594573967546,1.0,17/35,29.50%,NUP205;XPOT;NUP188;NOL6;RANBP2;TPR;RAE1;NUP93;AAAS;NUP54;NUP50;NUP98;NUP42;NUP133;NUP210;NUP35;NUP214
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.5736593784820669,1.3751532597638747,0.08529048207663782,0.3857713284517279,1.0,11/19,27.54%,HRG;NRP1;VEGFA;MYOC;ROCK1;KDR;FERMT2;COL16A1;SFRP1;LIMS1;S100A10
prerank,positive regulation of T cell differentiation (GO:0045582),0.5079166916315268,1.3751110948163316,0.06385404789053592,0.3852267377056658,1.0,7/36,6.39%,ZMIZ1;LEF1;ADAM8;TESPA1;IL12RB1;BCL6;GATA3
prerank,regulation of glucose import (GO:0046324),0.5297417325073108,1.3748143058400821,0.06621004566210045,0.38547052153810474,1.0,2/30,0.09%,IGF1;OSBPL8
prerank,activation of protein kinase B activity (GO:0032148),0.5208894478312566,1.3748063745912968,0.07701283547257877,0.38482510609341847,1.0,4/29,6.27%,IGF1;OSBPL8;NRG1;PDPK1
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.5564383383053165,1.37462797509086,0.08,0.38469020755831096,1.0,7/22,11.10%,SASH1;XDH;GDF6;SPHK1;MFHAS1;VEGFA;RELL1
prerank,regulation of platelet aggregation (GO:0090330),0.5898727042904738,1.3743733746502722,0.08939974457215837,0.3847704392607481,1.0,5/17,10.39%,CD9;PRKCQ;PDPN;PRKCD;SERPINE2
prerank,chloride transmembrane transport (GO:1902476),-0.353090743897536,-1.3741975381256935,0.038461538461538464,0.6353396782547333,1.0,18/48,14.06%,GABRB2;GABRB3;GLRA3;SLC1A3;GABRG3;GABRA2;SLC12A2;SLC12A9;SLC12A6;SLC6A1;LRRC8A;GABRA1;SLC12A8;GABRB1;GLRA2;ANO7;GABRR2;GLRA1
prerank,mammary gland development (GO:0030879),0.5590766046611914,1.373753540009421,0.10493827160493827,0.3859395359848954,1.0,5/21,7.03%,NRG1;CSN3;CAV1;ZBTB7B;VEGFA
prerank,oligosaccharide metabolic process (GO:0009311),-0.35616182761187226,-1.3737364958050888,0.058823529411764705,0.6289575548040252,1.0,9/46,6.87%,ST3GAL6;B3GALT5;AMY1A;AMY1B;AMY1C;ST8SIA4;ST6GAL2;GAL3ST4;B3GALT1
prerank,transition metal ion transport (GO:0000041),0.5133789316546591,1.3733495830390454,0.06292134831460675,0.3864115599151208,1.0,11/35,19.97%,TRPC4;SLC31A2;LTF;ATP7A;ATOX1;HEPH;SLC30A9;MELTF;TFRC;SLC11A1;FTH1
prerank,protein-DNA complex assembly (GO:0065004),0.46198427364036665,1.3729091906525825,0.021450459652706845,0.3870972566648759,1.0,52/116,29.81%,PSMD8;PSMD1;ORC3;UBA52;RPS27A;MCM7;MCM2;GRWD1;DAXX;SOX9;GMNN;PSMD6;PSMA1;DDB2;DDB1;PSMC3;XPA;PSMA8;DMC1;PSMD14;PSMD2;CHAF1B;PSMC6;PSMA6;PSMD5;PSMA5;ATRX;GTF2H1;UBC;MCM6;MCM8;NPM1;NAP1L3;XPC;PSMA3;ANP32B;PSMB8;GTF2H5;PSMB10;CUL4A;CETN2;PSMD7;PSMB6;PSMD10;H3-3A;PSMB5;RSF1;PSMB7;MNAT1;PSMC4;ASF1A;HMGB2
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.657443597616743,1.372850559564876,0.0931174089068826,0.3865949067703292,1.0,5/10,23.96%,PTPRC;TLE5;SIGIRR;MAPK7;MAP2K5
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.5902803137364279,1.3723549222231695,0.08914728682170543,0.3874326866619183,1.0,3/16,3.93%,IGF1;SLC9A1;NR4A3
prerank,regulation of mitochondrial translation (GO:0070129),0.5504931628045892,1.3720401132116404,0.0885286783042394,0.3877215552529948,1.0,17/21,36.66%,TRUB2;TRMT10C;RCC1L;ALKBH1;C1QBP;NSUN3;FASTKD3;MRPS27;RPUSD4;MALSU1;FASTKD2;MTG1;SHMT2;RMND1;NGRN;UQCC2;TSFM
prerank,regulation of cytokine production (GO:0001817),0.452658601131096,1.372037390394407,0.01627670396744659,0.3870577257446372,1.0,41/126,24.29%,GPNMB;PLD3;SIRPA;ITK;PTPRC;ANXA1;LTF;FGR;HDAC9;ATP2B1;NPTN;CD28;TRAF3;BCL6;GATA3;CADM1;TREM2;TXK;BTN3A3;IRF8;MAPKAPK2;PLA2R1;CRTAM;CCR2;TNFRSF1B;DTX4;CLEC6A;ASB1;RIPK3;IL6;SLC11A1;AGPAT2;CD47;SRGN;TRIM21;NLRP4;PTGER4;HTR2B;MIF;AGPAT1;TNF
prerank,limb development (GO:0060173),-0.38295694776020095,-1.371470781400524,0.08125,0.6277236099808206,1.0,7/28,9.69%,SALL1;PCSK5;FGF10;BMPR1B;COMP;KAT2B;INTU
prerank,positive regulation of endothelial cell migration (GO:0010595),0.46103710831509487,1.3714538478635252,0.037383177570093455,0.3881563411508963,1.0,27/84,18.68%,HIF1A;NRP2;P2RX4;TMSB4X;SASH1;PIK3CB;PTK2B;NRP1;FGF2;HSPB1;ANGPT4;PDPK1;GATA3;PLPP3;VEGFA;ANGPT1;RIN2;ADAM17;AAMP;FGF18;PRKD2;KDR;ANXA3;MAP2K3;SP1;GPI;ITGB1BP1
prerank,regulation of nervous system process (GO:0031644),-0.4283622587280338,-1.371327112236308,0.07179487179487179,0.620454657016477,1.0,7/18,11.21%,ROCK2;DLGAP1;SLC8A3;HTR2C;APP;SLC8A2;BEGAIN
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.4633755066117719,-1.3708716940182153,0.10256410256410256,0.6143055315154582,1.0,6/15,10.27%,ZFYVE27;CASP3;HAP1;NTRK2;SORT1;DDIT4
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.585626452352442,1.3705053361285786,0.09536082474226804,0.39027473316447336,1.0,2/16,3.77%,IGF1;CILP
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.4679009293998275,1.3705014526850643,0.03628601921024546,0.3896151728803612,1.0,33/72,28.03%,PTPRC;IRAK2;TRAF2;AXL;CD24;SPHK1;OTULIN;RUNX1;RNASEL;RACK1;PTPN2;TRAF1;HIPK1;JAK1;SHARPIN;GAS6;SYK;SIGIRR;USP18;PIAS1;AGPAT2;HSP90AB1;CD74;AGPAT1;TNF;SUMO1;JAK2;BIRC2;PTPN6;IFNAR2;IFNGR2;TNFAIP3;RIPK1
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.596653003839851,1.3703048528972053,0.08865710560625815,0.38952707413857385,1.0,11/16,33.97%,SOX9;BRCA1;APOC1;APPL2;SIRT4;ACADL;WDTC1;ERLIN1;CEACAM1;ACADVL;ERLIN2
prerank,endodermal cell differentiation (GO:0035987),0.5190504898428553,1.3699426575583202,0.06836616454229433,0.3899466910767769,1.0,6/31,9.45%,FN1;MMP8;ITGA5;MMP9;ITGA4;COL12A1
prerank,regulation of p38MAPK cascade (GO:1900744),0.5110837812114513,1.3688713168919115,0.06947608200455581,0.39259231306118836,1.0,10/35,11.10%,SASH1;XDH;GDF6;SPHK1;MFHAS1;PTPN22;VEGFA;TREM2;RASGRP1;RELL1
prerank,UV-damage excision repair (GO:0070914),0.6349578206720571,1.3687212472490478,0.09673024523160763,0.3923679829281612,1.0,5/12,14.44%,ERCC1;DDB2;DDB1;XPA;INO80
prerank,synaptic membrane adhesion (GO:0099560),-0.507323937710888,-1.3685100061671516,0.11304347826086956,0.613670267590433,1.0,3/14,1.36%,LRRC4C;LRFN5;PTPRD
prerank,T-helper cell differentiation (GO:0042093),0.5991747631332882,1.3682484777368453,0.10282776349614396,0.3930434278266068,1.0,7/14,26.14%,LEF1;ATP7A;TMEM98;IL6;HMGB1;PTGER4;GPR183
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.5438434700777225,1.368083585924625,0.07738095238095238,0.39289158307381994,1.0,5/23,14.42%,IGF1;HIF1A;PFKFB3;ENTPD5;NFKB1
prerank,RNA metabolic process (GO:0016070),0.44830435111312983,1.3679046221304574,0.02240325865580448,0.39271268384104674,1.0,46/127,19.31%,APOBEC1;DEDD2;ADARB1;AGO2;RNASE3;HNRNPA3;HNRNPUL1;HNRNPM;THOC1;XRN2;ATXN1;POLR2H;PAPOLA;RNASEH2A;HNRNPC;DDX17;RNASEL;PABPN1;M1AP;METTL3;RNASEH1;RBPMS;ALKBH1;PRPF4;HNRNPK;GTF2F1;DDX39B;SYNCRIP;HNRNPA2B1;POLR2D;RBFOX2;PCBP1;DUSP11;DHX36;RNASEH2B;RBM39;ISG20;HNRNPU;HNRNPF;DHX9;RNASE6;TP53RK;SNRNP40;ADAR;ATXN2;AGO3
prerank,regulation of oxidative phosphorylation (GO:0002082),0.5920593441944124,1.3677023441617604,0.09768637532133675,0.39267543806308874,1.0,5/16,9.82%,ATP7A;COX7A1;SLC25A33;AK4;VCP
prerank,inflammatory response (GO:0006954),0.4456394206834297,1.3675561156167095,0.004004004004004004,0.3924202322507022,1.0,47/195,16.70%,S100A8;S100A9;CYBA;CD96;FPR2;OLR1;PTGIR;ANXA1;ITGAL;CYBB;LAT;ADCY8;HDAC9;PARP4;CXCR2;CCL4;ADAM8;PTGFR;CD44;PRDX5;C3AR1;MFHAS1;HDAC4;MGLL;BLNK;NFX1;HPR;HP;TAC4;CCL13;MAPKAPK2;CRH;LTB4R;CCR2;CCL7;CCL5;ADGRE5;NRROS;CCL14;SIGLEC1;NFKB1;TPST1;ADORA2A;ITGB2;TUSC2;HSPG2;C5AR1
prerank,mitochondrial membrane organization (GO:0007006),0.5174207620358005,1.3674932338741184,0.08975834292289989,0.3919773106340715,1.0,11/32,17.81%,BCL2;BCL2L1;IMMT;SAMM50;RCC1L;MTX3;CHCHD6;GHITM;SLC25A31;HSPA9;TMEM11
prerank,lymphocyte chemotaxis (GO:0048247),0.5178225136093711,1.367306087123959,0.07736063708759955,0.3918832996885311,1.0,9/34,14.77%,CCL4;ADAM8;CCL13;CCL7;CCL5;GAS6;CCL14;CXCL16;CH25H
prerank,gene expression (GO:0010467),0.4339699130102859,1.3668495835406294,0.002,0.39254308190527787,1.0,150/348,28.60%,APOBEC1;RPS12;MRPS12;NUP205;DEDD2;ADARB1;AGO2;RPS27A;TNIP1;RPS6;EIF4G1;RPS14;MRPL51;RPL10A;RPL18;RPS24;HNRNPUL1;IGHMBP2;RPS7;RPL41;RPL36A;RPS20;RPS26;EEF1A1;RPL23;RPL17;MRPL23;RPS25;TSPAN17;RPL35A;THOC1;RPS28;RPLP2;RPL28;XRN2;ATXN1;POLR2H;DDX17;RPL27A;RNASEL;PABPN1;RPL11;RPS2;M1AP;MRPL52;NUP188;SRSF11;TASP1;RBPMS;RPL32;PRPF4;ANGPT2;DRG1;MRPS15;SRSF7;RPL21;MRPL24;PWP1;HNRNPK;TSPAN5;RPL9;AGFG1;RPL36;RPL37;MRPS33;MRPS16;DDX39B;RPL38;SYNCRIP;HNRNPA2B1;EIF4A3;POLR2D;RPS18;MRPS7;RANBP2;HSPD1;RPS19;RPS27;TPR;RPS23;NR4A2;DUSP11;SYMPK;CHTOP;RPL14;RPS16;SARS1;MRPL11;THOC2;RBM15B;RBM39;RAE1;RPL30;RPL31;HNRNPU;RPL12;GSPT1;HNRNPF;FARSB;RPL13A;RPS9;SNRNP40;RPL4;ADAR;SRSF2;RRBP1;RPS3;NUP93;RPS13;AAAS;PABPC4;RPSA;DKC1;RPL15;UPF3B;MRPS14;RBMS2;POLDIP3;SRRM1;NUP54;MRPL37;NUP50;GOLPH3;RPL7A;POLR2F;HNRNPL;NUP98;RRAGC;MRPL18;RPL23A;MCM3AP;RPL8;NOX4;RPLP1;NUP42;NUP133;RPL29;NUP210;FASTKD2;RPL37A;THOC6;EIF4E;MRPL41;MRPL27;SMG1;CREBL2;SRSF1;NUP35;RPS15A;MRPL42
prerank,mesoderm development (GO:0007498),0.5739100555268962,1.3665928548890534,0.0906832298136646,0.39258318885095883,1.0,4/18,7.67%,IKZF3;TCF15;VEGFA;HES7
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.6587449585627341,1.3662669275266268,0.08183079056865465,0.3929211607458262,1.0,4/10,10.55%,KMT2A;SPHK2;BRCA1;SMARCB1
prerank,negative regulation of axon extension (GO:0030517),-0.37555279136340775,-1.36607268469071,0.09740259740259741,0.6133019789395329,1.0,13/30,25.56%,SEMA6D;DIP2B;SEMA6A;MAP2;MAG;SEMA6C;SEMA4B;RTN4R;SEMA3B;SEMA4A;CDKL3;SEMA7A;PTPRS
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.6270083660248277,1.3660519684737245,0.09536423841059603,0.3928823021767035,1.0,9/12,29.44%,BCL2;MUC1;CD44;TRIAP1;ING2;CD74;MIF;KDM1A;SIRT1
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.6522881282411201,1.365026231922247,0.10975609756097561,0.3953519988911926,1.0,4/10,13.01%,GDF6;SOX9;PKDCC;ZBTB16
prerank,respiratory system development (GO:0060541),0.5136665369173153,1.3644216890785417,0.08208092485549133,0.39660032107219473,1.0,17/32,27.39%,PDPN;FGF2;VEGFA;BASP1;NKX2-1;FGF7;CEBPA;RBP4;ITGA3;DISP1;BMP4;FGFR2;FGF1;CCDC40;SMCHD1;CHD7;CCDC39
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.5936210814262719,1.3643122114512278,0.09261576971214018,0.39626460017453724,1.0,8/16,22.85%,PIGQ;PIGZ;PIGA;PIGN;PIGL;PIGC;PIGX;PIGH
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.5976367202229604,1.3639815594908111,0.09517601043024772,0.3965700222400873,1.0,11/15,29.44%,BCL2;MUC1;CD44;TRIAP1;ING2;CD74;MIF;MDM2;KDM1A;PTTG1IP;SIRT1
prerank,regulation of mitotic spindle organization (GO:0060236),0.5141250972266947,1.3638985286173713,0.07525655644241733,0.3961595960368676,1.0,13/35,18.99%,DYNC1H1;CHMP4B;PDCD6IP;DCTN1;VPS4B;DRG1;NUMA1;TACC3;TPR;RAE1;HNRNPU;PARP3;CCSAP
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.633791055766263,1.3638628764685727,0.063257065948856,0.3956360724483615,1.0,3/12,5.93%,CYBA;MMP8;ADGRB1
prerank,regulation of trophoblast cell migration (GO:1901163),0.5995641237333071,1.3634379471227511,0.10065359477124183,0.39621828108247326,1.0,7/14,22.50%,AGO2;VEGFA;YTHDF3;C1QBP;TIMP1;ARHGDIB;CALR
prerank,sulfate transport (GO:0008272),0.6028476611242024,1.3633943191155702,0.1038107752956636,0.3956829649380242,1.0,7/14,21.90%,SLC26A1;SLC13A4;SLC26A11;SLC25A14;SLC26A4;RACGAP1;SLC26A6
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.6511871078469997,1.3631943303526095,0.10363391655450875,0.3955999428691705,1.0,1/10,0.06%,XYLT1
prerank,regulation of protein kinase activity (GO:0045859),0.45307574647587273,1.3631912439701468,0.026503567787971458,0.3949603860380086,1.0,31/106,19.06%,IQGAP1;CSF1;SMCR8;PTPRC;CD4;FGR;LAT;ALS2;GNAQ;PTK2B;HSPB1;DAXX;PDPK1;DBNDD1;TAB1;DTNBP1;YWHAG;GAS6;PAK2;JTB;PPIA;LRP6;NF1;CHP1;MAP2K3;C5AR1;DDR2;PRKAG1;GSKIP;ITGB1BP1;TAF7
prerank,regulation of phospholipase activity (GO:0010517),0.6464794370281437,1.3630268159762378,0.09641873278236915,0.3948320788387892,1.0,6/10,25.24%,LRP1;PDPK1;RASGRP1;FGFR3;FGFR2;PLA2G5
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.5663713786684454,1.3629904148599805,0.09573091849935317,0.39430086934143166,1.0,12/18,30.14%,RAD51B;BRD4;FBXO5;CCNB1;VPS4B;STOX1;CDC7;RAB11A;CDK4;CDC25B;CDC25A;CCND1
prerank,regulation of cellular protein catabolic process (GO:1903362),0.5795728275415135,1.3624199496694516,0.09922680412371133,0.3954103351477741,1.0,6/18,13.10%,MSN;RGP1;WDR91;NELL1;RIC1;VPS11
prerank,positive regulation of protein depolymerization (GO:1901881),0.6403536749005663,1.3618681681908877,0.10889774236387782,0.39642481607436836,1.0,2/11,3.15%,PLEK;NES
prerank,negative regulation of autophagy (GO:0010507),0.4759380584497631,1.3615893107724568,0.06216505894962487,0.39661172897196145,1.0,13/54,13.51%,BCL2;ATG7;SMCR8;CTSA;MCL1;EIF4G1;PTPN22;TREM2;EIF4G2;DAPL1;DAP;ZKSCAN3;EIF4G3
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.6510681294037008,1.3603412640272265,0.11624649859943978,0.3997122089650643,1.0,4/10,13.09%,MALT1;TBX21;NFKBIZ;SMAD7
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.5013298957237775,1.3602141379955466,0.07190265486725664,0.3994534555184802,1.0,17/39,29.00%,NFE2L2;ITGA4;PDPK1;GATA3;ANGPT1;SERPINE1;TNIP2;GAS6;KDR;PDCD4;KRIT1;ANO6;MAPK7;TNF;PAK4;TNFAIP3;NDNF
prerank,negative regulation by host of viral transcription (GO:0043922),0.6136934877942841,1.3600435786342768,0.10560625814863103,0.3993259235262438,1.0,7/12,19.20%,CCL4;HDAC1;PSMC3;JUN;CCL5;TFAP4;TARDBP
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.41116631111917384,-1.3595416945404397,0.07647058823529412,0.6250645065319177,1.0,9/25,19.53%,ACVR2B;BMPR1B;RBPJ;UBE2O;ENG;SULF1;ACVR2A;FOXD1;FBXL15
prerank,O-glycan processing (GO:0016266),0.48440883725475264,1.3593193878705128,0.046637744034707156,0.4008547864204574,1.0,6/54,3.91%,B4GALT5;GALNT7;GALNT15;MUC1;MUC16;B3GNT3
prerank,regulation of presynapse assembly (GO:1905606),-0.44664452154175915,-1.3590394279742175,0.1,0.6121249196267029,1.0,6/18,11.52%,IL1RAPL1;LRFN5;PTPRD;IL1RAPL2;APP;MDGA1
prerank,regulation of presynapse organization (GO:0099174),-0.44664452154175915,-1.3590394279742175,0.1,0.6121249196267029,1.0,6/18,11.52%,IL1RAPL1;LRFN5;PTPRD;IL1RAPL2;APP;MDGA1
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.5852082956643414,1.3589933972748351,0.1020671834625323,0.40119096068837584,1.0,9/16,24.29%,SHFL;ETF1;IGF1R;CLN3;OGFOD1;MTRF1;GSPT1;BNIP3;TNF
prerank,positive regulation of inflammatory response (GO:0050729),0.4596519004170855,1.3587014723102262,0.03125,0.40141600783759773,1.0,33/86,28.14%,LPL;S100A8;S100A9;MMP8;TNIP1;ADAM8;OSMR;MAPK13;NAPEPLD;NFKBIZ;CEBPA;CCR2;SERPINE1;GPRC5B;RPS19;NINJ1;PDCD4;SNX4;IL6;DHX9;IL2;GPSM3;LBP;CD47;PTGER4;IL17RA;TNF;CX3CL1;MDK;TLR9;CCN4;RIPK1;ABCC1
prerank,histone lysine methylation (GO:0034968),0.5153190359203637,1.3586095840367414,0.08700564971751412,0.4010614866814189,1.0,15/33,27.26%,CXXC1;KMT2A;DYDC1;DOT1L;RBBP5;SMYD3;PRDM9;WDR5;SMYD2;SMYD1;SETMAR;KMT2D;TRMT112;WDR5B;SETDB1
prerank,regulation of cholesterol transport (GO:0032374),0.555033258465434,1.358466884779473,0.11234567901234568,0.40087673160806647,1.0,6/20,14.42%,LRP1;APOA2;ABCA13;ARV1;APOC1;NFKB1
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.4134582682577318,-1.357557543650324,0.09497206703910614,0.6094103666817565,1.0,11/24,14.02%,F11R;WASF2;PIK3R1;TMEFF2;TJP1;STMN1;CLASP2;CGNL1;INPP5K;PHLDB2;ARHGAP28
prerank,regulation of dendrite development (GO:0050773),-0.3670654979102368,-1.3570980883345036,0.044642857142857144,0.6040343750064012,1.0,10/37,10.41%,CSMD3;CDKL5;ADGRB3;HECW1;BCL11A;HECW2;CAMK1D;VLDLR;LRP8;DBN1
prerank,Golgi organization (GO:0007030),0.44800574951907485,1.356491393094557,0.020387359836901122,0.40634800600870785,1.0,29/112,18.44%,PLEKHM2;ARHGAP21;GOSR2;SYNE1;OPTN;ATP8B4;SEC22B;GOLGB1;VTI1A;ARL1;PI4K2A;TRAPPC8;STX6;HTT;COG4;GAK;PRMT5;HUWE1;GCC2;LMAN1;CDC42;CSNK1D;RAB1A;VAMP4;TRAPPC11;VPS51;TBC1D20;ARFGEF1;LMAN2
prerank,cellular response to interleukin-1 (GO:0071347),0.4467674730861919,1.3555099689901413,0.017189079878665317,0.4085526318565268,1.0,57/143,29.43%,HIF1A;SIRPA;PSMD8;PSMD1;UBA52;IRAK2;TANK;CCL4;RPS27A;MAPK13;SQSTM1;SOX9;TAB1;PSMD6;PSMA1;CCL13;PSMC3;CCL7;CCL5;PSMA8;TNIP2;PSMD14;CCL14;PSMD2;NFKB1;ACOD1;PSMC6;PSMA6;GBP2;IL1R2;PSMD5;MAP3K8;PSMA5;PTGIS;UBC;FBXW11;CUL1;CD47;IRAK4;EGR1;PSMA3;PSMB8;PSMB10;SFRP1;CX3CL1;PSMD7;PELI1;PSMB6;BTRC;PSMD10;RC3H1;PSMB5;PSMB7;MAPK3;IL1R1;PSMC4;TAB2
prerank,nucleus organization (GO:0006997),0.4832753845424337,1.3554015623354112,0.07276736493936053,0.40823621041013214,1.0,20/47,24.83%,NUP205;SYNE1;CTDNEP1;CHMP4A;CHMP4B;PDCD6IP;LEMD2;REEP3;WDR73;VPS4B;CHMP7;NUMA1;RPS19;TPR;SUN1;CHMP6;NUP93;USP36;NUP54;NUP98
prerank,positive regulation of multicellular organismal process (GO:0051240),0.432925557587512,1.3553048502190213,0.002004008016032064,0.407917546522836,1.0,94/308,23.69%,B4GALT5;CTNNB1;APOE;ITGAX;LCN2;PRKCH;ABCA1;LRP1;NIBAN2;SDCBP;FABP5;SLC27A1;ITK;FGR;LEF1;AGO2;GCNT2;PDPN;PEMT;BMP1;CYP27B1;VDR;GLIPR2;FGF2;CD28;DYNC1H1;UCP2;CAV1;FOXJ1;DAB2;ZBTB7B;SOX9;ACSL1;VEGFA;CADM1;TREM2;TXK;IGF1R;TRIM16;FBXO5;KDM3A;CRH;LRPAP1;BAMBI;PLA2R1;ENO1;CRTAM;CCR2;SERPINE1;KMT5B;RBM19;PPARGC1B;GAS6;ZBTB16;OGT;ABCA7;GHR;ROCK1;YBX2;NUMA1;RPS19;CLEC6A;VIP;C1QBP;SYK;PLAC8;APPL2;TFRC;CPT2;ADIPOR1;DECR1;SNX4;IL6;FERMT2;EHMT1;SLC11A1;IL2;AGPAT2;CFL1;FABP4;HSF1;LBP;ACADL;ETV4;BMP4;PTGER4;TERT;F2R;HTR2B;TGFBR2;ZBED3;GNAS;MIF;AGPAT1
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.5531159892864149,1.3551487180860224,0.08930817610062892,0.40768435187174673,1.0,9/21,29.29%,PTPA;MFHAS1;BOD1L1;YWHAB;GSK3B;PPP1R15A;PPP1R8;FKBP1B;FKBP1A
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.6174817015291628,1.3549325903339138,0.12101063829787234,0.40769836871347465,1.0,10/12,33.97%,BRCA1;APOC1;ACADL;WDTC1;ERLIN1;SIRT1;PIBF1;CEACAM1;ACADVL;ERLIN2
prerank,water-soluble vitamin metabolic process (GO:0006767),0.471181348514233,1.35488684090965,0.044633368756641874,0.40719752201571463,1.0,23/68,20.66%,FLAD1;SLC23A1;SLC23A2;ACP5;MTHFD2;SLC2A1;ABCD4;SLC46A1;PDXK;MTHFS;MMUT;SHMT1;SLC52A2;MTHFD1;FPGS;MMAB;MTRR;SLC19A1;AASDHPPT;ALDH1L2;CYB5R3;PDZD11;GSTO2
prerank,entry into host (GO:0044409),0.6082978452043972,1.3547431103332834,0.10158311345646438,0.40699082607921166,1.0,6/13,15.02%,CTNNB1;CD4;GRB2;CDH1;PPIA;CBL
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.4662814754933468,1.3540074449645625,0.04365904365904366,0.408608375069475,1.0,17/77,16.00%,LGALS3;IGF1;BCL2;BCL2L1;PLAUR;MCL1;MMP9;SIAH2;NOC2L;HTT;SLC35F6;TRIAP1;BIRC6;MPV17L;GHITM;CLU;NR4A2
prerank,cellular response to oxidative stress (GO:0034599),0.448221594563747,1.3537843638986906,0.0254841997961264,0.40863856480577554,1.0,51/118,28.45%,CYBA;HIF1A;NFE2L2;MSRA;SLC25A24;CYBB;ATP13A2;PRDX5;PRDX6;MMP9;PRKCD;PRDX1;CPEB2;SRXN1;EIF2S1;AGAP3;NCF4;ERO1A;PLA2R1;GSR;HMOX1;JUN;LONP1;TXNRD1;CHCHD2;RBM11;PPIA;DAPK1;MAPK9;CAT;FOXO1;SOD3;ALDH3B1;RPS3;SOD2;NUDT2;PRR5L;ATF4;PDGFRA;PYCR2;NCF2;NOX4;GPX1;SESN2;KEAP1;NCF1;STX4;ZFAND1;CYCS;MAPK3;PRDX3
prerank,regulation of cell cycle phase transition (GO:1901987),0.45712100811429335,1.3536323066184701,0.04149377593360996,0.40842896324458206,1.0,37/91,28.23%,PSMD8;PSMD1;FBXW7;ANAPC15;FZR1;FBXO5;PSMD6;PSMA1;DDB1;CCNB1;PSMC3;PSMA8;TFAP4;ANAPC1;PSMD14;PSMD2;PSMC6;PSMA6;PSMD5;PSMA5;CDC26;BUB1B;DBF4;CUL1;ANAPC7;XPC;PSMA3;TCIM;PSMB8;PSMB10;PSMD7;UBE2C;PSMB6;BTRC;PSMD10;PSMB5;PSMB7
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.6183644392328517,1.3535377037265663,0.09408602150537634,0.40744726262843173,1.0,5/12,14.71%,IGF1;SLC9A1;LMCD1;CHERP;SPPL3
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.6183644392328517,1.3535377037265663,0.09408602150537634,0.40744726262843173,1.0,5/12,14.71%,IGF1;SLC9A1;LMCD1;CHERP;SPPL3
prerank,catecholamine biosynthetic process (GO:0042423),0.6269993244084833,1.3533020164245886,0.10569105691056911,0.4074918970142365,1.0,2/11,6.39%,TH;GATA3
prerank,positive regulation of biosynthetic process (GO:0009891),0.5031128132167744,1.3527565132812873,0.061247216035634745,0.4085147318172638,1.0,12/40,17.58%,CYBA;APOE;MMP8;VIM;RUNX1;ADGRB1;SUCO;CCL5;SORBS1;SIRT4;SLC5A3;SERPINF2
prerank,positive regulation of translation (GO:0045727),0.45218229580200564,1.3526946455698634,0.035897435897435895,0.4080675534904035,1.0,40/94,24.60%,PKM;AGO2;EIF6;VIM;TRUB2;CD28;EEF2;PIWIL2;TRMT10C;RCC1L;LARP4;METTL3;CPEB3;YTHDF3;CCL5;LARP1;YBX3;EIF4A3;POLR2D;YTHDF2;C1QBP;DHX36;FXR2;CNBP;EIF3E;IL6;DHX9;RPS9;UPF3A;FASTKD3;EIF5AL1;EIF5A;NPM1;SAMD4A;CDC123;UPF3B;MRPS27;POLDIP3;RPUSD4;PYM1
prerank,histone H3-K4 trimethylation (GO:0080182),0.6294274880751594,1.3524229993072037,0.1232876712328767,0.40831817459655007,1.0,5/11,14.28%,KMT2A;TET3;PRDM9;OGT;SETD1A
prerank,glycerolipid catabolic process (GO:0046503),0.567829166560249,1.3522380619273746,0.08849557522123894,0.4082688852862141,1.0,7/19,16.55%,GDPD3;PRDX6;ABHD12;MGLL;SMPD4;LYPLA2;PNPLA6
prerank,regulated exocytosis (GO:0045055),0.43893623000921267,1.3521882317551694,0.009036144578313253,0.4077876451125424,1.0,55/173,22.61%,IGF1;CD9;FN1;TLN1;PLEK;FLNA;ANXA5;TMSB4X;ALDOA;TAGLN2;CHID1;PDGFA;CTSW;SCIN;HRG;CPLX4;A2M;LHFPL2;DNAJC5;PSAP;CDK5;SYNGR1;APLP2;ACTN1;TOR4A;VEGFA;RAB11FIP1;LAMP2;GTPBP2;CYB5R1;PIP5K1C;CD63;SERPINE1;F5;ECM1;LY6G6F;GAS6;CPLX2;PROS1;CLU;FAM3C;APOH;VAMP2;SERPINF2;OLA1;ARHGAP17;F8;SYT8;ACTN2;CDC37L1;TIMP1;ITGA2B;SRGN;ACTN4;TMEM79
prerank,regulation of cellular biosynthetic process (GO:0031326),0.5284342905700281,1.3516313168553404,0.0861244019138756,0.4087925363722596,1.0,8/28,11.70%,MFSD12;MITF;SIRPA;EIF6;SIRT5;C3;CCL5;TNFRSF1B
prerank,DNA-dependent DNA replication (GO:0006261),0.45095155185790925,1.3514343124128045,0.011156186612576065,0.4088013354099073,1.0,66/128,34.21%,PSMD8;PSMD1;ORC3;UBA52;RPS27A;MCM7;MCM2;DDX21;NOC3L;POLE;GMNN;PSMD6;PSMA1;PSMC3;PSMA8;BLM;CDK2;PSMD14;PSMD2;TWNK;CDC7;PSMC6;PSMA6;POLG2;POLB;PSMD5;WDHD1;PURA;PSMA5;RFC1;GINS1;POLG;UBC;MCM6;RECQL5;DBF4;MCM8;SRPK2;CDC34;POLE4;TOPBP1;POLA2;PSMA3;RFC2;PSMB8;PSMB10;BAZ1A;PSMD7;PSMB6;PSMD10;PSMB5;POLD4;PSMB7;PSMC4;PNKP;PSMD12;RFC4;GINS3;PSMD3;UBB;GINS2;POLA1;RFC5;MCM5;RAD51;REV3L
prerank,negative regulation of immune effector process (GO:0002698),0.6086202041465971,1.351048832368088,0.102803738317757,0.4092813105742739,1.0,7/13,21.74%,LGALS3;LILRB1;CD300A;RPS19;HAVCR2;CD55;CD47
prerank,response to interferon-alpha (GO:0035455),0.580700569084626,1.3496897487275288,0.09734513274336283,0.4127136726285622,1.0,8/16,19.32%,AXL;IFITM2;GATA3;IFITM1;GAS6;TPR;ADAR;BST2
prerank,neuromuscular process controlling balance (GO:0050885),-0.4727058083875788,-1.349615774580455,0.12719298245614036,0.618549099157249,1.0,3/12,2.62%,NRXN1;CDH23;PCDH15
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.41220924439960344,-1.3493766935521916,0.1032258064516129,0.6126074073374147,1.0,12/25,20.30%,CTSS;WNK1;GLRX;WNK3;DMD;SLC6A9;STAC;COX17;TRPC6;ANK2;ANK3;PDZK1
prerank,protein localization to Golgi apparatus (GO:0034067),0.5279865375082866,1.3492636626050627,0.08450704225352113,0.4133295510565126,1.0,10/27,16.60%,VPS13C;OPTN;ZDHHC15;ARL1;VPS13A;GAK;GCC2;PAQR3;CSNK1D;VPS13D
prerank,protein deacetylation (GO:0006476),0.4928420301204736,1.3490211248057709,0.07215332581736189,0.4134099777009533,1.0,20/41,26.47%,FLNA;HDAC9;HDAC7;RCOR1;HDAC4;MSL3;HDAC1;MIDEAS;SIRT5;SUDS3;SIRT4;RCOR3;MIER2;MORF4L1;MTA3;HDAC11;SIRT3;HDAC2;HDAC3;MORF4L2
prerank,Golgi ribbon formation (GO:0090161),0.602328885407027,1.3485847780925797,0.11477572559366754,0.4140071661344373,1.0,8/13,25.42%,OPTN;VTI1A;STX6;PRMT5;GCC2;VAMP4;GOLPH3;GOLGA2
prerank,positive regulation of type 2 immune response (GO:0002830),-0.47805799199072085,-1.3480848193012787,0.1059322033898305,0.6097340404285347,1.0,5/14,12.11%,IL18;CD86;CD81;NLRP3;PRKCZ
prerank,metallo-sulfur cluster assembly (GO:0031163),0.539910242624833,1.3479012032133877,0.09735576923076923,0.41551098704538136,1.0,8/22,22.01%,HSCB;NFU1;ISCA1;IBA57;CIAPIN1;HSPA9;ABCB7;CIAO1
prerank,epidermis development (GO:0008544),0.4724007450543976,1.347797572032247,0.05387931034482758,0.41519759711655546,1.0,17/56,25.29%,FOXN1;FABP5;OVOL1;HDAC1;UGCG;FLOT2;EVPL;FGF7;TGM5;SPINK5;ALDH3A2;LAMA3;ATP2A2;WAS;FGFR2;HDAC2;GRHL1
prerank,positive regulation of immune system process (GO:0002684),0.5852840314632595,1.347567908423637,0.11435832274459974,0.4152918664757377,1.0,5/16,14.10%,ANXA1;PIK3CB;GPR151;VEGFA;RSAD2
prerank,activation of protein kinase activity (GO:0032147),0.4466234287584105,1.3475096079431694,0.02456499488229273,0.41481265939572654,1.0,40/106,26.01%,IGF1;OSBPL8;MALT1;ADCY8;ADCY3;TRAF2;NRG1;TNFSF15;ADCY7;PTK2B;PAK6;PRKCD;TAOK3;PDPK1;STK3;VEGFA;ANGPT1;COPS8;CARD10;GAS6;PAK2;GHR;PPIA;TIRAP;MINK1;STK11;RIPK3;ITGB1BP1;SLC11A1;MARK2;PRRC1;PRKAR1A;TAOK1;TGFBR2;CCDC88A;JAK2;FGF1;TXN;PAK4;MAPKAP1
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.45582975006666454,1.3473405744077793,0.040498442367601244,0.41469982580596365,1.0,33/87,28.23%,GPNMB;CDK6;PSMD8;PSMD1;FBXO5;PSMD6;PSMA1;WEE1;PSMC3;PSMA8;PSMD14;PSMD2;USP47;PSMC6;PRMT2;PSMA6;PSMD5;PSMA5;CUL1;AVEN;PSMA3;PSMB8;DCUN1D3;CDK4;PSMB10;KANK2;PSMD7;PSMB6;PSMD10;CDK2AP2;DACT1;PSMB5;PSMB7
prerank,positive regulation of proteolysis (GO:0045862),0.47174793864616865,1.3471889990604402,0.06310160427807486,0.4145063710905928,1.0,20/55,26.50%,APOE;ASPH;TANK;TNIP1;ADAM8;SNX33;CYFIP2;TNFRSF1B;OGT;RCN3;FURIN;SH3D19;FBXW11;WDR48;TBC1D10A;TNF;IST1;HDAC2;MAPK12;BTRC
prerank,positive regulation of neuron differentiation (GO:0045666),-0.36603946246726504,-1.347171518735288,0.07964601769911504,0.6058652367811388,1.0,12/40,16.70%,MEF2C;ZEB1;MMD;BEND6;BRINP1;PCP4;REST;ECT2;SIN3A;VWC2;BMP2;TCF4
prerank,regulation of MAPK cascade (GO:0043408),0.4399488944336242,1.3465769829070222,0.02708124373119358,0.4157842199840846,1.0,46/157,23.08%,BCAR3;IGF1;IQGAP1;FLT1;FN1;MMP8;PTPRC;CD4;DAG1;PDGFA;CD24;PAK6;FGF2;TAOK3;CAV1;MYDGF;STK3;APIP;RASGRP1;IGF1R;PRDM15;IAPP;MYOC;ABCA7;PAK2;ROCK1;LPAR1;TMEM106A;DUSP3;SYK;NF1;KDR;MINK1;PIK3R2;DHX33;IL6;FAM83D;HMGB1;LAPTM5;RNF41;TAOK1;MAP2K2;FGFR3;ARHGEF5;F2R;CD74
prerank,negative regulation of cellular catabolic process (GO:0031330),0.46608315219005253,1.3464681235601512,0.059957173447537475,0.4155229533494499,1.0,18/63,15.50%,BCL2;RGP1;MCL1;EIF4G1;NELL1;PTPN22;TREM2;EIF4G2;HP;RIC1;DAPL1;DAP;APOC1;ZKSCAN3;TIMP4;EIF4G3;ROCK1;TIMP2
prerank,regulation of B cell activation (GO:0050864),0.5318956425537299,1.3463562751869453,0.10666666666666667,0.41523303333543293,1.0,12/25,27.94%,IKZF3;CD22;FOXJ1;SH3KBP1;SAMSN1;TNIP2;IL6;LAPTM5;AHR;TLR9;TNFAIP3;THEMIS2
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.5473251414636681,1.3455786762088366,0.12696493349455865,0.41691715479100766,1.0,6/21,10.83%,ADCY8;ADCY3;NPPA;ADCY7;AMPD2;NPR2
prerank,regulation of keratinocyte differentiation (GO:0045616),0.5405918335172124,1.3455560262275401,0.10416666666666667,0.4163664006695884,1.0,8/24,14.57%,PRKCH;CYP27B1;VDR;RUNX1;TRIM16;HOXA7;ROCK1;NUMA1
prerank,negative regulation of histone methylation (GO:0031061),0.6363693205596521,1.3450367070560494,0.11871508379888268,0.41734631655999366,1.0,6/10,18.73%,DNMT1;MTF2;BRCA1;WDR5;PHF1;DNMT3B
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.39462503122318665,-1.3447804494113338,0.09433962264150944,0.6064544402244827,1.0,7/26,6.05%,ROCK2;VSIR;EPHA4;PICALM;GRIN2B;STAT3;APH1B
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.5387165944267429,1.3442116310280539,0.1063321385902031,0.41919676097925607,1.0,7/24,21.45%,IGF1;GCK;DYRK2;SORBS1;EPM2AIP1;PPP1R3F;GSK3B
prerank,regulation of T cell cytokine production (GO:0002724),0.5855324397055789,1.3437002271342757,0.11734693877551021,0.4201048354483144,1.0,6/15,13.09%,MALT1;TRAF2;B2M;CCR2;TNFRSF1B;SMAD7
prerank,negative regulation of hippo signaling (GO:0035331),-0.4964949073466115,-1.3435458826900695,0.1487603305785124,0.6034631878354195,1.0,7/12,23.65%,MAPK14;WWC1;VGLL4;AJUBA;DLG5;CIT;WWC2
prerank,maturation of SSU-rRNA (GO:0030490),0.5041364509669505,1.343507872505711,0.08208092485549133,0.42001951148104655,1.0,15/34,23.44%,TSR1;RPS14;RIOK2;RPS28;BMS1;RIOK3;LSM6;RPS19;DDX52;RPS16;UTP4;SRFBP1;WDR3;NOL10;SNU13
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.628480559553831,1.3434312254170764,0.11914323962516733,0.4195985877467477,1.0,6/11,28.03%,YBX3;RIPK3;ARHGEF2;BIRC2;PELI1;RIPK1
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.4457352452346345,-1.3432107733832332,0.12,0.5980892413552111,1.0,6/16,14.80%,MEF2C;MAPK14;PLCB1;LRRC8A;IGFBP3;XKR8
prerank,cellular iron ion homeostasis (GO:0006879),0.4726744432451919,1.3428705139454549,0.07088331515812432,0.4206627464593071,1.0,20/55,21.21%,FTL;LCN2;ATP6V1A;ATP13A2;ATP6V0D1;ATP6V1G1;SLC46A1;HEPH;CYBRD1;TMEM199;ATP6AP1;HMOX1;FRRS1;TFRC;BMP6;SLC11A1;FTH1;CAND1;CUL1;ABCB7
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.6012699359215539,1.3427917456628875,0.10459183673469388,0.42028187460812216,1.0,6/14,16.11%,MALT1;TRAF2;TNFSF15;COPS8;CARD10;TIRAP
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.4374797629256899,1.3424421209640978,0.015090543259557344,0.42069144602624453,1.0,52/166,24.60%,BCAR3;IGF1;HIF1A;MMP8;P2RX4;SLC27A1;ATP7A;EIF6;VIM;GCK;TYRP1;DYRK2;FGF2;CD28;EEF2;PIWIL2;CTDNEP1;PTPN2;LARP4;DDB1;METTL3;CPEB3;LPGAT1;YTHDF3;CCL5;MID1IP1;PAOX;SLC45A3;EIF4A3;PRKD2;CLU;SORBS1;CHP1;FXR2;SP1;KAT7;EIF3E;IL6;EPM2AIP1;DHX9;UPF3A;STARD4;SREBF1;HSP90AB1;NPM1;SAMD4A;UPF3B;EGR1;POLDIP3;TNF;GIPC1;PYM1
prerank,negative regulation of cytokine production (GO:0001818),0.44010025024545013,1.3423370311894423,0.007056451612903226,0.4203741723300416,1.0,52/163,22.37%,GPNMB;CD84;FN1;MMP8;SIRPA;NLRC3;PTPRC;ANXA1;TMSB4X;RNF125;LEF1;HDAC9;HDAC7;TBX21;ATP2B1;CHID1;ANXA4;AXL;APOA2;ADCY7;NPTN;FOXJ1;CD274;PTPN22;CD200R1;IKBKE;TREM2;LILRB1;ABCD2;ILRUN;GAS6;HOMER2;DDIT3;UBE2L6;ACOD1;C1QBP;SIGIRR;APPL2;SARS1;PDCD4;ASB1;PIN1;IL6;HAVCR2;SLC11A1;HMGB1;LAPTM5;NLRC5;RNF216;SRGN;TRIB2;PTGER4
prerank,lamellipodium assembly (GO:0030032),-0.3854327892299516,-1.3422083412044516,0.0718954248366013,0.5946313049274198,1.0,9/26,16.40%,P2RY12;PTPRO;CARMIL1;ABLIM3;DMTN;CDH13;ARHGEF4;SPATA13;SRGAP2
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.6177515145349513,1.3421806552156004,0.10733695652173914,0.42024050282102,1.0,3/12,7.34%,APOBEC1;TRIM28;DNMT1
prerank,positive regulation of binding (GO:0051099),0.45464349716325797,1.3412763081869632,0.05301455301455302,0.4223064681226556,1.0,29/84,22.46%,IGF1;APOE;LRP1;MMP8;PLAUR;PON1;MMP9;CAV1;PPARG;STK3;GMNN;RPL11;BAMBI;B2M;NVL;SPPL3;DERL1;CEBPG;KDM4D;RALB;HIP1R;PIN1;DHX9;HMGB1;GSK3B;BMP4;TRIM21;TERT;USP33
prerank,regulation of neuron projection development (GO:0010975),-0.2870391371732265,-1.3408002273474906,0.0,0.5924806273799696,1.0,45/163,12.97%,CSMD3;TANC2;IL1RAPL1;LRRC4C;CTNNA2;ARSB;CDKL5;ABI3;EPHA4;SERPINI1;KANK1;ARHGAP44;PTPRO;RTN4RL1;TWF2;LRRK2;SIPA1L1;PRKCI;LRRC7;RIT2;RAPGEF2;PDLIM5;PSEN1;CDH2;NDRG4;ITGA6;CAMK1D;SHANK3;PPFIA2;NCS1;CRMP1;NTRK2;CAMK1;WNT5A;RET;DBN1;FKBP4;PRKD1;TRPV4;NTRK3;BRSK1;ARHGAP35;PAK3;MAG;CAMK2B
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.4701387276300894,1.3406295911175692,0.06923076923076923,0.42365907683762905,1.0,15/52,17.16%,LGALS3;PRKCH;LRP1;SQSTM1;PDPK1;TREM2;STAC2;RANGRF;RACK1;CLN3;RHOG;STX3;SORBS1;CNPY4;ITGA3
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.4728287433853001,1.3404524956564263,0.05976520811099253,0.4235574838684673,1.0,12/63,13.29%,LGALS3;IGF1;DEDD2;TRAF2;CAV1;BID;SIAH2;HTT;TRAF1;BIRC6;SP100;PAK2
prerank,regulation of mast cell degranulation (GO:0043304),0.5948037078615654,1.3403112443270089,0.10796915167095116,0.4233714601130007,1.0,6/14,19.82%,CD84;FGR;SPHK2;CD300A;SYK;GAB2
prerank,JNK cascade (GO:0007254),0.49937939012137766,1.3399741641663667,0.07110609480812641,0.42373291205472047,1.0,14/40,22.37%,UBA52;IRAK2;RPS27A;DUSP9;MAP4K2;MAP4K3;CRKL;TAB1;MAP3K12;MAPK9;MINK1;UBC;SH2D3C;PTGER4
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.5007256099973358,1.3399171316020602,0.07604994324631101,0.4232454594542241,1.0,18/37,23.20%,RNASE3;NUDT5;NUDT1;XRN2;RNASEH2A;RNASEH1;ENTPD5;DFFB;NUDT9;RNASEH2B;ISG20;ENTPD6;RNASE6;NUDT15;DNASE1L1;PABPC4;SND1;PPP1R8
prerank,regulation of multicellular organismal development (GO:2000026),0.5337717446445037,1.339628694141086,0.0954653937947494,0.4234508723953073,1.0,11/25,19.45%,CD24;DUSP9;TRIP12;GATA3;DUSP6;MYSM1;GBX1;RACGAP1;DHX36;CCSAP;EHMT1
prerank,phagosome-lysosome fusion (GO:0090385),0.6433903302171421,1.339364954091123,0.11173184357541899,0.4236556785034774,1.0,7/10,25.24%,RAB7B;ARL8B;CLN3;RAB7A;PIKFYVE;RAB20;PLA2G5
prerank,skeletal system development (GO:0001501),0.44043122245700844,1.3392689561803985,0.024193548387096774,0.4233026661254433,1.0,26/148,14.82%,IGF1;XYLT1;SH3PXD2B;ANKH;ATP7A;KIAA1217;DEAF1;AKAP13;CD44;BMP8B;COL10A1;MATN3;EVC;BMP1;PRDX1;SHOX2;SOX9;P3H1;PKDCC;ANKRD11;CREB3L2;MYOC;CHRD;ZBTB16;RBP4;HAPLN2
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.5571414144418406,1.3392332571673535,0.12155388471177944,0.4227557307966555,1.0,6/18,19.24%,LAX1;FPR2;C3AR1;SPG21;C5AR1;FCER1G
prerank,cellular response to cAMP (GO:0071320),-0.37328607026422633,-1.3388875680675616,0.07857142857142857,0.5913209989946882,1.0,14/30,28.49%,RAPGEF2;HCN1;IGFBP5;AKAP6;DMTN;INPP5K;EZR;PDE2A;RAPGEF3;KCNQ1;AQP1;SLC5A5;WT1;HCN2
prerank,regulation of macromolecule metabolic process (GO:0060255),0.4346996477534272,1.338480045025987,0.009072580645161291,0.4243787957034978,1.0,35/170,16.40%,IGF1;APOE;HIF1A;CDK6;C1D;SIRPA;PTPRC;AFF1;HRG;TRIM6;TRIM43;DHH;NELL1;TFEB;UBAP2;FUBP1;TREM2;TXK;CDH1;TAPBP;NFKBIZ;AFF4;HMG20B;PRDM9;HNRNPK;ZFP64;NPAT;CDK2;PCBP4;YBX3;YBX2;STOX1;PCBP1;NOVA2;RASA1
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.5600331132258073,1.3384035315087723,0.12265331664580725,0.42398141732909966,1.0,2/19,2.26%,APOE;CHRNB2
prerank,regulation of autophagy (GO:0010506),0.4322915182019821,1.3383839461671687,0.008016032064128256,0.42341498900691354,1.0,71/216,22.84%,BCL2;GPR137B;ABL2;RRAGD;ATP6V1C1;ATP6V0D2;SMCR8;ATP6V1A;CTSA;ATP6V0A1;MCL1;OPTN;ATP13A2;ATP6V1B2;EIF4G1;PIK3CB;TRIM6;PSAP;CDK5;FBXW7;ATP6V0D1;ATP6V0B;ATP6V1G1;TFEB;HSPB1;PTPN22;EEF1A1;ERN1;TREM2;EIF4G2;CAPN1;PLK2;DAPL1;TPCN2;VPS26A;TICAM1;RAB8A;DAP;NPRL2;ZKSCAN3;PLEKHF1;EIF4G3;ROCK1;DRAM1;DCN;DDIT3;UBQLN1;DAPK1;RMC1;FOXO1;PIK3R2;PRKAG1;STK11;CAPNS1;DAPK3;ATP6V0C;HAX1;GFAP;ATM;ORMDL3;CSNK2A2;HMGB1;MTDH;SREBF1;ATP6V1E1;GSK3B;TRIM21;USP33;USP36;HTR2B;VPS35
prerank,regulation of leukocyte migration (GO:0002685),0.573274923675933,1.3382079072225233,0.1111111111111111,0.42333328077548926,1.0,5/16,11.09%,ANXA1;VEGFA;HOXA7;HMOX1;RHOG
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.5325499189156481,1.338130936395765,0.10981308411214953,0.4229213088114246,1.0,10/24,24.57%,CTNNB1;MCL1;CDK5;FBXW7;BAX;DDIT3;NF1;SRPK2;TNF;ATF4
prerank,iron ion homeostasis (GO:0055072),0.4654713408160843,1.3361185202611225,0.07227615965480043,0.4284627951832974,1.0,21/58,21.21%,FTL;LCN2;ATP6V1A;ATP13A2;ATP6V0D1;ATP6V1G1;SLC46A1;HEPH;CYBRD1;TMEM199;ATP6AP1;B2M;HMOX1;FRRS1;TFRC;BMP6;SLC11A1;FTH1;CAND1;CUL1;ABCB7
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.6369680288718993,1.3360671555053738,0.11187845303867404,0.4280074366205524,1.0,3/10,20.85%,DNMT3A;PRMT7;ZFP57
prerank,'de novo' posttranslational protein folding (GO:0051084),0.5107305099327665,1.3356375461182008,0.10501750291715285,0.428711040608726,1.0,16/30,27.68%,CCT2;DNAJB14;ERO1A;GAK;SDF2L1;DNAJB13;HSPA8;ENTPD5;HSPA9;DNAJB1;PTGES3;HSPE1;HSPA5;ST13;HSPA2;DNAJB12
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.5921485703950045,1.3352229166325509,0.12264150943396226,0.42933563428977245,1.0,7/13,26.71%,SNX33;RANGRF;ABCA7;STX3;HSP90AB1;TNF;STX4
prerank,regulation of inflammatory response (GO:0050727),0.43356382896950296,1.335066953046667,0.012048192771084338,0.42916771330846426,1.0,56/190,22.88%,LPL;S100A8;S100A9;APOE;MMP8;FPR2;SIRPA;NLRC3;ANXA1;TMSB4X;PTGES;TNIP1;MAPK13;SPHK1;MMP9;PRKCD;MFHAS1;OTULIN;PPARG;MGLL;BCL6;CD200R1;GATA3;BRD4;NAPEPLD;CELF1;PPARD;NFKBIZ;PTPN2;CEBPA;CCR2;SERPINE1;CCL5;TNFRSF1B;SHARPIN;LPCAT3;GPRC5B;ACOD1;CASP4;PSMA6;NINJ1;PDCD4;VAMP2;SBNO2;USP18;IL6;DHX9;IL2;PTGIS;GPSM3;METRNL;CD47;PTGER4;IL17RA;VPS35;MAPK7
prerank,cellular copper ion homeostasis (GO:0006878),0.5837663335284221,1.3343465822245193,0.1245186136071887,0.4306782693373289,1.0,3/14,6.03%,SLC31A2;ATP7A;ATOX1
prerank,positive regulation of MAPK cascade (GO:0043410),0.43176447452136585,1.334179354820911,0.00501002004008016,0.4305781538017503,1.0,50/245,16.15%,GPNMB;BCAR3;IGF1;IQGAP1;FLT1;APOE;MMP8;FPR2;PTPRC;CD4;CCL4;GCNT2;ADAM8;PDGFA;CD44;CD24;ALKAL2;GLIPR2;PTK2B;FBXW7;NRP1;FGF2;MFHAS1;TAOK3;MYDGF;PIK3R5;PTPN22;VEGFA;CRKL;ANGPT1;TREM2;RASGRP1;IGF1R;CCL13;P2RY1;ATP6AP1;IAPP;CCL7;CCL5;MAP3K12;GAS6;ABCA7;ROCK1;CCL14;FGF18;PRKD2;LPAR1;TMEM106A;TIRAP;KDR
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.517203865974191,1.3337665665997909,0.1,0.4312111543709019,1.0,13/30,28.03%,BCL2L1;TRAF2;BRCA1;HMOX1;SERPINE1;TMBIM1;BMP5;ARHGEF2;GSK3B;TNFSF10;GPX1;TNFAIP3;RIPK1
prerank,protein-containing complex assembly (GO:0065003),0.4286613249324774,1.3337570830592125,0.004012036108324975,0.4306271208749317,1.0,106/259,29.37%,SH3PXD2B;CTNNB1;MITF;FN1;CD3E;CTSZ;CD247;TCF7;IL2RB;EPRS1;SLC9A1;KMT2A;GOSR2;LEF1;ADCY8;CAPG;TRAF2;TUBGCP4;CD3G;PTK2B;SLC2A1;SEC22B;PPP2R1A;DNAJB14;ANKRD28;SOX9;WIPF1;SAMM50;HDAC1;NAPA;TAPBP;SKAP2;RANBP9;TRAF1;CARD10;RBBP5;SEC24A;MAGI1;F5;LMAN1;AFG3L2;TFAP4;BLM;GPAA1;TSPAN4;LAMC1;SEC24D;NDUFAF1;MDN1;MCFD2;CSNK1D;RAB1A;PPP6C;AFDN;VAMP2;ELOB;GRIA1;TBC1D20;ANO6;JCHAIN;DHX9;ITGB1BP1;FERMT2;CUL3;FANCA;COL16A1;F8;STOML2;TCF7L1;PDZD11;CAND1;CUL1;HSF1;GSK3B;TEAD1;CDC123;TERT;WAS;LLGL1;CD74;PEX14;KMT2D;MDM2;TNF;USO1;SMARCA4;ST13;NCKAP1L;CX3CL1;GOLGA2;AIM2;GEMIN5;NOL3;PPIH;STX5;TMED2;HES1;DNAJB12;VAMP3;RIPK1;MNAT1;ZNHIT6;TLE1;TRAPPC4;SPG7;CLDN1
prerank,negative regulation of leukocyte migration (GO:0002686),0.6425089969370018,1.3335442049950865,0.1070460704607046,0.4306566341211195,1.0,6/10,20.65%,CD200R1;HOXA7;CD300A;HMOX1;BMP5;EMILIN1
prerank,protein methylation (GO:0006479),0.48918492070517705,1.3331268507296457,0.07954545454545454,0.43123111225994937,1.0,18/40,26.59%,ETFBKMT;ETF1;METTL22;PRMT5;PRMT7;CARM1;EEF1AKMT3;PRMT2;PRMT6;GSPT1;FAM98A;EHMT1;EEF2KMT;PRMT3;NSD3;TRMT112;NTMT1;NSD1
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.5794559777104205,1.3326993697914842,0.12450851900393185,0.43188294605674865,1.0,7/16,24.76%,VIM;RUNX1;SUCO;SERPINF2;BMP4;F2R;HDAC2
prerank,regulation of amyloid fibril formation (GO:1905906),0.5837473005787236,1.3324277662969135,0.1167979002624672,0.4320756216426369,1.0,6/15,18.49%,APOE;TREM2;IAPP;PFDN1;CLU;PFDN2
prerank,response to hydrogen peroxide (GO:0042542),0.48388186169560415,1.3324172259428348,0.08287895310796074,0.4314843210436122,1.0,23/45,29.44%,SIRPA;NFE2L2;ANXA1;MAPK13;PRKCD;STK24;HP;PLEKHA1;HMOX1;FYN;CYP1B1;CAT;GLRX2;RIPK3;IL6;RPS3;MAPK7;GPX1;TNFAIP3;RIPK1;PRDX3;APTX;SIRT1
prerank,stress granule assembly (GO:0034063),0.555638110398999,1.3323780632734428,0.10653753026634383,0.43095298442047014,1.0,11/20,23.81%,DYNC1H1;LSM14A;EIF2S1;YTHDF3;OGFOD1;YTHDF2;RPS23;UBAP2L;ATXN2;PRRC2C;G3BP1
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.5521227234613493,1.3320099407031787,0.1273644388398487,0.43146620162574456,1.0,6/18,9.01%,FLT1;FGF2;ITGA4;PPARG;PDPK1;ADAM17
prerank,negative regulation of dephosphorylation (GO:0035305),0.5621373330332655,1.3313682889932852,0.11794228356336262,0.43292508034039956,1.0,9/18,23.20%,PTPA;MFHAS1;ZCCHC9;PPP1R35;SH2D4A;CHP1;YWHAB;PPP1R15A;PPP1R8
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.49050026734753954,1.331325752520446,0.08194905869324474,0.43243022646196927,1.0,13/40,17.10%,DAB2;VEGFA;ANGPT1;B2M;HIP1;C3;CD63;SERPINE1;HNRNPK;SCYL2;CLU;CBL;DGKD
prerank,negative regulation of cell death (GO:0060548),0.4456008456370774,1.3313174495245654,0.051255230125523014,0.43183972997002645,1.0,30/88,26.95%,GPNMB;CSF1;TRAF2;ATP13A2;EIF4G1;CDK5;FGF2;CD200R1;NCK1;CHMP4A;CHMP4B;LRPAP1;INPP5A;FYN;VPS4B;TNFRSF1B;CLU;CCN6;WFS1;TMEM109;FERMT2;GSK3B;BMP4;HTR2B;VPS35;BNIP3;KANK2;PARP16;PACRG;CCN4
prerank,amyloid precursor protein catabolic process (GO:0042987),0.5777100274513323,1.3310738213671094,0.1256544502617801,0.4319408708246255,1.0,5/14,13.05%,ABCG1;PSEN2;ADAM17;CLN3;ABCA7
prerank,hexose transmembrane transport (GO:0008645),0.5405239456851275,1.331048876931364,0.10592686002522068,0.4314148530318471,1.0,8/21,21.90%,SLC5A1;SLC2A1;PPARD;SLC2A8;SLC45A3;SLC50A1;SLC5A3;SLC2A6
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.5715579383773681,1.3309825300798448,0.1272965879265092,0.43098263634996953,1.0,10/16,28.15%,CTNNB1;KMT2A;DNMT1;BRCA1;WDR5;DNMT3B;SNW1;PIH1D1;KDM1A;CTR9
prerank,ribosome assembly (GO:0042255),0.4855937870571476,1.3309085263432667,0.07886089813800658,0.4306222179712674,1.0,15/47,15.85%,EIF6;BRIX1;RPS14;RRP7A;RPS28;EIF2A;PPAN;RPL11;DHX29;EFL1;MRPS7;RPS19;RPS27;MDN1;C1QBP
prerank,pyroptosis (GO:0070269),0.5812300520528428,1.3309052638033607,0.10608020698576973,0.4300283773448758,1.0,6/15,18.62%,GZMB;GZMA;APIP;TREM2;CASP4;DHX9
prerank,regulation of cation channel activity (GO:2001257),-0.31750626066462767,-1.330847923746941,0.0425531914893617,0.6071687798891292,1.0,27/89,13.79%,CACNB2;MEF2C;GRIA4;NLGN1;FGF12;CTSS;NEFL;FGF14;DLG2;GRIN2A;GRIA3;CACNG3;NETO1;LRRC7;GRIN2B;DMD;APP;CACNG8;SHISA6;FGF11;NOS1;GRIN1;STAC;CAMK2B;CNIH3;PDE4D;CAMK2A
prerank,organic acid transport (GO:0015849),0.44763322313294085,1.3295793635784205,0.040123456790123455,0.43365449551084956,1.0,29/94,22.29%,SLC3A2;SLC27A1;SLC26A1;SLC38A1;SLC6A6;SLC7A1;PDPN;SLC7A11;SLC23A1;SLC23A2;SLC27A5;SLC6A19;SLC6A14;SLC16A10;SLC46A1;ACSL1;SLC7A6;PPARD;SFXN5;SLC1A5;SLC25A14;SLC7A8;SLC43A2;SLC19A1;SLC13A3;SLC38A2;SLC13A5;SLC26A6;SLC7A2
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.4617093023708082,1.3292214599909724,0.06389776357827476,0.43406632267893414,1.0,20/65,17.90%,BCAR3;PLAUR;MMP9;RHBDF2;SH3KBP1;GRB2;RHBDF1;MVP;PTPN2;HIP1;DOK1;PTPN12;CDC42;STAM2;MVB12A;CBL;DUSP3;DGKD;EPS15L1;HIP1R
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.6130498795543677,1.3290897996531272,0.1292517006802721,0.433864003030793,1.0,4/11,13.09%,PTPRC;KLRC1;LILRB1;SMAD7
prerank,cholesterol biosynthetic process (GO:0006695),-0.3690456426725911,-1.3287397103879859,0.06040268456375839,0.6073192283061946,1.0,13/31,18.75%,IDI1;DHCR7;HMGCS1;SC5D;INSIG1;NSDHL;MVK;INSIG2;FDPS;LSS;SQLE;HMGCR;GGPS1
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.5240420254182913,1.3285370668129384,0.11829268292682926,0.4349093898299473,1.0,11/27,21.08%,CCDC88C;UBA52;RPS27A;MAPK13;TNIP2;NFKB1;MAP3K8;KAT7;UBC;FBXW11;CUL1
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.5918597866023159,1.3281772103719756,0.12975098296199214,0.43541769807177455,1.0,7/13,21.68%,ZMIZ1;CDCA4;FAM47E;ZMIZ2;ELOF1;ARID1B;SERTAD1
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),-0.3854912254637083,-1.3279050105477175,0.07865168539325842,0.6037389271880358,1.0,2/25,0.31%,CACNB2;CAPN3
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.6241656427980058,1.3277163506234928,0.13821138211382114,0.43618985532894594,1.0,4/10,13.52%,LPGAT1;ABCD2;MID1IP1;SLC45A3
prerank,lysosome localization (GO:0032418),0.5005071688318756,1.327632077725058,0.09142212189616253,0.43584470142420517,1.0,9/37,15.36%,PLEKHM2;PLEKHM1;NR4A3;ARL8B;MILR1;TFEB;SPAG9;BORCS5;HPS6
prerank,regulation of calcium ion transport (GO:0051924),0.47497982383455895,1.3270858077354108,0.07096774193548387,0.437009481023337,1.0,15/54,14.58%,BCL2;CTNNB1;CD84;P2RX4;CD4;ATP2B1;CCL4;CRACR2A;LILRB1;SRI;CCL5;CACNA1D;SARAF;HOMER2;SLC8B1
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.5753679462727965,1.3269744990589638,0.13095238095238096,0.4367266369119763,1.0,9/15,24.53%,SPHK2;SPHK1;PRKCD;ORMDL1;RACK1;ORMDL3;SAMD8;TNF;SIRT3
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.5243850135853038,1.326756438745568,0.09917355371900827,0.43675659626428465,1.0,5/27,4.69%,FLT1;FPR2;FGR;PTK2B;FGF2
prerank,macrophage differentiation (GO:0030225),0.6029097412610519,1.3264381893363832,0.1202113606340819,0.4371334609242454,1.0,6/13,14.25%,CSF1;CD4;MMP9;VEGFA;CDC42;IL31RA
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.5109796616184424,1.3263952001824588,0.1038961038961039,0.43665220498535795,1.0,10/29,20.33%,APOE;SLC27A1;CTDNEP1;LPGAT1;MID1IP1;SLC45A3;SORBS1;CHP1;SIRT4;SREBF1
prerank,negative regulation of gene expression (GO:0010629),0.42328020212237133,1.3248101190797912,0.002004008016032064,0.44098416565569865,1.0,100/302,23.58%,GPNMB;IGF1;APOE;HIF1A;CD3E;DNMT3A;MMP8;EPRS1;SMCR8;HDAC9;AGO2;ATP2B1;XDH;ID2;GZMB;TRIM6;CILP;VDR;CLDN19;NCOR2;NCL;NPTN;FBXW7;FGF2;CD28;PTBP3;RUNX1;PTPN22;RPS26;ERN1;VEGFA;CRKL;DNMT1;HDAC1;NOCT;LSM14A;CELF1;PUS7;MTF2;PATL2;FLOT2;DIP2A;RACK1;METTL3;CPEB3;CNOT10;SHMT1;ZNF148;RNH1;DLL4;DXO;ENC1;LARP1;TLE5;TIPARP;PHF1;ILF3;YY1;EED;SYNCRIP;EIF4A3;STOX1;LSM6;NFKB1;EIF4ENIF1;DAPK1;YTHDF2;DHX36;KDR;EIF4E2;FXR2;MYADM;ASB1;DAPK3;BMI1;RPL13A;DNMT3B;HAVCR2;TARDBP;AGO3;SLC11A1;RPS3;EMILIN1;ZC3H12D;ANXA7;VHL;RPS13;BMP4;SAMD4A;SRGN;GIGYF2;PTGER4;TERT;CALR;SNX12;MAP2K2;CREBZF;RBBP7;REL;MIF
prerank,alcohol catabolic process (GO:0046164),0.6192404813236171,1.3247878156944322,0.14985994397759103,0.44044249363537397,1.0,3/10,7.89%,APOE;CEL;SRD5A3
prerank,cell-substrate junction assembly (GO:0007044),0.4999328818114273,1.324774937400096,0.10377358490566038,0.43988541868096565,1.0,12/33,21.56%,PEAK1;FN1;ACTN1;DLC1;RHOD;PLEC;LAMC1;SORBS1;FERMT2;ACTN2;DST;LAMA3
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.4714910181908838,1.3246588932136747,0.07641921397379912,0.43966884892410024,1.0,15/49,16.56%,RAB7B;KMT2A;PRKCQ;EIF6;CNOT4;SCIN;NR4A3;MYL9;RUNX1;HDAC1;RBBP5;WDR5;SETD1A;RBM15;PRMT6
prerank,response to muramyl dipeptide (GO:0032495),0.5956794649468865,1.3245741909458444,0.13378378378378378,0.4393264662694968,1.0,5/12,19.93%,VIM;PTPN22;ERBIN;IRF5;ARHGEF2
prerank,engulfment of apoptotic cell (GO:0043652),-0.455071676077106,-1.3236527821400441,0.13574660633484162,0.60937593914886,1.0,6/15,9.85%,RHOBTB1;XKR4;MEGF10;THBS1;XKR6;RHOBTB2
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.5221008680242282,1.32361750977764,0.11743772241992882,0.4415925059210284,1.0,10/25,19.18%,ERCC6;THOC1;HMGN1;ZNF326;WDR43;DDX39B;EAF1;KAT7;CCAR2;CCNT2
prerank,negative regulation of immune system process (GO:0002683),0.5748402301522982,1.323617156569848,0.13695090439276486,0.4409864891390856,1.0,6/16,16.92%,PDCD1;SOX9;HOXA7;HMOX1;FCRLB;SPINK5
prerank,positive regulation of DNA metabolic process (GO:0051054),0.46352489378073236,1.3233746088108322,0.07288317256162916,0.44115705649462567,1.0,22/61,20.16%,ERCC6;EYA4;FGF2;TRIM28;OTUD4;USP9X;BRCA1;ABRAXAS1;RAD50;PRKD2;CEBPG;DHX36;PPP1R10;TOX;UIMC1;PARP3;ATRX;GNL3;RTEL1;DHX9;HMGB1;RPS3
prerank,positive regulation of locomotion (GO:0040017),-0.3868759962639069,-1.322372555180449,0.10666666666666667,0.607250526174579,1.0,4/27,8.58%,P2RY12;CSF1R;AIF1;THBS1
prerank,microtubule depolymerization (GO:0007019),-0.43430980660471485,-1.3220614556726729,0.11940298507462686,0.602411442295512,1.0,8/17,18.92%,STMN3;STMN1;KIF14;STMN4;KIF2C;KIF2A;KIF18B;KIF19
prerank,lipid homeostasis (GO:0055088),0.46395423382147905,1.3215007871234397,0.08029978586723768,0.4464075083245722,1.0,18/57,21.77%,APOE;ABCG1;ABCA1;ATP13A2;FBXW7;PPARG;TLCD1;ORMDL1;TREM2;TLCD2;ABHD5;CEBPA;RCN3;THADA;USF2;ORMDL3;TM6SF2;ACOX3
prerank,regulation of collagen biosynthetic process (GO:0032965),0.5523833846927657,1.3204382166731659,0.1437578814627995,0.449185692888641,1.0,9/19,24.76%,VIM;RUNX1;SUCO;SERPINF2;IL6;EMILIN1;BMP4;F2R;HDAC2
prerank,protein import (GO:0017038),0.4467364493136547,1.32040204370839,0.04963805584281282,0.44872165909323747,1.0,39/84,29.68%,APOE;MMP12;TOMM22;HSPA4;GCKR;PRICKLE1;IPO5;SAMM50;SNX33;PEX2;E2F3;LAMP2;NUP188;RAB8B;NXT2;ABCD2;EIF4ENIF1;CLU;TPR;ABCD3;SYK;APPL2;PXMP2;PPP1R10;ALDH3A2;PEX16;NUP93;ACBD5;PEX14;NUP50;TNPO2;TNPO1;NUP133;NUTF2;IPO13;PTTG1IP;NUP214;PEX19;FIS1
prerank,regulation of interleukin-1 production (GO:0032652),0.5767467384939461,1.319868340540043,0.135678391959799,0.44978356906730793,1.0,5/15,22.71%,SIRPA;ANXA1;GAS6;HMGB1;F2R
prerank,mononuclear cell differentiation (GO:1903131),0.5245311942826226,1.319816468518126,0.12620192307692307,0.449318596507871,1.0,10/24,14.25%,PDE1B;AXL;PPARG;VEGFA;TREM2;LILRB1;IRF8;GAS6;PIR;IL31RA
prerank,negative regulation of inflammatory response (GO:0050728),0.42888076766638294,1.319531376542667,0.016080402010050253,0.44957214419645103,1.0,43/182,16.00%,IGF1;APOE;CD247;FPR2;SIRPA;NLRC3;PTGIR;FGR;ADCY8;ADCY3;CD3G;POMC;ADCY7;PRKCD;RHBDF2;MFHAS1;OTULIN;PPARG;CD200R1;GATA3;GPR83;SCTR;TREM2;PLK2;PPARD;ADAM17;CRH;PTPN2;IAPP;FYN;GPR176;TNFRSF1B;SHARPIN;LPCAT3;GIT1;GIPR;RPS19;ADORA2A;GLP1R;ACOD1;VIP;FURIN;SYK
prerank,copper ion transport (GO:0006825),0.6118974967556859,1.3189974664237805,0.15426997245179064,0.45058145743544964,1.0,3/11,6.03%,SLC31A2;ATP7A;ATOX1
prerank,sensory perception of pain (GO:0019233),0.5388165329181982,1.3184996141719554,0.12591687041564792,0.45152576745207745,1.0,5/21,16.18%,P2RX4;PTGES;CHRNB2;CCR2;RETREG1
prerank,negative regulation of neuron death (GO:1901215),0.44517974835477225,1.31827284700009,0.05595854922279793,0.451588760120887,1.0,18/93,11.70%,GPNMB;BCL2;APOE;CSF1;TRAF2;ADAM8;ATP13A2;EIF4G1;PTK2B;CDK5;CPEB4;CD200R1;CHMP4A;CHMP4B;INPP5A;CLN3;FGF20;TNFRSF1B
prerank,regulation of spindle organization (GO:0090224),0.5611527257196206,1.3182563251108326,0.14303482587064675,0.4510389430274806,1.0,6/18,17.95%,DYNC1H1;DCTN1;NUMA1;TACC3;RAE1;PARP3
prerank,regulation of focal adhesion assembly (GO:0051893),0.46912703206529194,1.3174478522620323,0.07889125799573561,0.452917184836874,1.0,20/54,19.34%,PEAK1;CORO1C;SLC9A1;PTPRA;MACF1;HRG;NRP1;VEGFA;DLC1;ACTG1;ARHGAP6;MYOC;RHOA;ROCK1;DUSP3;KDR;DAPK3;ITGB1BP1;FERMT2;COL16A1
prerank,autophagosome maturation (GO:0097352),0.4966145920623832,1.3171866936717351,0.10877192982456141,0.4530716158504316,1.0,13/32,24.45%,TECPR1;LIX1;LAMP2;LIX1L;VCP;CLN3;MAP1LC3B;UBQLN1;VIPAS39;MAP1LC3A;GABARAP;ATP2A2;VPS16
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.6308041193184059,1.3171790677384991,0.13086770981507823,0.452487667797964,1.0,7/10,29.68%,CPEB3;DHX36;PAF1;HSF1;CPEB1;NUDT21;LEO1
prerank,glucan biosynthetic process (GO:0009250),0.5984521455261844,1.3171746887113402,0.1587516960651289,0.4512778891937859,1.0,3/12,5.75%,NHLRC1;GYG1;GYS1
prerank,glycogen biosynthetic process (GO:0005978),0.5984521455261844,1.3171746887113402,0.1587516960651289,0.4512778891937859,1.0,3/12,5.75%,NHLRC1;GYG1;GYS1
prerank,sulfur compound transport (GO:0072348),0.5187955413966687,1.3169417300392317,0.10083036773428232,0.4514514862589841,1.0,8/27,15.61%,SLC27A1;SLC26A1;SLC6A6;SLC13A4;SLC26A11;SLC25A14;SLC26A4;RACGAP1
prerank,potassium ion homeostasis (GO:0055075),0.5254791610625793,1.316594202470104,0.11658653846153846,0.4519348929117011,1.0,7/23,9.54%,ATP1B3;KCNJ2;KCNMA1;ATP1A4;ATP1A3;ATP1A1;SLC12A4
prerank,negative regulation of leukocyte activation (GO:0002695),0.5724128870862472,1.3160570614016114,0.1276864728192162,0.4530094225555526,1.0,6/15,18.79%,CD84;CD300LF;MILR1;CD300A;IL31RA;HAVCR2
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.43461603306770485,1.316048968314643,0.057318321392016376,0.45242343213945285,1.0,27/102,17.36%,MYO5A;EPRS1;PKM;ADCY8;ADCY3;HDAC9;GCK;MGARP;NR4A3;ADCY7;PRKCD;CAV1;PPARG;SLC25A33;PDPK1;CPEB2;DENND4C;RHOQ;RAB8A;RAB8B;PCK2;NFKB1;SORBS1;FOXO1;NR4A2;PIK3R2;VAMP2
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.5368751913164509,1.3157071763562795,0.1255980861244019,0.452864120845849,1.0,14/22,32.54%,RPS7;RPS20;RPL23;PLA2R1;RPL37;CHD5;ATM;SPRED2;EIF5A;SPRED3;ATR;HEXIM1;UBB;RPS15
prerank,regulation of macrophage activation (GO:0043030),0.5073361172418674,1.315395179202638,0.12183908045977011,0.45321798095321375,1.0,12/30,23.58%,GPR137B;MMP8;SPHK1;MFHAS1;CEBPA;TNIP2;IL31RA;HSPD1;IL6;LBP;CD74;MIF
prerank,negative regulation of T cell proliferation (GO:0042130),0.5132666328983571,1.3152349452409842,0.11162790697674418,0.453069891152915,1.0,5/28,11.17%,GPNMB;SPN;CD274;LILRB1;CRTAM
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.6346588281923582,1.3148125635452554,0.11805555555555555,0.4537235519514477,1.0,5/10,15.94%,RGP1;NELL1;RIC1;EFNA1;FURIN
prerank,glial cell development (GO:0021782),0.5157502697996392,1.314748849913377,0.11269276393831554,0.453344981675538,1.0,10/25,25.80%,S100A9;CDK6;NRROS;NF1;EIF2B2;CSPG5;EIF2B4;SOX10;MDK;MYRF
prerank,positive regulation of embryonic development (GO:0040019),0.5476802666488914,1.3146310080632744,0.11547911547911548,0.45309994536312703,1.0,4/19,12.74%,B4GALT5;NIBAN2;RACK1;RBM19
prerank,positive regulation of lipid kinase activity (GO:0090218),0.5073471144995176,1.3142608497033934,0.10915492957746478,0.4536874902562354,1.0,5/29,4.69%,FLT1;DGKZ;FGR;PTK2B;FGF2
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.43116357381693227,1.3141224249020624,0.027300303336703743,0.45351008683981653,1.0,27/142,15.42%,CACNA1A;TRPC4;ABL2;FPR2;PTGIR;ADCY8;ATP2B1;CXCR2;PTGFR;CD24;EDNRA;BDKRB1;HCRTR1;NPTN;C3AR1;CD52;CAV1;TAC4;P2RY1;IAPP;CLN3;CCR2;SLC8B1;SPPL3;GLP1R;LPAR1;ATP1A2
prerank,response to steroid hormone (GO:0048545),0.4968982454170079,1.3134599814782961,0.11784897025171624,0.4549171834424252,1.0,10/31,19.57%,MGARP;SOX30;CAV1;TFPI;ATP1A3;ATP1A1;UBE2L3;ATP1A2;WBP2;NR3C1
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.5293157195681862,1.3132267655825005,0.1282367447595561,0.45504398141369273,1.0,4/22,4.85%,MAN1C1;UBA52;RPS27A;EDEM1
prerank,positive regulation of MAP kinase activity (GO:0043406),0.45838389346399716,1.313136835767731,0.06276150627615062,0.4547204021801804,1.0,11/66,7.88%,FLT1;SASH1;TRAF2;ADAM8;PDGFA;CD24;FGF2;TAOK3;PIK3R5;VEGFA;RASGRP1
prerank,hexose metabolic process (GO:0019318),0.48392256923344634,1.312866668677239,0.09761634506242906,0.4549142073421588,1.0,10/39,13.84%,SORD;ALDOA;GAA;HK1;PPARD;GALK2;FUCA1;ALDOC;AKR1A1;FUOM
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.5760550701500566,1.3126905359152663,0.12690355329949238,0.45488374326697945,1.0,7/15,24.96%,IRX5;MTHFD1;EIF4A3;NIPBL;TGFBR2;FGFR2;PDGFRA
prerank,hydrogen peroxide metabolic process (GO:0042743),0.5544260339369637,1.312355520400172,0.11306532663316583,0.4553471236578753,1.0,3/19,5.55%,CYBA;PRDX5;PRDX1
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.5104719001500791,1.311904568783136,0.11614401858304298,0.45615139569451857,1.0,14/29,22.41%,ANKRD28;RAD50;GAR1;CDK2;PPIA;PPP6C;RFC1;RTEL1;PTGES3;TERF1;HSP90AB1;ACD;DKC1;TERT
prerank,cardiac cell development (GO:0055006),0.6114885051881921,1.3118383858243794,0.13101604278074866,0.4557684281735878,1.0,4/11,20.63%,JAG1;VEGFA;MYH11;ALPK3
prerank,regulation of DNA replication (GO:0006275),0.47617865808980203,1.3118193253298938,0.08657047724750278,0.4552118584553737,1.0,14/49,20.13%,BCAR3;ORC3;GTPBP4;S100A11;PPP2R1A;WAPL;FBXO5;GMNN;OBI1;BLM;SMC3;KAT7;DHX9;TERF1
prerank,fluid transport (GO:0042044),0.6016850437219802,1.311038402348851,0.13581890812250333,0.4569263004094433,1.0,3/12,21.90%,PDPN;AQP4;SLC26A6
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.6067362486971067,1.310820286341105,0.15426251691474965,0.457011763065738,1.0,8/11,33.72%,TRIM28;DNMT1;TPR;RESF1;SETDB1;ATF7IP;TASOR;MPHOSPH8
prerank,sodium ion transmembrane transport (GO:0035725),0.44130785082008395,1.3107909972345002,0.058212058212058215,0.4564955786639781,1.0,15/84,7.45%,SLC9A1;SLC6A6;SLC24A4;ATP1B3;SLC5A1;SLC6A19;SLC6A14;SCN4A;ASIC3;SLC6A8;SLC6A7;ATP1A4;ATP1A3;ATP1A1;SLC6A4
prerank,cardiocyte differentiation (GO:0035051),0.6329974334591195,1.3105460030210634,0.12872628726287264,0.4566370681760983,1.0,3/10,6.73%,AKAP13;NRG1;SIK1
prerank,negative regulation of protein transport (GO:0051224),0.5187025031414956,1.3102348794030552,0.13468414779499405,0.45702581404694886,1.0,6/25,14.10%,APOE;RHBDF2;SERGEF;RHBDF1;PKDCC;RSAD2
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.553276514030068,1.310097087919667,0.13909774436090225,0.4568832378702284,1.0,8/16,20.13%,TNKS2;HNRNPA2B1;ERCC4;SLX4;DHX36;ATM;RTEL1;TERF1
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.5893488967890639,1.3095237228521626,0.12755102040816327,0.45805122480292854,1.0,7/14,28.90%,TMSB4X;MDFI;SUFU;CCDC22;KEAP1;PSMD10;FAF1
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.49281404161363834,1.3094439610893294,0.11995386389850057,0.4577151086600189,1.0,15/32,30.69%,CTNNB1;PRKCQ;CCT2;TNKS2;PKIB;CCT8;ATM;CCT5;ACD;MAPK15;ATR;MAPK3;XRCC5;PNKP;MAPK1
prerank,global genome nucleotide-excision repair (GO:0070911),0.524931753950892,1.3094184066954275,0.1359338061465721,0.45721519439448455,1.0,14/26,25.49%,UBA52;RPS27A;ERCC1;DDB2;DDB1;RNF111;XPA;ERCC4;GTF2H1;UBC;XPC;GTF2H5;CUL4A;CETN2
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.6331235192269591,1.3091258954354543,0.13623595505617977,0.4575033246855303,1.0,6/10,31.24%,NOC2L;THAP7;BRCA1;TAF7;SIRT1;SET
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.5242571262484953,1.308775857384341,0.12934131736526946,0.4574474777971661,1.0,13/23,33.84%,SDCBP;DAB2;ADAM17;RNF111;ING2;STK11;HSP90AB1;GIPC1;SNW1;TGFB1I1;EP300;CREBBP;HIPK2
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.5242571262484953,1.308775857384341,0.12934131736526946,0.4574474777971661,1.0,13/23,33.84%,SDCBP;DAB2;ADAM17;RNF111;ING2;STK11;HSP90AB1;GIPC1;SNW1;TGFB1I1;EP300;CREBBP;HIPK2
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.5943931564096406,1.3086186767432204,0.13642384105960265,0.4573318546171751,1.0,3/12,7.29%,STAP1;MMP8;TREM2
prerank,phagolysosome assembly (GO:0001845),0.5989518491312923,1.3084525290341409,0.14,0.457219146420805,1.0,7/12,25.24%,RAB7B;ARL8B;CLN3;RAB7A;PIKFYVE;RAB20;PLA2G5
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.6285555858070165,1.307924863379851,0.1348464619492657,0.45819954319416706,1.0,4/10,11.47%,LRP1;PTGIR;PTPN2;PTPN12
prerank,negative regulation of MAPK cascade (GO:0043409),0.44616799316313044,1.307879680648083,0.06147540983606557,0.4577557150610282,1.0,32/87,22.09%,APOE;SIRPA;PTPRC;DAG1;TNIP1;PIK3CB;DUSP9;PRKCD;CAV1;PRDM15;CD300A;RANBP9;PTPN2;DUSP6;FBLN1;PAQR3;CNKSR3;ABCA7;SPRY4;PPIA;STK38;DUSP3;FOXO1;SMPD1;NF1;PIK3R2;PIN1;ITGB1BP1;SPRED2;EMILIN1;BMP4;LMO3
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.5258994302648676,1.307789534692244,0.1366906474820144,0.45743558522294,1.0,10/21,23.29%,GCK;DERA;PGLS;HK1;TKT;HK3;GPI;RPIA;PGM2;TALDO1
prerank,regulation of programmed cell death (GO:0043067),0.4241449603026354,1.307644260168933,0.019153225806451613,0.45732201871036937,1.0,56/161,24.61%,CTSB;IKZF3;CD3E;LGALS1;MALT1;SGK1;TRAF2;RAF1;CDK5;DAXX;BID;RBM25;BCL6;RTKN;ACTN1;TPT1;SOX9;BCL2L11;VCP;BAX;HIP1;RABGGTB;TRIAP1;NDRG1;HS1BP3;GLS2;BIRC5;CLU;DAPK1;APAF1;HTATIP2;TNFSF9;WFS1;RIPK3;DAPK3;HAX1;ATM;ASAH1;TARDBP;AIFM2;ACTN2;RPS3;CRADD;TRIM24;MARK4;DFFA;FBXO11;USP36;CALR;ACTN4;PRELID1;BNIP3;ANP32B;TNF;JAK2;BIRC2
prerank,lipoprotein catabolic process (GO:0042159),0.6143153343267443,1.30669026906535,0.1350210970464135,0.4597083375173796,1.0,6/11,20.64%,APOE;CTSD;LYPLA2;ABHD17C;ABHD17A;ABHD10
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.5797501897956739,1.3061990686515232,0.14304635761589404,0.4606247546940522,1.0,7/13,25.39%,FGF2;ITGA4;PDPK1;ADAM17;SP1;HMGB1;MDK
prerank,regulation of nuclear division (GO:0051783),0.5444244475076133,1.306072531582535,0.13691931540342298,0.4604271328849892,1.0,7/20,18.26%,FBXO5;CDK13;CUL9;PRMT5;RCC1;DAPK3;PIN1
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.43770467026071397,1.3058716324764568,0.051934826883910386,0.46053187801376544,1.0,35/107,22.76%,LCK;SLC24A4;ATP2B1;ATP13A2;NPTN;CSRP3;CAV1;TPT1;TPCN2;CCL13;CHERP;SLC39A6;CCR2;CCL7;SLC39A7;CCL5;SLC30A9;CCL14;SLC8B1;VAPB;TMEM165;STOML2;SLC11A1;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;ATP13A1;ATP2A2;CALR;HTR2B
prerank,cellular metal ion homeostasis (GO:0006875),0.4380225702248172,1.3058271485486288,0.05737704918032787,0.4600825644103208,1.0,24/102,15.42%,SLC9A1;SLC24A4;ATP1B3;ATP2B1;ATP13A2;NPTN;CSRP3;KCNJ2;CAV1;KCNMA1;TPT1;ATP1A4;ATP1A3;ATP1A1;TPCN2;CCL13;CHERP;CCR2;CCL7;CCL5;CCL14;SLC8B1;VAPB;ATP1A2
prerank,DNA methylation (GO:0006306),0.5230909715490208,1.3052867635259657,0.13510253317249699,0.46120061734356205,1.0,8/23,20.85%,DNMT3A;DNMT1;GATAD2A;MTRR;ATRX;DNMT3B;EHMT1;ZFP57
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.5008873028662433,1.304802647421134,0.12870159453302962,0.46197640102604554,1.0,15/30,30.91%,NCOR2;RNF14;DAB2;RNF6;HDAC1;SAFB2;PRMT2;KLK3;SMARCA4;SFRP1;H3-3A;KDM1A;SIRT1;TRIM68;EP300
prerank,bile acid and bile salt transport (GO:0015721),-0.37903346388527404,-1.3047413977996694,0.10614525139664804,0.6449400587909828,1.0,4/24,6.05%,SLCO2B1;NCOA1;SLCO1B1;NCOA2
prerank,regulation of DNA biosynthetic process (GO:2000278),0.5115096051562363,1.3046079152716048,0.10600706713780919,0.46200904901193507,1.0,7/27,20.07%,NIBAN2;PARP4;PDGFA;FGF2;PRKD2;ATM;DACH1
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.5485041052977961,1.3044992000998599,0.1276864728192162,0.4617339342946806,1.0,10/20,26.39%,SLC27A1;FBXW7;SIK1;BRCA1;APOC1;BMP5;PRMT3;ACADL;WDTC1;ERLIN1
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.4976703191499632,1.3038516884056537,0.12327188940092165,0.46315797579842793,1.0,8/31,12.72%,CDK6;HDAC7;PPARG;SOX9;NOCT;BAMBI;RIOX1;CHRD
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.5817944857374433,1.30375456882344,0.14888010540184454,0.46288082198558633,1.0,7/14,27.78%,ERCC6;ARID2;RAD51AP1;WAS;WDR48;FUS;ACTR2
prerank,regulation of tissue remodeling (GO:0034103),0.5389718628694993,1.303180155003584,0.14612452350698857,0.4641113044570384,1.0,3/18,5.98%,GPNMB;RUNX1;SUCO
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.5296895084441612,1.3031481579122017,0.12167300380228137,0.46366072893778965,1.0,13/21,30.14%,RAD51B;BRD4;FBXO5;CCNB1;VPS4B;STOX1;CDC7;RAB11A;NPM1;CDK4;CDC25B;CDC25A;CCND1
prerank,modified amino acid transport (GO:0072337),0.5578531274126926,1.3029918525350974,0.13612565445026178,0.4635643663015205,1.0,3/15,6.97%,PDPN;SLC6A8;SLC46A1
prerank,carboxylic acid catabolic process (GO:0046395),0.5850733844083759,1.3025585998884384,0.16164383561643836,0.4643830594073706,1.0,8/12,27.29%,RENBP;PON1;GNPDA1;NAGK;NPL;GNPDA2;AMDHD2;ACOT8
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.44554013135082227,1.3022469488769677,0.06583072100313479,0.46471989758228754,1.0,37/78,31.23%,NFE2L2;RNF14;PRICKLE1;CAV1;DAB2;FZR1;RNF180;RACK1;VCP;USP5;SOCS5;CEBPA;SMAD7;SUMO2;UBQLN1;CLU;CSNK1D;ELOB;HECTD1;PIAS1;RNF19A;GSK3B;TRIB2;GABARAP;MDM2;SUMO1;PLK3;BBS7;KEAP1;PSMD10;GSK3A;CSNK1E;RCHY1;RNF19B;NUB1;HERPUD1;SIRT2
prerank,regulation of cellular catabolic process (GO:0031329),0.4591734715885363,1.3021610687803964,0.07387580299785867,0.46436640168456156,1.0,17/62,18.32%,GPR137B;ABL2;RRAGD;SMCR8;WDR91;PSAP;HSPB1;TPCN2;RAB8A;ROCK1;DRAM1;DDIT3;DAPK1;RMC1;PIK3R2;DAPK3;ATM
prerank,dermatan sulfate metabolic process (GO:0030205),0.5826450439252703,1.3020194794420052,0.1366120218579235,0.4642416353707037,1.0,8/13,29.07%,CSPG4;DCN;BGN;CHST12;IDUA;CSPG5;DSEL;DSE
prerank,connective tissue development (GO:0061448),0.49419917879299574,1.3018488771710695,0.10798650168728909,0.46418583038874606,1.0,8/35,13.01%,SH3PXD2B;ARID5B;ATP7A;CD44;SOX9;CREB3L2;NAMPT;ZBTB16
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),-0.3587262526210998,-1.3018025272524927,0.072,0.6473059207818088,1.0,14/37,17.95%,BICD1;CYLD;EFNA5;TRIM36;STMN3;STMN1;MAP6;SKA2;CLASP2;PHLDB2;STMN4;TPPP;CAMSAP3;SKA3
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.48504336885714355,1.3017694173357337,0.1275395033860045,0.46383559242161265,1.0,13/37,18.40%,HIF1A;PLD3;SIRPA;NLRC3;CHID1;CD6;ADCY7;TREM2;TICAM1;ABCD2;APPL2;PDCD4;IL6
prerank,regulation of RNA metabolic process (GO:0051252),0.4586469270964431,1.3011807027404323,0.08064516129032258,0.46506504406772914,1.0,28/59,29.06%,AHNAK2;MITF;MBNL3;PTBP3;GRSF1;CELF1;SON;HNRNPLL;ZNF326;TNFRSF1B;PCBP4;MBNL2;FASTK;PCBP1;YTHDF2;NOVA2;RASA1;HNRNPF;CLK4;AHNAK;USP36;HNRNPL;RRP1B;RC3H1;FUS;OASL;TRA2B;MED1
prerank,positive regulation of ERAD pathway (GO:1904294),0.5818134597225817,1.3011215400015144,0.14583333333333334,0.46468418661239785,1.0,5/13,17.41%,NFE2L2;CAV1;ATXN3;UBQLN1;RNFT1
prerank,chromatin assembly or disassembly (GO:0006333),0.6120896588000799,1.3010910723983393,0.14479025710419485,0.46421446211117856,1.0,4/11,15.12%,NOC2L;M1AP;HIRIP3;CHAF1B
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.46613101823033753,1.2999431766622112,0.1184939091915836,0.46706992505942024,1.0,11/43,11.65%,IGF1;ID2;NR4A3;MEF2D;MMP9;FGF2;ERN1;DNMT1;HMOX1;JUN;CCL5
prerank,pyruvate metabolic process (GO:0006090),0.46390100084676883,1.2994812364248962,0.10423452768729642,0.4679031516665114,1.0,24/52,28.70%,PKM;ALDOA;GCK;NR4A3;HK1;PFKL;PGK1;LDHA;ENO1;PCK2;ALDOC;ME2;SLC16A3;ENO2;HK3;GPI;PDHB;SLC16A1;PDHX;ME1;SRR;DLAT;BSG;PGM1
prerank,regulation of protein sumoylation (GO:0033233),0.5423867317453757,1.2994564122813093,0.14052697616060225,0.4673946392326686,1.0,9/17,25.81%,CTNNB1;ZMIZ1;HDAC4;GNL3;PIAS1;SAE1;RWDD3;EGR1;PIAS4
prerank,synaptic vesicle cycle (GO:0099504),-0.36795782472808947,-1.299327262900932,0.09722222222222222,0.6488482792804351,1.0,11/30,11.55%,SNAP25;NLGN1;CPLX1;SYT10;RIMS1;RAB3A;SNAPIN;PLD2;SLC32A1;STX1A;BRSK1
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.5140426790832037,1.2992771794315514,0.12960760998810938,0.46736947415566255,1.0,5/25,3.49%,CD226;MALT1;TRAF2;SPHK2;TRIM6
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.5194176753332188,1.2983078558163035,0.13398294762484775,0.4697870471240655,1.0,6/24,14.57%,HIF1A;NIBAN2;ITGA5;PRKCB;CADM4;PRKD2
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.5221003209056682,1.2974134112133475,0.14218009478672985,0.4721685233271131,1.0,6/23,10.87%,TOMM22;HSPA4;SAMM50;BCL2L11;BAX;TIMM9
prerank,regulation of protein phosphorylation (GO:0001932),0.41980515581030003,1.297320046626574,0.011,0.47186794684578187,1.0,60/256,16.47%,GPNMB;FNIP2;FN1;CORO1C;ATF3;CCDC88C;RAP2A;FPR2;SIRPA;PLAUR;CD4;FGR;XDH;PDGFA;HRG;CLDN19;NPTN;MMP9;FGF2;PPP2R5C;HSPB1;DAXX;MYDGF;DAB2;PLPP3;SOX9;BRD4;VEGFA;CRKL;ANGPT1;TREM2;RASGRP1;ILK;ADAM17;P2RY1;RACK1;CADM4;KRAS;FGF7;FYN;C3;FGF20;FBLN1;PAQR3;GAS6;PTPN13;EFNA1;FGF18;PPIA;LRP6;PPP1R15B;CSNK1D;ITGB2;TFRC;CCND2;KDR;KDM4D;CHP1;FXR2;MYADM
prerank,response to interferon-beta (GO:0035456),0.5259692000023594,1.2973068967105372,0.14558472553699284,0.4713201092010313,1.0,11/22,26.79%,SHFL;TRIM6;IFITM2;IKBKE;IRGC;IFITM1;ACOD1;BST2;CDC34;AIM2;IFNAR2
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.5145531781835051,1.297102579879701,0.1276595744680851,0.47135532770970556,1.0,16/25,31.60%,SF3B3;PRPF4;SMNDC1;PRPF6;SNRNP40;PRPF8;SF3A3;SRRM1;SF3B1;KHSRP;GEMIN2;SRSF10;TRA2B;WDR83;DBR1;MPHOSPH10
prerank,regulation of immunoglobulin production (GO:0002637),0.5191648485721246,1.2966888696156993,0.1416256157635468,0.47203517833428127,1.0,13/23,31.66%,PTPRC;CD22;DNAJB9;RBP4;GPI;IL6;IL2;SASH3;TLR9;STX4;VAMP3;EPHB2;XBP1
prerank,regulation of pH (GO:0006885),0.5938407933873483,1.2965743130560312,0.14939434724091522,0.4718148578507194,1.0,6/11,20.02%,SLC9A1;ATP1A4;ATP6AP1;SLC9A7;SLC26A4;ATP6V0A4
prerank,metal ion export (GO:0070839),0.49778253142561263,1.296325291030675,0.1261682242990654,0.47197273466445566,1.0,6/31,7.31%,SLC9A1;ATP7A;ATP1B3;ATP1A4;ATP1A3;ATP1A1
prerank,proteolysis (GO:0006508),0.4138674563757497,1.2961941897463067,0.012024048096192385,0.4717841510034511,1.0,75/252,24.05%,PLAU;ADAM33;CTSB;CTSD;ANPEP;MMP8;CTSZ;MMP12;CAPN15;PGPEP1L;OLR1;ST14;MALT1;CTSA;CTSW;ATG4D;CPA4;CPA3;GZMB;GZMA;TMPRSS2;ADAMTS13;BMP1;MMP9;ECEL1;CPXM2;CLPP;SDE2;NAPSA;CAPN1;DPP7;CNDP2;PSEN2;PSMD6;ADAM17;CPA6;AEBP1;TASP1;CLN3;LONP1;CTSE;DDI2;SPCS3;AFG3L2;OGT;KLKB1;CPD;MMP19;CASP7;SPPL3;ATG4A;CASP4;FURIN;PSMA6;XPNPEP1;KLK3;TMPRSS5;FBXL6;DESI1;DESI2;TMPRSS7;VHL;MMP17;TPP1;SENP1;SRGN;PITRM1;SUFU;NLN;CLPX;PARL;TMPRSS4;ECE1;TRABD2B;MDM2
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.5957873106591718,1.2959927804648408,0.16506189821182943,0.4718310214292686,1.0,3/11,2.96%,CORO1C;PDPN;CD44
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.3019694240682836,-1.2951763665699227,0.041666666666666664,0.6550687190932311,1.0,21/75,12.80%,OPHN1;MEF2C;CTNNA2;BTBD3;MEF2A;CNTN4;PLPPR4;RAB3A;DSCAML1;MAP2;MAP6;APP;PAX2;SLITRK4;APBB1;DCDC2;BRSK1;MAP1B;KLF7;PAK3;RAB10
prerank,regulation of supramolecular fiber organization (GO:1902903),0.5218938103968939,1.2947339809080851,0.15318627450980393,0.4750891652077989,1.0,6/22,13.71%,APOE;AKAP13;AEBP1;PRUNE1;HSPA8;EFEMP2
prerank,cellular defense response (GO:0006968),0.47994324537410393,1.2947280883375518,0.12557077625570776,0.474519176137071,1.0,11/40,10.97%,TCIRG1;KLRC2;ITK;CXCR2;SPN;PTK2B;NCR1;TRAT1;PRF1;CD5L;ZNF148
prerank,negative regulation of synaptic transmission (GO:0050805),-0.38901552591444183,-1.2944493497346239,0.1329479768786127,0.6512290605468082,1.0,11/23,26.63%,GRIK3;LRRK2;SLC30A1;ARF1;STXBP1;ACHE;IL1B;TMEM25;CBLN1;MTMR2;SLC24A1
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.47455924085609463,1.2938192084493603,0.1222466960352423,0.47679736942524964,1.0,17/43,25.02%,HIF1A;FGF2;PPARG;GATA3;SOX9;PPARD;JUN;SRF;GNL3;NR3C1;NFATC3;BMP4;TEAD1;TERT;EGR1;TNF;SMARCA4
prerank,regulation of mononuclear cell migration (GO:0071675),0.5231209026237948,1.2932214926848904,0.14976415094339623,0.47809626408083594,1.0,3/23,1.76%,LGALS3;CSF1;MSN
prerank,negative regulation of DNA replication (GO:0008156),0.5783332065938742,1.292985198630056,0.16795865633074936,0.4782315827588188,1.0,4/13,8.73%,GTPBP4;S100A11;WAPL;GMNN
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.5618576333766808,1.2922028204833496,0.1422976501305483,0.47999339349001013,1.0,5/15,19.57%,ANXA1;BCL2L11;UBE2L3;HNRNPU;NR3C1
prerank,endochondral bone morphogenesis (GO:0060350),-0.502366639306742,-1.2921022567691682,0.15613382899628253,0.652183910456702,1.0,3/11,3.29%,MEF2C;TMEM119;BMPR1B
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.517014861414488,1.2920203240831452,0.13132530120481928,0.47998061554608035,1.0,10/24,19.34%,IQSEC1;HRG;NRP1;VEGFA;MYOC;ROCK1;DUSP3;KDR;FERMT2;COL16A1
prerank,cellular component maintenance (GO:0043954),0.5919492329122622,1.2920074960491,0.16666666666666666,0.47945440614365253,1.0,6/12,29.37%,TREM2;IGF1R;FYN;ITGA3;SUPV3L1;CLDN1
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.4480575817789171,1.2913048786588004,0.08130939809926083,0.481193598612813,1.0,17/72,16.15%,IGF1;FLT1;FN1;FGR;PDGFA;PIK3CB;FGF2;MYDGF;PIK3R5;SOX9;TREM2;IGF1R;MYOC;CCL5;DCN;CBL;KDR
prerank,regulation of apoptotic process (GO:0042981),0.40739500765199804,1.290827444382394,0.0,0.482024526672918,1.0,224/676,25.41%,IGF1;BCL2;CTNNB1;CTSB;ABR;IKZF3;ARHGAP10;CD3E;CTSD;BCL2L1;NIBAN2;FLNA;IL2RB;ATG7;ANXA5;PLAUR;LGALS1;ANXA1;LTF;MALT1;SGK1;GNA13;LEF1;UBA52;TRAF2;RPS27A;MCL1;PDPN;FIGNL1;AKAP13;SPHK2;RPS6;PTPA;CD44;ANXA4;PRDX5;AXL;SCIN;HRG;GZMA;DUSP9;SPHK1;PTK2B;SQSTM1;MMP9;RAF1;MTCH1;CDK5;CD28;HYPK;SERPINB9;HSPB1;DAXX;ANGPT4;BID;SIAH2;MYDGF;RBM25;BCL6;DAB2;RTKN;STK3;KCNMA1;ACTN1;TPT1;SOX9;APIP;VEGFA;ANGPT1;ING4;HDAC1;HTT;BCL2L11;TFPT;PLK2;IGF1R;PSEN2;DIABLO;NAA16;LILRB1;SON;UFM1;RACK1;VCP;BAX;HIP1;IAPP;MGMT;NAT8;UTP11;RABGGTB;ARHGEF1;ATF5;JUN;DNM2;SUDS3;CLN3;DUSP6;TRIAP1;PIM1;WDR73;TCTN3;IRF5;ARHGEF18;NDRG1;BIRC6;ATAD3A;PRDM9;HS1BP3;TFAP4;HNRNPK;GLS2;GAS6;FSTL1;PAK2;BIRC5;PPIA;IL31RA;MTCH2;NFKB1;BFAR;CLU;DAPK1;CYP1B1;HSPD1;CIAPIN1;CBL;ARHGEF11;HSPA9;ING3;APAF1;VIP;RNF157;CAT;USP47;C1QBP;FOXO1;PRMT2;BARD1;SMPD1;NF1;TFRC;HTATIP2;CCND2;KDR;KALRN;RASA1;TNFSF9;ING5;RPS6KA2;WFS1;RIPK3;HIP1R;DAPK3;HAX1;ATM;ANO6;IL6;ARL6IP5;CCAR2;HIGD2A;CCAR1;TARDBP;BNIP2;AIFM2;CASP9;IFIT2;IL2;ARHGEF2;CTNNBL1;ACTN2;HMGB1;UBC;RPS3;MTDH;CRADD;CFL1;VHL;TRIM24;PLEKHG2;GSK3B;NPM1;DFFA;TNFSF10;BMP4;MELK;FBXO11;EGLN3;NSMF;LATS1;USP36;CALR;ACTN4;KLF11;ARHGEF5;HTR2B;VAV3;CD74;ADAMTSL4;PRELID1;BAG3;BNIP3;AVEN;MIF;DNAJA1;SOCS2;ANP32B;GOLPH3;TNF;TCIM;JAK2;PLK3;GADD45A;ATF4;BIRC2;HDAC2;DCUN1D3;HSPA5;RRP1B;VAV1;NCKAP1L;SFRP1;CX3CL1;YWHAZ
prerank,negative regulation of transport (GO:0051051),0.4590532958062675,1.2907354186213866,0.10239651416122005,0.48174067774748186,1.0,12/51,15.24%,LGALS3;SIRPA;MCTP1;NRG1;FER1L5;TRAT1;SNX33;LILRB1;RACK1;RAB7A;ABCA7;YRDC
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.49993632291723833,1.2901761760807882,0.12888377445339472,0.48288142404361306,1.0,12/29,24.29%,LGALS3;FPR2;MOSPD2;CCR2;SERPINE1;CCL5;GAS6;C1QBP;ANO6;HMGB1;CALR;TNF
prerank,positive regulation of metabolic process (GO:0009893),0.42543569747993293,1.2901240337388922,0.061601642710472276,0.48246381971743524,1.0,38/103,27.23%,LCN2;FABP5;ACACA;PEMT;DYNC1H1;UCP2;CAV1;PIGA;ZBTB7B;ACSL1;VEGFA;IGF1R;KDM3A;CCR2;PPARGC1B;OGT;YBX2;SYK;PLAC8;APPL2;CPT2;ADIPOR1;DECR1;JCHAIN;ACACB;EHMT1;FABP4;HSF1;ACADL;GNAS;AGPAT1;TNF;JAK2;FASN;HADH;HDAC3;CXCR4;KDM1A
prerank,cellular component assembly (GO:0022607),0.4140455100858213,1.2894196659141266,0.011022044088176353,0.4840801615733365,1.0,82/253,23.47%,FBLIM1;LCP1;MITF;CD3E;CD247;FLNA;IL2RB;EPRS1;KMT2A;CAPG;TRAF2;TUBGCP4;PDGFA;SCIN;CD3G;PKP1;PTK2B;MICAL1;SLC2A1;NEDD9;PPP2R1A;FOXJ1;NOC2L;TLCD1;SPAG16;SOX9;WIPF1;LIMS2;RHOD;ACTG1;RHOQ;TAPBP;ILK;SKAP2;TLCD2;RANBP9;M1AP;TRAF1;CARD10;RHOG;PARVA;YTHDF3;MAGI1;GSN;RHOA;DNAJB13;RHOU;AFG3L2;TFAP4;GAS6;CDC42;FZD1;GPAA1;DCX;TSPAN4;ACTB;LAMC1;NDUFAF1;ESPN;CHAF1B;MDN1;YTHDF2;PKP2;VAMP2;ELOB;JCHAIN;PARVB;FERMT2;FANCA;MYO9A;VASP;TRIP13;PLS1;BAIAP2;SYCE2;ACD;TEAD1;WAS;LLGL1;CD74;PEX14;BAIAP2L2
prerank,actin filament organization (GO:0007015),0.4192374747787539,1.2893979920076215,0.04040404040404041,0.4835729891097186,1.0,28/151,12.86%,MYO1E;GAS2L3;LCP1;MYO5A;ARHGAP25;CORO1C;FLNA;MYO1F;CAPG;ALDOA;PPP1R9B;SCIN;POF1B;MYO1A;TPM2;NEDD9;ACTN1;INPPL1;RHOD;FAT1;CORO7;TPM4;RUFY3;HIP1;RHOG;GSN;RHOA;CDC42
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.5814747550754189,1.289244841749067,0.1625487646293888,0.48286192908097175,1.0,5/12,21.45%,DYRK2;RCAN1;HOMER2;CHP1;GSK3B
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.5814747550754189,1.289244841749067,0.1625487646293888,0.48286192908097175,1.0,5/12,21.45%,DYRK2;RCAN1;HOMER2;CHP1;GSK3B
prerank,RNA modification (GO:0009451),0.4519879127212621,1.288905502559357,0.1101511879049676,0.48335808616171605,1.0,16/54,19.19%,AARS1;ADARB1;THG1L;METTL1;PUS7;ANKRD16;MRM2;METTL3;ALKBH1;FTSJ3;QTRT1;RBM15;RBM15B;NSUN3;ADAR;NSUN2
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.44833786756465116,1.288552454338151,0.10476190476190476,0.48379716166155723,1.0,35/60,37.44%,CTNNB1;PRKCQ;CCT2;FGF2;TNKS2;NVL;PKIB;CCT8;PRKD2;POLG2;ATM;PTGES3;CCT5;HSP90AB1;ACD;DKC1;RFC2;MAPK15;ATR;MAPK3;PARM1;XRCC5;PNKP;MAPK1;RFC4;MAP3K4;RFC5;PCNA;PDGFB;NAF1;MYC;SMOC2;FGFR4;HGF;GREM1
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.5797382283115633,1.2882206083375554,0.1793478260869565,0.4841975653855863,1.0,7/12,27.07%,BRCA1;METTL3;RBM15;RBM15B;HNRNPU;SMCHD1;CDYL
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.6048054206895171,1.2881497869120266,0.15832205683355885,0.48382237626544544,1.0,7/11,31.96%,PAPOLA;BARD1;DHX36;PAF1;ZC3H3;LEO1;AHCYL1
prerank,icosanoid biosynthetic process (GO:0046456),-0.49230132224806233,-1.2878075561677975,0.16943521594684385,0.6585522724374113,1.0,2/10,1.67%,LTC4S;ALOX5
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.5085042433502036,1.287498887131819,0.14695340501792115,0.4852062000937061,1.0,12/26,29.71%,NCOR2;DAB2;HDAC1;VPS18;BRCA1;VPS11;CALR;SMARCA4;SFRP1;KANK2;SIRT1;CNOT9
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.5879792724168688,1.2873920925812075,0.16108247422680413,0.48495769008952144,1.0,6/13,16.30%,MDFIC;UFM1;SP100;TPR;BARD1;CHP1
prerank,positive regulation of cell migration (GO:0030335),0.41163718033299057,1.2873471772380718,0.012024048096192385,0.4845322003926493,1.0,44/253,11.65%,GPNMB;PLAU;IGF1;FLT1;HIF1A;FN1;ITGAX;CSF1;SDCBP;MGAT5;PTPRC;FGR;LEF1;AGO2;GCNT2;PDPN;PDGFA;FAM110C;SPHK1;GLIPR2;PTK2B;MMP9;NRP1;NEDD9;S100A11;CAV1;FAM83H;DAB2;SOX9;VEGFA;CRKL;RHOD;ACTG1;IGF1R;FBXO5;SPAG9;ADAM17;PLAA;RACK1;RUFY3;MYOC;CCR2;CCL7;CCL5
prerank,negative regulation of protein binding (GO:0032091),0.4517689078284523,1.287254133833881,0.07995735607675906,0.4842525017304044,1.0,25/71,23.23%,CTSZ;NES;PRKCD;ITGA4;CAV1;DAB2;RACK1;LRPAP1;BAX;B2M;TLE5;GTF2F1;ROCK1;ADAM15;ACTB;PSME3IP1;SYMPK;RALB;PIN1;ITGB1BP1;IFIT2;GSK3B;ATP2A2;USP33;PEX14
prerank,regulation of sequestering of calcium ion (GO:0051282),0.5841510644724588,1.287100302724766,0.16981132075471697,0.48408915421655024,1.0,3/12,11.44%,PTK2B;ANXA6;DIAPH1
prerank,negative regulation of coagulation (GO:0050819),0.5627312791843566,1.2870212587914704,0.16389244558258642,0.4837709193411812,1.0,6/14,16.20%,APOE;TFPI;SERPINE2;SERPINE1;PROCR;APOH
prerank,GTP metabolic process (GO:0046039),0.5550132050514561,1.287007806116213,0.16429495472186287,0.4832322219713713,1.0,5/15,13.33%,GIMAP7;AK4;AK3;RHOQ;EFL1
prerank,regulation of epithelial cell proliferation (GO:0050678),0.43398244498730215,1.286923158389484,0.060291060291060294,0.4829085431918799,1.0,17/85,16.84%,IGF1;CDK6;NLRC3;DEAF1;NR4A3;FGF2;MTSS1;SOX9;VEGFA;ANGPT1;PEX2;B2M;FGF7;FGF18;LAMC1;C5AR1;BMP6
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.5838235055566852,1.286760117137022,0.15782493368700265,0.4828542964242203,1.0,3/13,4.08%,APOE;PLEK;CYP27B1
prerank,regulation of blood coagulation (GO:0030193),0.5081335606533713,1.2866328419266075,0.13647342995169082,0.48274866302037894,1.0,7/27,16.20%,APOE;HRG;CAV1;TFPI;SERPINE2;SERPINE1;APOH
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.4246929884997807,1.2866217608169295,0.03636363636363636,0.4822172887553232,1.0,50/151,26.14%,GPNMB;APOE;FPR2;PTPRC;CD4;CCL4;GCNT2;PDGFA;CD44;ALKAL2;GLIPR2;PTK2B;FBXW7;NRP1;FGF2;MFHAS1;PTPN22;CRKL;ANGPT1;TREM2;RASGRP1;CCL13;P2RY1;ATP6AP1;CCL7;CCL5;MAP3K12;GAS6;ABCA7;CCL14;PRKD2;TIRAP;KDR;C5AR1;SERPINF2;FERMT2;SCIMP;HMGB1;FGFR3;F2R;HTR2B;CD74;MIF;FGFR2;TNF;PDGFRA;PLA2G5;CX3CL1;DSTYK;GPR183
prerank,microvillus assembly (GO:0030033),0.5660867641268159,1.2861294775423375,0.16666666666666666,0.4831417131750969,1.0,5/14,16.42%,RAP2A;FXYD5;RAPGEF6;ESPN;MINK1
prerank,ceramide transport (GO:0035627),0.5907862215785967,1.2858086234375994,0.15734720416124837,0.4835566080937053,1.0,3/12,9.16%,PSAP;GLTP;ABCA13
prerank,renal filtration (GO:0097205),0.6206451408703537,1.2849053210245789,0.18181818181818182,0.4858139742461503,1.0,1/10,0.01%,MYO1E
prerank,positive regulation of protein catabolic process (GO:0045732),0.4347514301838763,1.2844845517065582,0.08020833333333334,0.4865356243357249,1.0,37/84,28.90%,APOE;ATG7;MSN;ADAM8;C4BPB;C4BPA;SEC22B;SNX33;PLK2;FZR1;VCP;DDB1;OAZ3;RAB7A;HUWE1;TNFRSF1B;VPS11;TIPARP;VIP;FOXO1;BARD1;FURIN;SH3D19;GSK3B;RNF41;VPS35;TNF;PLK3;VPS28;RILP;STX5;GSK3A;DACT1;TNFAIP3;PTTG1IP;WWP2;FAF1
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.6104741069587031,1.2840370548744824,0.15164520743919885,0.4873329129229393,1.0,7/10,32.23%,DNMT1;BRCA1;ATRX;DNMT3B;KDM1A;SIRT1;MYB
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.5238265875404403,1.2837573225467556,0.14864864864864866,0.48759958248821567,1.0,2/21,0.19%,CHST11;CSPG4
prerank,positive regulation of acute inflammatory response (GO:0002675),0.5534109638320709,1.2830759258042486,0.15214564369310793,0.4892838996897916,1.0,5/14,27.81%,ADAM8;OSMR;IL6;TNF;PTGER3
prerank,synapse assembly (GO:0007416),-0.29168385460843993,-1.282363157786638,0.05660377358490566,0.6689434295181651,1.0,15/67,10.22%,GABRB2;NRXN1;GABRB3;NLGN1;ADGRL3;LRRTM3;SDK1;GRID2;GABRA2;CDH2;FLRT3;SHANK3;DNER;WNT5A;GABRA1
prerank,icosanoid metabolic process (GO:0006690),-0.3331569351384388,-1.281969393458004,0.07758620689655173,0.6643452828049001,1.0,13/40,15.56%,PTGS1;HPGD;LTC4S;ALOX5;GGT5;PON3;PNPLA8;PON2;EPHX1;DAGLB;PLA2G4C;PTGR1;ALOXE3
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.5366396641078934,1.281953494999573,0.15723270440251572,0.4921461934895626,1.0,6/18,19.97%,NLRC3;B4GALT7;PEX2;CD300A;NF1;FTH1
prerank,negative regulation of interleukin-8 production (GO:0032717),0.5472451608885937,1.2819239756294687,0.12939698492462312,0.4916662884099129,1.0,4/17,6.11%,ANXA1;TMSB4X;ANXA4;PTPN22
prerank,long-chain fatty acid biosynthetic process (GO:0042759),-0.38157285299114757,-1.2815939785739463,0.10344827586206896,0.6597175991265678,1.0,4/23,3.24%,HPGD;LTC4S;ALOX5;ELOVL6
prerank,cytokine-mediated signaling pathway (GO:0019221),0.4063793451821892,1.281572855854702,0.0,0.4921348414887842,1.0,201/532,29.44%,BCL2;LCP1;LCK;HIF1A;FN1;ITGAX;LCN2;ABL2;CSF1;BCL2L1;IL2RB;CD300LF;PSMD8;SLC27A1;GRAP2;IL18R1;ANXA1;PSMD1;TMSB4X;CD4;IL18RAP;MSN;CSF2RA;UBA52;TEC;IRAK2;CXCR2;TRAF2;CCL4;RPS27A;VIM;MCL1;MUC1;LTB;CD44;PIK3CB;OSMR;STAT4;IRF6;TNFSF15;POMC;GSTA2;PTK2B;SQSTM1;MMP9;PRKCD;PLP2;FGF2;IL3RA;TRAF3;IL27;IL12RB1;IFITM2;BCL6;GATA3;GRB2;VEGFA;CRKL;IL27RA;BCL2L11;INPPL1;UGCG;P4HB;TAB1;IFITM1;ILK;PSMD6;PSMA1;ADAM17;CCL13;IRF8;RNASEL;TRAF1;B2M;PSMC3;HMOX1;FYN;SOCS5;PIM1;CEBPA;CCR2;CCL7;JAK1;CCL5;IRF5;TNFRSF1B;PSMA8;TNIP2;RHOU;CDC42;SP100;HSPA8;TNFRSF9;PAK2;GHR;PSMD14;STX3;BIRC5;CCL14;PSMD2;RSAD2;TNFSF8;HNRNPA2B1;PPIA;IL31RA;NFKB1;CBL;HSPA9;ITGB2;LAMA5;PSMC6;FOXO1;PSMA6;SYK;APPL2;GBP2;TNFSF9;IL1R2;ADIPOR1;PDCD4;PSMD5;ISG20;MAP3K8;HNRNPF;PSMA5;IL6;ADAR;FCER1G;BST2;IFIT2;IL2;CNTFR;GAB2;UBC;IL5;FBXW11;CFL1;SOD2;EIF5A;TIMP1;EPO;CUL1;TNFRSF11B;LBP;TRIM21;CDIP1;IRAK4;CANX;ACTN4;IL17RA;IL34;EGR1;STAT5B;TALDO1;IL20RA;MIF;SOCS2;PSMA3;TNF;JAK2;BIRC2;PSMB8;SMARCA4;POU2F1;VAV1;PSMB10;CX3CL1;YWHAZ;COL1A2;PSMD7;AIM2;PELI1;PSMB6;MT2A;PTPN6;BTRC;IL12RB2;STX4;IFNAR2;PSMD10;IFNGR2;LIMS1;TRIM8;PSMB5;GREM2;RIPK1;ITGB1;CTR9;PSMB7;MAPK3;OASL;IL1R1;HSP90B1;IL21R;JUNB;GSTO1;PYDC1;PSMC4;TNFRSF8;TAB2;SIRT1
prerank,protein import into nucleus (GO:0006606),0.4412553822073077,1.2812897370507448,0.09129511677282377,0.49240738818114005,1.0,29/66,29.50%,MMP12;RGPD1;GCKR;PRICKLE1;IPO5;RPL23;KPNA4;E2F3;NUP188;KPNA6;NXT2;EIF4ENIF1;RANBP2;TPR;SYK;APPL2;CBLB;PPP1R10;NUP93;NUP54;NUP50;TNPO2;TNPO1;NUP133;NUTF2;IPO13;NUP35;PTTG1IP;NUP214
prerank,regulation of B cell proliferation (GO:0030888),0.4670438731681335,1.2805164482613054,0.11333333333333333,0.4943170876768217,1.0,19/44,27.10%,BCL2;IKZF3;PTPRC;CHRNB2;CD22;CD300A;TFRC;TIRAP;ATM;IL2;AHR;VAV3;CD74;MIF;NCKAP1L;SASH3;TLR9;GPR183;RC3H1
prerank,muscle organ development (GO:0007517),0.4594577180532439,1.280370590316201,0.10129310344827586,0.4941987202115829,1.0,13/54,12.85%,IGF1;SPEG;LARGE1;TAGLN;EVC;SGCA;MEF2D;ZBTB42;COL6A3;SRI;MEF2B;CHODL;UTRN
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.520311020634043,1.280266865603781,0.17712177121771217,0.49396525771856115,1.0,5/21,14.85%,CTNNB1;CAV1;FRAT1;FZD1;LRP6
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.5752792534186593,1.2802046696739726,0.1547314578005115,0.4935794709953642,1.0,4/13,11.11%,TMSB4X;TREM2;VCP;ENO1
prerank,atrial septum morphogenesis (GO:0060413),-0.4994517716752789,-1.2786578214189297,0.1701388888888889,0.6624594020112591,1.0,5/10,30.47%,NOTCH2;ZFPM1;BMPR2;ISL1;SOX4
prerank,cAMP biosynthetic process (GO:0006171),0.6149403923102409,1.2786563420033326,0.17969821673525377,0.49780689888588514,1.0,3/10,4.21%,ADCY8;ADCY3;ADCY7
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.4774486194028039,1.278267191482819,0.14419695193434937,0.49840772475588674,1.0,15/34,27.82%,PTPRC;SPHK2;TRIM6;PTPN22;DNAJB9;RBP4;GPI;IL6;SCIMP;IL2;LAPTM5;SASH3;TLR9;STX4;VAMP3
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.4731480310124736,1.277460797063549,0.1414141414141414,0.5003231137640198,1.0,10/37,11.17%,ALCAM;ITGAL;NECTIN1;CD6;AMIGO1;CADM1;FAT4;NECTIN3;JAML;CRTAM
prerank,positive regulation of TORC1 signaling (GO:1904263),0.556348154270943,1.2774071869433405,0.1545338441890166,0.49992242916410856,1.0,2/16,0.97%,GPR137B;RRAGD
prerank,positive regulation of secretion (GO:0051047),0.6042574694480798,1.2772973825754574,0.18037135278514588,0.49968400348624836,1.0,2/11,3.43%,SCIN;TRH
prerank,nucleosome organization (GO:0034728),0.45313549189851277,1.2771189207659552,0.10457516339869281,0.499638808600102,1.0,33/55,34.38%,GRWD1;DAXX;SOX9;BPTF;SMARCB1;PRDM9;ACTR6;SMARCC1;H1-0;ARID2;INO80;CHAF1B;SRCAP;PAF1;ATRX;VPS72;NPM1;SMARCD2;NAP1L3;ANP32B;SMARCA4;MCM3AP;H3-3A;RSF1;NASP;ASF1A;HMGB2;DMAP1;SET;ANP32E;SART3;SETD2;NFE2
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.5501980382141152,1.2768137379972673,0.18688118811881188,0.5000148034696446,1.0,8/17,23.76%,PTPRC;PTPA;PPP1R12A;CD300A;PPP1R15B;HSP90AB1;PPP1R15A;CALM3
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.5047970798678965,-1.276595252070593,0.1881918819188192,0.6626565966039706,1.0,5/10,21.66%,POGLUT3;GALNT2;POGLUT1;GALNT4;GALNT13
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.6032098010114274,1.2764595494758753,0.1825503355704698,0.5005309161533075,1.0,6/11,21.21%,FYN;ABCD2;TRAP1;MPV17L;SLC18A2;ABCB7
prerank,positive regulation of exosomal secretion (GO:1903543),0.5537198711666355,1.2763639810025593,0.1836734693877551,0.5002312047919575,1.0,5/15,11.55%,SDCBP;ATP13A2;PDCD6IP;RAB7A;VPS4B
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.49239588310647747,1.276279926523137,0.13418903150525088,0.4999147409659886,1.0,9/30,19.11%,MGAT5;DERL3;MAGT1;STT3B;LMAN1;MCFD2;ST6GAL1;TUSC3;DDOST
prerank,cellular response to ketone (GO:1901655),0.47848363442873154,1.276197115671014,0.13580246913580246,0.49960015995997464,1.0,16/35,25.22%,SPP1;MSN;ADCY8;ADCY3;PTGFR;SPHK2;PCK2;LARP1;ADAM15;ACOD1;GNB1;NR3C1;PTGER4;AHR;GOLPH3;SFRP1
prerank,negative regulation of axonogenesis (GO:0050771),0.5042265216995956,1.2759508586592008,0.1559202813599062,0.4997815306493633,1.0,6/27,12.09%,FGF13;LRP4;RNF6;GDI1;RUFY3;RHOA
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.43922106674746525,1.275593723418816,0.0948905109489051,0.5003389952288725,1.0,37/73,28.29%,MYO10;CD247;ARPC2;FGR;ARPC3;ARPC5;PIK3CB;CD3G;NR4A3;PRKCD;GRB2;WIPF1;NCK1;ACTG1;CYFIP2;FYN;LIMK1;CDC42;ACTR3;ACTB;ARPC1B;SYK;PIK3R2;FCER1G;BAIAP2;MYO1G;HSP90AB1;ABI1;WAS;VAV3;VAV1;NCKAP1L;YES1;NCKIPSD;CYFIP1;ACTR2;MAPK3
prerank,positive regulation of interleukin-2 production (GO:0032743),0.5109529909945678,1.2755843769966253,0.13647058823529412,0.4997947286597722,1.0,7/25,5.86%,PTPRC;ANXA1;CD4;MALT1;TRAF2;CD28;RUNX1
prerank,positive regulation of cellular metabolic process (GO:0031325),0.42431664791259593,1.2749128241668115,0.09326424870466321,0.501424699067407,1.0,31/98,24.88%,APOE;CSF1;ACACA;XDH;EIF4G1;APOA2;PPARG;GATA3;GRB2;VEGFA;ANGPT1;PPARD;CCNB1;APOC1;CD63;CCL5;CHCHD2;SCYL2;GHITM;ACOD1;RAB1A;CBR1;ACACB;STARD4;RNF41;TGFBR2;PRELID1;AGPAT1;ECE1;GADD45A;FASN
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.4846075613611889,1.2748753934074348,0.14514285714285713,0.5009577899749006,1.0,13/33,25.02%,HIF1A;FGF2;PPARG;GATA3;JUN;SRF;GNL3;NR3C1;TEAD1;TERT;EGR1;TNF;SMARCA4
prerank,ether lipid biosynthetic process (GO:0008611),-0.5101661345562495,-1.274620768065054,0.1795774647887324,0.6624287673421565,1.0,3/10,5.97%,LPCAT2;PEX7;AGPS
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.44536456585426254,1.2745675877675764,0.10191082802547771,0.5013453314488131,1.0,27/65,31.11%,PSMD8;PSMD1;PSMD6;PSMA1;PSMC3;PSMA8;PSMD14;PSMD2;USP47;PSMC6;PSMA6;PSMD5;PSMA5;CUL1;AVEN;PSMA3;ZFYVE19;PSMB8;PSMB10;PSMD7;PSMB6;PSMD10;PSMB5;PSMB7;PSMC4;NABP1;PSMD12
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.41656730795967783,1.2744800642299579,0.042467138523761376,0.5010558136678894,1.0,57/158,27.43%,LITAF;FLNA;LGALS1;LTF;CD4;MALT1;TRAF2;AKAP13;TRIM6;CC2D1A;DDX21;IKBKE;BRD4;PLK2;PRKCB;EEF1D;TICAM1;HMOX1;WLS;DDX1;SHARPIN;TNIP2;RHOA;ECM1;GPRC5B;LPAR1;CLEC6A;TMEM106A;TFRC;TIRAP;DHX36;NEK6;S100B;BST2;MTDH;SHISA5;GPR89A;TNFSF10;TRIM21;IRAK4;F2R;HTR2B;CCDC22;CD74;REL;JMJD8;TNF;BIRC2;SLC20A1;CX3CL1;SLC44A2;TLR9;PELI1;PPM1A;TERF2IP;TBK1;TRIM8
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.44533615496943674,1.2741848989295892,0.1014957264957265,0.5013526196258342,1.0,11/63,6.85%,BCL2;CD3E;PTPRC;ANXA1;SLC7A1;CHRNB2;CD6;CD28;NCK2;CD274;NCK1
prerank,regulation of cell motility (GO:2000145),0.4214452462717259,1.2738903005415874,0.056179775280898875,0.5017027740534948,1.0,29/121,14.03%,PLXNC1;CDK6;ABL2;FLNA;PLXNA2;TMSB4X;SGK1;SGK3;MACF1;NRG1;RAF1;FGF2;LMO4;GATA3;TMSB10;LMNA;CADM4;PLXND1;FGF7;SERPINE2;DIAPH1;FGF20;FBLN1;PHPT1;RHOA;MEMO1;PKN2;ROCK1;FGF18
prerank,protein polymerization (GO:0051258),0.4503546841676101,1.2734731851831904,0.11496746203904555,0.5024849474724365,1.0,12/55,12.65%,FGF13;GAS7;TRIM6;MSRB1;WASHC5;CHMP4A;CHMP4B;CORO7;ARHGAP6;DIAPH1;GSN;MID1IP1
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.5383923359898837,1.2733114519268884,0.16149068322981366,0.5024110376638514,1.0,9/18,29.83%,BID;BAX;SLC35F6;MPV17L;HIP1R;GSK3B;ACAA2;GSK3A;MUL1
prerank,ribosomal small subunit assembly (GO:0000028),0.5570509339019405,1.2729656851030484,0.16644474034620507,0.5029432374187375,1.0,6/16,15.05%,RPS14;RRP7A;RPS28;MRPS7;RPS19;RPS27
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.48914408882759686,1.272815409372022,0.15657142857142858,0.5028735554207875,1.0,14/32,23.76%,PTPA;PRKCD;DLC1;CD300A;PPIA;SPPL3;PPP1R15B;SMPD1;SYMPK;PIN1;HSP90AB1;NSMF;PPP1R15A;CALM3
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.478611715470885,1.27274254854859,0.16203703703703703,0.5025594536675015,1.0,11/32,18.68%,ANXA1;HDAC9;HDAC7;FGF2;VEGFA;CARD10;HMOX1;DLL4;RHOA;KDR;ITGB1BP1
prerank,regulation of cellular localization (GO:0060341),-0.3172347567429824,-1.2724247441763217,0.09195402298850575,0.6629366445836441,1.0,12/46,12.64%,LRP5;FER;EFNA5;LRRK2;WWC1;ADCY5;MAP2;PRKN;EPHA5;STXBP4;BRSK1;GOSR1
prerank,tRNA modification (GO:0006400),0.44620453203560145,1.272316787826142,0.11027837259100642,0.5033922206069285,1.0,31/62,31.83%,PUS1;AARS1;THG1L;METTL1;PUS7;ANKRD16;ALKBH1;QTRT1;METTL2B;METTL2A;TRMT13;THADA;TPRKB;NSUN2;TARBP1;TRMT112;GTPBP3;THUMPD2;ELP5;MOCS3;TRMT5;TRMT6;OSGEP;CDKAL1;WDR4;ALKBH8;METTL6;TRMT12;LCMT2;NSUN6;PUSL1
prerank,presynapse assembly (GO:0099054),-0.42302424067442423,-1.2720124305313945,0.14102564102564102,0.658680540246288,1.0,6/16,10.25%,IL1RAPL1;NLGN1;PTPRD;LRRTM3;WNT5A;BSN
prerank,cellular response to topologically incorrect protein (GO:0035967),0.4907297023494311,1.2719146347732528,0.155011655011655,0.5040851437690211,1.0,14/31,27.68%,OPTN;DAXX;DNAJB14;ERN1;ATXN3;BAX;HSPA8;HSPA9;HSF1;BAG3;HSPA5;HSPA2;PACRG;DNAJB12
prerank,regulation of receptor recycling (GO:0001919),0.5510748318043024,1.271802653094575,0.17503217503217502,0.5038516129371695,1.0,7/16,28.35%,OPTN;TRAT1;ECE1;TBC1D16;KIF16B;VAMP3;LAMTOR1
prerank,secondary alcohol metabolic process (GO:1902652),0.45887813254425336,1.2717735246198512,0.13157894736842105,0.503383085271579,1.0,11/42,19.63%,APOE;ABCG1;ABCA1;APOA2;SOAT1;PPARD;SOAT2;CH25H;GBA2;IDH3A;SULT2B1
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.44588811437702797,1.2716791474431652,0.13616557734204793,0.5031315387338512,1.0,14/52,17.16%,LGALS3;PRKCH;LRP1;SQSTM1;PDPK1;TREM2;STAC2;RANGRF;RHOG;STX3;NUMA1;SORBS1;CNPY4;ITGA3
prerank,positive regulation of mitochondrial translation (GO:0070131),0.5532173052030003,1.2710960324370222,0.174496644295302,0.5043427352405722,1.0,11/14,35.13%,TRUB2;TRMT10C;RCC1L;C1QBP;FASTKD3;MRPS27;RPUSD4;FASTKD2;RMND1;NGRN;UQCC2
prerank,regulation of cell projection organization (GO:0031344),0.5673103477464789,1.2709968193665548,0.15261044176706828,0.5040770726424025,1.0,3/13,7.29%,MACF1;FAM110C;TREM2
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.40652897539940464,1.2708922131447582,0.006,0.5038244608619536,1.0,93/390,16.66%,BCAR3;IGF1;FLT1;LCK;CYBA;STAP1;NRP2;CD3E;CSF1;TCIRG1;SDCBP;ATP6V1C1;ATP6V0D2;CD8B;ARPC2;ATP6V1A;CD4;FGR;CYBB;CD8A;ARPC3;ATP6V0A1;ATP6V1B2;ARPC5;PDGFA;PIK3CB;AXL;NRG1;CD7;SH2D2A;NR4A3;PTK2B;MMP9;NRP1;NEDD9;FGF2;ATP6V0D1;ATP6V0B;ATP6V1G1;NCK2;BLNK;MTSS1;GRB2;NCK1;HNRNPM;VEGFA;ANGPT1;CLNK;ACTG1;IGF1R;POLR1G;POLR2H;PSEN2;RHOQ;MAPKAPK3;CYFIP2;MVP;ATP6AP1;MAPKAPK2;NCF4;PTPN2;FGF7;FYN;ANGPT2;FGF20;ATP6V1F;RHOA;NAMPT;CDC42;PAK2;GTF2F1;EFNA1;GHR;ROCK1;AAMP;ACTR3;FGF18;ACTB;GIT1;POLR2D;IL31RA;PRKD2;RBFOX2;CBL;SORBS1;ARPC1B;FOXO1;SYK;EFNB2;KDR;KALRN;RASA1;PIK3R2
prerank,nucleic acid metabolic process (GO:0090304),0.43726897165779505,1.2705896501463905,0.11063829787234042,0.5042535436410793,1.0,27/69,24.78%,HNRNPA3;HNRNPM;XRN2;POLR2H;HNRNPC;METTL3;RAD50;DDX1;DXO;HNRNPK;GTF2F1;DNASE2;HNRNPA2B1;POLR2D;RBFOX2;PCBP1;DUSP11;HNRNPU;HNRNPF;ATXN2;POLG;RECQL5;DNASE1L1;SETMAR;TOPBP1;POLR2F;HNRNPL
prerank,peptidyl-lysine dimethylation (GO:0018027),0.5343036492657771,1.270438381407074,0.16981132075471697,0.5042047317866127,1.0,11/18,33.57%,KMT2A;PRDM9;SETD1A;SMYD2;EHMT1;SETMAR;KMT2D;ASH1L;SUV39H2;KMT2B;SETD2
prerank,glycoprotein metabolic process (GO:0009100),0.448376499956666,1.2703808207006815,0.10694597574421169,0.5038387955337567,1.0,11/53,11.00%,B4GALT5;HIF1A;MAN1C1;LARGE1;B4GALT7;TNIP1;ADAMTS13;STT3B;ST8SIA6;OGA;ERP44
prerank,negative regulation of viral genome replication (GO:0045071),0.4732678286190945,1.2702817186033988,0.13489409141583056,0.5035932050727688,1.0,16/40,21.47%,LTF;SHFL;SRPK1;TNIP1;TRIM6;IFITM2;IFITM1;RNASEL;CCL5;ILF3;RSAD2;ZC3HAV1;ISG20;BST2;RESF1;SRPK2
prerank,regulation of telomerase activity (GO:0051972),0.45871717836700066,1.269909222320169,0.13134657836644592,0.5041738414643749,1.0,19/45,30.69%,CTNNB1;PRKCQ;PARP4;CCT2;NVL;PKIB;ERCC4;ATM;PTGES3;TERF1;HSP90AB1;ACD;DKC1;MAPK15;MAPK3;PARM1;XRCC5;PNKP;MAPK1
prerank,regulation of viral entry into host cell (GO:0046596),0.4891343948753632,1.2699032611658645,0.13365155131264916,0.5036381220854346,1.0,8/30,11.96%,LGALS1;CD4;TRIM6;TMPRSS2;IFITM2;P4HB;IFITM1;GSN
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.4837735649418206,1.2697162642148743,0.14965986394557823,0.5036824233961038,1.0,10/33,12.09%,APOE;HRG;FGF2;PPARG;ANGPT4;CARD10;JUP;ANGPT2;DLL4;RHOA
prerank,cellular response to alkaloid (GO:0071312),-0.42816732278947084,-1.2696546236054305,0.16,0.6601510921474885,1.0,4/17,6.83%,RYR3;TGM2;CASP3;CASP6
prerank,cellular response to fatty acid (GO:0071398),0.5757401856882282,1.2688412977225096,0.16955941255006676,0.5057542561704421,1.0,1/12,0.31%,LPL
prerank,response to insulin (GO:0032868),0.4300738329783451,1.2687190683260217,0.09947643979057591,0.5055550107760947,1.0,23/80,18.53%,MYO5A;EPRS1;SLC27A1;PKM;HDAC9;EIF6;GCK;PPARG;SLC25A33;PDPK1;CPEB2;ZBTB7B;DENND4C;RHOQ;RAB8A;RAB8B;PCK2;OGT;SORBS1;FOXO1;PIK3R2;VAMP2;EPM2AIP1
prerank,cellular response to osmotic stress (GO:0071470),-0.38987111939893987,-1.268302845587203,0.14583333333333334,0.658609809963209,1.0,5/21,10.90%,CAPN3;RCSD1;SCN2A;WNK3;TRPV4
prerank,defense response to fungus (GO:0050832),0.5390938225018491,1.2680939584272806,0.18467336683417085,0.5068741398301958,1.0,4/17,3.34%,S100A8;S100A9;LTF;HRG
prerank,actin polymerization or depolymerization (GO:0008154),0.4564548330572051,1.2676692143165562,0.1301969365426696,0.5076084808717922,1.0,19/50,25.44%,MICAL2;GAS7;CAPG;SCIN;MICAL1;MSRB1;WASHC5;CORO7;ARHGAP6;DIAPH1;GSN;SVIL;MICALL2;EVL;CFL1;ABI1;WAS;JAK2;ABI2
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.6017620792314835,1.267555122062705,0.18387553041018387,0.5074335653751391,1.0,5/10,25.17%,RUNX1;ZBTB7B;HMGB1;RUNX3;NCKAP1L
prerank,amino acid import (GO:0043090),0.5136663902898245,1.2674307993837484,0.17590361445783131,0.5072780150359635,1.0,7/21,19.07%,SLC6A6;SLC7A1;SLC6A14;SFXN1;SLC7A8;SFXN2;SLC16A2
prerank,chromosome organization (GO:0051276),0.42778671349749764,1.2673196992465434,0.08290155440414508,0.5070681537807933,1.0,40/99,29.91%,UBA52;RPS27A;COPS3;DOT1L;SATB1;COPS4;COPS8;HDAC1;MTF2;GEM;HMGN1;DDB2;DDB1;COPS2;XPA;COPS6;PHF1;CENPT;RAE1;EHMT1;GATAD1;TCF7L1;UBC;LATS1;XPC;MTHFR;HDAC11;HDAC2;SMARCA4;CUL4A;CETN2;HDAC3;NUP133;H3-3A;SUPT4H1;SAFB;SIRT1;CENPH;HMGB2;COPS7A
prerank,regulation of protein import into nucleus (GO:0042306),0.4734370212197136,1.2670306213772549,0.1555806087936866,0.507423610452264,1.0,17/36,26.03%,MDFIC;FLNA;PRKCD;IPO5;TRIM28;CDH1;UFM1;JUP;TPR;CHP1;PIK3R2;BMP4;SUFU;BAG3;RBM22;HDAC3;ZPR1
prerank,positive regulation of telomerase activity (GO:0051973),0.47750878071953307,1.2669471786061774,0.16357308584686775,0.5071361456404733,1.0,15/33,30.69%,CTNNB1;PRKCQ;CCT2;NVL;PKIB;PTGES3;HSP90AB1;ACD;DKC1;MAPK15;MAPK3;PARM1;XRCC5;PNKP;MAPK1
prerank,regulation of actin filament polymerization (GO:0030833),-0.3026559338374751,-1.2665903774832932,0.06382978723404255,0.6581415066705723,1.0,10/69,4.91%,SSH2;CYRIB;FCHSD2;BIN1;PRKCE;FER;KANK1;TWF2;CARMIL1;NCKAP1
prerank,DNA catabolic process (GO:0006308),0.5949816394404197,1.266170643946824,0.17718120805369128,0.5090415555822416,1.0,5/11,21.92%,XRN2;DFFB;ISG20;DNASE1L1;SETMAR
prerank,regulation of interferon-gamma production (GO:0032649),0.4332132821741314,1.2658905024827074,0.10714285714285714,0.5093415050259043,1.0,25/71,21.74%,SIRPA;IL18R1;CD226;CD2;AXL;IL27;IL12RB1;CD274;PTPN22;TXK;RASGRP1;LILRB1;CRTAM;CCR2;GAS6;DDIT3;HSPD1;CEBPG;C1QBP;RIPK3;HAVCR2;SLC11A1;HMGB1;LAPTM5;CD47
prerank,regulation of spindle assembly (GO:0090169),0.5056788812432138,1.2657234454528357,0.1553973902728351,0.5093523920343568,1.0,9/25,18.99%,DYNC1H1;CHMP4B;PDCD6IP;VPS4B;DRG1;NUMA1;TPR;HNRNPU;CCSAP
prerank,response to glucose (GO:0009749),0.45547052651123504,1.2656652905176744,0.13318534961154274,0.5089798672264525,1.0,12/46,17.65%,LPL;ADCY8;GCK;APOA2;ERN1;IGF1R;PFKL;RACK1;PCK2;GAS6;VAMP2;EIF2B2
prerank,stress-activated MAPK cascade (GO:0051403),0.44624446284304403,1.2653315060051336,0.11063372717508056,0.5094382925664446,1.0,21/61,22.37%,UBA52;IRAK2;RPS27A;MAPK13;DUSP9;MAP4K2;MAP4K3;CRKL;TAB1;TNIP2;MAP3K12;NFKB1;MAPK9;MINK1;MAP2K3;MAP3K8;UBC;FBXW11;SH2D3C;CUL1;PTGER4
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.5653587763031861,1.2653035378878448,0.2052980132450331,0.5089890878103118,1.0,5/13,13.33%,GIMAP7;AK4;AK3;RHOQ;EFL1
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.4851364850550751,1.26507934355641,0.1625,0.5091328441495817,1.0,5/31,9.33%,GPNMB;SPN;CD274;LILRB1;CD300A
prerank,regulation of programmed necrotic cell death (GO:0062098),0.5279586103200853,1.2647148109740742,0.15206812652068127,0.5096833905190298,1.0,10/20,28.03%,SDCBP;MLKL;PDCD6IP;FLOT2;OGT;RIPK3;ASAH1;BIRC2;PELI1;RIPK1
prerank,mitochondrion transport along microtubule (GO:0047497),0.5628784396230343,1.2646623670325432,0.18791064388961892,0.5092772573249779,1.0,3/13,3.66%,UXT;HIF1A;MGARP
prerank,histone H3 deacetylation (GO:0070932),0.5564851325427844,1.264575269024803,0.17237008871989862,0.509018418067198,1.0,8/15,31.23%,HDAC9;HDAC4;HDAC1;ELK4;HDAC2;HDAC3;SIRT1;SIRT2
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.44029592506395454,1.264519740230407,0.13528138528138528,0.5086380731654885,1.0,20/62,24.05%,BCL2;BCL2L1;NFE2L2;PLAUR;MCL1;MMP9;HSPB1;NOC2L;TPT1;ENO1;YBX3;PPIA;CLU;CCAR2;ARHGEF2;SOD2;EPO;MAPK7;DNAJA1;MDM2
prerank,regulation of protein modification process (GO:0031399),0.45304218331043317,1.2643708473767274,0.1299126637554585,0.5085738171025613,1.0,13/50,20.14%,FNIP2;FN1;CORO1C;CCDC88C;ATG7;HSPB1;CADM4;HPF1;KDM4D;ASPSCR1;PIN1;CCAR2;SPRED2
prerank,positive regulation of protein phosphorylation (GO:0001934),0.4060307379595645,1.2641322636697025,0.01,0.5088081683609108,1.0,78/348,18.40%,GPNMB;BCAR3;IGF1;FNIP2;CSPG4;IQGAP1;CSF1;SDCBP;RAP2A;FPR2;PLAUR;PTPRC;CD4;LAT;ITGA5;TEC;PDGFA;CD44;EIF4G1;ALS2;BMP8B;TRIM6;GDF6;SPHK1;CLDN19;PTK2B;NPTN;MMP9;RAF1;NRP1;FGF2;CAV1;DAXX;ANGPT4;MYDGF;DAB2;SOX9;VEGFA;CRKL;ANGPT1;TREM2;RASGRP1;ILK;ADAM17;P2RY1;RACK1;KRAS;FGF7;C3;RAD50;RBPMS;FGF20;GAS6;PAK2;EFNA1;GHR;JTB;FGF18;CAB39;PPIA;STOX1;PRKD2;CSNK1D;DOCK7;CLEC6A;TFRC;CCND2;KDR;FXR2;MAP2K3;BMP6;DDR2;PRKAG1;RALB;HAX1;PIN1;TESK1;IL6
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.45130429192986116,-1.263986618348393,0.19183673469387755,0.6601622880931459,1.0,5/14,8.35%,PIK3R1;STAT5A;PRLR;STAT3;PTK2
prerank,tetrahydrofolate metabolic process (GO:0046653),0.6075270659111067,1.2634231250670256,0.1917989417989418,0.5104965805748832,1.0,8/10,35.11%,MTHFD2;MTHFS;SHMT1;MTHFD1;MTHFR;SHMT2;MTHFD1L;TYMS
prerank,positive regulation of cell motility (GO:2000147),0.4073723799009294,1.2633016994011894,0.0320962888665998,0.5103144684724161,1.0,33/205,11.95%,GPNMB;PLAU;IGF1;FLT1;ITGAX;CSF1;SDCBP;MGAT5;FGR;LEF1;GCNT2;PDPN;PDGFA;FAM110C;SPHK1;PTK2B;MMP9;NEDD9;CAV1;FAM83H;DAB2;VEGFA;RHOD;ACTG1;IGF1R;SPAG9;ADAM17;RACK1;RUFY3;MYOC;CCL7;CCL5;PHPT1
prerank,regulation of histone methylation (GO:0031060),0.5680150853547407,1.263268303399485,0.18072289156626506,0.5098538347102416,1.0,8/13,28.15%,TTLL12;FAM47E;CHTOP;PAF1;MTHFR;NSD1;PIH1D1;CTR9
prerank,telomere maintenance via telomerase (GO:0007004),0.49414834006368963,1.2632614033695486,0.15456674473067916,0.5093319110950136,1.0,13/28,22.41%,ANKRD28;RAD50;GAR1;CDK2;PPP6C;RFC1;RTEL1;PTGES3;TERF1;HSP90AB1;ACD;DKC1;TERT
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.5778981221663649,1.2626611827979979,0.18503937007874016,0.5100816281989157,1.0,6/11,31.26%,SRI;CALM3;FKBP1B;GSTO1;FKBP1A;CALM1
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.5778981221663649,1.2626611827979979,0.18503937007874016,0.5100816281989157,1.0,6/11,31.26%,SRI;CALM3;FKBP1B;GSTO1;FKBP1A;CALM1
prerank,midbody abscission (GO:0061952),0.5357989905384926,1.2625152783972733,0.18306351183063513,0.5099510322071694,1.0,6/17,13.36%,CHMP4A;CHMP4B;PDCD6IP;VPS4B;CHMP7;KIF20A
prerank,peptidyl-lysine trimethylation (GO:0018023),0.49898046504811394,1.2624675574217188,0.15529411764705883,0.5095552595728221,1.0,10/26,24.28%,KMT2A;ETFBKMT;TET3;KMT5B;PRDM9;OGT;SETD1A;EEF2KMT;KMT2D;SMYD5
prerank,bone development (GO:0060348),0.46127456580258974,1.2623058588555731,0.14972067039106146,0.5095167929495835,1.0,12/39,23.93%,SH3PXD2B;PTPRC;LTF;AKAP13;P3H1;MYOC;LRP6;MBTPS2;PTGER4;FGFR3;GNAS;FGFR2
prerank,amino acid import across plasma membrane (GO:0089718),0.5037491845099324,1.2621408170481405,0.1644657863145258,0.5094566960750386,1.0,8/24,22.29%,SLC3A2;SLC6A6;SLC7A1;SLC6A14;SLC1A5;SLC7A8;SLC16A2;SLC7A2
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.4293126006777487,1.2620509040752574,0.07564766839378238,0.509193933678514,1.0,40/94,29.43%,PSMD8;PSMD1;UBA52;IRAK2;RPS27A;SQSTM1;TAB1;PSMD6;PSMA1;PSMC3;PSMA8;TNIP2;PSMD14;PSMD2;NFKB1;PSMC6;PSMA6;IL1R2;PSMD5;MAP3K8;PSMA5;UBC;FBXW11;CUL1;IRAK4;EGR1;PSMA3;PSMB8;PSMB10;PSMD7;PELI1;PSMB6;BTRC;PSMD10;PSMB5;PSMB7;MAPK3;IL1R1;PSMC4;TAB2
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.5897218879168009,1.2620271002789334,0.1753681392235609,0.5087291525648672,1.0,7/12,36.82%,NCOR2;PPARG;TERT;TNF;ZC3H12A;ELAVL1;TGFB1
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.43574225957238183,1.2614807477274244,0.113107822410148,0.5099513528020643,1.0,19/74,20.14%,CTNNB1;SDCBP;DAG1;LEF1;GCNT2;PDPN;GLIPR2;DAB2;GATA3;NKX2-1;BAMBI;PHLDB1;SMAD7;EFNA1;ADIPOR1;IL6;FERMT2;BMP5;SPRED2
prerank,response to chemokine (GO:1990868),-0.45968100069546314,-1.2612856242693282,0.2127659574468085,0.6624216514150814,1.0,4/13,5.53%,DOCK8;LRCH1;WNK1;SLC12A2
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.481136618991746,1.2611428672674554,0.16996507566938301,0.5105126269047909,1.0,8/29,11.17%,STAP1;KLRC2;CD226;IL12RB1;CADM1;RASGRP1;KLRK1;CRTAM
prerank,glial cell differentiation (GO:0010001),-0.3517456074335921,-1.2607262335446485,0.12213740458015267,0.6589692037337229,1.0,11/28,15.00%,FGF10;SLC8A3;SOX8;ADGRG6;STAT3;CDH2;ERBB3;PAX2;GPC1;NFIB;TPPP
prerank,membrane lipid biosynthetic process (GO:0046467),0.44360042458259674,1.2606926676265495,0.13177470775770456,0.511309199358565,1.0,21/58,24.41%,SGMS1;SPHK2;SPHK1;HACD2;CERS6;SPTSSA;PLPP3;ST8SIA6;HACD1;KDSR;PRKD2;VAPB;ALDH3A2;ALDH3B1;ELOVL2;SAMD8;ELOVL1;ST3GAL2;SPTLC3;PRKD3;GBGT1
prerank,response to hydroxyurea (GO:0072710),0.5866721874078504,1.2606918231858764,0.17103448275862068,0.5107686369709485,1.0,4/11,18.23%,DDI2;BLM;ATRX;KAT7
prerank,regulation of interleukin-6 production (GO:0032675),0.42267862171724546,1.2606051875684998,0.08565531475748193,0.5104824480279838,1.0,36/96,26.46%,RAB7B;LPL;CYBA;MMP8;SIRPA;NLRC3;SPHK2;MAPK13;FOXJ1;PTPN22;CD200R1;TREM2;MAPKAPK2;POU2AF1;GAS6;MBP;HSPD1;TMEM106A;SYK;TIRAP;IL6;DHX9;SCIMP;ARHGEF2;HMGB1;LBP;CD47;F2R;IL17RA;CD74;IL17D;TNF;NCKAP1L;CX3CL1;TLR9;PTPN6
prerank,import into cell (GO:0098657),0.46302520576753264,1.2599620248751817,0.14905450500556172,0.5118943986942432,1.0,14/41,19.07%,LRRC8C;SLC27A1;SLC38A1;SLC6A6;SLC7A1;SLC6A14;SLC46A1;TREM2;SLC12A4;ATP1A2;SLC7A8;SLC5A3;SLC19A1;SLC16A2
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.49621468651202677,1.2598112369766696,0.16987951807228915,0.5118237599216385,1.0,15/25,30.07%,DNAJB14;ERO1A;GAK;SDF2L1;DNAJB13;HSPA8;HSPA9;DNAJB1;PTGES3;HSPE1;HSPA5;ST13;HSPA2;DNAJB12;SDF2
prerank,calcium ion transport into cytosol (GO:0060402),-0.4019137713572972,-1.2597158578788954,0.15476190476190477,0.656733212408633,1.0,9/21,22.16%,CACNA2D1;GRIN2A;GRIN2B;TRPV4;GRIN1;CACNA1C;ADRA1A;TRPM2;TRPM1
prerank,positive regulation of epithelial cell migration (GO:0010634),0.4214407670320528,1.2596911870964258,0.10740354535974973,0.5116544472843442,1.0,25/92,18.68%,HIF1A;NRP2;IQSEC1;SASH1;PIK3CB;GLIPR2;PTK2B;MMP9;NRP1;FGF2;ANGPT4;GATA3;SOX9;VEGFA;ANGPT1;RIN2;FGF7;DOCK5;AAMP;PRKD2;KDR;ANXA3;GPI;RAB11A;ITGB1BP1
prerank,muscle cell development (GO:0055001),0.4844557004623144,1.2595620204603641,0.17149478563151796,0.511500513889995,1.0,4/30,7.03%,IGF1;MYOF;FER1L5;VEGFA
prerank,regulation of wound healing (GO:0061041),0.45811935960258837,1.259372568646735,0.15730337078651685,0.5115612846603914,1.0,9/42,11.33%,PLAU;ANXA1;HRG;CLDN19;FGF2;CAV1;ACTG1;CADM4;SERPINE1
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.4593833275036946,1.2590821543846582,0.15955056179775282,0.5118885501891058,1.0,8/41,12.81%,IGF1;SIRPA;NLRC3;POMC;PTPN22;LILRB1;ILRUN;GAS6
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.40871010976054856,1.2590549194247629,0.0482897384305835,0.5114492598015868,1.0,40/182,14.42%,IGF1;APOBEC1;APOE;HIF1A;CD3E;MMP8;SDCBP;SMCR8;AGO2;XDH;OPTN;ID2;TRIM6;CILP;VDR;CLDN19;FBXW7;FGF2;CD28;RUNX1;PTPN22;TRAT1;VEGFA;CRKL;DNMT1;HDAC1;NOCT;CELF1;FLOT2;DIP2A;RACK1;ANKRD13B;LRPAP1;ZNF148;DLL4;TLE5;TIPARP;YY1;STOX1;NFKB1
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.5725133400759956,1.2588542376394567,0.18655692729766804,0.5115643878853682,1.0,7/12,29.07%,CSPG4;DCN;BGN;CHST12;CSPG5;DSEL;DSE
prerank,intracellular lipid transport (GO:0032365),0.5171431379061421,1.258789441167126,0.18214716525934863,0.511205346288494,1.0,9/21,19.13%,ACACA;ABCD4;ARV1;ABCD2;MID1IP1;ABCD3;CPT2;ACACB;NPC2
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.4257846031973941,1.2586269901908924,0.12054507337526206,0.5111616116974107,1.0,37/76,29.83%,MALT1;TANK;TNIP1;SPHK1;FBXW7;PRICKLE1;HDAC4;CAV1;ANGPT1;UBE2L3;BRCA1;HUWE1;SMAD7;DCUN1D2;CENPX;UBQLN1;DERL1;WFS1;GNL3;CUL3;PIAS1;SAE1;DCUN1D4;LAPTM5;RWDD3;WDR48;BIRC2;DCUN1D3;HDAC3;PIAS4;CENPS;PSMD10;GSK3A;PTTG1IP;FKBP1A;RCHY1;MUL1
prerank,regulation of tumor necrosis factor production (GO:0032680),0.41624037369966377,1.2579666803785827,0.0736949846468782,0.5126539481586929,1.0,33/112,21.74%,IGF1;LPL;CYBA;MMP8;SIRPA;NLRC3;PTPRC;LTF;SPN;SPHK2;CD2;POMC;HSPB1;PTPN22;RASGRP1;LILRB1;MAPKAPK2;ARFGEF2;CCR2;ILRUN;GAS6;CLU;TMEM106A;SYK;TIRAP;IL6;DHX9;HAVCR2;ARHGEF2;HMGB1;FRMD8;LBP;CD47
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.42467168622401663,1.2578581330662209,0.09773662551440329,0.5124534385120366,1.0,22/100,16.15%,IGF1;FLT1;FN1;NLRC3;FGR;PDGFA;PIK3CB;FGF2;PPP2R5C;MYDGF;PIK3R5;SOX9;TREM2;IGF1R;PIP5K1C;MYOC;CCL5;PTPN13;ENTPD5;DCN;CBL;KDR
prerank,cellular response to decreased oxygen levels (GO:0036294),0.44030063184921814,1.2577209809748269,0.10932475884244373,0.5123532647019791,1.0,24/65,25.76%,HIF1A;ADAM8;MGARP;CPEB4;ANGPT4;CPEB2;AK4;VEGFA;P4HB;LMNA;PGK1;HMOX1;HP1BP3;NDRG1;UBQLN1;PTGIS;EGLN1;EGLN3;TERT;BNIP3;CPEB1;MDM2;SFRP1;ACAA2
prerank,mitochondrial transport (GO:0006839),0.4442680285266774,1.2574878502648463,0.1282608695652174,0.512524069241257,1.0,17/53,24.81%,BCL2;BCL2L1;SLC25A24;TOMM22;MGARP;TIMM44;TIMM9;TOMM5;TOMM40;SLC25A31;TMEM14C;FBXO7;TIMM17A;PITRM1;TIMM23;BNIP3;FLVCR1
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.4103703634799765,1.2571673528340717,0.03507014028056112,0.5130116776555895,1.0,72/214,26.46%,GPNMB;APOE;FN1;FPR2;SIRPA;PTPRC;CD4;CCL4;GCNT2;TNIP1;PDGFA;CD44;ALKAL2;DUSP9;GLIPR2;PTK2B;FBXW7;NRP1;FGF2;MFHAS1;PTPN22;APIP;CRKL;ANGPT1;TREM2;RASGRP1;CCL13;P2RY1;ATP6AP1;RANBP9;PTPN2;DUSP6;CCL7;CCL5;FBLN1;CNKSR3;MAP3K12;GAS6;ABCA7;CCL14;PRKD2;DUSP3;SYK;TIRAP;KDR;C5AR1;SERPINF2;PIN1;ITGB1BP1;FERMT2;FAM83D;SCIMP;HMGB1;SPRED2;EMILIN1;LMO3;FGFR3;ARHGEF5;F2R;HTR2B;CD74;MIF;FGFR2;SPRED3;TNF;PDGFRA;PLA2G5;CX3CL1;YWHAZ;DSTYK;GPR183;PTPN6
prerank,peptidyl-asparagine modification (GO:0018196),0.48122376254666677,1.2565873978539732,0.14930555555555555,0.5142633249014097,1.0,9/31,19.11%,MGAT5;DERL3;MAGT1;STT3B;LMAN1;MCFD2;ST6GAL1;TUSC3;DDOST
prerank,defense response to virus (GO:0051607),0.4180846683275255,1.256569450784886,0.09352517985611511,0.5137784985304977,1.0,27/100,19.49%,LYST;BCL2;BCL2L1;FLNA;ATG7;PTPRC;SHFL;MLKL;AGBL5;EXOSC4;IFITM2;AKAP1;PRF1;IFITM1;LILRB1;RNASEL;ATAD3A;ZDHHC1;RSAD2;ACOD1;RIPK3;ISG20;IL6;RNASE6;EXOSC5;BST2;IFIT2
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.5006809470273941,1.2561926704815753,0.18226600985221675,0.5143986363766979,1.0,10/22,24.73%,SPHK2;TRIM6;APOA2;LILRB1;CCR2;TNFRSF1B;SCIMP;LAPTM5;TNF;BTK
prerank,cellular response to cytokine stimulus (GO:0071345),0.3981711248554686,1.2561757955803405,0.005,0.5139294641733657,1.0,118/416,20.16%,BCL2;LCK;HIF1A;FN1;ITGAX;LCN2;ABL2;CSF1;BCL2L1;TCF7;IL2RB;EPRS1;SIRPA;GRAP2;NFE2L2;IL18R1;ANXA1;CD4;CSF2RA;LEF1;UBA52;TEC;IRAK2;TANK;CCL4;RPS27A;VIM;MCL1;MUC1;PIK3CB;OSMR;PDE1B;AXL;STAT4;MAPK13;TRIM6;RUFY4;POMC;RIPOR2;PTPN23;MMP9;PLP2;FGF2;IL3RA;IL12RB1;IFITM2;BCL6;GATA3;GRB2;SOX9;ERBIN;VEGFA;CRKL;IRGC;IL27RA;BCL2L11;INPPL1;SMPD4;CCL13;IRF8;BRCA1;PTPN2;HMOX1;FYN;SOCS5;SHMT1;NPR2;PIM1;CEBPA;CCR2;CCL7;PTPN12;JAK1;CCL5;IRF5;TNFRSF1B;RHOA;RHOU;GAS6;HSPA8;PTPN13;GHR;YBX3;STX3;BIRC5;CCL14;SYNCRIP;IL31RA;NFKB1;DAPK1;CBL;TPR;ITGB2;ACOD1;LAMA5;FOXO1;SYK;SIGIRR;GBP2;IL1R2;AQP4;SBNO2;HNRNPU;DAPK3;HAX1;IL6;RPL13A;DHX9;ASAH1;IL2;CNTFR;PTGIS;GAB2;MT1X;ARHGEF2;UBC;IL5;RPS3
prerank,aggrephagy (GO:0035973),0.49495631564438497,1.2557139846778356,0.17942583732057416,0.514842571945808,1.0,11/27,24.26%,UBA52;RPS27A;VIM;SQSTM1;DYNC1H1;UBQLN1;DYNC1LI2;IFT88;UBC;ACBD5;WDFY3
prerank,positive regulation of lymphocyte activation (GO:0051251),0.48603466025533015,1.2556417763167433,0.16430260047281323,0.5145383583954976,1.0,12/28,25.90%,LCK;SIRPA;PRKCQ;SH3KBP1;TICAM1;CCR2;TNIP2;HSPD1;IL6;CD47;NCKAP1L;TLR9
prerank,melanosome organization (GO:0032438),0.49469573398162775,1.2551015218571073,0.18257756563245822,0.5156521878244161,1.0,9/26,19.39%,LYST;BLOC1S3;TYRP1;DTNBP1;RAB32;HPS1;AP1G1;AP3D1;PIKFYVE
prerank,protein alkylation (GO:0008213),0.5065698006485848,1.255028587345832,0.187422934648582,0.5153793254876181,1.0,8/22,21.33%,ETFBKMT;ETF1;METTL22;PRMT2;GSPT1;FAM98A;EEF2KMT;PRMT3
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.40332650592666913,1.2547290066930854,0.023023023023023025,0.5157480648518713,1.0,61/234,20.56%,RAB7B;S100A8;CTNNB1;S100A9;PRKCH;IL18R1;LTF;PRKCQ;IL18RAP;MALT1;ARID5B;ADCY8;UBA52;IRAK2;TRAF2;RPS27A;ADAM8;TRIM6;SPHK1;HDAC4;CAV1;PPARG;PLPP3;STK3;IKBKE;VEGFA;PRKCB;TAB1;FLOT2;TICAM1;TRAF1;JUP;SMARCB1;CRTC1;PPARGC1B;FZD1;FZD4;PPIA;DDIT3;NFKB1;PRKD2;CLU;LRP6;NHLH2;SRF;CEBPG;PSMA6;TFRC;TIRAP;ANXA3;DDR2;RIPK3;MBTPS2;DHX33;IL6;DHX9;ARHGEF2;UBC;RPS3;MTDH;RIPK4
prerank,positive regulation of chromosome organization (GO:2001252),0.5437560871621214,1.2546103636493091,0.20408163265306123,0.5155732976226669,1.0,6/15,18.50%,RAD50;DHX36;PPP1R10;ATRX;GNL3;RTEL1
prerank,mitochondrial fusion (GO:0008053),0.5280729152728284,1.254438468474934,0.18424396442185514,0.5155289314337144,1.0,10/18,32.17%,THG1L;BAX;AFG3L2;STOML2;USP30;SPG7;FIS1;MFF;MIGA2;MFN1
prerank,epithelial to mesenchymal transition (GO:0001837),0.4475183202238189,1.2534271207506475,0.14096916299559473,0.5180566111384735,1.0,7/47,8.76%,CTNNB1;HIF1A;LEF1;EOMES;TRIM28;SOX9;DDX17
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.4621018652852019,1.2530368173540265,0.16147635524798154,0.5187465640190744,1.0,14/36,23.69%,HIF1A;CSF1;CD300LF;AXL;TRIM6;TXK;ADAM17;GAS6;CASP4;AGPAT2;LAPTM5;NLRC5;CD74;AGPAT1
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.5454955421781269,1.2529473637474189,0.18242343541944075,0.5184972972968477,1.0,7/15,21.23%,TTLL12;PTPN2;METTL3;YTHDF3;YTHDF2;USP18;NLRC5
prerank,regulation of mitotic cell cycle (GO:0007346),0.40924250497071585,1.2529129468013616,0.05639476334340383,0.5180856130191985,1.0,58/171,27.52%,IQGAP1;SDCBP;PSMD8;PSMD1;SPHK1;TTLL12;ANAPC15;SIK1;BRINP2;FZR1;FBXO5;PSMD6;PSMA1;DYNLT3;CDK13;DDB1;CCNB1;PSMC3;CUL9;PRMT5;PSMA8;TFAP4;CDK11B;ANAPC1;PKN2;PSMD14;PSMD2;RCC1;PSMC6;DUSP3;PSMA6;PSMD5;HNRNPU;NEK6;DAPK3;PSMA5;CDC26;PIN1;BUB1B;RNF20;CUL1;HSF1;CKS2;ANAPC7;XPC;PSMA3;MDM2;USP2;PSMB8;CDC25B;PSMB10;PSMD7;UBE2C;PSMB6;BTRC;PSMD10;EIF4E;PSMB5
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.48114474805192475,1.2528850074334725,0.1716937354988399,0.5176445153302234,1.0,13/30,32.21%,NIBAN2;HNRNPC;EXOSC10;ERCC4;HNRNPU;DACH1;TERF1;ACD;XRN1;NAT10;TENT4B;TERF2;DCP2
prerank,regulation of dendritic spine development (GO:0060998),-0.4046232736419372,-1.2528167589591712,0.1702127659574468,0.6715911255681714,1.0,9/19,13.99%,TANC2;MEF2C;NLGN1;PSEN1;SHANK3;PPFIA2;CAMK1;CAMK2B;DLG5
prerank,positive regulation of macrophage differentiation (GO:0045651),0.5885980060255095,1.2524178200345133,0.18518518518518517,0.5185915924083546,1.0,2/11,3.18%,CSF1;ID2
prerank,maturation of LSU-rRNA (GO:0000470),0.49236705883304827,1.252391799019304,0.14952153110047847,0.5181508793983045,1.0,10/26,24.33%,EIF6;RPL10A;NSA2;WDR12;MAK16;FTSJ3;DDX18;MRPL1;SNU13;RPL7A
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.479422502638169,1.2522692074005968,0.16276346604215455,0.5179929469833418,1.0,17/30,29.44%,BCL2L1;CD44;TPT1;THOC1;FBXO5;DDX39B;CLU;RTEL1;CCAR2;RPS3;CD74;MIF;MDM2;PSMD10;KDM1A;PTTG1IP;SIRT1
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.5386697561955761,1.2522547557820098,0.1813664596273292,0.5175173761985409,1.0,7/17,23.47%,STAP1;CDK5;NRP1;CDC42;HAX1;BAIAP2;BAIAP2L2
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.48974040023417964,1.2522450536303125,0.166270783847981,0.5170189003334668,1.0,5/27,10.08%,FGF13;CAV1;RANGRF;SRI;JUP
prerank,regulation of response to stress (GO:0080134),0.5962948018674801,1.25216080858888,0.1772853185595568,0.5167589060360699,1.0,5/10,20.37%,ADCY8;EIF4G1;STOX1;SLC38A2;MLC1
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.549695501150967,1.2520253078713799,0.21236559139784947,0.5166517203750302,1.0,9/13,30.83%,MGAT5;PTPRC;DOT1L;IL6;JAK2;HES1;PIGU;CRLF2;JAK3
prerank,positive regulation of actin filament polymerization (GO:0030838),-0.32103706156042494,-1.2517227410525515,0.09183673469387756,0.6696792451909698,1.0,9/44,7.61%,FCHSD2;BIN1;PRKCE;FER;SPIRE1;CARMIL1;NCKAP1;CDC42EP4;ARPC4
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.4390082664793463,1.251408234544686,0.12363238512035012,0.5175503843592025,1.0,21/51,29.16%,NUP205;PPP2R1A;CHMP4A;CHMP4B;AHCTF1;LMNA;LEMD2;CCNB1;NUP188;REEP3;CHMP7;RCC1;CHMP6;NUP93;SUMO1;IST1;NUP98;NUP133;NUP35;LBR;ANKLE2
prerank,mitotic nuclear membrane organization (GO:0101024),0.4390082664793463,1.251408234544686,0.12363238512035012,0.5175503843592025,1.0,21/51,29.16%,NUP205;PPP2R1A;CHMP4A;CHMP4B;AHCTF1;LMNA;LEMD2;CCNB1;NUP188;REEP3;CHMP7;RCC1;CHMP6;NUP93;SUMO1;IST1;NUP98;NUP133;NUP35;LBR;ANKLE2
prerank,negative regulation of GTPase activity (GO:0034260),-0.3853885902624935,-1.251359581660168,0.13259668508287292,0.6658314203804079,1.0,5/22,4.61%,F11R;LRCH1;WNK1;LRRK2;RCC2
prerank,DNA metabolic process (GO:0006259),0.40449491378281194,1.250919601705132,0.023046092184368736,0.5185477797414288,1.0,107/270,30.13%,DCTPP1;ORC3;UBA52;PARP4;RAD51B;RPS27A;DOT1L;MCM7;MCM2;ERCC1;NUDT1;IGHMBP2;DDX21;TRIM28;DNMT1;LIG1;NOC3L;POLE;RNASEH2A;GMNN;DDB2;ZRANB3;BRCA1;VCP;DDB1;MGMT;SMARCB1;RAD50;LONP1;RNASEH1;ALKBH1;XPA;DMC1;KMT5B;BLM;SP100;CDK2;MBD4;ADPRS;DNASE2;INO80;ERCC4;DFFB;SLX4;CDC7;BARD1;POLB;GLRX2;UBE2V2;WDHD1;CNBP;PURA;PARP3;RAD54L;RFC1;GTF2H1;ATM;RTEL1;RAD1;FANCA;PTGES3;POLG;TOP1;HMGB1;RAD51AP1;UBC;TERF1;MCM6;RECQL5;DBF4;NUDT15;MCM8;DNASE1L1;SRPK2;ALKBH3;NPM1;CDC34;ACD;SETMAR;TERT;POLE4;TOPBP1;POLA2;XPC;PARP2;RFC2;SUMO1;GADD45A;GEN1;LIG3;HMGB3;CENPS;TERF2IP;PDS5A;SUPV3L1;POLD4;ATR;MNAT1;RAD9A;HINFP;TICRR;CSNK1E;XRCC5;ASF1A;HMGB2;PARG;PNKP
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.4321937266512763,1.2509030934011014,0.12656903765690378,0.518062639045131,1.0,36/71,28.29%,MYO10;CD247;ARPC2;FGR;ARPC3;ARPC5;PIK3CB;CD3G;PRKCD;GRB2;WIPF1;NCK1;ACTG1;CYFIP2;FYN;LIMK1;CDC42;ACTR3;ACTB;ARPC1B;SYK;PIK3R2;FCER1G;BAIAP2;MYO1G;HSP90AB1;ABI1;WAS;VAV3;VAV1;NCKAP1L;YES1;NCKIPSD;CYFIP1;ACTR2;MAPK3
prerank,neuropeptide signaling pathway (GO:0007218),-0.3102660181413845,-1.250673720198883,0.09375,0.6627617178247726,1.0,19/58,20.25%,SORCS1;GLRA3;PPY;CPE;GPR37;CYSLTR1;RAPGEF2;SORL1;PENK;SORT1;GPR149;GLRA2;GLRA1;OPRD1;PDYN;SSTR2;NXPH2;NPY;NMU
prerank,cellular response to unfolded protein (GO:0034620),0.49500050548454666,1.2505262626901403,0.18105515587529977,0.5186101846195211,1.0,12/26,26.92%,OPTN;DAXX;ERN1;BAX;HSPA8;HSPD1;HSPA9;HSF1;BAG3;HSPA5;HSPA2;PACRG
prerank,RNA stabilization (GO:0043489),0.479615385360187,1.250308249454233,0.1765389082462253,0.5188168445627825,1.0,12/33,21.95%,TENT5C;NOCT;PABPC1;TAF15;LARP1;EIF4ENIF1;VIP;DHX36;HNRNPU;NSUN2;SLC11A1;DKC1
prerank,negative regulation of interleukin-6 production (GO:0032715),0.49699522988002975,1.2502452334610337,0.167458432304038,0.5184563331706253,1.0,12/27,27.90%,SIRPA;NLRC3;FOXJ1;PTPN22;CD200R1;GAS6;TNF;NCKAP1L;CX3CL1;TLR9;PTPN6;TNFAIP3
prerank,release of cytochrome c from mitochondria (GO:0001836),0.5354802499655856,1.2500216464385299,0.2066420664206642,0.5186144362778407,1.0,5/17,14.67%,BCL2;BCL2L1;BID;BAX;CLU
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.4883810146402756,1.2499499499959696,0.16748166259168704,0.5183246589598508,1.0,4/25,4.64%,STAP1;ARHGAP24;HRG;PRKCD
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.5338071142424712,1.2498388307736,0.18980891719745224,0.5181564723745604,1.0,4/18,14.97%,BCL2;BCL2L1;ALKBH7;SLC25A31
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.5819132735746592,1.2495899555239602,0.2020997375328084,0.5183922583445201,1.0,3/12,7.38%,NCOR2;DAB2;HDAC1
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.4930534688154149,-1.2495405596812388,0.19540229885057472,0.6610124854384907,1.0,3/10,1.63%,CACNB2;CACNA2D1;NOS1AP
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.4704068474185503,1.2495229198811841,0.14285714285714285,0.5180902735280934,1.0,17/36,28.82%,MACF1;OPTN;GOLGA4;RILPL2;NECTIN3;RAB7A;GCC2;GGA2;VAMP4;AFDN;VAMP2;RILPL1;GOLPH3;GGA1;GOLPH3L;RAB31;ARFRP1
prerank,lipid transport (GO:0006869),0.4184311333371496,1.2488038500179257,0.09856262833675565,0.5197345128465225,1.0,20/97,13.05%,OSBPL8;APOE;ABCG1;ABCA1;FABP5;SLC27A1;SLC27A5;ABCA4;ACSL1;GLTP;UGCG;PPARD;ABCA13;CLN3;TRIAP1;PITPNC1;ABCD2;OSBPL2;PRELID2;ABCA7
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.5329548178444342,1.248616951063959,0.17958656330749354,0.5198005019338824,1.0,4/17,6.78%,FOXN1;FGF2;FOXJ1;SOX9
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.5954682085395089,1.2485480748137985,0.21052631578947367,0.5190177494560322,1.0,6/10,26.09%,ASCC3;MGMT;ALKBH1;ALKBH3;ASCC1;ASCC2
prerank,DNA dealkylation (GO:0035510),0.5954682085395089,1.2485480748137985,0.21052631578947367,0.5190177494560322,1.0,6/10,26.09%,ASCC3;MGMT;ALKBH1;ALKBH3;ASCC1;ASCC2
prerank,carbohydrate transport (GO:0008643),0.5913885483786288,1.2481690925709563,0.19119669876203577,0.519643307030801,1.0,3/11,3.31%,SLC23A1;SLC23A2;SLC5A1
prerank,regulation of protein neddylation (GO:2000434),0.5931837717838954,1.248130594171758,0.17302452316076294,0.5192248943758365,1.0,5/10,24.79%,HIF1A;RPL11;DCUN1D2;DCUN1D4;DCUN1D3
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.4216099508527508,1.2480549150261433,0.11703239289446186,0.5189252045325958,1.0,20/78,17.16%,LGALS3;PRKCH;LRP1;BCL2L1;SQSTM1;CDK5;DAB2;PDPK1;TREM2;STAC2;RANGRF;RHOQ;CLN3;RHOG;TMBIM1;STX3;ACTB;SORBS1;CNPY4;ITGA3
prerank,digestive tract morphogenesis (GO:0048546),0.5408329114657666,1.2478237789143496,0.20801033591731266,0.519113436917684,1.0,5/14,26.16%,ID2;NIPBL;FGFR2;PDGFRA;BBS7
prerank,regulation of regulated secretory pathway (GO:1903305),-0.33847712764323634,-1.2474486004483916,0.11811023622047244,0.6622614112794658,1.0,11/34,14.26%,SYT10;RIMS1;LRRK2;RAB3A;SNAPIN;SYT1;SYT2;RIMS2;SYN1;SYT9;RAB15
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.4295349166797717,1.2474316021050227,0.11962224554039874,0.5198560882426261,1.0,27/73,29.71%,BCAR3;FNIP2;CD44;EIF4G1;TRIM6;RAF1;CAV1;VEGFA;GAS6;STOX1;PRKD2;DOCK7;TFRC;HAX1;IL6;SH2D3C;HSP90AB1;LATS1;MIF;TNF;TXN;TERF2IP;TBK1;FNIP1;CREBL2;STK4;CNOT9
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.381599385749623,-1.2471482666943206,0.125,0.6582556946965934,1.0,10/20,19.23%,DIP2B;PAXIP1;PPARGC1A;RPS6KA5;NOS1;RPS6KA4;IL1B;TADA2B;TADA2A;ARRB1
prerank,regulation of interleukin-17 production (GO:0032660),0.4760189785719997,1.246927300803874,0.17942583732057416,0.5208556376638298,1.0,8/31,19.64%,RFTN1;PRKCQ;SPHK1;ZBTB7B;LY9;DDIT3;IL6;IL2
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.4064686279809926,-1.2467537264395472,0.1443850267379679,0.6546184919960324,1.0,7/19,12.97%,IL1RAPL1;PTPRD;CDKL5;LRP8;DBN1;CUX2;CAMK2B
prerank,polyol metabolic process (GO:0019751),-0.3219220658552064,-1.2463158069918596,0.04597701149425287,0.6512501099894756,1.0,18/46,19.60%,INPP5D;INPP4B;PLD4;PLCB1;PLCG2;IP6K1;INPP5J;ITPK1;IPPK;PPIP5K2;NUDT11;INPP1;PLCE1;INPP5B;ITPKA;IMPA2;PLCH1;IP6K3
prerank,negative regulation of peptidase activity (GO:0010466),0.4468628016570346,1.246168074371677,0.15726681127982647,0.5226781690350984,1.0,13/47,17.58%,LRP1;CST7;HRG;SERPINA10;SERPINB9;CSTB;SERPINE2;SERPINE1;ECM1;TIMP4;TIMP2;SPINK5;SERPINF2
prerank,positive regulation of natural killer cell activation (GO:0032816),0.5573196083158272,1.2461588233891705,0.19815059445178335,0.5221904722127265,1.0,5/13,15.68%,KLRC2;AXL;TICAM1;GAS6;AP1G1
prerank,regulation of gluconeogenesis (GO:0006111),0.48471630306144364,1.2458662008616537,0.18571428571428572,0.5225947603103037,1.0,6/27,13.02%,GCK;SIK1;GNMT;PTPN2;DDB1;OGT
prerank,neuron apoptotic process (GO:0051402),0.5244129708684095,1.245445058331301,0.17901234567901234,0.5233474380104776,1.0,4/19,8.49%,BCL2;CDK5;BID;DIABLO
prerank,response to fatty acid (GO:0070542),0.5246206036287213,1.2452588625920085,0.18364779874213835,0.5233908525618232,1.0,4/17,20.21%,LPL;SOX9;FOXO1;PDK3
prerank,regulation of myotube differentiation (GO:0010830),0.49382395682581026,1.2448408116798022,0.1950920245398773,0.524138232176935,1.0,6/24,8.78%,HDAC9;PIEZO1;HDAC4;SIK1;HDAC1;BHLHE41
prerank,DNA replication checkpoint signaling (GO:0000076),-0.42896634209735895,-1.2447943345801293,0.1894273127753304,0.6510249566703519,1.0,8/16,22.31%,TIPIN;RAD17;CLSPN;CDT1;ORC1;TIMELESS;RAD9B;CDC45
prerank,striated muscle cell development (GO:0055002),-0.45446054701194316,-1.2446526867507257,0.1864406779661017,0.646768543315923,1.0,2/14,8.84%,CAPN3;PGM5
prerank,negative regulation of complement activation (GO:0045916),0.5934709795622719,1.2442156879296578,0.19647696476964768,0.5255764214653726,1.0,3/10,4.12%,C4BPB;C4BPA;A2M
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.5341400455206382,1.2440882159919644,0.19206145966709348,0.5254807947846171,1.0,3/16,9.02%,SLC27A1;CTDNEP1;ABHD5
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.5270894513060502,1.2438413657996956,0.19293820933165196,0.5257468852782768,1.0,10/17,29.44%,NFE2L2;HSPB1;TREM2;P4HB;PPIA;UBQLN1;SOD2;MAPK7;NOL3;SIRT1
prerank,C21-steroid hormone biosynthetic process (GO:0006700),-0.4608696773465275,-1.2435555593727203,0.18867924528301888,0.645296491596841,1.0,4/12,15.95%,FDXR;TSPOAP1;STAR;STARD3
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.5235593092004048,1.2435098182166837,0.18853503184713377,0.5262572460659964,1.0,7/18,22.88%,HIF1A;NFE2L2;HSPB1;TRAP1;PPIA;SOD2;MAPK7
prerank,negative regulation of epithelial cell migration (GO:0010633),0.46643769216748243,1.2432685615813441,0.1791569086651054,0.5264929827306423,1.0,11/33,19.46%,APOE;CORO1C;PTPN23;ADGRB1;DLL4;SP100;DCN;APOH;ADIPOR1;KRIT1;EVL
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.48988553186420214,1.2432437999991657,0.15384615384615385,0.5260433778021999,1.0,14/26,35.10%,EIF6;BRCA1;LPGAT1;APOC1;MID1IP1;SLC45A3;ADIPOR1;ACADL;WDTC1;ERLIN1;CEACAM1;ACADVL;ERLIN2;NR1H2
prerank,regulation of tau-protein kinase activity (GO:1902947),0.5859212371529305,1.242870129484066,0.2152777777777778,0.5267149922374975,1.0,5/10,23.03%,NAB2;CLU;C5AR1;HSP90AB1;EGR1
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.49071323292132085,1.242356829590633,0.1778846153846154,0.5277510390234493,1.0,9/26,26.03%,IQGAP1;EEF1A1;PDPK1;SOX9;PTPN12;DUSP3;SYAP1;STAT5B;ZPR1
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.5310181938780754,1.242295922896207,0.1989795918367347,0.5274283120856584,1.0,7/17,26.39%,APOE;ABCG1;LPCAT3;MBTPS2;SREBF1;FGF1;ERLIN1
prerank,regulation of biomineral tissue development (GO:0070167),0.49327170516155056,1.242218326779983,0.17391304347826086,0.5271411249564635,1.0,8/26,17.04%,ANKH;CYP27B1;SOX9;FBXO5;ECM1;GAS6;ROCK1;DDR2
prerank,sulfur compound catabolic process (GO:0044273),0.4635862403392425,1.2420509394516461,0.1797752808988764,0.5271354804014009,1.0,14/38,24.36%,CSPG4;GALNS;GNS;HEXA;GLB1;DCN;ACAT1;BGN;TST;IDUA;MPST;LUM;CSPG5;OGN
prerank,negative regulation of immune response (GO:0050777),0.40449291408177335,1.2420340833418095,0.06167846309403438,0.5266789257005857,1.0,41/154,19.04%,LGALS3;CD247;NLRC3;PTGIR;PDCD1;FGR;ADCY8;ADCY3;CD3G;POMC;ADCY7;RHBDF2;GPR83;SCTR;TREM2;PLK2;SAMSN1;LILRB1;ADAM17;CRH;CD300A;IAPP;FYN;FCRLB;GPR176;CCR2;ILRUN;GIPR;ADORA2A;GLP1R;ACOD1;VIP;C1QBP;FURIN;SYK;SPINK5;GPR84;IL6;HAVCR2;GNB1;LYAR
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.5827631780097041,1.2417529593433265,0.20985915492957746,0.5270029028172537,1.0,4/11,13.10%,MSN;PTPN23;DAB2;VPS11
prerank,negative regulation of kinase activity (GO:0033673),0.4340975042877716,1.2416654936022589,0.14042553191489363,0.5267937485439879,1.0,19/62,19.06%,SMCR8;PTPRC;GNAQ;HSPB1;PDPK1;DBNDD1;TAB1;DTNBP1;NPRL2;YWHAG;PAK2;PPIA;LRP6;NF1;CHP1;GSKIP;HNRNPU;ITGB1BP1;TAF7
prerank,negative regulation of secretion by cell (GO:1903531),0.4590234525354134,1.2413827990431474,0.15074798619102417,0.5271517197285158,1.0,9/38,14.10%,APOE;ANXA1;TRH;RHBDF2;SERGEF;LILRB1;RHBDF1;TNFRSF1B;RSAD2
prerank,negative regulation of viral process (GO:0048525),0.44116009494352926,1.2411991920478602,0.1427038626609442,0.5271708806887583,1.0,19/57,22.13%,LTF;SHFL;SRPK1;TNIP1;TRIM6;IFITM2;TRIM28;IFITM1;RNASEL;CCL5;ILF3;MBL2;RSAD2;PPIA;ZC3HAV1;ISG20;BST2;SRPK2;TRIM21
prerank,nuclear pore organization (GO:0006999),0.5406073805725035,1.2410598897209655,0.2012820512820513,0.5270523152100166,1.0,8/14,28.39%,NUP205;AHCTF1;TPR;NUP93;NUP54;NUP98;NUP133;NUP35
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.3588927122003974,-1.2409118816977804,0.10062893081761007,0.6480964884184343,1.0,10/28,17.95%,STMN3;STMN1;MAP2;SKA2;CLASP2;FKBP4;MAP1B;STMN4;CAMSAP3;SKA3
prerank,cellular response to light stimulus (GO:0071482),0.4295698095417855,1.240539775044826,0.12552742616033755,0.5281601030663294,1.0,32/66,32.52%,MAPK13;PRKCD;NOC2L;SDE2;SAG;EIF2S1;METTL3;TRIAP1;PDE6B;CNGB1;RRH;YY1;INO80;ERCC4;USP47;SMPD1;DHX36;GNB1;CASP9;NPM1;USP28;ATF4;PDE6G;KDM1A;ATR;RUVBL2;CDC25A;EP300;ZBTB1;NEDD4;CREBBP;TMEM161A
prerank,negative regulation of DNA binding (GO:0043392),0.4804927697930611,1.2405005565960026,0.18341121495327103,0.5277738729637608,1.0,7/28,12.89%,LEF1;GZMA;MDFI;JUN;ILRUN;TFAP4;SP100
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.5442332853227058,1.2400615239935573,0.20689655172413793,0.5286022595988575,1.0,5/14,18.07%,SEC24A;SEC24D;RAB1A;SAR1A;TBC1D20
prerank,regulation of protein dephosphorylation (GO:0035304),0.4641354412563136,1.240050842696369,0.17800453514739228,0.5281206367396596,1.0,15/37,23.76%,PTPA;PRKCD;MFHAS1;HTT;DLC1;PPIA;SPPL3;SMPD1;SYMPK;YWHAB;PIN1;NSMF;PPP1R15A;PPP1R8;CALM3
prerank,lytic vacuole organization (GO:0080171),0.47191751992071285,1.2399059637173635,0.17873831775700935,0.5280500287036324,1.0,12/32,17.48%,ABCA1;GNPTAB;TFEB;GAA;HOOK1;TPCN2;VPS18;CLN3;HPS1;ZKSCAN3;ACP3;HOOK3
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.5174529214761535,1.2396209443229071,0.20151133501259447,0.5284335599595549,1.0,3/18,5.53%,ABL2;ATP7A;POR
prerank,negative regulation of autophagosome assembly (GO:1902902),0.5503056436917096,1.2396155501279478,0.21456953642384105,0.5279348025734908,1.0,4/13,7.52%,SMCR8;SEC22B;CHMP4A;CHMP4B
prerank,regulation of proteolysis (GO:0030162),0.44221594087122085,1.2395006798455805,0.16500553709856036,0.527773166787999,1.0,12/48,13.02%,ASPH;PLAUR;CDK5;GSAP;TRAF3;CAV1;CSTB;CYFIP2;SERPINE2;CLN3;DNAJC1;OGT
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.4882061778402427,1.2394515118009932,0.1936619718309859,0.5274095564115329,1.0,7/27,12.70%,FBXL17;ID2;SIK1;RBM4B;BHLHE40;CRTC1;PDE6B
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.5058872463067066,1.2392935503309503,0.19319562575941676,0.5273625371479778,1.0,12/20,33.38%,AK4;AK3;AMPD2;GART;ATIC;ADSS1;PPAT;ADSL;HPRT1;GMPS;NT5C2;ADSS2
prerank,RNA catabolic process (GO:0006401),0.4492264905513672,1.239268960555148,0.16331096196868009,0.5269392568124932,1.0,19/46,23.20%,RNASE3;ERN1;XRN2;RNASEH2A;METTL3;CNOT10;RNASEH1;RNH1;DXO;LSM6;YTHDF2;RNASEH2B;ISG20;RNASE6;AGO3;ZC3H12D;PABPC4;SND1;PPP1R8
prerank,positive regulation of telomere capping (GO:1904355),0.5273493768530276,1.2392244933192396,0.196870925684485,0.5265843511276088,1.0,9/17,32.86%,PRKCQ;TNKS2;PKIB;RTEL1;MAPK15;MAPK3;PNKP;MAPK1;MAP3K4
prerank,positive regulation of cytokine production (GO:0001819),0.39560634326719624,1.2391754109941329,0.03203203203203203,0.5262291490987487,1.0,95/292,24.57%,RAB7B;RFTN1;LPL;CTNNB1;CYBA;HIF1A;MMP8;ITK;IL18R1;PTPRC;ANXA1;PRKCQ;CD226;CD4;MALT1;FGR;TRAF2;SPHK2;LTB;CD2;MAPK13;TRIM6;APOA2;CD6;SPHK1;CD28;IL27;RUNX1;IL12RB1;CD274;PTPN22;GATA3;ZBTB7B;CADM1;TXK;RASGRP1;POLR2H;LY9;LILRB1;ADAM17;LRRFIP1;BRCA1;TICAM1;PLA2R1;HMOX1;POLR3E;POU2AF1;POLR3D;C3;CRTAM;CCR2;SERPINE1;IRF5;MBP;DDIT3;NFKB1;PRKD2;CYP1B1;HSPD1;CLEC6A;TMEM106A;CEBPG;SYK;TIRAP;DHX36;RAB1A;SERPINF2;DHX33;IL6;DHX9;HAVCR2;FCER1G;STOML2;SLC11A1;SCIMP;IL2;ARHGEF2;HMGB1;RPS3;AGPAT2;LAPTM5;LBP;PTGER4;F2R;IL17RA;HTR2B;EGR1;CD74;MIF;IL17D;AGPAT1;G3BP1;TNF;POLR2F;ATF4
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.5570773569336536,1.2390455844157855,0.2101740294511379,0.52612285300847,1.0,5/12,13.60%,APOE;FLOT2;RANBP9;ABCA7;ROCK1
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.40359896046496674,1.2390393340776757,0.08282828282828283,0.5256350182430027,1.0,55/136,29.44%,FLNA;NLRC3;TMSB4X;IRAK2;ANXA4;ID2;EOMES;TRAF3;HDAC4;OTULIN;FOXJ1;SIK1;ERBIN;BHLHE40;MDFI;SFRP5;DAP;PIM1;RNF2;GAS6;SP100;SMAD7;DDIT3;CYP1B1;ACOD1;CEBPG;PRMT2;SIGIRR;CHP1;WFS1;HAVCR2;PTGIS;EGLN1;NLRC5;RWDD3;TRIM21;ID1;SUFU;PEX14;MAP2K5;GLIS2;SUMO1;HDAC2;AIM2;TLR9;KEAP1;BTRC;PSMD10;KDM1A;HES1;UFL1;TNFAIP3;WWP2;PYDC1;SIRT1
prerank,negative regulation of endothelial cell migration (GO:0010596),0.46312019477843064,1.239033241495895,0.16704035874439463,0.5251510441919768,1.0,14/36,19.98%,APOE;HRG;FGF2;PPARG;ANGPT4;ADGRB1;JUP;ANGPT2;DLL4;SP100;DCN;APOH;KRIT1;HMGB1
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.4391690749660688,1.238687657175484,0.14285714285714285,0.5256648638462319,1.0,25/51,32.86%,CTNNB1;PRKCQ;CCT2;TNKS2;HNRNPC;EXOSC10;PKIB;CCT8;HNRNPU;ATM;TERF1;CCT5;ACD;XRN1;MAPK15;NAT10;ATR;MAPK3;TENT4B;XRCC5;PNKP;MAPK1;TERF2;DCP2;MAP3K4
prerank,mesonephric tubule development (GO:0072164),-0.439378524259155,-1.2386707704759392,0.18604651162790697,0.6496628936929978,1.0,6/15,21.61%,SALL1;ROBO2;OSR1;NPNT;PKD1;SLIT2
prerank,regulation of angiogenesis (GO:0045765),0.3992581979913247,1.2385814222790075,0.0641925777331996,0.5254874729819735,1.0,49/192,17.80%,GPNMB;FLT1;CTNNB1;HIF1A;ITGAX;NIBAN2;SASH1;AGO2;HRG;SPHK1;FGF2;HSPB1;PPARG;ANGPT4;MYDGF;RUNX1;ADGRB1;PDPK1;VEGFA;PRKCB;PGK1;BRCA1;JUP;PLXND1;HMOX1;HIPK1;RNH1;CCR2;SERPINE1;ECM1;SP100;ROCK1;FGF18;DCN;PRKD2;CYP1B1;NF1;HTATIP2;HSPG2;KDR;APOH;NINJ1;ANXA3;CCN6;SARS1;SPINK5;KLK3;SP1;KRIT1
prerank,axon development (GO:0061564),-0.28435442981384895,-1.2384192766392503,0.08888888888888889,0.6459295515116413,1.0,20/78,12.80%,GRM7;GAP43;CTNNA2;CNTN4;RTN4RL1;PLP1;PLPPR4;RAB3A;NREP;DSCAML1;APP;PAX2;SLITRK4;APBB1;BRSK1;MAP1B;ARHGAP35;KLF7;PAK3;RAB10
prerank,tRNA methylation (GO:0030488),0.4686776613158119,1.2383565571304274,0.16896551724137931,0.5256391575936986,1.0,22/34,36.70%,METTL1;TRMT10C;PRORP;METTL2B;METTL2A;TRMT13;THADA;NSUN2;TARBP1;TRMT112;GTPBP3;THUMPD2;TRMT5;ALKBH8;METTL6;TRMT12;LCMT2;NSUN6;TRMT10A;MTO1;TRMT1L;TRMT44
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.4277339883908026,1.238278495312024,0.1377497371188223,0.5253834248846354,1.0,33/72,31.49%,ERCC6;UBA52;RPS27A;COPS3;ERCC1;COPS4;COPS8;LIG1;POLR2H;HMGN1;DDB1;COPS2;XPA;COPS6;POLR2D;ERCC4;PPIE;RFC1;GTF2H1;UBC;RFC2;POLR2F;GTF2H5;CUL4A;LIG3;POLD4;MNAT1;ERCC8;COPS7A;EP300;TCEA1;ERCC2;RFC4
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.4953041197455343,1.238032237766386,0.16878612716763006,0.5256154908415538,1.0,11/27,24.73%,UBA52;IRAK2;RPS27A;TNIP1;TAB1;MAP3K1;HSPD1;TIRAP;UBC;IRAK4;BTK
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.5810680976619226,1.2377226381418993,0.20273972602739726,0.5260498060430848,1.0,2/11,6.34%,SLC27A1;CTDNEP1
prerank,response to tumor necrosis factor (GO:0034612),0.4150708684469916,1.237570603579248,0.12136929460580913,0.5260346977878088,1.0,22/91,20.16%,NFE2L2;TANK;CCL4;SPHK1;GATA3;ERBIN;MAP4K3;SMPD4;CCL13;BRCA1;CCL7;CCL5;YBX3;CCL14;CXCL16;ACOD1;SMPD1;GBP2;DHX9;ASAH1;ARHGEF2;RPS3
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.43148346243716035,1.2371715821279503,0.14027630180658873,0.5267213972005409,1.0,26/65,29.73%,SNX25;UBA52;RPS27A;CAV1;VEPH1;PDPK1;WFIKKN1;ADAM17;NKX2-1;BAMBI;NRROS;SMAD7;DAND5;PIN1;FAM89B;UBC;SPRED2;EMILIN1;TGFBR2;PMEPA1;SPRED3;ASPN;PPM1A;FKBP1A;SIRT1;TGFB1I1
prerank,positive regulation of nuclear division (GO:0051785),0.4849345715576833,1.2362706609648446,0.20212765957446807,0.5289908230387043,1.0,2/25,4.74%,IGF1;CD28
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.42866978908646736,1.2361332375161875,0.14195583596214512,0.5288937444428069,1.0,35/70,28.29%,MYO10;CD247;ARPC2;FGR;ARPC3;ARPC5;PIK3CB;CD3G;PRKCD;GRB2;WIPF1;NCK1;ACTG1;CYFIP2;FYN;LIMK1;CDC42;ACTR3;ACTB;ARPC1B;SYK;PIK3R2;BAIAP2;MYO1G;HSP90AB1;ABI1;WAS;VAV3;VAV1;NCKAP1L;YES1;NCKIPSD;CYFIP1;ACTR2;MAPK3
prerank,regulation of exocytosis (GO:0017157),-0.31819523931114085,-1.2354579660263876,0.10526315789473684,0.6495959044550369,1.0,17/46,16.35%,IL1RAPL1;CADPS;CPLX1;STXBP5L;RAB3A;RAB2B;SYT1;RIMS2;HAP1;RAB27B;CLASP2;RAB10;RAB15;CPLANE2;LGI3;RAB26;RAB3B
prerank,regulation of interleukin-4 production (GO:0032673),0.5060140265947474,1.2353467051297418,0.19636363636363635,0.5308537303664882,1.0,8/21,19.24%,PRKCQ;LEF1;CD28;GATA3;DDIT3;SYK;HAVCR2;FCER1G
prerank,regulation of cell migration (GO:0030334),0.3927781033227401,1.2343466699922019,0.011011011011011011,0.5334146230557226,1.0,76/382,14.03%,GPNMB;PLAU;IGF1;PLXNC1;FLT1;MITF;ITGAX;CORO1C;CSF1;SDCBP;FLNA;RAP2A;PLXNA2;MGAT5;ANXA1;TMSB4X;SASH1;SGK1;DAG1;FGR;LEF1;ADARB1;SGK3;GCNT2;MACF1;PDPN;MCTP1;PDGFA;FAM110C;GTPBP4;SPHK1;CLDN19;PTK2B;MMP9;NEDD9;FGF2;LMO4;CAV1;FAM83H;JAG1;CLIC4;DAB2;STK24;VEGFA;DLC1;RHOD;ACTG1;TMSB10;IGF1R;CDH1;LMNA;IFITM1;SPAG9;ADAM17;RACK1;NKX2-1;RUFY3;PLXND1;FGF7;SERPINE2;CLN3;MYOC;SERPINE1;CCL7;YTHDF3;CCL5;FGF20;RHOA;CHRD;SMAD7;ROCK1;CPNE3;ARID2;ADAM15;CXCL16;FGF18
prerank,negative regulation of protein phosphorylation (GO:0001933),0.40437629220646437,1.234332405246521,0.07258064516129033,0.5329523627119975,1.0,50/150,24.43%,CORO1C;SIRPA;SMCR8;PTPRC;SNX25;XDH;EIF4G1;GNAQ;PRKCD;CAV1;HSPB1;NCK2;PDPK1;DBNDD1;PLPP3;NCK1;CRKL;TAB1;SAMSN1;DTNBP1;MVP;RACK1;CADM4;YWHAG;FBLN1;PAQR3;CNKSR3;SMAD7;PTPN13;PAK2;PPIA;LRP6;PPP1R15B;NF1;CHP1;MYADM;GSKIP;TESK1;ITGB1BP1;TAF7;TARDBP;SPRED2;EMILIN1;TRIB2;ZBED3;DNAJC10;CALM3;PMEPA1;SPRED3;PRR5L
prerank,aminoglycan biosynthetic process (GO:0006023),0.44048608100225317,1.2341823394856346,0.16416309012875535,0.5329154305568542,1.0,10/49,10.77%,XYLT1;HS3ST3B1;B4GALT7;GCNT2;B4GAT1;B3GNT3;HEXA;SLC35D2;B3GALT6;NDST1
prerank,regulation of microtubule nucleation (GO:0010968),0.5845370343124205,1.2340308008127294,0.2175141242937853,0.532870875569531,1.0,3/10,14.17%,RANGRF;DCTN1;GIT1
prerank,negative regulation of receptor internalization (GO:0002091),0.5593907074137575,1.233635889135313,0.21727748691099477,0.5335872517381179,1.0,5/12,19.26%,SDCBP;ANKRD13B;LRPAP1;ANKRD13A;ATXN2
prerank,protein polyglutamylation (GO:0018095),-0.47615251319719853,-1.233581595330203,0.20149253731343283,0.6500056746282605,1.0,7/11,22.78%,TTLL7;TPGS1;TTLL5;TTLL4;TTLL9;CFAP20;TTLL6
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.398335929417416,1.2334220635349042,0.05511022044088176,0.5337312202778138,1.0,81/208,29.83%,LITAF;FLNA;NLRC3;LGALS1;LTF;CD4;MALT1;TANK;TRAF2;TNIP1;OPTN;AKAP13;SPHK2;TRIM6;SQSTM1;CC2D1A;TRAF3;HSPB1;DDX21;PDPK1;IKBKE;BRD4;TREM2;PLK2;PRKCB;TNIP3;EEF1D;TICAM1;TRAF1;HMOX1;WLS;RIOK3;DDX1;SHARPIN;TNIP2;RHOA;ECM1;GPRC5B;LPAR1;CLEC6A;TMEM106A;TFRC;TIRAP;DHX36;NEK6;S100B;CARD19;BST2;MTDH;SHISA5;GPR89A;TNFSF10;TRIM21;IRAK4;F2R;HTR2B;CCDC22;CD74;REL;JMJD8;TNF;BIRC2;SLC20A1;CX3CL1;SLC44A2;TLR9;PELI1;PPM1A;TERF2IP;TBK1;TRIM8;UFL1;TNFAIP3;RIPK1;ZFAND6;TLE1;FKBP1A;TAB2;SIRT1;TRIM68;MUL1
prerank,regulation of defense response (GO:0031347),0.4162454542795902,1.2331492071519474,0.12828601472134596,0.5340762775247851,1.0,20/76,18.70%,APOE;ANXA1;TMSB4X;FGR;PTGES;TRAF3;MGLL;BCL6;PTPN22;BRD4;TREM2;CELF1;CCR2;CASP4;PSMA6;APPL2;TIRAP;SBNO2;USP18;ELMOD2
prerank,secondary alcohol biosynthetic process (GO:1902653),-0.34570025102170626,-1.232897478132988,0.14285714285714285,0.6472806528677565,1.0,12/30,18.75%,IDI1;DHCR7;HMGCS1;INSIG1;NSDHL;MVK;INSIG2;FDPS;LSS;SQLE;HMGCR;GGPS1
prerank,regulation of histone deacetylation (GO:0031063),0.5502743953045938,1.2326238853470832,0.21296296296296297,0.5351650160690914,1.0,6/13,22.91%,SPHK2;ZBTB7B;SAP30BP;ING2;PRMT6;NIPBL
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.5750413496854718,1.232157491763498,0.18157181571815717,0.5361320763632441,1.0,6/11,21.68%,ZMIZ1;CDCA4;ZMIZ2;ELOF1;ARID1B;SERTAD1
prerank,histone methylation (GO:0016571),0.48252133821523335,1.2321484752974277,0.18461538461538463,0.5356468329145682,1.0,16/26,33.72%,PRMT5;PRMT7;SMYD3;CARM1;PRMT2;PRMT6;SMYD2;EHMT1;SMYD1;NSD3;TRMT112;NTMT1;NSD1;SUV39H2;CREBBP;PRMT1
prerank,calcium ion import (GO:0070509),0.47957360873052557,1.2317592989451098,0.2007168458781362,0.5363145414901956,1.0,2/28,0.25%,CACNA1A;TRPC4
prerank,regulation of neuron death (GO:1901214),0.41745818628464215,1.231746703149191,0.13912133891213388,0.5358500782066471,1.0,21/82,16.30%,GPNMB;CTSZ;CSF1;TRAF2;ATP13A2;EIF4G1;CDK5;DAXX;CD200R1;CHMP4A;CHMP4B;EIF2S1;INPP5A;FYN;CCL5;TNFRSF1B;SARM1;CLU;ITGB2;EFNB2;CHP1
prerank,glycosaminoglycan metabolic process (GO:0030203),0.43824425127791433,1.2316477797117564,0.16143011917659805,0.5356515492314109,1.0,12/54,11.74%,XYLT1;HS3ST3B1;GNS;B4GALT7;GCNT2;HEXA;GLB1;SLC35D2;B3GALT6;NDST1;FUCA1;GUSB
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.5203029290125633,1.231603489915305,0.20306513409961685,0.5352771648305056,1.0,6/18,19.57%,ANXA1;BCL2L11;UBE2L3;PCK2;HNRNPU;NR3C1
prerank,regulation of protein catabolic process (GO:0042176),0.4133894555498524,1.2314586803331273,0.12102564102564102,0.5352051650987663,1.0,48/99,31.80%,FLNA;ATG7;CTSA;WDR91;ATP13A2;C4BPB;C4BPA;AZIN1;SEC22B;ADGRB1;EEF1A1;SF3B3;PLK2;FZR1;VCP;DDB1;OAZ3;RAB7A;HUWE1;TIPARP;VIP;FOXO1;BARD1;FURIN;ODC1;PIN1;GFAP;FAM83D;CHMP6;GSK3B;RNF41;SNX12;MDM2;TNF;VPS28;RILP;STX5;GSK3A;DACT1;TNFAIP3;WWP2;FAF1;AZIN2;SNF8;SIRT2;TNFSF12;EEF1A2;NEDD4
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.4208638545982238,1.2314518159479253,0.1581151832460733,0.5347197023691959,1.0,22/69,21.65%,LPL;CYBA;MMP8;PTPRC;SPN;SPHK2;CD2;HSPB1;RASGRP1;ARFGEF2;CCR2;CLU;TMEM106A;SYK;TIRAP;IL6;DHX9;HAVCR2;ARHGEF2;HMGB1;FRMD8;LBP
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.41045992717936003,1.2313026658970556,0.11522633744855967,0.5346873033700287,1.0,31/90,27.23%,LCN2;FABP5;PEMT;DYNC1H1;UCP2;CAV1;ZBTB7B;ACSL1;VEGFA;IGF1R;KDM3A;CCR2;PPARGC1B;OGT;YBX2;SYK;PLAC8;APPL2;CPT2;ADIPOR1;DECR1;EHMT1;FABP4;HSF1;ACADL;GNAS;JAK2;HADH;HDAC3;CXCR4;KDM1A
prerank,sulfur amino acid metabolic process (GO:0000096),0.49330497724123534,1.2312384084378294,0.19612590799031476,0.5343911353897691,1.0,10/24,26.03%,MSRA;MMUT;MTHFD1;AHCY;MTRR;TST;CDO1;MPST;MTHFR;NOX4
prerank,regulation of endothelial cell migration (GO:0010594),0.4170802713543277,1.231141239019027,0.1310272536687631,0.5342073997920935,1.0,25/85,18.68%,APOE;NRP2;SASH1;PIK3CB;PTK2B;NRP1;FGF2;ANGPT4;ADGRB1;GATA3;VEGFA;ANGPT1;RIN2;DLL4;SP100;AAMP;DCN;PRKD2;NF1;KDR;APOH;ANXA3;GPI;KRIT1;ITGB1BP1
prerank,telomere maintenance via recombination (GO:0000722),0.5817033431627933,1.2310472506129444,0.22606382978723405,0.5339974827233803,1.0,6/11,24.93%,NSMCE2;ERCC1;RAD50;ERCC4;TPRKB;SMC6
prerank,regulation of autophagosome assembly (GO:2000785),0.4630397342417494,1.2309877526631765,0.18620689655172415,0.5336914250211917,1.0,12/33,20.48%,SMCR8;SEC22B;CHMP4A;CHMP4B;NPRL2;RAB5A;IFT88;TBC1D12;RALB;RAB3GAP2;PIKFYVE;NPRL3
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.48957146533726575,1.230901317332808,0.19902912621359223,0.5334710308341174,1.0,13/24,32.21%,TNKS2;HNRNPC;EXOSC10;ERCC4;SLX4;HNRNPU;TERF1;ACD;XRN1;NAT10;TENT4B;TERF2;DCP2
prerank,positive regulation of DNA replication (GO:0045740),0.5284205181870821,1.2307189591949208,0.19625,0.5334909802206221,1.0,1/16,0.03%,BCAR3
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.5791597482951031,1.2306179342725503,0.22420907840440166,0.5332909990526353,1.0,4/10,12.89%,MUC1;ING4;TFAP4;SP100
prerank,membrane organization (GO:0061024),0.39766088106892217,1.2303585484339157,0.050100200400801605,0.5335854549377982,1.0,61/227,17.90%,MYOF;CORO1C;IGF2R;RABEP1;ARPC2;CD4;UBA52;ARPC3;RPS27A;ARPC5;FER1L5;CD3G;MTCH1;SYNGR1;TLCD1;DAB2;SH3KBP1;CTDNEP1;TOR1AIP2;GRB2;GLTP;CHMP4A;CHMP4B;NAPA;ACTG1;PDCD6IP;TLCD2;LEMD2;GAK;HIP1;REEP3;PIP5K1C;DNM2;CLN3;HUWE1;VPS4B;CHMP7;OSBPL2;RAB5A;LPCAT3;HSPA8;STAM2;AGFG1;KIF20A;SLC2A8;FZD4;ACTR3;NPC1;ACTB;GCA;CBL;VAPB;TFRC;AP3D1;CHP1;MYADM;SAR1A;VAMP4;VAMP2;EPS15L1;HIP1R
prerank,mRNA modification (GO:0016556),0.4885806241060127,1.2303181968567545,0.20634920634920634,0.5332218478119598,1.0,11/22,29.64%,PUS1;TRUB2;TRMT10C;PUS7;METTL3;NSUN2;DKC1;CBLL1;METTL8;TRMT6;PCIF1
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.4291230078754125,-1.2299214610303064,0.17408906882591094,0.6512482515702132,1.0,2/13,3.33%,CPE;RBPJ
prerank,positive regulation of defense response (GO:0031349),0.41882742829105857,1.2299048052705053,0.12058212058212059,0.5339807428201153,1.0,17/89,11.65%,LPL;S100A8;S100A9;CYBA;FPR2;TNIP1;OPTN;ADAM8;MAPK13;NAPEPLD;NFKBIZ;POLR3D;CEBPA;CCR2;SERPINE1;RIOK3;CCL5
prerank,regulation of telomere capping (GO:1904353),0.4869788077842989,1.2298279895177726,0.19583843329253367,0.5337236919658016,1.0,12/23,32.86%,PRKCQ;TNKS2;RAD50;PKIB;ATM;RTEL1;MAPK15;MAPK3;PNKP;MAPK1;TERF2;MAP3K4
prerank,mitochondrial gene expression (GO:0140053),0.4495826180433907,1.229770554320858,0.16150442477876106,0.5334051152278172,1.0,16/42,23.64%,MRPS12;MRPL47;MRPL51;SLC25A33;MRPL23;LARS2;MRPS15;MRPL12;MRPS16;MRPS7;TWNK;GATB;MRPS28;GFM2;MRPS14;FASTKD5
prerank,protein kinase A signaling (GO:0010737),0.5455004044467819,1.2295181528019163,0.21536351165980797,0.5336896622239123,1.0,1/12,0.30%,LCP1
prerank,small GTPase mediated signal transduction (GO:0007264),0.41399488807599844,1.2289801029151257,0.11566018423746162,0.534777265090594,1.0,32/103,18.99%,IGF1;ABR;CCDC88C;GRAP2;LAT;FGF2;BRAP;SIAH2;TRIM28;GRB2;RAPGEF6;CRKL;DNMT1;RASGRP1;PLK2;RASGRP3;RIN2;NRAS;KRAS;JUN;ARHGEF18;CDK2;RASGRP2;NF1;CHP1;RIT1;ARHGAP30;RALB;KRIT1;NTN1;RRAD;GNB1
prerank,epithelium development (GO:0060429),0.40887370273639645,1.2289253092165133,0.10618556701030928,0.5344333046451367,1.0,32/107,25.28%,LGALS3;CTSB;DAG1;TAGLN2;ANXA4;TAGLN;GSTA2;PPARG;FOXJ1;DHRS9;SOX9;VEGFA;DMBT1;PGK1;ALDOC;EHF;MTHFD1;RCN3;KDR;PTER;SPINK5;TST;CBR1;RIPK4;ANXA7;IFT122;TPP1;FGFR2;SOX10;JAK2;CPT1A;KANK2
prerank,histone H4-K16 acetylation (GO:0043984),0.5053951344469426,1.2282121499045144,0.2017766497461929,0.5360966372168547,1.0,10/19,26.99%,KMT2A;MSL3;ING4;WDR5;OGT;JADE3;KAT7;MSL1;HCFC1;KANSL1
prerank,negative regulation of cell adhesion (GO:0007162),0.42297121396228665,1.2279303580692469,0.14634146341463414,0.536425356727096,1.0,18/72,14.76%,PLXNC1;PLXNA2;PTPRC;SPN;GCNT2;MUC1;HRG;GTPBP4;RIPOR2;JAG1;ANGPT1;CDH1;PLXND1;SERPINE1;FBLN1;RHOA;FZD4;CYP1B1
prerank,positive regulation of cellular process (GO:0048522),0.3875366921540841,1.2274415772405634,0.006,0.5374298521141858,1.0,169/565,25.39%,IGF1;COLEC12;BCL2;FLT1;S100A8;S100A9;CYBA;FN1;ITGAX;LRP1;CSF1;TCIRG1;SDCBP;IL2RB;P2RX4;FPR2;SIRPA;DOCK2;SLC6A6;LEF1;ACACA;CXCR2;GCNT2;ADAM8;PDPN;PDGFA;PTGFR;RPS6;CST7;EIF4G1;OSMR;NRG1;APOA2;SPHK1;PTK2B;DOT1L;PRKCD;FGF2;DYNC1H1;HDAC4;CAV1;EXOSC4;SLC25A33;RPL23;ECHDC3;SOX9;VEGFA;CRKL;EGR2;TREM2;HDAC1;EIF4G2;HPR;HP;CELF1;CAPN1;RHOD;IGF1R;P4HB;KITLG;EAPP;FBXO5;LMNA;ADAM17;DDX49;CDK13;BAMBI;KRAS;FGF7;SLC35F6;RHOG;CCL5;FGF20;TNFRSF1B;EXOSC9;NAMPT;CHRD;GAS6;CDC42;CDK2;ABCA7;CDCA7L;STX3;BIRC5;CCL14;CXCL16;FGF18;STOX1;IL31RA;INO80;NUMA1;PRKD2;LRP6;RPS19;SRF;VIP;NCMAP;USP47;CDC7;C1QBP;EFNB2;CCND2;DHX36;KDR;CHTOP;FXR2;BMP6;SINHCAF;CAPNS1;SERPINF2;CNBP;S100B;ATM;IL6;LMAN2;FAM98A;ACACB;ITGB1BP1;RPS9;CCAR1;LYAR;CUL3;FCER1G;SLC11A1;IL2;BMP5;GAB2;MLC1;MEIS3;TIMP1;EPO;CNOT6;VHL;HSP90AB1;HSF1;SRPK2;NPM1;LBP;SERTAD1;CD47;BMP4;CIAO1;CDC123;TRIM21;CALR;FGFR3;ACTN4;F2R;IL34;HTR2B;TGFBR2;KMT2D;AGPAT1;NSMCE1;FGFR2;MDM2;TNF;HDAC2;FASN;SMC6;PDGFRA;CDK4;MAPK15;CDC25B;SFRP1;PLA2G5;CX3CL1;FGF1;MDK
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.39025542354069076,1.226972784353511,0.005,0.538402638275676,1.0,104/509,16.66%,BCAR3;IGF1;OSBPL8;BCL2;IQGAP1;FLT1;LITAF;S100A8;S100A9;LCK;FN1;MMP8;BCL2L1;RRAGD;FLNA;P2RX4;SMCR8;LGALS1;PTPRC;LTF;CD4;MALT1;SASH1;FGR;TRAF2;CCL4;GCNT2;ADAM8;AKAP13;PDGFA;SPHK2;PIK3CB;AXL;FAM110C;NRG1;TRIM6;SPHK1;FGF2;CD28;MFHAS1;CC2D1A;CAV1;BID;DDX21;MYDGF;RPS20;PIK3R5;PDPK1;TRAT1;RPL23;GATA3;SCTR;GRB2;SOX9;IKBKE;BRD4;VEGFA;ANGPT1;TREM2;BCL2L11;PLK2;IGF1R;PRKCB;KITLG;ILK;EEF1D;RACK1;TICAM1;BAX;HMOX1;FGF7;HIP1;IAPP;FYN;MYOC;WLS;RHOG;DDX1;CCL5;FGF20;SHARPIN;TNIP2;RHOA;ECM1;GAS6;RPL37;GPRC5B;ROCK1;FGF18;DCN;DDIT3;PRKD2;CBL;LPAR1;CLEC6A;TMEM106A;C1QBP;TFRC;TIRAP;DHX36;KDR;CHD5;PUM1;PIK3R2
prerank,cellular calcium ion homeostasis (GO:0006874),0.4060461422050642,1.2265648707787915,0.10212335692618807,0.53911906641538,1.0,26/133,15.20%,BCL2;TRPC4;SLC24A4;ADCY8;ATP2B1;ATP13A2;HCRTR1;NPTN;KCTD17;CSRP3;CAV1;TPT1;ANXA6;PACS2;TPCN2;CCL13;BAX;CHERP;CLN3;CCR2;CCL7;CCL5;AFG3L2;CCL14;SLC8B1;VAPB
prerank,melanocyte differentiation (GO:0030318),0.5690373710750991,1.2263432137136303,0.23443708609271524,0.5393077951637413,1.0,3/11,5.45%,MITF;TYRP1;LRMDA
prerank,modulation by symbiont of host process (GO:0044003),0.5851439583675921,1.2262745994064326,0.22868741542625168,0.5390019191125571,1.0,5/10,11.11%,UBA52;RPS27A;PGK1;B2M;ENO1
prerank,myeloid leukocyte differentiation (GO:0002573),0.42454213175385686,1.2261437552726675,0.16381156316916487,0.5389225818523428,1.0,23/65,23.69%,CSF1;CD4;LEF1;PDE1B;MMP9;PPARG;RUNX1;VEGFA;TREM2;SNX10;CEBPA;CDC42;CDK2;PIR;IL31RA;DEK;CAMK4;SBNO2;GAB2;MT1G;BMP4;TGFBR2;RXRA
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.416737207356976,1.22610756058985,0.1316062176165803,0.5385451447978951,1.0,35/85,31.11%,PSMD8;PSMD1;DAAM1;PRICKLE1;PSMD6;PSMA1;PSMC3;PSMA8;RHOA;CDC42;FZD1;CELSR1;PSMD14;FZD4;PSMD2;PSMC6;PSMA6;PSMD5;PSMA5;PFN1;PSMA3;PSMB8;PSMB10;PSMD7;VANGL1;PSMB6;PSMD10;PSMB5;PARD6A;ARHGEF19;PSMB7;PSMC4;CELSR2;CELSR3;PSMD12
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.5184674789821908,1.225959610812736,0.21419676214196762,0.5384756512052478,1.0,9/18,22.43%,MDFIC;MFHAS1;UFM1;ILRUN;POLR1A;CHP1;GSK3B;SUFU;LATS1
prerank,translational termination (GO:0006415),0.4145197445482675,1.2256787616474143,0.13182286302780638,0.5388495902097,1.0,40/95,28.60%,MRPS12;MRPL47;MRPL51;MRPL4;MRPL23;ETF1;MRPL21;CHCHD1;MRPL52;MRPL17;MRPS15;MRPL24;DAP3;MRPL12;MTRF1L;MRPS33;MRPS16;MRPS7;MRPL53;MRPL11;MTRF1;GSPT1;MRPS22;MRPS35;MRPS28;MRPS30;MRPL19;MRPL15;GFM2;MRPS27;MRPL1;MRPS14;TRMT112;MRPL37;MRPL18;MRPL39;MRPL41;MRPL27;MRPL33;MRPL42
prerank,protein modification by small protein removal (GO:0070646),0.3930848599760343,1.2252444635321995,0.047,0.539615716322612,1.0,116/252,32.39%,HIF1A;PSMD8;PSMD1;UBA52;TRAF2;RPS27A;TNIP1;COPS3;JOSD1;TRAF3;SIAH2;USP12;GATA3;USPL1;COPS4;COPS8;RNF128;OTUD4;ATXN3;TFPT;TAB1;TNIP3;PSMD6;USP9X;PSMA1;DDB2;BRCA1;VCP;USP5;ABRAXAS1;PSMC3;ASXL2;COPS2;SUDS3;BAP1;PSMA8;MYSM1;TNIP2;RHOA;COPS6;OGT;STAM2;SMAD7;SMAD1;USP40;YY1;PSMD14;PSMD2;ACTB;INO80;ASXL1;USP47;PSMC6;BARD1;PSMA6;POLB;SENP5;PSMD5;UIMC1;PSMA5;USP18;DESI1;DESI2;USP46;UBC;USP28;SENP1;USP33;USP36;USP14;WDR48;OTUD1;PSMA3;USP50;MDM2;USP2;USP8;BIRC2;PSMB8;USP32;PSMB10;USP1;PSMD7;HCFC1;USP19;PSMB6;KEAP1;OTUD5;BRCC3;PSMD10;PSMB5;TNFAIP3;USP34;RIPK1;STAMBP;USP42;PSMB7;USP30;PSMC4;CDC25A;USP13;COPS7A;BECN1;USP48;SKP2;PTEN;EP300;PSMD12;STAMBPL1;ACTR8;USP15;PSMD3;USP11;USP38;ZC3H12A;UBB
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.4418850690255353,1.225064869661879,0.15982721382289417,0.5397018877572978,1.0,23/52,29.78%,BCL2;GZMB;FBXW7;BID;UBE2L3;HUWE1;BAP1;YWHAG;RHOU;VPS11;MICALL2;YWHAB;UBL5;PPP3CC;CSNK2A2;SAE1;USP36;PPP3R1;YWHAZ;GSK3A;ATG13;TOMM7;LEPROT
prerank,iron-sulfur cluster assembly (GO:0016226),0.4830748056145482,1.225000390527874,0.2174432497013142,0.5394049976128834,1.0,8/24,22.01%,HSCB;NFU1;ISCA1;IBA57;CIAPIN1;HSPA9;ABCB7;CIAO1
prerank,regulation of establishment of planar polarity (GO:0090175),0.414501186699384,1.2249689803669321,0.12939958592132506,0.5390079246067555,1.0,36/88,31.11%,PSMD8;PSMD1;DAAM1;PRICKLE1;PSMD6;PSMA1;PSMC3;PSMA8;RHOA;CDC42;FZD1;CELSR1;PSMD14;FZD4;PSMD2;PSMC6;PSMA6;PSMD5;PSMA5;PFN1;PSMA3;PSMB8;PSMB10;PSMD7;VANGL1;PSMB6;PSMD10;DACT1;PSMB5;PARD6A;ARHGEF19;PSMB7;PSMC4;CELSR2;CELSR3;PSMD12
prerank,mitochondrial translational termination (GO:0070126),0.41674552996374303,1.2248549384564194,0.1344364012409514,0.538860839467476,1.0,37/88,28.60%,MRPS12;MRPL47;MRPL51;MRPL4;MRPL23;MRPL21;CHCHD1;MRPL52;MRPL17;MRPS15;MRPL24;DAP3;MRPL12;MTRF1L;MRPS33;MRPS16;MRPS7;MRPL53;MRPL11;MTRF1;MRPS22;MRPS35;MRPS28;MRPS30;MRPL19;MRPL15;GFM2;MRPS27;MRPL1;MRPS14;MRPL37;MRPL18;MRPL39;MRPL41;MRPL27;MRPL33;MRPL42
prerank,response to laminar fluid shear stress (GO:0034616),0.589525747439331,1.2244730755692104,0.22826086956521738,0.5395662981731093,1.0,5/10,23.96%,ABCA1;NFE2L2;SMAD7;MAPK7;MAP2K5
prerank,central nervous system neuron axonogenesis (GO:0021955),0.5641472728245945,1.2244480581176118,0.21571238348868177,0.5391563340689988,1.0,2/12,2.26%,B4GALT5;CHRNB2
prerank,nuclear membrane reassembly (GO:0031468),0.4292259833111713,1.224192385260877,0.15536105032822758,0.5394468510400628,1.0,21/54,29.16%,NUP205;PPP2R1A;CHMP4A;CHMP4B;AHCTF1;LMNA;LEMD2;CCNB1;NUP188;REEP3;CHMP7;RCC1;CHMP6;NUP93;SUMO1;IST1;NUP98;NUP133;NUP35;LBR;ANKLE2
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.49000665510105246,1.2241022209774752,0.19854721549636803,0.5392299901103861,1.0,11/24,27.05%,DNMT3A;DNMT1;MTF2;PHF1;EED;BMI1;DNMT3B;CREBZF;RBBP7;SMYD5;H3-3A
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.3161825391595215,-1.2240673763896652,0.1388888888888889,0.6630170969101924,1.0,17/39,16.99%,PRKCE;FGF12;FGF14;WNK1;HECW1;NETO1;GLRX;HECW2;WNK3;DMD;FGF11;YWHAH;PTPN3;OSR1;FXYD2;NEDD4L;SCN2B
prerank,negative regulation of proteolysis (GO:0045861),0.46216617665569815,1.2238844018606287,0.1731651376146789,0.5393912494525809,1.0,14/34,22.53%,CST7;CDK5;CSTB;SERPINE2;CLN3;ECM1;DNAJC1;TIMP4;EFNA1;ROCK1;TIMP2;TIMP1;TRIM21;SNX12
prerank,positive regulation of cellular catabolic process (GO:0031331),0.40348858188696474,1.223829421099897,0.10111223458038422,0.5390628069708012,1.0,50/132,27.69%,IGF1;APOE;HIF1A;MSN;OPTN;ADAM8;PIK3CB;TRIM6;PRKCD;TFEB;PFKFB3;GRSF1;SNX33;PLK2;ABHD5;TICAM1;NPRL2;ABCD2;TNFRSF1B;DXO;PLEKHF1;VPS11;ENTPD5;ROCK1;DCN;DAPK1;ZSWIM8;FOXO1;ZC3HAV1;FURIN;SH3D19;STK11;ORMDL3;HMGB1;MTDH;LAPTM5;GSK3B;TRIM21;VPS35;BNIP3;TNF;PRR5L;PIK3C2A;KHSRP;RC3H1;SUPV3L1;TRIM8;GSK3A;DACT1;UFL1
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.5557800536511541,1.2236111557302503,0.23828125,0.5392303481171359,1.0,9/13,26.71%,KLRC2;FGR;SPHK2;ITGB2;AP1G1;SYK;GAB2;LAMP1;STX4
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.48734365928926887,1.22360229938745,0.20093457943925233,0.5387724892650574,1.0,8/28,15.84%,BCL2;TRAF2;ERN2;ERN1;ERO1A;BAX;DDIT3;CASP4
prerank,regulation of mRNA metabolic process (GO:1903311),0.5627722750247383,1.2231911255757641,0.22402159244264508,0.5394583003028667,1.0,7/11,29.21%,SRPK1;CDK11B;SAFB2;DHX9;SRPK2;SLTM;SAFB
prerank,phosphorylation (GO:0016310),0.3897296336401204,1.222411453382218,0.02,0.5412846985623972,1.0,108/384,22.10%,FNIP2;FAM20C;CDK14;LCK;PEAK1;CDK18;CDK6;PRKCH;DGKZ;GNPTAB;CDK8;SGK1;FGR;CERK;TEC;SGK3;SGK2;SRPK1;GK;SPHK2;PIK3CB;SPHK1;MAP4K5;MAP4K2;DYRK2;PTK2B;PAK6;CDK5;PRKCD;TAOK3;ERN2;PDPK1;STK24;STK3;ERN1;SIK1;IKBKE;MAP4K3;COPS8;TXK;PLK2;PRKCB;HK1;ILK;RNASEL;MAPKAPK2;PGK1;CDK13;NEK4;FYN;COPS2;CDK17;HIPK1;PIM1;RSKR;JAK1;BIRC6;MAP3K12;CDK11B;LIMK1;GAS6;CDK2;PKN2;PAK2;ILF3;ROCK1;BIRC5;MAP3K1;PRKD2;FASTK;DAPK1;CSNK1D;MAPK9;STK38;SYK;DGKA;PLK4;DGKH;MINK1;TLK1;PRKAG1;DGKD;CAMK4;STK11;NLK;NEK6;DAPK3;ATM;MEX3B;TP53RK;MAP3K9;TOP1;CDK16;PDK3;MAK;MARK2;LMTK2;PI4KA;GSK3B;PRAG1;SRPK2;MARK4;RUNX3;NIM1K;TAOK1;CERKL;MELK;TRIB2
prerank,negative regulation of apoptotic process (GO:0043066),0.3902457308553288,1.2223454054280132,0.014,0.5409852816979015,1.0,94/444,16.40%,IGF1;BCL2;CTNNB1;APOE;ARHGAP10;PRKCH;BCL2L1;NIBAN2;FLNA;IL2RB;ANXA5;PLAUR;ANXA1;LTF;MALT1;LEF1;ITGA5;UBA52;RPS27A;MCL1;ADAM8;PDPN;FIGNL1;CD44;ANXA4;PRDX5;AXL;SPHK1;PTK2B;SQSTM1;MMP9;RAF1;PRKCD;CD28;CPEB4;HYPK;CAV1;SERPINB9;HSPB1;ANGPT4;BID;SIAH2;MYDGF;DAB2;TPT1;SOX9;APIP;VEGFA;ANGPT1;TREM2;HDAC1;PLK2;IGF1R;PSEN2;NAA16;SON;UFM1;MGMT;NAT8;ATF5;CLN3;TRIAP1;PIM1;WDR73;FGF20;BIRC6;ATAD3A;PRDM9;HNRNPK;GAS6;FSTL1;PAK2;BIRC5;IL31RA;NFKB1;BFAR;HSPD1;CIAPIN1;CBL;HSPA9;VIP;RNF157;CAT;USP47;FOXO1;BARD1;NR4A2;TFRC;HTATIP2;CCND2;KDR;RETREG1;APOH;RASA1
prerank,mitochondrion localization (GO:0051646),-0.3862629332493853,-1.222228062971201,0.1693121693121693,0.6637542273586664,1.0,8/19,16.67%,MEF2A;LRRK2;ATCAY;HAP1;NECTIN2;MSTO1;MARK1;BRAT1
prerank,fatty acid beta-oxidation (GO:0006635),0.44128927667448054,1.2220309832951104,0.14859002169197397,0.5414151980905454,1.0,23/51,28.08%,ACAD11;ABCD4;PEX2;PPARD;ABCD2;CRAT;ACAD10;ECI2;ACAT1;ABCD3;CPT2;DECR1;GCDH;ACADS;EHHADH;ACADL;ACOX3;ACADM;HADHA;HADH;ACAA2;ACOT8;ACOXL
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.28109848057229075,-1.2216861360555697,0.09090909090909091,0.6607589749974561,1.0,11/76,7.09%,P2RY12;CX3CR1;GNA15;CHRM2;TGM2;GRM1;HTR2A;GRM5;HTR2C;AGT;C5AR2
prerank,photoperiodism (GO:0009648),0.4784325027466738,1.2214374058892477,0.20941176470588235,0.5426746826959488,1.0,7/28,12.70%,FBXL17;ID2;SIK1;RBM4B;BHLHE40;CRTC1;PDE6B
prerank,synaptic vesicle transport (GO:0048489),0.5549824131242542,1.221406387891259,0.24343015214384509,0.5422900427873529,1.0,3/11,10.79%,CDK5;TMEM230;DNM2
prerank,carnitine metabolic process (GO:0009437),0.5563947825780484,1.2213911156049377,0.22357723577235772,0.5418578170925689,1.0,8/12,25.15%,BBOX1;SHMT1;CRAT;CPT2;ACADL;CPT1A;TMLHE;ACADM
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.5704260187260608,1.221310051382425,0.23108108108108108,0.5411402442034433,1.0,6/11,23.14%,IL2RB;PTK2B;JAK1;SYK;IL2;STAT5B
prerank,cellular response to interleukin-2 (GO:0071352),0.5704260187260608,1.221310051382425,0.23108108108108108,0.5411402442034433,1.0,6/11,23.14%,IL2RB;PTK2B;JAK1;SYK;IL2;STAT5B
prerank,amide transport (GO:0042886),0.4831356289980008,1.2213008073644456,0.21251475796930341,0.5406911247185145,1.0,7/26,18.10%,SLC27A1;PDPN;SLC46A1;GLTP;ABCA13;DISP1;SLC19A1
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.43490266192974564,1.221139660704163,0.17497231450719822,0.5406766293364377,1.0,14/48,18.40%,STAP1;PTPRC;TTLL12;PPARG;TREM2;OTUD4;PTPN2;METTL3;YTHDF3;GAS6;YTHDF2;SIGIRR;USP18;IL6
prerank,supramolecular fiber organization (GO:0097435),0.3885668652150068,1.2210662840472697,0.028,0.5404100770318798,1.0,94/333,20.65%,MYO1E;FGF13;MYO5A;ARHGAP25;CORO1C;CCDC88C;MYO1F;LTF;MAP10;ATP7A;UBA52;COLGALT1;ALDOA;PPP1R9B;B4GALT7;RPS27A;VIM;FIGNL1;TUBGCP4;POF1B;MYO1A;COL10A1;NPPA;TPM2;BMP1;DYNC1H1;SIAH2;CLIP2;ACTN1;COL4A1;COL20A1;P3H1;INPPL1;RHOD;P4HB;FAT1;CORO7;HOOK1;COL18A1;USP9X;CRTAP;COL6A3;COL12A1;TPM4;ADAMTS14;RUFY3;B2M;HIP1;IAPP;PLEC;NAT8;DCTN1;RHOG;WDR73;VPS4B;GSN;ADAMTS2;RHOA;CDC42;TSPAN5;CRIPT;EFEMP2;UBE2L6;ARHGAP12;CYP1B1;KLHL24;P4HA3;GGA2;FURIN;NF1;HSPG2;CHP1;COL8A2;COL9A3;DDR2;RIPK3;HOOK3;SERPINF2;HIP1R;PIN1;GFAP;ARHGAP17;MYH11;COL16A1;EVL;P4HA1;LTBP2;LTBP3;ARHGEF2;DST;UBC;COL9A1;SLAIN2;EMILIN1
prerank,nucleosome assembly (GO:0006334),0.46881956360406074,1.2209696046337966,0.2048054919908467,0.540220100138613,1.0,17/31,29.81%,GRWD1;CABIN1;DAXX;SOX9;UBN1;CHAF1B;ATRX;NPM1;NAP1L3;ASF1B;ANP32B;HAT1;H3-3A;RSF1;NASP;ASF1A;HMGB2
prerank,sterol biosynthetic process (GO:0016126),-0.33263355375076964,-1.2207488981770835,0.14492753623188406,0.6588971140086922,1.0,13/33,18.75%,IDI1;DHCR7;HMGCS1;SC5D;INSIG1;NSDHL;MVK;INSIG2;FDPS;LSS;SQLE;HMGCR;GGPS1
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.46569207513831506,-1.2205417941095256,0.1986754966887417,0.6551340119036989,1.0,7/10,32.61%,ABCA3;MTMR9;MTMR4;MTMR2;PHB2;MTMR3;GNB3
prerank,histone H4 acetylation (GO:0043967),0.43513795076700734,1.2203694146542998,0.17439293598233996,0.5415719491411243,1.0,22/47,28.11%,KMT2A;LEF1;MSL3;ING4;TRIM16;WDR5;OGT;ING3;CHD5;ING5;JADE3;KAT7;EP400;MORF4L1;MSL1;ZZZ3;HCFC1;HAT1;MORF4L2;KANSL1;RUVBL2;BRD8
prerank,hyaluronan catabolic process (GO:0030214),0.5175176457614593,1.220082711709422,0.20614596670934698,0.5419329353076467,1.0,6/18,16.30%,SLC9A1;CD44;FGF2;HEXA;GUSB;CHP1
prerank,regulation of G0 to G1 transition (GO:0070316),0.4595517518774606,1.2198518409300945,0.19036954087346025,0.542130641125384,1.0,15/38,26.50%,UXT;BRCA1;RNF2;EED;MGA;APAF1;CDC7;CBX3;BMI1;EHMT1;YAF2;RBBP7;E2F6;L3MBTL2;PCGF6
prerank,vitamin transport (GO:0051180),0.47054639946835064,1.2191384286195728,0.1979045401629802,0.5437642765150053,1.0,9/29,22.99%,SLC27A1;PDPN;SLC23A1;SLC46A1;SLC52A2;SLC2A8;SLC19A1;SLC2A6;SLC19A2
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.5067457655512845,1.2191211334770384,0.21505376344086022,0.5433511914287151,1.0,3/20,2.66%,BCL2;BCL2L1;MCL1
prerank,phospholipid catabolic process (GO:0009395),0.48222753386905226,1.2191119378070348,0.21160822249093109,0.5429009889453732,1.0,8/24,19.95%,GDPD3;PRDX6;APOA2;ABHD12;SMPD4;SMPD1;PNPLA6;PLBD2
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.48189554748718544,-1.2190859351766963,0.2261904761904762,0.6548175440183069,1.0,3/11,8.58%,LGALS9;CD34;THBS1
prerank,camera-type eye morphogenesis (GO:0048593),0.5832022004653801,1.2189875044341305,0.22727272727272727,0.5428090248953297,1.0,5/10,21.28%,TH;VEGFA;LRP6;NF1;IFT122
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.46797763148220844,1.2187642419107465,0.1976470588235294,0.5430329699800548,1.0,9/29,19.31%,AGO2;ZC3H7B;SNIP1;METTL3;SMAD1;HNRNPA2B1;PUM1;ADAR;AGO3
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.4894803133404697,1.2187361085013486,0.20430107526881722,0.5426291788835871,1.0,14/24,33.78%,UBA52;RPS27A;LIG1;POLE;POLB;RFC1;UBC;RFC2;LIG3;POLD4;RFC4;UBB;RFC5;PCNA
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.5168260749482863,1.2181721737518159,0.20854271356783918,0.5438352739829588,1.0,7/17,15.52%,IGF1;NR4A3;NRP1;S100A11;CCL5;DOCK5;DOCK7
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.46204577195901003,1.2179459679804177,0.20157657657657657,0.5440577229581317,1.0,15/36,26.50%,UXT;BRCA1;RNF2;EED;MGA;APAF1;CDC7;CBX3;BMI1;EHMT1;YAF2;RBBP7;E2F6;L3MBTL2;PCGF6
prerank,cellular response to calcium ion (GO:0071277),-0.29030951002491256,-1.217838648174878,0.06557377049180328,0.6540270611084721,1.0,16/67,11.05%,MEF2C;CAPN3;NLGN1;LGMN;RYR3;MEF2A;SYT10;PLCG2;SYT1;SYT2;ADGRV1;KCNH1;MCOLN1;ECT2;WNT5A;DMTN
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.47846892245003536,1.2176474375830428,0.20163170163170163,0.5445191179340313,1.0,15/27,29.44%,CD44;KMT5A;PLA2R1;SMYD2;ATM;SPRED2;CD74;MIF;SPRED3;MDM2;PSMD10;KDM1A;ATR;PTTG1IP;SIRT1
prerank,regulation of protein processing (GO:0070613),0.49619672812347776,1.217632728405643,0.2148859543817527,0.544076033589273,1.0,4/21,10.88%,ADAM8;RUNX1;SERPINE2;CLN3
prerank,positive regulation of protein polymerization (GO:0032273),-0.2915767249748742,-1.2175063936112407,0.08064516129032258,0.6509352678982935,1.0,8/65,6.80%,NAV3;FCHSD2;BIN1;PRKCE;FER;CARMIL1;NCKAP1;CDC42EP4
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.47256781580068874,1.2174669892116947,0.1939252336448598,0.544088296640453,1.0,5/29,11.17%,CTNNB1;TCF7;LEF1;HDAC1;RBBP5
prerank,positive regulation of hormone secretion (GO:0046887),0.520520888273769,1.217294646316836,0.22431077694235588,0.5441416637518026,1.0,2/17,3.81%,SPP1;CYP19A1
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.4850956134219263,-1.2170937496502396,0.19927536231884058,0.6479289101551761,1.0,3/10,14.11%,PLA2G15;PNPLA8;ENPP2
prerank,lysosome organization (GO:0007040),0.45258104520908593,1.2166065596739055,0.19748858447488585,0.5457331144142611,1.0,13/36,18.81%,ABCA1;GNPTAB;TFEB;GAA;HOOK1;TPCN2;VPS18;CLN3;HPS1;ZKSCAN3;ACP3;HOOK3;TMEM165
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.46886809830308485,-1.216439584577778,0.23346303501945526,0.6457156164435278,1.0,6/11,34.41%,PTS;PRKG2;QDPR;DHFR;GCH1;GCHFR
prerank,regulation of macroautophagy (GO:0016241),0.4068843754830929,1.2164210856232356,0.12512820512820513,0.54584741914998,1.0,38/105,28.35%,RRAGD;ATP6V1C1;ATP6V0D2;SMCR8;ATP6V1A;ATP6V0A1;ATP13A2;ATP6V1B2;RUFY4;CDK5;ATP6V0D1;ATP6V0B;ATP6V1G1;ERN1;CAPN1;VPS26A;CLN3;LARP1;DCN;UBQLN1;KDR;PRKAG1;CAPNS1;ATP6V0C;ATP6V1E1;USP36;VPS35;BNIP3;RRAGC;ATP6V0E1;SESN2;LAMTOR3;TBK1;EXOC4;ATG13;SMG1;BNIP3L;LAMTOR1
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.5341228957928797,1.2163395796062975,0.20897435897435898,0.5456244663821597,1.0,9/14,31.47%,TNKS2;ATRX;ACD;TPP1;TERT;TERF2IP;ATR;XRCC5;TERF2
prerank,cellular response to UV (GO:0034644),0.41962494798180655,1.216292069373325,0.1519916142557652,0.5453181585779154,1.0,35/76,32.52%,MAPK13;MMP9;PRKCD;ERCC1;NOC2L;SDE2;EIF2S1;DDB2;DDB1;METTL3;TRIAP1;XPA;YY1;INO80;ERCC4;USP47;SMPD1;DHX36;STK11;CASP9;TIMP1;NPM1;USP28;XPC;ATF4;KDM1A;ATR;RUVBL2;SIRT1;CDC25A;EP300;ZBTB1;NEDD4;CREBBP;TMEM161A
prerank,cytoplasmic sequestering of protein (GO:0051220),0.5603736225292847,1.216206945572703,0.22994652406417113,0.54511564102511,1.0,6/13,26.38%,FLNA;MDFI;YWHAB;SUFU;LATS1;KEAP1
prerank,organelle organization (GO:0006996),0.3864026546357794,1.2160667502989448,0.019,0.5450726708176361,1.0,138/388,27.65%,PLEKHM2;APOE;ARHGAP10;ARHGAP21;ANK1;MICAL2;VPS13C;PLAAT3;ATP7A;SYNE1;OPTN;ODF2;ATP8B4;MICAL1;PAK6;FMNL2;NEDD9;ABCD4;GOLGB1;CAV1;SLC25A33;SH3KBP1;FGD6;TOR1AIP2;ARL1;PI4K2A;TRAPPC8;STRIP1;HTT;CHMP4A;CHMP4B;PEX2;FMNL3;PDCD6IP;SMPD4;GEM;VPS18;CCL13;COG4;RANBP9;LARP4;RAB32;GAK;SIRT5;NRF1;AFG1L;LONP1;RAB7A;DOP1B;WDR73;ALAS1;CCL7;DIAPH1;ABCD2;HUWE1;VPS4B;YTHDF3;ATAD3A;LMAN1;RHOU;CHMP7;CDC42;PLEKHF1;VPS11;CHCHD2;PALLD;CENPT;PPIA;SLC25A36;MTX3;NUMA1;TWNK;VAPB;CSNK1D;HPS6;YTHDF2;ABCD3;RAB1A;VPS13D;SAR1A;TRAPPC11;SH3D19;SIRT4;POLG2;VPS51;TMEM11;GABPB1;TBC1D20;HAX1;ARFGEF1;LMAN2;PEX16;AGTPBP1;RHOT2;PIKFYVE;MTFR2;STOML2;DST;CFL1;CHMP6;PYROXD2;FGD5;MARK4;ZMYM4;TMED3;MTFR1;TERT;TOR1B;PPRC1;CSPG5;SNX11;PEX14;GOLPH3;SIPA1L3;ATP5F1B;SIRT3;SIPA1;MAPK15;RAB3GAP1;MDK;TRAPPC12;NDP;GOLGA2;ABI2;HCFC1;STX7;PAK4;GOLPH3L;NCKIPSD;STX4;PI4K2B;SURF4;ARC;PRPF40A;MREG;TMED2;RAB31;PACSIN2
prerank,regulation of B cell differentiation (GO:0045577),0.518900810362167,1.2152566412907604,0.22122762148337596,0.5469801948510776,1.0,7/17,25.90%,IKZF3;ID2;SYK;BTK;NCKAP1L;SFRP1;TLR9
prerank,organophosphate catabolic process (GO:0046434),0.5603449807776921,1.2152303057290288,0.22554347826086957,0.5465832177765553,1.0,3/11,4.27%,APOA2;PON1;ABHD12
prerank,liver development (GO:0001889),0.4621005302593075,1.2151619802520832,0.19700460829493088,0.5463031326601473,1.0,14/32,33.41%,ANXA1;ARID5B;CEBPA;PCK2;CEBPG;NF1;IL6;GFER;PRKCSH;CCDC40;CCDC39;XBP1;CEBPB;PHF2
prerank,translational elongation (GO:0006414),0.40708123227474063,1.215116190087521,0.1408016443987667,0.5459641560774007,1.0,40/101,28.60%,MRPS12;MRPL47;MRPL51;EEF2;MRPL4;EEF1A1;MRPL23;MRPL21;CHCHD1;EEF1D;RACK1;GTPBP2;MRPL52;MRPL17;MRPS15;MRPL24;DAP3;MRPL12;MRPS33;MRPS16;MRPS7;MRPL53;MRPL11;MRPS22;MRPS35;MRPS28;MRPS30;MRPL19;MRPL15;GFM2;MRPS27;MRPL1;MRPS14;MRPL37;MRPL18;MRPL39;MRPL41;MRPL27;MRPL33;MRPL42
prerank,cation transmembrane transport (GO:0098655),0.44534167809674036,1.2148922137340903,0.1905286343612335,0.5461544023694181,1.0,10/44,17.09%,MFSD12;SLC3A2;SLC7A1;ATP13A2;SLC36A4;SFXN1;TRPM7;ATP1A2;SLC7A8;SFXN2
prerank,regulation of transforming growth factor beta production (GO:0071634),0.5133675951722572,1.2144518514837819,0.22164948453608246,0.5469857355056148,1.0,3/18,8.96%,HIF1A;FN1;LILRB1
prerank,microvillus organization (GO:0032528),0.5415195889325062,1.2143877381264019,0.25,0.5467036216621155,1.0,3/13,6.88%,RAP2A;FXYD5;RAPGEF6
prerank,ERBB signaling pathway (GO:0038127),0.4192612884761563,1.2143605541700144,0.17763845350052246,0.5463213147627158,1.0,15/64,17.10%,IQGAP1;NRG1;PTK2B;NCK2;PDPK1;GRB2;SOX9;ERBIN;ADAM17;MVP;PTPN12;AAMP;CPNE3;CBL;DGKD
prerank,cytosolic transport (GO:0016482),0.40416062500419137,1.2142169612837415,0.12525667351129363,0.5462696931766391,1.0,27/108,12.82%,TBC1D10C;EEA1;GOSR2;VPS13C;RGP1;WDR91;PTPN23;TMEM87B;VTI1A;BET1L;ARL1;STX6;RIC1;CORO7;HOOK1;SPAG9;TBC1D23;VPS26A;VPS13A;GAK;DCTN1;VPS50;CLN3;RAB7A;DOP1B;GCC2;RAB5A
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.5087156325798899,1.213983872628556,0.22744599745870395,0.5464747210526527,1.0,7/18,19.05%,ABL2;RIPOR2;DLC1;MYOC;KCTD10;ITGA3;CUL3
prerank,protein sumoylation (GO:0016925),0.4309988590992885,1.213652879395115,0.16108108108108107,0.5470062033107408,1.0,23/49,29.50%,NUP205;NSMCE2;TRIM28;EGR2;NUP188;SUMO2;RANBP2;TPR;RAE1;PIAS1;SAE1;NUP93;AAAS;NUP54;NUP50;SUMO1;NUP98;PIAS4;NUP42;NUP133;NUP210;NUP35;NUP214
prerank,positive regulation of stem cell proliferation (GO:2000648),0.5083764007135646,1.2134853411135824,0.23581336696090793,0.5470447765711774,1.0,8/17,27.69%,PTPRC;HNRNPU;KAT7;FERMT2;LTBP3;TERT;KDM1A;N4BP2L2
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.5637221216188922,1.2133280477804065,0.24267782426778242,0.5470498673155798,1.0,3/11,9.53%,HIF1A;NR4A3;RACK1
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.4943803030093437,1.212876859265335,0.2193939393939394,0.5479520069655304,1.0,6/21,16.14%,MITF;JUN;MED17;SRF;MED13;DHX36
prerank,defense response to symbiont (GO:0140546),0.40705096701649307,1.212638342659616,0.14270941054808686,0.5481722578206845,1.0,24/92,19.49%,LYST;BCL2;BCL2L1;FLNA;ATG7;PTPRC;SHFL;MLKL;AGBL5;EXOSC4;IFITM2;PRF1;IFITM1;LILRB1;RNASEL;RSAD2;ACOD1;RIPK3;ISG20;IL6;RNASE6;EXOSC5;BST2;IFIT2
prerank,focal adhesion assembly (GO:0048041),0.49602704574216866,1.212539506972886,0.22952853598014888,0.547970247330028,1.0,7/21,19.96%,PEAK1;ACTN1;DLC1;RHOD;SORBS1;FERMT2;ACTN2
prerank,regulation of sister chromatid cohesion (GO:0007063),0.5582580982138472,1.212532457299984,0.22483660130718955,0.5475197043725721,1.0,2/12,6.30%,CTNNB1;WAPL
prerank,GPI anchor metabolic process (GO:0006505),0.47226272641212796,1.2123778340200002,0.2186046511627907,0.5475331207171142,1.0,7/26,15.40%,PIGQ;PIGZ;PIGA;PGAP1;PIGN;PIGL;PIGC
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.5773419410645273,1.2123639634338381,0.2315202231520223,0.5471047234154094,1.0,4/10,18.30%,CAV1;MVP;CHP1;TESK1
prerank,cell-matrix adhesion (GO:0007160),0.4078623823613249,1.2123495137749636,0.15113871635610765,0.5466840542151572,1.0,26/95,20.65%,PEAK1;FN1;CD96;ITGAL;CD44;ADAMTS13;ITGA4;OTOA;ACTN1;DLC1;RHOD;ILK;CD63;ADAM15;SIGLEC1;SORBS1;ITGB2;ITGA11;ITGA3;ZYX;ITGB1BP1;ECM2;FERMT2;ACTN2;PPFIA1;EMILIN1
prerank,positive regulation of macroautophagy (GO:0016239),0.4406101685881667,1.2117299185155253,0.17829457364341086,0.5480526911016379,1.0,19/48,29.44%,SMCR8;OPTN;RUFY4;HTT;FYCO1;LARP1;DCN;KDR;VPS13D;RALB;RAB3GAP2;BAG3;BNIP3;RAB3GAP1;SESN2;TBK1;SPTLC2;BNIP3L;SIRT1
prerank,monoacylglycerol metabolic process (GO:0046462),0.539945506863609,1.2116244864922103,0.2269021739130435,0.5478657830247263,1.0,2/13,5.96%,ABHD12;MGLL
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.39685505393654563,1.2113162407697273,0.11557788944723618,0.5483077893695558,1.0,55/161,29.34%,DKK2;APOE;CCDC88C;PSMD8;PSMD1;BICC1;TBX18;PRICKLE1;CAV1;SIAH2;LRP4;DAB2;STK3;SOX9;HDAC1;ZNRF3;PSMD6;PSMA1;SFRP5;PSMC3;PSMA8;TLE5;PSMD14;FZD4;SCYL2;PSMD2;DDIT3;LRP6;PSMC6;PSMA6;LZTS2;STK11;PSMD5;PSMA5;CUL3;FRMD8;TPBG;GSK3B;LATS1;PSMA3;PSMB8;PSMB10;SFRP1;MDK;PSMD7;PSMB6;PSMD10;GSK3A;DACT1;PSMB5;RUVBL2;PSMB7;TLE1;STK4;PSMC4
prerank,regulation of stem cell proliferation (GO:0072091),0.5070368927861677,1.2108590804971862,0.23155216284987276,0.5492159443095601,1.0,7/17,29.81%,PTPRC;FBLN1;HNRNPU;AGO3;TERT;KDM1A;HMGB2
prerank,sensory organ development (GO:0007423),0.43305221594446314,1.2102025179109537,0.19104803493449782,0.5507152528398341,1.0,17/51,27.17%,SH3PXD2B;BLOC1S3;SOX3;GATA3;HIPK1;SMG9;SMOC1;RBP4;CPAMD8;MEIS3;PBX1;PBX2;ECE1;SIPA1L3;MYO7A;SMCHD1;CHD7
prerank,receptor internalization (GO:0031623),0.4383529270894364,1.210017566073292,0.17700112739571588,0.5508415058585352,1.0,13/44,16.06%,CD9;LRP1;CXCR2;CAV1;GRB2;SAG;LILRB1;DNM2;RAB5A;SCYL2;ITGB2;SYK;TFRC
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.40687506279864727,1.2096068451312292,0.14182194616977226,0.5515826972318185,1.0,30/95,24.94%,SDCBP;SNX25;UBA52;RPS27A;CAV1;VEPH1;DAB2;PDPK1;WFIKKN1;ADAM17;NKX2-1;BAMBI;RNF111;SMAD7;ING2;ITGA3;STK11;DAND5;PIN1;FAM89B;UBC;SPRED2;EMILIN1;HSP90AB1;LATS1;TGFBR2;PMEPA1;SPRED3;GIPC1;ASPN
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.39969835496543316,1.2093417726779363,0.11303462321792261,0.5519111356934374,1.0,20/138,8.03%,FLT1;LCK;STAP1;CD3E;CSF1;CD8B;CD4;FGR;CD8A;PIK3CB;AXL;CD7;NPPA;PTK2B;NEDD9;BLNK;MTSS1;CLNK;IGF1R;POLR1G
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.5791316736198162,1.209143505104813,0.22959889349930843,0.5520308431630743,1.0,8/10,35.32%,NCK1;JUN;DNAJB1;VHL;BAG3;SIRT2;HIF1AN;IMPACT
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.41202243452856585,1.209135465446193,0.18219895287958116,0.5515844290387756,1.0,22/73,20.42%,LPL;CYBA;MMP8;PTPRC;SPN;ADAM8;SPHK2;CD2;HSPB1;RASGRP1;ARFGEF2;CCR2;CLU;TMEM106A;SYK;TIRAP;IL6;DHX9;HAVCR2;ARHGEF2;HMGB1;FRMD8
prerank,regulation of macrophage migration (GO:1905521),-0.4759838550075228,-1.2089314620819365,0.2508591065292096,0.6622127832914387,1.0,4/10,6.06%,P2RY12;CX3CR1;MTUS1;CD81
prerank,positive regulation of cellular protein localization (GO:1903829),0.4128162658837186,1.2089286093667764,0.17473684210526316,0.5517154675139797,1.0,26/69,27.86%,GPR137B;SNX33;RANGRF;CARD10;FYN;ABCA7;CEP250;STX3;NUMA1;TFRC;SLC5A3;KAT7;TESK1;GNL3;ORMDL3;FERMT2;HSP90AB1;GSK3B;MARK4;CCDC88A;TNF;TRAPPC12;VPS28;SESN2;STX4;PARD6A
prerank,purine nucleotide biosynthetic process (GO:0006164),0.545403688125876,1.208484766807048,0.23521505376344087,0.5525436105895408,1.0,8/12,25.97%,AMPD2;GART;PRPSAP1;MTHFD1;PRPS2;PPAT;ADSL;HPRT1
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.4594100682289216,1.208233656595377,0.2119815668202765,0.5528413129005064,1.0,14/31,26.50%,FBXW7;UBE2L3;FZR1;RPS2;DCUN1D2;RAB1A;PIN1;BMI1;DCUN1D4;ARRDC4;DCUN1D3;GOLGA2;UBE2C;BTRC
prerank,cellular response to starvation (GO:0009267),0.39521001663147415,1.207869277323304,0.10584677419354839,0.553493492000914,1.0,55/147,30.69%,TCIRG1;RRAGD;ATG7;ATP6V1C1;ATP6V0D2;ATP6V1A;ATP6V1B2;ATP6V0D1;CPEB4;ATP6V0B;ATP6V1G1;TFEB;STK24;SIK1;EIF2S1;DAPL1;FADS1;WDR45;LAMP2;DAP;NPRL2;ATP6V1F;MAP1LC3B;NUPR2;HSPA8;FOXO1;MYBBP1A;PRKAG1;RALB;ATP6V0C;XPR1;SREBF1;ATP6V1E1;NPRL3;NIM1K;MAP1LC3A;GABARAP;USP33;LARS1;ATF4;HSPA5;RRAGC;SFRP1;ATP6V0E1;SESN2;LAMTOR3;FNIP1;KLF10;MAPK3;LAMTOR1;SIRT1;BECN1;RRAGB;ASNS;MAPK1
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.4216336689929507,1.2073649573213463,0.179596174282678,0.5545061504443403,1.0,14/59,15.59%,CTNNB1;MITF;CDK8;LEF1;MED15;TRIM28;SOX9;CCNC;CCNB1;BAX;JUN;MED17;NFKB1;MED13
prerank,protein localization to vacuole (GO:0072665),0.5386274711666428,1.2073629043957128,0.24895688456189152,0.5540409390783781,1.0,2/13,7.62%,ATP13A2;RNF128
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.4328606217554681,1.2069081028983817,0.20089285714285715,0.5549437320860692,1.0,7/46,5.66%,IGF1;CTNNB1;PTGIR;ID2;NR4A3;PPARG;ELN
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.5027306810168397,1.2069028359759433,0.23865110246433205,0.5544935706218114,1.0,9/18,31.48%,MSN;PTPN23;DAB2;VPS11;SNX12;MAP2K2;MAPK3;MAPK1;RDX
prerank,glycoprotein catabolic process (GO:0006516),0.5041358556697555,1.206886842202986,0.2364341085271318,0.5540845921634765,1.0,4/17,9.12%,MMP12;EDEM1;STT3B;OGA
prerank,protein homotetramerization (GO:0051289),0.43803150020064185,1.2067968986991826,0.18232662192393737,0.5538859803603101,1.0,15/49,20.57%,ACACA;ALDOA;THG1L;KCNJ2;APIP;GNMT;B2M;SHMT1;UPB1;OSBPL2;GLS;APPL2;AQP4;ACACB;SOD2
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.43462047660406666,1.2066181155774247,0.2006651884700665,0.5539573054327478,1.0,11/45,17.10%,IQGAP1;PTK2B;NCK2;PDPK1;GRB2;SOX9;ERBIN;ADAM17;AAMP;CBL;DGKD
prerank,B cell proliferation (GO:0042100),0.5188252000619802,1.2065793233647075,0.2300771208226221,0.5535884170719286,1.0,3/17,7.88%,BCL2;PTPRC;RASGRP1
prerank,nuclear pore complex assembly (GO:0051292),0.5651820977067533,1.206526150384615,0.24064171122994651,0.5532887224927672,1.0,5/10,24.83%,NUP205;AHCTF1;TPR;NUP93;NUP98
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.39348762788717534,-1.2065146931782187,0.18994413407821228,0.6649761358113865,1.0,9/20,30.72%,SEMA6D;SEMA6A;SEMA6C;SEMA4B;SEMA3B;SEMA4A;SEMA7A;SEMA3C;SEMA3F
prerank,copper ion homeostasis (GO:0055070),0.5043517418919997,1.2064297445782608,0.2379746835443038,0.5530897353371921,1.0,3/17,6.03%,SLC31A2;ATP7A;ATOX1
prerank,regulation of execution phase of apoptosis (GO:1900117),0.5617583244119537,1.2060108131652387,0.25068493150684934,0.5538640349625986,1.0,4/11,21.83%,BCL2L1;DLC1;PTGIS;DFFA
prerank,post-translational protein modification (GO:0043687),0.38674156705927404,1.2060062636530968,0.037,0.5534118187969953,1.0,107/332,26.50%,FAM20C;SPP1;APOE;HIF1A;FN1;CSF1;IGFBP7;PSMD8;LGALS1;PSMD1;SERPINA10;COPS3;APOA2;MATN3;ENAM;FSTL3;NEURL2;WSB2;FBXW7;FBXO32;RNF7;ANO8;STT3B;APLP2;COPS4;COPS8;SPSB2;P4HB;FBXO31;PSMD6;PSMA1;DDB2;FBXW4;RAB8A;DDB1;PSMC3;CUL9;KLHL13;COPS2;C3;RABGGTB;SOCS5;RBBP5;F5;PSMA8;KCTD7;COPS6;WDR5;GAS6;RAB5A;ZBTB16;FSTL1;UBE2F;PSMD14;PSMD2;LAMC1;FBXL19;PSMC6;PSMA6;MELTF;CKAP4;RAB1A;KLHL25;TULP4;WFS1;ASB1;PSMD5;DCAF17;ELOB;PTP4A2;WSB1;PSMA5;RAB11A;IL6;CUL3;SPARCL1;SPSB3;FBXO7;FBXW11;SHISA5;TIMP1;CAND1;CUL1;VHL;CALU;FBXW5;BMP4;FBXO11;CUL2;CCDC22;RBBP7;SOCS2;DCAF6;PSMA3;PRKCSH;PSMB8;WDTC1;DCUN1D3;PSMB10;FBXO41;CUL4A;PSMD7;PSMB6;KLHL21;KLHL11;KEAP1;BTRC
prerank,response to glucocorticoid (GO:0051384),0.4746200542645961,1.2059689311122028,0.212636695018226,0.553040663994227,1.0,7/26,24.29%,ANXA1;BCL2L11;UBE2L3;HNRNPU;IL6;NR3C1;TNF
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.5150466212116059,1.2057877838551412,0.23037974683544304,0.5531114255590456,1.0,5/16,20.16%,BCL2L1;TPT1;CLU;CCAR2;RPS3
prerank,adenine nucleotide transport (GO:0051503),0.5091040590160103,1.2057254842389056,0.24875,0.5528323992201329,1.0,2/17,1.78%,LRRC8C;SLC25A24
prerank,nucleotide-excision repair (GO:0006289),0.40591022731037907,1.2056073089025687,0.14581178903826267,0.5527191547303466,1.0,49/101,33.78%,ERCC6;UBA52;RPS27A;COPS3;ERCC1;COPS4;COPS8;ATXN3;LIG1;POLR2H;POLE;HMGN1;DDB2;DDB1;RNF111;COPS2;XPA;COPS6;SLC30A9;POLR2D;ERCC4;SLX4;POLB;PPIE;RFC1;GTF2H1;UBC;XPC;RFC2;POLR2F;GTF2H5;CUL4A;CETN2;LIG3;POLD4;MNAT1;ERCC8;SIRT1;COPS7A;PNKP;EP300;TCEA1;ERCC2;RFC4;HUS1;UBB;POLA1;RFC5;PCNA
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.47831592266142975,1.2054070925889124,0.22623345367027678,0.5527934133238974,1.0,5/25,10.08%,FGF13;TBX18;CAV1;RANGRF;JUP
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.40958969028180814,1.2053201730259973,0.1749209694415174,0.5525953191515848,1.0,17/75,17.73%,HIF1A;NRP2;NRP1;FGF2;ITGA4;MYDGF;PDPK1;VEGFA;ADAM17;NRAS;HMOX1;ECM1;EGFL7;PRKD2;VIP;KDR;SP1
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.45985512452423927,1.2052267653903024,0.21679909194097616,0.5524111557601754,1.0,9/33,16.66%,IGF1;PIK3CB;PIK3R5;GATA3;IGF1R;PLEKHA1;C1QBP;NF1;PIK3R2
prerank,long-term memory (GO:0007616),0.49913809065247783,1.20487026927729,0.22950819672131148,0.5529653374576861,1.0,5/19,17.31%,APOE;SGK1;CPEB3;NPAS4;CAMK4
prerank,cellular response to type I interferon (GO:0071357),0.4386583525027975,1.2048292580519988,0.2068206820682068,0.5521572641435714,1.0,14/41,19.49%,IRF6;IFITM2;IFITM1;IRF8;RNASEL;JAK1;IRF5;SP100;RSAD2;GBP2;ISG20;ADAR;BST2;IFIT2
prerank,type I interferon signaling pathway (GO:0060337),0.4386583525027975,1.2048292580519988,0.2068206820682068,0.5521572641435714,1.0,14/41,19.49%,IRF6;IFITM2;IFITM1;IRF8;RNASEL;JAK1;IRF5;SP100;RSAD2;GBP2;ISG20;ADAR;BST2;IFIT2
prerank,ribosomal large subunit biogenesis (GO:0042273),0.42866296280982125,1.204613055171817,0.1881081081081081,0.5523112540609106,1.0,19/54,25.69%,EIF6;BRIX1;RPL10A;NSA2;NOC2L;WDR12;MAK16;RPL35A;PPAN;RPL11;NVL;MDN1;RPL14;NPM1;MRPL1;SNU13;RPL7A;MALSU1;RPL23A
prerank,hexose biosynthetic process (GO:0019319),0.4423481571793318,1.204431846164678,0.1962719298245614,0.5523634113650608,1.0,10/42,17.78%,SORD;ALDOA;SLC25A1;PGK1;ENO1;PCK2;ALDOC;RBP4;ENO2;GPI
prerank,positive regulation of ion transport (GO:0043270),0.4326824954430124,1.20442118816196,0.20021762785636563,0.551930010826932,1.0,16/48,19.96%,P2RX4;ATP2B1;CHRNB2;CCL4;PRSS8;CRACR2A;CCL5;SCN1B;CACNA1D;CNKSR3;SCN3B;PKP2;WFS1;SNX4;ANO6;ACTN2
prerank,regulation of cell growth (GO:0001558),0.3928334271206477,1.204309525054359,0.09959758551307847,0.5518015536602321,1.0,40/204,16.06%,APBB2;BCL2;S100A8;S100A9;SDCBP;PRKCQ;SGK1;SGK3;SGK2;PPP1R9B;SPHK2;EIF4G1;HRG;SPHK1;CYP27B1;PPP2R1A;EXOSC4;SLC25A33;BCL6;DCBLD2;EIF4G2;ADAM17;DDX49;RACK1;ENO1;BAP1;EXOSC9;ATAD3A;CDK11B;CDC42;ADAM15;CXCL16;INO80;ARHGEF11;RASGRP2;OSGIN2;SERTAD3;USP47;MELTF;TFRC
prerank,toxin transport (GO:1901998),0.577280758978178,1.2042925876744746,0.25842696629213485,0.551398046193441,1.0,2/10,6.72%,ANTXR2;SLC22A3
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.4651666032088807,1.2042159229407128,0.2219626168224299,0.5511538166382244,1.0,12/29,24.79%,FBXW7;UBE2L3;FBXO5;RPS2;LIMK1;SMAD7;DCUN1D2;PIN1;BMI1;DCUN1D4;ARRDC4;DCUN1D3
prerank,COPII-coated vesicle budding (GO:0090114),0.4162650437219129,1.2041091198257352,0.1832627118644068,0.5510153624473995,1.0,19/68,19.36%,CTSZ;GOSR2;SEC22B;ANKRD28;NAPA;SEC24A;F5;LMAN1;SEC24D;VAPB;MCFD2;CSNK1D;RAB1A;SAR1A;PPP6C;GRIA1;TBC1D20;CUL3;F8
prerank,extracellular matrix organization (GO:0030198),0.3857496309512934,1.2039727402618914,0.064,0.5509798943385519,1.0,83/276,22.21%,SH3PXD2B;LCP1;SPP1;FN1;ITGAX;MMP8;MMP12;POSTN;ITGAL;DAG1;ITGA5;ATP7A;COLGALT1;CAPG;ADAM8;PDGFA;CD44;COL10A1;ADAMTS13;MATN3;BMP1;A2M;MMP9;FGF2;ITGA4;ELN;ADAMTS10;COL4A1;COL20A1;P3H1;CAPN1;P4HB;CDH1;COL18A1;SCUBE3;CRTAP;COL6A3;COL12A1;ADAMTS14;PLEC;ADAMTSL5;SERPINE1;GSN;ADAMTS2;SMOC1;GAS6;KLKB1;ADAM15;MMP19;DCN;LAMC1;CYP1B1;ITGB2;LAMA5;P4HA3;TIMP2;FURIN;NF1;HSPG2;KDR;COL8A2;COL9A3;BGN;ITGA11;SPINK5;DDR2;ITGA3;CAPNS1;SERPINF2;ECM2;COL16A1;ADAMTSL1;P4HA1;DST;COL9A1;TIMP1;ITGA2B;MMP17;LAMA4;LAMA3;CD47;MMP28;LUM
prerank,embryonic skeletal system development (GO:0048706),0.4514118390257464,1.203742640569252,0.19479048697621745,0.5511759179111773,1.0,4/35,3.78%,XYLT1;KIAA1217;DEAF1;HOXA4
prerank,protein-DNA complex disassembly (GO:0032986),0.5158597080716605,1.203481670011452,0.21957340025094102,0.5514910226783163,1.0,7/16,25.02%,GRWD1;RPL23;SMARCB1;SMARCC1;ARID2;SMARCD2;SMARCA4
prerank,chromatin assembly (GO:0031497),0.44976002347522487,1.2034600421182275,0.203579418344519,0.5511015315911152,1.0,20/38,32.91%,GRWD1;DAXX;NOC2L;SOX9;M1AP;PRDM9;H1-0;CHAF1B;PAF1;ATRX;NPM1;NAP1L3;ANP32B;H3-3A;RSF1;SIRT1;ASF1A;HMGB2;BAHD1;SART3
prerank,regulation of protein metabolic process (GO:0051246),0.4372369433568838,1.203430697567715,0.17275747508305647,0.5507311515525899,1.0,20/44,29.94%,APOE;PLAUR;GSAP;TRAF3;ABCA7;FURIN;WFS1;ODC1;FAM83D;CHMP6;HSP90AB1;VPS35;MAPK7;PARL;MAP2K5;MDM2;MTPN;FAF1;FKBP1A;SNF8
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.40988811379331264,1.202984874789189,0.16458333333333333,0.5515801607866272,1.0,38/85,31.23%,RNF14;FBXW7;PRICKLE1;DAB2;TREM2;ATXN3;RNF180;RACK1;VCP;USP5;PSMC3;SOCS5;CEBPA;SMAD7;SUMO2;CLU;CSNK1D;PSMC6;RNFT1;ELOB;HECTD1;PIAS1;RNF19A;GSK3B;TRIB2;GABARAP;MDM2;SUMO1;BBS7;KEAP1;PSMD10;GSK3A;CSNK1E;RCHY1;USP13;RNF19B;NUB1;SIRT2
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.5761007840430346,1.2029010063267584,0.24687933425797504,0.5513541516682997,1.0,2/10,2.58%,UBA52;RPS27A
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.3941982356118183,1.2027017629911185,0.10696266397578204,0.5515321517970622,1.0,55/145,30.28%,PSMD8;PSMD1;RAD51B;ODF2;DYNC1H1;PPP2R1A;NINL;BRD4;FBXO5;PSMD6;PSMA1;HAUS8;CCNB1;PSMC3;CEP41;DCTN1;VPS4B;YWHAG;PSMA8;CDK2;CEP250;PSMD14;PSMD2;STOX1;CSNK1D;USP47;CDC7;PSMC6;PSMA6;PLK4;PSMD5;TUBB;PSMA5;RAB11A;HAUS2;CUL1;AVEN;PSMA3;PSMB8;CDK4;CDC25B;PSMB10;CETN2;PSMD7;PSMB6;MAPRE1;PSMD10;PSMB5;PSMB7;ALMS1;PSMC4;CSNK1E;CDC25A;CCND1;CEP57
prerank,tRNA wobble uridine modification (GO:0002098),0.5239957325025247,1.2025108587852755,0.24473684210526317,0.5516496145449235,1.0,12/14,39.73%,KTI12;ELP3;TRMU;GTPBP3;MOCS3;ALKBH8;ELP1;DPH3;MTO1;CTU1;CTU2;URM1
prerank,transcription by RNA polymerase III (GO:0006383),-0.3476361220007569,-1.2022443312047182,0.16993464052287582,0.6731499501408609,1.0,9/27,14.06%,IVNS1ABP;POLR3K;GTF3C2;GTF3C1;BRF1;GTF3C6;POLR2L;ICE2;SNAPC5
prerank,apoptotic nuclear changes (GO:0030262),0.48249435856483847,1.2016892261292915,0.23207776427703525,0.5536889568501187,1.0,8/24,21.83%,DEDD2;ERN2;H1-0;DNASE2;DFFB;ACIN1;HMGB1;DFFA
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.36160026426252184,-1.2015074571419322,0.189873417721519,0.6710699187124173,1.0,8/26,12.42%,LRP5;EFNA5;ADCY5;TRPM4;EPHA5;STXBP4;PPP3CB;KLF7
prerank,COPII vesicle coating (GO:0048208),0.41940352224376765,1.2015028295798942,0.19230769230769232,0.5528622972404158,1.0,17/61,19.36%,CTSZ;GOSR2;SEC22B;ANKRD28;NAPA;SEC24A;F5;LMAN1;SEC24D;MCFD2;CSNK1D;RAB1A;PPP6C;GRIA1;TBC1D20;CUL3;F8
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.41940352224376765,1.2015028295798942,0.19230769230769232,0.5528622972404158,1.0,17/61,19.36%,CTSZ;GOSR2;SEC22B;ANKRD28;NAPA;SEC24A;F5;LMAN1;SEC24D;MCFD2;CSNK1D;RAB1A;PPP6C;GRIA1;TBC1D20;CUL3;F8
prerank,vesicle coating (GO:0006901),0.41940352224376765,1.2015028295798942,0.19230769230769232,0.5528622972404158,1.0,17/61,19.36%,CTSZ;GOSR2;SEC22B;ANKRD28;NAPA;SEC24A;F5;LMAN1;SEC24D;MCFD2;CSNK1D;RAB1A;PPP6C;GRIA1;TBC1D20;CUL3;F8
prerank,apoptotic mitochondrial changes (GO:0008637),0.4674002367854295,1.2011463387178443,0.2018348623853211,0.5534648442131536,1.0,13/32,23.46%,BCL2;BCL2L1;BID;BAX;CLU;HSPD1;CCAR2;AIFM2;IFIT2;SOD2;BIK;VPS35;BNIP3
prerank,ketone body metabolic process (GO:1902224),0.5706798258085028,1.2008114546907194,0.26045883940620784,0.5540006281242519,1.0,5/10,15.73%,SLC27A5;OXCT1;AACS;ACAT1;BDH1
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.49978123360735877,1.20077797669971,0.2541935483870968,0.5536312081215851,1.0,4/18,13.10%,APOE;MSN;RNF128;VPS11
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.31224951686191516,-1.2006572126117852,0.19090909090909092,0.6693369791961921,1.0,19/38,26.36%,CACNB2;CACNA2D1;BIN1;KCND3;KCNJ3;TRPM4;KCNH2;CACNA1C;DSG2;SCN2B;CACNA1G;KCNQ1;ANK2;SCN4B;KCNE3;DSP;KCNE4;ISL1;KCNJ5
prerank,cardiac muscle cell differentiation (GO:0055007),0.4921527624149766,1.2000446830914007,0.23309178743961353,0.5553438907175273,1.0,5/21,7.03%,AKAP13;NRG1;SHOX2;SIK1;VEGFA
prerank,regulation of complement activation (GO:0030449),0.4410400373520084,1.200004541115121,0.19911991199119913,0.5549856059951968,1.0,12/40,22.21%,C4BPB;C4BPA;C3AR1;C3;C8G;PROS1;CLU;C1QBP;C5AR1;CFP;CD55;CR1L
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.46194454847869565,1.1997887915110876,0.22247706422018348,0.5551673498882157,1.0,8/29,17.25%,TSR1;RPS14;KRI1;BMS1;UTP20;RPS19;RPS16;UTP4
prerank,sphingosine biosynthetic process (GO:0046512),0.5645718207247429,1.1997588969883057,0.25675675675675674,0.5543550463077189,1.0,5/11,27.70%,SPHK2;SPHK1;ASAH1;SPTLC3;SPTLC2
prerank,sphingoid biosynthetic process (GO:0046520),0.5645718207247429,1.1997588969883057,0.25675675675675674,0.5543550463077189,1.0,5/11,27.70%,SPHK2;SPHK1;ASAH1;SPTLC3;SPTLC2
prerank,peptidyl-amino acid modification (GO:0018193),0.5752165066639903,1.1996409131991055,0.26227208976157085,0.5542413026258262,1.0,2/10,3.58%,ATP7A;APOA2
prerank,regulation of DNA recombination (GO:0000018),0.4559297862354136,1.1996308007019842,0.21724137931034482,0.5538191914013149,1.0,9/32,19.98%,FIGNL1;PPP4C;THOC1;ZRANB3;RAD50;BLM;H1-0;RTEL1;RAD51AP1
prerank,inositol phosphate metabolic process (GO:0043647),-0.30561729437996626,-1.1994776064343493,0.09302325581395349,0.6684297067461727,1.0,16/46,16.93%,INPP5D;INPP4B;PLD4;PLCB1;PLCG2;IP6K1;INPP5J;ITPK1;IPPK;PPIP5K2;NUDT11;INPP1;PLCE1;INPP5B;ITPKA;IMPA2
prerank,regulation of biosynthetic process (GO:0009889),0.5579112618713647,1.1990604542118384,0.2513812154696133,0.5550665630689867,1.0,5/11,19.39%,SPHK2;SLC25A33;MID1IP1;CCN6;PIKFYVE
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.39673126040197226,1.199039579114879,0.11878172588832488,0.5546857610370429,1.0,51/124,31.26%,CTNNB1;CCDC88C;PSMD8;PSMD1;LEF1;AGO2;DAAM1;PRICKLE1;PLCB2;PSMD6;PSMA1;SFRP5;PSMC3;PSMA8;RHOA;PDE6B;CDC42;FZD1;CELSR1;PSMD14;FZD4;PSMD2;PSMC6;PSMA6;PSMD5;NLK;PSMA5;GNB1;AGO3;PFN1;PSMA3;PPP3R1;PSMB8;PSMB10;SFRP1;PSMD7;VANGL1;PSMB6;PDE6G;PSMD10;PSMB5;PARD6A;ARHGEF19;PSMB7;PSMC4;CELSR2;PLCB3;FRZB;CELSR3;PSMD12;CALM1
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.4199713817070272,1.1988947327606874,0.1839572192513369,0.5546670168580571,1.0,9/61,7.88%,IGF1;AKAP13;ALS2;PIK3CB;GPR174;GRB2;ERBIN;CRKL;RASGRP1
prerank,metal ion transport (GO:0030001),0.408685171901067,1.1988701336483343,0.1548856548856549,0.5542937513393632,1.0,20/86,17.22%,CACNA1A;TRPC4;SLC3A2;KCNN4;CHRNB2;CYP27B1;PANX1;MAGT1;CAV1;TPT1;PSEN2;FYN;CCL5;SLC30A9;CACNA1D;CACNG7;TRPM7;TUSC3;NIPAL1;CACNB3
prerank,purine ribonucleotide transport (GO:0015868),0.5129402713940224,1.1986893384788861,0.255050505050505,0.5543750431290958,1.0,2/16,1.78%,LRRC8C;SLC25A24
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.5280631152871245,1.1984785974961232,0.25098554533508544,0.5545730986941895,1.0,2/14,9.19%,CSF1;ATP6AP1
prerank,protein stabilization (GO:0050821),0.39201311665457056,1.1981113899909863,0.08853118712273642,0.5551492030437947,1.0,65/168,29.83%,IGF1;FLNA;ATP1B3;CCT2;GNAQ;CSN3;APOA2;GTPBP4;FBXW7;PRKCD;HYPK;RPS7;RPL23;PLPP3;STK3;P3H1;NAA16;FLOT2;USP9X;CRTAP;RPL11;LAMP2;HIP1;PARVA;TNIP2;SMAD7;EFNA1;CCT8;CLU;HSPD1;GET1;CHP1;WFS1;NLK;HIP1R;PIN1;PTGES3;CCT5;CDC37L1;TBRG1;VHL;MCM8;HSP90AB1;USP33;USP36;CALR;PFN1;ZBED3;BAG3;USP2;SUMO1;HCFC1;USP19;ATP1B2;LAMP1;NAA15;CREBL2;AFM;PER3;STK4;ATF7IP;PEX19;RABL3;USP13;MUL1
prerank,sensory perception of smell (GO:0007608),0.5524235662721146,1.1979445903173684,0.25333333333333335,0.5551934449813789,1.0,2/11,2.04%,SLC24A4;ADCY3
prerank,protein deubiquitination (GO:0016579),0.38472557348367287,1.1976967961844485,0.071,0.5554609857884337,1.0,109/242,32.39%,HIF1A;PSMD8;PSMD1;UBA52;TRAF2;RPS27A;TNIP1;JOSD1;TRAF3;OTULIN;SIAH2;USP12;GATA3;RNF128;OTUD4;ATXN3;TFPT;TAB1;TNIP3;PSMD6;USP9X;PSMA1;DDB2;BRCA1;VCP;USP5;ABRAXAS1;PSMC3;ASXL2;SUDS3;BAP1;PSMA8;MYSM1;TNIP2;RHOA;OGT;STAM2;SMAD7;SMAD1;USP40;YY1;PSMD14;PSMD2;ACTB;INO80;ASXL1;USP47;PSMC6;BARD1;PSMA6;POLB;PSMD5;UIMC1;PSMA5;USP18;DESI2;USP46;UBC;USP28;USP33;USP36;USP14;WDR48;OTUD1;PSMA3;USP50;MDM2;USP2;USP8;BIRC2;PSMB8;USP32;PSMB10;USP1;PSMD7;HCFC1;USP19;PSMB6;KEAP1;OTUD5;BRCC3;PSMD10;PSMB5;TNFAIP3;USP34;RIPK1;STAMBP;USP42;PSMB7;USP30;PSMC4;CDC25A;USP13;BECN1;USP48;SKP2;PTEN;MINDY2;SHMT2;EP300;PSMD12;STAMBPL1;ACTR8;USP15;PSMD3;USP11;USP38;ZC3H12A;UBB
prerank,protein targeting to lysosome (GO:0006622),0.498773425159719,1.197646820078365,0.20634920634920634,0.5551643759711522,1.0,6/20,14.67%,GNPTAB;LAMP2;RAB7A;GCC2;HSPA8;CLU
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.47963410750940616,1.1973963491763895,0.22914072229140722,0.555404452935689,1.0,5/21,14.71%,PRKCQ;DAG1;PSEN2;ADAM17;SPPL3
prerank,regulation of protein localization (GO:0032880),0.41632294622716065,1.197230571886716,0.19402985074626866,0.5554385163672189,1.0,24/58,29.57%,PLEKHM2;CTSD;TRIM6;FBXW7;STX6;TRIM67;RACK1;SLC26A4;TPR;VIP;AFDN;TESK1;HSP90AB1;TRIM21;SUMO1;USP8;RAB9A;KDM1A;UFL1;DNAJB6;MMD2;FKBP1A;CSNK1E;TRIM68
prerank,homologous chromosome segregation (GO:0045143),-0.3673374126736588,-1.196994615917301,0.1958762886597938,0.6713181128247834,1.0,10/20,28.35%,PTTG1;FMN2;ZCWPW1;IHO1;SGO1;MAJIN;KASH5;TERB1;MEIOB;SIRT7
prerank,Golgi to endosome transport (GO:0006895),0.5235587993270475,1.1969481564719064,0.22824716267339218,0.5558335159530647,1.0,4/16,11.19%,VPS13C;CORO7;VPS13A;DOP1B
prerank,positive regulation of actin nucleation (GO:0051127),-0.461087846812115,-1.19656107238692,0.24253731343283583,0.6683628503843082,1.0,3/11,4.91%,FCHSD2;WASF2;NCKAP1
prerank,regulation of transmembrane transport (GO:0034762),0.4527320630896677,1.196463949472395,0.23411764705882354,0.5568135088738703,1.0,7/31,14.04%,BCL2;SLC2A1;KCNJ2;PRKCB;PIM1;KCNJ10;ACTB
prerank,negative regulation of protein catabolic process (GO:0042177),0.4433296649807942,1.1959924778224635,0.21333333333333335,0.5577616901675172,1.0,14/40,22.53%,FLNA;CTSA;RGP1;AZIN1;NELL1;ADGRB1;SF3B3;RIC1;TIMP4;ROCK1;TIMP2;PIN1;TIMP1;SNX12
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.5269951266027892,1.195544642973729,0.23803191489361702,0.5585801438605088,1.0,9/15,34.41%,CSPG4;DCN;BGN;CHST12;CSPG5;DSEL;DSE;CSGALNACT2;B3GAT3
prerank,negative regulation of cellular component movement (GO:0051271),0.519432352549795,1.1949600971857184,0.24119241192411925,0.5598795123072952,1.0,7/15,22.48%,CD9;GATA3;ACTN1;FBLN1;SP100;PIN1;WAS
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.404425591009779,1.1945819361550643,0.17578947368421052,0.5605498370175993,1.0,34/83,30.14%,CDK14;CDK18;CDK6;CDK5;BRD4;PLK2;FBXO5;POLE;E2F3;CDK17;NPAT;CDK2;RCC1;CDC7;PPP6C;CDKN3;GSPT1;CUL3;CDK16;DBF4;CUL1;CDC34;CUL2;LATS1;KLF11;PLK3;CDK4;CUL4A;EIF4E;NASP;MNAT1;HINFP;CDC25A;CCND1
prerank,regulation of mitotic nuclear division (GO:0007088),0.42391420048224926,1.19440631218009,0.1956989247311828,0.5605999594956191,1.0,12/55,18.26%,IGF1;CD28;ANAPC15;FBXO5;CDK13;CCNB1;CUL9;PRMT5;RCC1;NME6;DAPK3;PIN1
prerank,brain development (GO:0007420),-0.25557944277509576,-1.1941897888708746,0.0,0.671363175972769,1.0,32/136,11.52%,ZFHX3;CX3CR1;CTNNA2;ADGRL3;PHF8;GRIN2A;ROGDI;PBX3;CNTN4;EML1;DSCAML1;GRIN2B;RAPGEF2;CDH2;UBE3A;NDRG4;SHANK3;NNAT;CNTNAP2;ADGRG1;NDUFS4;HAP1;PAX2;PAFAH1B2;ROBO2;PAFAH1B3;MEIS1;DDIT4;APOD;DNAJC30;GRIN1;MDGA1
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.46851117956996113,1.1941520542335462,0.23297491039426524,0.5608901298252622,1.0,7/26,18.40%,HIF1A;BRCA1;C3;CCR2;CYP1B1;SARS1;IL6
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.39998768811222885,1.1940337937242136,0.16956077630234934,0.5607959387232775,1.0,12/95,7.25%,XYLT1;CHST11;CSPG4;B4GALT5;HS3ST3B1;B4GALT7;GCNT2;B4GAT1;B3GNT3;HEXA;SLC35D2;ANGPT1
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.51603603210145,1.1940247927637602,0.23431498079385404,0.5603719442454531,1.0,7/15,24.29%,HIF1A;CD6;TICAM1;IL6;IL17RA;IL17D;TNF
prerank,retinoic acid metabolic process (GO:0042573),-0.41625337409659957,-1.1939506633592525,0.23893805309734514,0.6679586898136349,1.0,9/14,29.03%,BCO2;CYP26C1;ALDH1A2;ALDH1A3;ALDH8A1;CYP2S1;UGT1A7;UGT1A8;UGT1A1
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.43028895079846713,1.1939499780659453,0.19805194805194806,0.5601556976769975,1.0,17/48,25.00%,SLC26A1;ADCY8;ADCY3;NPPA;ADCY7;AMPD2;NPR2;PPCS;AK5;ACAT1;ADSS1;NPPC;COASY;NUDT2;ADCY10;ADSL;SLC35B3
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.505277192409552,1.1935686346371281,0.2540272614622057,0.5608307115672655,1.0,6/17,18.26%,IGF1;APOE;ABCA7;ROCK1;CLU;PIN1
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.5055182298144548,1.1932889770249198,0.24873096446700507,0.5612111581007077,1.0,8/17,31.91%,ATP1A3;ATP1A1;ATP1A2;PKP2;ATP1B2;FKBP1B;GJC1;GJD3
prerank,regulation of macrophage differentiation (GO:0045649),0.5186465452153223,1.1932649452039643,0.24744897959183673,0.5608408395279691,1.0,5/15,22.74%,CSF1;ID2;PTPN2;HSF1;IL34
prerank,mitotic cytokinetic process (GO:1902410),0.4920643513772562,1.1930774765877574,0.23658536585365852,0.5609503122610459,1.0,7/20,13.36%,CHMP4A;CHMP4B;PDCD6IP;VPS4B;RHOA;CHMP7;KIF20A
prerank,membrane assembly (GO:0071709),0.44444123086426135,1.1929721102703268,0.22145328719723184,0.5608007884182549,1.0,10/34,12.33%,RFTN1;CEL;LRP4;TLCD1;CHMP4B;UGCG;FLOT2;TLCD2;GAK;CHMP7
prerank,negative regulation of cell cycle process (GO:0010948),0.4214958535597344,1.192711744356739,0.19957537154989385,0.5611404501660098,1.0,23/61,26.58%,UXT;WAPL;FBXO5;BRCA1;RNF2;EED;MGA;APAF1;CDC7;PPP1R10;NME6;CBX3;BMI1;EHMT1;YAF2;TERF1;BMP4;RBBP7;E2F6;ZFYVE19;L3MBTL2;PCGF6;ESPL1
prerank,cellular response to inorganic substance (GO:0071241),0.4802488680576226,1.1926798159967327,0.23803680981595093,0.5607883206469161,1.0,6/21,23.51%,DDI2;BLM;CDK2;FOXO1;ATRX;ADCY10
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.44583020197156126,-1.1926075557040354,0.23728813559322035,0.6676104675411809,1.0,4/12,10.56%,DOCK4;MEF2C;IGFBP5;FGF9
prerank,positive regulation of transmembrane transport (GO:0034764),0.5407523956083296,1.1921202894096365,0.24764468371467024,0.5619682418413551,1.0,6/13,21.90%,NR4A3;AZIN1;ACSL1;C3;ANO6;SLC26A6
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.3910257076748588,1.1920318642224674,0.11414141414141414,0.5617780726251365,1.0,38/149,20.56%,RAB7B;S100A8;S100A9;PRKCH;IL18R1;LTF;PRKCQ;IL18RAP;MALT1;UBA52;IRAK2;TRAF2;RPS27A;ADAM8;TRIM6;SPHK1;CAV1;PRKCB;TAB1;FLOT2;TICAM1;TRAF1;PPIA;NFKB1;PRKD2;CLU;PSMA6;TFRC;TIRAP;RIPK3;DHX33;IL6;DHX9;ARHGEF2;UBC;RPS3;MTDH;RIPK4
prerank,regulation of cell adhesion (GO:0030155),0.39347673950222894,1.1913690277228546,0.14619289340101524,0.5632671193055254,1.0,31/129,16.47%,PLAU;PLXNC1;ABL2;CYTH1;PLXNA2;SPN;ADAM8;PKP4;HRG;RIPOR2;PTK2B;PPP2R1A;VEGFA;ANGPT1;PPP1R12A;RHOD;ATXN3;P4HB;PLXND1;CCL5;FBLN1;CHRD;EFNA1;ROCK1;STX3;PRKD2;YTHDF2;C1QBP;RASA1;MINK1;MYADM
prerank,chemokine-mediated signaling pathway (GO:0070098),0.43534474289301783,1.1912436815177243,0.20620842572062084,0.5631712121477281,1.0,8/42,14.55%,CCL4;PTK2B;CCL13;CCR2;CCL7;CCL5;CCL14;RBM15
prerank,response to zinc ion (GO:0010043),0.4674966912467992,1.1911193418324209,0.2609223300970874,0.5630690217124638,1.0,10/25,19.88%,P2RX4;ATP13A2;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X
prerank,GPI anchor biosynthetic process (GO:0006506),0.46003794023499256,1.190908980749956,0.2202797202797203,0.5632627592850563,1.0,11/30,22.85%,PIGQ;PIGZ;PIGA;PGAP1;PIGN;GPAA1;PIGL;PIGC;PIGX;PIGT;PIGH
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.43555955468875474,1.1908603230510575,0.22783389450056116,0.562969524793772,1.0,21/42,32.24%,ERCC6;HDAC1;CHD3;HNRNPC;SMARCB1;GATAD2B;ACTR6;SMARCC1;ACTB;INO80;SRCAP;VPS72;ARID1B;SMARCD2;HDAC2;SMARCA4;NASP;PBRM1;DMAP1;ACTR8;ANP32E
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.5029687118012859,1.1905454932374526,0.242503259452412,0.5634462992813599,1.0,6/17,16.15%,NRP1;FGF2;VEGFA;SRF;EFNB2;KDR
prerank,male meiosis I (GO:0007141),0.5207943779264266,1.190448145826176,0.2567049808429119,0.5632872852144081,1.0,5/16,16.62%,SYCP3;FOXJ3;SLC25A31;ING2;HSF2BP
prerank,positive regulation of leukocyte activation (GO:0002696),0.5008586888513713,1.190244458056058,0.24721878862793573,0.5634449892279678,1.0,7/18,21.65%,CD226;CD2;CEBPA;TNIP2;HSPD1;CLEC4D;LBP
prerank,positive regulation of protein localization to membrane (GO:1905477),0.39835650135149414,1.189743868209632,0.16597938144329896,0.5644886592191783,1.0,24/98,18.68%,LGALS3;BCL2;PRKCH;LRP1;GZMB;SQSTM1;BID;PDPK1;TREM2;STAC2;RANGRF;FYN;RHOG;YWHAG;STX3;SORBS1;ITGB2;CHP1;CNPY4;ITGA3;SLC5A3;YWHAB;PPP3CC;ITGB1BP1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.5166443516346407,1.1897133651382403,0.2483912483912484,0.5637000061157958,1.0,4/15,16.14%,AGO2;PABPC1;CPEB3;DHX36
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.5166443516346407,1.1897133651382403,0.2483912483912484,0.5637000061157958,1.0,4/15,16.14%,AGO2;PABPC1;CPEB3;DHX36
prerank,regulation of necroptotic process (GO:0060544),0.4826669922466386,1.1890621209451486,0.2385542168674699,0.5651810880876467,1.0,11/23,28.03%,SDCBP;MLKL;PDCD6IP;FLOT2;OGT;YBX3;RIPK3;ARHGEF2;BIRC2;PELI1;RIPK1
prerank,regulation of cell morphogenesis (GO:0022604),0.4519266169618187,1.1890511986358694,0.24421296296296297,0.5647700780013272,1.0,11/30,21.72%,MACF1;PDPN;CD44;FMNL2;STRIP1;LARP4;SH3D19;FERMT2;MYO9A;CFL1;ZMYM4
prerank,negative regulation of JUN kinase activity (GO:0043508),0.5676731245726441,1.1886307465139334,0.25869262865090403,0.5655223501109587,1.0,6/10,33.39%,NPPA;PTPN22;PDCD4;DNAJA1;AIDA;DUSP10
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.49141636843987824,1.1884422280327913,0.23383084577114427,0.5656144945600188,1.0,6/19,14.67%,IGF1;APOE;FLOT2;ABCA7;ROCK1;CLU
prerank,cation transport (GO:0006812),0.38710214372749124,1.1882411523415508,0.11740890688259109,0.565773373464735,1.0,39/167,19.06%,FGF13;SLC3A2;SLC6A6;KCNN4;SGK1;SLC7A1;SLC23A1;SLC5A1;PANX3;SLC6A14;SCN4A;SLC36A4;PANX1;PIEZO1;KCNA3;SLC36A3;KCNJ2;KCNMA1;SLC22A3;PIEZO2;ATP1A4;SLC7A6;KCNA4;CLN3;KCNMB4;CNGB1;KCNJ10;SLC8B1;TRPM7;ATP1A2;SCN3B;CHP1;SLC7A8;SLC18A2;NDUFA9;SLC38A7;KCNC4;ANO6;TAF7
prerank,positive regulation of axonogenesis (GO:0050772),0.43838693113048616,1.187925148189358,0.22111111111111112,0.5662255624887663,1.0,10/43,12.80%,PLXNC1;PLXNA2;MACF1;GOLGA4;AMIGO1;RUFY3;PLXND1;CHODL;RHOA;LIMK1
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.43979583638531883,1.187925109803829,0.24382022471910111,0.5657835440949422,1.0,7/38,9.79%,DAG1;XDH;PIK3CB;PPP2R5C;PLEKHA1;RACK1;SFRP5
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.49533266389525815,1.1879053899645002,0.2670807453416149,0.565410525939314,1.0,10/18,29.13%,ACSBG1;ACSBG2;HACD2;ACSL1;HACD1;ELOVL2;ELOVL1;HSD17B12;TECR;ACSF3
prerank,regulation of lipase activity (GO:0060191),0.525375584427212,1.1876184105082,0.2784471218206158,0.5658222558893183,1.0,4/13,15.94%,LPL;APOA2;RHOA;FURIN
prerank,cGMP-mediated signaling (GO:0019934),0.5349357672089657,1.1875375647555713,0.26572528883183566,0.5656242646209241,1.0,2/13,3.62%,APOE;NPPA
prerank,regulation of humoral immune response (GO:0002920),0.43065373002556284,1.1875245135014207,0.22657952069716775,0.5652268826984366,1.0,12/44,22.21%,C4BPB;C4BPA;C3AR1;C3;C8G;PROS1;CLU;C1QBP;C5AR1;CFP;CD55;CR1L
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.44842958292646046,1.1873748711056764,0.23185011709601874,0.5652133690504175,1.0,16/33,31.39%,RNF14;RUNX1;RNF6;UFM1;CARM1;SAFB2;PRMT2;KLK3;LATS1;CALR;H3-3A;KDM1A;UFL1;TRIM68;EP300;UBA5
prerank,positive regulation of histone deacetylation (GO:0031065),0.539775918771864,1.1873535724361663,0.2532981530343008,0.5648382869776019,1.0,5/12,15.29%,ZBTB7B;VEGFA;SAP30BP;PRKD2;ING2
prerank,cell projection organization (GO:0030030),0.4593040412526017,1.186987449961812,0.23693379790940766,0.5655192514405195,1.0,10/30,12.86%,PLEK;CAPG;PDGFA;SCIN;RHOQ;RHOG;PARVA;GSN;RHOU;CDC42
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.4541131796072234,1.1869735477996937,0.2309495896834701,0.5651113341876529,1.0,2/31,0.60%,GPNMB;CDK6
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.5575686960236663,1.1867139485525753,0.2544951590594744,0.5654492279254706,1.0,3/11,13.05%,AGO2;SOAT1;ABCA7
prerank,hepaticobiliary system development (GO:0061008),0.49106300888338555,1.1866033699418688,0.265,0.5653472518551201,1.0,7/20,24.58%,ARID5B;CEBPA;CEBPG;NF1;GFER;NIPBL;PRKCSH
prerank,mitochondrial translation (GO:0032543),0.3989528442263264,1.1864843148014255,0.1687116564417178,0.5652367638592326,1.0,42/104,28.60%,MRPS12;MRPL47;MRPL51;MRPL4;MRPL23;MRPL21;CHCHD1;LARS2;MRPL52;MRPL17;MRPS15;MRPL24;DAP3;MRPL12;MTRF1L;EARS2;MRPS33;MRPS16;MRPS7;MRPL53;MRPL11;MTRF1;GATB;MRPS22;MRPS35;MRPS28;MRPS30;MRPL19;MRPL15;GFM2;MRPS27;MRPL1;MRPS14;MRPL37;MRPL18;FASTKD2;MRPL39;MRPL41;MRPL27;MRPL33;RARS2;MRPL42
prerank,serine family amino acid metabolic process (GO:0009069),0.5167094377394793,1.1861694170007822,0.26184538653366585,0.5657241991514179,1.0,10/16,35.42%,SHMT1;MTHFD1;GLYAT;SARS1;CDO1;SRR;SHMT2;CBS;CTH;SEPSECS
prerank,positive regulation of apoptotic process (GO:0043065),0.3804842548884612,1.1858810196521163,0.066,0.566111726130537,1.0,101/293,25.22%,CTNNB1;ABR;CTSD;ATG7;GNA13;UBA52;RPS27A;AKAP13;SPHK2;RPS6;PTPA;SCIN;HRG;GZMA;DUSP9;SQSTM1;MTCH1;CDK5;BID;BCL6;STK3;KCNMA1;SIK1;ING4;HTT;DLC1;BCL2L11;TFPT;PSEN2;DIABLO;LILRB1;RACK1;BAX;IAPP;UTP11;ARHGEF1;JUN;DNM2;SUDS3;DUSP6;TCTN3;IRF5;ARHGEF18;TLE5;TFAP4;MTCH2;DDIT3;CLU;DAPK1;CYP1B1;HSPD1;ARHGEF11;ING3;APAF1;C1QBP;FOXO1;PRMT2;BARD1;SMPD1;NF1;KALRN;ING5;RPS6KA2;MYBBP1A;HIP1R;DAPK3;ATM;ANO6;IL6;ARL6IP5;CCAR2;CCAR1;AIFM2;CASP9;IFIT2;PTGIS;ARHGEF2;CTNNBL1;HMGB1;UBC;RPS3;CRADD;PLEKHG2;SRPK2;TNFSF10;BMP4;MELK;LATS1;KLF11;ARHGEF5;VAV3;ADAMTSL4;BNIP3;DNAJA1;TNF;GADD45A;ATF4;DCUN1D3;RRP1B;VAV1;SFRP1
prerank,body fluid secretion (GO:0007589),0.5205536501404358,1.1853888752641082,0.26947637292464877,0.5671064925365351,1.0,4/15,15.63%,CSN3;ZBTB7B;VEGFA;VIP
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.4968816540505382,1.1852663432923707,0.25161290322580643,0.5670130598929779,1.0,5/17,16.20%,LPL;HDAC9;APOC1;FURIN;APOH
prerank,nuclear membrane disassembly (GO:0051081),0.5235159260505767,1.1852083946852268,0.2578947368421053,0.5667462589850772,1.0,5/14,17.88%,CTDNEP1;PRKCB;CCNB1;DCTN1;NEK6
prerank,negative regulation of MAP kinase activity (GO:0043407),0.43249042293762785,1.184922018173732,0.2081949058693245,0.567136511437957,1.0,12/44,17.17%,APOE;PIK3CB;NPPA;PRKCD;PTPN22;CD300A;PAQR3;SPRY4;STK38;SMPD1;NF1;PDCD4
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.4012557697415072,1.1845056851895475,0.19267015706806281,0.5679612358069772,1.0,19/80,12.11%,RAB7B;TBC1D10C;GOSR2;SNX8;RGP1;TMEM87B;VTI1A;BET1L;ARL1;STX6;RIC1;SPAG9;TBC1D23;VPS26A;DCTN1;VPS50;RAB7A;GCC2;LMAN1
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.459140574332661,1.1841093207930828,0.22843822843822845,0.5686131460667813,1.0,11/30,21.92%,ACSBG1;SLC27A5;HACD2;ABCD4;ACSL1;PEX2;ABCD2;HACD1;ABCD3;ELOVL2;ELOVL1
prerank,establishment of spindle localization (GO:0051293),0.5179010676337827,1.1839556279449681,0.27320261437908494,0.568626928382174,1.0,7/14,26.58%,DYNC1H1;LLGL2;CFL1;LLGL1;ZBED3;MAP4;ESPL1
prerank,RNA processing (GO:0006396),0.38323403846755355,1.1837337203087972,0.13266331658291458,0.568822138730934,1.0,69/176,27.33%,APOBEC1;SNRNP35;DEDD2;ADARB1;SRPK1;PPP1R9B;HNRNPUL1;PPP2R1A;ZRSR2;PIWIL2;SF3B3;THOC1;CELF1;XRN2;ATXN1;HNRNPC;DDX17;SON;RNASEL;PABPN1;M1AP;METTL3;SRSF11;RBPMS;PRPF4;SRSF7;HNRNPK;DDX39B;SYNCRIP;HNRNPA2B1;LSM6;DUSP11;PRPF6;RBM39;HNRNPU;HNRNPF;KIN;SNRNP40;CCAR2;ZMAT5;ADAR;TARDBP;SRSF2;PPIG;PRPF8;PABPC4;USB1;SRPK2;SMU1;DKC1;SF3A3;LSM4;RBMS2;SRRM1;FASTKD5;SNRPG;SF3B2;SF3B1;HNRNPL;KHSRP;GEMIN2;RRAGC;SNRPF;LSM3;MTPAP;FASTKD2;NOL3;FUS;SUPT4H1
prerank,regulation of cell development (GO:0060284),0.4410733210275368,1.1836085812038617,0.22789115646258504,0.5687700927923152,1.0,10/36,15.88%,CTNNB1;HDAC9;HES7;BHLHE40;BHLHE41;PRUNE1;RPS19;YTHDF2;DOCK7;FOXO1
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.5344497316771315,1.1836077412494983,0.2627450980392157,0.5683370430446174,1.0,8/13,31.39%,ATG7;DESI1;DESI2;SAE1;UBA6;ATG10;UBA3;UBA5
prerank,sterol metabolic process (GO:0016125),0.41134799085893453,1.183605497382115,0.19893048128342247,0.5679085585281367,1.0,12/60,14.77%,APOE;ABCG1;ABCA1;LIPA;APOA2;CYP19A1;SOAT1;PPARD;ARV1;SOAT2;CYP1B1;CH25H
prerank,neuron remodeling (GO:0016322),-0.46484990640844487,-1.1835961361761076,0.25190839694656486,0.6886314107434043,1.0,4/10,7.95%,ADGRB3;ANKS1A;FARP2;APP
prerank,negative regulation of type I interferon production (GO:0032480),0.43468998777135576,1.1835116527033323,0.21793416572077184,0.5677855980541026,1.0,18/40,27.90%,SIRPA;NLRC3;RNF125;IKBKE;LILRB1;ILRUN;YY1;UBE2L6;ACOD1;PIN1;HAVCR2;NLRC5;RNF216;REL;TRAF3IP1;OTUD5;TBK1;TNFAIP3
prerank,autonomic nervous system development (GO:0048483),0.5003370768881716,1.1833819508706427,0.25157232704402516,0.5677243759514435,1.0,3/17,6.39%,FN1;NRP1;GATA3
prerank,positive regulation of programmed cell death (GO:0043068),0.37945121193652925,1.183205398062404,0.07707707707707707,0.5677994886329666,1.0,97/272,25.22%,CTNNB1;ABR;CTSD;ATG7;GNA13;UBA52;RPS27A;AKAP13;SPHK2;RPS6;PTPA;SCIN;HRG;GZMA;DUSP9;SQSTM1;MTCH1;BID;BCL6;STK3;KCNMA1;ING4;HTT;BCL2L11;TFPT;PRF1;PSEN2;DIABLO;LILRB1;RACK1;BAX;IAPP;UTP11;ARHGEF1;JUN;DNM2;SUDS3;DUSP6;TCTN3;IRF5;ARHGEF18;TFAP4;MTCH2;CLU;DAPK1;CYP1B1;HSPD1;ARHGEF11;ING3;APAF1;C1QBP;FOXO1;PRMT2;BARD1;SMPD1;SYK;NF1;HTATIP2;KALRN;ING5;RPS6KA2;HIP1R;DAPK3;ATM;ANO6;IL6;ARL6IP5;CCAR2;CCAR1;AIFM2;CASP9;IFIT2;ARHGEF2;CTNNBL1;HMGB1;UBC;CRADD;LAPTM5;PLEKHG2;MARK4;TNFSF10;BMP4;MELK;LATS1;KLF11;ARHGEF5;VAV3;ADAMTSL4;BNIP3;DNAJA1;TNF;GADD45A;ATF4;DCUN1D3;RRP1B;VAV1;SFRP1
prerank,heart process (GO:0003015),-0.41561218189130855,-1.1831156736906145,0.24324324324324326,0.6857670106950599,1.0,2/14,0.77%,SGCZ;SGCD
prerank,positive regulation of integrin activation (GO:0033625),0.5449182258830476,1.1830198884407817,0.2640750670241287,0.567890045075841,1.0,3/11,4.51%,SKAP1;PLEK;PIEZO1
prerank,photoreceptor cell development (GO:0042461),0.5278255022726599,1.1830140205979334,0.25921219822109276,0.5674674238782871,1.0,5/14,27.96%,TH;VEGFA;DCX;MYO7A;ARL3
prerank,adipose tissue development (GO:0060612),0.5513101205198472,1.1828660868658893,0.25688073394495414,0.567472654121713,1.0,2/11,1.81%,SH3PXD2B;ARID5B
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.41841316955948327,1.1826599920744627,0.2222222222222222,0.567207768214267,1.0,22/50,29.50%,NUP205;AGO2;EIF4G1;POLR2H;NUP188;POLR2D;RANBP2;TPR;PUM1;RAE1;NUP93;AAAS;NUP54;NUP50;POLR2F;NUP98;NUP42;NUP133;NUP210;H3-3A;NUP35;NUP214
prerank,regulation of gene silencing by RNA (GO:0060966),0.41841316955948327,1.1826599920744627,0.2222222222222222,0.567207768214267,1.0,22/50,29.50%,NUP205;AGO2;EIF4G1;POLR2H;NUP188;POLR2D;RANBP2;TPR;PUM1;RAE1;NUP93;AAAS;NUP54;NUP50;POLR2F;NUP98;NUP42;NUP133;NUP210;H3-3A;NUP35;NUP214
prerank,macroautophagy (GO:0016236),0.3904117454637109,1.182640458756799,0.15853658536585366,0.5668264760422309,1.0,35/118,22.19%,TECPR1;TCIRG1;ATG7;TOMM22;ATP13A2;PLEKHM1;SQSTM1;ARL8B;CHMP4A;CHMP4B;LIX1;LAMP2;LIX1L;PLAA;VCP;CLN3;VPS4B;VTA1;MTMR14;MAP1LC3B;ILRUN;STAM2;TOMM5;UBQLN1;TOMM40;MVB12A;VIPAS39;ATG16L1;PRKAG1;CSNK2A2;CHMP6;UBXN6;VPS39;MAP1LC3A;GABARAP
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.43968159710908394,1.1826280056691891,0.23284589426321708,0.5664256299863017,1.0,12/40,20.69%,BCL2;BCL2L1;SLC25A33;VCP;BAX;STOX1;SLC25A36;TUSC2;CCN6;ARL6IP5;STOML2;SPART
prerank,regulation of cell cycle process (GO:0010564),0.39916085862110573,1.1820010477144354,0.1511746680286006,0.5678747472390828,1.0,38/104,27.01%,CTNNB1;BCL2L1;DYNC1H1;SOX9;PLK2;AHCTF1;FBXO5;CDK13;CUL9;KLHL13;PRMT5;ATF5;BIRC6;CDC42;KIF20A;CEP250;GIT1;NUMA1;RCC1;YTHDF2;RACGAP1;PLK4;DAPK3;RAB11A;PIN1;CSNK2A2;DBF4;RAB11FIP4;MARK4;SND1;CALM3;PLK3;DCUN1D3;SFRP1;CETN2;USP19;KLHL21;PRPF40A
prerank,negative regulation of phosphatase activity (GO:0010923),0.4680775944469011,1.1819938727706343,0.24087591240875914,0.5674683015497253,1.0,10/25,29.29%,PTPA;ZCCHC9;BOD1L1;PPP1R35;SH2D4A;CHP1;GSK3B;PPP1R15A;FKBP1B;FKBP1A
prerank,regulation of cell cycle (GO:0051726),0.3805005164978316,1.1818763587302294,0.083,0.5673885157926039,1.0,80/271,25.35%,APBB2;IQGAP1;CDK6;SDCBP;PTPRC;FBXL17;ADARB1;MYBL2;PPP1R9B;FIGNL1;ID2;IRF6;TTLL12;CDK5;RPL23;GATA3;ERN1;SIK1;SOX9;NUDT6;WDR12;ING4;EIF4G2;FBXO5;GMNN;LILRB1;SON;DYNLT3;BRCA1;RACK1;CCNB1;METTL3;JUN;BAP1;PRCC;TFAP4;NUPR2;CDK11B;BIRC5;LRP6;BARD1;PUM1;RPS6KA2;MYBBP1A;PDCD4;STK11;CDKN3;HNRNPU;NEK6;DAPK3;CDC26;ATM;FBXL6;RNF167;TARDBP;CSNK2A2;TAF6;RNF20;TBRG1;HSP90AB1;SRPK2;RUNX3;CKS2;SND1;BMP4;SETMAR;CDC123;TRIM21;CALR;PPP1R15A;MIF;FGFR2;MDM2;GADD45A;BIRC2;SIPA1;DCUN1D3;CDK4;SFRP1;MAPK12
prerank,regulation of chondrocyte differentiation (GO:0032330),0.4724870894870793,1.1815078969349293,0.2496954933008526,0.5680669828952537,1.0,5/24,13.01%,SCIN;GDF6;SOX9;PKDCC;ZBTB16
prerank,cellular response to heat (GO:0034605),0.4437802334668163,1.181014801258871,0.23469387755102042,0.5690745998447179,1.0,16/35,28.89%,DAXX;ATXN3;VCP;HMOX1;POLR2D;TPR;DHX36;HSP90AB1;HSF1;RBBP7;BAG3;SUMO1;TCIM;FGF1;ZFAND1;IER5
prerank,negative regulation of cellular component organization (GO:0051129),0.4017244254860114,1.1801133457164352,0.20569620253164558,0.5712130839176435,1.0,18/74,18.50%,LGALS3;MCTP1;APOA2;PON1;RAF1;VEGFA;SNX33;LILRB1;IAPP;DNM2;RIOK3;CDC42;HSPA8;ABCA7;CLU;BMP6;DNAJB1;RTEL1
prerank,nuclear envelope organization (GO:0006998),0.48952752942766986,1.1800291087301538,0.26982097186700765,0.5710405845623183,1.0,9/20,33.25%,CTDNEP1;LEMD2;REEP3;SUN1;NUP93;TOR1B;SPAG4;TMEM43;NEMP1
prerank,peptide hormone secretion (GO:0030072),0.46759632680289187,1.180004196320368,0.24105011933174225,0.5706851587534361,1.0,7/26,19.92%,ANXA1;SNX19;CYB5R4;VIP;RAB1A;IL6;CDK16
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.3850910381740201,1.1793773636137048,0.142570281124498,0.5721630658264485,1.0,61/186,29.34%,DKK2;APOE;LRP1;CCDC88C;PSMD8;PSMD1;BICC1;SOX30;PRICKLE1;CAV1;SIAH2;LRP4;DAB2;STK3;SOX9;HDAC1;MDFI;ZNRF3;PSMD6;PSMA1;RACK1;SFRP5;PSMC3;PSMA8;TLE5;PSMD14;FZD4;SCYL2;PSMD2;DDIT3;LRP6;PSMC6;PSMA6;LZTS2;STK11;PSMD5;NLK;PSMA5;CUL3;FRMD8;TPBG;GSK3B;LATS1;TRABD2B;WWOX;PSMA3;PSMB8;PSMB10;SFRP1;MDK;PSMD7;PSMB6;PSMD10;GSK3A;DACT1;PSMB5;RUVBL2;PSMB7;TLE1;STK4;PSMC4
prerank,response to reactive oxygen species (GO:0000302),0.42064881443142954,1.1793549107366255,0.19804134929270947,0.571798875497128,1.0,23/54,29.44%,APOE;HIF1A;PRDX5;MMP9;STK24;HP;AGAP3;HMOX1;FYN;JUN;MAPK9;CAT;GLRX2;RPS3;SOD2;PLK3;PDGFRA;GPX1;NCF1;MAPK3;PRDX3;APTX;SIRT1
prerank,cell-cell junction assembly (GO:0007043),0.4129894700750528,1.1793050827648568,0.20084566596194503,0.5715081899930529,1.0,17/63,18.72%,CTNNB1;CD9;TLN1;GJB2;PKP4;PKP1;ACTG1;JUP;PIP5K1C;RHOA;SMAD7;PKN2;PAK2;ACTB;PKP2;PATJ;GJB6
prerank,actin filament polymerization (GO:0030041),0.45591415363025456,1.1784777085255915,0.2558139534883721,0.5734218410521907,1.0,8/29,16.58%,GAS7;MSRB1;WASHC5;CORO7;ARHGAP6;DIAPH1;GSN;MICALL2
prerank,canonical Wnt signaling pathway (GO:0060070),0.40878610303294954,1.1784261646833722,0.20210526315789473,0.5731342051962302,1.0,15/68,16.00%,CTNNB1;TCF7;LEF1;CAV1;GATA3;PLPP3;WNT6;SFRP5;RAB5A;FRAT1;FZD1;FZD4;SCYL2;LRP6;NR4A2
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.4422483814418826,1.1778422802757973,0.24276169265033407,0.5743618177553121,1.0,7/36,14.04%,APOE;HIF1A;PIK3CB;CAV1;GLA;DNM2;NOSTRIN
prerank,cAMP metabolic process (GO:0046058),0.5338855732867333,1.1778083445606122,0.2859042553191489,0.5740287347366008,1.0,3/13,4.21%,ADCY8;ADCY3;ADCY7
prerank,cilium-dependent cell motility (GO:0060285),0.47931670635425727,1.1777590034915748,0.25814234016887816,0.573738996023794,1.0,10/22,28.87%,CFAP44;TEKT2;DNAH8;TEKT5;DNAH3;EFHC1;CCDC65;DNAI3;CCDC39;DNAH17
prerank,cellular protein-containing complex assembly (GO:0034622),0.38347331831073783,1.1775012633066801,0.14285714285714285,0.5740765770897233,1.0,56/159,28.30%,CYBA;CD3E;NUP205;TRAF2;CCT2;HSPA4;NRG1;COX7A1;BBS10;TESPA1;NCK2;DNAJB14;NCK1;SAMM50;ANGPT1;CHMP4A;CHMP4B;AHCTF1;TBCA;COG4;HIP1;LONP1;MID1IP1;CENPT;SMAD1;RPL38;CLU;HSPD1;NDUFAF1;TPR;VAMP4;VAMP2;MKKS;HIP1R;DHX9;HIGD2A;PTGES3;FCHO1;NUP93;HSP90AB1;HSF1;COX7A2L;TTC12;EIF4B;PSMG3;COX7A2;PIK3C2A;CCDC65;NUP98;CENPA;CCDC40;CCDC39;ARL6;DNAJB12;VAMP3;CALY
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.40622460805424104,1.1771562715152417,0.2091295116772824,0.5746435915974353,1.0,12/66,10.02%,APOE;CDK6;NLRC3;XDH;VDR;FBXW7;CAV1;GATA3;MTSS1;SOX9;PEX2;B2M
prerank,negative regulation of protein kinase activity (GO:0006469),0.3964012746534899,1.1771027568104515,0.20330237358101136,0.5743769439811319,1.0,24/88,19.18%,CORO1C;SMCR8;PTPRC;ADARB1;GNAQ;CAV1;HSPB1;PDPK1;DBNDD1;TAB1;DTNBP1;MVP;YWHAG;PAK2;PPIA;LRP6;DUSP3;NF1;CHP1;GSKIP;TESK1;ITGB1BP1;TAF7;ADAR
prerank,regulation of immune effector process (GO:0002697),0.4307356398611294,1.1770033437304839,0.2239297475301866,0.5742235866282183,1.0,12/41,22.21%,C4BPB;C4BPA;C3AR1;C3;C8G;PROS1;CLU;C1QBP;C5AR1;CFP;CD55;CR1L
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.4526280842112145,1.1768894128192555,0.2618483412322275,0.5741085690860349,1.0,13/29,31.39%,RUNX1;VPS18;UFM1;BRCA1;CARM1;VPS11;WBP2;LATS1;KMT2D;KANK2;UFL1;CNOT9;UBA5
prerank,regulation of TORC1 signaling (GO:1903432),0.4475153866485876,1.1765317939871374,0.2471655328798186,0.5747172764587754,1.0,3/33,1.38%,GPR137B;RRAGD;SMCR8
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.4193866349771434,1.176445027523106,0.23624595469255663,0.5745602032705388,1.0,12/47,17.85%,CYBA;MMP8;FPR2;XDH;PRKCD;ADGRB1;GRB2;ITGB2;ACOD1;SYK;SLC5A3;CBR1
prerank,central nervous system neuron development (GO:0021954),0.5152150785716159,1.1764308315326957,0.2692307692307692,0.5741683711299196,1.0,2/15,2.10%,B4GALT5;ATP7A
prerank,hyaluronan metabolic process (GO:0030212),0.4711986749188873,1.176349728578264,0.2673860911270983,0.5739769852559142,1.0,6/23,16.30%,SLC9A1;CD44;FGF2;HEXA;GUSB;CHP1
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.4511960577097936,1.1757534774286382,0.267816091954023,0.5752279146829058,1.0,12/31,27.44%,BCL2;GZMB;BID;BAX;YWHAG;HIP1R;YWHAB;PPP3CC;GSK3B;PPP3R1;YWHAZ;GSK3A
prerank,axonal transport of mitochondrion (GO:0019896),0.5354920853475156,1.1755320902252802,0.25864453665283543,0.5754434984468234,1.0,3/11,7.99%,HIF1A;MGARP;TRAK1
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.4792725711334182,1.175409547368743,0.2670886075949367,0.5753857976768442,1.0,6/19,14.19%,XDH;PIK3CB;HRG;CADM4;CD63;DCN
prerank,negative regulation of histone acetylation (GO:0035067),0.5522734711868372,1.1752302106767216,0.2960969044414536,0.5755153267039957,1.0,6/11,31.24%,NOC2L;THAP7;BRCA1;TAF7;SIRT1;SET
prerank,regulation of lymphocyte migration (GO:2000401),0.5522400123549207,1.1748203443357428,0.2827586206896552,0.5762215766930641,1.0,3/10,14.58%,MSN;SPN;SLC8B1
prerank,aortic valve development (GO:0003176),0.4410563954060497,1.1745281047738538,0.23636363636363636,0.5766468567594283,1.0,9/34,13.60%,NPPA;JAG1;ELN;GATA3;SOX9;TNFRSF1B;DLL4;EFNA1;ROCK1
prerank,negative regulation of protein modification process (GO:0031400),0.4039665013333035,1.1744410384616868,0.19895833333333332,0.5764833527135858,1.0,37/79,32.38%,CORO1C;SIRPA;XDH;PTPA;MFHAS1;PLPP3;CRKL;P3H1;CRTAP;CADM4;FBLN1;PAQR3;PTPN13;PPIA;LRP6;PPP1R15B;CHP1;MYADM;YWHAB;TARDBP;GSK3B;FXYD1;PPP1R15A;ZBED3;PPP1R8;DNAJC10;PRR5L;TRAF3IP1;CDYL;TERF2IP;SIRT1;PNKP;PTEN;EPHB2;DBI;PID1;ZC3H12A
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.5475239630184928,1.174283769276983,0.29335071707953064,0.5765376520633576,1.0,6/11,18.71%,PRKCD;STK24;DIABLO;CYP1B1;GSKIP;ARL6IP5
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.507098071612019,1.174015469088919,0.2858990944372574,0.5769232542250161,1.0,4/15,8.63%,RIPOR2;ADGRB1;TREM2;CD53
prerank,myeloid cell activation involved in immune response (GO:0002275),0.4889493095274261,1.1739226574831556,0.28117359413202936,0.5767742404889479,1.0,6/18,21.65%,DOCK2;FER1L5;SYK;SBNO2;FCER1G;LBP
prerank,mitochondrial translational elongation (GO:0070125),0.39730413602775233,1.1727963822379115,0.20863309352517986,0.5795612724595888,1.0,35/88,28.60%,MRPS12;MRPL47;MRPL51;MRPL4;MRPL23;MRPL21;CHCHD1;MRPL52;MRPL17;MRPS15;MRPL24;DAP3;MRPL12;MRPS33;MRPS16;MRPS7;MRPL53;MRPL11;MRPS22;MRPS35;MRPS28;MRPS30;MRPL19;MRPL15;GFM2;MRPS27;MRPL1;MRPS14;MRPL37;MRPL18;MRPL39;MRPL41;MRPL27;MRPL33;MRPL42
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.5047721630956614,1.1724080543849107,0.28081321473951715,0.5802382777303604,1.0,6/16,27.44%,KLK6;PRMT5;C3;ACP3;PDE6G;GSK3A
prerank,establishment of epithelial cell polarity (GO:0090162),0.49254240029018126,1.1723912198787458,0.25093167701863356,0.579856840158691,1.0,9/19,24.09%,RAP2A;CYTH1;MSN;RHOA;CDC42;MYO9A;SYNE4;GOLPH3;SIPA1L3
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.40274142943004154,1.172001539628702,0.20515574650912996,0.5805446602809671,1.0,24/66,26.37%,FLNA;CCT2;PRKCD;IPO5;TRIM28;CDH1;CARD10;JUP;CCT8;TPR;TFRC;PIK3R2;KAT7;TESK1;ORMDL3;FERMT2;CCT5;DKC1;TERT;BAG3;RBM22;HDAC3;ZPR1;SESN2
prerank,dendritic cell differentiation (GO:0097028),0.4776509375944082,1.1717053470993704,0.26438188494492043,0.5809729433445254,1.0,6/22,17.31%,AXL;TREM2;LILRB1;IRF8;GAS6;CAMK4
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.38492185195926876,1.1715935560801807,0.14416243654822336,0.5808681621535235,1.0,29/150,11.67%,OSBPL8;LCK;P2RX4;GCNT2;ADAM8;PDGFA;PIK3CB;AXL;FAM110C;NRG1;FGF2;CD28;MFHAS1;MYDGF;PIK3R5;PDPK1;TRAT1;GATA3;GRB2;ANGPT1;IGF1R;KITLG;FGF7;HIP1;IAPP;FYN;MYOC;RHOG;FGF20
prerank,error-free translesion synthesis (GO:0070987),0.4760845455501857,1.1714474050054018,0.2943980929678188,0.5808858521124874,1.0,12/22,33.78%,UBA52;RPS27A;VCP;RFC1;UBC;REV1;RFC2;RCHY1;RFC4;UBB;RFC5;PCNA
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.5592520697097324,1.171386637792866,0.2741046831955923,0.5806320678797647,1.0,4/10,17.49%,HK1;PFKL;PFKP;HK3
prerank,DNA replication (GO:0006260),0.38939819890040483,1.1712491027977203,0.18488253319713993,0.5806191840278113,1.0,37/105,24.21%,ORC3;MCM7;MCM2;GRWD1;IGHMBP2;ING4;PTMS;RMI1;POLE;RNASEH2A;BRCA1;RAD50;BLM;CDK2;CDC7;BARD1;ING5;POLG2;POLB;WDHD1;RFC1;KAT7;ATM;KIN;RAD1;POLG;TOP1;MCM6;DUT;RECQL5;TBRG1;DBF4;MCM8;TOPBP1;POLA2;REV1;RFC2
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.36498890790508504,-1.1709631262907507,0.2328042328042328,0.7168622997326568,1.0,3/20,6.87%,ST3GAL6;B3GALT5;B3GALT1
prerank,response to molecule of bacterial origin (GO:0002237),0.4045775503360718,1.1707060859918943,0.21647307286166842,0.5816965049559046,1.0,28/69,29.81%,S100A8;S100A9;CD24;TRIM6;CD6;CYP27B1;PTPN22;ERBIN;NOCT;MAPKAPK3;ADAM17;MAPKAPK2;IRF5;ACOD1;TIRAP;IL6;SLC11A1;LBP;F2R;JAK2;TLR9;PELI1;SRR;OTUD5;TNFAIP3;PRDX3;TAB2;HMGB2
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.44120247757958,1.1706166419378523,0.24305555555555555,0.5815384545933326,1.0,2/33,0.60%,GPNMB;CDK6
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),0.5459033950731101,1.1697887856609714,0.28730822873082285,0.5834710783386954,1.0,3/11,13.44%,IGF1;IGF1R;GHR
prerank,defense response to protozoan (GO:0042832),0.5265956202234378,1.1696982023158398,0.2934051144010767,0.5833254058377648,1.0,1/12,0.11%,LYST
prerank,positive regulation of interferon-gamma production (GO:0032729),0.41804498818543206,1.169549145781585,0.22958057395143489,0.583303875601841,1.0,13/48,15.77%,IL18R1;CD226;CD2;IL27;IL12RB1;PTPN22;TXK;RASGRP1;LILRB1;CRTAM;CCR2;HSPD1;CEBPG
prerank,positive regulation by host of viral transcription (GO:0043923),0.5100389827758643,1.1694645394684495,0.26851851851851855,0.5831055722297663,1.0,8/15,26.57%,LEF1;SMARCB1;JUN;TFAP4;SP1;SMARCA4;RRP1B;SNW1
prerank,regulation of developmental growth (GO:0048638),0.4451071917037367,1.169252978176791,0.26247030878859856,0.5833004193541451,1.0,9/29,23.14%,IGF1;APOE;DNM2;GHR;GSK3B;LATS1;FGFR3;NIPBL;STAT5B
prerank,mitochondrion organization (GO:0007005),0.3832137323818396,1.1692155028058613,0.15090543259557343,0.5829757722635115,1.0,71/165,29.88%,BCL2L1;VPS13C;ATP7A;TOMM22;THG1L;MGARP;COX7A1;BID;SLC25A33;SAMM50;TRAK1;TIMM44;RAB32;BAX;SIRT5;DNM2;TIMM9;NRF1;AFG1L;LONP1;ALAS1;ATAD3A;AFG3L2;CHCHD2;MTFP1;TOMM5;SLC25A36;MTX3;TOMM40;HSPD1;TWNK;ATPAF1;VPS13D;SIRT4;POLG2;TMEM11;GABPB1;HAX1;HIGD2A;AGTPBP1;RHOT2;AIFM2;MTFR2;IFIT2;STOML2;FBXO7;TIMM17A;PYROXD2;BIK;COX7A2L;PITRM1;MTFR1;TIMM23;TERT;PPRC1;BNIP3;ATP5F1B;COX7A2;SIRT3;HCFC1;SUPV3L1;BNIP3L;FMC1;CYCS;PRDX3;USP30;TOMM7;SPG7;FIS1;MUL1;MFF
prerank,blood vessel morphogenesis (GO:0048514),0.41674491382686696,1.1691141338492923,0.2245119305856833,0.5828213173778938,1.0,14/54,17.58%,FLT1;NRP1;CAV1;COL4A1;VEGFA;SMAD7;EGFL7;CYP1B1;SYK;NF1;EFNB2;KDR;RASA1;SERPINF2
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.42868074477487905,1.1689600127913873,0.2425629290617849,0.5828679226682388,1.0,8/39,12.09%,MYO1E;MYO5A;MYO1F;MYO1A;HTT;TRAK1;CLN3;KIF1A
prerank,nitrogen compound transport (GO:0071705),0.38519710679499525,1.1689017043366818,0.16497975708502025,0.5826216041941104,1.0,32/141,19.58%,SLC3A2;SLC38A1;SLC6A6;SLC15A3;SLC7A1;PDPN;SLC7A11;SLC23A1;HRG;SLC48A1;SLC6A19;CD3G;SLC6A14;TOM1;SLC6A8;SLC16A10;SLC22A3;SLC6A4;SLC18A1;SLC7A6;RAB7A;SLC1A5;SLC52A2;RCN3;SLC7A8;SLC18A2;SLC43A2;SNX4;VAMP2;ARL6IP5;SLC38A2;SLC11A1
prerank,hydrogen peroxide catabolic process (GO:0042744),0.5512964282002012,1.168872184547772,0.2830188679245283,0.5822954284249415,1.0,8/11,38.65%,PRDX5;PRDX1;CAT;GPX1;PRDX3;PXDNL;GPX3;PXDN
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.41026419144477566,1.1687718026217997,0.2357984994640943,0.5821411775174087,1.0,7/57,4.49%,RGS1;FLNA;FPR2;ADCY8;ADCY3;ADCY7;PSAP
prerank,cellular response to glucagon stimulus (GO:0071377),0.49194406125528933,1.1676195708788684,0.29028132992327366,0.5850383593246247,1.0,3/17,4.21%,ADCY8;ADCY3;ADCY7
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.39080917475560073,1.1674854667480261,0.20081967213114754,0.5849757183570036,1.0,21/93,18.40%,BCAR3;FNIP2;CD44;EIF4G1;TRIM6;RAF1;CAV1;NCK2;NCK1;VEGFA;RACK1;PAQR3;CNKSR3;GAS6;SMAD7;STOX1;PRKD2;DOCK7;TFRC;HAX1;IL6
prerank,regulation of cellular component biogenesis (GO:0044087),0.4367420066859099,1.1673231458901514,0.23986486486486486,0.5850257375421988,1.0,9/39,13.60%,APOE;MSN;TRAF2;FAM110C;HRG;BBS10;HSPA8;VPS11;ROCK1
prerank,response to cytokine (GO:0034097),0.38430241714700675,1.1671634869510952,0.1519756838905775,0.5850157401723745,1.0,46/141,24.97%,BCL2;BCL2L1;IL18R1;ANXA1;LEF1;SHFL;IRAK2;MCL1;OSMR;SPHK1;CYP27B1;PTPN23;HDAC4;IFITM2;CD274;IKBKE;MAP4K3;IFITM1;MAPKAPK3;MAPKAPK2;PTPN2;PTPN12;RHOA;TLE5;SP100;TIMP4;PTPN13;CXCL16;TIMP2;SRF;SMPD1;SIGIRR;HAX1;DDOST;ADAR;BST2;SLC11A1;TIMP1;TRIM21;CD74;REL;PTPN9;JAK2;KYNU;PTPN18;KHSRP
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.42653254893158704,1.1671493670137878,0.24164810690423164,0.584632304707559,1.0,10/44,15.76%,LTF;CST7;CD44;RAF1;SIAH2;VEGFA;CAST;TRIAP1;GAS6;USP47
prerank,regulation of actomyosin structure organization (GO:0110020),0.5303809780416201,1.166713357514478,0.2787958115183246,0.5854886842704864,1.0,7/13,22.48%,SLC9A1;AKAP13;ACTG1;CDC42;ROCK1;PTGER4;WAS
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.41579664794906324,-1.16649779418835,0.2638888888888889,0.7258983122735666,1.0,9/15,24.75%,IL16;F3;NTRK3;CDH13;VEGFD;F7;VEGFC;CXCL12;PGF
prerank,positive regulation of phosphorylation (GO:0042327),0.37958773560680886,1.1664407468190394,0.11033099297893681,0.5858158389205247,1.0,52/240,18.30%,GPNMB;IGF1;FLT1;HIF1A;SDCBP;RAP2A;FPR2;PLAUR;CD4;AXL;CLDN19;NPTN;MMP9;NRP1;FGF2;LMO4;DAXX;MYDGF;DAB2;SOX9;PFKFB3;VEGFA;CRKL;ANGPT1;TREM2;RASGRP1;IGF1R;VAC14;ILK;ADAM17;P2RY1;RACK1;KRAS;FGF7;C3;RAD50;CCL5;FGF20;GAS6;EFNA1;ENTPD5;FGF18;PPIA;CSNK1D;TFRC;CCND2;KDR;FXR2;DDR2;RALB;PIN1;TESK1
prerank,negative regulation by host of viral process (GO:0044793),0.5499835144430654,1.1662843503550344,0.28456375838926173,0.5858281729688217,1.0,2/10,10.06%,LTF;PSMC3
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.46970281545658465,1.1662133282783613,0.27007299270072993,0.5856259150159321,1.0,3/23,2.09%,NLRC3;TMSB4X;HDAC7
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.4440250254025407,1.16612854773781,0.2529411764705882,0.5854615283320614,1.0,5/29,7.88%,IGF1;GRB2;ERBIN;CRKL;RASGRP1
prerank,aortic valve morphogenesis (GO:0003180),0.4460716101419701,1.1659081012883905,0.2549019607843137,0.5856323967114447,1.0,8/30,13.60%,NPPA;JAG1;ELN;GATA3;SOX9;DLL4;EFNA1;ROCK1
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.5509975162585616,1.1658490774584223,0.296551724137931,0.5853851009061729,1.0,8/11,29.67%,CABIN1;UBN1;ATRX;ASF1B;HAT1;H3-3A;NASP;ASF1A
prerank,cellular response to hydrogen peroxide (GO:0070301),0.44447662037000907,1.16570700296056,0.24567474048442905,0.5853352061491572,1.0,10/33,20.16%,SIRPA;NFE2L2;ANXA1;MAPK13;PRKCD;PLEKHA1;CYP1B1;RIPK3;IL6;RPS3
prerank,positive regulation of B cell proliferation (GO:0030890),0.45114507716532426,1.165606902019444,0.2619617224880383,0.5852001572489068,1.0,13/29,26.14%,BCL2;PTPRC;CHRNB2;TFRC;TIRAP;IL2;VAV3;CD74;MIF;NCKAP1L;SASH3;TLR9;GPR183
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.49070096495758525,1.1652966826464592,0.2909090909090909,0.5856776078742021,1.0,7/18,19.04%,FLNA;MAF1;UBTF;WDR43;DHX33;RASL11A;LYAR
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.46189981407708636,1.165252770626282,0.26421800947867297,0.585383304949261,1.0,6/22,12.33%,WDR12;KRI1;UTP20;EXOSC9;EXOSC10;FTSJ3
prerank,positive regulation of gene expression (GO:0010628),0.36931694873903664,1.1650781746780212,0.06,0.5854332596638037,1.0,131/442,24.60%,IGF1;MITF;STAP1;HIF1A;FN1;ITGAX;ERCC6;CD3E;MMP8;CSF1;ITK;NFE2L2;MSN;FGR;LEF1;AGO2;EIF6;VIM;ATP13A2;SPHK2;PIK3CB;ID2;VDR;CLDN19;PKP1;POU3F1;TAF1D;FGF2;CD28;EEF2;SERPINB9;DDX21;RPS7;PTPN22;PIWIL2;RPL23;ERN1;ZBTB7B;SOX9;FUBP1;VEGFA;CADM1;ANGPT1;TREM2;DNMT1;TXK;CELF1;ACTG1;POLR1G;POLR2H;DTNBP1;LILRB1;HNRNPLL;WNT6;RPL11;BRCA1;TICAM1;NKX2-1;LARP4;PLA2R1;KRAS;METTL3;FGF7;CPEB3;NAT8;CRTAM;YTHDF3;FGF20;DLL4;GSN;GAS6;SMAD1;ROCK1;FGF18;ACTB;EIF4A3;STOX1;CLU;ACTA2;DEK;MAPK9;CLEC6A;POLR1A;TFRC;DHX36;FXR2;BMP6;MYBBP1A;PRKAG1;AFDN;TBP;SP1;WBP2;BAZ1B;EIF3E;ATM;IL6;FAM98A;DNMT3B;UPF3A;AGO3;SLC38A2;SLC11A1;RPS3;AGPAT2;EMILIN1;TAF1A;GSK3B;SRPK2;NPM1;BMP4;SAMD4A;UPF3B;PTGER4;MAP2K2;HTR2B;VPS35;TAF1C;EGR1;CD74;RBM22;POLDIP3;AMH;MIF;AGPAT1;TNF;POLR1F;SF3B1;POLR2F;ATF4;PYM1
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.5400529616590172,1.1647347292087753,0.2938775510204082,0.5860340530746896,1.0,4/11,12.89%,MUC1;ING4;TFAP4;SP100
prerank,endoderm development (GO:0007492),0.5237534335307164,1.164253496449104,0.28879892037786775,0.5869831787013625,1.0,5/13,29.33%,EOMES;SOX7;LAMC1;KIF16B;DUSP5
prerank,protein targeting to mitochondrion (GO:0006626),0.412721210694854,1.164122447606876,0.2510729613733906,0.5869323868074962,1.0,16/52,22.35%,TOMM22;HSPA4;MGARP;SAMM50;PMPCA;DNAJC15;TIMM44;TIMM9;TOMM5;TOMM40;HSPD1;TIMM21;FBXO7;TIMM17A;PITRM1;TIMM23
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.436131689304466,1.1640245671203844,0.2574370709382151,0.5867822496464213,1.0,3/34,4.74%,IGF1;NSMCE2;CD28
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.47275632054350075,1.1639960057304612,0.2840095465393795,0.5864511659452242,1.0,6/24,10.23%,LCK;PTPRC;FGF2;ANXA6;ERO1A;CHERP
prerank,regulation of endothelial cell proliferation (GO:0001936),0.392714507366938,1.1639717032752577,0.22164948453608246,0.5861074174908569,1.0,19/88,16.20%,APOE;HIF1A;NRP2;XDH;NRP1;FGF2;CAV1;MYDGF;VEGFA;ANGPT1;NRAS;ECM1;EGFL7;FGF18;PRKD2;VIP;NF1;KDR;APOH
prerank,negative regulation of RNA metabolic process (GO:0051253),0.49270646979434374,1.1639556003641063,0.2736318407960199,0.5857349837062351,1.0,6/18,24.29%,NCOR2;PTBP3;RPS26;RPS13;TERT;TNF
prerank,regulation of gene expression (GO:0010468),0.36584012012688266,1.1634028979404256,0.011,0.5868668512874176,1.0,207/903,19.58%,APBB2;IGF1;AHNAK2;CXXC1;MITF;APOE;STAP1;HIF1A;FN1;ITGAX;CDK6;CD3E;C1D;MMP8;CSF1;TCF7;SIRPA;NFYA;NFE2L2;SMCR8;PTPRC;LTF;PRKCQ;MSN;AFF1;LEF1;AGO2;TBX21;MYBL2;XDH;GCNT2;ATP13A2;JMJD1C;MBNL3;PIK3CB;ID2;HRG;SOX3;TRIM6;TRIM43;CILP;DHH;VDR;CLDN19;PKP1;POU3F1;RNF14;ZC3H7B;PAK6;FBXW7;NFIL3;NELL1;FGF2;CD28;PERM1;TRAF3;TFEB;HDAC4;SERPINB9;DAXX;PPP2R1A;PTBP3;RPS7;RUNX1;BCL6;UBAP2;PTPN22;RPL23;GATA3;RNF6;ZBTB7B;SOX9;FUBP1;VEGFA;GRSF1;MSL3;CRKL;ANGPT1;TREM2;DNMT1;HDAC1;NOCT;NFX1;TXK;CELF1;GON4L;ACTG1;BHLHE40;ATXN1;UBE2L3;ZNF395;CDH1;MTF2;BTN3A3;FADS1;DTNBP1;TAPBP;FLOT2;CHD3;LILRB1;SON;HNRNPLL;WNT6;DIP2A;THAP7;PABPN1;FOXN3;RPL11;ZNF326;NFKBIZ;BRCA1;RACK1;TICAM1;NKX2-1;LARP4;SOX7;KRAS;FGF7;NAT8;PRMT5;ATF5;DNM2;AFF4;ZNF148;HMG20B;NAB2;CEBPA;SBNO1;HP1BP3;FGF20;DLL4;TGFBRAP1;GSN;LARP1;PRDM9;TLE5;CARM1;HNRNPK;ZFP64;NPAT;CDK11B;PPARGC1B;GAS6;CDK2;PCBP4;TIPARP;PHF1;SMAD1;YY1;ROCK1;YBX3;NFYB;YBX2;FGF18;STOX1;MBNL2;DDIT3;NFKB1;FASTK;CLU;ACTA2;ING2;PCBP1;YTHDF2;MAPK9;NOVA2;SERTAD3;MYT1;TFRC;DHX36;KDR;MYADM;PUM1;BMP6;PSPC1;MYBBP1A;PRKAG1;AFDN;GLRX2;UTP4;PPIE;SBNO2;SP1;NLK;CNBP;GPBP1L1;HNRNPF;DAPK3;ATRX;GCFC2;KAT7;CLK4;PIN1;ATM;BMI1;IL6;FAM98A;DNMT3B;HAVCR2;CCAR2;CCAR1;TARDBP;AGO3;SLC38A2;YAF2;NR3C1;SLC11A1
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.5395107476236511,1.1631811591561187,0.28492392807745504,0.5870589183300037,1.0,2/11,6.39%,JAG1;GATA3
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.3824840669260581,1.1630857751253023,0.1791497975708502,0.5869217086057193,1.0,34/140,23.09%,CACNA1A;ABL2;P2RX4;FPR2;PTGIR;ADCY8;CXCR2;PTGFR;CD24;EDNRA;BDKRB1;NPTN;C3AR1;CD52;CAV1;GPR174;TAC4;P2RY1;IAPP;CCR2;SPPL3;JPH1;GLP1R;LPAR1;C5AR1;CACNB3;ITPR3;HMGB1;CXCR3;CD55;GPR65;PTGER4;F2R;S1PR4
prerank,cellular glucose homeostasis (GO:0001678),0.42979427017308314,1.162679782129088,0.25252525252525254,0.5876531639707745,1.0,12/41,17.49%,HIF1A;ADCY8;GCK;ERN1;IGF1R;HK1;RACK1;PCK2;GAS6;FOXO1;PIK3R2;HK3
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.5075730815920575,1.162527455855026,0.2703045685279188,0.5876734506463145,1.0,7/16,20.52%,MCM7;MCM2;BLM;TWNK;PURA;MCM6;RECQL5
prerank,cellular response to exogenous dsRNA (GO:0071360),0.5324707215372231,1.1622370768186658,0.2857142857142857,0.5880830177406118,1.0,4/12,18.62%,COLEC12;CAV1;RALB;DHX9
prerank,regulation of fibrinolysis (GO:0051917),0.5264481416001867,1.1617576914812748,0.2897800776196636,0.5890399843213692,1.0,6/13,17.58%,HRG;F11;SERPINE1;KLKB1;APOH;SERPINF2
prerank,female gamete generation (GO:0007292),0.4531499375740425,1.1616729020154903,0.2718676122931442,0.5888677636473313,1.0,11/29,25.39%,PIWIL2;USP9X;M1AP;METTL3;DMC1;PRDM9;TRIP13;MCM8;KMT2D;MEI4;MDK
prerank,melanosome transport (GO:0032402),0.4832346631205619,1.161269367900826,0.2812105926860025,0.5891766128634316,1.0,8/18,29.41%,MYO5A;BLOC1S3;MKKS;RAB11A;BBS7;MREG;ARL6;RAB11B
prerank,pigment granule transport (GO:0051904),0.4832346631205619,1.161269367900826,0.2812105926860025,0.5891766128634316,1.0,8/18,29.41%,MYO5A;BLOC1S3;MKKS;RAB11A;BBS7;MREG;ARL6;RAB11B
prerank,glycosaminoglycan catabolic process (GO:0006027),0.4150499585541916,1.1609135352716,0.24810400866738894,0.5897464981725448,1.0,20/55,24.77%,CSPG4;GALNS;SLC9A1;GNS;CD44;FGF2;HEXA;GLB1;FUCA1;GUSB;DCN;HSPG2;CHP1;BGN;IDUA;LUM;SDC3;CSPG5;OGN;SDC4
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.4440416534955601,1.1608757977030546,0.2523364485981308,0.5894404677405909,1.0,15/26,31.54%,SPHK1;CCNB1;PKN2;DUSP3;PPP1R10;CUL3;HSF1;MDM2;USP2;CDC25B;EIF4E;HES1;KLHL18;ASNS;CCDC57
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.47894624126979,1.1606570055954593,0.276885043263288,0.5896205361889224,1.0,8/20,24.79%,HIF1A;ZMIZ1;DAXX;DCUN1D2;UBQLN1;HSP90AB1;EGR1;DCUN1D3
prerank,glucose homeostasis (GO:0042593),0.39514224592877045,1.1605621030042546,0.22350472193074503,0.5894731915130611,1.0,21/83,18.40%,HIF1A;ADCY8;GCK;RPS6;GCKR;PPARG;IGF1R;CYB5R4;HK1;PTPN2;CEBPA;RBP4;SLC8B1;FOXO1;APPL2;PIK3R2;ADIPOR1;WFS1;STK11;HK3;IL6
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.48031999690685157,1.1603379902319984,0.28292682926829266,0.5896739105619172,1.0,11/22,25.49%,UBA52;RPS27A;DDB2;DDB1;XPA;GTF2H1;UBC;XPC;GTF2H5;CUL4A;CETN2
prerank,cellular response to estradiol stimulus (GO:0071392),-0.3698731857541947,-1.1598147082623507,0.2459016393442623,0.7416914840818081,1.0,10/18,34.90%,NRIP1;EGFR;KAT5;FAM210B;SSTR2;RAMP3;NCOA3;GPER1;POU4F2;POU4F1
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.47263098677101834,1.1596642765217362,0.2647412755716005,0.5907339085826122,1.0,6/23,18.45%,BCL2;GZMB;BID;YWHAG;YWHAB;PPP3CC
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.47263098677101834,1.1596642765217362,0.2647412755716005,0.5907339085826122,1.0,6/23,18.45%,BCL2;GZMB;BID;YWHAG;YWHAB;PPP3CC
prerank,mitotic recombination (GO:0006312),0.5111811257079398,1.159565581454888,0.29219143576826195,0.5905782715774547,1.0,7/15,24.93%,NSMCE2;ERCC1;RAD50;DMC1;TPRKB;GEN1;SMC6
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.5359003083930398,1.1594770178425862,0.2808683853459973,0.5904293314083734,1.0,6/12,29.93%,ACSL1;FADS1;ELOVL2;ELOVL1;ACOT8;SCP2
prerank,lung development (GO:0030324),0.43553350598458973,1.1593460324073055,0.2711670480549199,0.5903855963775926,1.0,15/33,27.39%,PDPN;FGF2;FOXJ1;VEGFA;NKX2-1;FGF7;CEBPA;RBP4;RCN3;ITGA3;BMP4;FGFR2;FGF1;CCDC40;CCDC39
prerank,cellular response to nutrient levels (GO:0031669),0.4008494851870281,1.1593040034706406,0.2592986184909671,0.5900853704681327,1.0,20/62,25.22%,LPL;RRAGD;ATG7;EIF4G1;TFEB;STK24;FADS1;WDR45;LAMP2;MAP1LC3B;NUPR2;HSPA8;FOXO1;RALB;SREBF1;MAP1LC3A;USP33;CD68;RRAGC;SFRP1
prerank,positive regulation of B cell activation (GO:0050871),0.4119793096186767,1.1592208630889298,0.24342105263157895,0.5899019047381452,1.0,19/50,26.14%,BCL2;PTPRC;CHRNB2;SH3KBP1;TNIP2;KMT5B;SYK;TFRC;TIRAP;IL6;IL2;VAV3;CD74;MIF;BTK;NCKAP1L;SASH3;TLR9;GPR183
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.3918806099107303,-1.1590448351356708,0.2571428571428571,0.7397977620201543,1.0,10/15,29.61%,WHRN;COL11A1;ADGRV1;HPN;TMC1;KCNK4;SCN1A;TMC2;PDZD7;LHFPL5
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.44866339205644024,-1.1588068635980775,0.25735294117647056,0.7363645838881048,1.0,3/10,15.81%,PRKCE;IRS2;PMAIP1
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.48959349161478816,1.158628518498227,0.2974683544303797,0.5911761876322339,1.0,3/16,11.07%,IGF1;FGF2;PIM1
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.5370725446170631,1.1581059443471617,0.2956989247311828,0.5922263696426227,1.0,5/11,21.95%,CCT2;CCT8;TERF1;CCT5;DKC1
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.482041710988414,1.1580064625849553,0.27441285537700866,0.5921127291324992,1.0,2/19,2.11%,XYLT1;HS3ST3B1
prerank,response to hexose (GO:0009746),0.44979694210271837,1.157853579319139,0.28741092636579574,0.5921567921946065,1.0,8/25,24.02%,LPL;APOA2;GCKR;PFKL;VAMP2;EIF2B2;ZBED3;EIF2B4
prerank,regulation of cell-substrate adhesion (GO:0010810),0.42390918183675075,1.1573744401191703,0.25752508361204013,0.5931589879830309,1.0,11/42,18.93%,CORO1C;GCNT2;PDPN;PIK3CB;ATXN3;RHOA;FZD4;NF1;MINK1;MYADM;ECM2
prerank,protein N-linked glycosylation (GO:0006487),0.40326939672377793,1.1569577474945025,0.24385026737967913,0.5939080602395146,1.0,18/66,19.72%,MAN1C1;MGAT5;B4GALT7;DERL3;MAGT1;STT3B;SRD5A3;MPDU1;LMAN1;ALG10B;ENTPD5;MCFD2;DPAGT1;ST6GAL1;TUSC3;TMEM165;DDOST;B4GALT1
prerank,regulation of protein kinase B signaling (GO:0051896),0.3754063894658194,1.1568522128070642,0.1457286432160804,0.5938007045896927,1.0,39/193,14.60%,OSBPL8;LCK;P2RX4;DAG1;XDH;GCNT2;ADAM8;PDGFA;PIK3CB;AXL;FAM110C;NRG1;FGF2;CD28;MFHAS1;PPP2R5C;MYDGF;PIK3R5;PDPK1;TRAT1;GATA3;GRB2;ANGPT1;IGF1R;KITLG;PLEKHA1;RACK1;SFRP5;FGF7;HIP1;IAPP;FYN;MYOC;RHOG;FGF20;GAS6;FGF18;DDIT3;RCN3
prerank,tyrosine metabolic process (GO:0006570),0.549929142465992,1.1566559261048392,0.32217573221757323,0.5939634290035943,1.0,1/11,3.80%,TH
prerank,regulation of protein secretion (GO:0050708),0.37786316528849956,1.1566531550046433,0.19331983805668015,0.5935536191367645,1.0,26/119,19.10%,CACNA1A;IGF1;APOE;ABCG1;GCK;ADAM8;ATP13A2;SLC2A1;RHBDF2;TREM2;P3H1;SERGEF;RHBDF1;CCL5;CACNA1D;DNAJC1;RSAD2;PPIA;LLGL2;SLC8B1;GIPR;GLP1R;BMP6;DISP1;IL6;ITPR3
prerank,regulation of cellular protein metabolic process (GO:0032268),0.4169597733510429,1.1566306788187528,0.25,0.5932092752472148,1.0,17/47,29.64%,APOE;CSF1;WDR91;EIF4G1;RBM4B;EIF2A;NOLC1;NFKB1;TCOF1;ATXN2;VPS35;EIF2B4;GEMIN5;CYFIP1;EIF4E;MTPN;PCIF1
prerank,protein modification by small protein conjugation (GO:0032446),0.36778840769945276,1.1565528434592578,0.085,0.5930221853020115,1.0,133/361,29.83%,HIF1A;ATG7;MYLIP;NFE2L2;NUP205;FBXL17;UBA52;RPS27A;NSMCE2;CNOT4;TRIM6;TRIM43;RNF14;FBXW7;FBXO32;BRAP;OTULIN;RNF7;RNF6;TRIM28;EGR2;TSPAN17;SDE2;NFX1;KLHL7;SPSB2;PEX2;UBE2H;UBE2L3;ZNRF3;USP9X;VPS18;UFM1;BRCA1;RACK1;VCP;DDB1;NUP188;RNF111;USP5;CUL9;KLHL13;HUWE1;SHPRH;BIRC6;UBE2R2;ENC1;VPS11;UBE2F;DCUN1D2;KCTD10;SUMO2;DTX2;MKRN2;RANBP2;CBL;ZSWIM8;DTX4;DERL1;TPR;KLHL24;RNF157;BARD1;KLHL25;ASB1;RAE1;UBE2V2;ELOB;PAF1;UBR2;CUL3;DTX3;PIAS1;FBXO7;SAE1;UBC;RNF20;FBXW11;DCUN1D4;CAND1;CUL1;VHL;TRIM24;NUP93;FBXW5;AAAS;RNF41;CDC34;FBXO11;TRIM21;CUL2;ARRDC4;UBA6;CCDC22;PEX14;ANAPC7;NUP54;NUP50;MDM2;TRIM72;SUMO1;DCUN1D3;NUP98;CUL4A;TRIM7;ATG10;PIAS4;ABCB11;UBE2C;KLHL21;KEAP1;NUP42;BTRC;NUP133;CBLL1;NUP210;ATG3;UBE2Z;UFL1;MOCS3;CTR9;OS9;KLHL41;NUP35;WWP2;UBA3;KLHL18;SIRT1;NUP214;TRIM68;RCHY1;LEO1;MUL1
prerank,skeletal muscle tissue development (GO:0007519),0.4339163362039571,1.1563715217168746,0.27920560747663553,0.5931109403837297,1.0,6/32,9.80%,SELENON;CSRP3;CAV1;EGR2;IGSF8;LEMD2
prerank,positive regulation of behavior (GO:0048520),-0.4444592074451368,-1.1561796443134416,0.2828282828282828,0.7400774419611243,1.0,4/10,7.10%,MEF2C;NLGN1;NPAS2;SGIP1
prerank,positive regulation of cell killing (GO:0031343),0.525804375299502,1.1559956090651764,0.29945054945054944,0.5937311396722544,1.0,3/13,16.00%,CYBA;PRF1;SYK
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.37654984910078804,1.1555310655356337,0.1584754262788365,0.5945943825154525,1.0,74/184,32.39%,PSMD8;PSMD1;UBA52;PPP1R9B;RPS27A;ODF2;ID2;ANAPC15;DYNC1H1;PPP2R1A;NINL;RIOK2;FZR1;FBXO5;PSMD6;PSMA1;HAUS8;DDB1;CCNB1;PSMC3;CEP41;DCTN1;YWHAG;PSMA8;TFAP4;CDK2;ANAPC1;CEP250;PSMD14;PSMD2;INO80;CSNK1D;PSMC6;PSMA6;APPL2;PLK4;PSMD5;TUBB;NEK6;PSMA5;CDC26;MAD2L1BP;HAUS2;CUL3;BUB1B;UBC;CUL1;ANAPC7;XPC;PSMA3;PSMB8;PSMB10;CETN2;PSMD7;UBE2C;PSMB6;PTPN6;BTRC;MAPRE1;PSMD10;PSMB5;PSMB7;KLHL18;ALMS1;PSMC4;CSNK1E;CEP57;PSMD12;SIRT2;ERCC2;APPL1;PSMD3;UBB;DYNC1I2
prerank,cellular response to DNA damage stimulus (GO:0006974),0.36967314178446165,1.1553440285636376,0.085,0.5946832758724245,1.0,121/336,30.23%,FNIP2;BCL2;BCL2L1;PARP4;RAD51B;TANK;MCL1;DYRK2;DOT1L;MCM7;TAOK3;TRIP12;SUSD6;ERCC1;NUDT1;IGHMBP2;BID;BCL6;TRIM28;GRB2;IKBKE;BCL2L11;LIG1;FBXO31;ALKBH7;DDB2;MAPKAPK2;ZRANB3;BRCA1;VCP;DDB1;NEK4;BOD1L1;BAX;METTL3;MGMT;FANCF;RAD50;RBBP5;ALKBH1;XPA;TNFRSF1B;SHPRH;KMT5B;HPF1;NUPR2;BLM;PHF1;MBD4;YY1;ADPRS;DDIT3;CHCHD6;INO80;ERCC4;SLX4;ZBTB40;USP47;FOXO1;BARD1;SIRT4;POLB;STK11;WDHD1;PARP3;BAZ1B;RAD54L;GTF2H1;CBX3;ATM;KIN;RTEL1;RAD1;FANCA;CASP9;RAD51AP1;RPS3;RECQL5;MCM8;ALKBH3;NPM1;TAOK1;USP28;TOPBP1;PPP1R15A;WDR48;NIPBL;UBA6;VAV3;XPC;PARP2;ZBTB4;RFC2;SUMO1;PLK3;GADD45A;SMC6;MAPK15;MAPK12;CUL4A;CENPS;CDKN2AIP;PDS5A;ATR;UFL1;MNAT1;MAPK3;RNF169;RAD9A;ERCC8;HINFP;APTX;TICRR;SIRT1;CSNK1E;XRCC5;ASF1A;ALKBH8;PNKP;CCND1;OARD1
prerank,regulation of potassium ion transport (GO:0043266),-0.3330629792573822,-1.1553377921772467,0.23846153846153847,0.7385394840460688,1.0,13/31,20.81%,KCNIP4;DPP10;KCNIP3;DPP6;KCNN2;NOS1;KCNAB2;KCNIP1;KCNH2;ANK2;ANK3;KCNIP2;ADRA2A
prerank,divalent inorganic cation homeostasis (GO:0072507),0.4565822229908269,1.1546959194086397,0.28502415458937197,0.5961475387323406,1.0,7/25,17.22%,ATP13A2;SELENON;CYP27B1;CAV1;CNNM2;TRPM7;WFS1
prerank,regulation of muscle contraction (GO:0006937),0.4604789483201032,1.1545729061141312,0.2822014051522248,0.5960954306145358,1.0,8/26,18.05%,TNNT3;MYL9;CAV1;ANXA6;SRI;ENO1;ATP1A2;DAPK3
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.3979888418479823,1.1545109865261602,0.22560335781741866,0.5958540583334022,1.0,35/76,31.23%,RNF14;FBXW7;PRICKLE1;DAB2;RNF180;RACK1;VCP;USP5;SOCS5;CEBPA;SMAD7;SUMO2;CLU;CSNK1D;ELOB;HECTD1;PIAS1;RNF19A;LAPTM5;GSK3B;TRIB2;GABARAP;CCDC22;MDM2;SUMO1;BBS7;KEAP1;PSMD10;GSK3A;CSNK1E;RCHY1;RNF19B;PTEN;NUB1;SIRT2
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.4113077347948508,1.1543021834083482,0.25054229934924077,0.5960403276180775,1.0,13/56,23.79%,SDCBP;SNX25;BMP8B;GDF6;DAB2;RBPMS;SMAD7;BMP6;PIN1;BMP5;EMILIN1;BMP4;PMEPA1
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.3717150625760894,1.154273184152078,0.14,0.5957115199905827,1.0,58/248,19.05%,DKK2;CTNNB1;CDK14;APOE;CCDC88C;CCNY;PSMD8;PSMD1;BICC1;GNAQ;TNKS2;PRICKLE1;OTULIN;CAV1;SIAH2;LRP4;DAB2;STK3;SOX9;HDAC1;PRDM15;ZNRF3;ILK;PSMD6;PSMA1;CSNK1G1;BAMBI;SFRP5;SOX7;VCP;PSMC3;JUP;WLS;PSMA8;TLE5;FRAT1;GPRC5B;JRK;PSMD14;FZD4;SCYL2;PSMD2;DDIT3;NFKB1;LRP6;CSNK1D;USP47;PSMC6;PSMA6;LZTS2;GSKIP;STK11;PSMD5;DAPK3;PSMA5;PIN1;CCAR2;CUL3
prerank,chondroitin sulfate catabolic process (GO:0030207),0.5233457085792204,1.1542561580761195,0.296875,0.5953513251984373,1.0,6/13,22.78%,CSPG4;HEXA;DCN;BGN;IDUA;CSPG5
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.36576719144392533,1.1541650030429118,0.056,0.5952002418624871,1.0,184/497,31.24%,MDFIC;CTNNB1;ZHX2;NIBAN2;EPRS1;ARID5B;SCML4;LEF1;HDAC9;DEDD2;TBX21;DEAF1;RCOR1;ID2;NRG1;GZMB;GTPBP4;VDR;NCOR2;NCL;CDK5;NFIL3;CIC;S100A11;PRICKLE1;HDAC4;PPARG;DAXX;BCL6;ERN2;WAPL;GATA3;TRIM28;SOX9;ING4;HDAC1;LSM14A;KMT5A;PUS7;BHLHE40;ATXN1;PATL2;GMNN;BHLHE41;PPARD;BASP1;MIDEAS;THAP7;HOXA7;FOXN3;BRCA1;RACK1;NKX2-1;SOX7;CPEB3;DAP;CNOT10;ATF5;JUN;SHMT1;SUDS3;ZNF148;ENO1;CEBPA;BAP1;RIOX1;ZKSCAN3;ENC1;LARP1;TLE5;TFAP4;GAS6;HSPA8;ZBTB16;GATAD2A;ILF3;CBFA2T2;BIRC5;EED;SYNCRIP;EIF4A3;DDIT3;EIF4ENIF1;RBM15;RBFOX2;DAPK1;USP47;FOXO1;PRMT2;ELK3;DHX36;EIF4E2;FXR2;PRMT6;PSPC1;MYBBP1A;RBM15B;PDCD4;RCOR3;SBNO2;UIMC1;DAPK3;GCFC2;CBX3;KAT7;RPL13A;CCAR2;TAF7;EHMT1;YAF2;NR3C1;DACH1;TERF1;RPS3;FBXW11;YEATS2;GSK3B;BMP4;SAMD4A;ID1;GIGYF2;CALR;NIPBL;AHR;ZNF568;CREBZF;PEX14;L3MBTL3;ZBTB4;MDM2;MTA3;TNF;GLIS2;SUMO1;CCDC85B;MALSU1;HDAC2;ZGPAT;SMARCA4;POU2F1;KDM5C;SFRP1;DPF3;HDAC3;PIAS4;L3MBTL2;HIC2;TMPRSS6;PCGF6;BTRC;SNW1;LBH;PDS5A;LIMS1;KDM1A;HES1;GSK3A;ATR;KLF10;RSF1;WWP2;RIDA;ARID4A;HINFP;TLE1;ATF7IP;PBXIP1;SIRT1;XRCC5;PCIF1;CNOT9;HMGB2;MTERF3;SUV39H2;GMNC;QARS1;HEXIM1;DMAP1;CAPRIN1;RUNX2;SAMD4B;GLI3;SIRT2;SET
prerank,erythrocyte differentiation (GO:0030218),0.41725765583542673,1.1541642142666233,0.26535087719298245,0.5947879018649757,1.0,19/44,31.39%,ID2;RPS14;MFHAS1;VEGFA;PTPN2;ALAS1;RPS19;HSPA9;CEBPG;ACIN1;LYAR;EPO;JAK2;FLVCR1;NCKAP1L;UFL1;MED1;JAK3;UBA5
prerank,chromatin remodeling (GO:0006338),0.38789712683454575,1.154105526826448,0.21810699588477367,0.5945336109624939,1.0,44/100,32.42%,ERCC6;NUDT5;HDAC4;DAXX;SOX9;SATB1;HDAC1;BPTF;NPM3;CHD3;HNRNPC;SMARCB1;GATAD2B;MYSM1;SMARCC1;ACTB;INO80;KDM4D;SRCAP;BAZ1B;ATRX;CBX3;DR1;GATAD1;TOP1;ARID1B;NPM1;SMARCD2;HDAC2;SMARCA4;KDM5C;BAZ1A;HCFC1;PIH1D1;RUVBL2;RSF1;SIRT1;PBRM1;SUV39H2;SATB2;ZBTB1;ACTR8;MYB;BAHD1
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.516666791321906,1.1540203723277451,0.29697766097240474,0.5943650605597246,1.0,4/13,14.47%,AGO2;PABPC1;CPEB3;EIF4ENIF1
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.5258603657144485,1.1536224604584124,0.28191489361702127,0.5950803562981601,1.0,5/12,21.95%,CCT2;CCT8;GNL3;CCT5;DKC1
prerank,response to lipopolysaccharide (GO:0032496),0.3764970291181654,1.15347446998025,0.2016210739614995,0.5950406226791719,1.0,35/138,19.98%,S100A8;S100A9;STAP1;SIRPA;VIM;AXL;TRIM6;CD6;CYP27B1;CD274;PTPN22;ERBIN;NOCT;TNIP3;MAPKAPK3;LILRB1;ADAM17;PABPN1;MAPKAPK2;PLAA;TICAM1;SERPINE1;TNFRSF1B;TNIP2;RHOA;GIT1;NFKB1;ACOD1;TIRAP;PDCD4;SBNO2;PAF1;IL6;SLC11A1;HMGB1
prerank,regulation of defense response to virus (GO:0050688),0.5026014491617636,1.1533901638120352,0.2923898531375167,0.5948784093362429,1.0,8/14,27.90%,TRAF3;ILRUN;C1QBP;DHX9;ELMOD2;RNF216;TRAF3IP1;TNFAIP3
prerank,tRNA wobble base modification (GO:0002097),0.508841417457404,1.1529879191365873,0.2994722955145119,0.5956164980634202,1.0,11/14,39.73%,KTI12;ALKBH1;ELP3;GTPBP3;MOCS3;ALKBH8;DPH3;MTO1;CTU1;CTU2;URM1
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.44421585544553166,-1.1529027206734532,0.2692307692307692,0.7418301500731852,1.0,1/11,0.29%,MEF2C
prerank,positive regulation of interleukin-6 production (GO:0032755),0.3977152872604504,1.1528597628705493,0.24309978768577495,0.5955673342567661,1.0,23/68,24.29%,RAB7B;LPL;CYBA;MMP8;SPHK2;MAPK13;POU2AF1;MBP;HSPD1;TMEM106A;SYK;TIRAP;IL6;DHX9;SCIMP;ARHGEF2;HMGB1;LBP;F2R;IL17RA;CD74;IL17D;TNF
prerank,regulation of actin nucleation (GO:0051125),0.5162163856891283,1.1528522216688772,0.30434782608695654,0.5951759921023865,1.0,3/12,11.96%,SCIN;WASHC5;GSN
prerank,activation of adenylate cyclase activity (GO:0007190),0.43490890631855794,1.152598069265678,0.2601626016260163,0.595507835458984,1.0,6/35,5.14%,ADCY8;ADCY3;EDNRA;ADCY7;RAF1;CAP1
prerank,regulation of cell death (GO:0010941),0.3850105562163241,1.1521266776604246,0.22633744855967078,0.596439958469122,1.0,39/94,32.70%,LRP1;CTSZ;SLC25A24;EIF4G1;FGF2;NCK1;CHMP4B;HPR;HP;CELF1;LRPAP1;VPS4B;CCL5;TNFRSF1B;SARM1;CLU;CHP1;CCN6;TMEM109;RILPL1;FERMT2;BMP4;HTR2B;VPS35;BNIP3;PARP16;PACRG;CCN4;TBK1;BNIP3L;FAF1;BECN1;CCN2;NOA1;OLFM4;GPR75;ZC3H12A;UBB;ATG5
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.49216323321360234,1.1519858008922752,0.2907975460122699,0.596447870586439,1.0,7/17,19.98%,FPR2;MOSPD2;CCR2;SERPINE1;CCL5;ANO6;HMGB1
prerank,positive regulation of cartilage development (GO:0061036),0.49482761504240613,1.1519310135786522,0.3053817271589487,0.5961859524064779,1.0,5/17,13.01%,GDF6;BMP1;SOX9;PKDCC;ZBTB16
prerank,spindle assembly (GO:0051225),0.39875071751973507,1.1518976189136116,0.26031746031746034,0.5958711680795199,1.0,23/67,26.78%,FLNA;TUBGCP4;LSM14A;HAUS8;BCCIP;ABRAXAS1;RHOA;INO80;NUMA1;RCC1;SMC3;CSNK1D;TOGARAM2;KIFC1;NEK6;RAB11A;HAUS2;RPS3;AAAS;STAG1;GOLGA2;HDAC3;MAPRE1
prerank,positive regulation of lipid metabolic process (GO:0045834),0.4685032842111597,1.151891703333605,0.2844932844932845,0.5954742322238465,1.0,6/22,16.80%,APOE;APOA2;PPARG;PPARD;SORBS1;SIRT4
prerank,protein homotrimerization (GO:0070207),0.5046194015721026,1.1517444436063478,0.30687830687830686,0.5950810702079588,1.0,7/14,24.15%,MLKL;SLC1A5;DISP1;CLYBL;MIF;ASIC1;STEAP4
prerank,protein trimerization (GO:0070206),0.5046194015721026,1.1517444436063478,0.30687830687830686,0.5950810702079588,1.0,7/14,24.15%,MLKL;SLC1A5;DISP1;CLYBL;MIF;ASIC1;STEAP4
prerank,regulation of multicellular organism growth (GO:0040014),0.5028510885376085,1.1517208244107873,0.3002577319587629,0.5947392718179786,1.0,1/15,0.06%,IGF1
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.4697749260175895,1.1517047004285803,0.2934648581997534,0.5943811912251292,1.0,2/20,6.73%,GCK;SIK1
prerank,lysine catabolic process (GO:0006554),0.5274668054540871,1.1514338278393483,0.3189771197846568,0.594318188203699,1.0,5/12,19.09%,PIPOX;PHYKPL;DLST;SLC25A21;GCDH
prerank,lysine metabolic process (GO:0006553),0.5274668054540871,1.1514338278393483,0.3189771197846568,0.594318188203699,1.0,5/12,19.09%,PIPOX;PHYKPL;DLST;SLC25A21;GCDH
prerank,positive regulation of phospholipase C activity (GO:0010863),0.42200193322185686,1.1513385065270576,0.2759776536312849,0.5941589407659759,1.0,9/40,10.17%,FLT1;ABL2;ITK;GNAQ;EDNRA;FGF2;TXK;PLCB2;ARHGAP6
prerank,myotube differentiation (GO:0014902),0.4927008306833981,1.1511279772516498,0.2864516129032258,0.59435489105461,1.0,2/17,1.00%,IGF1;PLD3
prerank,negative regulation of viral life cycle (GO:1903901),0.49928901317219276,1.1511030510271738,0.30038022813688214,0.5940115116825604,1.0,5/15,19.32%,IFITM2;IFITM1;GSN;PPIA;BST2
prerank,regulation of interleukin-13 production (GO:0032656),0.5215400206272883,1.1510047659742044,0.30066225165562915,0.5938896394036155,1.0,3/13,6.39%,LEF1;SPHK2;GATA3
prerank,positive regulation of organelle organization (GO:0010638),0.4375169637701076,1.150605985502906,0.2517084282460137,0.5945882735908049,1.0,12/32,26.98%,SMCR8;ANXA1;MGARP;TREM2;FYCO1;LMAN1;RAB3GAP2;PFDN2;GSK3B;RAB3GAP1;PLA2G5;SURF4
prerank,carboxylic acid metabolic process (GO:0019752),0.4386971309409263,1.1505053143609003,0.2759433962264151,0.5944786688515494,1.0,16/33,29.29%,SLC23A1;SLC23A2;PON1;SLC2A1;GNMT;GLYAT;ST6GAL1;SIRT4;PTGIS;CYB5R3;GSTO2;MIF;TBXAS1;LIPT2;ST3GAL1;GSTO1
prerank,positive regulation of signaling receptor activity (GO:2000273),0.42441037267627973,1.150435568835437,0.29621125143513205,0.5942519834506219,1.0,6/36,11.26%,HIF1A;FBXW7;NRP1;HDAC1;ADAM17;CCR2
prerank,response to organic cyclic compound (GO:0014070),0.41068216476204716,1.1503277807124979,0.2548596112311015,0.5941580071793636,1.0,6/52,4.08%,CTNNB1;SPP1;ANXA1;CHRNB2;CYP19A1;CYP27B1
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.43563289726438104,1.1502358751238873,0.2669683257918552,0.594021902554485,1.0,4/35,4.62%,NRP2;FLNA;PLXNA2;NRP1
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.42616611055107656,-1.1501354333630334,0.2784313725490196,0.7464147338428355,1.0,4/13,7.13%,TMEM30A;SORL1;CD81;SAR1B
prerank,striated muscle tissue development (GO:0014706),-0.33424490671862295,-1.1499756429751864,0.22377622377622378,0.7427402604319229,1.0,6/29,8.84%,MEF2C;SGCZ;SGCD;ZBTB18;MYH14;PGM5
prerank,regulation of steroid metabolic process (GO:0019218),0.46271262246608874,1.149801745471679,0.28784403669724773,0.594860676434621,1.0,2/23,0.50%,APOE;ABCG1
prerank,anion transport (GO:0006820),0.4324752598464701,1.1496146542139716,0.26865671641791045,0.5950003010311997,1.0,10/33,20.53%,LRRC8C;VDAC2;SLC17A5;SLC22A3;SLC13A4;SLC26A4;SLC4A2;SLC19A1;SLC13A3;SLC13A5
prerank,positive regulation of neutrophil migration (GO:1902624),0.4896441283759786,1.1487811042878537,0.2934648581997534,0.5969274739243725,1.0,8/18,25.39%,ADAM8;RIPOR2;MOSPD2;C1QBP;TIRAP;CD74;NCKAP1L;MDK
prerank,endodermal cell fate commitment (GO:0001711),0.5510603899299116,1.148585783982759,0.3164218958611482,0.5971069575984499,1.0,4/10,29.68%,EOMES;PAF1;CTR9;LEO1
prerank,cellular amide metabolic process (GO:0043603),0.3814211507499485,1.1483247825632217,0.23565573770491804,0.5974152983244188,1.0,33/102,26.15%,PLAAT3;CERK;MTHFD2;ACOT9;PPP2R1A;CPXM2;ORMDL1;PLPP3;SLC46A1;NAPEPLD;MTHFS;AEBP1;DNPEP;SHMT1;ACOT6;MTHFD1;CPD;FPGS;GLYAT;SMPD1;ST6GAL1;MTRR;SLC19A1;ORMDL3;AASDHPPT;ALDH1L2;PDZD11;NLN;ABHD4;MTHFR;ATF4;ACOT1;HLCS
prerank,positive regulation of neuron death (GO:1901216),0.4162819408599181,1.1482752508079173,0.26732673267326734,0.5971568060864638,1.0,17/46,24.57%,CTNNB1;CDK5;DAXX;EIF2S1;BAX;FYN;SARM1;DDIT3;CLU;ITGB2;NF1;EFNB2;GSK3B;SRPK2;EGR1;TNF;ATF4
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.45003881053528083,1.1473632010493982,0.2921478060046189,0.5993048155411868,1.0,10/27,26.76%,AK8;AK4;GSR;TXNRD1;AK6;AK5;DUT;AK7;GUK1;DTYMK
prerank,sphingoid metabolic process (GO:0046519),0.5261032088999475,1.14702983462557,0.3032679738562091,0.5998225587655311,1.0,4/12,13.56%,SPHK2;SPHK1;PLPP3;KDSR
prerank,regulation of glucose transmembrane transport (GO:0010827),0.47675698335291217,1.1469374012507572,0.3048327137546468,0.5996772557910922,1.0,4/18,10.58%,NR4A3;SLC2A1;PRKCB;C3
prerank,establishment of melanosome localization (GO:0032401),0.4733012325116319,1.1468679725268256,0.2928660826032541,0.5994619686613775,1.0,2/19,1.29%,MYO5A;BLOC1S3
prerank,regulation of exosomal secretion (GO:1903541),0.47159678644123415,1.1468236911963037,0.3048327137546468,0.5992036547463809,1.0,5/19,11.55%,SDCBP;ATP13A2;PDCD6IP;RAB7A;VPS4B
prerank,positive regulation of TOR signaling (GO:0032008),0.4245409798989149,1.1466794913663116,0.2737306843267108,0.5992171001296478,1.0,16/40,28.35%,GPR137B;RRAGD;SMCR8;TREM2;GAS6;LARS1;GOLPH3;RRAGC;NCKAP1L;SIK3;HDAC3;LAMTOR3;PIH1D1;FNIP1;RICTOR;LAMTOR1
prerank,insulin secretion (GO:0030073),0.4819000938204602,1.1464988685425868,0.3058968058968059,0.5993335252341038,1.0,3/19,8.21%,ANXA1;SNX19;CYB5R4
prerank,cellular response to hydroxyurea (GO:0072711),0.5421245085528128,1.1464695789092902,0.31888111888111886,0.5990147491898936,1.0,3/10,18.09%,DDI2;BLM;ATRX
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.3788099198731141,1.1463877861355323,0.21747967479674796,0.5988246335301795,1.0,32/122,22.15%,BCAR3;IGF1;EIF6;VIM;GCK;DYRK2;FGF2;CD28;EEF2;PIWIL2;LARP4;METTL3;CPEB3;YTHDF3;NAMPT;EIF4A3;NFKB1;PRKD2;SORBS1;TMEM106A;KDR;FXR2;KAT7;EIF3E;IL6;EPM2AIP1;DHX9;UPF3A;NLRC5;NPM1;SAMD4A;UPF3B
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.37641257244379306,1.146121461056168,0.19939271255060728,0.599148038067181,1.0,39/148,19.46%,SGK1;DYRK2;CDK5;PPP2R5C;DAXX;NOC2L;RPS20;PDPK1;RPL23;TAF4B;HDAC1;KMT5A;RMI1;CHD3;RPL11;BRCA1;PRMT5;RAD50;HIPK1;TAF15;BLM;CDK2;RPL37;ING2;BARD1;CHD5;ING5;SMYD2;PRKAG1;STK11;TBP;PIN1;ATM;RAD1;TP53RK;TAF7;CSNK2A2;EHMT1;TAF6
prerank,protein polyubiquitination (GO:0000209),0.3667636032458704,1.146055695913803,0.104,0.5989087824949872,1.0,78/297,22.13%,BCL2;CTNNB1;MYLIP;PSMD8;PSMD1;SASH1;RNF125;FBXL17;UBA52;TRAF2;RPS27A;TRIM6;RNF14;FBXW7;FBXO32;TNKS2;TRIP12;TRAF3;NHLRC1;HECTD2;SIAH2;TTC3;RNF6;UBE2H;UBE2L3;FZR1;FBXO31;PSMD6;PSMA1;DDB2;FBXW4;BRCA1;TRAF1;NHLRC3;PSMC3;UBE4A;HUWE1;SHPRH;PSMA8;UBE3B;SHARPIN;UBE2R2;TPP2;UBE2Q1;ANAPC1;PSMD14;PSMD2;UBE2L6;BFAR;BLMH;FBXL19;PSMC6;BARD1;PSMA6;UBE3C;PSMD5;UBE2V2;WSB1;UBE4B;PSMA5;CDC26;UBR2;RNF167;CUL3;HECTD1;FBXO7;UBC;RNF20;FBXW11;RNF19A;CUL1;FBXW5;RNF216;RNF41;CDC34;ZNRF2;FBXO11;TRIM21
prerank,positive regulation of keratinocyte migration (GO:0051549),0.5453220770783879,1.146006887275021,0.29346314325452016,0.5986465807708392,1.0,3/10,10.20%,IQSEC1;MMP9;FGF7
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.4005722650935059,1.1458348568678502,0.2555205047318612,0.5987170995648021,1.0,15/67,17.04%,FLT1;LCK;ABL2;ITK;FGR;TEC;PTK2B;TXK;IGF1R;PKDCC;FYN;GHR;SYK;KDR;DDR2
prerank,protein deacylation (GO:0035601),0.4544795867738699,1.1458320530677877,0.28437132784958874,0.5983207434198519,1.0,13/23,31.23%,HDAC7;HDAC4;HDAC1;SIRT5;LYPLA2;ABHD17C;ABHD17A;ABHD10;SIRT3;HDAC3;ABHD17B;SIRT1;SIRT2
prerank,synaptic vesicle exocytosis (GO:0016079),-0.30645265439419656,-1.145677229677616,0.18018018018018017,0.7516341464503064,1.0,10/40,7.80%,SNAP25;CPLX1;SYT10;RIMS1;RAB3A;SNAPIN;UNC13B;SYT1;SYT2;RIMS2
prerank,L-amino acid transport (GO:0015807),0.44453442497005874,1.1456495832766311,0.2793427230046948,0.5984330472118883,1.0,10/28,22.29%,SLC3A2;SLC7A1;SLC36A4;SLC36A3;SFXN1;SLC7A8;ARL6IP5;SLC25A18;SLC38A2;SLC7A2
prerank,positive regulation of chromatin organization (GO:1905269),0.5313292860045443,1.145427407064326,0.3203753351206434,0.5986537196089804,1.0,7/12,31.47%,DAXX;ATRX;TERF1;ACD;H3-3A;TERF2IP;TERF2
prerank,termination of RNA polymerase I transcription (GO:0006363),0.4387672016576283,1.145348339494907,0.3008036739380023,0.598459408042548,1.0,16/30,31.46%,TAF1D;POLR1G;POLR2H;TTF1;UBTF;POLR1A;TBP;GTF2H1;TAF1A;TAF1C;POLR1F;POLR2F;GTF2H5;MNAT1;POLR1H;ERCC2
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.5359989527409467,1.145327193027378,0.30962343096234307,0.5981229028913605,1.0,7/10,31.94%,PPARG;RXRB;ACTN4;RXRA;SNW1;RXRG;RARG
prerank,cellular response to dsRNA (GO:0071359),0.5022587180477729,1.1450038126756394,0.2849673202614379,0.5986355493115818,1.0,6/15,21.52%,COLEC12;CAV1;RIOK3;RALB;DHX9;NPM1
prerank,prostanoid metabolic process (GO:0006692),-0.40173167896164214,-1.144884052300172,0.2863070539419087,0.7499861670914942,1.0,3/13,7.43%,PTGS1;HPGD;HPGDS
prerank,neurogenesis (GO:0022008),0.41886862970313354,1.1448693927591433,0.26356589147286824,0.5986261053130416,1.0,8/43,16.99%,CDK6;ERCC6;ANXA1;FAT4;TRAK1;METTL3;LPAR1;THOC2
prerank,negative regulation of interferon-gamma production (GO:0032689),0.4605352689849442,1.1447849737008,0.28606060606060607,0.5984690638566867,1.0,9/23,20.98%,AXL;CD274;LILRB1;GAS6;DDIT3;C1QBP;HAVCR2;HMGB1;LAPTM5
prerank,receptor metabolic process (GO:0043112),0.40162374465465606,1.144691765257522,0.26956521739130435,0.5983448613485598,1.0,14/53,16.06%,CD9;LRP1;SNX25;CXCR2;CAV1;GRB2;REP15;LILRB1;ARFGEF2;DNM2;MVB12A;ITGB2;SYK;TFRC
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.5246903115046293,1.144160233093551,0.3045212765957447,0.59941575402996,1.0,4/12,17.88%,CTDNEP1;PRKCB;CCNB1;NEK6
prerank,regulation of interleukin-2 production (GO:0032663),0.41149714441872026,1.1438967056180933,0.28230184581976114,0.5997839458355168,1.0,9/43,5.86%,PTPRC;ANXA1;CD4;MALT1;HDAC7;TBX21;TRAF2;CD28;RUNX1
prerank,membrane protein proteolysis (GO:0033619),0.4213539563635616,1.1438330695745926,0.2798165137614679,0.5995641370400758,1.0,10/37,17.49%,PRKCQ;DAG1;CLPP;NAPSA;PSEN2;ADAM17;AFG3L2;NFKB1;SPPL3;MBTPS2
prerank,protein localization to nucleus (GO:0034504),0.3836257094424051,1.1438308834891495,0.21923474663908996,0.5991717395150731,1.0,33/102,24.85%,MMP12;GCKR;PRICKLE1;IPO5;CTDNEP1;TOR1AIP2;NOL8;LMNA;E2F3;RPL11;NUP188;ARL2BP;NXT2;XPA;ABCA7;EIF4ENIF1;TPR;SYK;APPL2;GBP2;PPP1R10;HNRNPU;PAF1;PIKFYVE;TBRG1;NUP93;BMP4;CALR;TOR1B;NUP50;MDM2;TNPO2;TNPO1
prerank,catecholamine metabolic process (GO:0006584),0.5081175526552921,1.1437830846772308,0.312579415501906,0.5989140121656342,1.0,3/14,8.53%,ATP7A;TH;RNF180
prerank,establishment of protein localization to membrane (GO:0090150),0.3978902553332689,1.143774926074321,0.2622601279317697,0.5985327246816246,1.0,25/66,29.41%,RFTN1;SDCBP;ZDHHC15;ZDHHC18;NACA;BID;NECTIN3;SEC63;ZDHHC1;NPC1;YIF1B;AFDN;RAB3GAP2;RAB11A;REEP1;PIKFYVE;GRIN3B;RAB3GAP1;RTP4;NCF1;ATG3;ARL6;ZDHHC21;FRMPD1;RAB11B
prerank,clathrin-dependent endocytosis (GO:0072583),-0.34152486724511094,-1.1433564302974117,0.2684563758389262,0.7502028383218384,1.0,9/26,15.00%,FCHSD2;SNAP91;PICALM;SGIP1;ITSN1;LMBRD1;AP2A1;FCHO2;CLTB
prerank,positive regulation of cell population proliferation (GO:0008284),0.3621279922785379,1.1431796773473306,0.095,0.5998096504361761,1.0,126/423,25.39%,IGF1;BCL2;FLT1;FN1;ITGAX;CDK6;PRKCH;CSF1;TCIRG1;SDCBP;PTPRC;LTF;LEF1;CXCR2;GCNT2;PDGFA;PTGFR;RPS6;OSMR;NES;ID2;NRG1;NR4A3;SPHK1;PTK2B;DOT1L;FGF2;S100A6;HDAC4;SLC25A33;RPL23;SOX9;VEGFA;CRKL;HDAC1;CAPN1;IGF1R;KITLG;EAPP;FBXO5;ADAM17;CDK13;BAMBI;KRAS;HMOX1;FGF7;SLC35F6;PIM1;RHOG;CCL5;FGF20;DLL4;NAMPT;CHRD;GAS6;CDK2;CDCA7L;STX3;BIRC5;CCL14;FGF18;STOX1;IL31RA;LAMC1;VIP;CDC7;EFNB2;CCND2;KDR;CHTOP;C5AR1;BMP6;DDR2;SINHCAF;CAPNS1;SERPINF2;TOX;HNRNPU;CNBP;S100B;BMI1;IL6;DHX9;FAM98A;ITGB1BP1;RPS9;CCAR1;CUL3;BST2;IL2;BMP5;GAB2;MEIS3;TIMP1;EPO;CNOT6;HSF1;SRPK2;NPM1;SERTAD1;CD47;BMP4;CIAO1;CDC123;TERT;CALR;FGFR3;F2R;IL34;HTR2B;TGFBR2;CD74;KMT2D;MIF;FGFR2;MDM2;TNF;HDAC2;PDGFRA;CDK4;MAPK15;CDC25B;SFRP1;CX3CL1;FGF1;MDK
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.3735291777501319,-1.1431682586832894,0.2932692307692308,0.7467241164019717,1.0,4/18,5.98%,IL6R;FER;STAT3;ST18
prerank,chondroitin sulfate metabolic process (GO:0030204),0.44037099928181994,1.1430067070731493,0.2867132867132867,0.599847497291362,1.0,15/30,31.98%,CHST11;CSPG4;HEXA;DCN;BGN;CHST12;IDUA;CSPG5;CHST3;DSEL;HEXB;NDNF;DSE;CHST9;CSGALNACT2
prerank,RNA splicing (GO:0008380),0.3858822358217953,1.1430019267779472,0.2401656314699793,0.5994690522752493,1.0,42/95,30.15%,SNRNP35;SRPK1;PPP1R9B;PPP2R1A;ZRSR2;SF3B3;HNRNPC;SRSF11;PRPF4;SMNDC1;SRSF7;DDX39B;SYNCRIP;LSM6;PRPF6;SNRNP40;CCAR2;ZMAT5;TARDBP;SRSF2;PPIG;PRPF8;USB1;SRPK2;SMU1;SF3A3;LSM4;SRRM1;SNRPG;SF3B2;SF3B1;KHSRP;GEMIN2;RRAGC;SNRPF;NOL3;FUS;SRSF10;WBP4;TRA2B;WDR83;DBR1
prerank,regulation of response to cytokine stimulus (GO:0060759),0.470276751711044,1.1423313866734577,0.30337078651685395,0.6009636297385769,1.0,7/19,23.96%,IRAK2;CD24;RUNX1;TLE5;DHX9;MAPK7;MAP2K5
prerank,DNA recombination (GO:0006310),0.4267796271349318,1.14232904819655,0.2907239819004525,0.600576173978099,1.0,13/37,27.31%,RAD51B;ERCC1;IGHMBP2;RAD50;DMC1;BLM;RAD54L;RTEL1;HMGB1;RECQL5;GEN1;HMGB3;SUPV3L1
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.4589596438210195,1.142096765886542,0.2872467222884386,0.6008076327923803,1.0,4/23,7.03%,ITGAX;FGF2;SOX9;VEGFA
prerank,actin cytoskeleton reorganization (GO:0031532),0.39726100033857126,1.1419955168984717,0.27650273224043714,0.6006950818803782,1.0,13/63,12.09%,PLEK;FLNA;RAP2A;ANXA1;CLDN19;NRP1;NEDD9;GRB2;DTNBP1;FGF7;PARVA;GSN;RHOA
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.48897489569462727,1.141960711294855,0.30164765525982257,0.600395451727049,1.0,10/16,38.40%,CPEB3;DHX36;TARDBP;ZC3H12D;KHSRP;RC3H1;PLEKHN1;ZC3H12A;TRIM71;ZFP36L2
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.42329608478581043,-1.1418083995582493,0.3076923076923077,0.7464895581986062,1.0,5/12,20.00%,SNAP25;STX1A;SNAP23;STX19;SNAP47
prerank,intestinal absorption (GO:0050892),0.5088557848459742,1.141690527519932,0.33157894736842103,0.6006911826291514,1.0,4/13,7.71%,SLC5A1;TJP2;SLC46A1;UGCG
prerank,positive regulation of protein modification process (GO:0031401),0.3730362080852131,1.1414730695320763,0.1713426853707415,0.6009374235976002,1.0,49/203,18.30%,GPNMB;ATG7;RAP2A;FPR2;PLAUR;CD4;PTPA;CLDN19;NPTN;MMP9;PRKCD;FGF2;DAXX;MYDGF;DAB2;SOX9;VEGFA;CRKL;ANGPT1;TREM2;DLC1;RASGRP1;ILK;ADAM17;P2RY1;RACK1;KRAS;FGF7;C3;FGF20;ALG10B;GAS6;EFNA1;FGF18;PPIA;SPPL3;CSNK1D;SMPD1;TFRC;CCND2;KDR;SYMPK;CHP1;FXR2;ASPSCR1;RALB;RAB3GAP2;PIN1;TESK1
prerank,establishment of vesicle localization (GO:0051650),0.46487178716921523,1.1412660890982673,0.3035019455252918,0.6010905829595514,1.0,5/18,18.30%,CDK5;TMEM230;DNM2;RAB11A;TESK1
prerank,regulation of cell population proliferation (GO:0042127),0.3598597423920863,1.1412103499500594,0.04,0.6008344716507107,1.0,175/691,22.76%,GPNMB;IGF1;BCL2;FLT1;CTNNB1;FN1;ITGAX;CDK6;CSF1;NIBAN2;TCIRG1;SDCBP;IGFBP7;SPEG;SGK1;LEF1;ADARB1;CXCR2;SGK3;SGK2;PPP1R9B;GCNT2;PDPN;PDGFA;PTGFR;RPS6;OSMR;ID2;STAT4;SCIN;HRG;NRG1;IRF6;GTPBP4;NR4A3;CYP27B1;VDR;CLDN19;PTK2B;DOT1L;RAF1;FGF2;MNT;S100A11;PPP2R5C;HDAC4;JAG1;ELN;NCK2;SLC25A33;RUNX1;ADGRB1;BCL6;RPL23;GATA3;SOX9;NUDT6;VEGFA;CRKL;COPS8;ING4;P3H1;HDAC1;DLC1;CELF1;CAPN1;IGF1R;KITLG;EAPP;FBXO5;LMNA;IFITM1;COL18A1;ADAM17;CDK13;PTPN2;CADM4;BAMBI;SFRP5;SOX7;JUP;KRAS;FGF7;CHERP;UTP20;ATF5;JUN;SLC35F6;RHOG;CEBPA;BAP1;HP1BP3;FGF20;DLL4;BIRC6;RHOA;NAMPT;TFAP4;NUPR2;CDK2;TNFRSF9;CDCA7L;STX3;ARID2;BIRC5;CCL14;FGF18;STOX1;IL31RA;RBFOX2;CLU;CYP1B1;VIP;CDC7;MELTF;TFRC;EFNB2;CCND2;KDR;CHD5;CHTOP;CCN6;ING5;BMP6;RPS6KA2;SMYD2;SINHCAF;STK11;CAPNS1;CDKN3;CNBP;S100B;GNL3;IL6;FAM98A;ITGB1BP1;RPS9;CCAR1;CUL3;AGO3;SULT2B1;IL2;PIAS1;BMP5;GAB2;ARHGEF2;FTH1;GNRH1;MEIS3;SOD2;TBRG1;TIMP1;EPO;CNOT6;CDCA7;VHL;DUSP15;HSF1;SRPK2;RNF41;NPM1;SERTAD1;CD47;BMP4;ABI1;CIAO1;TES;CDC123;EGLN3;CALR;FGFR3;KLF11;F2R;IL34;HTR2B
prerank,regulation of urine volume (GO:0035809),-0.46050255243282234,-1.1407424654519331,0.27340823970037453,0.745687245092889,1.0,6/10,36.13%,INPP5K;TFAP2B;HYAL2;ADM;HAS2;NPR3
prerank,regulation of neurotransmitter secretion (GO:0046928),-0.30890707498828973,-1.1400974398763652,0.24113475177304963,0.7436340238420478,1.0,7/32,4.84%,MEF2C;SNCAIP;CPLX1;RIMS1;LRRK2;SNAPIN;SLC30A1
prerank,T cell proliferation (GO:0042098),0.5130800462651937,1.1400592692883804,0.31926121372031663,0.6036262304534427,1.0,5/13,11.17%,MSN;CADM1;RASGRP1;LILRB1;CRTAM
prerank,negative regulation of cholesterol transport (GO:0032375),0.5327167706716072,1.1397887649967469,0.34112792297111416,0.6040127738256156,1.0,3/10,14.42%,APOA2;APOC1;NFKB1
prerank,positive regulation of interleukin-4 production (GO:0032753),0.48176057960617236,1.1397001254030301,0.29987608426270135,0.6038450753365068,1.0,6/17,19.24%,PRKCQ;CD28;GATA3;SYK;HAVCR2;FCER1G
prerank,regulation of receptor internalization (GO:0002090),0.4259262148570894,1.1392443874766245,0.2908458864426419,0.6047809850518849,1.0,8/35,15.21%,SDCBP;VEGFA;ANGPT1;ANKRD13B;LRPAP1;CD63;SCYL2;ANKRD13A
prerank,intraciliary retrograde transport (GO:0035721),0.520326428852882,1.139152122321985,0.3193166885676741,0.6046337564211972,1.0,6/12,27.48%,TTC21A;IFT43;WDR35;IFT122;DYNC2I1;DYNLT2B
prerank,leukotriene metabolic process (GO:0006691),-0.3646460304970399,-1.1387498186835667,0.2604166666666667,0.7438498826420564,1.0,3/19,3.78%,LTC4S;ALOX5;GGT5
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.4299632054176321,-1.1387276145541025,0.2899628252788104,0.740001473356253,1.0,4/11,6.14%,PARP8;PARP14;PARP12;PARP11
prerank,melanosome localization (GO:0032400),0.46004578271275204,1.1386562311959858,0.29325153374233126,0.6056087306121661,1.0,2/21,1.29%,MYO5A;BLOC1S3
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.4309087186880393,1.1384776250251611,0.3030998851894374,0.6057051974512353,1.0,5/34,4.69%,FLT1;FGR;WDR91;PTK2B;FGF2
prerank,negative regulation of phosphorylation (GO:0042326),0.3877212931097812,1.1384061947145354,0.25933609958506226,0.6055148887186987,1.0,22/85,19.20%,STAP1;CORO1C;SIRPA;XDH;HDAC4;PLPP3;CRKL;CADM4;NPRL2;FBLN1;PAQR3;PTPN13;ROCK1;PPIA;GIT1;LRP6;PPP1R15B;CHP1;MYADM;HNRNPU;TESK1;TARDBP
prerank,skeletal muscle organ development (GO:0060538),0.4413291416853162,1.1380956641805584,0.29904306220095694,0.6060139385700435,1.0,7/26,17.80%,LARGE1;CSRP3;CAV1;BASP1;IGSF8;SVIL;DISP1
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.40762363169288085,1.1380195391693346,0.26601520086862107,0.605802323220201,1.0,19/48,22.78%,FLNA;NRP1;NEDD9;CUX1;CRKL;LIMS2;P4HB;ILK;SS18L2;MYOC;CDC42;DOCK5;C1QBP;MYADM;TESK1;FERMT2;TRIOBP;CALR;CSPG5
prerank,ribonucleoprotein complex assembly (GO:0022618),0.3745096592005565,1.1379562153106941,0.2305327868852459,0.6055656441006486,1.0,51/132,28.75%,EIF3A;EIF6;SRPK1;LUC7L2;BRIX1;RPS14;RRP7A;ZRSR2;DENR;RPS28;CELF1;PPAN;RPL11;PRMT5;PRMT7;DDX1;DHX29;DDX39B;RPL38;POLR2D;MRPS7;PUF60;SART1;RPS19;RPS27;MDN1;PRPF6;CELF6;GCFC2;DHX9;PTGES3;EIF2S2;CPSF7;HSP90AB1;SRPK2;RPSA;LSM4;EIF4B;GEMIN8;SNRPG;SF3B1;GEMIN2;SNRPF;RPL23A;GEMIN5;NOL3;TARBP2;EIF2D;SRSF1;SRSF10;NUDT21
prerank,negative regulation of intracellular protein transport (GO:0090317),0.4635827015040697,1.1379382658330792,0.3133971291866029,0.6052113166131886,1.0,8/22,18.68%,MDFIC;GDI1;UFM1;LMAN1;SP100;BARD1;CHP1;ITGB1BP1
prerank,inorganic anion transmembrane transport (GO:0098661),-0.27788962238712206,-1.1378757606619476,0.10526315789473684,0.7389045297654708,1.0,20/63,14.06%,GABRB2;GABRB3;GLRA3;SLC1A3;GABRG3;GABRA2;SLC12A2;SLC12A9;SLC25A11;SLC12A6;SLC6A1;LRRC8A;GABRA1;SLC12A8;GABRB1;GLRA2;ANO7;SLC37A4;GABRR2;GLRA1
prerank,atrial septum development (GO:0003283),-0.40398653560218767,-1.1376709866263397,0.2697095435684647,0.735667964277155,1.0,7/13,29.34%,NOTCH2;ZFPM1;ANK2;BMPR2;ISL1;GJA5;NPHP3
prerank,sodium-independent organic anion transport (GO:0043252),-0.4453407796403488,-1.137535845242573,0.27402135231316727,0.7322495432707267,1.0,3/10,7.24%,SLCO2B1;SLCO1B1;SLCO4A1
prerank,synaptic vesicle recycling (GO:0036465),-0.32134727194233553,-1.1372858812525204,0.216,0.7292064243360793,1.0,7/31,6.71%,OPHN1;NLGN1;AMPH;RAB3A;SYT1;SYT2;PLD2
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.47077017702433643,1.1371028528116383,0.30387409200968524,0.6072030849039755,1.0,9/21,26.50%,RPS7;RPL23;FZR1;FBXO5;RPL11;RAB1A;GOLGA2;UBE2C;BTRC
prerank,striated muscle cell differentiation (GO:0051146),0.4883321380231185,1.1367346235376796,0.3167305236270754,0.6078305156232495,1.0,4/16,6.73%,PLD3;AKAP13;NRG1;SIK1
prerank,regulation of protein binding (GO:0043393),0.38007922723993476,1.136111124677004,0.23194303153611392,0.609112274236339,1.0,36/114,23.23%,LRP1;CTSZ;NES;PRKCD;HDAC4;CAV1;DAB2;STK3;RPL11;RACK1;LRPAP1;BAMBI;BAX;B2M;PRMT7;NVL;TLE5;GTF2F1;ROCK1;ACTB;SPPL3;DERL1;PSME3IP1;SYMPK;RALB;HIP1R;PIN1;ITGB1BP1;IFIT2;MARK2;GSK3B;BMP4;TRIM21;TERT;USP33;PEX14
prerank,proteasomal protein catabolic process (GO:0010498),0.369661874110071,1.1360793090510375,0.17051153460381144,0.6087904560554668,1.0,82/201,32.42%,CTNNB1;PSMD8;NFE2L2;PSMD1;FBXL17;TBX21;KCTD17;FBXW7;NHLRC1;PPP2R5C;SIAH2;ZFAND2A;SPSB2;ATXN3;PSMD6;PSMA1;AGAP3;PLAA;VCP;DDB1;NHLRC3;PSMC3;HUWE1;PSMA8;SHARPIN;DDI2;ENC1;PSMD14;KCTD10;PSMD2;DDIT3;BFAR;RCN3;ZSWIM8;DERL1;FBXL19;PSMC6;PSMA6;RMND5B;PSMD5;UBE4B;PSMA5;CUL3;SPSB3;FBXW11;UBXN6;FBXW5;RNF216;RNF41;CDC34;PSMA3;MDM2;TRIM72;BIRC2;PSMB8;PSMB10;CUL4A;PSMD7;PELI1;PSMB6;BTRC;KCTD2;PSMD10;GSK3A;PSMB5;TRIM3;DNAJB12;PSMB7;WWP2;ERCC8;FAF1;PSMC4;SIRT1;SKP2;RNF34;PSMD12;SIRT2;ATE1;NEDD4;SYVN1;PSMD3;FEM1C
prerank,regulation of gene silencing by miRNA (GO:0060964),0.39073722565934504,1.1360580012157784,0.26299045599151644,0.6084471372591727,1.0,24/62,29.50%,NUP205;AGO2;EIF4G1;PPARG;POLR2H;NUP188;POLR2D;RANBP2;TPR;PUM1;RAE1;DHX9;NUP93;AAAS;NUP54;NUP50;POLR2F;NUP98;NUP42;NUP133;NUP210;H3-3A;NUP35;NUP214
prerank,regulation of telomere maintenance (GO:0032204),0.44892385284514136,1.135897789786858,0.3028503562945368,0.6085085346661308,1.0,12/26,31.47%,ERCC1;RAD50;ERCC4;DHX36;PPP1R10;ATRX;GNL3;RTEL1;TERF2IP;SMG1;XRCC5;TERF2
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.45677711775443175,1.135868650674444,0.3141852286049238,0.6082049869320185,1.0,5/25,9.98%,PLAUR;MMP9;BID;BCL2L11;BAX
prerank,protein ubiquitination (GO:0016567),0.3596992555229473,1.1354596533376995,0.078,0.6089784803072764,1.0,160/471,29.87%,BCL2;CTNNB1;HIF1A;MYLIP;PSMD8;NFE2L2;PSMD1;SASH1;RNF125;FBXL17;UBA52;TRAF2;RPS27A;CNOT4;TRIM6;TRIM43;RNF14;FBXW7;FBXO32;TNKS2;TRIP12;BRAP;NHLRC1;OTULIN;RNF7;HECTD2;SIAH2;RNF6;TSPAN17;SDE2;NFX1;KLHL7;SPSB2;PEX2;UBE2H;UBE2L3;FBXO31;ZNRF3;PSMD6;USP9X;VPS18;PSMA1;DDB2;FBXW4;BRCA1;RACK1;VCP;DDB1;OBI1;RNF111;USP5;NHLRC3;PSMC3;CUL9;KLHL13;UBE4A;HUWE1;SHPRH;PSMA8;UBE3B;BIRC6;UBE2R2;ENC1;TPP2;VPS11;UBE2Q1;PSMD14;KCTD10;PSMD2;UBE2L6;BFAR;BLMH;DTX2;MKRN2;CBL;ZSWIM8;DTX4;DERL1;FBXL19;KLHL24;RNF157;PSMC6;BARD1;PSMA6;UBE3C;KLHL25;ASB1;RNFT1;PSMD5;UBE2V2;ELOB;WSB1;PAF1;UBE4B;PSMA5;UBR2;RNF167;CUL3;DTX3;FBXO7;UBC;RNF20;FBXW11;RNF19A;CAND1;CUL1;VHL;TRIM24;FBXW5;RNF41;CDC34;ZNRF2;FBXO11;TRIM21;CUL2;ARRDC4;UBA6;CCDC22;PEX14;ANAPC7;PSMA3;MDM2;TRIM72;BIRC2;PSMB8;PSMB10;FBXO41;CUL4A;TRIM7;PSMD7;ABCB11;PELI1;UBE2C;PSMB6;KLHL21;KEAP1;BTRC;CBLL1;ATG3;PSMD10;RC3H1;PSMB5;UBE2Z;TRIM3;RNF13;CTR9;OS9;KLHL41;PSMB7;LONRF1;WWP2;KLHL18;ERCC8;PSMC4;SIRT1;TRIM68;RCHY1;LEO1;MUL1;RNF19B
prerank,regulation of chemotaxis (GO:0050920),-0.32224168940831543,-1.13480000370654,0.22666666666666666,0.7328171824846524,1.0,3/30,0.46%,P2RY12;CYRIB;ZSWIM6
prerank,presynapse organization (GO:0099172),-0.45794260472272535,-1.1344928790834892,0.29642857142857143,0.7300558153320177,1.0,5/10,19.58%,NLGN1;LRRTM3;WNT5A;NLGN2;NLGN3
prerank,Ras protein signal transduction (GO:0007265),0.37532136517064635,1.134337019221382,0.20242914979757085,0.6116656729406342,1.0,37/137,18.05%,IGF1;MYO9B;RAP2A;GRAP2;GNA13;LAT;PDPN;FGF2;BRAP;RTKN;TRIM28;GRB2;RAPGEF6;CRKL;DNMT1;RHOD;RASGRP1;PLK2;RASGRP3;GDI1;NRAS;KRAS;ARHGAP6;ARHGEF1;JUN;RHOG;RHOA;LIMK1;CDK2;CELSR1;ROCK1;ARHGEF11;RASGRP2;NF1;RIT1;RALB;NTN1
prerank,response to estradiol (GO:0032355),0.4325733290022217,1.1342362358877236,0.31014823261117447,0.611552010628871,1.0,3/31,3.81%,CTNNB1;ANXA1;CYP19A1
prerank,negative regulation of cell population proliferation (GO:0008285),0.36274575886431754,1.134205804374754,0.116,0.611241980939843,1.0,86/351,22.07%,GPNMB;CTNNB1;CDK6;NIBAN2;IGFBP7;NLRC3;PTGIR;SPEG;ADARB1;B4GALT7;PDPN;SCIN;HRG;IRF6;GTPBP4;CYP27B1;VDR;CLDN19;PTK2B;RAF1;NELL1;MNT;S100A11;PPP2R5C;PPARG;NCK2;ADGRB1;GATA3;MTSS1;SOX9;NUDT6;TREM2;COPS8;ING4;P3H1;DLC1;CELF1;PEX2;LMNA;IFITM1;COL18A1;E2F3;CD300A;PTPN2;SFRP5;SOX7;B2M;HMOX1;CHERP;UTP20;ATF5;CEBPA;BAP1;DLL4;FBLN1;TFAP4;NUPR2;ARID2;RBP4;CYP1B1;VIP;NF1;APPL2;CHD5;CCN6;ING5;RPS6KA2;SMYD2;STK11;CDKN3;IL6;ITGB1BP1;SLC16A2;SULT2B1;BMP5;FTH1;GNRH1;SOD2;TBRG1;VHL;RNF41;NPM1;RUNX3;BMP4;ABI1;TES
prerank,positive regulation of cell junction assembly (GO:1901890),-0.27606230047112074,-1.1339294511402038,0.2111111111111111,0.7279922464237009,1.0,22/56,20.25%,IL1RAPL1;NRXN1;NLGN1;PTPRD;CLSTN2;PTPRJ;GRID2;CLSTN3;EPHB1;AGT;CNTNAP2;CUX2;DLG5;CLSTN1;FLOT1;EPHA2;IL1RAP;NPHP1;NLGN2;NLGN3;SYNDIG1;CLDN5
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.47728127328603387,1.1339239400589851,0.326302729528536,0.6116623598707055,1.0,10/18,36.82%,NCOR2;IL6;BMP4;TERT;MAP2K2;TNF;RIPK1;ZC3H12A;MAP2K1;TGFB1
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.5224092239644422,1.1338800250312415,0.3156498673740053,0.6113909878235693,1.0,1/12,0.51%,CHAMP1
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.43918774308107306,1.133828518447681,0.2958715596330275,0.6111265715472375,1.0,15/30,29.78%,FBXW7;UBE2L3;HUWE1;BAP1;RHOU;VPS11;MICALL2;UBL5;CSNK2A2;SAE1;USP36;GSK3A;ATG13;TOMM7;LEPROT
prerank,Wnt signaling pathway (GO:0016055),0.3831824587167677,1.1336546192659627,0.24691358024691357,0.6112485697362217,1.0,23/92,21.45%,CTNNB1;TCF7;CCDC88C;LEF1;UBA52;RPS27A;CD24;PLPP3;WNT6;VPS26A;CSNK1G1;SFRP5;WLS;FRAT1;FZD1;FZD4;LRP6;NR4A2;FERMT2;TCF7L1;UBC;CUL1;GSK3B
prerank,regulation of cellular metabolic process (GO:0031323),0.409889008241042,1.1334951348583229,0.3054298642533937,0.6112899479374423,1.0,21/45,32.35%,ABCG1;ACACA;EIF6;NCOR2;CYP1B1;ACACB;NPC2;PDK3;RNF41;VPS35;PARL;AGPAT1;MBOAT7;FASN;TBC1D16;ABCB11;KIF16B;LAMTOR1;RNF34;RSPO1;PID1
prerank,regulation of JUN kinase activity (GO:0043506),0.4246316454295522,1.1333467246918736,0.3,0.6113266588930043,1.0,11/33,25.90%,SASH1;TRAF2;NPPA;TAOK3;PTPN22;PDCD4;RPS3;ARHGEF5;DNAJA1;TNF;TLR9
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.5334519848190441,1.1326949987953103,0.32332878581173263,0.6127550942929246,1.0,4/11,12.78%,NPPA;LRRC52;TREM2;ALG10B
prerank,phosphate ion transport (GO:0006817),0.4870980435916832,1.1322214393569066,0.3291298865069357,0.6136215162425815,1.0,6/16,25.43%,SLC37A2;SLC25A3;SLC25A14;XPR1;SLC20A1;SLC37A3
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.42476304464260384,-1.131882836805031,0.30158730158730157,0.7308469686076002,1.0,2/12,3.54%,SERINC3;SEPHS1
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.4919722481471279,1.1315701840923846,0.31202046035805625,0.6150170217501656,1.0,5/15,18.40%,LRP1;PDPN;MELTF;DDR2;IL6
prerank,positive regulation of collagen metabolic process (GO:0010714),0.48597352190065873,1.131310856197002,0.31421121251629724,0.6153523188760461,1.0,7/17,24.76%,VIM;RUNX1;SUCO;SERPINF2;BMP4;F2R;HDAC2
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.5344968324737386,1.1313053197315828,0.340080971659919,0.6149684568051402,1.0,5/10,29.34%,PSMC3;PSMC6;HMGB1;ATF7IP;PSMC4
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.43555450033185716,1.1305438257764546,0.29683698296836986,0.6166637196693764,1.0,15/29,30.77%,TRIM6;TTLL12;RNASEL;PTPN2;METTL3;YTHDF3;YTHDF2;USP18;NLRC5;HSP90AB1;PTPN6;IFNAR2;MUL1;PTPN1;MAVS
prerank,regulation of Wnt signaling pathway (GO:0030111),0.3743114680837272,1.1302972931118254,0.2489754098360656,0.616948098304315,1.0,16/108,10.93%,MDFIC;CTNNB1;CDK14;LRP1;CCNY;MACF1;GNAQ;SOX30;OTULIN;PPP2R1A;RUNX1;MDFI;RACK1;SFRP5;SOX7;WLS
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.5043675745415239,1.130265977996625,0.3096514745308311,0.6166472243845723,1.0,2/14,3.90%,ATP1B3;LRRC52
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.4557866260987841,1.130209840534595,0.3077858880778589,0.6164057129089824,1.0,6/23,17.54%,MYO10;CCDC88C;HOOK1;KIF1A;HOOK3;TUBB
prerank,carbohydrate homeostasis (GO:0033500),0.39086118520866747,1.1298783648762096,0.2725344644750795,0.616941174607019,1.0,16/67,18.40%,ADCY8;GCK;RPS6;GCKR;PPARG;IGF1R;CYB5R4;PTPN2;CEBPA;RBP4;SLC8B1;APPL2;ADIPOR1;WFS1;STK11;IL6
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.4592516118077773,1.1296851343104954,0.2962056303549572,0.617093756288746,1.0,11/22,26.69%,NCL;UBTF;WDR43;SMARCB1;PWP1;DHX33;RASL11A;LYAR;ATF4;SMARCA4;PIH1D1
prerank,cholesterol metabolic process (GO:0008203),0.3836950793543632,1.1294863081947943,0.2823779193205945,0.6172389477820993,1.0,10/68,11.34%,APOE;ABCG1;ABCA1;PLPP6;CEL;APOA2;SOAT1;PPARD;ARV1;SOAT2
prerank,nucleosome disassembly (GO:0006337),0.4982007881332535,1.1294372391949905,0.32993630573248406,0.6165881947874444,1.0,6/14,25.02%,GRWD1;SMARCB1;SMARCC1;ARID2;SMARCD2;SMARCA4
prerank,chromatin disassembly (GO:0031498),0.4982007881332535,1.1294372391949905,0.32993630573248406,0.6165881947874444,1.0,6/14,25.02%,GRWD1;SMARCB1;SMARCC1;ARID2;SMARCD2;SMARCA4
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.42251353805427816,1.1293221229493366,0.29814385150812067,0.6165258534951353,1.0,10/35,19.05%,ABL2;ARHGAP24;RIPOR2;DLC1;MYOC;KCTD10;SPRY4;SYNGAP1;ITGA3;CUL3
prerank,sphingolipid catabolic process (GO:0030149),0.4928876482139838,1.1292759721005943,0.3251612903225806,0.616254842721105,1.0,6/15,24.16%,SPHK1;SMPD4;GLA;SMPD1;ASAH1;PDXDC1
prerank,positive regulation of axon extension (GO:0045773),0.4654853202514805,1.129237004060478,0.31143552311435524,0.6159672289252337,1.0,8/22,20.74%,MACF1;GOLGA4;NRP1;VEGFA;RUFY3;LIMK1;NTN1;DSCAM
prerank,nucleotide catabolic process (GO:0009166),0.49553736220232064,1.129105781265676,0.3405889884763124,0.615916480200017,1.0,4/16,11.98%,XDH;DERA;VCP;ITPA
prerank,regulation of neuron migration (GO:2001222),-0.33958440182922933,-1.128992956193249,0.26875,0.7353714539062848,1.0,13/26,22.99%,CTNNA2;SEMA6A;RAPGEF2;NEXMIF;ADGRG1;PHACTR1;CAMK2B;CAMK2A;SRGAP2;NTNG1;PLXNB2;SHTN1;TNN
prerank,cellular response to interferon-gamma (GO:0071346),0.3777819642359398,1.128837714620173,0.25654450261780104,0.6162258493843434,1.0,26/88,22.13%,EPRS1;SIRPA;CCL4;CD44;IRF6;PRKCD;IL12RB1;CCL13;IRF8;B2M;CCL7;JAK1;CCL5;IRF5;SP100;CCL14;SYNCRIP;DAPK1;ACOD1;GBP2;AQP4;DAPK3;RPL13A;CD47;SLC26A6;TRIM21
prerank,negative regulation of signaling (GO:0023057),0.4513633561960601,1.1285851013090749,0.32201405152224827,0.616522460394937,1.0,4/25,10.69%,OPTN;BRAP;TRAT1;SOCS5
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.43963735021173755,1.1284668856848385,0.30578512396694213,0.6164441434614603,1.0,5/27,9.58%,PRKCQ;PRKCD;NCK1;PRKCB;PTPN2
prerank,positive regulation of kinase activity (GO:0033674),0.37903223404207026,1.1284655047500183,0.2530737704918033,0.6160527017083551,1.0,21/107,17.08%,IQGAP1;FLT1;CSF1;PTPRC;CD4;LAT;ALS2;AXL;PTK2B;LMO4;DAXX;TREM2;IGF1R;VAC14;RAD50;GAS6;JTB;KDR;MAP2K3;DDR2;PRKAG1
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.37948408273708134,1.1283032881371506,0.2612244897959184,0.6160611583827975,1.0,16/93,11.10%,MMP8;SDCBP;SASH1;TRAF2;XDH;GDF6;SPHK1;MAP4K2;PTK2B;MFHAS1;TAOK3;TRAF3;VEGFA;RASGRP1;TRAF1;RELL1
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.30256886666994404,-1.1276433240549388,0.2553191489361702,0.7356529022315128,1.0,12/41,11.50%,CACNA2D1;GRIN2A;RYR3;ITPR2;SLC8A3;PLCG2;HTR2A;GRIN2B;HTR2C;SLC8A2;TRPV4;GRIN1
prerank,rRNA catabolic process (GO:0016075),0.48109494712479683,1.1274779873777065,0.3342140026420079,0.6179348750610153,1.0,5/16,12.26%,DEDD2;EXOSC4;ERN2;EXOSC9;EXOSC10
prerank,response to endoplasmic reticulum stress (GO:0034976),0.378477427422541,1.1271638355377347,0.23608247422680412,0.6184506262481964,1.0,42/107,28.82%,BCL2;ATF3;TRAF2;ERN2;ERN1;NCK1;BCL2L11;EIF2S1;P4HB;UFM1;ERO1A;VCP;BAX;TMX1;CREB3L2;JUN;ERP44;DNAJB9;DDIT3;UBQLN1;RCN3;DERL1;PPP1R15B;CASP4;PIK3R2;WFS1;MBTPS2;UBXN6;GSK3B;ATP2A2;PPP1R15A;DNAJC10;ATF4;HSPA5;ATG10;TMCO1;USP19;DNAJB12;UFL1;OS9;ITPR1;HSP90B1
prerank,regulation of cellular response to heat (GO:1900034),0.38204943957295445,1.1269095224206103,0.2946708463949843,0.6188075626474511,1.0,38/77,33.76%,NUP205;MAPKAPK2;NUP188;HSPA8;RANBP2;TPR;CHORDC1;DNAJB1;RAE1;ATM;CCAR2;PTGES3;NUP93;HSP90AB1;HSF1;AAAS;GSK3B;BAG3;NUP54;NUP50;NUP98;NUP42;NUP133;NUP210;ATR;MAPK3;DNAJC2;NUP35;DNAJB6;IER5;SIRT1;NUP214;MAPK1;EP300;CREBBP;NUP62;BAG1;CAMK2G
prerank,positive regulation of protein import into nucleus (GO:0042307),0.43497790512291556,1.126737903475189,0.3187721369539551,0.6189023430199676,1.0,16/28,32.76%,FLNA;PRKCD;IPO5;TRIM28;CDH1;JUP;TPR;PIK3R2;BAG3;RBM22;HDAC3;ZPR1;DMAP1;MAVS;ZC3H12A;UBR5
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.39054966718422857,1.1267230467069183,0.2765509989484753,0.6185496735350609,1.0,25/72,25.42%,UBA52;RPS27A;ERCC1;XRN2;DDB2;DDB1;RAD50;DDX1;XPA;DXO;DCP1A;ERCC4;EDC4;ISG20;RFC1;GTF2H1;RNASE6;UBC;DNASE1L1;SETMAR;MEI4;RFC2;EDC3;GTF2H5;CUL4A
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.3528917204364806,1.1267213362371367,0.031,0.6181625166579976,1.0,322/1082,26.03%,IGF1;MDFIC;LITAF;CTNNB1;CXXC1;SPP1;MITF;APOE;HIF1A;ERCC6;SKAP1;CSRNP1;ZMIZ1;NIBAN2;MMP12;ATF3;CDK8;MRTFA;TOX2;ELF4;SLC9A1;KMT2A;NFYA;NFIC;NFE2L2;CD4;LEF1;UBA52;AGO2;TBX21;MYBL2;DEAF1;RPS27A;BCL11B;TNIP1;MAFF;CDCA4;ID2;EOMES;SOX3;GDF6;IRF6;TCF15;POMC;SOX30;NR4A3;FSTL3;VDR;MEF2D;DOT1L;POU3F1;RNF14;SQSTM1;NFIL3;FGF2;CSRP3;TFEB;HDAC4;PPARG;JAG1;NCK2;FOXJ1;MYDGF;ZMIZ2;KLF6;RUNX1;DAB2;GATA3;RNF6;RFX5;TRIM28;SOX9;NCK1;BRD4;VEGFA;EGR2;PPP1R12A;HDAC1;BPTF;THOC1;TXK;MED21;ZNF395;CDH1;MTF2;RHOQ;TRIM16;TNIP3;NAA16;PRDM15;DDX17;KDM3A;HMGN1;ILK;PPARD;LILRB1;E2F3;IRF8;RNASEL;HOXA7;CCNC;BRCA1;NKX2-1;UBTF;TET3;BAMBI;WDR43;NEK4;SS18L2;RNF111;PSMC3;JUP;FGF7;ASXL2;POU2AF1;PCBD2;TASP1;SMARCB1;CREB3L2;MEF2B;ATF5;CRTC1;JUN;DNM2;NRF1;TRIAP1;ELF2;RHOG;MAML2;CEBPA;SERPINE1;MED17;TAF15;IRF5;MRTFB;RAI1;MYSM1;TNIP2;ZKSCAN3;SLC30A9;NAMPT;TFAP4;MAP3K12;ZFP64;NPAT;PPARGC1B;BLM;SMARCC1;SP100;MRPL12;FZD1;ZBTB16;OGT;ELK4;SMAD7;CHCHD2;GTF2F1;FOXJ3;SMAD1;ILF3;H1-0;YY1;EHF;FZD4;ACTR3;DDX39B;NFYB;DCN;IL31RA;DDIT3;NFKB1;INO80;PRKD2;PAXBP1;LRP6;ELOF1;ACTA2;SP7;SSBP4;ARHGEF11;HELZ2;ING2;PCBP1;NHLH2;ASXL1;SRF;MED13;SERTAD3;CEBPG;ECD;FOXO1;PRMT2;MTF1;NR4A2;PLAC8;ELK3;ZNF296;HTATIP2;DHX36;NPAS4;ING5;MAP2K3;PIK3R2;BMP6;PRPF6;AKIRIN1;CAMK4;SBNO2;TCF12;SERPINF2;SP1;HNRNPU;DHX33;CNBP;WBP2;GABPB1;GABPB2;ATRX;HAX1;GTF2H1;KAT7;PIN1;ATM;USF2;IL6;RASL11A;DHX9;ITGB1BP1;DR1;LYAR;TAF7;CCNT2;TAF6;YAF2;HOXB4;NR3C1;SLC11A1;BMP5;ARHGEF2;HMGB1;UBC;RNF20;TMF1;NFATC3;FBXW11;SPIB;SREBF1;ARID1B;MEIS3;EIF5A;EPO;VHL;RFXANK;NLRC5;PBX1;ZXDC;RXRB;HSF1;NPM1;RUNX3;SERTAD1;ETV4;BMP4;TEAD1;SENP1;GLYR1;ATAD2B;WAS;MAP2K2;ARNT2;PPRC1;F2R;RLF;NIF3L1;SMARCD2;NSD3;MAPK7;AHR;EGR1;ZBED3;CD74;PITHD1;STAT5B;PBX2;KMT2D;REL;LHX4;RXRA;WWOX;XPC;DCAF6;FGFR2;MAP2K5;SOX10;LPIN3;TNF;GLIS2;PPP3R1;EDF1;ATF4;HDAC2;SMARCA4;POU2F1;RRP1B;SFRP1;GRHL1;CX3CL1;FGF1;MED6;NDP;NOTCH4;CREB5;CSRNP3;DPF3;TFCP2;HDAC3;MYRF;HCFC1;LAGE3;TLR9;MLLT6;ZPR1
prerank,positive regulation of reproductive process (GO:2000243),0.4301351259895884,1.126636750412938,0.2943871706758305,0.6180118396555327,1.0,7/31,15.85%,AGO2;LHFPL2;VEGFA;TAC4;PRDM9;VIP;C1QBP
prerank,selective autophagy (GO:0061912),0.4008450761235093,1.1260256602800562,0.30257510729613735,0.6193022302319892,1.0,29/56,32.84%,UBA52;RPS27A;VIM;SQSTM1;DYNC1H1;UFM1;RAB7A;MAP1LC3B;UBQLN1;DYNC1LI2;IFT88;RETREG1;ATM;UBC;ATG2B;ACBD5;WDFY3;STBD1;UFL1;ATG13;AMBRA1;USP30;BECN1;UBA5;LGALS8;UBB;DYNC1I2;ATG5;TEX264
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.44439243770787173,1.1256201562134718,0.3041958041958042,0.620036953810316,1.0,2/25,1.06%,MMP8;P2RX4
prerank,protein localization to organelle (GO:0033365),0.3695404233764294,1.125537742866716,0.2257085020242915,0.6198821488399248,1.0,44/133,24.53%,TRAM1L1;OPTN;TTC21A;CSRP3;FAM83H;CTDNEP1;ARL1;TSPAN17;LMNA;WDR35;RPL11;SNX10;LAMP2;SEC61B;GAK;HMOX1;DDX1;XPA;GCC2;PAQR3;ABCA7;DCP1A;CEP250;MTCH2;CSNK1D;GET1;GBP2;VAMP2;PAF1;RAB11A;ALDH3A2;DHX9;PIKFYVE;IFT122;BMP4;CALR;TOR1B;PPP1R15A;VPS35;CD68;EHD1;DNAJA1;MDM2;WDR83OS
prerank,regulation of Rho protein signal transduction (GO:0035023),0.38787154812411406,1.125468973615615,0.2680084745762712,0.6196798169580353,1.0,21/72,22.71%,MYO9B;APOE;ABCA1;ABL2;AKAP13;RIPOR2;RAF1;NRP1;GPR174;DLC1;MYOC;ARHGEF18;KCTD10;LPAR1;ITGA3;CUL3;ARHGEF2;ARHGDIB;PRAG1;GPR65;F2R
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.45732364629812505,1.1253784169746843,0.3187203791469194,0.6195486358755824,1.0,4/21,9.39%,TEDC1;EVC;TEDC2;ARMC9
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.45865271266687613,1.1252125644375062,0.3173076923076923,0.6196224411908646,1.0,9/24,22.67%,APOE;PTK2B;RHBDF1;EFNA1;PSMD14;TMF1;NUDT15;LATS1;USP14
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.3935305288905093,1.1250118014099877,0.2813807531380753,0.6198107286548322,1.0,12/70,11.70%,BCL2;BCL2L1;DEDD2;TRAF2;MCL1;DAXX;BID;PDPK1;DIABLO;BAX;HIPK1;TNFRSF1B
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.33600323503808643,-1.1248380939990354,0.24431818181818182,0.7401983803189999,1.0,8/24,10.74%,MEF2C;MAPK14;CTNNA2;MEF2A;OLFM2;CDH2;CAMK1;RBM4
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.29592044528397693,-1.1245832364440527,0.17391304347826086,0.7372856428920394,1.0,13/39,14.77%,EPN2;ROBO1;BMP2K;RBPJ;PRKCI;TSPAN14;STAT3;KAT2B;PDCD10;ROBO2;POGLUT1;SRC;JAG2
prerank,ion transport (GO:0006811),0.37701208332630975,1.1240651737749492,0.2597535934291581,0.6219884300023042,1.0,23/111,14.93%,SLC9A1;SLC26A1;SLC24A4;KCNN4;SLC15A3;CHRNB2;VDAC2;PANX3;SLC17A5;PANX1;PIEZO1;PLP2;LASP1;SLC9A8;PIEZO2;ATP1A4;SLC12A4;SLC26A11;CNGB1;SLC9A7;SLC9A6;SLC8B1;SLC26A4
prerank,pentose-phosphate shunt (GO:0006098),0.5281900246931222,1.1240337300536005,0.3333333333333333,0.6216806193263023,1.0,6/11,23.29%,DERA;PGLS;TKT;RPIA;PGM2;TALDO1
prerank,fatty acid oxidation (GO:0019395),0.40099552600239435,1.1239853753954236,0.28950159066808057,0.6214213818553456,1.0,21/57,25.76%,ACAD11;ABCD4;PEX2;PPARD;ABCD2;ACAD10;ECI2;ACAT1;ABCD3;CPT2;ADIPOR1;DECR1;ALDH3A2;ACADS;EHHADH;ACADL;ADH5;ACADM;HADHA;HADH;ACAA2
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.40221691332092785,1.1239147267676506,0.3028953229398664,0.6212157621821035,1.0,14/44,20.79%,FLNA;KCNN4;ATP1B3;NPPA;KCNJ2;AMIGO1;KCNMA1;KCNMB4;KCNJ10;ANO6;GNB1;ACTN2;KCNJ6;KCNJ15
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.542738777075067,1.1238330585207537,0.336986301369863,0.6210495425540481,1.0,4/10,19.77%,DLL4;ARHGAP12;LRP6;BMP5
prerank,negative regulation of response to wounding (GO:1903035),-0.3698116738980719,-1.1238236873572842,0.30158730158730157,0.7359552932020281,1.0,5/19,4.51%,CASK;ALOX5;EPHA4;RTN4RL1;AJAP1
prerank,regulation of Rac protein signal transduction (GO:0035020),0.47955704144375905,1.1233305576197838,0.34491634491634493,0.622043554031642,1.0,7/16,22.19%,ARHGAP24;ALS2;PIK3CB;CADM4;OGT;ARHGAP17;GABARAP
prerank,negative regulation of cell migration (GO:0030336),0.36846947778565975,1.1232628230395447,0.23487903225806453,0.6218411352483223,1.0,47/137,25.76%,MITF;LRP1;CORO1C;RAP2A;DAG1;ADARB1;MCTP1;GTPBP4;CLDN19;PTPN23;FGF2;JAG1;CLIC4;STK24;DLC1;CDH1;IFITM1;HOXA7;NKX2-1;HMOX1;SERPINE1;CHRD;SMAD7;ARID2;ADAM15;CYP1B1;DUSP3;NF1;ADIPOR1;AFDN;SINHCAF;ITGB1BP1;BST2;EVL;RNF20;DACH1;TIMP1;ARHGDIB;SRGAP1;RNF41;CALR;CD74;MIF;MAPK15;SFRP1;CX3CL1;DNAI3
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.40193425754238427,1.1232191312380841,0.3065934065934066,0.6215730053809528,1.0,22/53,29.44%,ERCC6;EYA4;PRKCD;TRIM28;BRCA1;PLA2R1;ABRAXAS1;CEBPG;FXR2;UIMC1;ATM;DHX9;CCAR2;SPRED2;RPS3;NSMCE1;SPRED3;BRCC3;SMCHD1;ATR;ERCC8;SIRT1
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.3704222932915724,1.1228122667861287,0.27579162410623087,0.6222511933720144,1.0,21/113,16.84%,IGF1;HIF1A;NRP2;MMP12;NR4A3;NRP1;FGF2;MYDGF;SOX9;VEGFA;NRAS;FGF7;JAML;ECM1;EGFL7;PRKD2;LAMC1;VIP;KDR;C5AR1;BMP6
prerank,regulation of receptor binding (GO:1900120),0.5429083908670724,1.122731408693872,0.33242506811989103,0.6220963588978692,1.0,5/10,27.88%,MMP9;B2M;ADAM15;ATP2A2;GREM2
prerank,apoptotic process (GO:0006915),0.36474339264777245,1.1226150269142625,0.19519519519519518,0.6220299336019129,1.0,69/203,25.07%,BCL2;CSRNP1;BCL2L1;CD2;PDE1B;GZMB;GZMA;GDF6;PTK2B;MCM2;RAF1;PAK6;CDK5;PRKCD;PPP2R1A;BID;STK3;AKAP1;ING4;THOC1;DLC1;BCL2L11;PRF1;DIABLO;PPARD;CYFIP2;SFRP5;BAX;HIP1;IAPP;DAP;CDK11B;ZBTB16;OGT;ADAM15;PPIA;CASP7;DAPK1;HSPD1;ADORA2A;APAF1;ITGB2;CASP4;FOXO1;PDCD4;GLRX2;STK11;DAPK3;BNIP2;AIFM2;CASP9;IFIT2;BIK;MRPS30;YARS1;MELK;EGLN3;CDIP1;PPP1R15A;TGFBR2;AHR;NUDT2;BNIP3;MDM2;JAK2;PLK3;GADD45A;ATN1;RRAGC
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.36041819471223213,1.1225420968280615,0.146,0.6218473233993989,1.0,126/341,30.09%,CTNNB1;MYLIP;PSMD8;NFE2L2;PSMD1;RNF125;FBXL17;TBX21;WDR91;CNOT4;COPS3;PTPN23;RNF14;SQSTM1;KCTD17;FBXW7;ANAPC15;TRIP12;NHLRC1;PPP2R5C;RNF7;SIAH2;ZFAND2A;TTC3;RNF6;UBR4;RNF128;SPSB2;ATXN3;UBE2H;UBE2L3;FZR1;ZNRF3;PSMD6;USP9X;PSMA1;AGAP3;FBXW4;PLAA;VCP;DDB1;RNF111;NHLRC3;PSMC3;UBE4A;HUWE1;VPS4B;PSMA8;UBE3B;BIRC6;SHARPIN;UBE2R2;ANAPC1;PSMD14;KCTD10;UBAP1;PSMD2;DDIT3;UBQLN1;UBE2L6;BFAR;MVB12A;CBL;ZSWIM8;FBXL19;PSMC6;PSMA6;UBE3C;KLHL25;RMND5B;PSMD5;UBE4B;PSMA5;CDC26;RNF167;RNF149;CUL3;SPSB3;BUB1B;FBXO7;RNF20;FBXW11;RNF19A;FBXW5;RNF216;CDC34;FBXO11;USP33;UBA6;ANAPC7;PSMA3;MDM2;TRIM72;BIRC2;PSMB8;PSMB10;CUL4A;KCTD21;PSMD7;VPS28;PELI1;UBE2C;PSMB6;KEAP1;BTRC;KCTD2;PSMD10;RC3H1;GSK3A;PSMB5;TRIM3;RNF13;TNFAIP3;OS9;PSMB7;WWP2;ERCC8;FAF1;UBAP1L;PSMC4;SIRT1;RCHY1;TGFB1I1;RNF19B;MVB12B;SKP2
prerank,ERK1 and ERK2 cascade (GO:0070371),0.454870106995259,1.1223670895043159,0.31845597104945716,0.6219413849709591,1.0,6/21,22.76%,IGF1;SOX9;KDR;PTGER4;MAP2K2;HTR2B
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.3815768190684529,1.1223276471327936,0.26212590299277605,0.6216608015415978,1.0,35/88,31.23%,PSMD8;PSMD1;FBXL17;FBXW7;FBXO31;PSMD6;PSMA1;FBXW4;PSMC3;PSMA8;PSMD14;PSMD2;PSMC6;PSMA6;PSMD5;PSMA5;FBXL6;FBXW11;CUL1;FBXW5;CUL2;PSMA3;PSMB8;PSMB10;CUL4A;PSMD7;PSMB6;BTRC;PSMD10;PSMB5;PSMB7;PSMC4;SKP2;PSMD12;FBXL5
prerank,transcription by RNA polymerase I (GO:0006360),0.4231338855277104,1.1220793070598545,0.325,0.6219729337845014,1.0,18/34,31.46%,TAF1D;POLR1G;POLR2H;TTF1;UBTF;POLR1A;TCOF1;TBP;GTF2H1;TAF1A;TAF1C;POLR1F;POLR2F;GTF2H5;MNAT1;MAPK3;POLR1H;ERCC2
prerank,skin development (GO:0043588),0.39527606300108054,1.122040278952709,0.2857142857142857,0.6217060637671962,1.0,10/65,12.29%,ANXA1;ST14;ATP7A;PDGFA;JAG1;CLIC4;UGCG;EVPL;HRNR;ASCL4
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.5361214783202537,1.1218021074766382,0.336986301369863,0.6216061043108053,1.0,1/10,1.15%,MYLIP
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.5361214783202537,1.1218021074766382,0.336986301369863,0.6216061043108053,1.0,1/10,1.15%,MYLIP
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.5092488973383682,1.1217080156598835,0.328042328042328,0.6214786209439188,1.0,5/12,26.57%,DHRS3;TRIM16;ASXL1;CALR;SNW1
prerank,hemopoiesis (GO:0030097),0.3801415222501681,1.121663399438412,0.28229166666666666,0.6212184466456818,1.0,30/87,25.48%,FLT1;LCK;PLEK;KMT2A;PTPRC;FSTL3;JAG1;RUNX1;KITLG;ZNF160;CDK13;HIPK1;CEBPA;ZBTB16;ETV6;YTHDF2;TIRAP;KDR;TOX;BMI1;PRRC2C;RUNX3;BMP4;MELK;FUT10;TGFBR2;FGFR2;ATF4;SFRP1;NOTCH4
prerank,regulation of neurotransmitter transport (GO:0051588),-0.3783684978248942,-1.1216008932508303,0.23979591836734693,0.7386737283854505,1.0,4/16,2.39%,MEF2C;SNCAIP;CPLX1;RIMS1
prerank,regulation of protein localization to nucleus (GO:1900180),0.40664564807677067,1.120968732040215,0.30101465614430667,0.6227322144317143,1.0,15/43,22.43%,ATP13A2;MFHAS1;CARD10;NVL;ILRUN;TPR;TFRC;KAT7;PIN1;TESK1;ORMDL3;FERMT2;GSK3B;BMP4;LATS1
prerank,protein lipidation (GO:0006497),0.3961276800691043,1.1203108224101865,0.2934898612593383,0.6241310907555133,1.0,12/59,15.40%,ATG7;ZDHHC15;PIGQ;ZDHHC18;PIGZ;PIGA;UGCG;WDR45;PIGN;ZDHHC1;PIGL;PIGC
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.47784910036211675,1.120243665813749,0.33033419023136246,0.6239021075046046,1.0,4/16,11.73%,FGF2;VEGFA;HMOX1;DLL4
prerank,protein tetramerization (GO:0051262),0.38822112060240793,1.119952818938093,0.2926829268292683,0.6243296647928,1.0,19/67,21.01%,ACACA;ALDOA;THG1L;KCNJ2;APIP;GNMT;B2M;SHMT1;UPB1;OSBPL2;GLS;HSD17B8;FARSA;APPL2;AQP4;FARSB;ACACB;SOD2;CPSF7
prerank,positive regulation of cell death (GO:0010942),0.3900368780167912,1.1195859029144313,0.29989327641408753,0.6249043347474217,1.0,20/59,24.29%,LRP1;SLC6A6;EIF4G1;DAXX;HPR;HP;CELF1;EIF2S1;FYN;SARM1;CLU;ITGB2;EFNB2;HTATIP2;GSK3B;MARK4;BMP4;EGR1;BNIP3;TNF
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.4760978469292408,1.1194943144224172,0.3233082706766917,0.6247835877760347,1.0,8/16,29.14%,AMPD2;GART;ATIC;ADSS1;PPAT;NUDT2;ADSL;GMPS
prerank,negative regulation of response to stimulus (GO:0048585),0.39120589159981384,1.1194841007631968,0.2828389830508475,0.6244269262997476,1.0,15/60,17.22%,CDK6;VPS13C;PDCD1;MCTP1;BRAP;FBXO5;FCRLB;SOCS5;ZKSCAN3;TLE5;LPCAT3;CLU;APPL2;SPINK5;WFS1
prerank,respiratory tube development (GO:0030323),0.43001114864067114,1.1191742409586967,0.33796296296296297,0.6248897796550676,1.0,13/28,27.39%,PDPN;FGF2;VEGFA;NKX2-1;FGF7;CEBPA;RBP4;ITGA3;BMP4;FGFR2;FGF1;CCDC40;CCDC39
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.42404930392697726,1.1191373902453667,0.31712962962962965,0.6246049218080576,1.0,10/32,22.66%,TAOK3;FZR1;FOXN3;BRCA1;ABRAXAS1;BLM;UIMC1;ATM;TAOK1;TOPBP1
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.3114541526206188,-1.1191248598564218,0.2517482517482518,0.7424457011326431,1.0,9/32,13.51%,NAV3;TUBB4A;STMN1;APC;MAP2;CLASP2;FKBP4;DYRK1A;HDGFL3
prerank,amyloid fibril formation (GO:1990000),0.39927445914863885,1.1186978934838905,0.3176341730558598,0.6254208442384375,1.0,16/51,17.46%,LTF;UBA52;RPS27A;NPPA;SIAH2;USP9X;B2M;IAPP;NAT8;GSN;TSPAN5;UBE2L6;GGA2;FURIN;HSPG2;RIPK3
prerank,mesenchymal cell differentiation (GO:0048762),0.3959274107125376,1.1184388694569487,0.31201764057331866,0.6257370189011462,1.0,7/51,8.76%,CTNNB1;HIF1A;FBXL17;LEF1;TRIM28;SOX9;DDX17
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.5319504997515124,1.1184045292809837,0.3398328690807799,0.625442070872672,1.0,5/10,20.78%,INO80;CDC7;ATRX;STOML2;DBF4
prerank,positive regulation of protein import (GO:1904591),0.4287828682710032,1.118263267456815,0.32051282051282054,0.6254526644746492,1.0,17/30,32.76%,FLNA;PRKCD;IPO5;TRIM28;CDH1;JUP;TPR;PIK3R2;ARHGEF5;BAG3;RBM22;HDAC3;ZPR1;DMAP1;MAVS;ZC3H12A;UBR5
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.5075105672776848,1.118056160719557,0.3602150537634409,0.6256422045866499,1.0,7/13,30.75%,SOCS5;CBL;CBLB;CHMP6;ZGPAT;SOCS4;ERRFI1
prerank,regulation of MAP kinase activity (GO:0043405),0.38039313598610336,1.1178460383278768,0.2766393442622951,0.6258579597565461,1.0,18/92,16.05%,FLT1;APOE;ADAM8;PDGFA;PIK3CB;CD24;PRKCD;FGF2;PIK3R5;VEGFA;RASGRP1;CD300A;PAQR3;FGF18;SPRY4;STK38;SMPD1;NF1
prerank,axonogenesis (GO:0007409),-0.22767750518298355,-1.1178162870586277,0.0,0.7427767380031692,1.0,67/237,15.02%,OPHN1;NRXN3;NRXN1;PIK3R1;CTNNA2;EPHA6;ROBO1;SEMA6D;GAB1;EPHA4;CNTN4;EFNA5;PTPRO;SEMA6A;GFRA1;PLPPR4;RAB3A;NOTCH2;DSCAML1;TNR;NCAM1;CNTN6;RPS6KA5;DOK6;FEZ1;IRS2;FEZ2;EPHB1;SHANK3;UNC5D;APP;PTK2;PAX2;SLITRK4;SPTBN1;VLDLR;APBB1;GPC1;EPHA5;ULK1;SPTBN2;ROBO2;NTN4;ULK2;WNT5A;RAP1GAP;RET;TUBB3;B4GALT6;BRSK1;MAP1B;PPP3CB;ARHGAP35;KLF7;PAK3;RAB10;SEMA6C;VSTM2L;SRC;SEMA4B;EZR;EFNA3;PIK3CD;SIAH1;CNTN2;NOTCH3;CCK
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.37424214808894857,1.1177045837481647,0.2826530612244898,0.6258386967294911,1.0,43/100,31.23%,SDCBP;RNF14;PRICKLE1;DAB2;RNF180;RPL11;RACK1;VCP;USP5;SOCS5;CEBPA;XPO1;OGT;SMAD7;SUMO2;CLU;CSNK1D;ELOB;DESI1;CCAR2;HECTD1;PIAS1;RNF19A;HSP90AB1;GSK3B;TRIB2;GABARAP;MDM2;SUMO1;GIPC1;EIF3H;BBS7;KEAP1;PSMD10;GSK3A;UFL1;GNA12;CSNK1E;RCHY1;RNF19B;NUB1;HERPUD1;SIRT2
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.4531890000747729,1.1176638514227244,0.33007334963325186,0.625561579034202,1.0,7/23,20.59%,PTPRC;CAV1;MVP;SOCS5;CBL;CBLB;CHMP6
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.31737796180271727,-1.1172432882187335,0.2721518987341772,0.7409435003359504,1.0,6/27,11.55%,IL1RAPL1;CTNNA2;PSEN1;NCS1;FCGR2B;BRSK1
prerank,negative regulation of stem cell differentiation (GO:2000737),0.5055197383002699,1.11658370481164,0.33422818791946307,0.6281687450633333,1.0,6/12,27.69%,TCF15;JAG1;YTHDF2;HNRNPU;HES1;N4BP2L2
prerank,positive regulation of protein binding (GO:0032092),0.3950725634815623,1.1165039119469133,0.3037837837837838,0.6279929277845636,1.0,19/56,22.46%,APOE;LRP1;MMP9;CAV1;STK3;RPL11;BAMBI;B2M;NVL;SPPL3;DERL1;RALB;HIP1R;PIN1;GSK3B;BMP4;TRIM21;TERT;USP33
prerank,regulation of RNA splicing (GO:0043484),0.38240575248956993,1.1155058740119552,0.3125,0.6303875754509978,1.0,26/69,26.03%,AHNAK2;SRPK1;MBNL3;PTBP3;RPS26;ERN1;GRSF1;CELF1;SON;HNRNPLL;ZNF326;HNRNPK;MBNL2;FASTK;RBM39;HNRNPF;CLK4;CWC22;SLC38A2;RPS13;AHNAK;SRPK2;RBM22;HNRNPL;RRP1B;ZPR1
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.330443749488562,-1.1153606225858315,0.3111111111111111,0.7426645741326616,1.0,8/24,15.80%,PDE3B;RAPGEF2;PEX5L;PRKAR2A;PRKAR2B;PDE4D;GPR61;PDE2A
prerank,negative regulation of defense response (GO:0031348),0.38407170162929016,1.1153517195883162,0.27424400417101147,0.6303944422761155,1.0,23/77,22.88%,APOE;FPR2;SIRPA;NLRC3;PRKCD;MFHAS1;OTULIN;PPARG;GATA3;PPARD;PTPN2;SHARPIN;ILRUN;LPCAT3;ACOD1;C1QBP;LYAR;PTGIS;METRNL;TRIM21;PTGER4;VPS35;MAPK7
prerank,positive regulation of response to external stimulus (GO:0032103),0.36883619783090066,1.1146675199870768,0.24721377912867273,0.6318992881548368,1.0,33/128,20.05%,LPL;S100A8;S100A9;CYBA;FPR2;SASH1;TNIP1;OPTN;ADAM8;MAPK13;HRG;NAPEPLD;TREM2;NFKBIZ;POLR3D;CEBPA;CCR2;SERPINE1;RIOK3;CCL5;GPRC5B;STX3;ACOD1;APOH;NINJ1;PUM1;BMP6;PDCD4;SERPINF2;DHX9;SCIMP;IL2;GPSM3
prerank,regulation of mitotic spindle assembly (GO:1901673),0.46521125685405745,1.1142086289773236,0.3333333333333333,0.6327706192126689,1.0,7/19,18.99%,CHMP4B;PDCD6IP;VPS4B;DRG1;TPR;HNRNPU;CCSAP
prerank,regulation of DNA repair (GO:0006282),0.4064427992657005,1.1139378241390494,0.3303370786516854,0.6330816246692006,1.0,24/44,33.78%,ERCC6;EYA4;TRIP12;TRIM28;BRCA1;ABRAXAS1;DEK;CEBPG;UBE2V2;UIMC1;KAT7;DHX9;RPS3;USP1;BRCC3;SMCHD1;ERCC8;SIRT1;PARG;TMEM161A;UBR5;EYA3;BABAM2;PCNA
prerank,external encapsulating structure organization (GO:0045229),0.359411047245882,1.1129780682659516,0.23046092184368738,0.6352824029861226,1.0,58/205,22.21%,SPP1;FN1;ITGAX;MMP8;MMP12;POSTN;ITGAL;DAG1;ITGA5;ATP7A;PDGFA;CD44;COL10A1;ADAMTS13;MATN3;MMP9;FGF2;ITGA4;ELN;ADAMTS10;COL4A1;CDH1;COL18A1;COL6A3;ADAMTS14;ADAMTSL5;SERPINE1;HRNR;ADAMTS2;SMOC1;ADAM15;MMP19;DCN;LAMC1;ITGB2;LAMA5;FURIN;NF1;HSPG2;KDR;COL8A2;COL9A3;BGN;ITGA11;SPINK5;DDR2;ITGA3;ECM2;COL16A1;ADAMTSL1;COL9A1;ITGA2B;MMP17;LAMA4;LAMA3;CD47;MMP28;LUM
prerank,cellular biogenic amine metabolic process (GO:0006576),0.5102259014210409,1.112912913316908,0.3554054054054054,0.6350754503408236,1.0,3/12,6.72%,ATP7A;TRH;SLC22A3
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.41559268937293287,1.1124494176893238,0.3164983164983165,0.6359989520579293,1.0,19/38,29.78%,FBXW7;UBE2L3;HUWE1;BAP1;LMAN1;RHOU;VPS11;MICALL2;HAX1;UBL5;CSNK2A2;SAE1;SREBF1;USP36;PARL;GSK3A;ATG13;TOMM7;LEPROT
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.446271111522621,1.1123835174416186,0.3213429256594724,0.6357893148325225,1.0,7/23,20.24%,NPPA;PTK2B;PSEN2;FYN;DIAPH1;ATP1A2;CACNB1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.5263890819939282,1.1123574103487806,0.35075653370013754,0.6354756691856166,1.0,5/11,24.88%,ATF3;DDIT3;MBTPS2;ATF4;HSPA5
prerank,snRNA transcription (GO:0009301),0.3825792662806669,1.1118415478422534,0.30623020063357975,0.6365382433949939,1.0,21/70,25.02%,SNAPC1;USPL1;POLR2H;SNAPC2;GTF2A2;INTS14;ELL2;GTF2F1;POLR2D;INTS2;INTS6;TBP;SP1;RPRD1A;CCNT2;TAF6;SNAPC4;GTF2E2;INTS7;POLR2F;POU2F1
prerank,regulation of keratinocyte migration (GO:0051547),0.5175413678091247,1.111820277814693,0.3415977961432507,0.6362070630329443,1.0,3/12,10.20%,IQSEC1;MMP9;FGF7
prerank,acylglycerol biosynthetic process (GO:0046463),-0.34336906509022536,-1.1116868390586376,0.2727272727272727,0.7499385318510604,1.0,8/23,15.48%,AGMO;LPIN2;PLA2G15;GPAM;GPAT3;PNPLA3;PNPLA2;PLCE1
prerank,protein localization to chromatin (GO:0071168),0.4721675639043166,1.1115746895283969,0.34827144686299616,0.6364982395854761,1.0,8/18,27.91%,FAM47E;WAPL;LEMD2;CHMP7;MCM8;NIPBL;PIH1D1;RUVBL2
prerank,genitalia development (GO:0048806),-0.4173577537130341,-1.1105021023742754,0.2948207171314741,0.7498488802492478,1.0,7/12,35.01%,WNT5A;TIFAB;PKD1;SHH;WT1;LHCGR;STRA6
prerank,cellular response to lipid (GO:0071396),0.36018508629789964,1.1103278584894563,0.22110552763819097,0.639496444536756,1.0,44/191,20.21%,LPL;SPP1;STAP1;ABL2;SIRPA;MSN;ADCY8;ADCY3;VIM;SPHK2;AXL;MGARP;PTK2B;TFPI;CD274;SOX9;ATP1A3;ATP1A1;BRINP2;UBE2L3;TNIP3;LILRB1;WNT6;PABPN1;PLAA;TICAM1;SERPINE1;TNFRSF1B;TNIP2;RHOA;FZD4;ADAM15;GIT1;NFKB1;ACOD1;ATP1A2;PDCD4;SBNO2;PAF1;ATM;IL6;NR3C1;HMGB1;PDK3
prerank,aorta morphogenesis (GO:0035909),0.47101202558728683,1.1102962921027457,0.33045622688039455,0.639193317778636,1.0,4/17,13.71%,LRP1;JAG1;DLL4;EFEMP2
prerank,peptidyl-tyrosine modification (GO:0018212),0.3924625490532017,1.1101437577033482,0.30818278427205104,0.6392445111511018,1.0,20/56,26.46%,FLT1;LCK;ABL2;FGR;TEC;PTK2B;PKDCC;FYN;TPST1;SYK;KDR;DDR2;ABI1;FGFR3;FGFR2;JAK2;BTK;PDGFRA;ABI2;PTPN6
prerank,extracellular structure organization (GO:0043062),0.3586633643598449,1.109849867311022,0.23246492985971945,0.639646267335695,1.0,58/204,22.21%,SPP1;FN1;ITGAX;MMP8;MMP12;POSTN;ITGAL;DAG1;ITGA5;ATP7A;PDGFA;CD44;COL10A1;ADAMTS13;MATN3;MMP9;FGF2;ITGA4;ELN;ADAMTS10;COL4A1;CDH1;COL18A1;COL6A3;ADAMTS14;ADAMTSL5;SERPINE1;ADAMTS2;SMOC1;ADAM15;MMP19;DCN;LAMC1;ITGB2;LAMA5;FURIN;NF1;HSPG2;KDR;COL8A2;COL9A3;BGN;ITGA11;SPINK5;DDR2;ITGA3;TEX14;ECM2;COL16A1;ADAMTSL1;COL9A1;ITGA2B;MMP17;LAMA4;LAMA3;CD47;MMP28;LUM
prerank,peptidyl-lysine methylation (GO:0018022),0.43654035853445056,1.1096794160845687,0.3317757009345794,0.6397337783928254,1.0,9/26,23.64%,ETFBKMT;KMT5A;SMYD3;EEF1AKMT3;SMYD2;EHMT1;SMYD1;EEF2KMT;TRMT112
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.36812756045180395,1.109212754172725,0.2842535787321063,0.6406600428883353,1.0,36/101,26.50%,CSF1;ASPH;ATG7;MSN;EIF6;VIM;EIF4G1;CD28;EEF2;PIWIL2;CYFIP2;LARP4;METTL3;CPEB3;YTHDF3;OGT;VPS11;EIF4A3;FXR2;ASPSCR1;EIF3E;IL6;UPF3A;FBXW11;NPM1;SAMD4A;UPF3B;VPS35;TBC1D10A;POLDIP3;IST1;PYM1;HDAC2;ATG10;NAT10;BTRC
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.3885448669900141,-1.1089542692846002,0.3013698630136986,0.7512591445796102,1.0,5/14,13.51%,DDX60;DHX58;TLR2;TLR5;ZCCHC3
prerank,positive regulation of response to stimulus (GO:0048584),0.4087077194344903,1.108760533183766,0.31447963800904977,0.6415448434087386,1.0,10/40,18.62%,SELENON;GPR151;PRKCD;GATA3;ECHDC3;ILK;B2M;RSAD2;FXR2;DHX9
prerank,positive regulation of sodium ion transport (GO:0010765),0.5087077278035569,1.108618367078193,0.35876840696117807,0.6415504173053561,1.0,5/12,16.83%,PRSS8;SCN1B;CNKSR3;SCN3B;PKP2
prerank,response to peptide hormone (GO:0043434),0.40188516359060794,1.1083354016768547,0.3101903695408735,0.641961943071139,1.0,14/43,24.02%,SLC27A1;ANXA1;EIF6;STAT4;CAV1;ZBTB7B;TRIM16;OGT;ROCK1;EIF2B2;EPM2AIP1;ZBED3;STAT5B;EIF2B4
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.39215612978967285,1.107239114237662,0.33872707659115425,0.6445600950458454,1.0,25/58,29.81%,ERCC6;NSMCE2;ERCC1;CYREN;MDC1;BRCA1;ABRAXAS1;RAD50;PSMD14;ERCC4;BARD1;POLB;UBE2V2;UIMC1;ATM;HMGB1;DCLRE1A;SETMAR;SUMO1;PIAS4;LIG3;BRCC3;ERCC8;XRCC5;HMGB2
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.3643709042483097,1.1070113168773017,0.2765957446808511,0.6447761533166528,1.0,47/129,28.23%,DKK2;PSMD8;PSMD1;TNKS2;CAV1;PRDM15;ILK;PSMD6;PSMA1;CSNK1G1;BAMBI;VCP;PSMC3;JUP;WLS;PSMA8;FRAT1;GPRC5B;JRK;PSMD14;PSMD2;NFKB1;CSNK1D;USP47;PSMC6;PSMA6;GSKIP;PSMD5;DAPK3;PSMA5;PIN1;CCAR2;ZBED3;PSMA3;FGFR2;USP8;PSMB8;PSMB10;SFRP1;PSMD7;PSMB6;PSMD10;PPM1A;DACT1;PSMB5;USP34;PSMB7
prerank,actin filament network formation (GO:0051639),0.5140260161112967,1.1068201113901677,0.3488372093023256,0.6449096680022807,1.0,2/11,6.59%,LCP1;ACTN1
prerank,positive regulation of protein maturation (GO:1903319),0.5139512957653409,1.1065265203128714,0.3506139154160982,0.6453317568318824,1.0,1/11,2.72%,ADAM8
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.2993506311014309,-1.1064933892983675,0.25757575757575757,0.7548301545136962,1.0,7/32,5.38%,IL1RAPL1;PTPRD;CDKL5;ADGRB3;HECW1;HECW2;RAPGEF2
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.4222617388097194,1.1062944600216527,0.34466588511137164,0.6455518967816886,1.0,11/32,18.68%,CORO1C;MMP12;JAG1;DLC1;HOXA7;ARHGAP6;MYOC;SERPINE1;ADAM15;RASA1;ITGB1BP1
prerank,regulation of myelination (GO:0031641),0.43723527631067916,1.1062773924893334,0.3392857142857143,0.6452011728658763,1.0,6/25,15.75%,ITGAX;CST7;EGR2;TMEM98;TNFRSF1B;NCMAP
prerank,mitotic metaphase plate congression (GO:0007080),0.39469416559703796,1.1060883036910056,0.32112068965517243,0.6453371920660202,1.0,18/51,29.95%,CHAMP1;EML4;CHMP4A;CHMP4B;PDCD6IP;CCNB1;VPS4B;CHMP7;KIFC1;RAB11A;CUL3;CHMP6;SPDL1;EML3;KIF22;NUDC;PIBF1;BECN1
prerank,positive regulation of mitochondrion organization (GO:0010822),0.3923324695914495,1.1056079447416967,0.30810234541577824,0.6462563583778056,1.0,18/57,23.46%,DDHD1;PLAUR;MGARP;MMP9;BID;TREM2;HTT;BCL2L11;BAX;DCN;KDR;HIP1R;FBXO7;BIK;GSK3B;TNFSF10;VPS35;BNIP3
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.42207172793105074,1.1054858417452667,0.3352601156069364,0.6462276097370055,1.0,13/33,22.41%,ANKRD28;RAD50;GAR1;CDK2;PPP6C;RFC1;RTEL1;PTGES3;TERF1;HSP90AB1;ACD;DKC1;TERT
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.2707859121837943,-1.1051082774690673,0.2597402597402597,0.755338253390607,1.0,15/53,19.51%,CHRM2;CALCRL;HTR2A;HTR2C;CCR1;CHRM3;AGT;HRH2;HTR1F;CCL2;OPRD1;SSTR2;CNR1;HTR6;NPY
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.39951083606778864,1.1049316798415763,0.32861806311207836,0.6474204927972658,1.0,15/46,19.01%,PEAK1;FN1;NRP1;ITGA4;ILK;PARVA;RHOA;EFNA1;ATRN;LAMC1;MEGF9;LAMA5;MICALL2;PARVB;FERMT2
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.35383314463300886,1.1047994340744325,0.22044088176352705,0.6473867654531535,1.0,100/264,28.92%,SNRNP35;SRPK1;CD2BP2;HNRNPA3;HNRNPUL1;ZRSR2;SNIP1;SF3B3;HNRNPM;RBM4B;POLR2H;PAPOLA;HNRNPC;DDX17;PABPN1;CDK13;PABPC1;DNAJC8;METTL3;CHERP;SYF2;SRSF11;PRMT5;PRMT7;DDX1;PRPF4;SMNDC1;PRCC;SRSF7;HNRNPK;RBM19;HSPA8;GTF2F1;DDX39B;SYNCRIP;HNRNPA2B1;EIF4A3;POLR2D;LSM6;RBM15;PUF60;SART1;WBP11;PCBP1;NOVA2;SYMPK;PNN;PSPC1;RBM15B;PRPF6;PPIE;HNRNPU;HNRNPF;GCFC2;UBL5;IK;CWC22;DHX9;SNRNP40;CCAR1;ZMAT5;SRSF2;CTNNBL1;ZMAT2;SNRPB2;CPSF7;RALY;PRPF8;SRPK2;SMU1;UPF3B;SF3A3;LSM4;GEMIN8;SNU13;RBM22;SRRM1;SNRPG;SF3B2;SF3B1;POLR2F;HNRNPL;GEMIN2;SNRPF;LSM3;SNW1;GEMIN5;PRPF40A;SNRPA;SF3B5;PPIH;FUS;CSTF2;SRSF1;PPIL3;SRSF10;DDX41;NUDT21;WBP4;TRA2B
prerank,postreplication repair (GO:0006301),0.3989175183829968,1.1046960084208894,0.3377049180327869,0.6472958568691434,1.0,21/45,35.94%,UBA52;RPS27A;BRCA1;VCP;UBE2L6;UBE2V2;RFC1;UBC;NSMCE1;REV1;RFC2;POLD4;ZBTB1;RFC4;UBB;WDR33;RFC5;PCLAF;PCNA;UBE2A;POLK
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.48335496030570196,1.104643041709295,0.36082474226804123,0.6470599372533087,1.0,4/15,19.28%,SAT1;TH;PAOX;SMOX
prerank,protein O-linked glycosylation (GO:0006493),0.37043213856057916,1.104623244221536,0.30501535312180145,0.6467259747693122,1.0,14/96,10.21%,B4GALT5;GALNT7;GALNT15;LARGE1;MUC1;MUC16;B4GAT1;B3GNT3;B3GALNT2;TRAK1;ST8SIA6;OGA;TET3;SDF2L1
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.41253610145670844,1.104339836851559,0.3261117445838084,0.6471017895579932,1.0,17/35,30.83%,PTPRC;DOT1L;CAV1;CCL5;GHR;CYP1B1;ADIPOR1;NLK;IL6;VHL;F2R;TNF;JAK2;HES1;PIGU;LEPROT;JAK3
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.38076644133444887,1.1041312718229883,0.3175604626708728,0.6472966920914209,1.0,22/70,19.01%,PEAK1;FN1;UNK;POF1B;NRP1;ITGA4;RILPL2;ACTN1;ILK;METTL3;PARVA;RHOA;EFNA1;ATRN;LAMC1;MEGF9;LAMA5;YTHDF2;MICALL2;RILPL1;PARVB;FERMT2
prerank,long-term synaptic potentiation (GO:0060291),-0.3345386212479208,-1.1040714675369436,0.29473684210526313,0.754904096913745,1.0,8/21,12.21%,TSHZ3;GRIN2A;SLC8A3;GRIN2B;RGS14;SLC8A2;PRKCZ;MPP2
prerank,RNA methylation (GO:0001510),0.38049710495819977,1.1035810093097587,0.3240641711229946,0.6484470946753607,1.0,36/60,36.78%,METTL1;TRMT10C;MRM2;METTL3;FTSJ3;METTL2B;METTL2A;RBM15;TRMT13;THADA;RBM15B;NSUN3;NSUN2;TARBP1;TRMT112;DIMT1;GTPBP3;THUMPD2;CBLL1;METTL8;NSUN4;TRMT5;TRMT6;PCIF1;ALKBH8;METTL6;TRMT12;LCMT2;NSUN6;ZCCHC4;TRMT10A;MTO1;TGS1;ZC3H13;TRMT44;METTL14
prerank,collagen fibril organization (GO:0030199),0.37208987666507937,1.1032112333917603,0.3029045643153527,0.6490737783867091,1.0,28/88,22.21%,ATP7A;COLGALT1;COL10A1;BMP1;COL4A1;COL20A1;P3H1;P4HB;COL18A1;CRTAP;COL6A3;COL12A1;ADAMTS14;PLEC;ADAMTS2;CYP1B1;P4HA3;NF1;COL8A2;COL9A3;DDR2;SERPINF2;COL16A1;P4HA1;DST;COL9A1;LAMA3;LUM
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.49574852560304683,1.1031349641190842,0.35286284953395475,0.6489013613959236,1.0,3/13,9.53%,NFE2L2;NR4A3;RACK1
prerank,error-prone translesion synthesis (GO:0042276),0.4541568296213877,1.1030379939719113,0.34863523573200994,0.6487952834444827,1.0,12/21,35.94%,UBA52;RPS27A;RFC1;UBC;REV1;RFC2;RFC4;UBB;RFC5;PCNA;REV3L;POLK
prerank,MAPK cascade (GO:0000165),0.35421733771555425,1.1028012386915307,0.2092092092092092,0.6490485549246706,1.0,96/295,26.87%,IGF1;FGF13;BCL2L1;IL2RB;PTPRA;PSMD8;PSMD1;PRKCQ;CSF2RA;LAT;UBA52;RPS27A;PDGFA;PIK3CB;MAPK13;NRG1;DUSP9;RAF1;FGF2;TAOK3;BRAP;IL3RA;GRB2;SOX9;ANGPT1;RASGRP1;RASGRP3;KITLG;PSMD6;PSMA1;PABPN1;MAPKAPK2;RANBP9;PSMC3;NRAS;KRAS;FGF7;FYN;RASAL1;DUSP6;JAK1;CCL5;FGF20;PSMA8;PAQR3;TNIP2;PSMD14;MBP;PSMD2;FGF18;IL31RA;NFKB1;RASA2;ABHD17C;PSMC6;PSMA6;NF1;KDR;SYNGAP1;RASA1;MINK1;PIK3R2;PSMD5;MAP3K8;YWHAB;PSMA5;CUL3;IL2;ABHD17A;ACTN2;UBC;IL5;FBXW11;CUL1;HSF1;TAOK1;RASAL2;PTGER4;MAP2K2;FGFR3;HTR2B;PSMA3;FGFR2;TNF;JAK2;PSMB8;PDGFRA;PSMB10;FGF1;MAPK12;PSMD7;PSMB6;LAMTOR3;BTRC;ABHD17B;PSMD10
prerank,negative regulation of protein processing (GO:0010955),0.5108891101331164,1.1023722580748943,0.38348868175765644,0.6498207662144081,1.0,5/12,22.53%,CTSZ;SERPINE2;SERPINE1;SERPINF2;SNX12
prerank,negative regulation of receptor binding (GO:1900121),0.5282534979640028,1.1019352818956671,0.35374149659863946,0.6506598967611772,1.0,3/10,22.34%,B2M;ADAM15;ATP2A2
prerank,negative regulation of cellular process (GO:0048523),0.35030785321324653,1.101848272539195,0.146,0.6504992626591448,1.0,151/521,26.60%,GPNMB;APBB2;PLXNC1;BCL2;CTNNB1;CD9;CDK6;NIBAN2;IGFBP7;SIRPA;PLXNA2;VPS13C;SPEG;ADARB1;PPP1R9B;SPN;PDPN;SPHK2;SCIN;HRG;FER1L5;IRF6;GTPBP4;CYP27B1;VDR;CLDN19;RIPOR2;PTK2B;RAF1;FGF2;MNT;S100A11;PPP2R5C;PPP2R1A;NCK2;ADGRB1;BCL6;PIWIL2;GATA3;ACTN1;NUDT6;NCK1;DCBLD2;ANGPT1;TREM2;COPS8;ING4;ANXA6;P3H1;CHMP4B;DLC1;CELF1;FBXO5;LMNA;IFITM1;COL18A1;GMNN;LILRB1;RACK1;PTPN2;LRPAP1;SFRP5;SOX7;PLXND1;CHERP;UTP20;ATF5;ENO1;CEBPA;TMEM98;VPS4B;BAP1;TNFRSF1B;DLL4;FBLN1;TFAP4;NUPR2;BLM;SP100;LPCAT3;ARID2;ADAM15;CLU;CYP1B1;OSGIN2;SERTAD3;APPL2;CHD5;RASA1;CCN6;ING5;RPS6KA2;SMYD2;PDCD4;SINHCAF;WFS1;STK11;CDKN3;NME6;IL6;UBR2;TMEM109;RNF167;ITGB1BP1;CCAR2;FERMT2;BST2;TAF6;SULT2B1;BMP5;FTH1;GNRH1;SOD2;EMILIN1;TBRG1;DSCAM;EPO;ARHGDIB;VHL;RNF41;NPM1;RUNX3;BMP4;ABI1;TES;KLF11;F2R;HTR2B;VPS35;RBBP7;BNIP3;MIF;ANP32B;SMYD5;CCDC85B;JAK2;SIPA1;MALSU1;DCUN1D3;SMARCA4;SFRP1;KANK2;MDK;NOTCH4;NOX4;PARP16;SESN2;P3H3;PTPN6;PLXNA1;CBLL1
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.510411584891576,1.1017213912493418,0.3716216216216216,0.65044565776677,1.0,5/12,24.29%,SMCR8;IGF1R;FYCO1;BNIP3;TNF
prerank,positive regulation of lipid catabolic process (GO:0050996),0.4609891430035178,1.1014825502696395,0.3399503722084367,0.6507337893998594,1.0,4/19,11.44%,APOA2;PRKCD;ABHD5;ABCD2
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.41035688195903275,-1.1014573923433029,0.32751091703056767,0.759030423048603,1.0,1/11,0.29%,MEF2C
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.29965556993047315,-1.101269647082304,0.296875,0.7560770361222806,1.0,8/35,11.54%,NLGN1;CDH23;CDH9;CDH10;CDH6;CDH8;CDH12;CDH13
prerank,regulation of cellular response to stress (GO:0080135),0.3630650773516832,1.1012031039918704,0.3009118541033435,0.6511215772187596,1.0,57/115,34.11%,ATF3;NUP205;ADCY8;MCL1;EIF4G1;MAPKAPK2;NEK4;NUP188;CLN3;HSPA8;CHCHD2;RANBP2;TPR;ING2;CHORDC1;DNAJB1;RAE1;MBTPS2;NEK6;ATM;CCAR2;PTGES3;AIFM2;CASP9;SLC38A2;NUP93;HSP90AB1;HSF1;AAAS;GSK3B;NPM1;BAG3;NUP54;NUP50;ATF4;NUP98;USP19;NUP42;NUP133;NUP210;ATR;SMG1;MAPK3;DNAJC2;NUP35;DNAJB6;SIRT1;NUP214;MAPK1;EP300;RSL1D1;CREBBP;CEBPB;NUP62;BAG1;CAMK2G;OPRM1
prerank,regulation of ruffle assembly (GO:1900027),0.4326189096638426,1.100833194717853,0.3353437876960193,0.6517057367218368,1.0,5/23,5.32%,STAP1;ARHGAP24;P2RX4;PLEKHM1;CAV1
prerank,organelle transport along microtubule (GO:0072384),0.42169049076310244,1.1004275547023288,0.3263888888888889,0.6524353657157379,1.0,12/31,23.23%,UXT;ARHGAP21;HTT;TRAK1;CLN3;CDC42;BORCS5;RAB1A;RHOT2;FBXW11;TMEM201;PEX14
prerank,negative regulation of cation channel activity (GO:2001258),0.4342421178291299,1.0998733363379067,0.3341232227488152,0.6535774096179539,1.0,12/26,31.36%,MMP9;SRI;UBQLN1;EPO;CALM3;KCNAB1;FKBP1B;DRD3;GSTO1;FKBP1A;CALM1;EPHB2
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.4282472982715395,1.0996396507872044,0.3422897196261682,0.6538129286723086,1.0,4/27,4.23%,SLC3A2;SLC38A1;SLC7A1;SLC36A4
prerank,gluconeogenesis (GO:0006094),0.4097173787864802,1.0993227569860142,0.36089385474860336,0.6543180934467048,1.0,9/39,17.78%,ALDOA;SLC25A1;PGK1;ENO1;PCK2;ALDOC;RBP4;ENO2;GPI
prerank,transition metal ion homeostasis (GO:0055076),0.41955928870292664,1.0991399491730596,0.3505275498241501,0.6544392719039085,1.0,6/28,10.16%,FTL;ATP13A2;HEPH;CYBRD1;B2M;HMOX1
prerank,regulation of trans-synaptic signaling (GO:0099177),0.40754512419489186,1.0991082477281566,0.34486735870818913,0.6541261446052014,1.0,4/33,2.30%,CACNA1A;ABR;FABP5;CEL
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.34511068428332503,1.0989622548252629,0.096,0.6541368451126328,1.0,241/834,25.99%,IGF1;LITAF;CTNNB1;MITF;HIF1A;SKAP1;CSRNP1;MICAL2;ZMIZ1;MMP12;ATF3;CDK8;MRTFA;TOX2;ELF4;SLC9A1;KMT2A;NFIC;NFE2L2;LEF1;UBA52;AGO2;MYBL2;RPS27A;BCL11B;TNIP1;MAFF;MUC1;EOMES;SOX3;IRF6;TCF15;POMC;SOX30;NR4A3;FSTL3;VDR;MEF2D;DOT1L;SQSTM1;FGF2;CSRP3;TFEB;HDAC4;PPARG;JAG1;NCK2;FOXJ1;MYDGF;ZMIZ2;KLF6;RUNX1;DAB2;GATA3;RFX5;SOX9;NCK1;BRD4;VEGFA;EGR2;PPP1R12A;HDAC1;BPTF;TXK;MED21;ZNF395;MTF2;RHOQ;EAPP;TNIP3;PRDM15;DDX17;PPARD;LILRB1;E2F3;IRF8;RNASEL;HOXA7;CCNC;BRCA1;NKX2-1;CDK13;TET3;SS18L2;RNF111;PSMC3;JUP;PLXND1;ASXL2;POU2AF1;SMARCB1;MEF2B;ATF5;CRTC1;JUN;NRF1;TRIAP1;MAML2;CEBPA;SERPINE1;MED17;IRF5;MRTFB;MYSM1;TNIP2;SLC30A9;NAMPT;ZFP64;NPAT;PPARGC1B;OGT;ELK4;SMAD7;CHCHD2;GTF2F1;FOXJ3;SMAD1;YY1;EHF;ACTR3;NFYB;DCN;DDIT3;NFKB1;INO80;PRKD2;PAXBP1;LRP6;SP7;SSBP4;HELZ2;PCBP1;NHLH2;ASXL1;SRF;MED13;CEBPG;ECD;FOXO1;MTF1;NR4A2;PLAC8;ELK3;ZNF296;HTATIP2;DHX36;NPAS4;PIK3R2;BMP6;PRPF6;AKIRIN1;SBNO2;TCF12;SERPINF2;SP1;HNRNPU;CNBP;WBP2;GABPB1;GABPB2;ATRX;HAX1;KAT7;PIN1;ATM;GNL3;USF2;IL6;DHX9;ITGB1BP1;DR1;TAF7;CCNT2;TAF6;HOXB4;NR3C1;SLC11A1;BMP5;ARHGEF2;HMGB1;UBC;TMF1;NFATC3;SPIB;SREBF1;MEIS3;EIF5A;RFXANK;NLRC5;PBX1;RXRB;HSF1;NPM1;ETV4;BMP4;TEAD1;SENP1;GLYR1;ATAD2B;TERT;WAS;ARNT2;PPRC1;RLF;SMARCD2;MAPK7;AHR;EGR1;ZBED3;STAT5B;PBX2;KMT2D;REL;LHX4;RXRA;WWOX;DCAF6;FGFR2;MAP2K5;LPIN3;TNF;GLIS2;PPP3R1;ATF4;HDAC2;SMARCA4;POU2F1;RRP1B;GRHL1;CX3CL1;FGF1;MED6;NOTCH4;CSRNP3;DPF3;TFCP2;HDAC3;HCFC1;LAGE3;TLR9;MLLT6
prerank,negative regulation of protein secretion (GO:0050709),0.40674850666025264,1.0989213905200033,0.33979475484606614,0.6538539891947297,1.0,8/38,16.80%,APOE;FAM3D;RHBDF2;RAB11FIP1;SERGEF;RHBDF1;RSAD2;SIRT4
prerank,regulation of B cell apoptotic process (GO:0002902),0.4971399352770741,1.0987451318341246,0.377027027027027,0.6539345443932232,1.0,6/12,27.74%,NOC2L;BCL6;ORMDL3;IL2;BTK;FNIP1
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.44076180015161154,1.0986562825063442,0.35005973715651134,0.653797531021554,1.0,12/23,32.48%,RANGRF;VCP;SEC61B;LMAN1;DERL1;TECPR2;SURF4;OS9;HSP90B1;HERPUD1;SYVN1;FAF2
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.3553129106835258,-1.0978436229731279,0.3299492385786802,0.7625670772405109,1.0,6/18,10.78%,NAT8L;NIT2;SLC25A12;FOLH1;ASPA;NAALAD2
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.40296416755211717,1.0975036192494434,0.34093376764386535,0.6565939088063673,1.0,16/46,23.99%,SIRPA;PTPRC;TNIP1;DUSP9;RANBP9;PTPN2;DUSP6;FBLN1;CNKSR3;DUSP3;PIN1;ITGB1BP1;SPRED2;EMILIN1;LMO3;SPRED3
prerank,Rho protein signal transduction (GO:0007266),0.3908709579817636,1.097343885463612,0.3227571115973742,0.65664243972819,1.0,15/53,15.17%,MYO9B;GNA13;PDPN;RTKN;RHOD;ARHGAP6;ARHGEF1;RHOG;RHOA;RHOU;LIMK1;CDC42;CELSR1;ROCK1;ARHGEF11
prerank,membrane repolarization (GO:0086009),0.47276357175273453,1.096749838678642,0.36220472440944884,0.6578912314894574,1.0,4/15,15.42%,ATP1B3;KCNJ2;ATP1A1;ATP1A2
prerank,histone mRNA catabolic process (GO:0071044),0.4713364301420765,1.0965675439060834,0.36787564766839376,0.6579806340382395,1.0,9/15,33.96%,EXOSC4;EXOSC10;ATM;XRN1;MTPAP;TENT4B;DCP2;TUT1;ERI1
prerank,glucose metabolic process (GO:0006006),0.38892853297259117,1.096535797412034,0.3282773564463705,0.6576725135797409,1.0,12/58,14.89%,SORD;ALDOA;SLC25A1;GAA;PPARD;PGK1;ENO1;PCK2;ALDOC;AKR1A1;RBP4;ENO2
prerank,regulation of secretion (GO:0051046),0.4920825638919048,1.096451827014195,0.35917312661498707,0.6575047980441774,1.0,3/13,3.34%,SGK1;SCIN;NRG1
prerank,positive regulation of establishment of protein localization (GO:1904951),0.46091358414923106,1.0962209813113128,0.35286783042394015,0.6577330207819266,1.0,9/18,27.13%,CCT2;TREM2;CCT8;CHP1;CCT5;CEP120;DKC1;TNF;CEP295
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.41207560155022593,1.0958732288507316,0.3449074074074074,0.6582985997101674,1.0,3/33,3.26%,RAB7B;HIF1A;SCIN
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.40642618819336573,1.0957956104060784,0.34324942791762014,0.65812779869131,1.0,19/38,29.79%,CABIN1;UBN1;CENPO;CENPT;CENPX;ATRX;KNL1;NPM1;RBBP7;ASF1B;CENPK;CENPA;HAT1;CENPS;H3-3A;RSF1;NASP;ASF1A;CENPH
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.46537335382881784,1.0955751761188381,0.35625,0.6583287517019163,1.0,7/18,17.41%,ERN1;NCK1;BCL2L11;ATXN3;BAX;DDIT3;RNFT1
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.45287624124991016,1.0954386010308568,0.35168961201501875,0.6583170192932696,1.0,5/20,16.25%,HIF1A;NFE2L2;VEGFA;SMAD1;CHD6
prerank,cellular respiration (GO:0045333),0.4027764400223872,1.0948960182578646,0.34728506787330315,0.6593849571415936,1.0,14/41,24.53%,NDUFS7;NR4A3;COQ10B;SDHB;SLC25A14;SURF1;COX10;UQCRH;MTFR2;MTFR1;SDHC;UQCR10;UQCRB;SIRT3
prerank,positive regulation of protein kinase activity (GO:0045860),0.3576599609698212,1.0941177108600537,0.297079556898288,0.6611272984424138,1.0,46/148,24.29%,IQGAP1;CSF1;SLC27A1;PTPRC;LTF;CD4;LAT;ALS2;PTK2B;PAK6;PRKCD;NEDD9;TAOK3;DAXX;STK3;VEGFA;NAB2;CCL5;RHOA;GAS6;PAK2;EFNA1;GPRC5B;JTB;CAB39;STOX1;CLU;MINK1;MAP2K3;DDR2;PRKAG1;STK11;RIPK3;RALB;SLC11A1;MARK2;HSP90AB1;SYAP1;TAOK1;MAP2K2;IL34;TGFBR2;EGR1;CALM3;CCDC88A;TNF
prerank,endocytic recycling (GO:0032456),0.3868321243391093,1.093804202137952,0.34156820622986034,0.6615975557308803,1.0,26/50,30.84%,PTPN23;STX6;VPS26A;VPS50;RAB7A;VPS26C;MICALL2;SNX4;VPS51;EHD4;VPS35L;ARL4C;RAB11FIP4;LMTK2;VPS39;SNX31;SNX12;VPS35;CCDC22;EHD1;DENND1B;SNX27;SNX17;RAB11B;SNF8;ARF6
prerank,protein catabolic process (GO:0030163),0.376276243408889,1.0934198254542502,0.3519913885898816,0.6622035528909596,1.0,11/59,12.97%,APOE;CTSD;SIAH2;STT3B;OGA;LAMP2;VCP;DDB1;PSMA8;DDI2;HSPA8
prerank,protein localization to condensed chromosome (GO:1903083),0.503612814937706,1.0933327953052723,0.3763586956521739,0.6620455568130084,1.0,4/12,22.61%,CHAMP1;IK;KNL1;SPDL1
prerank,calcium ion transport (GO:0006816),0.36765609308644553,1.0933033917976893,0.3125,0.6617294237231169,1.0,25/113,18.81%,CACNA1A;TRPC4;P2RX4;MCOLN2;SLC3A2;SLC24A4;KCNN4;CHRNB2;CYP27B1;PANX1;CAV1;CRACR2A;TPT1;PSEN2;FYN;CCL5;CACNA1D;GAS6;CACNG7;TRPM7;CRACR2B;MCOLN3;CACNB3;ANO6;TMEM165
prerank,intermediate filament organization (GO:0045109),0.45810772092177254,1.0932007654705274,0.36809045226130654,0.6616390205419092,1.0,5/17,18.29%,VIM;PKP1;KLHL24;PKP2;GFAP
prerank,calcium ion homeostasis (GO:0055074),0.369056734258017,1.0930876287819113,0.3172978505629478,0.6615648968039214,1.0,25/95,22.76%,SLC24A4;ATP2B1;ATP13A2;SELENON;CYP27B1;NPTN;CSRP3;CAV1;TPT1;TPCN2;CCL13;CHERP;CCR2;CCL7;CCL5;CCL14;SLC8B1;VAPB;WFS1;TMEM165;STOML2;ATP13A1;ATP2A2;CALR;HTR2B
prerank,modification-dependent protein catabolic process (GO:0019941),0.35403449833548245,1.0929299188168595,0.2925851703406814,0.661584848435073,1.0,50/193,20.37%,MYLIP;RNF125;UBA52;WDR91;RPS27A;CNOT4;COPS3;RNF14;SQSTM1;ANAPC15;TRIP12;RNF7;SIAH2;TTC3;RNF6;UBR4;RNF128;SPSB2;ATXN3;UBE2H;UBE2L3;FZR1;ZNRF3;FBXW4;DDB1;RNF111;UBE4A;LONP1;UBE3B;BIRC6;UBE2R2;ANAPC1;PSMD14;KCTD10;UBQLN1;UBE2L6;BFAR;CBL;UBE3C;KLHL25;UBE4B;CDC26;RNF167;RNF149;CUL3;BUB1B;FBXO7;UBC;RNF20;RNF19A
prerank,regulation of adaptive immune response (GO:0002819),0.46529512488592667,1.0924387212260946,0.3754740834386852,0.6625363286679908,1.0,3/18,8.41%,SKAP1;ADCY7;SAMSN1
prerank,blood vessel endothelial cell migration (GO:0043534),0.43692429896403473,1.0922669872045363,0.36666666666666664,0.6626083058683441,1.0,6/22,16.15%,NRP1;FGF2;VEGFA;SRF;EFNB2;KDR
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.36203917684880954,1.0921111929823277,0.30635245901639346,0.662653306719174,1.0,27/116,18.99%,CD247;PTGIR;FGR;ADCY8;ADCY3;CD3G;POMC;ADCY7;RHBDF2;GPR83;SCTR;TREM2;PLK2;ADAM17;CRH;IAPP;FYN;GPR176;GIPR;ADORA2A;GLP1R;VIP;FURIN;SYK;GPR84;IL6;GNB1
prerank,activation of protein kinase A activity (GO:0034199),0.4702818539835192,1.0919381475162602,0.363754889178618,0.6627436455244861,1.0,3/16,4.21%,ADCY8;ADCY3;ADCY7
prerank,sphingolipid biosynthetic process (GO:0030148),0.37822671246603495,1.091764514649349,0.33473684210526317,0.6628171653203189,1.0,22/71,24.31%,LARGE1;SGMS1;SPHK2;SPHK1;HACD2;CERS6;SPTSSA;PLPP3;SMPD4;HACD1;KDSR;PRKD2;VAPB;SMPD1;ALDH3A2;ASAH1;ALDH3B1;ELOVL2;SAMD8;ELOVL1;SPTLC3;PRKD3
prerank,cardiac conduction system development (GO:0003161),0.4419054998236675,1.091732241262733,0.3614163614163614,0.6625088090020951,1.0,6/24,21.85%,NPPA;TBX18;SHOX2;SMAD1;GJB6;BMP4
prerank,regulation of type I interferon production (GO:0032479),0.36767567351341757,1.0917106451279421,0.3434873949579832,0.6621775620516354,1.0,36/84,30.91%,CTNNB1;RNF125;TRAF3;PTPN22;IKBKE;POLR2H;IRF8;LRRFIP1;POLR3E;POLR3D;IRF5;ILRUN;NFKB1;UBE2L6;DTX4;ACOD1;TIRAP;DHX36;DHX33;PIN1;DHX9;NLRC5;RNF216;TRIM21;NLRP4;G3BP1;POLR2F;TRAF3IP1;OTUD5;TBK1;TNFAIP3;CRCP;DDX41;XRCC5;MAVS;EP300
prerank,regulation of cell differentiation (GO:0045595),0.3571358550117255,1.0913453121258578,0.3058350100603622,0.6628125735131588,1.0,25/148,13.60%,LGALS3;CDK6;CSF1;SLC6A6;DAG1;CD24;ID2;SCIN;RAF1;PPP2R1A;ZFHX2;RUNX1;BCL6;KLK6;GATA3;SIK1;PRKCB;FADS1;FLOT2;DDX17;PHLDB1;YWHAG;SMOC1;SMAD7;ROCK1
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.4975816665904635,1.0913328574457666,0.37231182795698925,0.6624600983365239,1.0,3/12,15.39%,UMPS;UCKL1;CAD
prerank,telomere maintenance via telomere trimming (GO:0090737),0.5232044135214495,1.0912601032513023,0.3870094722598105,0.6615038219056188,1.0,4/10,20.13%,ERCC1;BLM;SLX4;TERF1
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.5232044135214495,1.0912601032513023,0.3870094722598105,0.6615038219056188,1.0,4/10,20.13%,ERCC1;BLM;SLX4;TERF1
prerank,t-circle formation (GO:0090656),0.5232044135214495,1.0912601032513023,0.3870094722598105,0.6615038219056188,1.0,4/10,20.13%,ERCC1;BLM;SLX4;TERF1
prerank,telomere organization (GO:0032200),0.3935767822860469,1.0911471427653947,0.34233261339092874,0.6614036475175619,1.0,24/43,37.71%,DOT1L;RAD50;BLM;SP100;ERCC4;PARP3;ATM;RTEL1;PTGES3;TERF1;ACD;TERT;H3-3A;TERF2IP;POLD4;ATR;XRCC5;TERF2;HUS1;PCNA;RIF1;RAD51D;CTC1;TINF2
prerank,protein localization to cell periphery (GO:1990778),0.3572493956901651,1.0910957653879236,0.31781376518218624,0.661161680328666,1.0,35/133,18.68%,FGF13;MYO5A;ANK1;FLNA;RAP2A;RABEP1;ATP1B3;TTC7B;RAB40C;CAV1;EFR3B;RAPGEF6;DENND4C;TSPAN17;PACS2;CDH1;FLOT2;P2RY1;RAB8A;RAB8B;JUP;GAK;PRAM1;GAS6;TSPAN5;PLEKHF1;ROCK1;LRP6;SCN3B;MYADM;PKP2;CACNB3;EHD4;RAB11A;ITGB1BP1
prerank,fatty acid catabolic process (GO:0009062),0.379705448517147,1.0910720201925344,0.3350622406639004,0.6608339495292401,1.0,24/67,25.76%,AIG1;CEL;ACAD11;ABCD4;PEX2;PPARD;MMUT;ABCD2;ACAD10;ECI2;ACAT1;ABCD3;CPT2;DECR1;ALDH3A2;ACADS;EHHADH;ACADL;ACBD5;LPIN3;ACADM;HADHA;HADH;ACAA2
prerank,regulation of response to biotic stimulus (GO:0002831),0.4288417044766502,1.0907779111901197,0.35537190082644626,0.6612117636570028,1.0,10/28,25.33%,FGR;TRAF3;PTPN22;TREM2;APPL2;TIRAP;ELMOD2;CD55;BIRC2;CX3CL1
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.34723696857226605,1.090313117633626,0.194,0.6621148870424207,1.0,124/417,26.57%,MDFIC;CTNNB1;ZHX2;NIBAN2;ARID5B;SCML4;LEF1;HDAC9;DEDD2;TBX21;DEAF1;RCOR1;ID2;NRG1;VDR;NCOR2;CDK5;NFIL3;CIC;PRICKLE1;HDAC4;PPARG;DAXX;BCL6;ERN2;GATA3;TRIM28;SOX9;ING4;HDAC1;KMT5A;BHLHE40;ATXN1;GMNN;BHLHE41;PPARD;BASP1;MIDEAS;THAP7;HOXA7;FOXN3;BRCA1;NKX2-1;SOX7;DAP;COPS2;ATF5;JUN;SUDS3;ZNF148;ENO1;CEBPA;BAP1;RIOX1;ZKSCAN3;TLE5;TFAP4;GAS6;HSPA8;ZBTB16;GATAD2A;ILF3;CBFA2T2;BIRC5;EED;DDIT3;RBM15;RBFOX2;USP47;FOXO1;PRMT2;ELK3;PRMT6;PSPC1;MYBBP1A;RBM15B;PDCD4;RCOR3;SBNO2;UIMC1;GCFC2;CBX3;KAT7;CCAR2;TAF7;EHMT1;YAF2;NR3C1;DACH1;FBXW11;YEATS2;EIF4A2;BMP4;ID1;CALR;NIF3L1;NIPBL;AHR;ZNF568;CREBZF;PEX14;L3MBTL3;ZBTB4;MDM2;MTA3;TNF;GLIS2;SUMO1;CCDC85B;HDAC2;ZGPAT;SMARCA4;POU2F1;KDM5C;SFRP1;DPF3;HDAC3;PIAS4;L3MBTL2;HIC2;TMPRSS6;PCGF6;BTRC;SNW1
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.38400388390955387,1.0901571894217188,0.32356134636264927,0.6621603746364224,1.0,12/54,16.00%,TRAF2;SPHK1;OTULIN;ADAM17;RACK1;PTPN2;TRAF1;HIPK1;SHARPIN;GAS6;CASP4;SYK
prerank,stabilization of membrane potential (GO:0030322),0.46412582002015246,1.0899437463223418,0.36246786632390743,0.6623467143941326,1.0,2/16,2.46%,KCNN4;KCNK13
prerank,protein transport (GO:0015031),0.3461740442375964,1.0895781862753513,0.231,0.6629843001586789,1.0,132/332,31.40%,APOE;ABCG1;ABCA1;LRP1;TBC1D10C;TCIRG1;ATP6V1C1;ATP6V0D2;TBC1D22A;ATP6V1A;CTSA;ARF3;SNX8;ATP6V0A1;MACF1;OPTN;ATP6V1B2;GOLGA4;CD3G;ATP6V0D1;TOM1;ATP6V0B;ATP6V1G1;PPARG;TBC1D2;ARL1;STX6;RAB5C;SNX33;NAPA;REP15;RIC1;PRKCB;SIL1;VPS26A;ATP6AP1;LAMP2;ARL11;RAB32;RAB8A;RAB8B;MON1A;DNM2;WLS;RAB7A;ATP6V1F;GCC2;RAB5A;STX3;RCN3;CLU;GGA2;VPS26C;TFRC;AP3D1;VIPAS39;RAB22A;RAB1A;SAR1A;TBC1D22B;VAMP4;TLK1;TBC1D12;SNX4;VAMP2;RAB3GAP2;ATP6V0C;TMEM167A;ARL6IP5;LTBP2;ARHGEF2;ATP6V0A4;ATP6V1E1;ARL4C;LAPTM5;LMTK2;ARFGAP3;NPM1;SNX31;ACD;RAB3D;TMED3;CANX;ARRDC4;VPS35;TBC1D10A;CD74;EHD1;RAB20;SNX1;SCAMP3;GOLPH3;SGSM1;USO1;TBC1D16;ATP6V0E1;GGA1;STX7;ARRDC2;RILP;GOLPH3L;COPZ2;TBC1D15;STX4;RAB5B;STX5;TMED2;RAB31;ARL6;EIF2D;COPA;ARHGAP1;AFM;ARFRP1;HSP90B1;SNX27;SNX17;RAB43;RAB11B;RABL3;TANGO2;RUFY1;COPG1;AP3B1;SEC23IP;COPB2;COPG2;ARF6;UNC119B;TBC1D8B;RAB24;COG7
prerank,positive regulation of autophagy (GO:0010508),0.3733102253382419,1.0894487820460184,0.32771338250790305,0.662956467516864,1.0,34/81,29.57%,OPTN;PIK3CB;TRIM6;RUFY4;TFEB;HTT;PLK2;TICAM1;NPRL2;LARP1;PLEKHF1;ROCK1;DCN;DAPK1;FOXO1;KDR;STK11;ORMDL3;FBXO7;HMGB1;MTDH;GSK3B;TRIM21;BNIP3;PLK3;PIK3C2A;SESN2;TBK1;TRIM8;GSK3A;UFL1;BNIP3L;SIRT1;TRIM68
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.5063822779238218,1.0890552430208702,0.38324175824175827,0.6636591521122818,1.0,3/11,14.43%,P4HB;FYN;UBQLN1
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.4182097261600051,1.0890500308072748,0.38515901060070673,0.6632812869807684,1.0,4/30,3.95%,FLT1;PLEK;PTPRC;FSTL3
prerank,estrogen metabolic process (GO:0008210),0.4621907912408121,1.0888503262744618,0.36560509554140125,0.6634138981610535,1.0,3/15,14.76%,CYP19A1;HSD17B8;CYP1B1
prerank,outer dynein arm assembly (GO:0036158),0.48693584847999916,1.0887598367639744,0.3823146944083225,0.6632855845263667,1.0,3/14,10.37%,ODAD2;DNAH8;DNAAF5
prerank,steroid biosynthetic process (GO:0006694),-0.27095388194268566,-1.0886460905760598,0.25675675675675674,0.7866533342356259,1.0,14/56,12.41%,CYP27A1;PRLR;FDXR;OSBPL9;DHCR7;SC5D;INSIG1;INSIG2;OSBPL7;SLC27A2;CYP7B1;CYP39A1;STAR;LSS
prerank,positive regulation of lymphocyte migration (GO:2000403),-0.3831189105949203,-1.0885909892122019,0.3031496062992126,0.7832387531558136,1.0,4/12,7.95%,DOCK8;JAM2;AIF1;APP
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.4695975813683848,1.0885307725343394,0.36989795918367346,0.6635176885270958,1.0,8/15,36.93%,APOA2;LILRB1;SMAD7;TNF;JAK3;CUEDC2;TGFB1;TGFB2
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.40680668961069777,1.0883709033126883,0.36741573033707864,0.6635703775600152,1.0,12/38,19.61%,CYBA;FPR2;SASH1;ADAM8;POLR3D;RIOK3;CCL5;ACOD1;PUM1;BMP6;DHX9;SCIMP
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.35974061367707183,1.0882635845384248,0.31832139201637666,0.6634816561327092,1.0,27/117,18.99%,CD247;PTGIR;FGR;ADCY8;ADCY3;CD3G;POMC;ADCY7;RHBDF2;GPR83;SCTR;TREM2;PLK2;ADAM17;CRH;IAPP;FYN;GPR176;GIPR;ADORA2A;GLP1R;VIP;FURIN;SYK;GPR84;IL6;GNB1
prerank,cellular response to interferon-beta (GO:0035458),0.4746586202201353,1.0876646152805234,0.37595907928388744,0.6647309611374952,1.0,6/14,25.70%,TRIM6;IFITM2;IRGC;ACOD1;CDC34;AIM2
prerank,carbohydrate derivative transport (GO:1901264),0.45365951929910625,1.0875414944545285,0.34047919293820933,0.6646840276082692,1.0,5/18,21.65%,ABCG1;SLC15A3;CLN3;NPC2;LBP
prerank,muscle filament sliding (GO:0030049),0.40340811493732687,1.0875181219383536,0.3674832962138085,0.6639862734176853,1.0,8/38,24.28%,TNNT3;VIM;TPM2;TPM4;ACTN2;MYL1;TNNI1;MYL4
prerank,actin-myosin filament sliding (GO:0033275),0.40340811493732687,1.0875181219383536,0.3674832962138085,0.6639862734176853,1.0,8/38,24.28%,TNNT3;VIM;TPM2;TPM4;ACTN2;MYL1;TNNI1;MYL4
prerank,ceramide metabolic process (GO:0006672),0.3931680636832043,1.0875164508527337,0.35412026726057905,0.6636092242718192,1.0,8/49,8.69%,CERK;SGMS1;PPP2R1A;CERS6;ORMDL1;SPTSSA;PLPP3;SMPD4
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.4096665751132561,1.0871713447312186,0.36107854630715125,0.6641669857152678,1.0,6/32,12.95%,SLC27A1;PEMT;APOA2;STARD10;CHKB;LPCAT3
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.4863089718581749,1.086605277340973,0.3805774278215223,0.665281943563515,1.0,8/13,29.44%,CD44;CD74;MIF;MDM2;PSMD10;KDM1A;PTTG1IP;SIRT1
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.3948938192703172,-1.086440927641132,0.34439834024896265,0.7860950084486652,1.0,1/13,0.08%,CYRIB
prerank,eye photoreceptor cell differentiation (GO:0001754),0.5089520697389921,1.0860615402533431,0.3784135240572172,0.6663270271151689,1.0,6/12,24.80%,TH;VEGFA;AGTPBP1;DSCAM;PROM1;MYO7A
prerank,microtubule anchoring at centrosome (GO:0034454),0.5118354177649843,1.0860219106285098,0.3732590529247911,0.6660461735054967,1.0,3/10,17.48%,NINL;DCTN1;HOOK3
prerank,regulation of mitochondrial fusion (GO:0010635),0.5111995698657843,1.0857449507618069,0.3796423658872077,0.6663752208039385,1.0,7/11,32.35%,VAT1;HUWE1;TFRC;BNIP3;MUL1;ZDHHC6;PID1
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.38667739804907963,1.0855591528857975,0.3572216097023153,0.6665183710208847,1.0,14/46,22.35%,TOMM22;MGARP;DNAJC15;HK1;TIMM44;TIMM9;TOMM5;TOMM40;HSPD1;TIMM21;FBXO7;TIMM17A;PITRM1;TIMM23
prerank,Golgi to plasma membrane transport (GO:0006893),0.3883024108486421,1.0846151143401355,0.34486607142857145,0.6687020619671398,1.0,20/47,28.82%,RABEP1;MACF1;OPTN;GOLGA4;ARFGEF2;EXOC2;GCC2;GGA2;VAMP4;VAMP2;VPS35L;LLGL1;CCDC22;GOLPH3;GGA1;GOLPH3L;RAB31;EXOC4;ARL3;ARFRP1
prerank,synaptic vesicle endocytosis (GO:0048488),-0.3019018799446819,-1.0843074449473193,0.27007299270072993,0.7891625913806526,1.0,7/33,6.31%,OPHN1;NLGN1;SNAP91;AMPH;PICALM;SYT1;SYT2
prerank,protein localization to plasma membrane (GO:0072659),0.3560360860694236,1.084163418307522,0.31771894093686354,0.6695106963260228,1.0,35/129,18.68%,FGF13;MYO5A;ANK1;FLNA;RAP2A;ATP1B3;TTC7B;RAB40C;EFR3B;RAPGEF6;DENND4C;TSPAN17;PACS2;NECTIN3;CDH1;FLOT2;P2RY1;RAB8A;RAB8B;JUP;GAK;PRAM1;GAS6;TSPAN5;PLEKHF1;ROCK1;LRP6;SCN3B;MYADM;PKP2;AFDN;CACNB3;EHD4;RAB11A;ITGB1BP1
prerank,cellular response to acid chemical (GO:0071229),0.41752136518577954,1.083967417513342,0.36160188457008247,0.6696494643582486,1.0,14/27,31.66%,RRAGD;CPEB4;IPO5;VEGFA;CPEB3;NSMF;LARS1;CPEB1;RRAGC;SESN2;LAMTOR3;LAMTOR1;RRAGB;XBP1
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.3479319354802106,1.0839316958017626,0.28128128128128127,0.6693571618875329,1.0,95/241,30.15%,SNRNP35;CD2BP2;HNRNPA3;HNRNPUL1;ZRSR2;SNIP1;SF3B3;HNRNPM;RBM4B;POLR2H;PAPOLA;HNRNPC;PABPN1;PABPC1;DNAJC8;METTL3;CHERP;SYF2;SRSF11;PRPF4;SMNDC1;PRCC;SRSF7;HNRNPK;RBM19;HSPA8;GTF2F1;DDX39B;SYNCRIP;HNRNPA2B1;EIF4A3;POLR2D;LSM6;RBM15;PUF60;SART1;WBP11;PCBP1;NOVA2;SYMPK;PNN;PSPC1;RBM15B;PRPF6;PPIE;HNRNPU;HNRNPF;GCFC2;UBL5;IK;CWC22;DHX9;SNRNP40;CCAR1;ZMAT5;SRSF2;CTNNBL1;ZMAT2;SNRPB2;CPSF7;RALY;PRPF8;SMU1;UPF3B;SF3A3;LSM4;SNU13;RBM22;SRRM1;SNRPG;SF3B2;SF3B1;POLR2F;HNRNPL;SNRPF;LSM3;SNW1;GEMIN5;PRPF40A;SNRPA;SF3B5;PPIH;FUS;CSTF2;SRSF1;PPIL3;SRSF10;DDX41;NUDT21;WBP4;TRA2B;PRPF31;SUGP1;WDR83;DBR1
prerank,phospholipid biosynthetic process (GO:0008654),0.4050273613007215,1.0836178640993241,0.35903337169159955,0.6698325707462434,1.0,18/36,33.92%,SGMS1;SPHK2;SRD5A3;FADS1;CLN3;CPNE3;DPAGT1;HDHD5;CPNE6;SAMD8;NUS1;PCYT2;DOLPP1;GNPAT;LPCAT1;PIP5K1A;AGPAT3;SGMS2
prerank,ncRNA transcription (GO:0098781),0.4810410258470642,1.082856589481628,0.3784135240572172,0.6715473648088504,1.0,3/13,8.51%,USPL1;POLR1G;SNAPC2
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.4187644210205386,1.0828272729768091,0.38148984198645597,0.6712259163965091,1.0,7/28,15.48%,NIBAN2;FBXW7;METTL3;DLL4;DLK2;EGFL7;YTHDF2
prerank,regulation of axonogenesis (GO:0050770),0.389581796381506,1.0826821344486177,0.35714285714285715,0.671241552335492,1.0,11/51,13.29%,PLXNC1;PLXNA2;KIF13B;LRP4;AMIGO1;GDI1;RUFY3;PLXND1;CHODL;RHOA;PAK2
prerank,regulation of osteoblast differentiation (GO:0045667),0.36965090260584316,1.0821321212838129,0.3555787278415016,0.6723534935276673,1.0,16/82,12.72%,IGF1;CDK6;LTF;HDAC7;NELL1;PPARG;SUCO;SOX9;NOCT;FBXO5;IFITM1;ATP6AP1;BAMBI;RIOX1;SMOC1;CHRD
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.5086284935461423,1.0820288859974454,0.3956043956043956,0.6722392879474514,1.0,5/11,26.69%,NCL;SMARCB1;PWP1;SMARCA4;PIH1D1
prerank,hematopoietic stem cell differentiation (GO:0060218),0.5160109953130357,1.081910958046959,0.3781163434903047,0.6721705742211196,1.0,8/10,41.24%,SP7;HOXB4;SFRP1;UFL1;LMBR1L;MLLT3;BATF;TP53
prerank,positive regulation of nervous system process (GO:0031646),0.45309227640886446,1.0818965749127638,0.3775,0.6718287633866892,1.0,5/18,15.75%,ITGAX;CST7;EGR2;TNFRSF1B;NCMAP
prerank,positive regulation of phospholipid transport (GO:2001140),0.5105324991050492,1.0816883081817996,0.38482758620689655,0.6719933003374261,1.0,3/10,13.05%,APOE;TRIAP1;ABCA7
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.47720134071100834,1.0816206827952388,0.3836317135549872,0.6717982819024254,1.0,7/14,30.52%,BCL2L11;BAX;DNAJB9;BFAR;HSPA5;UFL1;PTPN1
prerank,regulation of lipid biosynthetic process (GO:0046890),0.4127814236267499,1.0815783568401443,0.36488027366020526,0.6715176115189785,1.0,8/32,18.83%,APOE;EIF6;C3;MID1IP1;SORBS1;SIRT4;ADIPOR1;ASAH1
prerank,establishment of protein localization to organelle (GO:0072594),0.3701341195242086,1.081529014392613,0.3572938689217759,0.6712708950403071,1.0,29/72,29.55%,MMP12;GCKR;ZDHHC15;PRICKLE1;IPO5;TSPAN17;HK1;E2F3;LAMP2;NUP188;NXT2;EIF4ENIF1;TPR;SYK;APPL2;PPP1R10;RAB11A;NUP93;CD68;NUP50;TNPO2;TNPO1;NUP133;LAMP1;NUTF2;IPO13;PTTG1IP;NUP214;PEX19
prerank,cell differentiation in hindbrain (GO:0021533),-0.40945946347718754,-1.0808877508491928,0.35984848484848486,0.7962815032231922,1.0,2/11,3.95%,OPHN1;GRID2
prerank,regulation of cardiac muscle contraction (GO:0055117),0.41016142630235564,1.080500359911936,0.37993235625704624,0.6737183032958669,1.0,5/34,13.09%,P2RX4;SLC9A1;NPPA;SRI;SMAD7
prerank,regulation of myoblast differentiation (GO:0045661),-0.3029397382447925,-1.08021425605025,0.28688524590163933,0.7948261748209018,1.0,7/32,11.27%,MEF2C;MAPK14;PLCB1;SOX8;LRRC8A;IGFBP3;EID2B
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.37692658494480474,1.0800547014015829,0.3459915611814346,0.6745514791427164,1.0,16/60,19.31%,CTNNB1;CDK8;LEF1;MED15;TRIM28;SOX9;CCNC;CCNB1;BAX;MED17;NFKB1;SRF;MED13;DHX36;IL6;AGO3
prerank,Rap protein signal transduction (GO:0032486),0.5087784346408868,1.0799463043005413,0.38926174496644295,0.6744626593554475,1.0,2/10,7.92%,RAP2A;PLK2
prerank,regulation of myoblast fusion (GO:1901739),0.5006609808988308,1.0799453200832005,0.40551724137931033,0.6740840705964892,1.0,3/11,8.63%,RIPOR2;ADGRB1;CD53
prerank,regulation of glycogen metabolic process (GO:0070873),-0.39862436100651977,-1.079888895887738,0.34980988593155893,0.792290497287643,1.0,5/12,24.80%,KHK;INPP5K;PPP1R3E;RUBCNL;PPP1R3D
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.4617800833352917,1.079809240455303,0.3721518987341772,0.6740557555308414,1.0,11/16,35.23%,CHMP4A;CHMP4B;VTA1;CHMP7;TMEM50B;CHMP6;VPS28;LEPROT;SNF8;LEPROTL1;CHMP5
prerank,negative regulation of viral entry into host cell (GO:0046597),0.4916329464101975,1.079615309150038,0.3835800807537012,0.6741858243034727,1.0,3/12,11.96%,IFITM2;IFITM1;GSN
prerank,regulation of actin filament-based movement (GO:1903115),0.5181184892019416,1.079417090262182,0.3983739837398374,0.6743249870917774,1.0,2/10,9.82%,PDPN;SRI
prerank,peptidyl-lysine modification (GO:0018205),0.36089565208307506,1.079356777457382,0.3498452012383901,0.6740980024991364,1.0,42/99,31.43%,NUP205;HDAC9;ATP7A;NSMCE2;HDAC4;ETFBKMT;USPL1;TRIM28;EGR2;NUP188;SIRT5;SUMO2;RANBP2;EEF1AKMT3;TPR;VIPAS39;SIRT4;SENP5;RAE1;PIAS1;SAE1;NUP93;AAAS;GCSH;SENP1;NUP54;NUP50;SUMO1;SIRT3;NUP98;PIAS4;P3H3;NUP42;NUP133;NUP210;NUP35;LIPT2;SIRT1;NUP214;EP300;SIRT2;LOXL3
prerank,autophagosome organization (GO:1905037),0.38632216566216954,1.0791735767285666,0.35815991237677985,0.6742122487786241,1.0,25/50,32.70%,ATG7;ATP13A2;RUFY4;PACS2;WDR45;TMEM41B;RAB7A;MAP1LC3B;UBQLN1;RAB1A;ATG16L1;ATG2B;MAP1LC3A;GABARAP;ATP2A2;ATG3;ATG13;AMBRA1;RAB43;TP53INP2;BECN1;ATG16L2;VMP1;UBQLN2;ATG5
prerank,regulation of interleukin-8 production (GO:0032677),0.37243873905626,1.0785022648932057,0.35691657866948256,0.6756669999705879,1.0,21/69,24.29%,PTPRC;ANXA1;TMSB4X;ANXA4;CD2;APOA2;PTPN22;SERPINE1;DDIT3;PRKD2;SYK;TIRAP;RAB1A;IL6;HMGB1;LBP;F2R;CD74;IL17D;MAP2K5;TNF
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.4917800150688231,1.078453777804545,0.38140161725067384,0.6754177422222324,1.0,6/12,24.88%,CHMP4A;CHMP4B;SEC61B;SEC63;GET3;HSPA5
prerank,cellular response to ATP (GO:0071318),-0.37521998238782545,-1.0778894342189809,0.3418803418803419,0.7949185373560923,1.0,2/14,2.08%,P2RY12;RYR3
prerank,protein localization to membrane (GO:0072657),0.3469957559999883,1.0776911026101796,0.32160804020100503,0.6770890324835626,1.0,51/187,20.29%,SH3PXD2B;FGF13;RFTN1;MYO5A;ANK1;FLNA;RAP2A;RABEP1;ITGAL;ATP1B3;TTC7B;RAB40C;ZDHHC15;ITGA4;CAV1;BID;EFR3B;RAPGEF6;DENND4C;TSPAN17;PACS2;CDH1;FLOT2;P2RY1;RAB32;RAB8A;RAB8B;JUP;GAK;PRAM1;GAS6;TSPAN5;PLEKHF1;ROCK1;NPC1;SAV1;LRP6;HPS6;ITGB2;AP3D1;SCN3B;MYADM;PKP2;CACNB3;EHD4;RAB11A;ITGB1BP1;FERMT2;ABHD17A;ACTN2;PDZD11
prerank,negative regulation of bone remodeling (GO:0046851),0.5015059268947221,1.0776414693857599,0.39242219215155616,0.6768427065134294,1.0,1/11,0.21%,GPR137B
prerank,regulation of protein localization to Cajal body (GO:1904869),0.5016230815841178,1.0773108092547612,0.37567567567567567,0.6769603774028272,1.0,4/11,21.95%,CCT2;CCT8;CCT5;DKC1
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.5016230815841178,1.0773108092547612,0.37567567567567567,0.6769603774028272,1.0,4/11,21.95%,CCT2;CCT8;CCT5;DKC1
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.49703181530509427,1.0771503440386703,0.40083217753120665,0.6770208372324086,1.0,5/11,21.59%,TARM1;RUNX1;CD274;HMGB1;RUNX3
prerank,sensory perception of taste (GO:0050909),0.5048627274891656,1.0770015834608906,0.4024725274725275,0.6770289638891295,1.0,3/10,28.74%,ASIC3;ASIC1;PKD2L1
prerank,substrate-dependent cell migration (GO:0006929),-0.379730412260644,-1.0767944491717272,0.3397129186602871,0.7947881595781208,1.0,4/14,4.63%,P2RY12;OPHN1;ANKS1A;CD2AP
prerank,negative regulation of transferase activity (GO:0051348),0.4172253351774726,1.076772273918201,0.3833718244803695,0.6772133044801266,1.0,10/28,21.74%,FBXO5;NPRL2;PHPT1;LIMK1;SMAD7;ERCC4;HNRNPU;TERF1;GSK3B;EIF4A2
prerank,regulation of establishment of protein localization (GO:0070201),0.4755834353151943,1.076414097390525,0.3888888888888889,0.6777973015311192,1.0,5/13,27.13%,CTSD;TREM2;CEP120;DNAJA1;CEP295
prerank,manganese ion transport (GO:0006828),0.4722525704556761,1.0760964431017135,0.37707006369426754,0.6782762875541007,1.0,1/14,0.25%,TRPC4
prerank,dicarboxylic acid metabolic process (GO:0043648),0.3825791467098918,1.0759323517464683,0.35473340587595215,0.6783220836019909,1.0,26/52,36.67%,MDH1B;MTHFD2;SLC46A1;MTHFS;SHMT1;ME2;MTHFD1;FPGS;MTRR;DLST;SLC19A1;ALDH1L2;MTHFR;ME1;SDHAF3;ACOT8;MDH2;IDH2;SHMT2;MTHFD1L;SLC25A32;HOGA1;ACLY;ACOT4;IDH1;L2HGDH
prerank,sensory perception of chemical stimulus (GO:0007606),0.46958582551640016,1.0757456206967844,0.38831168831168833,0.6784560278202905,1.0,5/15,23.12%,SLC24A4;ADCY3;C5AR1;MKKS;GNAS
prerank,negative regulation of wound healing (GO:0061045),0.4145942935142392,1.0754885066080808,0.38235294117647056,0.6787695560871698,1.0,6/28,11.33%,APOE;CLDN19;FGF2;TFPI;SERPINE2;SERPINE1
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.34722108936027063,1.075415591082887,0.3306532663316583,0.6785793001679254,1.0,65/173,33.16%,ANK1;CTSZ;GOSR2;SEC22B;DYNC1H1;GOLGB1;VTI1A;BET1L;TRAPPC8;NAPA;RANGRF;PGAP1;COG4;DCTN1;SEC24A;F5;LMAN1;GAS6;PROS1;SEC24D;DYNC1LI2;VAPB;MCFD2;YIF1B;RAB1A;SAR1A;VAMP4;TRAPPC11;GRIA1;TBC1D20;LMAN2;CUL3;F8;YKT6;CD55;ARFGAP3;ARFGAP1;DCTN4;TMED3;DCTN6;USO1;F9;TRAPPC12;GOLGA2;ARFGAP2;COPZ2;COG6;STX5;TMED2;USE1;COPA;TEX261;COG8;TRAPPC4;SPTAN1;KDELR2;COPG1;COPB2;COPG2;COG7;DYNC1I2;MIA3;CNIH4;DCTN5;ACTR10
prerank,histone H2A acetylation (GO:0043968),0.4599967754364994,1.0752875967863698,0.410062893081761,0.6785424897130621,1.0,13/16,38.54%,SPHK2;MSL3;ING3;EP400;MORF4L1;MORF4L2;RUVBL2;BRD8;DMAP1;TRRAP;EPC1;RUVBL1;NAA40
prerank,regulation of autophagosome maturation (GO:1901096),0.4842473315378779,1.075221819753346,0.38,0.6783428602728223,1.0,3/13,10.88%,SMCR8;FYCO1;CLN3
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.4447596000109296,1.0750668163654509,0.38141809290953543,0.6783490576527598,1.0,4/20,13.96%,SLC27A1;CNDP2;MTHFS;FPGS
prerank,negative regulation of interleukin-10 production (GO:0032693),0.4690015614542731,1.0746266032997347,0.37969924812030076,0.6791943226418229,1.0,3/16,8.96%,MMP8;CD274;LILRB1
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.3383181812160777,1.0738586793296465,0.16,0.680872681208406,1.0,246/807,27.84%,FNIP2;MDFIC;CTNNB1;MITF;UXT;ZHX2;DNMT3A;NIBAN2;ATF3;SDCBP;FLNA;NFIC;ARID5B;SCML4;LEF1;HDAC9;DEDD2;UBA52;TBX21;DEAF1;RPS27A;RCOR1;MUC1;PRDX5;ID2;EOMES;NRG1;SOX3;SOX30;NR4A3;VDR;NCOR2;RPS14;CDK5;TGIF1;NFIL3;MNT;CIC;PRICKLE1;HDAC4;CAV1;PPARG;DAXX;SHOX2;FOXJ1;NOC2L;KLF12;RUNX1;BCL6;ERN2;DAB2;RPL23;GATA3;CUX1;TRIM28;ZBTB7B;SOX9;VEGFA;SATB1;MAF1;ING4;HDAC1;BPTF;NFX1;ZBTB2;PEX2;KMT5A;BHLHE40;ATXN1;MTF2;MDFI;CHD3;GMNN;BHLHE41;PPARD;USP9X;BASP1;IRF8;MIDEAS;THAP7;HOXA7;FOXN3;LRRFIP1;BRCA1;NKX2-1;OTP;AEBP1;SOX7;CPEB3;DAP;FOXP4;ATF5;JUN;SUDS3;FOSB;ZNF148;ENO1;NAB2;CEBPA;GATAD2B;RNF2;BAP1;DLL4;RIOX1;ZKSCAN3;TLE5;TFAP4;NUPR2;GAS6;SP100;HSPA8;ZBTB16;ELK4;SMAD7;GATAD2A;EFNA1;ILF3;H1-0;MAFK;CBFA2T2;YY1;BIRC5;EED;ETV6;DDIT3;NFKB1;RBM15;RBFOX2;TCF25;TPR;USP47;C1QBP;FOXO1;PRMT2;NR4A2;ELK3;PRMT6;SARS1;BMP6;PSPC1;MYBBP1A;SMYD2;RBM15B;PDCD4;WFS1;RCOR3;DNAJB1;SBNO2;HNRNPU;CNBP;UIMC1;PURA;PAF1;GCFC2;CBX3;KAT7;BMI1;CBX2;DNMT3B;ZNF177;CCAR2;DR1;LYAR;MIER2;TAF7;EHMT1;YAF2;NR3C1;HMGB1;UBC;DACH1;JDP2;MTDH;FBXW11;VPS72;PRDM6;YEATS2;ZFP57;EPO;VHL;HSF1;RUNX3;BMP4;ID1;SUFU;CALR;KLF11;NIPBL;AHR;ZNF568;CREBZF;PEX14;RXRA;WWOX;L3MBTL3;FGFR2;MAP2K5;E2F6;ZBTB4;MDM2;USP2;SOX10;MTA3;TNF;GLIS2;SUMO1;CCDC85B;PLK3;GADD45A;ATF4;HDAC2;ZGPAT;ATN1;MCPH1;SMARCA4;POU2F1;KDM5C;SFRP1;KANK2;NOTCH4;DPF3;HDAC3;PIAS4;HCFC1;L3MBTL2;HIC2;NR6A1;TMPRSS6;FST;PCGF6;BTRC;SNW1;NSD1;PSMD10;PPM1A;CBX7;LBH;LIMS1;KDM1A;SUPT4H1;HES1;DACT1;FRK;N4BP2L2;FNIP1;KLF10
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.33531061230881165,-1.0738229282512226,0.3604060913705584,0.800089229249093,1.0,4/22,3.32%,SSH2;CYRIB;KANK1;TWF2
prerank,TOR signaling (GO:0031929),0.4176821199853813,1.0732440409701212,0.3837072018890201,0.6821397855592963,1.0,12/26,28.09%,RPS6;GATA3;LARP1;NPRL3;SYAP1;RHEBL1;CCDC88A;PRR5L;MAPKAP1;FNIP1;RICTOR;SMG1
prerank,miRNA mediated inhibition of translation (GO:0035278),0.49689510021683925,1.072943407033986,0.388283378746594,0.6821695403765955,1.0,2/11,2.43%,AGO2;EIF6
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.49689510021683925,1.072943407033986,0.388283378746594,0.6821695403765955,1.0,2/11,2.43%,AGO2;EIF6
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.422472567475801,1.0728056290586545,0.37857142857142856,0.6821502406141204,1.0,10/26,26.58%,NSMCE2;ANAPC15;RIOK2;FBXO5;CCNB1;NEK6;CUL3;ANAPC7;UBE2C;ESPL1
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.46577659711115027,1.0726166755438125,0.3958602846054334,0.6823107303048757,1.0,4/15,14.47%,AGO2;PABPC1;CPEB3;EIF4ENIF1
prerank,myeloid dendritic cell activation (GO:0001773),0.49210030082341183,1.0724682411708162,0.4060446780551905,0.682325487346707,1.0,4/12,23.00%,DOCK2;CAMK4;HMGB1;TGFBR2
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.4346488843934081,1.0724662712519624,0.37995049504950495,0.681949271362467,1.0,7/21,13.09%,CAV1;NCK2;NCK1;RACK1;PAQR3;CNKSR3;SMAD7
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.355655739918674,-1.0723448917248757,0.36492890995260663,0.8010233694273498,1.0,7/17,24.88%,SNTA1;KCNH2;NEDD4L;KCNQ1;ANK2;KCNE3;KCNE4
prerank,histone H3-K9 demethylation (GO:0033169),0.5012848770044476,1.0719205040943374,0.3970189701897019,0.6830262498955076,1.0,5/11,16.27%,JMJD1C;HR;KDM3A;KDM3B;KDM4D
prerank,cellular protein modification process (GO:0006464),0.3377960528729233,1.0714700190645272,0.172,0.6838346800320285,1.0,301/982,26.89%,FNIP2;FAM20C;B4GALT5;SPP1;CDK14;LCK;APOE;PEAK1;HIF1A;FN1;CDK18;CDK6;PRKCH;ABL2;CD247;CSF1;IGFBP7;CDK8;ATG7;PTPRA;PSMD8;LGALS1;PTPRC;ANXA1;PSMD1;MSRA;UBL4A;SGK1;FGR;UBA52;LARGE1;PARP4;CEL;TEC;SGK3;SGK2;SRPK1;B4GALT7;GCNT2;SERPINA10;COPS3;APOA2;CD3G;MATN3;ENAM;B3GNT3;FSTL3;DUSP9;MAP4K5;MAP4K2;DYRK2;PTK2B;NEURL2;PAK6;CDK5;WSB2;FBXW7;PRKCD;FBXO32;PPM1J;TNKS2;TAOK3;PPP2R5C;RNF7;ANO8;PPP2R1A;B3GALNT2;PPM1H;ERN2;PTPN22;STT3B;PDPK1;CTDNEP1;APLP2;STK24;STK3;ERN1;SIK1;IKBKE;MAP4K3;GNMT;COPS4;PPP1R12A;COPS8;P3H1;TXK;SPSB2;UGCG;PLK2;PRKCB;P4HB;UBE2L3;TAB1;FBXO31;PGAP1;WDR45;ST8SIA6;PTAR1;ILK;PSMD6;PSMA1;OGA;RNASEL;DDB2;MAPKAPK2;FBXW4;ERO1A;CDK13;EVPL;RAB8A;DDB1;NEK4;PSMC3;CUL9;KLHL13;FYN;COPS2;SIRT5;C3;RABGGTB;SOCS5;CDK17;DUSP6;HIPK1;PIM1;RBBP5;RSKR;ART4;PTPN12;JAK1;BAP1;OGFOD1;F5;PSMA8;BIRC6;PHPT1;KCTD7;COPS6;WDR5;MAP3K12;TGM5;CDK11B;ALG10B;LIMK1;GAS6;RAB5A;GPAA1;CDK2;ZBTB16;ABCA7;TIPARP;PTPN13;FSTL1;UBE2F;PKN2;PAK2;ILF3;ROCK1;PSMD14;NPC1;BIRC5;PSMD2;MAP3K1;UBE2L6;PRKD2;LAMC1;FASTK;DAPK1;FBXL19;CSNK1D;MAPK9;STK38;PSMC6;QPCT;ZC3HAV1;PSMA6;MELTF;SYK;DUSP11;PLK4;CKAP4;MINK1;RAB1A;KLHL25;TULP4;TLK1;SIRT4;PPP6C;PRKAG1;WFS1;ASB1;CAMK4;STK11;PSMD5;RIPK3;DCAF17;ELOB;NLK;PTP4A2;NEK6;PARP3;WSB1;DAPK3;PSMA5;RAB11A;UBL5;ATM;MEX3B;IL6;PPP3CC;TP53RK;CUL3;SPARCL1;DDOST;SPSB3;AGA;MAP3K9;PTPN21;FBXO7;CDK16;FBXW11;PDK3;SHISA5;MAK;TIMP1;MARK2;CAND1;LMTK2;DUSP12;CUL1;VHL;CALU;FBXW5;GSK3B;PRAG1;SRPK2;MARK4;RUNX3;NIM1K;PIGT;CDC34;TAOK1;BMP4;TRIOBP;MELK;FBXO11;TRIB2;EGLN3;CUL2;LATS1;FUT10;PIGH;ST3GAL2;DUSP16;CCDC22;TGFBR2;RBBP7;PTPN9;SOCS2;DCAF6;PSMA3;PARP2;NAA80;JAK2;SIRT3;PRKCSH;PSMB8;STK38L;WDTC1;BTK;DCUN1D3;COQ8B;PTPN18;CDK4;CDC25B;PSMB10;FBXO41;YES1;YWHAZ;CUL4A;GOLGA2;SIK3;PSMD7;SLC35A1;HCST;ATG10;PAK4;PSMB6;PARP16;HLCS;KLHL21;KLHL11;KEAP1;METAP1D;PTPN6;BTRC;PTPRM;B3GALT4;ATG3;PSMD10;PPM1A
prerank,negative regulation of signaling receptor activity (GO:2000272),0.4209504706504502,1.071392625206366,0.38882282996432815,0.6836579420272728,1.0,11/25,31.36%,PPARG;SOCS5;CBL;CNRIP1;CBLB;CHMP6;TNF;ZGPAT;SOCS4;ERRFI1;EPHB2
prerank,postsynaptic membrane organization (GO:0001941),0.44864800424862084,1.0712111224631233,0.3981841763942931,0.6837501518279989,1.0,3/17,5.82%,APOE;CEL;LRP4
prerank,ion homeostasis (GO:0050801),-0.3073620869892716,-1.0711899190654994,0.30405405405405406,0.8013179291753827,1.0,7/30,10.68%,UNC80;SLC4A7;WNK1;KLHL3;WNK3;SLC30A4;SLC4A10
prerank,aromatic amino acid family metabolic process (GO:0009072),0.5130737357714837,1.0709460153158457,0.4074074074074074,0.684100660384963,1.0,1/10,2.10%,ATP7A
prerank,T cell differentiation in thymus (GO:0033077),0.46970406326203884,1.0704107043468172,0.3978638184245661,0.6851785446284316,1.0,3/14,17.46%,PTPRC;ADAM17;RIPK3
prerank,protein localization to cell-cell junction (GO:0150105),0.4648295386958237,1.0700712781359512,0.4117647058823529,0.6856823983646914,1.0,6/15,14.04%,TJP2;ACTG1;JAK1;ARHGEF18;PAK2;ACTB
prerank,cell proliferation in forebrain (GO:0021846),-0.4277380832008494,-1.0700084508311525,0.34965034965034963,0.8013230937955516,1.0,1/10,0.09%,NUMB
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.442123749852194,1.0699487803264973,0.40663390663390664,0.6856335444202262,1.0,2/21,2.11%,XYLT1;HS3ST3B1
prerank,positive regulation of dephosphorylation (GO:0035306),0.41936933825397876,1.0693706544815378,0.392018779342723,0.6868094252395333,1.0,11/27,23.76%,PTPA;PRKCD;DLC1;PPIA;SPPL3;SMPD1;SYMPK;RIPK3;PIN1;NSMF;CALM3
prerank,regulation of cellular protein localization (GO:1903827),0.3895545193317244,1.0690852449926498,0.4078516902944384,0.6871973854450288,1.0,5/45,9.82%,LCP1;CTNNB1;ATP13A2;TRIM67;VCP
prerank,response to ATP (GO:0033198),-0.3402182528271123,-1.0680029376380769,0.3248730964467005,0.8040472063552776,1.0,5/18,14.57%,P2RY12;RYR3;ABCC9;PDXP;CIB2
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.4632572102606674,1.067705048131545,0.39095744680851063,0.6905302635618009,1.0,5/14,20.89%,FLNA;LIMS2;CD63;ITGB1BP1;TIMP1
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.4854039670549376,1.067194625975433,0.41492146596858637,0.6915163281124052,1.0,6/13,21.85%,PPARG;SOX9;PPARD;SRF;NFATC3;BMP4
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.507381132333424,1.0671942356570117,0.4065040650406504,0.6911343448895712,1.0,4/10,21.95%,CCT2;CCT8;CCT5;DKC1
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.3477031143475477,1.067162517522623,0.34475806451612906,0.690826648477486,1.0,40/151,24.31%,B4GALT5;APOE;SLC27A1;LARGE1;TNIP1;SGMS1;SPHK2;PEMT;APOA2;GSTA2;SPHK1;HACD2;CERS6;SPTSSA;PLPP3;STARD10;CHKB;MOCOS;ALAS1;LPCAT3;HACD1;KDSR;AKR1A1;PRKD2;VAPB;FURIN;NANP;CDO1;ALDH3A2;ALDH3B1;CSNK2A2;ELOVL2;GSTO2;SAMD8;ELOVL1;ST3GAL2;SPTLC3;GOLPH3;LPIN3;PRKD3
prerank,regulation of neuroblast proliferation (GO:1902692),-0.34934562048500395,-1.0670612588848316,0.3771186440677966,0.8033043399237124,1.0,3/15,3.51%,CX3CR1;TAFA1;LRRK2
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.42646454932762123,1.067021078293304,0.4011764705882353,0.690821910238462,1.0,9/26,22.76%,LCK;PTPRC;FGF2;ERO1A;CHERP;SLC8B1;ITPR3;F2R;HTR2B
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),-0.3377741418174704,-1.0670151646518458,0.37373737373737376,0.7999536477715216,1.0,5/18,7.80%,NLGN1;RIMS1;LRRK2;SNAPIN;RIMS2
prerank,eye photoreceptor cell development (GO:0042462),0.4667392042164171,1.0670143248492245,0.3860759493670886,0.6904572783571942,1.0,2/15,7.03%,TH;VEGFA
prerank,regulation of amyloid-beta formation (GO:1902003),0.3996479305375348,1.0667541874172843,0.4046242774566474,0.6907679795310026,1.0,10/34,18.26%,IGF1;APOE;ABCG1;GSAP;ABCA7;EFNA1;ROCK1;CLU;SP1;PIN1
prerank,nuclear transport (GO:0051169),0.4577315092973266,1.0666044093811067,0.40533672172808133,0.690786910746401,1.0,8/16,27.66%,NUP205;NXT2;XPO1;RBM15B;AAAS;NPM1;NUP98;NUTF2
prerank,peptidyl-lysine monomethylation (GO:0018026),0.506924790741301,1.0665902272312593,0.3951612903225806,0.6904386463127848,1.0,3/10,19.45%,KMT5A;SMYD2;EHMT1
prerank,diol metabolic process (GO:0034311),0.4479686650461977,1.066522412726849,0.410958904109589,0.690232384915545,1.0,3/19,6.48%,SPHK2;SPHK1;PLPP3
prerank,histone deacetylation (GO:0016575),0.38984836979461945,1.0661135008252853,0.38461538461538464,0.6909160343585559,1.0,16/43,26.47%,HDAC9;RCOR1;HDAC4;MSL3;HDAC1;MIDEAS;SUDS3;ELK4;RCOR3;MIER2;MORF4L1;MTA3;HDAC11;HDAC2;HDAC3;MORF4L2
prerank,regulation of gastrulation (GO:0010470),0.4717737487757009,1.0659990254161307,0.41318977119784656,0.6908096591270269,1.0,3/14,11.25%,DAG1;RACK1;PHLDB1
prerank,positive regulation of viral transcription (GO:0050434),0.4151707865650923,1.065608071744414,0.4167664670658683,0.6915309496184432,1.0,8/25,27.98%,MDFIC;POLR2H;GTF2F1;POLR2D;DHX9;POLR2F;SUPT4H1;RSF1
prerank,regulation of interleukin-1 beta production (GO:0032651),0.36743603192441937,1.0653702494269066,0.3839572192513369,0.6918022922875522,1.0,7/66,8.34%,IGF1;LPL;SIRPA;MALT1;PANX1;HSPB1;TRIM16
prerank,regulation of primary metabolic process (GO:0080090),0.35236851284750065,1.0652169972527328,0.3623481781376518,0.6918301086770628,1.0,47/126,28.23%,APOE;PSMD8;NFYA;PSMD1;ACACA;ID2;NCOR2;AZIN1;PSAP;PPARG;PPARD;PSMD6;PSMA1;OAZ3;PSMC3;PSMA8;CARM1;ABCA7;PSMD14;NFYB;PSMD2;HELZ2;PSMC6;PSMA6;ADIPOR1;ODC1;PSMD5;SP1;PSMA5;ACACB;SREBF1;TM6SF2;PMVK;RXRA;PSMA3;EDF1;PSMB8;FASN;LACTB;PSMB10;PSMD7;HDAC3;PSMB6;PSMD10;PSMB5;NQO1;PSMB7
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.33983039650890096,1.065083260975215,0.304,0.6918147649167818,1.0,79/348,21.47%,IGF1;MITF;STAP1;HIF1A;FN1;ITGAX;CD3E;MMP8;CSF1;NFE2L2;MSN;LEF1;AGO2;ATP13A2;PIK3CB;ID2;VDR;CLDN19;PKP1;POU3F1;FGF2;CD28;SERPINB9;RPS7;PTPN22;RPL23;TRIM28;ZBTB7B;SOX9;FUBP1;VEGFA;ANGPT1;TREM2;DNMT1;CELF1;ACTG1;DTNBP1;LILRB1;WNT6;RPL11;BRCA1;TICAM1;NKX2-1;KRAS;FGF7;NAT8;CD63;FGF20;DLL4;GSN;GAS6;SMAD1;ROCK1;SCYL2;FGF18;STOX1;CLU;ACTA2;MAPK9;TFRC;DHX36;BMP6;PRKAG1;AFDN;WFS1;SP1;ATM;IL6;FAM98A;DNMT3B;AGO3;SLC38A2;SLC11A1;RPS3;EMILIN1;LAPTM5;RESF1;GSK3B;SRPK2
prerank,regulation of response to interferon-gamma (GO:0060330),0.4737597158791531,1.0650780915363698,0.41888297872340424,0.6914534716899186,1.0,8/14,31.01%,PTPN2;JAK1;PIAS1;HSP90AB1;SUMO1;JAK2;IFNGR2;PARP9
prerank,snRNA 3'-end processing (GO:0034472),0.4433526862630951,1.0649322954846128,0.3888888888888889,0.6914702437181419,1.0,8/19,23.74%,EXOSC4;EXOSC9;INTS14;INTS2;INTS6;EXOSC5;USB1;INTS7
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.33687014991881686,1.0642468898889998,0.235,0.6928866780164289,1.0,177/572,27.84%,FNIP2;MITF;UXT;ZHX2;DNMT3A;ATF3;SDCBP;NFIC;ARID5B;HDAC9;UBA52;TBX21;DEAF1;RPS27A;ID2;EOMES;SOX3;SOX30;NR4A3;VDR;NCOR2;RPS14;TGIF1;NFIL3;MNT;CC2D1A;HDAC4;CAV1;PPARG;SHOX2;FOXJ1;NOC2L;KLF12;RUNX1;BCL6;DAB2;RPL23;GATA3;CUX1;ZBTB7B;SOX9;VEGFA;SATB1;HDAC1;BPTF;NFX1;ZBTB2;PEX2;KMT5A;BHLHE40;ATXN1;MTF2;MDFI;CHD3;BHLHE41;PPARD;USP9X;IRF8;THAP7;HOXA7;LRRFIP1;NKX2-1;OTP;AEBP1;CPEB3;FOXP4;JUN;SUDS3;FOSB;ZNF148;ENO1;GATAD2B;RNF2;DLL4;ZKSCAN3;TLE5;NUPR2;SP100;ZBTB16;ELK4;SMAD7;GATAD2A;EFNA1;H1-0;MAFK;YY1;EED;ETV6;DDIT3;NFKB1;TCF25;TPR;SRF;C1QBP;NR4A2;SARS1;BMP6;SMYD2;WFS1;DNAJB1;HNRNPU;CNBP;PURA;PAF1;ATRX;BMI1;CBX2;DNMT3B;ZNF177;DR1;LYAR;MIER2;TAF7;NR3C1;HMGB1;UBC;DACH1;JDP2;NFATC3;MTDH;VPS72;PRDM6;YEATS2;ZFP57;EPO;VHL;HSF1;RUNX3;BMP4;ID1;SUFU;CALR;KLF11;NIPBL;ZNF568;BAG3;RXRA;WWOX;FGFR2;MAP2K5;E2F6;ZBTB4;MDM2;USP2;SOX10;MTA3;TNF;GLIS2;SUMO1;PLK3;GADD45A;ATF4;HDAC2;ZGPAT;ATN1;MCPH1;SMARCA4;KANK2;NOTCH4;HDAC3;HCFC1;NR6A1;TMPRSS6;FST;SNW1;NSD1;PSMD10;PPM1A;CBX7;KDM1A;SUPT4H1;HES1;DACT1;FRK;N4BP2L2;FNIP1;KLF10
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.44280481842691916,1.0637994886127542,0.3848101265822785,0.6936744780765579,1.0,10/18,31.19%,TMEM98;TNFRSF1B;SLC45A3;NF1;IL34;MDK;CXCR4;HES1;DRD3;PTPRZ1
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.4229973557234791,1.0637115365159477,0.40665873959571935,0.6935509158320592,1.0,10/23,29.13%,ACSBG1;ACSBG2;HACD2;ACSL1;HACD1;ELOVL2;ELOVL1;HSD17B12;TECR;ACSF3
prerank,diol biosynthetic process (GO:0034312),0.46627194347385836,1.063536099151366,0.4098573281452659,0.6936323783814886,1.0,5/15,27.70%,SPHK2;SPHK1;ASAH1;SPTLC3;SPTLC2
prerank,positive regulation of cell adhesion (GO:0045785),-0.24509665593227065,-1.0634211740788089,0.3488372093023256,0.8073681291125636,1.0,7/74,3.93%,ZFHX3;P2RY12;EPB41L4B;EPHA4;TGM2;PTPRJ;MEGF10
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.3510194805380079,-1.0632966655375584,0.3668639053254438,0.8043132372912949,1.0,6/19,14.83%,ITGAM;PRKCE;LGALS9;TRIL;NMI;PIK3AP1
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.41542194948208466,1.06324823627994,0.41086186540731995,0.6940284498886772,1.0,11/26,30.75%,FBXW7;NCK2;ADAM17;SOCS5;CBL;CBLB;CHMP6;ZGPAT;NCF1;SOCS4;ERRFI1
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.3506014896767425,1.0631772528327232,0.36465781409601633,0.6938480144564261,1.0,37/121,24.95%,IGF1;CSPG4;PTPRC;ITGA5;TEC;CD44;PTK2B;NRP1;NEDD9;ANGPT4;VEGFA;ANGPT1;TREM2;FGF7;ARL2BP;CCL5;GAS6;PAK2;EFNA1;GHR;GPRC5B;IL31RA;CLEC6A;BMP6;HAX1;IL6;IL2;ARHGEF2;IL5;EPO;FGFR3;IL34;CD74;MIF;TNF;JAK2;PECAM1
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.35652261941864416,1.0630067585212677,0.3675564681724846,0.6938879356323092,1.0,28/104,24.94%,SNX25;UBA52;RPS27A;CILP;FSTL3;CAV1;PPARG;VEPH1;PDPK1;WFIKKN1;ADAM17;NKX2-1;BAMBI;LEMD2;CHRD;SMAD7;SMAD1;DAND5;PIN1;FAM89B;UBC;SPRED2;EMILIN1;SPART;TGFBR2;PMEPA1;SPRED3;ASPN
prerank,activation of GTPase activity (GO:0090630),0.35522370620523536,1.0628800259506368,0.38802889576883387,0.6938069311382263,1.0,11/89,7.88%,ABR;ARHGAP25;CORO1C;TBC1D10C;ARHGAP24;TBC1D22A;RALGAPA2;SIPA1L2;FOXJ1;TBC1D2;RASGRP1
prerank,regulation of organelle organization (GO:0033043),0.3622747168584226,1.0621843897719228,0.3953732912723449,0.6952749084740995,1.0,38/80,33.53%,S100A8;S100A9;MYO5A;MSN;ATP13A2;SQSTM1;CLIC4;CLN3;DIAPH1;LMAN1;VPS11;PAK2;STOX1;PRMT6;SAR1A;RHOT2;MARK2;TAOK1;ARHGEF5;VPS35;PARL;GOLPH3;MAPK15;SURF4;STX5;MAPK3;FIS1;MUL1;MFF;MAPK1;MAVS;EP300;RDX;TBC1D25;ARMH3;PDE4DIP;STX18;PLXNB1
prerank,regulation of blood circulation (GO:1903522),-0.2855539579766969,-1.0619744768047479,0.36065573770491804,0.8049833706779165,1.0,13/34,22.37%,CELF2;ADORA3;AGT;KCNMB2;TMIGD3;KCNJ12;KCNG2;BDKRB2;KCNQ1;PLN;KCNIP2;TBX2;DES
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.4105919040564736,1.0619520183790734,0.3988235294117647,0.695528774592941,1.0,5/28,9.58%,PRKCQ;PRKCD;NCK1;PRKCB;PTPN2
prerank,RNA transport (GO:0050658),0.3642833034960738,1.0618855990478513,0.39112050739957716,0.6953435633053476,1.0,27/71,30.08%,RFTN1;SIDT1;THOC1;NUP188;SRSF11;SRSF7;DDX39B;HNRNPA2B1;EIF4A3;TPR;CHTOP;THOC2;RAE1;TST;ATXN2;SRSF2;UPF3B;TGFBR2;POLDIP3;SRRM1;ARC;THOC6;EIF4E;SRSF1;NUP214;NXF1;RTRAF
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.43993955248642225,1.061743827395921,0.42336683417085424,0.695327530663469,1.0,10/19,32.21%,HNRNPC;EXOSC10;HNRNPU;TERF1;ACD;XRN1;NAT10;TENT4B;TERF2;DCP2
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.337195311984116,1.0615553819809782,0.281,0.6954465118182587,1.0,130/476,25.83%,IGF1;MDFIC;CTNNB1;CXXC1;SPP1;MITF;APOE;HIF1A;SKAP1;ZMIZ1;NIBAN2;ELF4;KMT2A;NFYA;CD4;LEF1;TBX21;DEAF1;ID2;EOMES;GDF6;IRF6;POU3F1;RNF14;NFIL3;FGF2;TFEB;HDAC4;PPARG;KLF6;RUNX1;GATA3;RNF6;TRIM28;SOX9;BRD4;EGR2;HDAC1;CDH1;TRIM16;NAA16;KDM3A;ILK;PPARD;BRCA1;NKX2-1;BAMBI;NEK4;RNF111;FGF7;PCBD2;TASP1;CREB3L2;ATF5;JUN;DNM2;ELF2;RHOG;MED17;TAF15;RAI1;ZKSCAN3;TFAP4;MAP3K12;NPAT;BLM;SMARCC1;SP100;MRPL12;FZD1;ZBTB16;ILF3;EHF;FZD4;IL31RA;DDIT3;NFKB1;LRP6;ACTA2;ARHGEF11;ING2;MED13;SERTAD3;FOXO1;PRMT2;ING5;MAP2K3;CAMK4;SP1;CNBP;WBP2;GTF2H1;IL6;YAF2;RNF20;FBXW11;ARID1B;EPO;VHL;ZXDC;RXRB;NPM1;RUNX3;BMP4;TEAD1;MAP2K2;ARNT2;F2R;RLF;NIF3L1;NSD3;AHR;EGR1;CD74;PITHD1;RXRA;XPC;SOX10;TNF;GLIS2;EDF1;ATF4;HDAC2;SMARCA4;SFRP1;NDP;NOTCH4;CREB5;MYRF;HCFC1
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.35834734181184236,1.0615077972965385,0.35550935550935553,0.6951811389203003,1.0,33/87,30.69%,CD44;FGF2;GRB2;HNRNPM;POLR2H;FGF7;CCL5;FGF20;DLL4;GTF2F1;FGF18;POLR2D;RBFOX2;CBL;HNRNPF;ITGB1BP1;SPRED2;FGFRL1;FGFR3;FGFR2;POLR2F;FLRT2;SFRP1;FGF1;DSTYK;KIF16B;MAPK3;SHOC2;NDNF;TIAL1;GALNT3;CEP57;MAPK1
prerank,negative regulation of cell motility (GO:2000146),0.35367185608116797,1.061199118345859,0.36548223350253806,0.6956197126461127,1.0,39/108,25.76%,MITF;RAP2A;DAG1;ADARB1;MCTP1;GTPBP4;CLDN19;JAG1;CLIC4;GATA3;STK24;DLC1;CDH1;IFITM1;NKX2-1;SERPINE1;FBLN1;CHRD;SMAD7;ARID2;ADAM15;CYP1B1;DUSP3;NF1;AFDN;SINHCAF;PIN1;BST2;RNF20;DACH1;SRGAP1;RNF41;WAS;CD74;MIF;MAPK15;SFRP1;CX3CL1;DNAI3
prerank,ethanol metabolic process (GO:0006067),-0.39662873515818065,-1.0609170567508466,0.39759036144578314,0.8048775873558619,1.0,4/12,22.29%,ACSS1;SULT1A1;ACSS2;ALDH1B1
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.4143840924384848,1.0608230710463484,0.3897316219369895,0.6962425012776612,1.0,11/26,31.26%,SRI;UBQLN1;ATP1A2;THADA;CALM3;TLR9;FKBP1B;DRD3;GSTO1;FKBP1A;CALM1
prerank,visual system development (GO:0150063),0.39757158463067194,1.0606182464489193,0.39637599093997733,0.6964072890532723,1.0,12/37,24.09%,SH3PXD2B;BLOC1S3;C3;HIPK1;SMG9;SMOC1;RBP4;CPAMD8;MEIS3;PBX1;PBX2;SIPA1L3
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.4106588451163539,-1.0603375558157333,0.3656716417910448,0.8033031942305855,1.0,3/10,15.80%,PDE3B;PDE4D;PDE2A
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.3866313866707831,1.0602875468682762,0.39144736842105265,0.6969004367611292,1.0,8/45,21.85%,SDCBP;BMP8B;GDF6;DAB2;RBPMS;BMP6;BMP5;BMP4
prerank,regulation of cardiac conduction (GO:1903779),0.3754334177258405,1.0599247417617184,0.4065573770491803,0.6974849669643921,1.0,20/54,30.03%,ASPH;ATP1B3;ATP2B1;NPPA;ATP1A4;ATP1A3;ATP1A1;NPR2;ATP1A2;FXYD4;ITPR3;NPPC;ATP2A2;FXYD1;CORIN;ATP1B2;FKBP1B;ITPR1;STIM1;NPR1
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.42668990405292867,1.0597481362675585,0.39902676399026765,0.6975851667206542,1.0,2/22,0.92%,STAP1;PLEK
prerank,protein phosphorylation (GO:0006468),0.3371765386441939,1.0595746732894376,0.283,0.6976802794869379,1.0,121/478,22.10%,FNIP2;FAM20C;FLT1;CDK14;LCK;PEAK1;CDK18;CDK6;PRKCH;ABL2;CDK8;PRKCQ;SGK1;FGR;TEC;SGK3;SGK2;SRPK1;ATP13A2;MAPK13;GDF6;MAP4K5;MAP4K2;DYRK2;PTK2B;PAK6;CDK5;PRKCD;TAOK3;ERN2;PDPK1;STK24;STK3;ERN1;SIK1;IKBKE;MAP4K3;RIOK2;COPS8;TXK;SBK1;PLK2;IGF1R;PRKCB;MAPKAPK3;ILK;RNASEL;PKDCC;MAPKAPK2;CSNK1G1;CDK13;STK32A;NEK4;FYN;COPS2;CDK17;HIPK1;PIM1;RSKR;JAK1;BIRC6;MAP3K12;CDK11B;LIMK1;GAS6;CDK2;SMAD7;PKN2;PAK2;ILF3;ROCK1;BIRC5;MAP3K1;CAB39;PRKD2;FASTK;DAPK1;CSNK1D;CAD;MAPK9;STK38;CDC7;SYK;HTATIP2;KDR;PLK4;MINK1;TLK1;RPS6KA2;DDR2;PRKAG1;CAMK4;STK11;RIPK3;NLK;NEK6;BAZ1B;DAPK3;GTF2H1;ATM;MEX3B;TP53RK;CSNK2A2;MAP3K9;TOP1;CDK16;PDK3;MAK;MARK2;LMTK2;GSK3B;PRAG1;SRPK2;MARK4;RUNX3;NIM1K;TAOK1;BMP4;ABI1;MELK;TRIB2
prerank,regulation of interferon-alpha production (GO:0032647),0.42390007115166917,1.059523189205976,0.3983152827918171,0.6974270086168755,1.0,11/23,35.30%,NLRC3;IRF5;HSPD1;DHX36;DHX9;HAVCR2;TLR9;TBK1;MAVS;SETD2;DDX3X
prerank,organophosphate ester transport (GO:0015748),0.42402908616183527,1.0594033079929281,0.40425531914893614,0.697372921959095,1.0,5/24,13.02%,OSBPL8;TRIAP1;PITPNC1;OSBPL2;PRELID2
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.34505474210394854,1.0593634481344336,0.34934934934934936,0.6970908244678243,1.0,38/190,17.10%,BCL2;ARHGAP25;BCL2L1;PLEK;NLRC3;PLAUR;TMSB4X;DAG1;HDAC7;TANK;XDH;TNIP1;MCL1;PIK3CB;MMP9;PPP2R5C;CAV1;CD22;NOC2L;TREM2;TNIP3;PRDM15;PLEKHA1;RACK1;SFRP5;NPRL2;RIOK3;ABCA7;DDIT3;ARHGAP12;RNF157;DUSP3;NF1;MYADM;MAP2K3;PIK3R2;ADIPOR1;DGKD
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.42380080896115196,1.059269726778776,0.40987654320987654,0.696985649436464,1.0,3/22,7.68%,SLC9A1;HTT;STAC2
prerank,phospholipid translocation (GO:0045332),0.4120358572738141,1.059059450566843,0.40442890442890445,0.6971823289178045,1.0,6/28,13.05%,ABCA1;PLSCR2;ATP8B4;ABCA4;ATP9B;ABCA7
prerank,mitotic spindle assembly (GO:0090307),0.38780574585282457,1.0590212284084537,0.3993174061433447,0.6969041007921033,1.0,14/42,25.42%,FLNA;MAP10;LSM14A;BCCIP;ABRAXAS1;RHOA;SMC3;RACGAP1;TOGARAM2;KIFC1;RAB11A;AAAS;STAG1;GOLGA2
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.3853704152774212,1.0588918001983292,0.39687848383500557,0.6969000362292838,1.0,19/45,31.01%,GCNT2;ZC3H7B;RBM4B;EIF2A;NOLC1;LARP4;LARP1;PUM1;TCOF1;ATXN2;EIF2B4;GEMIN5;CYFIP1;RC3H1;EIF4E;MTPN;NUDT21;PCIF1;PARP9
prerank,striated muscle contraction (GO:0006941),0.3761850561121291,1.058879932860726,0.39740820734341253,0.6965572752241911,1.0,10/53,16.28%,TNNT3;ALDOA;CSRP3;GAA;STAC2;SCN1B;DTNA;ARHGEF11;ATP1A2;SCN3B
prerank,phosphate ion transmembrane transport (GO:0035435),0.4871618667083121,1.058876468107563,0.41509433962264153,0.6961917664856765,1.0,6/12,25.43%,SLC37A2;SLC25A3;SLC25A14;XPR1;SLC20A1;SLC37A3
prerank,regulation of sensory perception of pain (GO:0051930),0.49132292744392203,1.0587256805300294,0.41152815013404825,0.6962156002483159,1.0,5/11,22.71%,ZFHX2;MGLL;ACP3;VIP;F2R
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.40695832467296644,1.0583416504417913,0.39247943595769685,0.6968189406390857,1.0,12/30,28.82%,MACF1;OPTN;GOLGA4;GCC2;GGA2;VAMP4;VAMP2;GOLPH3;GGA1;GOLPH3L;RAB31;ARFRP1
prerank,lipid phosphorylation (GO:0046834),0.5004178735327588,1.0580661214838458,0.40431266846361186,0.697175434013259,1.0,4/10,17.10%,DGKZ;DGKA;DGKH;DGKD
prerank,regulation of protein kinase A signaling (GO:0010738),-0.337438243685945,-1.0577913408407846,0.35294117647058826,0.8081474417133409,1.0,6/20,11.54%,LRRK2;ADGRV1;AKAP6;PRKAR2A;AKAP12;PRKAR2B
prerank,regulation of epithelial cell migration (GO:0010632),0.3737243424796033,1.0576850518854881,0.4079822616407982,0.6978127577018519,1.0,7/51,6.78%,HIF1A;CORO1C;SASH1;MACF1;GLIPR2;PTPN23;SOX9
prerank,positive regulation of protein ubiquitination (GO:0031398),0.35846387591995454,1.0576424956736086,0.3881856540084388,0.6975491134211299,1.0,32/80,29.58%,MALT1;SPHK1;FBXW7;PRICKLE1;CAV1;ANGPT1;UBE2L3;RPS2;BRCA1;HUWE1;SMAD7;DCUN1D2;CENPX;UBQLN1;DERL1;WFS1;PIN1;BMI1;CUL3;DCUN1D4;LAPTM5;ARRDC4;BIRC2;DCUN1D3;HDAC3;CENPS;PSMD10;KDM1A;GSK3A;PTTG1IP;FKBP1A;RCHY1
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.41479663900944336,1.057642002734489,0.4110718492343934,0.6971738274254552,1.0,9/27,22.54%,AGO2;EIF4G1;EIF4ENIF1;EIF4E2;PUM1;IL6;DHX9;BMP4;MAP2K2
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.4695579019139543,1.05754800115506,0.41970310391363025,0.6970479012820446,1.0,8/13,32.16%,AXL;GAS6;DHX9;AGPAT2;CD74;AGPAT1;MAVS;IL7
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.4145318127322472,1.0572724347085,0.3943990665110852,0.6973682358961404,1.0,2/26,1.06%,MMP8;P2RX4
prerank,cellular response to reactive oxygen species (GO:0034614),0.37298716198563253,1.05720948067184,0.4038668098818475,0.6971672960880491,1.0,23/59,29.44%,SIRPA;NFE2L2;ANXA1;PRDX5;MAPK13;MMP9;PRKCD;PLEKHA1;AGAP3;JUN;CYP1B1;MAPK9;RIPK3;IL6;RPS3;MAPK7;PDGFRA;NCF1;TNFAIP3;RIPK1;MAPK3;PRDX3;SIRT1
prerank,cellular response to growth factor stimulus (GO:0071363),0.3450349516180796,1.05693325870328,0.37829614604462475,0.6974718927362333,1.0,40/151,23.96%,IQGAP1;FLT1;CTNNB1;ANXA1;CD44;CILP;SPHK1;NRP1;HSPB1;EEF1A1;PDPK1;ERN1;SOX9;VEGFA;CRKL;MAPKAPK2;RACK1;PTPN12;CCL5;DLL4;SMAD7;CPNE3;PRKD2;DUSP3;APPL2;KDR;MAP2K3;BMP6;ITGB1BP1;NR3C1;MT1G;SYAP1;BMP4;MAPK7;TGFBR2;STAT5B;EHD1;KIDINS220;WWOX;MAP2K5
prerank,organelle fission (GO:0048285),0.41973358239730635,1.0565929225047932,0.4094775212636695,0.6980119974204467,1.0,12/24,32.07%,CORO1C;WASHC5;DNM2;MTFP1;MTFR2;MTFR1;ACOT8;PEX19;FIS1;MUL1;MFF;PEX11G
prerank,positive regulation of ATPase activity (GO:0032781),0.38694924469036523,1.05614731598793,0.40225988700564974,0.6988249659687473,1.0,13/41,26.35%,TNNT3;ATP1B3;TOR1AIP2;CHTOP;DNAJB1;HNRNPU;DHX9;DNAJC9;SETMAR;PFN1;DNAJC10;MYL4;ATP1B2
prerank,plasma membrane invagination (GO:0099024),-0.299160243363469,-1.0560000000711627,0.3424657534246575,0.8102891038998216,1.0,6/29,6.57%,ELMO1;ITGAM;BIN2;SPIRE1;AIF1;FCGR1A
prerank,ether lipid metabolic process (GO:0046485),0.46840944644505134,1.0559716138087476,0.4070221066319896,0.6989018922382172,1.0,3/14,6.15%,NCEH1;PLAAT3;PEDS1
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.5061563749589293,1.0555832534959113,0.43091655266757867,0.6995479818257669,1.0,1/10,0.92%,PLEK
prerank,receptor-mediated endocytosis (GO:0006898),0.3440478294155007,1.0555648764037118,0.4004085801838611,0.6992187537699258,1.0,31/132,19.39%,COLEC12;CD9;APOE;LRP1;IGF2R;FPR2;CXCR2;CAV1;DAB2;GRB2;HPR;HP;TPCN2;LILRB1;GAK;AP4E1;PIP5K1C;DNM2;MASP1;CLN3;CXCL16;LRP6;ITGB2;AP1G1;SYK;TFRC;HSPG2;HIP1R;JCHAIN;FCER1G;PIKFYVE
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.47533839579138326,1.0554521135255683,0.3900523560209424,0.699148547814164,1.0,4/12,19.58%,IL18R1;IL12RB1;CCR2;SLC11A1
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.4787080654765449,1.0552340487580758,0.42265193370165743,0.6993516741785194,1.0,6/12,35.95%,CAV1;SRI;CALM3;CALM1;GJD3;CAMK2D
prerank,glycerophospholipid metabolic process (GO:0006650),0.3608477191116635,1.0550656360916273,0.40396659707724425,0.699409032979971,1.0,17/75,16.55%,PLEK;GDPD3;PRDX6;PON1;ABHD12;PIGQ;PIGZ;PIGA;PLCB2;SMPD4;CLN3;PIGN;CPNE3;PIGL;PIGC;DGKH;PNPLA6
prerank,peptide catabolic process (GO:0043171),0.42142169349276876,1.0548736005318948,0.4126794258373206,0.6995306214900004,1.0,2/23,3.64%,ANPEP;ADAMTS13
prerank,chromatin organization (GO:0006325),0.3476070513302185,1.0548486292327095,0.38143289606458125,0.6992278767799878,1.0,51/132,31.40%,NUDT5;HDAC4;DAXX;FAM47E;SOX9;SATB1;HDAC1;BPTF;MTF2;NPM3;HMGN1;HIRIP3;SMARCB1;HP1BP3;MYSM1;SMARCC1;PHF1;INO80;KDM4D;BAZ1B;ATRX;CBX3;DR1;EHMT1;GATAD1;TOP1;TCF7L1;NPM1;SMARCD2;HDAC11;HDAC2;SMARCA4;KDM5C;BAZ1A;MCM3AP;HDAC3;HCFC1;PIH1D1;SETDB1;SUPV3L1;SUPT4H1;RUVBL2;RSF1;SAFB;SIRT1;PBRM1;HMGB2;SUV39H2;SATB2;HMGN2;ZBTB1
prerank,sphingosine metabolic process (GO:0006670),0.4499602968023941,1.054780168910946,0.41604010025062654,0.699015258146105,1.0,3/17,6.48%,SPHK2;SPHK1;PLPP3
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.3755572069589554,1.054626371648718,0.3959007551240561,0.6990585309642036,1.0,21/59,29.43%,NLRC3;UBA52;IRAK2;TANK;TRAF2;RPS27A;TAB1;TICAM1;SHARPIN;ROCK1;NKIRAS2;TBKBP1;UBC;REL;TNF;BIRC2;TLR9;TBK1;RIPK1;AZI2;TAB2
prerank,vitamin D metabolic process (GO:0042359),0.47025732356494665,1.0544534071440201,0.4090909090909091,0.6991447079920208,1.0,2/13,4.08%,CYP27B1;VDR
prerank,smooth muscle contraction (GO:0006939),0.4767423867516291,1.0544232013532313,0.42337662337662335,0.6988515095891136,1.0,6/14,19.24%,CHRNB2;EDNRA;TPCN2;ROCK1;ACTA2;MYH11
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.36377475304592183,1.0540996394721904,0.40274841437632136,0.6993374239382577,1.0,20/69,25.02%,SNAPC1;POLR2H;SNAPC2;GTF2A2;INTS14;ELL2;GTF2F1;POLR2D;INTS2;INTS6;TBP;SP1;RPRD1A;CCNT2;TAF6;SNAPC4;GTF2E2;INTS7;POLR2F;POU2F1
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.2364738025864137,-1.053844128982959,0.2553191489361702,0.8134254624142278,1.0,19/79,11.18%,LGMN;CTSS;DYNC1I1;SH3GL2;AP1S2;MFSD6;DYNC1LI1;KIF3C;KIF15;SAR1B;KIFAP3;AP1B1;CTSF;ARF1;SPTBN2;KIF4A;FCGR2B;ACTR1A;KIF23
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.33826049631228133,1.0537775705257508,0.34,0.6998108785067158,1.0,103/314,28.90%,CTNNB1;PSMD8;NFE2L2;PSMD1;FBXL17;UBA52;TBX21;RPS27A;DERL3;KCTD17;FBXW7;ANAPC15;EDEM1;NHLRC1;PPP2R5C;SIAH2;DNAJB14;ZFAND2A;STT3B;SPSB2;ATXN3;FZR1;FBXO5;FBXO31;PSMD6;PSMA1;AGAP3;FBXW4;PLAA;VCP;SEC61B;DDB1;CCNB1;NHLRC3;PSMC3;UBE4A;HUWE1;DNAJB9;PSMA8;SHARPIN;UBXN4;CDK2;ANAPC1;PSMD14;KCTD10;PSMD2;DDIT3;UBQLN1;BFAR;ZSWIM8;DERL1;FBXL19;PSMC6;PSMA6;RNF121;RMND5B;WFS1;PSMD5;UBE4B;PSMA5;CDC26;UBR2;FBXL6;CUL3;SPSB3;BUB1B;UBC;FBXW11;CUL1;FBXW5;RNF216;CDC34;CUL2;DNAJC10;ANAPC7;PSMA3;MDM2;TRIM72;BIRC2;PSMB8;HSPA5;PSMB10;CUL4A;PSMD7;USP19;PELI1;UBE2C;PSMB6;ECPAS;ERLIN1;BTRC;KCTD2;PSMD10;GSK3A;PSMB5;TRIM3;DNAJB12;OS9;PSMB7;WWP2;HSP90B1;ERCC8;FAF1
prerank,cellular lipid catabolic process (GO:0044242),0.4039823929015037,1.053622610603755,0.40048543689320387,0.6998237737094046,1.0,9/27,24.20%,CEL;APOA2;ABHD12;PPARD;CYP1B1;PLBD2;ACADL;ACBD5;LPIN3
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.49233771327133974,1.0535037656649904,0.43766937669376693,0.6997596587075638,1.0,3/11,11.96%,PLAUR;MMP9;GSN
prerank,positive regulation of ossification (GO:0045778),-0.27728820985911534,-1.0534390869885402,0.3392857142857143,0.8114571281954562,1.0,5/39,3.29%,MEF2C;TMEM119;ALOX5;ACVR2B;BMPR1B
prerank,regulation of actin filament bundle assembly (GO:0032231),0.4161500545193328,1.0533654107712918,0.4147196261682243,0.6997443865585053,1.0,13/26,31.48%,PLEK;SLC9A1;ACTG1;LIMK1;CDC42;ROCK1;PTGER4;WAS;PFN1;CX3CL1;ALMS1;SYNPO;RDX
prerank,embryonic hemopoiesis (GO:0035162),0.4774775326014521,1.0529842041127253,0.4007989347536618,0.7003769462503096,1.0,5/12,24.57%,KMT2A;KITLG;KDR;TGFBR2;ATF4
prerank,regulation of lamellipodium assembly (GO:0010591),-0.2905542462797134,-1.052522898626257,0.3559322033898305,0.8109182232321529,1.0,6/34,4.91%,WASF2;PIK3R1;ABI3;FER;TWF2;NCKAP1
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.5046776941828963,1.052404215973439,0.44677871148459386,0.7011606554396518,1.0,3/10,9.53%,SPHK2;PRKCD;RACK1
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.5046776941828963,1.052404215973439,0.44677871148459386,0.7011606554396518,1.0,3/10,9.53%,SPHK2;PRKCD;RACK1
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.34406372795632734,-1.0522892963957802,0.3695652173913043,0.8082725799449346,1.0,3/16,8.24%,LRRK2;UBAC2;TAPT1
prerank,regulation of cholesterol metabolic process (GO:0090181),0.44024288730713573,1.0521119437692923,0.41585365853658535,0.701569731763489,1.0,6/20,21.69%,APOE;ARV1;LPCAT3;MBTPS2;SREBF1;ACADL
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.32896234049008816,1.0520296445496327,0.175,0.7014238189456543,1.0,451/1668,25.90%,IGF1;FNIP2;LITAF;CTNNB1;MITF;APOE;UXT;HIF1A;IKZF3;ZHX2;SKAP1;DNMT3A;CSRNP1;ZMIZ1;TCF7;MMP12;ATF3;SDCBP;CDK8;MRTFA;TOX2;ELF4;SLC9A1;FOXN1;KMT2A;NFYA;NFIC;NFE2L2;ARID5B;LEF1;HDAC9;ZNF697;UBA52;AGO2;TBX21;MYBL2;DEAF1;RPS27A;BCL11B;TNIP1;MAFF;RCOR1;JMJD1C;MUC1;ANXA4;ID2;STAT4;EOMES;SOX3;IRF6;TCF15;OVOL1;SEBOX;HOXA4;POMC;SOX30;NR4A3;FSTL3;TBX18;VDR;NCOR2;MEF2D;SIX5;RPS14;DOT1L;POU3F1;RNF14;SQSTM1;TGIF1;NFIL3;FGF2;MNT;CSRP3;CC2D1A;CIC;TFEB;HDAC4;CAV1;PPARG;JAG1;SHOX2;NCK2;FOXJ1;MYDGF;ZFHX2;ZMIZ2;NOC2L;KLF12;KLF6;RUNX1;CCNL1;BCL6;ZKSCAN4;DAB2;MED15;RPL23;GATA3;CUX1;ZBTB42;HR;RFX5;TRIM28;ZBTB7B;SOX9;NCK1;BRD4;VEGFA;SATB1;EGR2;PPP1R12A;HDAC1;BPTF;NFX1;TOX4;TXK;HES7;ZBTB2;PEX2;KMT5A;TRAK1;BHLHE40;MED21;PRKCB;ATXN1;ZNF395;MTF2;RHOQ;MDFI;ZNF160;TNIP3;PRDM15;CHD3;DDX17;KDM3A;BHLHE41;PPARD;USP9X;LILRB1;E2F3;IRF8;MIDEAS;THAP7;RNASEL;HOXA7;CCNC;LRRFIP1;BRCA1;NKX2-1;CDK13;TET3;OTP;AEBP1;ZFX;CCNB1;SS18L2;BAX;RNF111;PSMC3;JUP;KLF13;CPEB3;ASXL2;POU2AF1;IRX5;SMARCB1;FOXP4;CREB3L2;MEF2B;CCNL2;ATF5;CRTC1;JUN;KTI12;SUDS3;NFE2L1;NRF1;FOSB;ZNF148;TRIAP1;VRTN;ELF2;ENO1;MAML2;CEBPA;TADA1;SERPINE1;MED17;GATAD2B;RNF2;IRF5;DLL4;ARID4B;MRTFB;ZFP41;DACH2;RAI1;MYSM1;TNIP2;GBX1;ZKSCAN3;ASCL4;ZNF83;SLC30A9;ZBTB34;NAMPT;MRGBP;ZNF569;TLE5;ZSCAN12;KDM3B;MAFG;TFAP4;HNRNPK;ZFP64;NUPR2;NPAT;PPARGC1B;SAFB2;SMARCC1;SP100;ZBTB16;OGT;ELK4;SMAD7;CHCHD2;GATAD2A;GTF2F1;EFNA1;FOXJ3;SMAD1;H1-0;MAFK;YY1;EHF;ACTR3;NFYB;EED;DCN;MGA;ETV6;DDIT3;PRRX1;NFKB1;INO80;PRKD2;PAXBP1;LRP6;HSPD1;TCF25;SP7;SSBP4;FBXL19;TPR;HELZ2;DEK;PCBP1;NHLH2;ASXL1;SRF;MED13;ZBTB40;CEBPG;ECD;C1QBP;FOXO1;MYT1;MTF1;NR4A2;PLAC8;ELK3;ZNF296;HTATIP2;DHX36;CHD5;GMEB2;HOXC5;NPAS4;MED29;PIK3R2;SARS1;BMP6;GMEB1;SRCAP;SMYD2;PRPF6;DMRTA2;AKIRIN1;ZBTB25;WFS1;RCOR3;DNAJB1;SBNO2;TCF12;SERPINF2;SP1;TOX;HNRNPU;CNBP;PURA;WBP2;BAZ1B;GABPB1;GABPB2;PAF1;ATRX;HAX1;GTF2H1;KAT7;PIN1;ATM;RPRD1A;BMI1;USF2;IL6;CBX2;DHX9;ITGB1BP1;DNMT3B;ZNF177;DR1;ZBTB6;LYAR;MIER2;TAF7;CCNT2;PHF20L1;AGO3;TAF6;HOXB4;NR3C1;SLC11A1;ZBTB39;PIAS1;SP9;BMP5;ARHGEF2;TCF7L1;HMGB1;UBC;DACH1;TMF1;JDP2;NFATC3;MTDH;SPIB;SREBF1;VPS72;SSU72;PRDM6;YEATS2;ARID1B;MEIS3;SOD2;CHD2;EIF5A;ZFP57;EPO;VHL;RFXANK;TCF24;NLRC5;HOXC9;ZNF18;PBX1;ZXDC;RXRB;HSF1;NPM1;PRKAR1A;RUNX3;ETV4;BMP4;TEAD1;SENP1;CIAO1;GLYR1;ID1;ATAD2B;SUFU;ELP3;WAS;CALR;ZBTB43;KLF11;ARNT2;PPRC1;RLF;PRRX2;SMARCD2;MAPK7;NIPBL;SP110;MED7;AHR;EGR1;ZBED3;ZNF568;STAT5B;CREBZF;PBX2;KMT2D;REL;TARBP1;LHX4;RXRA;WWOX;DCAF6;ZSCAN22;FGFR2;MAP2K5;E2F6;ZBTB4;MDM2;USP2;SOX10;LPIN3;ZSCAN20;MTA3;TNF;GLIS2;PPP3R1;SUMO1;PLK3;GADD45A;ATF4;HDAC2;ZGPAT;ATN1;GTF2H5;CDK4;MCPH1;SMARCA4;POU2F1;RRP1B;KANK2;GRHL1;CX3CL1;FGF1;MED6;BAZ1A;NOTCH4;CREB5;CSRNP3;DPF3;TFCP2;HDAC3;PIAS4;HCFC1;LAGE3;HIC2;TLR9
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.3964733814170178,1.0518250304939758,0.42491657397107896,0.7015627542960143,1.0,19/37,33.78%,UBA52;RPS27A;ERCC1;DDB2;DDB1;XPA;ERCC4;RFC1;GTF2H1;UBC;RFC2;GTF2H5;CUL4A;POLD4;ERCC2;RFC4;UBB;RFC5;PCNA
prerank,transcription by RNA polymerase II (GO:0006366),0.3353526157323387,1.0516961588131388,0.358,0.7015244457132667,1.0,116/305,32.31%,ERCC6;NFYA;NFIC;HDAC9;HDAC7;DEAF1;NPPA;NR4A3;VDR;NCOR2;MNT;PPARG;DDX21;SNAPC1;TAF4B;ZBTB7B;HDAC1;NOCT;NFX1;POLR2H;BTF3;PAPOLA;SNAPC2;GTF2A2;NRBF2;PPARD;E2F3;PABPN1;CDK13;KLF13;COPS2;AFF4;TBPL1;MAML2;MED17;TAF15;INTS14;ELL2;GTF2F1;PIR;YBX2;POLR2D;PRRX1;NFKB1;ELOF1;DEK;INTS2;NR4A2;SYMPK;GMEB2;INTS6;HSF2BP;C5AR1;EAF1;TBP;ELOB;SP1;PAF1;GTF2H1;RPRD1A;TAF7;CCNT2;RNMT;TAF6;NR3C1;MLLT1;TSC22D1;SSU72;TRIP13;CPSF7;TRIM24;RXRB;TAF1A;TEAD1;SNAPC4;GTF2E2;TAF1C;MED7;RXRA;INTS7;SNRPG;POLR2F;ATF4;GTF2H5;POU2F1;SNRPF;NOTCH4;TFCP2;HDAC3;NR6A1;SNW1;NR2C2AP;SUPT4H1;CSTF2;CTR9;MNAT1;PAX5;NUDT21;MED1;RXRG;MAZ;LEO1;MED27;CCN2;LSM11;CLP1;NABP1;ZBTB1;TCEA1;ERCC2;XBP1;NR4A1;RARG;CREBBP;NELFA;TAF5L
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.4603548908021449,1.051564678739497,0.4280104712041885,0.7015077634342337,1.0,7/14,23.08%,NR4A3;LILRB1;TICAM1;GPRC5B;CAMK4;LAPTM5;CD74
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.4120599292227214,1.051427234800098,0.40348837209302324,0.7014878626869095,1.0,11/29,25.49%,UBA52;RPS27A;DDB2;DDB1;XPA;GTF2H1;UBC;XPC;GTF2H5;CUL4A;CETN2
prerank,negative regulation of innate immune response (GO:0045824),0.3927249563347357,1.0513150575360446,0.4280742459396752,0.7014313261698608,1.0,13/34,22.13%,NLRC3;A2M;TTLL12;PTPN2;METTL3;YTHDF3;RPS19;ACOD1;YTHDF2;USP18;LYAR;NLRC5;TRIM21
prerank,establishment of apical/basal cell polarity (GO:0035089),0.45692544855448847,1.051191151464012,0.39974293059125965,0.7014136420683321,1.0,7/14,20.06%,RAP2A;MSN;FOXJ1;RHOA;CDC42;PATJ;MYO9A
prerank,modulation by host of symbiont process (GO:0051851),0.4004865021650419,1.0510051031805139,0.4177362893815636,0.701520908909309,1.0,11/31,19.20%,LEF1;CCL4;NAPEPLD;HDAC1;SMARCB1;JUN;CCL5;SAP30BP;TFAP4;SP1;TARDBP
prerank,protein localization to chromosome (GO:0034502),0.39489024187742394,1.0509777578953743,0.40159271899886234,0.7012098682094597,1.0,15/34,31.47%,TNKS2;FAM47E;WAPL;LEMD2;CHMP7;PARP3;ATRX;MCM8;ACD;TPP1;CENPA;TERF2IP;ATR;XRCC5;TERF2
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.5042255748683913,1.0508640367758155,0.4105409153952843,0.7011406876405245,1.0,5/10,25.15%,ACAD11;GCDH;ACADS;ACADL;ACADM
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.4044787981321127,1.0508387409796114,0.4106280193236715,0.7008334020279825,1.0,4/27,7.62%,SLC27A1;PLAAT3;NAPEPLD;CHKB
prerank,negative regulation of calcium ion transport (GO:0051926),-0.36453145704571166,-1.0503232936590166,0.36633663366336633,0.8111778414398807,1.0,7/15,20.81%,CD33;SLC30A1;TRIM27;NOS1;INPP5K;PLN;ADRA2A
prerank,positive regulation of potassium ion transport (GO:0043268),0.3817824564798973,1.0502821139056449,0.40203850509626277,0.7019020934706585,1.0,11/38,20.79%,FLNA;KCNN4;KCNJ2;AMIGO1;KCNMA1;KCNMB4;KCNJ10;GNB1;ACTN2;KCNJ6;KCNJ15
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.5015094373614327,1.0499337868248897,0.43337819650067294,0.7024218350502245,1.0,5/10,25.17%,PRKCQ;ZBTB7B;CD55;TGFBR2;NCKAP1L
prerank,response to glucagon (GO:0033762),0.43031781667842883,1.0498527387239263,0.44375,0.7022609058408957,1.0,3/19,4.21%,ADCY8;ADCY3;ADCY7
prerank,regulation of innate immune response (GO:0045088),0.3729181945142447,1.0496300981362985,0.4064864864864865,0.7024478079219307,1.0,27/57,31.01%,FPR2;NLRC3;FGR;ADAM8;PTPN22;TREM2;RNASEL;POLR3D;RIOK3;CCL5;ACOD1;APPL2;TIRAP;USP18;DHX9;LYAR;HSP90AB1;TRIM21;BIRC2;PTPN6;IFNAR2;TNFAIP3;TKFC;MUL1;PTPN1;PLSCR1;PARP9
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.35394466011829767,1.0486138906770075,0.4171907756813417,0.7047488777647681,1.0,31/76,30.81%,NLRC3;TMSB4X;IRAK2;ANXA4;TRAF3;OTULIN;FOXJ1;ERBIN;DAP;DDIT3;CYP1B1;ACOD1;PRMT2;CHP1;HAVCR2;PTGIS;NLRC5;RWDD3;TRIM21;CCDC22;MAP2K5;AIM2;TLR9;PSMD10;UFL1;TNFAIP3;FAF1;PYDC1;SIRT1;TRIM37;MTURN
prerank,regulation of metal ion transport (GO:0010959),0.46184004123088085,1.0486027214975449,0.42839195979899497,0.7044106502671891,1.0,3/16,9.82%,BCL2;CD4;SRI
prerank,positive regulation of defense response to virus by host (GO:0002230),0.41567199211970346,1.0484330691718287,0.41656662665066024,0.7044691731572785,1.0,5/24,13.22%,TRIM6;IL12RB1;PTPN22;LILRB1;ZDHHC1
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.4813125207894833,1.048396612121,0.4155495978552279,0.7041946239996245,1.0,4/11,12.80%,FBXO5;GMNN;ZRANB3;BLM
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.33524037368944126,1.0478083872398383,0.35435435435435436,0.7053234095684765,1.0,84/327,23.39%,APBB2;CXXC1;MITF;HIF1A;ZMIZ1;TCF7;NFYA;PRKCQ;TBX21;MYBL2;JMJD1C;SOX3;RNF14;PAK6;NFIL3;PERM1;TFEB;DAXX;PPP2R1A;RNF6;MSL3;NFX1;GON4L;BHLHE40;ATXN1;UBE2L3;ZNF395;MTF2;FADS1;CHD3;THAP7;FOXN3;SOX7;PRMT5;COPS2;ATF5;DNM2;NAB2;CEBPA;SBNO1;HP1BP3;TGFBRAP1;CARM1;CDK11B;PPARGC1B;PHF1;NFYB;DDIT3;ING2;SERTAD3;MYT1;PSPC1;MYBBP1A;GLRX2;UTP4;PPIE;SBNO2;SP1;NLK;CNBP;GPBP1L1;DAPK3;ATRX;GCFC2;KAT7;CCAR2;CCAR1;YAF2;NR3C1;TCF7L1;RNF20;VHL;RALY;RUNX3;SUFU;CALR;ACTN4;ARNT2;NIF3L1;PRRX2;NSD3;AHR;ASCC1;KMT2D
prerank,protein localization to kinetochore (GO:0034501),0.46635095818669786,1.0474170886905518,0.43443708609271525,0.7059381129438704,1.0,5/14,22.61%,CHAMP1;CENPT;IK;KNL1;SPDL1
prerank,positive regulation of catabolic process (GO:0009896),0.36337893932749615,1.0473908246089882,0.4044823906083244,0.705627945176284,1.0,16/65,15.90%,ATG7;APOA2;C4BPB;C4BPA;SEC22B;PLK2;FZR1;VCP;DDB1;OAZ3;RAB7A;HUWE1;TIPARP;VIP;FOXO1;BARD1
prerank,protein kinase B signaling (GO:0043491),0.41723336889279217,1.04733111353057,0.4082125603864734,0.7054083933354282,1.0,4/23,16.15%,IGF1;CCL5;GAS6;KDR
prerank,central nervous system development (GO:0007417),-0.2210446266201595,-1.0469244464397134,0.0,0.8185303389096257,1.0,48/250,10.29%,ZFHX3;CX3CR1;ITGAM;ADGRL3;PHF8;GRIN2A;ROGDI;PBX3;SERPINI1;SH3GL2;ADAM22;SLC8A3;VCAN;CNTN4;EML1;COX7B;SOX8;IL1RAPL2;DSCAML1;PTS;GRIN2B;TBX6;NCKAP1;CNTN6;PAX8;STAT3;CDH2;UBE3A;NDRG4;DHX30;NPAS2;NNAT;CNTNAP2;ADGRG1;NDUFS4;HAP1;PRKN;PAFAH1B2;MARCKS;SH3GL3;ACAN;DNER;ROBO2;PAFAH1B3;ZIC4;MEIS1;DDIT4;APOD
prerank,regulation of nervous system development (GO:0051960),0.3913488137225372,1.0466097033973605,0.43665158371040724,0.7068769917969854,1.0,9/37,15.52%,CTNNB1;HES7;BHLHE40;BHLHE41;TNFRSF1B;GBX1;PRUNE1;YTHDF2;DOCK7
prerank,protein neddylation (GO:0045116),0.4693427246780515,1.046550569218604,0.4238156209987196,0.7066516784270808,1.0,6/13,28.77%,RNF7;UBE2F;DCUN1D2;DCUN1D4;DCUN1D3;UBA3
prerank,presynaptic endocytosis (GO:0140238),-0.31816722331646646,-1.0464501936940542,0.38271604938271603,0.8166067935725065,1.0,5/24,6.31%,OPHN1;NLGN1;AMPH;SYT1;SYT2
prerank,axonal transport (GO:0098930),0.3867765737110557,1.0464053052702322,0.4061784897025172,0.7066298354619198,1.0,10/36,20.19%,HIF1A;BLOC1S3;MGARP;DYNC1H1;DTNBP1;DCTN1;KIF1A;AP3D1;DST;FBXW11
prerank,autophagosome assembly (GO:0000045),0.3721097855562618,1.04634082092556,0.39978094194961666,0.7064123514424631,1.0,25/52,32.70%,ATG7;RUFY4;TRAPPC8;PACS2;WDR45;TMEM41B;RAB7A;MAP1LC3B;UBQLN1;RAB1A;ATG16L1;ATG2B;MAP1LC3A;GABARAP;ATP2A2;ATG3;ATG13;AMBRA1;RAB43;TP53INP2;BECN1;ATG16L2;VMP1;UBQLN2;ATG5
prerank,neural crest cell migration (GO:0001755),0.39145908664850915,1.0462112784346362,0.4242081447963801,0.7063741377520317,1.0,4/36,7.35%,FN1;CORO1C;NRP1;ANXA6
prerank,inorganic cation transmembrane transport (GO:0098662),0.33490745722820886,1.0458486079861444,0.3813813813813814,0.7069234069785383,1.0,46/268,16.28%,CACNA1A;TRPC4;P2RX4;MCOLN2;SLC9A1;SLC6A6;SLC24A4;ATP6V1A;KCNN4;ATP1B3;KCNK13;SLC6A19;SLC6A14;LRRC52;SCN4A;ASIC3;ATP6V0D1;KCNA3;UCP2;SLC36A3;KCNJ2;SLC6A8;CCDC51;SLC6A7;SLC9A8;SLC46A1;ATP1A4;ATP1A3;ATP1A1;SLC6A4;KCNA4;SLC39A6;SLC39A7;ATP6V1F;SCN1B;CACNA1D;GAS6;KCNJ10;SLC25A14;SLC9A7;SLC9A6;TRPM7;ATP1A2;MCOLN3;KCNH8;SCN3B
prerank,primary miRNA processing (GO:0031053),0.49457581265803396,1.0445129774119664,0.42265193370165743,0.7099957747901747,1.0,3/10,14.15%,METTL3;SMAD1;HNRNPA2B1
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.37458917150410764,1.0440179773524714,0.43544857768052514,0.7108820130348187,1.0,17/50,28.43%,PLAUR;CD44;MMP9;RAF1;SIAH2;VEGFA;TRIAP1;GAS6;PAK2;USP47;MAP2K5;TNF;GPX1;PIH1D1;NOL3;FNIP1;DNAJB6
prerank,chordate embryonic development (GO:0043009),0.3696943530188745,1.043764647573007,0.422271223814774,0.7111664457267705,1.0,6/55,9.47%,XYLT1;KIAA1217;DEAF1;GATA3;VEGFA;BRCA1
prerank,glucose transmembrane transport (GO:1904659),0.43710926780747705,1.0436706762764147,0.43647798742138366,0.7110493181478055,1.0,6/18,21.90%,SLC5A1;SLC2A1;PPARD;SLC2A8;SLC5A3;SLC2A6
prerank,mRNA processing (GO:0006397),0.3335785414931455,1.043611595471589,0.37537537537537535,0.7108382908248427,1.0,107/287,28.92%,SNRNP35;CD2BP2;HNRNPA3;HNRNPUL1;ZRSR2;SNIP1;SF3B3;ERN1;HNRNPM;RBM4B;THOC1;CELF1;POLR2H;PAPOLA;HNRNPC;SON;PABPN1;PABPC1;DNAJC8;METTL3;CHERP;SYF2;SRSF11;PRPF4;SMNDC1;PRCC;SRSF7;HNRNPK;RBM19;HSPA8;GTF2F1;DDX39B;SYNCRIP;HNRNPA2B1;EIF4A3;POLR2D;LSM6;RBM15;PUF60;SART1;WBP11;PCBP1;NOVA2;SYMPK;PNN;CHTOP;PSPC1;THOC2;RBM15B;PRPF6;PPIE;HNRNPU;HNRNPF;GCFC2;GTF2H1;UBL5;RPRD1A;IK;KIN;CWC22;DHX9;SNRNP40;CCAR1;ZMAT5;RNMT;SRSF2;CTNNBL1;ZMAT2;SNRPB2;CPSF7;RALY;PRPF8;SMU1;UPF3B;SF3A3;LSM4;SNU13;RBM22;POLDIP3;SRRM1;SNRPG;SF3B2;SF3B1;POLR2F;HNRNPL;GTF2H5;GEMIN2;SNRPF;LSM3;SNW1;GEMIN5;PRPF40A;SNRPA;SF3B5;THOC6;PPIH;FUS;SUPT4H1;CSTF2;SRSF1;MNAT1;PPIL3;SRSF10;DDX41;NUDT21;WBP4;TRA2B
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.4490246323219855,1.0435237316444734,0.43796526054590573,0.7107071216207204,1.0,3/16,4.62%,PDGFA;NR4A3;NRP1
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.3913592019151897,1.043351912576062,0.42565266742338254,0.7108175320505326,1.0,5/35,5.42%,FLT1;APOE;XDH;CAV1;PPARG
prerank,telomere maintenance (GO:0000723),0.3739263394536798,1.0432994959190716,0.4068522483940043,0.7105767242366823,1.0,27/50,37.71%,NSMCE2;RAD50;BLM;SP100;ERCC4;PARP3;ATM;RTEL1;TPRKB;PTGES3;TERF1;ACD;TERT;SMC6;TERF2IP;POLD4;ATR;XRCC5;TEP1;TERF2;HUS1;PCNA;RAD51;RIF1;RAD51D;CTC1;TINF2
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.48689861541273793,1.0431732662479674,0.44413793103448274,0.7105232893738904,1.0,3/10,11.65%,ADAM17;CCR2;CCL5
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.37263594117595067,-1.0431523091222246,0.3765182186234818,0.8235428537881514,1.0,4/13,11.67%,GLUD1;GLUL;ASPA;GAD1
prerank,cellular macromolecule catabolic process (GO:0044265),0.36729942158328943,1.0425938203229217,0.40963855421686746,0.7116476900376126,1.0,15/49,23.20%,RNASE3;SIAH2;STT3B;XRN2;RNASEH2A;OGA;RNASEH1;DFFB;RNASEH2B;ISG20;RNASE6;DNASE1L1;PABPC4;SND1;PPP1R8
prerank,negative regulation of cell junction assembly (GO:1901889),-0.31447773040715976,-1.0425486260710002,0.42953020134228187,0.822050157063158,1.0,12/25,14.33%,ROCK2;DUSP22;RCC2;THBS1;ROBO2;CLASP2;APOD;DMTN;TLR2;SRC;PHLDB2;IL1B
prerank,Golgi localization (GO:0051645),0.48381348061765855,1.0425160556665762,0.43437077131258456,0.711468782381298,1.0,6/11,32.67%,ARHGAP21;CDC42;HOOK3;YWHAZ;COPG1;TBCCD1
prerank,replicative senescence (GO:0090399),0.4809188249120454,1.0424959636039357,0.4302788844621514,0.7111498055313416,1.0,5/12,27.61%,PLA2R1;SERPINE1;ATM;TERT;ATR
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.2798810043057349,-1.0424448964321795,0.4,0.8190728370569595,1.0,6/36,8.12%,OPHN1;FHIT;N4BP1;PRKCG;CAMLG;USP25
prerank,regulation of transport (GO:0051049),0.39072172439935854,1.0424193413501457,0.43035107587768967,0.710983509160812,1.0,10/36,18.71%,CLDN19;CDK5;NRP1;TRAT1;ACTG1;ACTB;YRDC;VAMP2;RAB11A;ARL6IP5
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.4585120602120515,1.0423210021803164,0.4247104247104247,0.7108528093935002,1.0,4/14,10.69%,ANXA1;MALT1;NFKBIZ;SOCS5
prerank,positive regulation of superoxide anion generation (GO:0032930),0.4707769743205698,1.0422362963930512,0.42724867724867727,0.7106873681834933,1.0,4/13,16.00%,FPR2;PRKCD;ITGB2;SYK
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.32609481068215823,1.042079443269071,0.218,0.7107434004513823,1.0,410/1646,24.57%,APBB2;IGF1;MDFIC;LITAF;CTNNB1;CXXC1;SPP1;CDK14;MITF;APOE;UXT;HIF1A;IKZF3;CDK18;ZHX2;ERCC6;SKAP1;CSRNP1;ZMIZ1;NIBAN2;TCF7;ATF3;TOX2;ELF4;FOXN1;KMT2A;NFYA;NFIC;NFE2L2;PRKCQ;CD4;ARID5B;SCML4;LEF1;HDAC9;DEDD2;ZNF697;TBX21;MYBL2;DEAF1;BCL11B;MAFF;RCOR1;JMJD1C;ANXA4;ID2;STAT4;EOMES;NRG1;SOX3;GDF6;IRF6;TCF15;OVOL1;SEBOX;HOXA4;SOX30;NR4A3;FSTL3;TBX18;VDR;NCOR2;MEF2D;SIX5;POU3F1;RNF14;PAK6;CDK5;TGIF1;NFIL3;FGF2;MNT;CC2D1A;CIC;PERM1;TFEB;PRICKLE1;HDAC4;PPARG;DAXX;PPP2R1A;SHOX2;FOXJ1;ZFHX2;FAM47E;ZMIZ2;KLF12;KLF6;RUNX1;CCNL1;BCL6;ZKSCAN4;ERN2;GATA3;CUX1;RNF6;ZBTB42;HR;RFX5;TRIM28;ZBTB7B;SOX9;BRD4;VEGFA;MSL3;SATB1;EGR2;ING4;HDAC1;BPTF;NFX1;TOX4;THOC1;HES7;ZBTB2;KMT5A;GON4L;TRAK1;BHLHE40;MED21;PRKCB;ATXN1;UBE2L3;ZNF395;CDH1;MTF2;TRIM16;FADS1;ZNF160;FBXO5;NAA16;PRDM15;CHD3;GMNN;DDX17;KDM3A;BHLHE41;ILK;PPARD;BASP1;E2F3;IRF8;MIDEAS;THAP7;HOXA7;FOXN3;CCNC;LRRFIP1;ZNF326;BRCA1;NKX2-1;BAMBI;SOX7;ZFX;NEK4;RNF111;KLF13;FGF7;DAP;IRX5;PRMT5;PCBD2;TASP1;SMARCB1;FOXP4;CREB3L2;MEF2B;CCNL2;ATF5;JUN;DNM2;KTI12;CDK17;SUDS3;NFE2L1;NRF1;FOSB;ZNF148;VRTN;ELF2;RHOG;ENO1;NAB2;CEBPA;TADA1;SBNO1;MED17;TAF15;BAP1;HP1BP3;IRF5;ARID4B;RIOX1;TGFBRAP1;ZFP41;DACH2;RAI1;GBX1;ZKSCAN3;ASCL4;ZNF83;ZBTB34;MRGBP;ZNF569;TLE5;ZSCAN12;KDM3B;CARM1;MAFG;TFAP4;MAP3K12;HNRNPK;NUPR2;NPAT;CDK11B;PPARGC1B;SAFB2;BLM;GAS6;SMARCC1;SP100;MRPL12;FZD1;HSPA8;ZBTB16;OGT;ELK4;SMAD7;GATAD2A;PHF1;FOXJ3;SMAD1;ILF3;MAFK;CBFA2T2;YY1;EHF;FZD4;BIRC5;NFYB;EED;MGA;IL31RA;ETV6;DDIT3;PRRX1;NFKB1;RBM15;RBFOX2;LRP6;HSPD1;ACTA2;SP7;ARHGEF11;FBXL19;ING2;DEK;NHLH2;SRF;MED13;SERTAD3;ZBTB40;USP47;CEBPG;FOXO1;PRMT2;MYT1;MTF1;NR4A2;ELK3;ZNF296;HTATIP2;DHX36;CHD5;GMEB2;HOXC5;NPAS4;MED29;PRMT6;ING5;MAP2K3;GMEB1;PSPC1;MYBBP1A;SRCAP;RBM15B;DMRTA2;PDCD4;ZBTB25;GLRX2;RCOR3;UTP4;PPIE;CAMK4;SBNO2;TCF12;SP1;TOX;NLK;CNBP;UIMC1;PURA;GPBP1L1;WBP2;BAZ1B;DAPK3;ATRX;GCFC2;GTF2H1;CBX3;KAT7;USF2;IL6;DHX9;ZNF177;CCAR2;ZBTB6;CCAR1;TAF7;CCNT2;PHF20L1;EHMT1;YAF2;HOXB4;NR3C1;ZBTB39;PIAS1;SP9;CDK16;TCF7L1;HMGB1;RNF20;DACH1;JDP2;NFATC3;MTDH;FBXW11;SPIB;SREBF1;YEATS2;ARID1B;MEIS3;SOD2;CHD2;ZFP57;EPO;VHL;RFXANK;TCF24;HOXC9;ZNF18;PBX1;ZXDC;RXRB;HSF1;NPM1;PRKAR1A;RUNX3;ETV4;BMP4;TEAD1;CIAO1;ID1;SUFU;ELP3;CALR;ZBTB43;MAP2K2;KLF11;ARNT2;F2R;RLF;NIF3L1;PRRX2;SMARCD2;NSD3;NIPBL;SP110;MED7;AHR;EGR1;CD74;ZNF568;PITHD1;STAT5B;CREBZF;PEX14;ASCC1;PBX2;KMT2D;REL;TARBP1;LHX4;RXRA;L3MBTL3;XPC;ZSCAN22;E2F6;ZBTB4;MDM2;SOX10;ZSCAN20;MTA3;TNF;GLIS2;SUMO1;CCDC85B;TCIM;EDF1;ATF4
prerank,positive regulation of signal transduction (GO:0009967),0.3355306056878095,1.0411011695203727,0.3953953953953954,0.7129267831046091,1.0,79/238,27.90%,IGF1;HIF1A;ZMIZ1;FLNA;TEDC1;MGAT5;PTPRC;CD226;SASH1;ITGA5;MACF1;AXL;EVC;CYP27B1;PTK2B;NPTN;NRP1;JAG1;KLK6;TEDC2;GATA3;ERN1;ZBTB7B;TREM2;HTT;LIMS2;PRKCB;TRIM16;ILK;ARMC9;BAX;ASXL2;SMARCB1;C3;WLS;CD63;MAML2;DLL4;GAS6;TSPAN5;PRKD2;SORBS1;ASXL1;CLEC6A;ING5;BMP6;ATP6V0C;IL6;ITGB1BP1;NEPRO;SCIMP;PTGIS;RPS3;AGPAT2;CRADD;ENHO;RWDD3;LMO3;TERT;VPS35;CD74;AGPAT1;FGFR2;JAK2;SMARCA4;SFRP1;FGF1;NOTCH4;DSTYK;PDE6G;SNW1;DEPDC1B;PIH1D1;CDKN2AIP;LIMS1;FGFBP3;DACT1;JCAD;TNFAIP3
prerank,ATP transport (GO:0015867),0.49667915510398764,1.0408340316381226,0.45095367847411444,0.7132454066910692,1.0,3/10,21.74%,SLC25A24;SLC17A9;CD47
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.4339426119331788,1.0406419720069195,0.4423558897243108,0.7133553985326462,1.0,5/20,18.07%,CDK6;PTK2B;ZBTB16;HSPA9;PAF1
prerank,methylguanosine-cap decapping (GO:0110156),0.5010023276674944,1.0404729084070454,0.4502840909090909,0.7134062443111144,1.0,4/10,14.88%,PATL1;PATL2;DCP1A;EDC4
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.414339698175514,1.0403335397087843,0.4356796116504854,0.7133790710011451,1.0,5/24,18.40%,HIF1A;BRCA1;C3;CYP1B1;IL6
prerank,negative regulation of transmembrane transport (GO:0034763),-0.4140714850548668,-1.040170399117612,0.40625,0.8226001209127753,1.0,6/10,18.26%,CTTNBP2NL;IRS2;THBS1;INPP5K;IL1B;RSC1A1
prerank,positive regulation of JUN kinase activity (GO:0043507),0.41498710925395155,1.0399087148449944,0.4380952380952381,0.7140985427132714,1.0,3/23,4.88%,SASH1;TRAF2;TAOK3
prerank,PERK-mediated unfolded protein response (GO:0036499),0.49389642504143,1.0398164984353457,0.4654939106901218,0.7139847337209495,1.0,5/10,24.88%,NFE2L2;EIF2S1;DDIT3;ATF4;HSPA5
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.44353725628055546,1.0396012089822064,0.4474708171206226,0.7141545477941129,1.0,4/16,8.96%,PTPRC;KLRC1;IL12RB1;LILRB1
prerank,filopodium assembly (GO:0046847),-0.35482053540860925,-1.039512782905818,0.3598130841121495,0.8214194176991756,1.0,7/16,16.40%,FGD2;FGD1;ARHGEF4;FGD3;EZR;SPATA13;SRGAP2
prerank,acute inflammatory response (GO:0002526),0.42420675871430347,1.0391740757256525,0.441527446300716,0.7148888019414364,1.0,8/23,21.65%,CD6;HPR;HP;MBL2;SIGIRR;ANO6;IL6;LBP
prerank,gland development (GO:0048732),0.36860341610946407,1.039095902843784,0.42919389978213507,0.7147264207439946,1.0,17/59,25.48%,ANXA1;MSN;ARID5B;NRG1;SOX3;CAV1;SOX9;NKX2-1;CEBPA;CEBPG;NF1;RIPK3;GFER;FGFR2;PRKCSH;MDK;NOTCH4
prerank,regulation of protein kinase C signaling (GO:0090036),0.45555862630627864,1.038867162915101,0.42522756827048114,0.7149596603640824,1.0,4/14,17.10%,SPHK2;VEGFA;MYADM;DGKD
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.3535244188635595,1.038862301068069,0.4154334038054968,0.7146047718492883,1.0,29/80,24.60%,ABCG1;EIF6;VIM;SPHK2;GSAP;PRKCD;CD28;EEF2;PIWIL2;RACK1;LARP4;METTL3;CPEB3;YTHDF3;EFNA1;EIF4A3;CLU;FXR2;SP1;EIF3E;IL6;UPF3A;NPM1;SAMD4A;UPF3B;POLDIP3;TNF;SIRT3;PYM1
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.48009444681175717,1.0384897275047889,0.4322033898305085,0.715191958582956,1.0,4/11,17.31%,STAP1;TICAM1;ITGB2;CAMK4
prerank,protein localization to phagophore assembly site (GO:0034497),0.4769466075158544,1.0383406667239123,0.4397163120567376,0.7152263904191768,1.0,3/11,8.76%,TRAPPC8;PACS2;WDR45
prerank,vasoconstriction (GO:0042310),0.4833079842024768,1.038232948437429,0.4474034620505992,0.715138149924649,1.0,4/11,24.58%,EDNRA;ACTA2;HTR2B;PIK3C2A
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.3785975294443655,1.0380073831343986,0.42904656319290463,0.7153218626239545,1.0,14/42,27.78%,ERCC6;FIGNL1;PPP4C;ARID2;PARPBP;RTEL1;RAD51AP1;WAS;WDR48;SMCHD1;TERF2IP;KDM1A;FUS;ACTR2
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.4069322695941505,1.0378240034511428,0.43478260869565216,0.7154336600163926,1.0,8/26,27.93%,SPHK2;SPHK1;CYP1B1;ASAH1;CYB5R3;SPTLC3;SPTLC2;NQO1
prerank,negative regulation of growth (GO:0045926),0.34527938200917985,1.0377843844419568,0.4087665647298675,0.7151738127719912,1.0,38/121,27.08%,APBB2;PPP1R9B;SPHK2;HRG;CYP27B1;PPP2R1A;BCL6;DCBLD2;ING4;RACK1;ENO1;ADAM15;OSGIN2;SERTAD3;ING5;STK11;NME6;CCAR2;BST2;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;FGFR3;RBBP7;TMPRSS4;CCDC85B;SIPA1;DCUN1D3;SMARCA4;SFRP1;MT2A;SESN2;CDKN2AIP
prerank,regulation of cellular pH (GO:0030641),0.4001862721872568,1.0377782152369504,0.42370892018779344,0.7148237512758597,1.0,10/29,17.85%,SLC9A1;SLC9A8;ATP1A4;ATP6AP1;CLN3;SLC9A7;SLC9A6;SLC4A9;CHP1;SLC4A2
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.34382043142050145,-1.037727464072622,0.37037037037037035,0.823720057996556,1.0,4/18,6.49%,CX3CR1;SELPLG;JAM2;ADD2
prerank,regulation of cell-cell adhesion (GO:0022407),0.38462056333909395,1.0373471960228517,0.42159090909090907,0.7155566521550054,1.0,10/39,17.18%,ADAM8;GTPBP4;FSTL3;JAG1;CDH1;FLOT2;MAGI1;SMAD7;MINK1;AFDN
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.38200846384911935,-1.0373293246603323,0.42570281124497994,0.8216867732449947,1.0,6/13,15.29%,GRIK2;RAB3A;SLC8A2;SHISA6;SLC4A10;SHISA7
prerank,cell cycle checkpoint signaling (GO:0000075),0.47820909492915115,1.0364136120363776,0.4344919786096257,0.7176252942018048,1.0,4/12,19.56%,PLK2;WEE1;PRCC;BUB1B
prerank,RNA destabilization (GO:0050779),0.43954378753214773,1.036182484134553,0.4381188118811881,0.7178285766974792,1.0,7/18,16.50%,CELF1;METTL3;YTHDF3;DXO;ROCK1;YTHDF2;PUM1
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.4552743490109368,1.035973361021481,0.44716494845360827,0.7179904175245577,1.0,3/14,5.32%,XDH;MMP9;CAV1
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.3387578303780265,-1.035804369756143,0.3744292237442922,0.8229653658123969,1.0,7/16,22.18%,SALL1;PAX8;PAX2;BMP2;NPNT;FOXD1;SHH
prerank,glycogen metabolic process (GO:0005977),0.4036344939137788,1.0355942491176584,0.4416365824308063,0.7185918627632728,1.0,11/27,28.70%,NHLRC1;GYG1;GAA;GYS1;PHKB;GSK3B;PYGM;PGM2;STBD1;GBE1;PGM1
prerank,positive regulation of protein secretion (GO:0050714),0.3572444999761018,1.0355264337475705,0.42826780021253985,0.7183949412703783,1.0,13/69,16.84%,IGF1;ABCG1;GCK;ADAM8;ATP13A2;TRH;PTPN23;TREM2;WLS;PPIA;RBP4;AACS;BMP6
prerank,programmed necrotic cell death (GO:0097300),0.43280841302102474,1.0353526062071412,0.4352651048088779,0.7184660867393905,1.0,5/18,17.46%,MLKL;ALKBH7;TICAM1;TRPM7;RIPK3
prerank,negative regulation of myotube differentiation (GO:0010832),0.47104151012746365,1.0348942645158283,0.42953020134228187,0.7192830486336994,1.0,3/12,8.78%,HDAC4;HDAC1;BHLHE41
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.33805602560353926,1.0348881837541344,0.4344758064516129,0.7189351000439309,1.0,53/152,28.23%,DKK2;PSMD8;PSMD1;MACF1;TNKS2;CAV1;PRDM15;ILK;PSMD6;PSMA1;CSNK1G1;BAMBI;VCP;PSMC3;JUP;WLS;PSMA8;FRAT1;GPRC5B;JRK;PSMD14;PSMD2;NFKB1;CSNK1D;USP47;PSMC6;PSMA6;GSKIP;PSMD5;DAPK3;ATP6V0C;PSMA5;PIN1;CCAR2;TERT;ZBED3;PSMA3;FGFR2;USP8;PSMB8;SMARCA4;PSMB10;SFRP1;PSMD7;PSMB6;DEPDC1B;PSMD10;PPM1A;DACT1;PSMB5;TNFAIP3;USP34;PSMB7
prerank,positive regulation of immunoglobulin production (GO:0002639),0.3925300402995591,1.0347599610588876,0.450354609929078,0.7188913856284913,1.0,14/31,31.66%,PTPRC;DNAJB9;KMT5B;RBP4;TFRC;GPI;IL6;IL2;SASH3;TLR9;STX4;VAMP3;EPHB2;XBP1
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.4378362146821738,1.0347563418449777,0.4434782608695652,0.71853203077461,1.0,5/17,16.00%,SKAP1;CD3E;PIEZO1;CCL5;SYK
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.4179685146364858,1.034503780776198,0.4394829612220917,0.7187869369950027,1.0,12/23,32.12%,RACK1;VCP;HHIP;IFT122;SUFU;GLIS2;GPR161;KCTD21;BTRC;HERC4;GLI3;MEGF8
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.43669163151698687,1.0342915075702939,0.4437726723095526,0.7189449479981098,1.0,7/19,25.39%,RIPOR2;MOSPD2;C1QBP;TIRAP;CD74;NCKAP1L;MDK
prerank,regulation of superoxide anion generation (GO:0032928),0.4582344705655844,1.0341929006616353,0.44357976653696496,0.7188291379948843,1.0,4/14,16.00%,FPR2;PRKCD;ITGB2;SYK
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.3929769641007391,1.0341796398301841,0.4426605504587156,0.718488193972961,1.0,16/32,31.46%,TAF1D;POLR1G;POLR2H;UBTF;POLR1A;TBP;GTF2H1;TAF1A;TAF1C;POLR1F;POLR2F;GTF2H5;MNAT1;MAPK3;POLR1H;ERCC2
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.4223853997530157,1.0330677799179153,0.42962962962962964,0.7209166826421552,1.0,4/21,14.31%,BCL2L1;NCK1;BCL2L11;DDIT3
prerank,cortical cytoskeleton organization (GO:0030865),0.3747383913710786,1.0330105185083311,0.44983089064261556,0.7207025703329364,1.0,11/41,14.50%,LCP1;PLEK;FMNL2;STRIP1;RHOD;FMNL3;RHOQ;RHOG;RHOA;ROCK1;LLGL2
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.45364922415650244,1.0329841515031142,0.4383033419023136,0.7203979871693227,1.0,4/15,14.85%,HDAC1;WNT6;ANKRD11;LRP6
prerank,cellular response to chemokine (GO:1990869),0.37436745594956694,1.032724657869803,0.4531422271223815,0.720682632114246,1.0,9/46,13.90%,CCL4;RIPOR2;PTK2B;CCL13;CCR2;CCL7;CCL5;RHOA;CCL14
prerank,establishment of spindle orientation (GO:0051294),0.4024522915722745,1.0324742314232316,0.447953216374269,0.7209509391035026,1.0,10/28,28.06%,HTT;DCTN1;LLGL2;NUMA1;FBXW11;SPDL1;LLGL1;CENPA;MAP4;ITGB1
prerank,cellular response to ionizing radiation (GO:0071479),0.3644340635497595,1.031947652096835,0.4445676274944568,0.7218735244354924,1.0,21/47,29.61%,TANK;FIGNL1;GRB2;EEF1D;BLM;INO80;KDM4D;ATM;TMEM109;RAD1;RAD51AP1;HSF1;NIPBL;INTS7;MDM2;GADD45A;KDM1A;ATR;RAD9A;SIRT1;XRCC5
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.4860002750342766,1.0314807350829103,0.4591549295774648,0.7227000135901299,1.0,1/11,0.50%,STAP1
prerank,tRNA metabolic process (GO:0006399),0.43471064045732705,1.0314563795474851,0.44458281444582815,0.7224013924254726,1.0,4/17,18.57%,AARS1;THG1L;SARS1;FARS2
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.38299189588005,1.0310444646160979,0.45298165137614677,0.7230650655214038,1.0,13/39,18.68%,CORO1C;GCNT2;JAG1;HOXA7;MYOC;FBLN1;RHOA;FZD4;ADAM15;SPRY4;MELTF;RASA1;ITGB1BP1
prerank,leukocyte tethering or rolling (GO:0050901),-0.35022516764645406,-1.0309765958990222,0.38425925925925924,0.8346091300337191,1.0,4/17,6.49%,CX3CR1;SELPLG;JAM2;ADD2
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.43566032443670283,1.0307657077048915,0.4420654911838791,0.7234017120505467,1.0,5/17,25.24%,PLAAT3;LPGAT1;PLA2G12A;MBOAT7;PLA2G5
prerank,regulation of endopeptidase activity (GO:0052548),0.362593514119082,1.0306347906440982,0.44193548387096776,0.7233535076662259,1.0,23/59,30.50%,ATP13A2;HRG;SERPINA10;SERPINB9;HDAC1;SERPINE2;SERPINE1;TIMP4;TIMP2;FURIN;SERPINF2;TIMP1;PRELID1;SERPINB8;PSMA3;BIRC2;PSMB8;SERPINA2;SPOCK1;APH1A;SERPINH1;SERPIND1;TIMP3
prerank,ESCRT III complex disassembly (GO:1904903),0.48653241093976857,1.0302171093635921,0.45564516129032256,0.7236888006124109,1.0,3/10,12.33%,VPS4B;VTA1;CHMP7
prerank,ESCRT complex disassembly (GO:1904896),0.48653241093976857,1.0302171093635921,0.45564516129032256,0.7236888006124109,1.0,3/10,12.33%,VPS4B;VTA1;CHMP7
prerank,negative regulation of T cell differentiation (GO:0045581),0.4876439317024546,1.029897771873059,0.4484181568088033,0.724102265867025,1.0,6/10,38.30%,FOXJ1;BMP4;MDK;GLI3;LAG3;CTLA4
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.328734381035784,1.0297574155821179,0.414,0.7240718323245966,1.0,108/366,27.36%,APBB2;CXXC1;MITF;HIF1A;TCF7;NFYA;PRKCQ;ORC3;TBX21;MYBL2;JMJD1C;PDGFA;SOX3;RNF14;PAK6;NFIL3;PERM1;TFEB;DAXX;PPP2R1A;RNF6;RBM4B;MSL3;NFX1;GON4L;EIF2A;BHLHE40;ATXN1;UBE2L3;ZNF395;MTF2;FADS1;FBXO5;CHD3;GMNN;THAP7;FOXN3;NOLC1;SOX7;OBI1;PRMT5;ATF5;DNM2;NAB2;CEBPA;SBNO1;HP1BP3;TGFBRAP1;CARM1;CDK11B;PPARGC1B;PHF1;NFYB;DDIT3;SMC3;ING2;SERTAD3;MYT1;TCOF1;PSPC1;MYBBP1A;GLRX2;UTP4;PPIE;SBNO2;SP1;NLK;CNBP;GPBP1L1;DAPK3;ATRX;GCFC2;KAT7;CCAR2;CCAR1;ATXN2;YAF2;NR3C1;TCF7L1;RNF20;VHL;RUNX3;SUFU;CALR;ARNT2;PRRX2;NSD3;AHR;ASCC1;KMT2D;ZBTB4;EIF2B4;CCDC88A;EDF1;ATF4;HCFC1;MLLT6;ASCC2;NSD1;GEMIN5;ATXN1L;CYFIP1;FOXN2;TERF2IP;CHD7;FUS;SUPT4H1;EIF4E
prerank,negative regulation of neurogenesis (GO:0050768),0.38963489000314916,1.0297476911981733,0.4416184971098266,0.7237243030848722,1.0,9/34,18.40%,LRP4;GDI1;RUFY3;B2M;RHOA;NF1;APPL2;HOOK3;IL6
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.384162393108121,-1.0291323657341527,0.3904382470119522,0.8371848332437237,1.0,6/11,25.12%,GTF2H2;GRK3;ARRB2;ARRB1;ADM;GRK2
prerank,actin filament depolymerization (GO:0030042),0.48575514045869206,1.0289375444648514,0.46765498652291104,0.7254358618483426,1.0,3/11,11.96%,MICAL2;MICAL1;GSN
prerank,regulation of cellular amide metabolic process (GO:0034248),0.3939434836758435,1.028489936126678,0.4557109557109557,0.726176758701365,1.0,14/32,29.64%,PRKCD;RBM4B;EIF2A;NOLC1;ROCK1;TCOF1;ATXN2;SAMD8;EIF2B4;GEMIN5;CYFIP1;EIF4E;MTPN;PCIF1
prerank,protein autophosphorylation (GO:0046777),0.3379427990245926,1.0284857092880286,0.41700404858299595,0.7258184124764666,1.0,44/157,22.59%,FLT1;PEAK1;ITK;FGR;TEC;ATP13A2;PTK2B;TAOK3;PDPK1;STK24;ERN1;SIK1;RIOK2;TXK;IGF1R;MAPKAPK3;MAPKAPK2;PIM1;MAP3K12;PAK2;PRKD2;DAPK1;CAD;HTATIP2;KDR;MINK1;DDR2;CAMK4;STK11;RIPK3;NEK6;DAPK3;ATM;MEX3B;PIKFYVE;MAP3K9;MAK;MARK2;LMTK2;GSK3B;TAOK1;MELK;MAP2K2;FGFR3
prerank,second-messenger-mediated signaling (GO:0019932),0.34942303924774404,1.0283543651592477,0.44363256784968685,0.7257753729783295,1.0,18/82,17.10%,APOE;P2RX4;FPR2;LAT;CXCR2;PPP1R9B;MCTP1;SPHK1;PPP2R1A;PDPK1;TPCN2;RCAN1;INPP5A;CCR2;RCAN3;MCTP2;LAT2;DGKD
prerank,sulfur compound biosynthetic process (GO:0044272),0.3427666405890354,1.0280776995370724,0.4484167517875383,0.7260887581197908,1.0,37/104,31.98%,CHST11;CSPG4;B4GALT5;SLC26A1;B4GAT1;B3GNT3;GSTA2;SLC35D2;ANGPT1;CNDP2;AKR1A1;DCN;BGN;CHST12;CDO1;B4GALT3;MPST;B4GALT1;GSTO2;LUM;CSPG5;ST3GAL2;OGN;SLC35B3;CHST2;CHST3;DSEL;GGTA1;DSE;ST3GAL1;GSTO1;FMOD;GSTK1;CBS;CHST9;ESD;CSGALNACT2
prerank,positive regulation of biomineral tissue development (GO:0070169),-0.2661278366132534,-1.028015919137172,0.35294117647058826,0.8373236368568082,1.0,5/40,3.29%,MEF2C;TMEM119;ALOX5;ACVR2B;BMPR1B
prerank,acetyl-CoA metabolic process (GO:0006084),0.4529704934989113,1.027936789850296,0.46727748691099474,0.7260630765443377,1.0,6/15,23.10%,ACACA;DIP2A;PPCS;ACAT1;ACACB;PMVK
prerank,cardiac muscle tissue development (GO:0048738),0.3706181688415591,1.027641088309108,0.42981501632208924,0.7264375610208029,1.0,7/50,6.73%,AKAP13;NRG1;NPPA;TBX18;CSRP3;SHOX2;SIK1
prerank,cellular response to hormone stimulus (GO:0032870),0.3516066864263593,1.0275803626954285,0.45291005291005293,0.7262215024256218,1.0,10/69,8.16%,CTSB;GCK;MGARP;NR4A3;CAV1;SERPINB9;TFPI;ATP1A3;ATP1A1;UBE2L3
prerank,regulation of centriole replication (GO:0046599),0.4330437657380273,1.0274853261809673,0.46201743462017436,0.7261030332378003,1.0,10/17,33.43%,PLK2;BRCA1;PLK4;MDM1;NPM1;CEP295NL;CEP295;ALMS1;TRIM37;NUP62
prerank,regulation of mRNA processing (GO:0050684),0.3892108460762221,1.0273911935545845,0.43757159221076747,0.725969316451849,1.0,11/32,21.47%,SRPK1;PAPOLA;SON;PABPN1;HNRNPK;CDK11B;SAFB2;RBM39;CWC22;DHX9;SRPK2
prerank,transport across blood-brain barrier (GO:0150104),0.3480883856823553,1.027057812096018,0.4617801047120419,0.7264623836290233,1.0,20/83,19.43%,LRP1;FABP5;SLC27A1;SLC38A1;SLC6A6;SLC7A1;SLC5A1;SLC2A1;SLC22A3;ATP1A4;SLC1A5;ATP1A2;TFRC;SLC7A8;SLC5A3;SLC19A1;SLC28A2;SLC13A3;SLC16A2;SLC38A2
prerank,stem cell development (GO:0048864),0.44478120770131974,1.026782179604464,0.4392059553349876,0.7267871139612252,1.0,4/16,16.51%,PTPRC;NRG1;NOLC1;TCOF1
prerank,cellular response to hexose stimulus (GO:0071331),0.41114892383165225,1.0267370777704887,0.4533492822966507,0.7265407351315486,1.0,6/23,12.81%,ADCY8;ERN1;IGF1R;RACK1;PCK2;GAS6
prerank,organophosphate biosynthetic process (GO:0090407),0.3870767868553825,1.0260433663149005,0.43068181818181817,0.7278864727298817,1.0,18/37,33.84%,ITPKB;GK;FGF2;MOCOS;FADS1;TKT;MOCS3;PCYT2;ITPKC;GNPAT;LPCAT1;IP6K2;PIP5K1A;MOCS2;MOCS1;AGPAT3;GPHN;PNPO
prerank,peptidyl-serine phosphorylation (GO:0018105),0.3363488029876972,1.0258488433204465,0.435793731041456,0.7280153311824983,1.0,49/153,23.00%,PRKCH;PRKCQ;SGK1;SGK3;SGK2;MAPK13;DYRK2;CDK5;PRKCD;PDPK1;ERN1;IKBKE;SBK1;PLK2;PRKCB;MAPKAPK3;MAPKAPK2;CSNK1G1;STK32A;HIPK1;MAP3K12;GAS6;CDK2;PKN2;PAK2;ROCK1;CAB39;PRKD2;CSNK1D;MAPK9;STK38;CDC7;TLK1;RPS6KA2;CAMK4;NLK;NEK6;ATM;CSNK2A2;PIKFYVE;TOP1;PDK3;MARK2;LMTK2;GSK3B;SRPK2;LATS1;MAP2K2;TGFBR2
prerank,response to UV (GO:0009411),0.3445855911940403,1.0258207835159876,0.4672131147540984,0.7277217240769925,1.0,45/95,33.78%,ERCC6;MAPK13;PRKCD;NOC2L;MAP4K3;SDE2;EIF2S1;DDB2;ZRANB3;METTL3;TRIAP1;XPA;YY1;INO80;ERCC4;CAT;USP47;SMPD1;DHX36;UBE4B;CCAR2;CASP9;NPM1;USP28;REV1;ATF4;DCUN1D3;USP1;GPX1;KDM1A;ATR;RUVBL2;ERCC8;CDC25A;CCND1;EP300;ZBTB1;ERCC2;NEDD4;CREBBP;CIRBP;TMEM161A;MAP3K4;PCLAF;PCNA
prerank,response to X-ray (GO:0010165),0.44847211097650647,1.0257666226497932,0.4702774108322325,0.7274988504883375,1.0,7/14,29.61%,ANXA1;BLM;ATM;IKBIP;NIPBL;BRCC3;XRCC5
prerank,negative regulation of translational initiation (GO:0045947),0.45349699090593404,1.0255557511576103,0.45103092783505155,0.7276593401958125,1.0,4/13,18.28%,AGO2;LARP1;TPR;EIF3E
prerank,protein O-linked mannosylation (GO:0035269),-0.3289997218806395,-1.025404595825663,0.39593908629441626,0.8423917170039317,1.0,5/18,7.88%,TMTC2;TMTC3;POMT2;TMTC1;FKRP
prerank,cochlea morphogenesis (GO:0090103),0.49065474439930534,1.0252858682996464,0.4511691884456671,0.7279328708798389,1.0,3/10,19.04%,TBX18;SOX9;MYO3B
prerank,ear morphogenesis (GO:0042471),-0.3140231232405976,-1.0252435097048385,0.42134831460674155,0.8396696515079201,1.0,6/20,20.20%,PAX8;MYO6;PAX2;OSR1;ZIC1;TIFAB
prerank,regulation of transferase activity (GO:0051338),0.4330552426898369,1.0251724945508138,0.44209215442092153,0.7278457964519901,1.0,9/17,35.20%,PARP4;ATM;PPP1R3F;NLRC5;JMJD8;SPTSSB;LDB2;LDB1;FEM1B
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.4882635922165793,1.0251637853457511,0.46164383561643835,0.7275061430578333,1.0,3/10,12.81%,AXL;LILRB1;GAS6
prerank,regulation of coagulation (GO:0050818),0.4776686748314516,1.025075893818552,0.4657718120805369,0.7273536883668886,1.0,4/11,22.71%,HRG;CAV1;PROCR;F2R
prerank,mRNA catabolic process (GO:0006402),0.3733102381352792,1.025065793459961,0.45050055617352613,0.7270136025909111,1.0,14/44,20.69%,EXOSC4;ERN1;XRN2;METTL3;CNOT10;DHX34;RNH1;EXOSC9;DXO;EXOSC10;LSM6;YTHDF2;AGO3;ZC3H12D
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.4895485835348059,1.0249769238563164,0.46206896551724136,0.7265195037788187,1.0,2/10,14.17%,HDAC4;GIT1
prerank,negative regulation of glycolytic process (GO:0045820),0.4895485835348059,1.0249769238563164,0.46206896551724136,0.7265195037788187,1.0,2/10,14.17%,HDAC4;GIT1
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.4687637647062991,1.0248488688675614,0.46121883656509693,0.7264989449280842,1.0,6/11,26.66%,STAT4;IL27RA;JAK1;CANX;JAK2;IL12RB2
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.4328516583917938,1.0246539427838472,0.4475,0.7266419449163274,1.0,7/18,29.75%,PABPN1;THOC2;NUP93;POLDIP3;MCM3AP;NUP133;NXF1
prerank,dendritic spine morphogenesis (GO:0060997),-0.3459047797499199,-1.0246498134965702,0.3944954128440367,0.8382738220403286,1.0,5/15,12.73%,CTNND2;EPHB1;DOCK10;SHANK3;PAK3
prerank,keratan sulfate biosynthetic process (GO:0018146),0.40459705987229283,1.0243470748345858,0.4458672875436554,0.7270381096198618,1.0,4/26,5.87%,B4GALT5;B4GAT1;B3GNT3;SLC35D2
prerank,positive regulation of cell differentiation (GO:0045597),0.33131989528073647,1.02432504764043,0.4444444444444444,0.7267174633503877,1.0,61/237,22.09%,IGF1;LPL;CTNNB1;PRKCH;CSF1;SDCBP;FOXN1;SLC6A6;LTF;LEF1;GCNT2;PDPN;ID2;GDF6;TCF15;GLIPR2;RIPOR2;NELL1;PPARG;SUCO;DAB2;SOX9;NOCT;BRINP2;RIN2;KITLG;FBXO5;IFITM1;SPAG9;PPARD;ATP6AP1;PKDCC;BAMBI;ASXL2;RHOA;CARM1;CDC42;ZBTB16;GPRC5B;NFKB1;SP7;MAPK9;SRF;DHX36;KDR;BMP6;DDR2;AKIRIN1;SERPINF2;IL6;FERMT2;BNIP2;HOXB4;ARHGEF2;SMYD1;VHL;HSP90AB1;SYAP1;ADIG;BMP4;LMO3
prerank,myoblast fusion (GO:0007520),-0.3891560144660047,-1.0242484309095958,0.41379310344827586,0.8362746681890613,1.0,6/12,11.36%,ADGRB3;ADAMTS5;JAM2;CD81;KCNH1;NOS1
prerank,negative regulation of signal transduction (GO:0009968),0.333139755550013,1.0241613517294217,0.44244244244244246,0.7267551661542448,1.0,46/249,16.01%,BCL2;LRP1;NIBAN2;PLEK;PTGIR;PTPRC;LTF;PRKCQ;XDH;PIK3CB;HRG;CILP;SOX30;FSTL3;FBXW7;PRKCD;FGF2;BRAP;SIAH2;GATA3;NCK1;OTUD4;PRKCB;MDFI;RACK1;PTPN2;CADM4;LRPAP1;SFRP5;VCP;METTL3;SOCS5;PTPN12;CCL5;DLL4;DLK2;TMBIM1;EGFL7;SPRY4;DCN;YTHDF2;ASXL1;RNF157;SMPD1;NR4A2;SIGIRR
prerank,cGMP biosynthetic process (GO:0006182),0.4892121060515585,1.0226268446345061,0.4616457461645746,0.7302076267488447,1.0,3/10,20.18%,NPPA;NPR2;NPPC
prerank,histone lysine demethylation (GO:0070076),0.40546838242856226,1.0222552080204172,0.4518002322880372,0.7307932379321662,1.0,7/25,16.27%,JMJD1C;HR;KDM3A;RIOX1;KDM3B;RIOX2;KDM4D
prerank,glycine metabolic process (GO:0006544),0.4647553403829986,1.0211569693753628,0.46461949265687585,0.7331120697189861,1.0,7/12,30.71%,SHMT1;GLYAT;AMT;GCSH;GCAT;RIDA;SHMT2
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.35310735374824853,-1.0209751017518798,0.3832599118942731,0.8431080270935709,1.0,6/15,19.32%,NLGN1;CNTNAP4;HAP1;STXBP1;ADRA1A;NLGN2
prerank,carbohydrate biosynthetic process (GO:0016051),-0.3121861312484822,-1.020904668494033,0.4175824175824176,0.8401335203821024,1.0,3/21,6.87%,ST3GAL6;B3GALT5;B3GALT1
prerank,histone modification (GO:0016570),0.34067864379971513,1.020876227226957,0.4548223350253807,0.7334815681438118,1.0,38/109,28.11%,HDAC9;EYA4;RCOR1;CPA4;PRKCD;HDAC4;MSL3;HDAC1;MIDEAS;SUDS3;PRMT7;HUWE1;MRGBP;CARM1;MAP3K12;CDK2;PRMT2;PRMT6;RCOR3;BAZ1B;MIER2;PHF20L1;EHMT1;TAF6;MORF4L1;USP36;NSD3;PARP2;MTA3;HDAC11;HDAC2;NTMT1;HLCS;MORF4L2;NSD1;UFL1;RUVBL2;BRD8
prerank,glycerophospholipid catabolic process (GO:0046475),0.39872192672438006,1.0204361029032658,0.45422116527942924,0.7342159337007976,1.0,4/27,8.69%,GDPD3;PRDX6;ABHD12;SMPD4
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.41837249711225794,1.020352455876023,0.4715346534653465,0.7340586791328855,1.0,6/20,22.41%,AGO2;ZC3H7B;SNIP1;PUM1;AGO3;TERT
prerank,neuron projection fasciculation (GO:0106030),-0.3977997948616533,-1.0195848929951083,0.4379310344827586,0.8409225338879541,1.0,3/10,12.13%,EPHA4;CNTN4;ARHGAP35
prerank,vesicle transport along microtubule (GO:0047496),0.410700047492103,1.0195816926688275,0.45212121212121215,0.7356142541800782,1.0,8/23,20.19%,DYNC1H1;HTT;TRAK1;FYCO1;CLN3;KIF1A;RAB1A;FBXW11
prerank,protein targeting to membrane (GO:0006612),0.3433294467544941,1.0189719345206358,0.45161290322580644,0.7367919776849592,1.0,28/83,27.72%,SDCBP;ZDHHC15;ZDHHC18;NACA;CHMP4A;CHMP4B;PEX2;SIL1;RAB8B;ABCD2;SRP14;SEC63;ZDHHC1;YIF1B;ABCD3;PXMP2;ALDH3A2;PEX16;PIKFYVE;GET3;ACBD5;PEX14;RTP4;NCF1;ATG3;SSR1;ARL6;ZDHHC21
prerank,response to ethanol (GO:0045471),0.4532341660734533,1.0188747575851291,0.44316730523627074,0.7366478159639882,1.0,3/14,4.21%,CHRNB2;TH;ADCY7
prerank,regulation of phosphatase activity (GO:0010921),0.40499895458565544,1.0186663682434183,0.45185185185185184,0.7368025269630429,1.0,7/24,17.46%,PTPA;ZCCHC9;HTT;PPP1R35;SH2D4A;CHP1;RIPK3
prerank,regulation of ion transmembrane transport (GO:0034765),-0.26890037188233584,-1.017316746530886,0.4244604316546763,0.8448176827377206,1.0,9/33,15.88%,WNK1;KCNJ3;CHRM3;WNK3;AKAP6;KCNJ13;KCNH2;NEDD4L;KCNJ12
prerank,positive regulation of fat cell differentiation (GO:0045600),0.3656019061877032,1.0172893558708402,0.47577092511013214,0.7398193350392643,1.0,16/47,22.09%,LPL;ID2;PPARG;ZBTB7B;NAPEPLD;NOCT;PPARD;ASXL2;PIM1;CARM1;ZBTB16;HNRNPU;SYAP1;METRNL;ADIG;LMO3
prerank,fatty acid biosynthetic process (GO:0006633),0.3529027860175221,1.0170535977206687,0.4624338624338624,0.7400444107601392,1.0,10/63,15.91%,LPL;ACACA;ACSBG1;ACSBG2;HACD2;FADS1;SCD5;HSD17B8;HACD1;ABCD3
prerank,regulation of defense response to virus by host (GO:0050691),0.38798123093931774,1.0169875150406678,0.4610011641443539,0.7398399731739145,1.0,14/30,32.38%,TRIM6;IL12RB1;PTPN22;LILRB1;ZDHHC1;DHX9;RNF216;AIM2;TARBP2;TNFAIP3;MUL1;MAVS;PARP9;ZC3H12A
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.38581479452708856,-1.0167024798553448,0.39914163090128757,0.8435320963599909,1.0,4/12,8.53%,SOX8;PAX8;AGT;PAX2
prerank,regulation of monocyte chemotaxis (GO:0090025),0.4104241499406026,1.0163802247798341,0.48056537102473496,0.7409562110384309,1.0,7/24,19.98%,FPR2;MOSPD2;CCR2;SERPINE1;CCL5;ANO6;HMGB1
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.36506497520930664,1.0162035679450656,0.4743729552889858,0.7410671341003355,1.0,24/51,30.62%,PLEK;NRP1;MYOC;RHOA;LIMK1;CDC42;LPAR1;SERPINF2;TESK1;ITGB1BP1;FERMT2;EVL;CD47;GPR65;PFN1;ARHGEF5;CCDC88A;SFRP1;CX3CL1;S100A10;SYNPO;CCN2;SORBS3;RHOC
prerank,mRNA export from nucleus (GO:0006406),0.33746800481827144,1.0160814775271287,0.4736297828335057,0.7410139319535608,1.0,38/102,29.75%,NUP205;THOC1;PABPN1;NUP188;SRSF11;SRSF7;AGFG1;DDX39B;HNRNPA2B1;EIF4A3;POLR2D;RANBP2;TPR;SYMPK;CHTOP;THOC2;RBM15B;RAE1;SRSF2;NUP93;AAAS;UPF3B;POLDIP3;SRRM1;NUP54;NUP50;NUP98;MCM3AP;NUP42;NUP133;NUP210;THOC6;EIF4E;SMG1;SRSF1;NUP35;NUP214;NXF1
prerank,regulation of response to oxidative stress (GO:1902882),0.4696807866446132,1.0157035747480836,0.45663956639566394,0.7415702570206109,1.0,4/11,19.36%,SELENON;MCTP1;STOX1;AIFM2
prerank,response to organophosphorus (GO:0046683),0.43252974358998875,1.015620519776452,0.4666666666666667,0.7414108065183174,1.0,2/16,8.34%,P2RX4;TRIM16
prerank,"DNA-templated transcription, termination (GO:0006353)",0.3480466250954624,1.0154292437253798,0.4778481012658228,0.7415117413753622,1.0,29/68,31.46%,TAF1D;POLR1G;POLR2H;PAPOLA;PABPN1;TTF1;UBTF;PRMT5;POLR1A;SYMPK;TBP;GTF2H1;SSU72;CPSF7;TAF1A;TAF1C;SNRPG;POLR1F;POLR2F;GTF2H5;SNRPF;CSTF2;MNAT1;NUDT21;MAZ;POLR1H;LSM11;CLP1;ERCC2
prerank,negative regulation of macroautophagy (GO:0016242),0.3912863241446164,1.0153989437486155,0.46144721233689207,0.7412209207493592,1.0,4/26,7.52%,SMCR8;SEC22B;CHMP4A;CHMP4B
prerank,regulation of axon extension (GO:0030516),0.3784896366635201,1.0146770675465013,0.4671857619577308,0.7425996247972305,1.0,7/37,12.80%,APOE;MACF1;GOLGA4;RNF6;RUFY3;DNM2;LIMK1
prerank,organelle assembly (GO:0070925),0.3238264280191345,1.0144487963156916,0.453,0.7428031602944535,1.0,132/384,29.95%,SH3PXD2B;FLNA;ATG7;ASAP1;CFAP44;TUBGCP4;TEKT2;RUFY4;PTPN23;ATP6V0D1;DYNC1H1;RILPL2;FOXJ1;SPAG16;IFT43;PATL1;CHMP4A;CHMP4B;LSM14A;TEKT5;PACS2;EIF2S1;EIF2A;PDCD6IP;PATL2;WDR35;WDR45;HAUS8;SNX10;ARMC9;RAB32;RAB8A;ABLIM1;RAB8B;CEP41;TMEM41B;RAB7A;TCTN3;PARVA;VPS4B;YTHDF3;OGFOD1;VTA1;HPS1;EXOC2;GSN;MAP1LC3B;CHMP7;DHX29;CNGB1;STAM2;CENPT;CEP250;ACTR3;UBQLN1;INO80;EIF4ENIF1;MVB12A;IFT88;RCC1;CSNK1D;YTHDF2;TMEM216;RPS23;PLK4;RAB1A;LZTFL1;IFT74;ATG16L1;UBAP2L;MKKS;NEK6;EHD4;RAB11A;CFAP70;HAUS2;RILPL1;ATXN2;BBIP1;RPS3;CHMP6;PRRC2C;MAK;ATG2B;IFT122;NPM1;MAP1LC3A;GABARAP;ATP2A2;LSM4;DYNC2I1;EHD1;G3BP1;IST1;EDC3;CYS1;CCDC65;GOLGA2;HDAC3;VPS28;STX7;CENPA;TRAF3IP1;RILP;LSM3;BBS7;TMEM107;MKS1;SCLT1;MAPRE1;ATG3;RC3H1;DYNLT2B;ARL6;EXOC4;ACTR2;TMEM237;ARL3;ATG13;DNAH5;AMBRA1;KLHL41;TMEM17;CEP83;IQCB1;RAB43;CFAP410;PIBF1;TP53INP2;SYNPO;SNF8;BECN1
prerank,regulation of T cell mediated immunity (GO:0002709),0.48147974201360366,1.0143492982836713,0.46837146702557203,0.7426715726451186,1.0,7/10,31.40%,CCR2;TNFRSF1B;RIPK3;HMGB1;WAS;AGER;ZBTB1
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.36642542767523134,-1.013991802308781,0.4163424124513619,0.8485821630801601,1.0,7/13,21.05%,GLUD1;GLUL;NOS1;GAD1;PRODH;ALDH4A1;DAO
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.4208095772438371,1.0138575381863222,0.4758364312267658,0.7435283518855157,1.0,5/20,19.09%,ACACA;SLC25A1;SCD5;HSD17B8;GCDH
prerank,granulocyte differentiation (GO:0030851),0.42324761672869826,1.01375225215542,0.49167733674775926,0.7434416169041995,1.0,8/18,30.91%,LEF1;CEBPA;CDK2;DEK;RXRA;CDK4;LBR;EP300
prerank,cellular response to interleukin-15 (GO:0071350),0.4620519199050519,1.013211885449577,0.49863387978142076,0.744112069986395,1.0,4/13,11.56%,IL2RB;CD4;GRB2;JAK1
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.4620519199050519,1.013211885449577,0.49863387978142076,0.744112069986395,1.0,4/13,11.56%,IL2RB;CD4;GRB2;JAK1
prerank,negative regulation of response to external stimulus (GO:0032102),0.33886558683899315,1.0130462350045653,0.46673490276356194,0.7441482130145081,1.0,22/105,16.01%,APOE;FPR2;SIRPA;NLRC3;LTF;CLDN19;PRKCD;FGF2;MFHAS1;OTULIN;PPARG;GATA3;PPARD;PTPN2;SERPINE1;SHARPIN;ILRUN;LPCAT3;ACOD1;C1QBP;DUSP3;SIGIRR
prerank,dicarboxylic acid transport (GO:0006835),0.390271011856957,1.013015656646236,0.4518779342723005,0.7438633818727358,1.0,10/28,24.39%,SLC26A1;PDPN;SLC46A1;SLC19A1;ARL6IP5;SLC13A3;SLC25A18;SLC13A5;SLC26A6;GIPC1
prerank,protein localization to synapse (GO:0035418),-0.3715436745020889,-1.0130008871449234,0.4385245901639344,0.8485452580179863,1.0,2/12,0.64%,NRXN1;NLGN1
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.36822295759090395,1.0129660766229642,0.4845474613686534,0.7436148057135852,1.0,8/43,15.08%,PRKCQ;PRKCD;ZBTB7B;NCK1;PRKCB;PTPN2;OGT;SORBS1
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.3419276866885523,1.0128256275414056,0.47741273100616016,0.7435987009550801,1.0,25/87,23.00%,ZMIZ1;UBA52;RPS27A;GCNT2;ZMIZ2;USP9X;BAMBI;JUN;ARHGEF18;TGFBRAP1;RHOA;NRROS;SMAD7;SMAD1;CBL;FURIN;APPL2;ZYX;NLK;FERMT2;LTBP2;UBC;DUSP15;ID1;TGFBR2
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.4475600900677241,1.0126739056533745,0.4823529411764706,0.7435995837430307,1.0,5/15,17.87%,EDEM1;ZFAND2A;SRP14;SPCS3;RAB3GAP2
prerank,protein autoprocessing (GO:0016540),0.4282622119083651,1.0124906108800058,0.48358585858585856,0.7436932656725116,1.0,4/17,15.84%,TMPRSS2;KLK6;AFG3L2;CASP4
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.23926611615146706,-1.0123629576425859,0.41025641025641024,0.847444241767931,1.0,13/80,9.32%,P2RY12;NLGN1;WASF2;PIK3R1;ANLN;EPS8;TWF2;TENM2;NCKAP1;CDC42EP4;APC;TAPT1;FUZ
prerank,positive regulation of bone mineralization (GO:0030501),-0.2758819919018004,-1.0122263000836211,0.43333333333333335,0.8447606656884347,1.0,5/35,3.29%,MEF2C;TMEM119;ALOX5;ACVR2B;BMPR1B
prerank,cytoskeleton organization (GO:0007010),0.3344911910495852,1.0120700102512779,0.48416751787538304,0.7443837763278072,1.0,22/114,13.14%,APOE;ARHGAP10;ANK1;MICAL2;MICAL1;PAK6;FMNL2;NEDD9;SH3KBP1;FGD6;STRIP1;RHOD;FMNL3;CCL13;RANBP9;LARP4;RHOG;CCL7;DIAPH1;RHOA;RHOU;PALLD
prerank,lipid translocation (GO:0034204),0.4136993187675894,1.0118468676112564,0.4715151515151515,0.7446055792799484,1.0,5/21,13.05%,ABCA1;ATP8B4;ABCA4;ATP9B;ABCA7
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.3804055453191028,1.011366765311142,0.4861111111111111,0.7454239998062171,1.0,14/35,31.26%,PTPA;PPP1R12A;HTT;CD300A;BOD1L1;PPP1R15B;HSP90AB1;GSK3B;PPP1R15A;CALM3;FKBP1B;HSP90B1;FKBP1A;CALM1
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.4202896532644983,1.0110871596565119,0.46916565900846435,0.7457785274678161,1.0,6/19,25.00%,SLC26A1;SULT6B1;TPST1;BPNT1;SULT2B1;SLC35B3
prerank,protein K63-linked ubiquitination (GO:0070534),-0.26392804411661075,-1.01053824824805,0.3829787234042553,0.8466752406598673,1.0,15/41,18.20%,ZFP91;ITCH;UBE2G1;UBE2O;TRIM56;PRKN;TRIM27;RNF168;UBE2E3;RNF152;PELI3;PRPF19;TRAF6;UBE2T;UBE2S
prerank,regulation of cellular component organization (GO:0051128),0.3322932230207392,1.0105300693013612,0.4783484390735146,0.7467737532537907,1.0,42/135,25.93%,APOE;ABL2;PRKCQ;SGK1;SGK3;SGK2;TRAF2;HRG;SPHK1;BBS10;CD22;RAB5C;HIP1;ATF5;BAP1;ATAD3A;CDK11B;RAB5A;HSPA8;RUFY2;ROCK1;SETD1A;SLITRK2;ARHGEF11;RASGRP2;MELTF;TFRC;STK11;HNRNPU;HIP1R;GFAP;TMEM97;MARK4;ARFGAP1;LATS1;SNX12;SOCS2;TNF;STK38L;HCFC1;STON1;PAK4
prerank,protein homooligomerization (GO:0051260),0.3347483414233652,1.0103001514527954,0.4826530612244898,0.7469491836220976,1.0,35/114,27.31%,ADCY8;ACACA;ALDOA;MLKL;THG1L;ALS2;KCNJ2;APIP;GNMT;PDCD6IP;PRF1;B2M;SHMT1;SLC1A5;UPB1;OSBPL2;GLS;BLM;APPL2;NINJ1;AQP4;DISP1;EHD4;ACACB;CLYBL;SOD2;EHD1;MIF;ASIC1;STEAP4;TRIM72;GOLGA2;HPRT1;ARC;FUS
prerank,transcription preinitiation complex assembly (GO:0070897),0.46331431341995344,1.0099809132684863,0.4698952879581152,0.7474043772261588,1.0,5/12,24.92%,GTF2A2;TBP;DR1;TAF7;BDP1
prerank,regulation of T cell chemotaxis (GO:0010819),0.46263913924537325,1.0099666944105974,0.48418156808803303,0.7470838427252798,1.0,3/11,11.65%,ADAM17;CCR2;CCL5
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.3913852507381849,1.0085837168019691,0.4758539458186101,0.7500872705783402,1.0,12/28,31.01%,ERCC6;CYREN;KMT5B;KDM4D;PARP3;HSF1;SETMAR;WAS;SMCHD1;ACTR2;PNKP;PARP9
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.4367234960108607,1.0085709789733122,0.4742138364779874,0.7497513422781635,1.0,7/17,25.39%,RIPOR2;MOSPD2;C1QBP;TIRAP;CD74;NCKAP1L;MDK
prerank,inositol phosphate biosynthetic process (GO:0032958),0.4784585469476789,1.008359342780302,0.48339973439575035,0.7499050441090388,1.0,2/11,4.69%,ITPKB;FGF2
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.36030235058413657,1.008323504143127,0.4794215795328142,0.7496265728033378,1.0,19/49,29.32%,NLRC3;RAF1;TREM2;IAPP;RIOK3;CDC42;CLU;RPL13A;HMGB1;HSF1;GSK3B;PTGER4;PMEPA1;HSPA5;TRAF3IP1;PPM1A;DACT1;AIDA;PYDC1
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.42462602399509514,1.0082041350116198,0.47577639751552797,0.7495521328910083,1.0,10/18,33.78%,MCM7;LIG1;POLE;GINS1;LIG3;RFC4;GINS3;GINS2;POLA1;PCNA
prerank,myeloid cell differentiation (GO:0030099),0.36464206649316505,1.0078949154044292,0.47744774477447743,0.749959416470583,1.0,17/47,31.39%,RPS14;MFHAS1;RUNX1;PTPN2;CEBPA;ZBTB16;RPS19;HSPA9;TIRAP;ACIN1;EPO;JAK2;FLVCR1;UFL1;PRDX3;JAK3;UBA5
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.4225327041268012,1.0072939486347399,0.46956521739130436,0.7511022970002832,1.0,2/18,2.58%,UBA52;RPS27A
prerank,monocyte differentiation (GO:0030224),0.4786746042171084,1.0072894700689263,0.4747612551159618,0.7507465583063226,1.0,7/10,21.85%,PDE1B;PPARG;VEGFA;PIR;IL31RA;MT1G;BMP4
prerank,cardiac muscle cell contraction (GO:0086003),0.41489976675454676,1.0062851741591177,0.4747225647348952,0.7528236189625559,1.0,7/19,16.83%,KCNJ2;ATP1A1;GSN;SCN1B;CACNA1D;SCN3B;PKP2
prerank,regulation of centrosome cycle (GO:0046605),0.41174728376140024,1.006103812017819,0.48972188633615477,0.7529298063248681,1.0,10/21,29.44%,CHMP4B;PDCD6IP;ATF5;VPS4B;FBXW5;MARK4;NPM1;GEN1;NAT10;SIRT1
prerank,protein localization to cell surface (GO:0034394),0.3927626340360741,1.005654464804413,0.4689403166869671,0.7536261122944141,1.0,4/26,10.20%,CTNNB1;FLNA;ANGPT1;FGF7
prerank,regulation of actin filament depolymerization (GO:0030834),0.4661332721515051,1.0051277343025744,0.48693259972489683,0.7545697723266762,1.0,1/12,0.92%,PLEK
prerank,multivesicular body assembly (GO:0036258),0.38642294275693895,1.0047688416517135,0.4831199068684517,0.7550774408845057,1.0,12/30,25.82%,CHMP4A;CHMP4B;PDCD6IP;VPS4B;VTA1;CHMP7;STAM2;MVB12A;RAB11A;CHMP6;IST1;VPS28
prerank,histone exchange (GO:0043486),0.37180436436568176,1.0046488595426621,0.4706559263521289,0.7550085811846374,1.0,19/37,33.44%,CENPO;ACTR6;CENPT;CENPX;SRCAP;KNL1;VPS72;NPM1;RBBP7;CENPK;CENPA;CENPS;RSF1;NASP;CENPH;DMAP1;ANP32E;CENPC;CENPW
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.367658021087215,1.0044691204768141,0.46136618141097424,0.7550808906115615,1.0,10/40,19.43%,MCL1;PRKCD;KMT5A;FBXO5;NEK4;ING2;FXR2;SMYD2;UBE2V2;CASP9
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.37384116925362915,1.0042544451110849,0.4801362088535755,0.7552349889419302,1.0,10/35,20.10%,ZMIZ1;RNF14;DAXX;DDX17;KDM3A;PPARGC1B;RBFOX2;WBP2;NR3C1;TMF1
prerank,myelination (GO:0042552),0.3628307041330138,1.0039586543335737,0.48368953880764903,0.7556260169548329,1.0,13/46,19.66%,B4GALT5;ACSBG1;MALL;AMIGO1;KLK6;MYOC;ABCD2;MPZ;MBP;NF1;EIF2B2;PMP22;MARVELD1
prerank,positive regulation of transferase activity (GO:0051347),0.3292598973081196,1.0034367982474208,0.5055499495459133,0.7565206465245284,1.0,39/142,25.03%,FLT1;CTNNB1;PRKCQ;CD4;CCT2;AXL;FBXW7;LMO4;TREM2;IGF1R;UBE2L3;VAC14;PABPN1;RPS2;RAD50;NVL;PKIB;DCUN1D2;HNRNPA2B1;KDR;POLG2;DDR2;PIN1;BMI1;EPM2AIP1;PTGES3;DCUN1D4;LMTK2;HSP90AB1;ACD;DKC1;FGFR3;ARRDC4;CD74;FGFR2;RFC2;DCUN1D3;PDGFRA;MAPK15
prerank,regulation of cell killing (GO:0031341),0.43369044687524905,1.0033603807451525,0.47684605757196497,0.7563409554283222,1.0,1/16,0.45%,CYBA
prerank,"transcription, DNA-templated (GO:0006351)",0.3219541131497561,1.0032024581415504,0.503006012024048,0.7563637210365949,1.0,51/207,21.41%,ERCC6;NFYA;NFIC;DEAF1;MNT;DDX21;SLC25A33;TAF4B;ZBTB7B;NOCT;NFX1;POLR2H;BTF3;SNAPC2;GTF2A2;TTF1;UBTF;KLF13;PRMT5;COPS2;AFF4;TBPL1;TAF15;DRG1;PWP1;MRPL12;GTF2F1;PIR;YBX2;POLR2D;NFKB1;TWNK;DEK;NR4A2;GMEB2;HSF2BP;EAF1;TBP;ELOB;PAF1;GTF2H1;TAF7;CCNT2;RNMT;TAF6;MLLT1;TSC22D1;TRIP13;TRIM24;TAF1A;HSF1
prerank,autophagy of peroxisome (GO:0030242),0.45609822313688825,1.0024730508901727,0.48641304347826086,0.7577319068722591,1.0,5/12,23.06%,SQSTM1;TRAPPC8;MAP1LC3B;ATM;ACBD5
prerank,cell cycle G1/S phase transition (GO:0044843),0.3469058114298006,1.0017732694941395,0.4968085106382979,0.759023541715501,1.0,25/61,30.14%,CDK6;PLK2;POLE;E2F3;CDK2;RCC1;CDC7;PPP6C;CDKN3;GSPT1;CUL3;DBF4;CUL1;CDC34;CUL2;LATS1;PLK3;CDK4;CUL4A;EIF4E;NASP;MNAT1;HINFP;CDC25A;CCND1
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.4464340207204961,1.001438043633785,0.47831632653061223,0.759483853599105,1.0,6/14,21.01%,NUDT5;NUDT1;ENTPD5;NUDT9;ENTPD6;NUDT15
prerank,response to ionizing radiation (GO:0010212),0.34428517624316074,1.0013380209583722,0.4830508474576271,0.7593537624592964,1.0,23/70,24.79%,ANXA1;TANK;FIGNL1;GRB2;EEF1D;BRCA1;AEN;ABRAXAS1;BLM;INO80;SMPD1;KDM4D;STK11;UIMC1;ATM;RAD1;IKBIP;RAD51AP1;USP28;TOPBP1;INTS7;GADD45A;DCUN1D3
prerank,endothelial tube morphogenesis (GO:0061154),0.47897305777733956,1.0013290602457932,0.5006765899864682,0.7590102177573564,1.0,3/10,14.57%,CTNNB1;RHOA;PRKD2
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.33156152024306484,1.0012080344055752,0.5141129032258065,0.7589511482092198,1.0,25/128,18.55%,CDK14;CCNY;FBXL17;OPTN;ODF2;NES;DYNC1H1;PPP2R1A;NINL;PPP1R12A;HAUS8;CCNB1;WEE1;CEP41;DCTN1;DNM2;YWHAG;PPME1;CDK2;CEP250;CSNK1D;PLK4;TUBB;HAUS2;FBXL6
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.47497749974540737,1.0011423464189273,0.46153846153846156,0.758737623903274,1.0,2/10,7.03%,CTNNB1;VEGFA
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.4661620207969285,1.000836397617066,0.48626373626373626,0.7591543112247048,1.0,3/11,12.81%,AXL;LILRB1;GAS6
prerank,potassium ion import across plasma membrane (GO:1990573),0.3685944244844394,1.0005755790663724,0.5084554678692221,0.7594025133952633,1.0,11/41,21.31%,ATP1B3;KCNJ2;ATP1A4;ATP1A3;ATP1A1;SLC12A4;KCNJ10;ATP1A2;KCNJ6;KCNJ15;SLC12A7
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.41087922251400977,1.0005178092848754,0.48093480934809346,0.7591709572981361,1.0,4/21,11.73%,CTNNB1;NES;VEGFA;DLL4
prerank,protein targeting (GO:0006605),0.33113785887217484,1.0000534948332662,0.49538461538461537,0.7599417734921028,1.0,43/118,29.88%,SDCBP;KIF13B;TOMM22;MGARP;ZDHHC15;EDEM1;ZDHHC18;NACA;ZFAND2A;TRAK1;TIMM44;RPL11;LAMP2;AP4E1;TIMM9;SRP14;SPCS3;SEC63;ZDHHC1;TOMM5;TOMM40;YIF1B;PEX16;PIKFYVE;FBXO7;LTBP2;TIMM17A;GABARAP;PITRM1;TIMM23;FUT10;GIPC1;RTP4;AP4S1;NCF1;ATG3;ARL6;ZDHHC21;ZFAND6;TOMM7;PEX19;FIS1;MFF
prerank,nervous system development (GO:0007399),-0.22092389895383702,-1.0,1.0,0.8760747813420036,1.0,79/429,10.18%,NAV3;OPHN1;RAPGEF5;MEF2C;LSAMP;NRXN1;NLGN1;FGF12;ADGRL3;CHRM2;BTBD3;ROBO1;MERTK;CRIM1;ROGDI;RBFOX1;SERPINI1;SH3GL2;SREBF2;ADAM22;VCAN;CNTN4;EFNA5;SEMA6A;ST8SIA4;GFRA1;COX7B;MBD5;SOX8;SDK1;NOTCH2;IL1RAPL2;DSCAML1;PTS;ADGRG6;SCN2A;TBX6;NCKAP1;CNTN6;APBA2;PAX8;STAT3;ADORA1;APBA1;RBFOX3;VXN;CHRM3;FEZ1;CDH2;FLRT3;FEZ2;EPHB1;STMN3;DHX30;APLP1;MYT1L;NPAS2;NAB1;SHANK3;ERBB3;APC;IRF2BPL;HAP1;DPYSL2;CRMP1;ADGRV1;PRKN;VLDLR;MARCKS;NAV2;SH3GL3;ACAN;DNER;TYRO3;INTU;ECT2;ROBO2;PAFAH1B3;ZIC4
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.3402384244920128,0.9995113537924262,0.5015384615384615,0.7608836053420378,1.0,25/80,29.68%,CTSD;GRAMD4;MALT1;CD44;RAF1;SIAH2;VEGFA;SOX7;TRIAP1;GAS6;DAPK1;USP47;SYK;ARL6IP5;HMGB1;TNFSF10;F2R;MAP2K5;TNF;GPX1;FNIP1;CYCS;DNAJB6;SIRT1;FIS1
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.31593835663332687,-0.999465822179739,0.4308510638297872,0.8744671885632781,1.0,4/22,11.31%,SH3GL2;RAPGEF2;NTRK2;NTRK3
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.3634938978000109,0.9994451417535729,0.5021978021978022,0.7606795501992403,1.0,12/44,16.50%,AGO2;CELF1;PABPC1;METTL3;CPEB3;YTHDF3;ROCK1;EIF4ENIF1;YTHDF2;ZC3HAV1;DHX36;PUM1
prerank,peptidyl-methionine modification (GO:0018206),0.4599455192471042,0.9992333250022623,0.4844384303112314,0.760810074526979,1.0,3/12,9.75%,APOA2;NAA16;NAA20
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.3272693807787556,-0.9990336950134441,0.43147208121827413,0.8726248175306173,1.0,5/19,8.40%,SYNJ2BP;DLG2;PRKCI;LRRC7;PARD3B
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.22442484430503207,-0.9989912867377427,0.38,0.8664352035885551,1.0,18/78,11.18%,LGMN;CTSS;DYNC1I1;SH3GL2;AP1S2;DYNC1LI1;KIF3C;KIF15;SAR1B;KIFAP3;AP1B1;CTSF;ARF1;SPTBN2;KIF4A;FCGR2B;ACTR1A;KIF23
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.22442484430503207,-0.9989912867377427,0.38,0.8664352035885551,1.0,18/78,11.18%,LGMN;CTSS;DYNC1I1;SH3GL2;AP1S2;DYNC1LI1;KIF3C;KIF15;SAR1B;KIFAP3;AP1B1;CTSF;ARF1;SPTBN2;KIF4A;FCGR2B;ACTR1A;KIF23
prerank,endoplasmic reticulum organization (GO:0007029),0.34491088505760187,0.9986469146974106,0.5057833859095688,0.7618439509304392,1.0,20/72,25.03%,TRAM1L1;TOR1AIP2;SMPD4;SEC61B;GAK;HMOX1;REEP3;DOP1B;LMAN1;LPCAT3;VAPB;GET1;VAMP2;LMAN2;ALDH3A2;REEP1;TOR1B;ZBED3;WDR83OS;MAPK15
prerank,renal water homeostasis (GO:0003091),0.40062244936051006,0.9982606898784555,0.49566294919454773,0.7624030915842843,1.0,7/23,21.57%,ADCY8;ADCY3;ADCY7;WFS1;AQP4;RAB11A;PRKAR1A
prerank,purine ribonucleotide metabolic process (GO:0009150),0.34491817813261194,0.9979199474781524,0.5005313496280552,0.7628679690897886,1.0,15/68,19.63%,GIMAP7;ACOT9;AK4;AK3;AMPD2;RHOQ;ACOT6;EFL1;SULT6B1;TPST1;BPNT1;ACAT1;GLYAT;ADSS1;SULT2B1
prerank,acyl-CoA metabolic process (GO:0006637),0.37673242433541065,0.9978979224800832,0.4936854190585534,0.7625585475073733,1.0,7/35,18.63%,ACACA;ACOT9;SUCLG2;ACOT6;GLYAT;DLST;ACACB
prerank,negative regulation of B cell activation (GO:0050869),0.40522334243767777,0.997852037789265,0.47665847665847666,0.7623098963841489,1.0,10/21,27.90%,ID2;FOXJ1;SAMSN1;CD300A;PARP3;ATM;LAPTM5;SFRP1;RC3H1;TNFAIP3
prerank,regulation of monooxygenase activity (GO:0032768),0.4032889591507395,0.9977348243255698,0.49700598802395207,0.7622364817177428,1.0,5/23,14.04%,VDR;CAV1;POR;DNM2;NOSTRIN
prerank,extracellular matrix assembly (GO:0085029),0.4042035857171775,0.9977061912785093,0.4981949458483754,0.7619448593902655,1.0,12/23,36.82%,ATP7A;GAS6;EFEMP2;MYH11;LTBP3;EMILIN1;TNXB;FBLN5;LAMB2;NTNG2;QSOX1;TGFB1
prerank,cell junction organization (GO:0034330),0.34132264460687994,0.9972862486000819,0.4941427050053248,0.762589519375969,1.0,18/71,20.55%,APBB2;FBLIM1;FLNA;TJP2;LRP4;LIMS2;ACTG1;ILK;RAB8B;RHOA;CDC42;ACTB;PIN1;FERMT2;MYO9A;VASP;PPFIA1;MARVELD2
prerank,multivesicular body organization (GO:0036257),0.3801452354426951,0.9967269668287784,0.5017381228273464,0.7636453634388921,1.0,12/31,25.82%,CHMP4A;CHMP4B;PDCD6IP;VPS4B;VTA1;CHMP7;STAM2;MVB12A;RAB11A;CHMP6;IST1;VPS28
prerank,positive regulation of GTPase activity (GO:0043547),0.3216403341986909,0.9959334754747454,0.5315315315315315,0.7651614281789033,1.0,52/188,26.11%,BCAR3;RGS1;ABR;ARHGAP25;CORO1C;TBC1D10C;ARHGAP24;TBC1D22A;RGP1;CCL4;RALGAPA2;ALS2;PKP4;SIPA1L2;FOXJ1;TBC1D2;RAPGEF6;RASGRP1;RIC1;CCL13;RACK1;MMUT;RHOG;CCL7;CCL5;CCL14;RASGRP2;DOCK7;NF1;TBC1D22B;TBC1D12;AFDN;TBC1D20;PIN1;FERMT2;GMIP;GSK3B;GPR65;ARHGEF5;F2R;TBC1D10A;LARS1;SIPA1L3;SGSM1;DOCK11;SIPA1;TBC1D16;RAB3GAP1;SFRP1;CX3CL1;RALGAPB;SNX18
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.3382874101939765,-0.9956152123957712,0.4429223744292237,0.8736820844764819,1.0,6/15,11.54%,LGMN;FER;RBPJ;EGF;EGFR;CDH13
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.35063988994274814,0.995386740444323,0.49572649572649574,0.766106591386064,1.0,17/57,25.70%,CTSD;ASPH;GRAMD4;MALT1;CYFIP2;SOX7;FYN;DAPK1;SYK;ARL6IP5;HMGB1;TNFSF10;F2R;TBC1D10A;USP50;TNF;AIM2
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.3743402623918307,0.9952863279416799,0.4933184855233853,0.7659888010220541,1.0,19/39,33.78%,UBA52;RPS27A;ERCC1;DDB2;DDB1;XPA;ERCC4;RFC1;GTF2H1;UBC;RFC2;GTF2H5;CUL4A;POLD4;ERCC2;RFC4;UBB;RFC5;PCNA
prerank,homeostasis of number of cells (GO:0048872),-0.3622451859465876,-0.9951284121252802,0.4533898305084746,0.87208596438181,1.0,1/12,0.09%,CX3CR1
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.3650344819493593,-0.9946525239427596,0.45041322314049587,0.8704980175637479,1.0,3/12,14.55%,TMEFF2;AP2A1;PF4
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.43883911266117354,0.9946358807027862,0.4878361075544174,0.7671896731428843,1.0,2/14,7.88%,CD84;RASGRP1
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.44977714136227986,0.9945158180230549,0.5220293724966623,0.7671069275078771,1.0,2/13,4.85%,DERL3;EDEM1
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.46076810422271536,0.9944399091740952,0.5,0.7669242746130316,1.0,4/11,33.52%,LPCAT3;VAPB;MOSPD3;STX18
prerank,meiosis I (GO:0007127),0.40633343369423935,0.9938756350014385,0.4975786924939467,0.7679061278555973,1.0,6/23,16.62%,BCL2L11;SYCP3;FOXJ3;SLC25A31;ING2;HSF2BP
prerank,positive regulation of innate immune response (GO:0045089),0.37977793282762673,0.9938541797039026,0.48667439165701043,0.7675836150256306,1.0,10/30,21.65%,FPR2;ADAM8;TRIM6;POLR3D;RIOK3;CCL5;RPS19;DHX9;NLRC5;LBP
prerank,cellular response to pH (GO:0071467),0.4234656654226082,0.9937215717898186,0.5117719950433705,0.7675478530503909,1.0,9/17,38.85%,SLC9A1;CHP1;ASIC1;PKD2L1;RAB11B;HVCN1;IMPACT;HYAL1;PKD1L3
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.33374211066014026,0.9930583502694803,0.5211558307533539,0.7687682935262296,1.0,24/84,18.51%,SRPK1;MBNL3;PRDX6;NCL;RBM25;CELF1;DDX17;SON;SRSF7;HNRNPK;PCBP4;RBM11;MBNL2;RBM15;RBFOX2;PUF60;NOVA2;C1QBP;FXR2;RBM15B;RBM39;HNRNPU;CELF6;CWC22
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.3780197645198221,0.9929999533093041,0.49035187287173665,0.7685480002980095,1.0,15/35,25.39%,STAP1;ABL2;PTK2B;CDK5;NRP1;PHPT1;IQGAP2;CDC42;DAPK3;HAX1;ARHGDIB;BAIAP2;BAIAP2L2;PDGFRA;MDK
prerank,regulation of centrosome duplication (GO:0010824),0.3887012149620229,0.9926659463897698,0.5040745052386496,0.7689725851325223,1.0,13/29,29.44%,CHMP4B;PLK2;PDCD6IP;VPS4B;FBXW5;NPM1;CEP120;GEN1;CEP295NL;NAT10;CEP295;ALMS1;SIRT1
prerank,carnitine shuttle (GO:0006853),0.4571667251057755,0.9926227001363177,0.4979973297730307,0.7687209600471487,1.0,5/11,24.87%,ACACA;MID1IP1;CPT2;ACACB;CPT1A
prerank,regulation of signal transduction (GO:0009966),0.32201209136400555,0.9925531468139985,0.5315947843530592,0.7685213111883517,1.0,34/190,14.67%,MDFIC;CD3E;IGFBP7;RGS3;FBXL17;IRAK2;CD24;DHRS3;MTCH1;BRAP;VEPH1;PPP2R1A;NCK2;RUNX1;MGLL;GATA3;NCK1;TREM2;UGCG;DTNBP1;ILK;PTPN2;UBTF;FYN;SOCS5;CD63;YWHAG;SHARPIN;SP100;OGT;PPIA;GIT1;LLGL2;CLU
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.34958185914259887,0.9922863366804948,0.49782135076252726,0.7688157807283138,1.0,17/55,24.55%,EIF6;XDH;SPHK2;SLC25A33;GRB2;BRCA1;SIRT5;CYP1B1;ACOD1;CCN6;CBR1;PIKFYVE;PDK3;RNF41;TGFBR2;PARL;GADD45A
prerank,regulation of T cell migration (GO:2000404),0.4126645370664621,0.9920790964512243,0.5076142131979695,0.7689293037896917,1.0,5/18,12.09%,SPN;RIPOR2;CD200R1;CCL5;RHOA
prerank,oogenesis (GO:0048477),0.4275274095577037,0.9918003921787225,0.4955640050697085,0.7692223349500529,1.0,6/15,25.39%,PIWIL2;METTL3;TRIP13;KMT2D;MEI4;MDK
prerank,negative regulation of RNA splicing (GO:0033119),0.41555014719140215,0.9917923120191763,0.5177215189873418,0.7688804572349505,1.0,6/19,21.26%,PTBP3;RPS26;SRSF7;PCBP4;C1QBP;RPS13
prerank,protein modification process (GO:0036211),0.3429690537347596,0.991704302318061,0.4946808510638298,0.7687154547209933,1.0,28/76,29.17%,ABL2;MSRA;UBL4A;UBA52;PARP4;B4GALT7;GNMT;UBE2L3;ERO1A;RABGGTB;BAP1;TGM5;UBE2L6;STK38;QPCT;RIPK3;UBL5;DUSP12;CDC34;FBXO11;PIGH;YES1;SLC35A1;ATG3;WWP2;UBA3;GGCX;ST3GAL1
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.4360966026018099,0.9914311025972835,0.49674054758800523,0.7689975635497817,1.0,4/14,17.26%,NCK1;PPP2R2D;PPP1R15B;PPP2R2C
prerank,fat cell differentiation (GO:0045444),0.3514802459636441,0.9913340640148971,0.5090715048025614,0.7688876011304072,1.0,16/57,26.16%,OSBPL8;GDF6;NR4A3;PPARG;EGR2;TMEM120B;ATF5;CEBPA;FOXO1;NR4A2;MKKS;METRNL;ADIG;STEAP4;PSMB8;BBS7
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.3748374984907895,-0.9912646149604053,0.4,0.8776369907280746,1.0,3/10,6.39%,SVIP;INSIG1;UBAC2
prerank,positive regulation of secretion by cell (GO:1903532),0.3371610256946957,0.9910598355225435,0.5121693121693122,0.7691529839661402,1.0,8/70,9.19%,IGF1;ABCG1;P2RX4;ADAM8;ATP13A2;TREM2;DTNBP1;ATP6AP1
prerank,urogenital system development (GO:0001655),0.4650328288678177,0.9908766085523737,0.513262599469496,0.769211565949334,1.0,2/11,6.78%,ANXA1;SOX9
prerank,glycolipid biosynthetic process (GO:0009247),0.3679382423406836,0.990626832362866,0.4910112359550562,0.7695073442568154,1.0,8/38,15.40%,LARGE1;PIGQ;PIGZ;PIGA;ST8SIA6;PIGN;PIGL;PIGC
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.4097112486995964,0.9903463591859627,0.49627791563275436,0.7698134254283755,1.0,6/20,17.22%,BCL2;KCTD17;PACS2;BAX;THADA;WFS1
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.47119119833655754,0.990323952217324,0.4973404255319149,0.7691392245992299,1.0,4/10,23.96%,MBP;MYADM;MAPK7;MAP2K5
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.47119119833655754,0.990323952217324,0.4973404255319149,0.7691392245992299,1.0,4/10,23.96%,MBP;MYADM;MAPK7;MAP2K5
prerank,DNA repair (GO:0006281),0.3179283457986023,0.9902155350973906,0.525,0.7690309994403421,1.0,119/284,34.22%,ERCC6;UBA52;PARP4;RAD51B;RPS27A;DOT1L;ERCC1;NUDT1;IGHMBP2;ASCC3;TRIM28;ATXN3;LIG1;POLE;RNASEH2A;MDC1;DDB2;ZRANB3;BRCA1;VCP;DDB1;ABRAXAS1;MGMT;FANCF;RAD50;ALKBH1;NEIL2;HUWE1;DDX1;XPA;BAP1;KMT5B;HPF1;SLC30A9;BLM;MBD4;ADPRS;CENPX;INO80;ERCC4;SLX4;USP47;BARD1;PMS1;PRMT6;POLB;UBE2V2;WDHD1;UIMC1;PARP3;BAZ1B;RAD54L;GTF2H1;ATM;RAD1;FANCA;RAD51AP1;UBC;RECQL5;TRIP13;DCLRE1A;ALKBH3;NPM1;TOPBP1;WDR48;ASCC1;NSMCE1;XPC;PARP2;RFC2;SUMO1;GADD45A;GTF2H5;USP1;CETN2;PIAS4;ASCC2;LIG3;CENPS;BRCC3;PDS5A;POLD4;ATR;MNAT1;RAD9A;ERCC8;HINFP;APTX;TICRR;SIRT1;CSNK1E;XRCC5;ASF1A;PNKP;TDP2;NABP1;PARP9;ZBTB1;ERCC2;RFC4;ACTR8;PDS5B;HUS1;UBB;TEX264;MLH3;WDR33;POLA1;SETD2;RFC5;EYA3;BABAM2;KDM4B;FANCE;SMARCAL1;PCNA;RAD51;CHEK2;TRRAP
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.3978171987418421,0.9901740130636848,0.4916467780429594,0.7687706826374715,1.0,5/24,13.62%,UBA52;IRAK2;RPS27A;TAB1;AAMP
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.4037477012174248,0.9898949304195518,0.49393203883495146,0.7690600738328341,1.0,6/22,16.14%,PSMC3;MED17;SRF;MED13;PSMC6;DHX36
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.32560339924068205,-0.9897923653751679,0.4626865671641791,0.8789889367707824,1.0,9/17,21.61%,CASK;PCSK6;TMEM204;XIAP;DOK5;SFRP4;SULF1;TFAP2B;SLIT2
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.3876802894915149,0.9894777107808173,0.5040369088811996,0.7697098922137622,1.0,5/26,13.62%,UBA52;IRAK2;RPS27A;TAB1;AAMP
prerank,membrane lipid metabolic process (GO:0006643),0.4057655707723916,0.9894364306139404,0.5043804755944932,0.7694515411733349,1.0,5/22,9.38%,CERK;SPHK2;TEX2;SPHK1;ARV1
prerank,nucleocytoplasmic transport (GO:0006913),0.357505816398733,0.9888289063032817,0.5027685492801772,0.7705112403379555,1.0,21/40,33.63%,NUP205;MALT1;ATXN1;NXT2;XPO1;HTATIP2;RBM15B;AAAS;NPM1;GEMIN8;SNRPG;NUP98;GEMIN2;SNRPF;GEMIN5;NUTF2;NEMF;SNRPD2;SNRPD1;PHAX;ANP32A
prerank,cell-cell junction maintenance (GO:0045217),-0.3886512276564407,-0.9886270581480459,0.46360153256704983,0.8796192076800008,1.0,2/11,5.09%,CSF1R;TJP1
prerank,neuron maturation (GO:0042551),0.4182161502616078,0.988344552747313,0.49813664596273294,0.7713146477798892,1.0,3/18,10.58%,B4GALT5;MTCH1;C3
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.38354795044033135,0.988295597941854,0.5131578947368421,0.7710693117136582,1.0,15/27,34.22%,CPA4;MSL3;NAT8;MRGBP;KAT7;PHF20L1;TAF6;MORF4L1;MORF4L2;RUVBL2;BRD8;EP300;CREBBP;NAA50;TRRAP
prerank,artery morphogenesis (GO:0048844),0.38439783734436406,0.9882779249957279,0.5065710872162486,0.770751948649962,1.0,6/30,16.05%,LRP1;NRP1;JAG1;VEGFA;SMAD7;NF1
prerank,polyamine metabolic process (GO:0006595),0.4427800331868271,0.9881235484446016,0.5054054054054054,0.770752954702962,1.0,4/13,19.28%,SAT1;PAOX;ODC1;SMOX
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.40564519548182837,0.988083914264802,0.4909090909090909,0.7704910170898417,1.0,6/20,18.40%,ITGA4;PLA2R1;GSN;PDCD4;ANO6;IL6
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.39711216627802653,0.9880036935320361,0.5096385542168674,0.7703229845650141,1.0,10/23,27.05%,PPARG;TXK;PTPN2;JAK1;PIAS1;NLRC5;HSP90AB1;SUMO1;JAK2;IFNGR2
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.46068645424290106,0.9879485651309159,0.49929676511954996,0.7700954060195372,1.0,7/10,40.03%,TREM2;TICAM1;CD68;MIA3;ADTRP;CD36;MYD88
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.3951898740149722,0.9875947279960445,0.4970202622169249,0.7705841487726951,1.0,7/23,21.92%,H1-0;DNASE2;DFFB;HMGB1;DNASE1L1;DFFA;SETMAR
prerank,pulmonary valve morphogenesis (GO:0003184),-0.32903372561231065,-0.9873885713456992,0.44221105527638194,0.8802545864286457,1.0,7/17,21.74%,ROBO1;NOTCH2;ROBO2;NFATC1;HEY1;SLIT2;HEYL
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.3274116301652364,0.9870373532605746,0.5162932790224033,0.7715763371998055,1.0,39/112,29.44%,ZMIZ1;UBA52;RPS27A;GCNT2;CILP;ZMIZ2;SOX9;CRKL;USP9X;BAMBI;JUN;ARHGEF18;TGFBRAP1;RHOA;NRROS;SMAD7;SMAD1;CBL;FURIN;APPL2;ZYX;NLK;FERMT2;NR3C1;LTBP2;UBC;DUSP15;ID1;MAPK7;TGFBR2;WWOX;SFRP1;COL1A2;LIMS1;PARD6A;ITGB1;CLEC3B;FKBP1A;SIRT1
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.4287213184693458,0.9869838261497487,0.49934296977660975,0.7713427678897465,1.0,2/14,7.62%,SLC27A1;CHKB
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.34077910103752584,0.9869773715358913,0.5166130760986066,0.7709988148130891,1.0,11/66,16.11%,GPNMB;CDK6;ANXA1;EIF4G1;ID2;ADAM17;WEE1;INO80;PRMT2;APPL2;CCND2
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.3420497883775828,0.9869754567268608,0.5376569037656904,0.7706404117772586,1.0,22/76,25.33%,STAP1;PLEK;NES;PTK2B;CDK5;NRP1;DYNC1H1;NCK2;NCK1;LIMK1;CDC42;NUMA1;PLK4;HAX1;PFDN2;EVL;VASP;BAIAP2;PFN1;BAIAP2L2;NCKAP1L;CX3CL1
prerank,polyol biosynthetic process (GO:0046173),0.43309414927404344,0.9867837346842946,0.5,0.770741010122659,1.0,3/16,4.69%,ITPKB;CYP27B1;FGF2
prerank,positive regulation of JNK cascade (GO:0046330),0.3421527927472327,0.9867257316915783,0.5173867228661749,0.7705225501009478,1.0,10/70,9.89%,MMP8;SDCBP;TRAF2;MAP4K2;PTK2B;MFHAS1;TAOK3;TRAF3;RASGRP1;TRAF1
prerank,calcium ion transmembrane transport (GO:0070588),0.33546802477779053,0.986681787788561,0.520703933747412,0.7702719368780865,1.0,17/86,19.56%,CACNA1A;TRPC4;P2RX4;MCOLN2;SLC24A4;ATP2B1;PMPCA;CACNA1D;AFG3L2;GAS6;SLC8B1;TRPM7;MCOLN3;CACNB3;ANO6;TMEM165;STOML2
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),-0.3808877351292208,-0.9864580576809002,0.44841269841269843,0.8739219301760829,1.0,3/11,5.58%,PANK4;PANK1;PPCDC
prerank,coenzyme A biosynthetic process (GO:0015937),-0.3808877351292208,-0.9864580576809002,0.44841269841269843,0.8739219301760829,1.0,3/11,5.58%,PANK4;PANK1;PPCDC
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),-0.3808877351292208,-0.9864580576809002,0.44841269841269843,0.8739219301760829,1.0,3/11,5.58%,PANK4;PANK1;PPCDC
prerank,chromosome condensation (GO:0030261),0.3644290490234688,0.9863363270184652,0.5152887882219706,0.770738319235554,1.0,10/36,19.35%,NCAPG;ERN2;NCAPG2;KMT5A;CCNB1;NCAPH;H1-0;DFFB;ACIN1;CSNK2A2
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.38265521354238924,0.9862255412616082,0.4988344988344988,0.7706418686749976,1.0,3/28,4.39%,APOE;ADCY8;SQSTM1
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.32909999361911135,0.9860874684092302,0.5202492211838006,0.7706277138417994,1.0,36/96,29.75%,NUP205;THOC1;NUP188;SRSF11;SRSF7;AGFG1;DDX39B;HNRNPA2B1;EIF4A3;RANBP2;TPR;SYMPK;CHTOP;THOC2;RBM15B;RAE1;SRSF2;NUP93;AAAS;UPF3B;POLDIP3;SRRM1;NUP54;NUP50;NUP98;MCM3AP;NUP42;NUP133;NUP210;THOC6;EIF4E;SMG1;SRSF1;NUP35;NUP214;NXF1
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),-0.2743429587864987,-0.9858995545884905,0.4740740740740741,0.8725756833120302,1.0,13/30,22.61%,CACNA2D1;FGF12;SNTA1;KCNH2;CACNA1C;NEDD4L;SCN2B;CACNA1G;KCNQ1;ANK2;SCN4B;SCN1A;KCNE3
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.46321152895936235,0.985734461887781,0.5013550135501355,0.7710809288178769,1.0,3/11,15.88%,P2RX4;LMNA;FOXO1
prerank,positive regulation of cell cycle process (GO:0090068),0.33368220874323334,0.9856633325600304,0.516162669447341,0.7708776381716165,1.0,25/91,25.94%,IGF1;MAP10;PKP4;CD28;DYNC1H1;CCNB1;RHOA;RANBP1;CDC42;PKN2;INO80;NUMA1;TPR;RACGAP1;CDC7;PLK4;SVIL;ATRX;CUL3;DBF4;CEP120;GIPC1;GEN1;CDC25B;USP19
prerank,positive regulation of cellular component movement (GO:0051272),0.3936542784381126,0.9856107228630722,0.5186522262334536,0.7706342033586091,1.0,7/24,18.05%,PDPN;VEGFA;ADAM17;PHPT1;RPS19;STK11;NTN1
prerank,regulation of intracellular protein transport (GO:0033157),0.3728371988371716,0.9855847305475154,0.5168539325842697,0.7703355031204226,1.0,9/32,24.51%,LCP1;ATP13A2;RUFY3;GCC2;TPR;VAMP2;BMP4;PRR5L;PLK3
prerank,cell cycle G2/M phase transition (GO:0044839),0.32631990097081903,0.9851244072370624,0.5500505561172901,0.771047327235793,1.0,25/129,18.55%,CDK14;CCNY;FBXL17;OPTN;ODF2;NES;DYNC1H1;PPP2R1A;NINL;PPP1R12A;HAUS8;CCNB1;WEE1;CEP41;DCTN1;DNM2;YWHAG;PPME1;CDK2;CEP250;CSNK1D;PLK4;TUBB;HAUS2;FBXL6
prerank,cellular response to glucose stimulus (GO:0071333),0.38054304827034646,0.9849315021971191,0.5192532088681447,0.7711311103729521,1.0,6/30,12.81%,ADCY8;ERN1;IGF1R;RACK1;PCK2;GAS6
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.3363546753437048,-0.9849155401132254,0.42592592592592593,0.8724614367403413,1.0,6/15,20.73%,TIPIN;NEK11;RAD17;MUS81;EME1;RAD9B
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.38263057091592717,0.9848352055444964,0.5034802784222738,0.7710073654390601,1.0,5/28,8.17%,UBA52;IRAK2;RPS27A;OTULIN;TAB1
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.3651321498405621,0.9846655355263442,0.5251959686450168,0.7710570037148634,1.0,17/40,31.52%,PTK2B;FBXW7;RPS7;RPL23;RPL11;XPO1;CLU;DESI1;CSNK2A2;LAPTM5;LATS1;CCDC22;UFL1;GNA12;PTEN;NUB1;PDCL3
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.4405836146903031,0.9846557360447759,0.5095057034220533,0.7707195262223093,1.0,2/13,3.91%,B4GAT1;B3GNT3
prerank,nuclear migration (GO:0007097),0.43567933650755764,0.9843903237588668,0.518324607329843,0.7709740482983489,1.0,7/13,23.22%,DYNC1H1;DCTN1;DOCK7;HOOK3;FBXW11;CEP120;TMEM201
prerank,positive regulation of protein transport (GO:0051222),0.33778690719885845,0.9843469742349619,0.5162986330178759,0.7707262725886111,1.0,13/67,17.36%,IGF1;ABCG1;ADAM8;ATP13A2;TREM2;RACK1;RUFY3;CLN3;PPIA;TPR;CHP1;BMP6;VAMP2
prerank,positive regulation of intracellular transport (GO:0032388),0.3657896598290374,0.9841506164426984,0.5209988649262202,0.7708364332018475,1.0,13/38,24.51%,DYNC1H1;PGAP1;RUFY3;NUMA1;TPR;STK11;VAMP2;TBC1D20;ACTN2;MLC1;EHD1;PRR5L;PLK3
prerank,negative regulation of cell differentiation (GO:0045596),0.3208013335257592,0.983639120248555,0.5563380281690141,0.7716662956622254,1.0,46/181,25.48%,ABCG1;CDK6;ABCA1;HDAC7;XDH;ID2;SOX3;PTK2B;CAV1;PPARG;JAG1;GATA3;SOX9;NOCT;NKX2-1;BAMBI;RIOX1;CHRD;ZBTB16;SMAD7;EFNA1;YTHDF2;ASXL1;FOXO1;PKP2;ADIPOR1;PDCD4;SINHCAF;HNRNPU;ANKRD26;PAF1;IL6;NEPRO;FERMT2;BMP5;SPRED2;BMP4;TRIB2;SUFU;CALR;SPRED3;ANP32B;TNF;CCDC85B;SFRP1;NOTCH4
prerank,aspartate family amino acid catabolic process (GO:0009068),0.4092432666836349,0.9834781477547494,0.5095057034220533,0.7716536461431079,1.0,5/19,19.09%,PIPOX;PHYKPL;DLST;SLC25A21;GCDH
prerank,positive regulation of T cell cytokine production (GO:0002726),0.4016732087031876,0.983378115225381,0.5181598062953995,0.7715003897080291,1.0,7/20,21.23%,IL18R1;MALT1;TRAF2;B2M;RSAD2;IL6;CD55
prerank,microtubule polymerization (GO:0046785),0.38737581993129144,0.9832677495117774,0.5166666666666667,0.77140245900262,1.0,6/28,20.41%,FGF13;TUBGCP4;RANBP9;CSNK1D;PIN1;SLAIN2
prerank,mRNA transport (GO:0051028),0.32595872771157947,0.9826505261641759,0.5391752577319587,0.772438426660771,1.0,37/101,29.75%,NUP205;THOC1;NUP188;SRSF11;SRSF7;AGFG1;DDX39B;HNRNPA2B1;EIF4A3;RANBP2;TPR;SYMPK;CHTOP;THOC2;RBM15B;RAE1;SRSF2;NUP93;AAAS;UPF3B;POLDIP3;SRRM1;NUP54;NUP50;NUP98;MCM3AP;NUP42;NUP133;NUP210;ARC;THOC6;EIF4E;SMG1;SRSF1;NUP35;NUP214;NXF1
prerank,positive regulation of amyloid-beta formation (GO:1902004),-0.3205760525986779,-0.9823462803279326,0.48372093023255813,0.8771314760196395,1.0,8/18,11.42%,ROCK2;EPHA4;PICALM;LRRTM3;RELA;CASP3;SLC2A13;IFNGR1
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.4501586610421814,0.981718181847436,0.5337748344370861,0.773877757818551,1.0,6/12,22.60%,CORO1C;FBLN1;SPRY4;MELTF;ITGB1BP1;ACTN4
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.4501586610421814,0.981718181847436,0.5337748344370861,0.773877757818551,1.0,6/12,22.60%,CORO1C;FBLN1;SPRY4;MELTF;ITGB1BP1;ACTN4
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.41169490222123895,0.9816282211243774,0.507537688442211,0.7737355969945287,1.0,8/19,22.48%,ATP13A2;FBXW7;HTT;HAX1;CSNK2A2;FBXO7;SREBF1;USP36
prerank,magnesium ion transport (GO:0015693),0.441442475831702,0.9813282749403003,0.5263157894736842,0.7740693100753959,1.0,4/12,22.47%,MAGT1;TUSC3;NIPAL1;NIPAL3
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.4430914570459022,0.9810405060955244,0.5091863517060368,0.7743791974294312,1.0,1/12,0.35%,CTSB
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.3677010490965274,0.9807633782017149,0.5150115473441108,0.7746483673119576,1.0,11/35,17.90%,PIK3CB;LRPAP1;B2M;HIP1;C3;APOC1;SERPINE1;HNRNPK;CLU;CBL;HIP1R
prerank,regulation of mRNA polyadenylation (GO:1900363),0.4154438078856499,0.980761564819884,0.5012531328320802,0.7742932418666097,1.0,8/17,28.75%,CPEB3;RNF20;ZC3H3;CPSF7;HSF1;CPEB1;CTR9;NUDT21
prerank,negative regulation of macrophage activation (GO:0043031),0.42199683596087467,0.9806269671002016,0.5180412371134021,0.7742550205371503,1.0,2/16,2.94%,PTPRC;CST7
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.35080305785338517,0.9804997741281584,0.5390539053905391,0.7741708252605706,1.0,9/51,16.42%,GAS7;SGK1;ATP7A;ALS2;TAOK3;DTNBP1;DNM2;SLC9A6;MINK1
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.32240819267475973,-0.9803569481624407,0.43946188340807174,0.8798719116157755,1.0,6/17,20.81%,RAPGEF2;ADRB1;ADCY9;GPR101;ADRA1A;ADRA2A
prerank,positive regulation of cell cycle (GO:0045787),0.3402504082236586,0.9801083434130182,0.4983853606027987,0.7747061376257897,1.0,29/62,34.49%,CCNY;SPHK1;ADAM17;CCNB1;PKN2;LRP6;DUSP3;CCND2;HSF1;SRPK2;TRIM21;CALR;FGFR2;MDM2;USP2;CDK4;CDC25B;HCFC1;USP19;PSMD10;EIF4E;RPS15A;CCND1;ASNS;CCDC57;NUDT16;USP22;SPDYA;PDGFB
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.41692432051029577,0.9799566033212067,0.5116580310880829,0.7747076480933639,1.0,7/16,29.18%,ATP5MG;STOML2;ATP5PD;ATP5F1B;ATP5MF;ATP5F1C;ATP5MC1
prerank,negative regulation of DNA recombination (GO:0045910),0.35872847481668335,0.9796674702711542,0.5186020293122886,0.7750082726747829,1.0,15/43,27.17%,DAXX;POLR2H;ZRANB3;BLM;H1-0;POLR2D;PARP3;ATRX;PARPBP;RTEL1;TERF1;ACD;POLR2F;SMCHD1;TERF2IP
prerank,regulation of organelle assembly (GO:1902115),0.337868085010046,0.9792893092772774,0.5304621848739496,0.7755012222862118,1.0,29/72,27.48%,TBC1D10C;TBC1D22A;MSN;TBC1D2;PLK2;PDCD6IP;NPRL2;GSN;RAB5A;VPS11;TBC1D24;IFT88;TBC1D22B;TBC1D12;TBC1D20;TBC1D19;ATXN2;PIKFYVE;NPRL3;NPM1;TBC1D10A;TBC1D16;MAPK15;CEP295NL;TRAPPC12;TBC1D15;ATG3;CEP295;DYNLT2B
prerank,embryonic axis specification (GO:0000578),-0.33477742198781946,-0.9789750280928561,0.5217391304347826,0.8811699042978162,1.0,15/15,66.56%,STIL;FZD5;HOXD8;COBL;CXXC4;RIPPLY2;SMAD2;MESP2;TBXT;WNT1;TBX3;PTCH1;WNT7A;SMAD6;TASOR
prerank,negative regulation of multicellular organismal process (GO:0051241),0.31789661067281216,0.9788250278519081,0.5784708249496981,0.776221361662496,1.0,53/199,25.39%,GPNMB;CORO1C;IL18R1;HDAC9;ATP2B1;APOA2;PON1;TBX18;PTPN23;NPTN;LRP4;GATA3;SOX9;RAB11FIP1;SLC6A4;ADAM17;HOXA7;NKX2-1;LRPAP1;GAS6;SMAD7;EFNA1;ROCK1;DDIT3;PROCR;RPS19;SRF;DOCK7;NOVA2;ADIPOR1;ASB1;STK11;PARP3;EVL;SLC11A1;BMP5;SPRED2;TIMP1;ARHGDIB;GSK3B;LAMA4;BMP4;SRGN;ID1;PTGER4;CALR;F2R;IL17D;SPRED3;TNF;ATF4;SFRP1;MDK
prerank,secondary palate development (GO:0062009),0.4324007401606233,0.9787367865374005,0.5186136071887034,0.7760517528430829,1.0,1/14,2.01%,LEF1
prerank,regulation of cytokinesis (GO:0032465),0.33409698950961303,0.9786918257278833,0.5574288724973656,0.7758125721972905,1.0,27/78,27.01%,BCL2L1;MAP10;PKP4;PLK2;AHCTF1;KLHL13;BIRC6;RHOA;CDC42;PKN2;KIF20A;GIT1;RACGAP1;PLK4;SVIL;RAB11A;PIN1;CUL3;RAB11FIP4;CALM3;ZFYVE19;GIPC1;PLK3;CDC25B;CETN2;KLHL21;PRPF40A
prerank,myelin assembly (GO:0032288),0.45740029594311454,0.9785001468650928,0.49728260869565216,0.7759197509420602,1.0,3/10,18.21%,CD9;NCMAP;PMP22
prerank,blood circulation (GO:0008015),0.35250391630953076,0.9781069815911347,0.5394736842105263,0.7764738009684513,1.0,12/49,20.90%,MYOF;OLR1;C3AR1;ELN;SCPEP1;DLL4;F5;ROCK1;ADORA2A;ITGB1BP1;CYB5R3;EPO
prerank,pore complex assembly (GO:0046931),0.4034481311805246,0.9778420452785919,0.5160493827160494,0.7767221779530857,1.0,8/19,24.83%,NUP205;AHCTF1;TPR;AFDN;ANO6;PDZD11;NUP93;NUP98
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.4368430375402687,0.9777889418682982,0.5078328981723238,0.776473786384587,1.0,4/13,19.63%,SULT6B1;TPST1;BPNT1;SULT2B1
prerank,regulation of secretion by cell (GO:1903530),0.3450846633628755,0.9776852141728076,0.5229946524064171,0.77634701618233,1.0,16/54,17.80%,ANXA1;MCTP1;CPLX4;RHBDF2;P3H1;RIC1;RHBDF1;RAB8A;RAB8B;KCNMB4;DNAJC1;CPLX2;LLGL2;MCTP2;VAMP2;DISP1
prerank,regulation of sprouting angiogenesis (GO:1903670),0.3721813692373886,0.9772501946521308,0.5244596131968146,0.7769745242318328,1.0,9/33,14.03%,PKM;ITGA5;PIK3CB;FGF2;PDPK1;VEGFA;JAK1;SMAD1;FGF18
prerank,muscle cell differentiation (GO:0042692),0.3669802876272941,0.977186693677659,0.5382882882882883,0.7767655419561007,1.0,4/32,4.00%,MRTFA;SPEG;SYNE1;TBX18
prerank,negative regulation of neuron projection development (GO:0010977),0.34623336738923854,0.977075940557375,0.5372972972972972,0.7766807754376391,1.0,12/56,16.08%,APOE;MYLIP;LRP4;GDI1;RUFY3;GAK;PAQR3;RHOA;EFNA1;CBFA2T2;LPAR1;EFNB2
prerank,DNA packaging (GO:0006323),0.4182541395874302,0.9770518981133766,0.5012406947890818,0.7763798422394919,1.0,4/16,15.12%,NOC2L;M1AP;H1-0;CHAF1B
prerank,positive regulation of lamellipodium organization (GO:1902745),-0.26900798036235574,-0.9762830515413314,0.45528455284552843,0.8863484375529684,1.0,6/32,4.91%,WASF2;PIK3R1;RREB1;TWF2;CARMIL1;NCKAP1
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.34420479142629073,-0.9761471147458656,0.46747967479674796,0.8837855083183116,1.0,3/13,11.35%,NR3C2;PLPP1;PGR
prerank,nuclear export (GO:0051168),0.330976401365605,0.9755112438297288,0.5409663865546218,0.7795426340535713,1.0,30/80,29.75%,MALT1;EGR2;THOC1;ATXN1;NUP188;SRSF11;CCHCR1;SRSF7;XPO1;DDX39B;EIF4A3;TPR;CHP1;CHTOP;THOC2;RAE1;DESI1;SRSF2;XPO6;UPF3B;CALR;POLDIP3;SRRM1;NUP42;THOC6;EIF4E;NUTF2;SRSF1;NUP214;NXF1
prerank,mitotic cytokinesis (GO:0000281),-0.2521063588607582,-0.9754669069185098,0.4731182795698925,0.8828329576684163,1.0,15/47,11.28%,ANLN;ROCK2;MYH10;TRIM36;CNTROB;STMN1;APC;NUSAP1;SPTBN1;KLHDC8B;KIF4A;ECT2;KIF23;SPAST;INCENP
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.3839668109690972,-0.9748580765445172,0.46308724832214765,0.8816578593695684,1.0,3/10,5.48%,STAT5A;PRLR;STAT3
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.36095632879042755,0.9747618811775018,0.5314917127071823,0.7809001282109733,1.0,9/39,16.15%,CTNNB1;NRP1;FGF2;COL4A1;VEGFA;NKX2-1;DLL4;LRP6;KDR
prerank,purine nucleotide metabolic process (GO:0006163),0.394602005146926,0.9743165451758625,0.5356695869837297,0.7815163880669187,1.0,12/24,26.30%,XDH;GART;PRPSAP1;ITPA;MTHFD1;NUDT15;PRPS2;PPAT;ADSL;GUK1;HPRT1;GPX1
prerank,negative regulation of chemotaxis (GO:0050922),-0.2747087161845072,-0.9743031373902019,0.5408805031446541,0.8803933033904674,1.0,8/31,13.39%,ROBO1;SEMA6D;SEMA6A;AIF1;THBS1;ROBO2;SEMA6C;SEMA4B
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.32640523033208524,0.974174688850358,0.55175983436853,0.7814887242339089,1.0,32/88,27.96%,MYO5A;FTL;BLOC1S3;VPS13C;RABEP1;GOLGB1;NAPA;CORO7;DTNBP1;VPS13A;AP4E1;ARFGEF2;DNM2;DOP1B;EXOC2;HSPA8;AP1G1;PUM1;SH3D19;VAMP2;VPS35L;FTH1;AP1M1;LLGL1;CCDC22;SCAMP3;CLINT1;AP4S1;STX4;KIF16B;EXOC4;ARL3
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.2627858806726156,-0.9741642897086986,0.47058823529411764,0.8778028786429273,1.0,10/33,14.97%,CCND3;FGF10;PLCB1;RPTOR;PLCG2;AIF1;EGFR;STXBP4;EZH2;TFDP1
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.40514032709245096,0.9736824767716467,0.532777115613826,0.782289214433602,1.0,5/19,16.14%,PRDX5;MAF1;NAB2;CEBPA;DHX36
prerank,cristae formation (GO:0042407),0.3776248963071757,0.9733652620856614,0.5259975816203144,0.7826943863739345,1.0,11/27,29.24%,IMMT;SAMM50;ATP5MG;AFG3L2;CHCHD6;ATP5PD;ATP5F1B;ATP5MF;ATP5F1C;ATP5MC1;SPG7
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.34482890899811447,0.9732875418719099,0.5137816979051819,0.7825273209278135,1.0,20/52,27.10%,CNOT4;EXOSC4;PATL1;PATL2;CNOT10;EXOSC9;NT5C3B;DCP1A;POLR2D;LSM6;EDC4;EXOSC5;CNOT6;SAMD4A;PAN2;LSM4;EDC3;LSM3;CNOT6L;RC3H1
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.3550289428714918,0.9730881623194784,0.5281146637265711,0.7826529442931422,1.0,9/45,21.85%,CTNNB1;BCL6;PLK2;BRINP2;WEE1;PRCC;NME6;BUB1B;BMP4
prerank,ephrin receptor signaling pathway (GO:0048013),0.3333549971161026,0.9730352226555876,0.5562435500515995,0.7824006497542371,1.0,20/82,16.40%,SDCBP;ARPC2;ARPC3;ARPC5;MMP9;NCK2;ACTG1;PSEN2;FYN;RHOA;CDC42;EFNA1;ROCK1;ACTR3;ACTB;GIT1;ARPC1B;EFNB2;KALRN;RASA1
prerank,endothelial cell proliferation (GO:0001935),0.4213213725486954,0.9728630889139198,0.532051282051282,0.7824431745998135,1.0,5/17,21.85%,ANGPT4;ERN1;HMOX1;ITGB1BP1;BMP4
prerank,microglial cell activation (GO:0001774),-0.3104449645515245,-0.9728559059875364,0.4528301886792453,0.8787449301308554,1.0,4/21,7.95%,CX3CR1;ITGAM;AIF1;APP
prerank,regulation of response to external stimulus (GO:0032101),0.32065950536931315,0.9726490868781192,0.5537359263050153,0.7826006606027496,1.0,27/121,18.70%,P2RX4;ANXA1;TMSB4X;FGR;PTGES;HRG;TRAF3;CAV1;MGLL;BCL6;PTPN22;STK24;BRD4;TREM2;SAG;CELF1;CCR2;PDE6B;CNGB1;CASP4;PSMA6;APPL2;EFNB2;TIRAP;SBNO2;USP18;ELMOD2
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.3476930567257093,0.9724015194962519,0.5322404371584699,0.7828015720677531,1.0,12/45,25.70%,LPL;MALT1;PANX1;HSPB1;TRIM16;TMEM106A;IL6;EGR1;USP50;TNF;JAK2;AIM2
prerank,positive regulation of DNA recombination (GO:0045911),0.37770735595556443,0.9723800530092659,0.5386416861826698,0.7824940745700439,1.0,10/27,27.78%,ERCC6;KMT5B;PRDM9;ARID2;TFRC;RAD51AP1;WAS;WDR48;FUS;ACTR2
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.4627400754575749,0.9720476722557924,0.52443857331572,0.7828828608759906,1.0,6/11,36.93%,GDF6;SMAD7;TGFBR2;USP15;TGFB1;TGFB2
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.3211271291649399,0.9717372148772567,0.557711950970378,0.7832097325468119,1.0,34/118,22.18%,GPNMB;CTNNB1;RAP2A;KIF13B;DAG1;CHRNB2;ZDHHC15;CDK5;FMNL2;FGF2;BCL6;STRIP1;LARP4;RUFY3;PLXND1;HMOX1;RNH1;PHLDB1;KIF1A;SP100;PAK2;SARM1;INF2;NF1;HTATIP2;SH3D19;IL6;FERMT2;EGLN1;CFL1;MARK2;GSK3B;ZMYM4;NSMF
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.3430753634057484,-0.9717260273349814,0.45933014354066987,0.8791957034058531,1.0,4/15,8.53%,SOX8;PAX8;AGT;PAX2
prerank,base-excision repair (GO:0006284),0.3498840644340106,0.9717027536218718,0.5449500554938956,0.7829320787023168,1.0,13/48,19.68%,ERCC6;LIG1;POLE;NEIL2;HUWE1;XPA;MBD4;ADPRS;USP47;PRMT6;POLB;RFC1;POLG
prerank,positive regulation of immune effector process (GO:0002699),0.37854592375340024,0.9715001431317238,0.5143540669856459,0.7830380445329251,1.0,8/27,21.65%,PTPRC;IL12RB1;LILRB1;CCR2;RPS19;APPL2;IL2;LBP
prerank,regulation of smoothened signaling pathway (GO:0008589),0.3531239201107174,0.9712665408290851,0.5475161987041036,0.7832040048150342,1.0,21/50,32.12%,TEDC1;FBXL17;EVC;TEDC2;ARMC9;RACK1;VCP;HHIP;IFT122;SUFU;FGFR2;GLIS2;SFRP1;KCTD21;BTRC;HERC4;GLI3;PDCL;TUBD1;CREBBP;MEGF8
prerank,regulation of intracellular signal transduction (GO:1902531),0.30859775346276974,0.9710657422496146,0.605,0.7833148333961689,1.0,119/420,25.34%,MYO9B;ABR;ARHGAP25;ARHGAP10;ARHGAP21;ARHGAP24;TMSB4X;SGK1;GNA13;TRAF2;SGMS1;OPTN;AKAP13;SPHK2;CD24;TRIM6;A2M;DYRK2;SQSTM1;PAK6;CDK5;TAOK3;TRAF3;PPP2R5C;HSPB1;DAXX;NOC2L;PTPN22;PDPK1;STK3;TAF4B;VEGFA;TREM2;HDAC1;DLC1;ARAP2;KMT5A;RHOD;RHOQ;RMI1;CHD3;RPL11;BRCA1;TRAF1;ARHGAP6;ARHGAP19;PRMT5;ARHGEF1;PIP5K1C;RAD50;MYOC;HIPK1;RHOG;TAF15;ARHGEF18;RHOA;RHOU;BLM;CDC42;CDK2;PTPN13;PAK2;ENTPD5;ARHGAP12;PRKD2;RCN3;ARHGEF11;ING2;CLEC6A;RACGAP1;FAM13B;BARD1;KALRN;MINK1;ING5;PIK3R2;SMYD2;PRKAG1;STK11;ARHGAP30;ARHGAP9;TBP;PIN1;ATM;ARHGAP17;RAD1;TP53RK;TAF7;CSNK2A2;RHOT2;FAM83D;EHMT1;TAF6;ARHGEF2;MYO9A;GMIP;ARHGDIB;SRGAP1;PLEKHG2;RNF41;PRKAR1A;TAOK1;ARHGEF5;TOPBP1;VAV3;RBBP7;PTPMT1;RHOF;PIP5K1B;MDM2;USP2;RFC2;TNF;PLK3;BIRC2;HDAC2;RRAGC;VAV1;FGF1
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.4178228480185451,0.9710373649661039,0.5363057324840764,0.7830228574383739,1.0,2/16,11.35%,CLDN19;CLDN18
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.36483606460782025,0.970941507888557,0.54337899543379,0.7828904006699179,1.0,8/33,18.68%,PLAU;MUC1;HRG;SERPINE1;EFNA1;CYP1B1;SYK;ITGB1BP1
prerank,positive regulation of vascular permeability (GO:0043117),0.44204957181314514,0.9708691890230704,0.5210526315789473,0.7827017733753214,1.0,3/12,7.25%,TJP2;VEGFA;ANGPT1
prerank,peptidyl-proline hydroxylation (GO:0019511),0.4604856447240611,0.9708471699243268,0.5314591700133868,0.7823929465936348,1.0,7/11,22.17%,P4HB;CRTAP;OGFOD1;P4HA3;EGLN1;P4HA1;EGLN3
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.44058606199087735,0.9708142578157033,0.5231958762886598,0.7821139021579298,1.0,2/12,3.91%,B4GAT1;B3GNT3
prerank,arachidonic acid secretion (GO:0050482),0.46695801715468244,0.9701549283684989,0.5281980742778541,0.7829000336665185,1.0,1/10,1.53%,ANXA1
prerank,arachidonate transport (GO:1903963),0.46695801715468244,0.9701549283684989,0.5281980742778541,0.7829000336665185,1.0,1/10,1.53%,ANXA1
prerank,cellular response to amino acid stimulus (GO:0071230),0.36476914736986643,0.9700026367826652,0.533256880733945,0.7828715716043545,1.0,15/33,31.66%,RRAGD;CPEB4;IPO5;CPEB3;FYN;UBR2;NSMF;LARS1;CPEB1;RRAGC;SESN2;LAMTOR3;LAMTOR1;RRAGB;XBP1
prerank,positive regulation of phosphatase activity (GO:0010922),0.4029125340033714,0.969978160636337,0.54125,0.7825721086451723,1.0,8/21,23.76%,PLEK;PTPA;CD300A;PPP1R15B;RIPK3;HSP90AB1;PPP1R15A;CALM3
prerank,regulation of chromatin binding (GO:0035561),0.4647427519167765,0.9698177709553372,0.5170532060027285,0.7825525592535905,1.0,3/10,16.27%,WAPL;GMNN;KDM4D
prerank,lipid droplet organization (GO:0034389),-0.2999207158920474,-0.9698037727819999,0.49693251533742333,0.8820964432284542,1.0,7/22,29.49%,CDS1;PLA2G4C;PNPLA3;SQLE;PPID;HILPDA;CDS2
prerank,gastrulation (GO:0007369),0.4150559710431677,0.9689744397531752,0.5317258883248731,0.7841508229420996,1.0,2/15,3.93%,EOMES;NR4A3
prerank,negative regulation of developmental growth (GO:0048640),0.37578432990247457,0.9687713302026538,0.5254041570438799,0.784277626496383,1.0,3/30,7.45%,FGF13;RNF6;SLC6A4
prerank,macrophage activation (GO:0042116),0.36625262927289076,0.9680228086769658,0.5458715596330275,0.7856283950544586,1.0,14/34,25.33%,FPR2;FER1L5;TREM2;CLU;ITGB2;TMEM106A;SYK;C5AR1;SBNO2;SLC11A1;LBP;TNF;JAK2;CX3CL1
prerank,regulation of viral transcription (GO:0046782),0.35294634048911516,0.9680203523156002,0.5308641975308642,0.7852774030540463,1.0,14/39,33.08%,MDFIC;POLR2H;GTF2F1;POLR2D;DHX9;TRIM21;POLR2F;TARBP2;SUPT4H1;RSF1;UBP1;HEXIM1;NELFA;TRIM11
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.3323493320517235,0.9679318930743496,0.5447839831401475,0.7851263501496869,1.0,26/72,30.69%,FGF2;GRB2;HNRNPM;POLR2H;FGF7;FGF20;GTF2F1;FGF18;POLR2D;RBFOX2;CBL;HNRNPF;SPRED2;FGFRL1;FGFR3;FGFR2;POLR2F;FLRT2;FGF1;KIF16B;MAPK3;SHOC2;TIAL1;GALNT3;CEP57;MAPK1
prerank,L-glutamate transmembrane transport (GO:0015813),-0.37928763579967295,-0.9675133663859966,0.49070631970260226,0.8858098765665056,1.0,5/10,20.64%,SLC1A3;SLC25A12;PRAF2;SLC1A1;SLC1A2
prerank,mitotic DNA replication (GO:1902969),0.4575881462353626,0.9674788591918242,0.5315934065934066,0.7858010863954565,1.0,4/10,20.26%,MCM2;LIG1;GINS1;MCM6
prerank,sprouting angiogenesis (GO:0002040),0.34654185782323377,0.9662349131587513,0.5369955156950673,0.7882321472727158,1.0,11/51,18.68%,PTK2B;NRP1;FGF2;OTULIN;VEGFA;ANGPT1;PARVA;SRF;EFNB2;KDR;ITGB1BP1
prerank,kidney development (GO:0001822),-0.2340873433502096,-0.9659494304338693,0.5471698113207547,0.8874080079032854,1.0,23/65,22.85%,SALL1;PCSK5;FGF10;VANGL2;ITGA8;PAX8;AGT;PAX2;GREB1L;ROBO2;SULF2;OSR1;IFT27;SULF1;PYGO2;TFAP2B;CENPF;BAG6;PKD1;MME;HYAL2;SHH;CEP290
prerank,vascular transport (GO:0010232),0.3279569895082681,0.9652055352046653,0.58377239199157,0.790259105539635,1.0,19/81,19.43%,LRP1;SLC27A1;SLC38A1;SLC6A6;SLC7A1;SLC5A1;SLC2A1;SLC22A3;ATP1A4;SLC1A5;ATP1A2;TFRC;SLC7A8;SLC5A3;SLC19A1;SLC28A2;SLC13A3;SLC16A2;SLC38A2
prerank,regulation of DNA recombination at telomere (GO:0072695),0.40423666440448147,0.9648804130169851,0.527363184079602,0.7902810347242927,1.0,8/19,27.17%,DAXX;POLR2H;POLR2D;ATRX;TERF1;ACD;POLR2F;TERF2IP
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.40423666440448147,0.9648804130169851,0.527363184079602,0.7902810347242927,1.0,8/19,27.17%,DAXX;POLR2H;POLR2D;ATRX;TERF1;ACD;POLR2F;TERF2IP
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.3715266826190865,-0.9645139879898189,0.5022026431718062,0.888600246520006,1.0,5/12,11.36%,WNK1;GLRX;WNK3;DMD;NOS1
prerank,ncRNA metabolic process (GO:0034660),0.35931072783411155,0.9644294895029474,0.5501138952164009,0.7909459883468556,1.0,3/37,8.76%,AGO2;PIWIL2;DDX17
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.3621461507463641,-0.9644294644307596,0.510548523206751,0.8859090299917101,1.0,5/12,9.37%,DPYD;CTPS1;DPYSL2;CRMP1;ALDH6A1
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.32310828780816747,0.9641713937165839,0.5573248407643312,0.7911739279059823,1.0,31/80,31.40%,ARF3;SEC22B;PLPP3;HTT;NAPA;KLC1;TAPBP;SCYL1;COG4;ATP9B;RACGAP1;RAB1A;LMAN2;ARFGAP3;ARFGAP1;TMED3;GOLPH3;ARFGAP2;GOLPH3L;COPZ2;SURF4;TMED2;USE1;COPA;KIF22;KDELR2;COPG1;COPB2;COPG2;DNAJC28;COG7
prerank,mitochondrion morphogenesis (GO:0070584),-0.37949407089953746,-0.9637693178672821,0.502127659574468,0.8849010881614117,1.0,3/11,8.10%,SLIRP;PNPT1;MYH14
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.38056352972051144,0.963662237919232,0.5303933253873659,0.7919375648636899,1.0,7/24,22.55%,TAPBP;B2M;SEC24A;SEC24D;FCER1G;CALR;CANX
prerank,negative regulation of cellular senescence (GO:2000773),0.4332070293525957,0.9634922881988853,0.5423280423280423,0.7919614678966673,1.0,3/13,12.28%,CDK6;FBXO5;ZKSCAN3
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.4376607388790577,0.9634255456071265,0.5305591677503251,0.791756470599535,1.0,3/12,25.90%,SOX9;RBP4;TLR9
prerank,nitric oxide mediated signal transduction (GO:0007263),0.4168357168450389,0.9634053255904002,0.5436654366543665,0.7914466301371189,1.0,1/16,0.47%,APOE
prerank,positive regulation of exocytosis (GO:0045921),0.35785060226587445,0.9632479356338826,0.5444191343963554,0.7914720903829932,1.0,7/35,12.82%,SDCBP;ATP13A2;PDCD6IP;ATP6AP1;RAB7A;VPS4B;RAB5A
prerank,mRNA 3'-end processing (GO:0031124),0.32519274445591395,0.9631505913906686,0.5711297071129707,0.7913291789303797,1.0,36/78,33.58%,GRSF1;THOC1;PAPOLA;PABPN1;PABPC1;SRSF11;SRSF7;DDX39B;EIF4A3;POLR2D;SYMPK;CHTOP;THOC2;PAF1;RPRD1A;SRSF2;SSU72;CPSF7;UPF3B;POLDIP3;SRRM1;MTPAP;PAPOLG;THOC6;CSTF2;SRSF1;NUDT21;TENT4B;LEO1;LSM11;CLP1;CDC40;AHCYL1;TUT1;WDR33;SLBP
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.3223952708456973,0.9629483020329034,0.5736196319018405,0.7914253529582728,1.0,29/101,26.87%,FLT1;CCNY;SLC27A1;LTF;ADAM8;PDGFA;CD24;FGF2;PIK3R5;VEGFA;RASGRP1;ADAM17;RHOA;FGF18;CAB39;CCND2;RALB;FERMT2;SYAP1;MAP2K2;IL34;HTR2B;CALM3;TNF;TCIM;FGF1;PARP16;PIH1D1;PSMD10
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.40492325833425347,0.9628366323973374,0.553770086526576,0.7913309074581576,1.0,9/19,30.91%,DYRK2;AEN;HIPK1;TMEM109;USP28;CDIP1;SNW1;SIRT1;EP300
prerank,RNA export from nucleus (GO:0006405),0.32034431936789803,0.9626798872847218,0.5563598759048604,0.7913062559735395,1.0,36/100,29.75%,NUP205;THOC1;NUP188;SRSF11;SRSF7;AGFG1;DDX39B;HNRNPA2B1;EIF4A3;RANBP2;TPR;SYMPK;CHTOP;THOC2;RBM15B;RAE1;SRSF2;NUP93;AAAS;UPF3B;POLDIP3;SRRM1;NUP54;NUP50;NUP98;MCM3AP;NUP42;NUP133;NUP210;THOC6;EIF4E;SMG1;SRSF1;NUP35;NUP214;NXF1
prerank,protein localization to cilium (GO:0061512),0.3689883692732796,0.9621806123869903,0.5469678953626635,0.7920936294968915,1.0,11/32,27.96%,RABEP1;TTC21A;WDR35;SNX10;CSNK1D;IFT122;EHD1;MAPK15;TMEM107;ARL6;ARL3
prerank,regulation of protein ubiquitination (GO:0031396),0.31870715608705985,0.9620488043574447,0.5794871794871795,0.7920235932744635,1.0,38/108,29.58%,MALT1;SASH1;GTPBP4;SPHK1;SQSTM1;FBXW7;PRICKLE1;CAV1;DAXX;ADGRB1;ANGPT1;UBE2L3;BRCA1;HUWE1;OGT;SMAD7;CENPX;UBQLN1;DERL1;CHP1;WFS1;CUL3;RPS3;LAPTM5;PRMT3;HSP90AB1;DNAJA1;BIRC2;HDAC3;VPS28;CENPS;PSMD10;GSK3A;UFL1;TNFAIP3;PTTG1IP;FKBP1A;RCHY1
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.3102202509265658,-0.9617648966297143,0.5169082125603864,0.8880444736910813,1.0,2/17,0.51%,CACNB2;CACNA2D1
prerank,peptidyl-arginine modification (GO:0018195),0.4208774075690547,0.9617501837694257,0.5356679636835279,0.7923367354524667,1.0,3/15,11.42%,PRMT5;PRMT7;ART4
prerank,oligodendrocyte development (GO:0014003),0.41232264671312896,0.9616966876507159,0.5167095115681234,0.7920942826161353,1.0,1/15,0.26%,B4GALT5
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.4426243918941719,0.9615702485509574,0.5357624831309041,0.7920088834786607,1.0,4/11,21.95%,EXOSC4;EXOSC10;EXOSC5;DKC1
prerank,protein ADP-ribosylation (GO:0006471),0.37584186966029,0.9613185789886892,0.5552941176470588,0.7921866568771139,1.0,15/28,31.23%,PARP4;TNKS2;SIRT5;ART4;HPF1;TIPARP;ZC3HAV1;SIRT4;PARP3;PARP2;SIRT3;PARP16;SIRT1;PARP9;SIRT2
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.3130660949618148,0.9612909840599358,0.5890688259109311,0.7918987216976853,1.0,24/152,15.63%,RGS1;ABCA1;FPR2;PTGIR;GNA13;ADCY8;ADCY3;PTGFR;GNAQ;ADCY7;PSAP;ADGRB1;SCTR;ADGRG5;IAPP;ADGRE5;CACNA1D;ADGRG7;GNA11;GIPR;ADORA2A;GLP1R;LPAR1;VIP
prerank,stress fiber assembly (GO:0043149),0.4227657614875936,0.9612433946387338,0.5390428211586902,0.7913122764613155,1.0,5/15,19.05%,PDLIM1;RHOA;SORBS1;ZYX;CUL3
prerank,contractile actin filament bundle assembly (GO:0030038),0.4227657614875936,0.9612433946387338,0.5390428211586902,0.7913122764613155,1.0,5/15,19.05%,PDLIM1;RHOA;SORBS1;ZYX;CUL3
prerank,double-strand break repair via homologous recombination (GO:0000724),0.32198038892187947,0.9610597499825948,0.5712799167533819,0.7913539669550219,1.0,28/95,25.08%,RAD51B;NSMCE2;MCM7;MCM2;AP5Z1;RMI1;BRCA1;RAD50;BLM;YY1;PSMD14;INO80;ERCC4;SLX4;SEM1;CDC7;KDM4D;RAD54L;MORF4L1;RAD51AP1;MCM6;RECQL5;MCM8;NIPBL;NSMCE1;GEN1;SMC6;PALB2
prerank,organic hydroxy compound biosynthetic process (GO:1901617),-0.2485333031327512,-0.9610373541862016,0.5714285714285714,0.8872826135166194,1.0,13/44,17.44%,CYP27A1;OSBPL9;DHCR7;SC5D;INSIG1;INSIG2;OSBPL7;SLC27A2;CYP7B1;CYP39A1;SQLE;CYP46A1;HMGCR
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.3736566430685911,0.9607706313885045,0.5265700483091788,0.7916608512628169,1.0,6/25,19.26%,SDCBP;ANKRD13B;LRPAP1;APOC1;ANKRD13A;ATXN2
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.32938696968770226,0.9604263057244307,0.5443037974683544,0.7920490356205148,1.0,27/69,32.57%,DERL3;EDEM1;DNAJB14;STT3B;VCP;SEC61B;UBE4A;DNAJB9;UBXN4;UBQLN1;DERL1;PSMC6;RNF121;WFS1;UBE4B;DNAJC10;HSPA5;USP19;ECPAS;ERLIN1;DNAJB12;OS9;HSP90B1;HERPUD1;SYVN1;FAF2;UBQLN2
prerank,positive regulation of chemotaxis (GO:0050921),0.35115752689189017,0.9601289016481491,0.5676274944567627,0.7923807047449648,1.0,12/43,16.15%,P2RX4;TMSB4X;NRP1;FGF2;HSPB1;VEGFA;TREM2;ADAM17;CCR2;STX3;PRKD2;KDR
prerank,positive regulation of cell projection organization (GO:0031346),0.31899592962786166,0.9601081971761056,0.5973360655737705,0.7920673181570744,1.0,19/115,13.71%,PLXNC1;S100A9;APOE;ABL2;PLXNA2;ALKAL2;PTK2B;NPTN;AMIGO1;CUX1;P3H1;SS18L2;PLXND1;CHODL;RHOA;SCN1B;FZD1;CBFA2T2;FZD4
prerank,primary neural tube formation (GO:0014020),0.3681602121651258,0.9592055776537599,0.5318655851680185,0.793717503039938,1.0,9/30,21.28%,DEAF1;LMO4;PRICKLE1;DLC1;CELSR1;MTHFD1;LRP6;VASP;IFT122
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.31860316153459706,0.9590849545230244,0.5750507099391481,0.7936372286627799,1.0,47/119,30.54%,SLC27A1;ARF3;TTC7B;ITPKB;PIK3CB;PIGQ;FGF2;PIGZ;PIK3R5;PIGA;PI4K2A;EFR3B;INPPL1;VAC14;PLEKHA1;SOCS5;PIP5K1C;MTMR14;PIGN;RAB5A;PTPN13;PIGL;MTMR12;PIGC;PIK3R2;PIKFYVE;PI4KA;PIGH;TTC7A;PIP5K1B;SOCS2;MBOAT7;PIK3C2A;SYNJ2;PI4K2B;MTMR6;MTMR1;PITPNM1;DPM3;SMG1;PIGU;PTEN;RUFY1;ITPKC;PIGG;SOCS4;SOCS7
prerank,cellular response to lipopolysaccharide (GO:0071222),0.3182043460687602,0.9589376250303965,0.5833333333333334,0.7936406785559345,1.0,26/101,20.17%,STAP1;SIRPA;VIM;AXL;CD6;CD274;PTPN22;TNIP3;LILRB1;PABPN1;PLAA;TICAM1;SERPINE1;CCL5;TNFRSF1B;TNIP2;RHOA;GIT1;NFKB1;ACOD1;PDCD4;SBNO2;PAF1;IL6;HMGB1;MTDH
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.42929676245779996,0.958866060468106,0.5532194480946123,0.7934565546981105,1.0,7/14,29.93%,CRAT;ECI2;EHHADH;ACOX3;ACOT8;ACOXL;SCP2
prerank,regulation of cell junction assembly (GO:1901888),0.3731700647744354,0.9581207989000217,0.5380116959064327,0.7947860473001453,1.0,4/27,5.86%,PRKCH;CHRNB2;CLDN19;RUNX1
prerank,inhibitory synapse assembly (GO:1904862),-0.3657001093866773,-0.9579673393525044,0.4852941176470588,0.893348937385324,1.0,5/11,10.22%,GABRB2;GABRB3;GABRA2;WNT5A;GABRA1
prerank,organic substance transport (GO:0071702),0.3164287332626049,0.9577763060045498,0.5969543147208122,0.7951976600592267,1.0,25/121,18.71%,MFSD12;ABCG1;ABCA1;SLC23A1;HRG;SLC48A1;CD3G;TOM1;ABCA4;SLC22A3;SLC6A4;SLC18A1;ABCA13;RAB7A;ABCD2;ABCA7;RCN3;ABCD3;SLC50A1;SLC18A2;SNX4;VAMP2;DISP1;SLC19A1;ARL6IP5
prerank,regulation of Ras protein signal transduction (GO:0046578),0.3213399679393277,0.9575131438991966,0.5639958376690947,0.7954233921601115,1.0,27/85,26.01%,IGF1;MYO9B;AKAP13;SQSTM1;RAF1;GRB2;ERBIN;CRKL;DENND4C;DLC1;RASGRP1;CADM4;ARHGEF18;OGT;SPRY4;SYNGAP1;ARHGAP17;ARHGEF2;EPO;ARHGDIB;ARFGAP1;GABARAP;DENND4B;JAK2;VAV1;KANK2;MAPKAP1
prerank,apoptotic cell clearance (GO:0043277),0.36768323819715887,0.9574976593650805,0.5615650172612198,0.7951097682684053,1.0,6/30,12.81%,LRP1;ANXA1;ADGRB1;TREM2;RHOG;GAS6
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.4308321261086762,0.9574673573260556,0.5478723404255319,0.7948198729555789,1.0,7/12,33.38%,GART;ATIC;ADSS1;PPAT;ADSL;GMPS;ADSS2
prerank,positive regulation of receptor internalization (GO:0002092),0.3878667770715031,0.9568347279379318,0.540272614622057,0.7958758039175171,1.0,4/22,13.91%,VEGFA;ANGPT1;CD63;SCYL2
prerank,intracellular protein transport (GO:0006886),0.30421708007089315,0.956177820295073,0.646,0.7969718029917997,1.0,118/304,31.40%,TBC1D10C;MMP12;TBC1D22A;KIF13B;CTSA;ARF3;SNX8;GCKR;PRICKLE1;IPO5;TBC1D2;ARL1;STX6;EGR2;RAB5C;NAPA;TRAK1;RIC1;RANGRF;SIL1;E2F3;VPS26A;RPL11;LAMP2;ARL11;RAB32;NUP188;AP4E1;WLS;NXT2;RAB7A;LMAN1;CCHCR1;XPO1;RAB5A;STX3;EIF4ENIF1;TPR;GGA2;VPS26C;SYK;APPL2;AP3D1;CHP1;VIPAS39;RAB22A;RAB1A;SAR1A;TBC1D22B;TECPR2;TLK1;TBC1D12;PPP1R10;RAB3GAP2;DESI1;XPO6;LTBP2;ARHGEF2;ARL4C;LAPTM5;NUP93;ARFGAP3;NPM1;SNX31;ACD;GABARAP;TMED3;CALR;FUT10;VPS35;TBC1D10A;CD74;EHD1;RAB20;BAG3;SNX1;NUP50;TNPO2;SGSM1;GIPC1;USO1;TNPO1;TBC1D16;VPS28;GGA1;STX7;AP4S1;NUP42;NUP133;COPZ2;TBC1D15;STX4;SURF4;RAB5B;STX5;TMED2;RAB31;ARL6;NUTF2;EIF2D;COPA;IPO13;PTTG1IP;ARFRP1;SNX27;SNX17;RAB43;NUP214;RABL3;SNF8;AP3B1;SEC23IP;COPB2;ARF6;BCS1L;TBC1D8B;RAB24;COG7
prerank,organic hydroxy compound transport (GO:0015850),-0.2556364980935766,-0.9558447589808611,0.46956521739130436,0.8964463128670619,1.0,4/36,6.05%,SLCO2B1;NCOA1;SLCO1B1;NCOA2
prerank,neuron projection morphogenesis (GO:0048812),0.31646526564075955,0.9557574969316965,0.6142131979695431,0.797562859211093,1.0,24/137,16.42%,ALCAM;IQGAP1;CTNNB1;GAS7;SGK1;ATP7A;ALS2;CDK5;TAOK3;S100A6;LRP4;ADGRB1;DTNBP1;DIP2A;RAB8A;DNM2;AFG3L2;CDC42;ROCK1;ACTB;SLC9A6;SLITRK2;DOCK7;MINK1
prerank,positive regulation of glial cell differentiation (GO:0045687),0.4019671601236654,0.9553845465996814,0.5422276621787026,0.7980363462309725,1.0,8/17,27.42%,ID2;EGR2;SERPINE2;TNFRSF1B;IL34;MDK;CXCR4;HES1
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.3443082674288013,0.9552855941481839,0.5472747497219133,0.7979149907976314,1.0,16/46,26.03%,FLNA;PRKCD;IPO5;TRIM28;CDH1;JUP;GAS6;TPR;PIK3R2;DHX9;GSK3B;BAG3;RBM22;ANP32B;HDAC3;ZPR1
prerank,positive regulation of T cell migration (GO:2000406),0.388130620923913,0.9549292868850632,0.5376078914919852,0.7983303319681085,1.0,5/20,12.09%,SPN;ADAM17;CCR2;CCL5;RHOA
prerank,cranial nerve development (GO:0021545),-0.35103241946075747,-0.9547716605394241,0.5151515151515151,0.8967632016845988,1.0,3/11,8.53%,SALL1;ERBB3;PAX2
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.3557988440629221,0.9546896730149838,0.5682870370370371,0.7984809515994612,1.0,9/36,19.31%,CTNNB1;LEF1;AGO2;PLCB2;PDE6B;FZD4;NLK;GNB1;AGO3
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.3920105114578363,0.9546348909030479,0.5484662576687117,0.7982588984787613,1.0,6/21,21.21%,BRCA1;SIRT5;ABCD2;TRAP1;SLC18A2;ABCB7
prerank,non-motile cilium assembly (GO:1905515),0.36193577293507,0.954447380739255,0.5619158878504673,0.7983132908618681,1.0,13/30,29.65%,BBS10;DCTN1;TBC1D32;CEP250;IFT88;CSNK1D;TMEM216;IFT122;TMEM107;TMEM17;RPGRIP1;GORAB;PIBF1
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.4259901927917036,0.9543779594476044,0.5436507936507936,0.7981094670114165,1.0,5/13,21.50%,ZBTB7B;NAPEPLD;PIM1;HNRNPU;METRNL
prerank,cilium organization (GO:0044782),0.30794002537805687,0.9542399415161494,0.6276276276276276,0.7980633482557902,1.0,65/209,29.65%,FLNA;ASAP1;CFAP44;ODF2;TEKT2;PTPN23;ATP6V0D1;RILPL2;FOXJ1;SPAG16;IFT43;TEKT5;WDR35;SNX10;ARMC9;RAB8A;ABLIM1;RAB8B;CEP41;RTTN;TCTN3;PARVA;EXOC2;GSN;CNGB1;CEP250;ACTR3;IFT88;TMEM216;PLK4;RAB1A;LZTFL1;IFT74;MKKS;EHD4;RAB11A;CFAP70;RILPL1;BBIP1;MAK;IFT122;MARK4;DYNC2I1;EHD1;CYS1;CCDC65;TRAF3IP1;RILP;BBS7;TMEM107;MKS1;SCLT1;DYNLT2B;ARL6;EXOC4;ACTR2;TMEM237;ARL3;DNAH5;TMEM17;CEP83;IQCB1;IQCG;CFAP410;PIBF1
prerank,negative regulation of double-strand break repair (GO:2000780),0.36561674117168597,0.9537919724350777,0.5683962264150944,0.7987000282359696,1.0,3/30,6.07%,ERCC6;TRIP12;CYREN
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.3553007556081483,0.9536095080919401,0.5728587319243604,0.7987447142722203,1.0,12/38,24.97%,MMP8;P2RX4;SIRPA;CAV1;GLA;CLU;PTGIS;HSP90AB1;CD47;TNF;JAK2;KHSRP
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.2979525778086107,-0.9535329438649208,0.53125,0.8974632999463322,1.0,7/22,20.81%,PDE3B;CCDC3;APOD;IL1B;HCAR2;ASXL3;ADRA2A
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.36785156874362035,0.9533489806571516,0.5596221959858324,0.7989628135287771,1.0,12/29,26.11%,EXOSC4;PATL1;EXOSC9;NT5C3B;DCP1A;LSM6;EDC4;EXOSC5;CNOT6;LSM4;EDC3;LSM3
prerank,regulation of cell division (GO:0051302),0.3276942352159616,0.9529606663152731,0.5726227795193313,0.7994548972710481,1.0,25/72,27.01%,BCL2L1;PLK2;AHCTF1;PRDM15;RACK1;KLHL13;BIRC6;BLM;KIF20A;GIT1;PLK4;RAB11A;PIN1;RAB11FIP4;HTR2B;EFHC1;CALM3;FGFR2;SMYD5;PLK3;FGF1;CETN2;KLHL21;CDK2AP2;PRPF40A
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.4221847169230547,0.952902981866911,0.5623376623376624,0.7992206585420515,1.0,5/14,19.20%,HNRNPC;MAPKAPK2;YBX3;TIRAP;TARDBP
prerank,central nervous system myelination (GO:0022010),0.44820554985214556,0.9527594254215601,0.5615696887686062,0.7991853631522357,1.0,1/11,0.26%,B4GALT5
prerank,tryptophan catabolic process (GO:0006569),-0.36169997428929457,-0.9526746323155811,0.5038167938931297,0.8970444296023282,1.0,3/11,15.22%,KMO;AFMID;HAAO
prerank,regulation of macrophage chemotaxis (GO:0010758),0.3901194452928327,0.9525773172398971,0.5483870967741935,0.799239133392934,1.0,3/21,4.24%,STAP1;CSF1;PTK2B
prerank,protein mannosylation (GO:0035268),-0.2892846945797675,-0.9525476831062148,0.48044692737430167,0.8945646310327264,1.0,5/22,7.88%,TMTC2;TMTC3;POMT2;TMTC1;FKRP
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.34543572311443116,0.9522376248062072,0.5696902654867256,0.7996421302541306,1.0,12/43,17.55%,SH3KBP1;GRB2;MVP;PTPN2;SOCS5;RAB7A;CDC42;STAM2;CBL;DUSP3;CBLB;EPS15L1
prerank,response to nitric oxide (GO:0071731),0.4274106955845491,0.952163457225831,0.5582901554404145,0.7994493462324229,1.0,4/13,25.61%,CDK2;FOXO1;EGLN1;TXN
prerank,negative regulation of endopeptidase activity (GO:0010951),0.3410344092648382,0.9515226460344346,0.5650273224043716,0.800521235307502,1.0,16/47,30.50%,LTF;HRG;SERPINA10;SERPINB9;SERPINE2;SERPINE1;TIMP4;TIMP2;SERPINF2;TIMP1;SERPINB8;SERPINA2;SPOCK1;SERPINH1;SERPIND1;TIMP3
prerank,negative regulation of locomotion (GO:0040013),0.42736431733986435,0.9514428350975247,0.5385656292286874,0.8003402937025059,1.0,6/12,22.48%,GATA3;PTPN2;FBLN1;DUSP3;PIN1;WAS
prerank,regulation of neuron apoptotic process (GO:0043523),0.32241019544101523,0.9510322681459669,0.6072164948453608,0.8008889763790616,1.0,24/96,25.39%,BCL2;CTNNB1;APOE;ADAM8;PTK2B;CDK5;CPEB4;TREM2;BAX;CLN3;FGF20;DDIT3;NF1;RETREG1;RASA1;WFS1;SOD2;SRPK2;EGLN3;NSMF;F2R;TNF;ATF4;MDK
prerank,neuron fate commitment (GO:0048663),0.42229838771327455,0.9509584226251455,0.5565789473684211,0.8007058010382614,1.0,2/14,11.73%,ID2;DLL4
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.32954304525165556,0.9507736433828813,0.5638528138528138,0.8007565102378676,1.0,24/56,31.48%,ANXA1;RAD51B;NSMCE2;EIF4G1;BRD4;FBXO5;ADAM17;CCNB1;VPS4B;STOX1;CDC7;CCND2;RAB11A;CUL3;ANAPC7;CDK4;CDC25B;UBE2C;ESPL1;KLHL18;CDC25A;CCND1;LSM11;RDX
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.31241187902906636,0.9505980371627157,0.6119554204660588,0.8007666033191628,1.0,38/140,21.44%,MYO9B;ABR;ARHGAP25;ARHGAP10;ARHGAP21;ARHGAP24;GNA13;AKAP13;A2M;SQSTM1;DLC1;ARAP2;RHOD;RHOQ;ARHGAP6;ARHGAP19;ARHGEF1;RHOG;ARHGEF18;RHOA;RHOU;CDC42;ARHGAP12;ARHGEF11;RACGAP1;FAM13B;KALRN;PIK3R2;ARHGAP30;ARHGAP9;ARHGAP17;RHOT2;ARHGEF2;MYO9A;GMIP;ARHGDIB;SRGAP1;PLEKHG2
prerank,regulation of chromatin organization (GO:1902275),0.4216382696983203,0.9503661251432167,0.5399484536082474,0.8009184035980477,1.0,4/14,17.76%,HPF1;SETD1A;TLK1;HNRNPU
prerank,apoptotic DNA fragmentation (GO:0006309),0.410825522351842,0.9497502940189202,0.5660621761658031,0.8018799045352851,1.0,5/16,21.83%,H1-0;DNASE2;DFFB;HMGB1;DFFA
prerank,positive regulation of cell communication (GO:0010647),-0.2717020003344154,-0.9496646598838608,0.5362318840579711,0.8999557926384678,1.0,6/28,7.80%,GRIK2;RIMS1;CLSTN2;CLSTN3;SYT1;RIMS2
prerank,phospholipid metabolic process (GO:0006644),0.3216590459317905,0.9488387571723194,0.6036131774707758,0.8034701596930928,1.0,8/71,9.48%,LPL;PLAAT3;APOA2;ABHD12;PLPP3;FADS1;PLCB2;PLAA
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.35326617147722067,0.9486644586957776,0.5669642857142857,0.803499522017769,1.0,10/37,24.63%,SDCBP;RPS7;RPL23;RPL11;OGT;CCAR2;CSNK2A2;HSP90AB1;GIPC1;EIF3H
prerank,cellular response to leucine starvation (GO:1990253),0.4569889550118608,0.9486518291268212,0.5423023578363384,0.8031707390341132,1.0,1/10,0.97%,RRAGD
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.37148375356892505,0.9481610381038158,0.5497005988023952,0.803858325271425,1.0,11/26,33.07%,ATP1B3;CACNA1D;CAB39;VAMP2;ACTN2;KCNAB1;ATP1B2;ITGB1;WWP2;NEDD4;STK39
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.42826291128603927,0.948086027220501,0.5633802816901409,0.8036772403111863,1.0,4/13,20.39%,DCTPP1;NEIL2;MBD4;DUT
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.45506835733650103,0.9478774693375964,0.5700934579439252,0.8037437811383777,1.0,4/10,20.84%,DLGAP4;DLGAP3;NPTX2;NPTX1
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.45093486414878364,0.9471314727434831,0.5585464333781965,0.8050044302384118,1.0,2/10,9.01%,FBXW7;ADAM17
prerank,regulation of filopodium assembly (GO:0051489),0.35475682378010154,0.9470294378367314,0.5862457722660653,0.8048585944437361,1.0,7/38,12.86%,MYO10;RIPOR2;NRP1;PRKCD;RHOQ;RAB5A;CDC42
prerank,regulation of intracellular pH (GO:0051453),0.35911760801090364,0.9468427945596882,0.5771889400921659,0.8049236461260424,1.0,13/34,24.46%,SLC9A1;SLC9A8;CLN3;SLC9A7;SLC9A6;SLC4A9;CHP1;SLC4A2;TMEM165;GPR89A;GPR89B;SLC26A6;ATP5F1B
prerank,membrane repolarization during action potential (GO:0086011),0.4207492085273832,0.9461979229305503,0.5649263721552878,0.8060033984891107,1.0,2/13,7.31%,KCNJ2;ATP1A1
prerank,tube closure (GO:0060606),0.36049840732796695,0.9459716045169829,0.5402298850574713,0.8061117837944041,1.0,9/31,21.28%,DEAF1;LMO4;PRICKLE1;DLC1;CELSR1;MTHFD1;LRP6;VASP;IFT122
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),-0.23150187369578393,-0.9458046509833771,0.5783132530120482,0.9083729067980546,1.0,26/56,21.46%,ANLN;ROCK2;MYH10;SPIRE1;TRIM36;STMN1;APC;NUSAP1;SPTBN1;KIF4A;ECT2;KIF23;SPAST;INCENP;SEPTIN9;AURKB;CKAP2;CECR2;PLK1;ANK3;RHOB;CIT;CEP55;RAB35;DCTN3;MITD1
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.421812260006161,0.9456831728016841,0.5642673521850899,0.8063738397785721,1.0,3/14,15.39%,UMPS;UPB1;CAD
prerank,regulation of JNK cascade (GO:0046328),0.3184841608907147,0.945672896696786,0.5938461538461538,0.8060492230676928,1.0,13/101,9.89%,MMP8;SDCBP;RAP2A;SIRPA;TRAF2;MAP4K2;PTK2B;MFHAS1;TAOK3;TRAF3;RASGRP1;IGF1R;TRAF1
prerank,mitotic cell cycle phase transition (GO:0044772),0.3063854247316711,0.9456326653926553,0.6633266533066132,0.8057793458366395,1.0,67/203,30.28%,CDK14;CDK6;CCNY;FBXL17;OPTN;ODF2;NES;DYNC1H1;PPP2R1A;NINL;PPP1R12A;CHMP4B;PLK2;POLE;E2F3;HAUS8;CCNB1;WEE1;CEP41;DCTN1;DNM2;YWHAG;PPME1;CHMP7;PPP2R2D;CDK2;ANAPC1;CEP250;TACC3;RCC1;CSNK1D;CDC7;CCND2;PLK4;PPP6C;TUBB;CDKN3;GSPT1;HAUS2;FBXL6;CUL3;FBXW11;DBF4;CUL1;CDC34;MELK;CUL2;LATS1;ANAPC7;PLK3;CDK4;CDC25B;CUL4A;CETN2;UBE2C;BTRC;MAPRE1;EIF4E;NASP;MNAT1;HINFP;ALMS1;CSNK1E;CDC25A;SKP2;CCND1;CEP57
prerank,response to thyroid hormone (GO:0097066),0.4200116789652459,0.9455236570448636,0.5402906208718626,0.8056597273198569,1.0,1/13,0.35%,CTSB
prerank,positive regulation of macrophage migration (GO:1905523),-0.29433314174130615,-0.945189530909946,0.5572916666666666,0.9073746906685239,1.0,2/19,0.16%,P2RY12;CSF1R
prerank,protein glycosylation (GO:0006486),0.31042683826785644,0.9444095570191559,0.6140529531568228,0.8077369568025419,1.0,26/125,19.72%,B4GALT5;MAN1C1;MGAT5;GALNT7;LARGE1;B4GALT7;GCNT2;B4GAT1;B3GNT3;MAGT1;B3GALNT2;STT3B;TRAK1;ST8SIA6;OGA;TET3;ALG10B;OGT;ENTPD5;NPC1;DPAGT1;TUSC3;GALNT6;TMEM165;DDOST;B4GALT1
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.3930629216107718,0.9437386494834867,0.5610687022900763,0.8088179538002667,1.0,1/19,0.06%,IGF1
prerank,smoothened signaling pathway (GO:0007224),0.3513359117079091,0.9419346319862287,0.5801169590643275,0.8123377025698096,1.0,5/32,11.35%,DHH;DYRK2;PTCHD1;HIPK1;TCTN3
prerank,prostaglandin metabolic process (GO:0006693),-0.27833610734360953,-0.9419251976382379,0.5668789808917197,0.9140274512651052,1.0,4/26,7.44%,PTGS1;HPGD;HPGDS;PNPLA8
prerank,regulation of fatty acid oxidation (GO:0046320),0.40602023904240686,0.9416782966202017,0.5734002509410289,0.8125123232629151,1.0,6/16,25.94%,NR4A3;SOX9;APPL2;SIRT4;ACADL;ABCB11
prerank,maintenance of protein location in nucleus (GO:0051457),0.3858934182656859,0.9415909014413248,0.555956678700361,0.8123551587724632,1.0,6/20,20.00%,SYNE1;ARL2BP;SP100;BARD1;HNRNPU;SUN1
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.31205596378097317,0.9415895331232085,0.6311475409836066,0.8120056809544827,1.0,17/110,15.63%,ABCA1;PTGIR;GNA13;ADCY8;ADCY3;PTGFR;GNAQ;ADCY7;ADGRB1;ADGRG5;IAPP;ADGRE5;ADGRG7;ADORA2A;GLP1R;LPAR1;VIP
prerank,mRNA destabilization (GO:0061157),0.3455677958257068,0.9415547645066876,0.57847533632287,0.8117279814893223,1.0,15/38,28.72%,CELF1;METTL3;CPEB3;YTHDF3;ROCK1;POLR2D;YTHDF2;DHX36;PUM1;TARDBP;ZC3H12D;GIGYF2;KHSRP;RC3H1;RIDA
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.3737606022832698,0.9410752834094984,0.5788177339901478,0.8124123779887893,1.0,7/25,19.05%,FBXL17;CLPP;ATXN3;VCP;LONP1;DERL1;CUL3
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.43728172522021164,0.9410056527654412,0.573997233748271,0.8122145321981278,1.0,6/11,31.66%,TMEM106A;TAF7;JAK2;HDAC2;SIRT1;XBP1
prerank,positive regulation of protein metabolic process (GO:0051247),0.31290196491297806,0.9407841276587631,0.6217882836587872,0.8123486551198752,1.0,38/110,28.58%,APOE;CSF1;ATG7;EIF4G1;C4BPB;C4BPA;SEC22B;RASGRP1;PLK2;FZR1;RANBP9;VCP;DDB1;OAZ3;RAB7A;HUWE1;TIPARP;CLU;VIP;FOXO1;BARD1;RAB1A;WFS1;GSK3B;RNF41;MAPK7;IL17D;MAP2K5;TNF;VPS28;TLR9;RILP;STX5;GSK3A;DACT1;TNFAIP3;MTPN;WWP2
prerank,regulation of cytoskeleton organization (GO:0051493),0.31295792792544475,0.9405143009400495,0.6232032854209446,0.8126099501994084,1.0,29/108,21.76%,IQGAP1;S100A8;S100A9;LRP1;PDGFA;HRG;PRKCD;CLIC4;DLC1;RHOD;RHOQ;CLN3;RHOG;PHLDB1;DIAPH1;RHOA;IQGAP2;CELSR1;PAK2;ROCK1;HIP1R;TESK1;PFDN2;ARHGAP17;BST2;MARK2;BAIAP2;GSK3B;TAOK1
prerank,transepithelial transport (GO:0070633),0.41090387644012927,0.9401172140721534,0.5615384615384615,0.8130964289363231,1.0,2/15,3.13%,SLC23A1;SLC23A2
prerank,dendritic cell migration (GO:0036336),-0.3170370346247216,-0.9400537797357984,0.5628140703517588,0.9163748568689585,1.0,6/16,12.06%,ALOX5;EPS8;CCR5;CCR1;TRPM4;CCR6
prerank,recombinational repair (GO:0000725),0.31965628031555865,0.9399286980437656,0.6101159114857745,0.8131521057345156,1.0,23/77,26.34%,RAD51B;NSMCE2;AP5Z1;RMI1;BRCA1;RAD50;BLM;YY1;PSMD14;INO80;ERCC4;SLX4;SEM1;KDM4D;MORF4L1;RAD51AP1;RECQL5;MCM8;NSMCE1;GEN1;SMC6;PALB2;LIG3
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.3214763212082356,-0.9397682122530622,0.5483870967741935,0.9143188876388036,1.0,8/16,30.88%,KLHL15;POLQ;SHLD3;MAD2L2;SHLD2;SHLD1;HELB;FANCB
prerank,telomere capping (GO:0016233),0.40330337148022516,0.939671943944995,0.5760309278350515,0.813349373461802,1.0,8/16,37.71%,RAD50;TERF1;DCLRE1A;ACD;TERF2IP;TERF2;CTC1;TINF2
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.30628457763549866,0.9385975849777561,0.6535750251762337,0.8152638719951212,1.0,55/166,30.03%,HDAC9;HDAC7;NPPA;NR4A3;VDR;NCOR2;TAF1D;PPARG;TAF4B;HDAC1;POLR1G;POLR2H;GTF2A2;NRBF2;PPARD;E2F3;UBTF;TBPL1;MAML2;MED17;TAF15;GTF2F1;POLR2D;POLR1A;NR4A2;TBP;GTF2H1;TAF7;TAF6;NR3C1;RXRB;TAF1A;TEAD1;GTF2E2;TAF1C;MED7;RXRA;POLR1F;POLR2F;GTF2H5;NOTCH4;HDAC3;NR6A1;SNW1;NR2C2AP;RSF1;MNAT1;MAPK3;CRCP;MED1;RXRG;MAZ;MED27;POLR1H;CCN2
prerank,cartilage development (GO:0051216),0.33841870172329425,0.9379476861170373,0.5973741794310722,0.8162458716345263,1.0,8/49,13.01%,ATP7A;CD44;FGF2;SNX19;RUNX1;SOX9;CREB3L2;ZBTB16
prerank,positive regulation of translational initiation (GO:0045948),0.4019055347885769,0.9373674946972758,0.5848101265822785,0.8171237876761318,1.0,6/18,22.11%,YTHDF3;CCL5;LARP1;POLR2D;YTHDF2;CDC123
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.3539620446703307,0.9372866884102018,0.6034090909090909,0.8169374123729385,1.0,12/36,25.33%,BCL2;SGMS1;TRAF1;PPIA;NR4A2;ING5;CSNK2A2;RPS3;CRADD;PTPMT1;TNF;CX3CL1
prerank,negative regulation of biosynthetic process (GO:0009890),0.40688697094755016,0.9372803947769326,0.5569155446756426,0.8166015243941562,1.0,6/16,21.21%,ABCD2;TRAP1;SLC18A2;IL6;EMILIN1;ABCB7
prerank,icosanoid secretion (GO:0032309),0.42816785195938273,0.9368602025034499,0.5802139037433155,0.8171508556595708,1.0,1/12,1.53%,ANXA1
prerank,positive regulation of interleukin-1 production (GO:0032732),0.33057118871802743,0.9365169051292029,0.5879180151024811,0.8175256107296262,1.0,13/51,25.70%,LPL;MALT1;PANX1;HSPB1;TRIM16;TMEM106A;IL6;HMGB1;EGR1;USP50;TNF;JAK2;AIM2
prerank,cellular response to radiation (GO:0071478),0.3436650716749665,0.936267947229051,0.5825688073394495,0.817683055981689,1.0,12/40,24.55%,TANK;FIGNL1;GRB2;EEF1D;BLM;RRH;INO80;KDM4D;RAD1;RAD51AP1;INTS7;GADD45A
prerank,sodium ion import across plasma membrane (GO:0098719),0.40133004019508733,0.93621944937713,0.5878712871287128,0.8174341827994339,1.0,4/17,14.56%,SLC9A1;SLC5A1;SLC9A7;SLC9A6
prerank,negative regulation of metabolic process (GO:0009892),-0.22219436848921054,-0.9361278676359474,0.573170731707317,0.921937960081838,1.0,11/54,14.97%,PLCL1;ADAMTS5;ACVR2B;RBPJ;IP6K1;MAP2K6;CCDC3;PCTP;ABHD6;IL1B;NR1H3
prerank,regulation of microtubule polymerization (GO:0031113),-0.24941717664724544,-0.9360781047836875,0.6261682242990654,0.9191814492246403,1.0,4/40,7.72%,NAV3;TUBB4A;STMN1;MAP2
prerank,mesenchymal to epithelial transition (GO:0060231),-0.36751100135719883,-0.9358452813745033,0.5175097276264592,0.917065938963128,1.0,3/10,8.53%,SALL1;PAX8;PAX2
prerank,positive regulation of interleukin-13 production (GO:0032736),0.44525947124346316,0.9358188553179935,0.5767123287671233,0.8179629396892764,1.0,2/10,6.39%,SPHK2;GATA3
prerank,cardiac muscle contraction (GO:0060048),0.35726169474319786,0.9357514578276468,0.5942196531791908,0.817755750462427,1.0,8/34,24.28%,CSRP3;GAA;GSN;SCN1B;ATP1A2;SCN3B;TNNI1;MYL4
prerank,microtubule anchoring (GO:0034453),0.4217449239333185,0.93564198106636,0.5658602150537635,0.8176467626962307,1.0,3/12,12.03%,DAG1;BCCIP;GCC2
prerank,positive regulation of developmental process (GO:0051094),0.3040334156047526,0.9355762295535867,0.676056338028169,0.8174355131175604,1.0,28/164,16.15%,B4GALT5;APOE;CORO1C;NIBAN2;DDHD1;SLC6A6;DAG1;AGO2;BMP1;ZDHHC15;LLPH;SOX9;VEGFA;FBXO5;LMNA;BASP1;CPEB3;PHLDB1;KMT5B;RBM19;ZBTB16;FZD4;DCN;NUMA1;SRF;C1QBP;TFRC;KDR
prerank,histone H4-K5 acetylation (GO:0043981),0.4013666898941396,0.9351400152855422,0.5664516129032258,0.8176529488824393,1.0,7/15,26.99%,ING4;WDR5;OGT;JADE3;KAT7;HCFC1;KANSL1
prerank,histone H4-K8 acetylation (GO:0043982),0.4013666898941396,0.9351400152855422,0.5664516129032258,0.8176529488824393,1.0,7/15,26.99%,ING4;WDR5;OGT;JADE3;KAT7;HCFC1;KANSL1
prerank,positive regulation of lamellipodium assembly (GO:0010592),-0.27868887385923224,-0.9350025819515544,0.535031847133758,0.9166928333880707,1.0,4/24,4.91%,WASF2;PIK3R1;TWF2;NCKAP1
prerank,negative regulation of potassium ion transport (GO:0043267),0.4198601545694034,0.9347753394447497,0.5599472990777339,0.8180592424875611,1.0,5/13,19.96%,PTK2B;CAV1;CAB39;VIP;ACTN2
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.34481149069874045,0.9347685051801318,0.5758928571428571,0.817721108531953,1.0,11/39,25.48%,GTPBP4;JAG1;FXYD5;VEGFA;CDH1;MBP;MYADM;BMP6;MAPK7;MAP2K5;NOTCH4
prerank,autophagy of mitochondrion (GO:0000422),0.34786414327265663,0.9341121736816516,0.6257110352673493,0.8187075416569104,1.0,16/38,29.95%,ATG7;SQSTM1;WDR45;MAP1LC3B;FBXO7;ATG2B;MARK2;MAP1LC3A;GABARAP;BNIP3;ATG3;ATG13;AMBRA1;USP30;FIS1;BECN1
prerank,regulation of cartilage development (GO:0061035),0.39488509178045894,0.9335992764408859,0.5780274656679151,0.8194283002859171,1.0,4/18,13.01%,SCIN;BMP1;SOX9;ZBTB16
prerank,cellular response to nitrogen compound (GO:1901699),0.38496510444474846,0.9334430374589543,0.572139303482587,0.8193883103435465,1.0,6/20,21.41%,DAXX;RIOK3;DDI2;BLM;ATRX;HSF1
prerank,receptor clustering (GO:0043113),0.3649141283774765,0.9331405299419738,0.5828367103694875,0.8196809603999627,1.0,7/27,18.68%,FLNA;ITGAL;ITGA4;LRP4;SAV1;ITGB2;ITGB1BP1
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.27282685033441284,-0.9330151220465568,0.608433734939759,0.9195114699429934,1.0,5/26,5.50%,CCND3;FGF10;PLCB1;RPTOR;AIF1
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.41825702358070266,0.9327215410790789,0.5834411384217335,0.8202256487767151,1.0,3/13,15.08%,ECHDC3;ZBTB7B;SORBS1
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.30254017391763366,-0.9325507821653427,0.53125,0.9180741882760708,1.0,3/18,7.00%,IL6R;MTUS1;CAMK1D
prerank,ATP synthesis coupled proton transport (GO:0015986),0.39127332227288025,0.9323372979514948,0.5580808080808081,0.8206696957377569,1.0,7/17,29.18%,ATP5MG;STOML2;ATP5PD;ATP5F1B;ATP5MF;ATP5F1C;ATP5MC1
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.3691772015521746,0.932077044200146,0.5754257907542579,0.8208538888547258,1.0,11/25,32.25%,BRD4;EAPP;CDK13;WDR43;EAF1;HNRNPU;RECQL5;SUPT4H1;LEO1;HEXIM1;NELFA
prerank,gene silencing by miRNA (GO:0035195),0.352269022253061,0.9319441382070146,0.5904872389791184,0.8207720336745461,1.0,8/32,20.91%,AGO2;EIF6;ZC3H7B;SNIP1;PUM1;ADAR;AGO3;CNOT6
prerank,positive regulation of intracellular protein transport (GO:0090316),0.30751641007119096,0.9319366966866973,0.6548940464177598,0.8204357808108677,1.0,43/144,26.03%,BCL2;FLNA;GZMB;FBXW7;PRKCD;BID;IPO5;TRIM28;UBE2L3;CDH1;RUFY3;JUP;FYN;HUWE1;BAP1;YWHAG;RHOU;GAS6;VPS11;TPR;ITGB2;CHP1;MICALL2;SAR1A;PIK3R2;VAMP2;YWHAB;UBL5;PPP3CC;ITGB1BP1;CSNK2A2;SAE1;GSK3B;USP36;BAG3;RBM22;ANP32B;PPP3R1;PRR5L;PLK3;YWHAZ;HDAC3;ZPR1
prerank,sarcomere organization (GO:0045214),0.35548953163758246,0.9317601101535254,0.5775962660443408,0.8204485260152952,1.0,2/27,4.82%,TNNT3;CSRP3
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.2957630355186352,-0.9313297189144858,0.5463414634146342,0.9186604186572274,1.0,7/20,20.81%,RAPGEF2;ADRB1;ADCY9;PDE4D;GPR101;ADRA1A;ADRA2A
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.30216298340404757,-0.9312334311646998,0.5481927710843374,0.9160828001302874,1.0,6/20,10.85%,BICD1;GRK3;RGS14;STMN1;APLP1;MRAP2
prerank,positive regulation of interleukin-8 production (GO:0032757),0.3336881642316486,0.931150416040966,0.5771739130434783,0.8213774310128242,1.0,16/49,25.90%,CD2;APOA2;SERPINE1;DDIT3;PRKD2;SYK;TIRAP;RAB1A;IL6;HMGB1;LBP;F2R;CD74;IL17D;TNF;TLR9
prerank,endoplasmic reticulum tubular network organization (GO:0071786),-0.32621230824954733,-0.9311502264857795,0.56,0.9134961291182626,1.0,5/15,16.69%,ZFYVE27;RAB10;REEP2;TMEM170A;ATL2
prerank,activin receptor signaling pathway (GO:0032924),-0.31874364060747407,-0.9308730322527148,0.5119617224880383,0.9115029697421583,1.0,7/15,28.79%,ACVR2B;INHBA;ACVR1B;ACVR2A;AMHR2;SMAD3;TGFBR1
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),0.44396332116393133,0.9308544833917578,0.5897079276773296,0.8216664959400104,1.0,3/10,12.82%,NPTN;SYNGR1;RAB5A
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.40080865300471535,0.9308377483882818,0.592496765847348,0.8213551871956325,1.0,8/15,33.32%,ERN1;DDX1;TSEN15;CSTF2;RTRAF;TSEN2;CLP1;RTCB
prerank,regulation of establishment of cell polarity (GO:2000114),0.40610116077049746,0.9305807452902877,0.5842985842985843,0.8215511262694353,1.0,8/16,18.25%,RIPOR2;PTK2B;RACK1;RUFY3;GSN;ROCK1;KRIT1;ARFGEF1
prerank,translesion synthesis (GO:0019985),0.3403308242825691,0.9302628430705292,0.6,0.8218553672111555,1.0,17/42,34.21%,UBA52;RPS27A;VCP;UBE2L6;RFC1;UBC;REV1;RFC2;POLD4;RCHY1;ZBTB1;RFC4;UBB;RFC5;PCLAF;PCNA;REV3L
prerank,outflow tract septum morphogenesis (GO:0003148),0.37106982457611704,0.9298926547585269,0.5857142857142857,0.8222937930792737,1.0,6/24,23.93%,NRP2;NRP1;PARVA;BMP4;TGFBR2;FGFR2
prerank,mitochondrial calcium ion homeostasis (GO:0051560),-0.29183789481034267,-0.929830515928955,0.5661375661375662,0.9115968665595123,1.0,4/21,5.73%,RAP1GDS1;SLC8A3;TGM2;MICU3
prerank,branched-chain amino acid catabolic process (GO:0009083),-0.2943061179636032,-0.9294309686145188,0.5846153846153846,0.9073701960688353,1.0,7/20,21.45%,MCCC2;BCKDHB;DLD;ALDH6A1;BCKDHA;IVD;AUH
prerank,branched-chain amino acid metabolic process (GO:0009081),-0.2943061179636032,-0.9294309686145188,0.5846153846153846,0.9073701960688353,1.0,7/20,21.45%,MCCC2;BCKDHB;DLD;ALDH6A1;BCKDHA;IVD;AUH
prerank,import into nucleus (GO:0051170),0.3171104266618614,0.9283999086648,0.6354056902002108,0.8250545704764914,1.0,27/73,29.50%,MMP12;GCKR;PRICKLE1;IPO5;E2F3;NUP188;NXT2;EIF4ENIF1;TPR;SYK;APPL2;HTATIP2;PPP1R10;NUP93;GEMIN8;NUP50;SNRPG;TNPO2;TNPO1;GEMIN2;SNRPF;NUP133;GEMIN5;NUTF2;IPO13;PTTG1IP;NUP214
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.4403950428184015,0.9280784296915959,0.5765027322404371,0.8253343994818886,1.0,4/10,12.86%,RAP2A;MSN;RHOA;CDC42
prerank,response to metal ion (GO:0010038),0.3213583357478053,0.9278542550132792,0.6113490364025695,0.8254316396944865,1.0,5/67,6.55%,BCL2;HIF1A;ANXA11;CAV1;KCNMA1
prerank,aorta development (GO:0035904),0.40922248513310666,0.9277942292018768,0.5938697318007663,0.8252088449551543,1.0,4/14,19.16%,LRP1;JAG1;EFEMP2;HECTD1
prerank,sulfation (GO:0051923),-0.3454965960616424,-0.927714274783259,0.48872180451127817,0.9096131708702001,1.0,1/11,0.72%,HS3ST5
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.3462394296338125,0.9274273013387286,0.5838150289017341,0.8255977421785714,1.0,3/32,6.27%,P2RX4;CAV1;PDPK1
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.3367139451958883,0.9271089384336684,0.6107456140350878,0.8259222863854888,1.0,7/43,9.19%,IGF1;LTF;NELL1;SUCO;FBXO5;IFITM1;ATP6AP1
prerank,phospholipid dephosphorylation (GO:0046839),-0.2426362006035079,-0.9264091318854111,0.6410256410256411,0.9104831241497092,1.0,12/37,16.29%,PLPPR4;MTMR9;SACM1L;PLPP1;SGPP1;MTMR7;INPP5J;INPP5K;PLPP4;EPHX2;INPP5B;PLPP2
prerank,neuron differentiation (GO:0030182),-0.19031682690236554,-0.9260054224376315,0.625,0.9088384547458639,1.0,22/165,11.99%,ATP8A2;OPHN1;MEF2C;IL1RAPL1;PTPRD;PBX3;WNK1;TENM2;ACSL4;CASP3;VXN;MYT1L;WNT5B;NTRK2;NRBP2;EPHA5;WNT5A;DDIT4;INHBA;BRSK1;WNT2B;ERCC3
prerank,cellular protein localization (GO:0034613),0.2918527734016124,0.925809360954549,0.7197197197197197,0.8282546273715481,1.0,107/285,31.40%,SH3PXD2B;CTNNB1;TBC1D10C;RRAGD;FLNA;RAP2A;TBC1D22A;CTSA;ARF3;SNX8;ZDHHC15;CSRP3;FOXJ1;TBC1D2;ARL1;TRAPPC8;STX6;RAB5C;ANGPT1;NAPA;PACS2;RIC1;SIL1;WDR45;VPS26A;ARL11;RAB32;FGF7;WLS;CD63;RAB5A;CELSR1;CEP250;STX3;HPS6;GGA2;VPS26C;AP3D1;VIPAS39;RAB22A;RAB1A;SAR1A;TBC1D22B;TLK1;TBC1D12;RAB3GAP2;REEP1;FERMT2;ABHD17A;ARHGEF2;ARL4C;LAPTM5;ARFGAP3;GRIN3B;NPM1;SNX31;ACD;ID1;TMED3;VPS35;NIPBL;TBC1D10A;CD74;EHD1;RAB20;SNX1;SGSM1;USO1;MYO7A;TBC1D16;TM9SF3;RRAGC;RTP4;ARMCX3;GGA1;STX7;LAMTOR3;COPZ2;TBC1D15;STX4;RAB5B;STX5;TMED2;RAB31;ARL6;EIF2D;COPA;ATG13;CORO1B;TM9SF2;LAMTOR1;ARFRP1;SNX27;SNX17;FBLN5;RAB43;RABL3;PIGU;RRAGB;AP3B1;SEC23IP;COPB2;ARF6;TBC1D8B;VCL;RAB24;COG7
prerank,negative regulation of organelle assembly (GO:1902116),0.33932222909953025,0.9256061649406315,0.5936435868331441,0.828338319629344,1.0,5/35,9.47%,SMCR8;SEC22B;CHMP4A;CHMP4B;BRCA1
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.38334458493421947,0.9254319280029033,0.596130592503023,0.8279959066119025,1.0,8/21,25.42%,ERCC1;DDB2;DDB1;XPA;ERCC4;GTF2H1;GTF2H5;CUL4A
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.38334458493421947,0.9254319280029033,0.596130592503023,0.8279959066119025,1.0,8/21,25.42%,ERCC1;DDB2;DDB1;XPA;ERCC4;GTF2H1;GTF2H5;CUL4A
prerank,calcium-mediated signaling (GO:0019722),0.3113288737940071,0.9251086832748933,0.639751552795031,0.8283200413363603,1.0,18/93,16.60%,P2RX4;SLC9A1;FPR2;PTPRC;LAT;CXCR2;PPP1R9B;MCTP1;PTGFR;SPHK1;PDPK1;TPCN2;RCAN1;CCR2;RCAN3;MCTP2;KDR;LAT2
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.27036056963068467,-0.924928620337694,0.5723684210526315,0.908933223042788,1.0,8/27,13.86%,SYT10;RIMS1;SDF4;SYT1;SYT2;RIMS2;PPP3CB;SYT9
prerank,fatty acid metabolic process (GO:0006631),0.3050243550311464,0.9247807217470123,0.6446028513238289,0.8286400180021377,1.0,17/115,12.85%,LPL;ACACA;CEL;ACSBG1;SLC27A5;PON1;ACSBG2;PPARG;ECHDC3;ACSL1;PEX2;PPARD;ALKBH7;ABCD2;CRAT;ACOT6;HSD17B8
prerank,peptidyl-glutamic acid modification (GO:0018200),-0.2743020096517029,-0.9244731733878375,0.5680473372781065,0.9074552738638269,1.0,8/24,16.67%,AGBL4;TTLL7;NAA10;TPGS1;TTLL5;TTLL4;TTLL9;CFAP20
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.39267441790081725,0.924387737741892,0.5868725868725869,0.8290830761609128,1.0,5/16,18.62%,HNRNPM;DDX17;CDK13;PUF60;DHX9
prerank,positive regulation of glucose metabolic process (GO:0010907),0.4061741030506749,0.924260174965231,0.5978975032851511,0.8289941882001114,1.0,3/14,13.52%,PTPN2;DDB1;SLC45A3
prerank,neuron development (GO:0048666),0.3007988496955647,0.9238488532182854,0.6717019133937563,0.8294755058611541,1.0,36/141,21.59%,B4GALT5;APOE;ERCC6;BLOC1S3;LRP12;ATP7A;PPP1R9B;ATXN10;UNK;GPRIN1;GRXCR1;CDK5;RUNX1;UGCG;DTNBP1;FRYL;TBC1D23;MYOC;DCX;ROCK1;STX3;TBC1D24;SRF;DOCK7;MICALL2;THOC2;HS6ST1;RAB11A;IL6;GBA2;CDK16;HMGB1;GPRIN3;PBX1;GSK3B;RUNX3
prerank,necroptotic process (GO:0070266),0.39409612588899634,0.9236756423363224,0.5810473815461347,0.829471816641911,1.0,4/16,17.46%,MLKL;TICAM1;TRPM7;RIPK3
prerank,protein oxidation (GO:0018158),0.44361551428863677,0.9235938860749812,0.6196236559139785,0.8292877204017274,1.0,1/11,3.58%,APOA2
prerank,integrated stress response signaling (GO:0140467),0.411356929604955,0.9233348932212194,0.587467362924282,0.8294360417434536,1.0,5/14,24.88%,NFE2L2;EIF2S1;DDIT3;ATF4;HSPA5
prerank,ureteric bud development (GO:0001657),-0.3077585511909596,-0.9231377169665208,0.5745614035087719,0.908507937100815,1.0,6/17,21.61%,SALL1;ROBO2;OSR1;BMP2;NPNT;SLIT2
prerank,peptide metabolic process (GO:0006518),0.3095846751000869,0.9231034437226986,0.6337148803329865,0.8295541231088024,1.0,14/75,17.21%,ANPEP;ADAMTS13;GSTA2;CPXM2;PSEN2;AEBP1;GSR;DNPEP;NAT8;SPCS3;CPD;SPPL3;FURIN;GLRX2
prerank,regulation of mitochondrion organization (GO:0010821),0.3321003638570824,0.923039272542105,0.6037527593818984,0.8293431335996121,1.0,25/47,32.35%,ATP13A2;MGARP;SQSTM1;FBXW7;TREM2;IAPP;INF2;STOX1;PRMT6;HAX1;CSNK2A2;RHOT2;SREBF1;GSK3B;USP36;VPS35;PARL;GOLPH3;GSK3A;FIS1;MUL1;MFF;EP300;MYO19;PID1
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.3533261356342147,-0.9226096704819379,0.56,0.9072764952984097,1.0,4/12,14.67%,GLUD1;IDH3B;ACO1;IREB2
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.42446100813994736,0.922451575398595,0.5762032085561497,0.8302284298113778,1.0,6/12,26.04%,ACTG1;CELSR1;ACTB;LAMA5;LAMA3;TRAF3IP1
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.30377400740062444,0.9223957147073526,0.6643145161290323,0.8299803826666331,1.0,33/128,23.57%,ZMIZ1;UBA52;RPS27A;GCNT2;BMP8B;GDF6;ZMIZ2;USP9X;BAMBI;RNF111;JUN;ARHGEF18;TGFBRAP1;RHOA;NRROS;SMAD7;SMAD1;CBL;FURIN;APPL2;BMP6;PDCD4;ZYX;NLK;FERMT2;BMP5;LTBP2;UBC;DUSP15;BMP4;ID1;TGFBR2;AMH
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.34436410977346626,0.9222994877521775,0.6105499438832772,0.8298278900996524,1.0,6/38,11.43%,NLRC3;TANK;TNIP1;TREM2;TNIP3;RIOK3
prerank,monocarboxylic acid metabolic process (GO:0032787),0.30333602843987617,0.9221973783346246,0.6700715015321757,0.8296742382024811,1.0,30/117,26.48%,IGF1;LPL;ACSBG2;PPARG;SLC6A8;ECHDC3;MTHFS;PPARD;ALKBH7;SCPEP1;LDHA;ACOT6;ME2;NPC1;SLC16A3;GLYAT;GBA2;AASDHPPT;PDZD11;PDHB;SLC16A1;KYNU;CPT1A;FASN;PDHX;ACOT1;ABCB11;ME1;HLCS;DLAT
prerank,cellular response to purine-containing compound (GO:0071415),-0.36796672247458573,-0.9221877094491978,0.5218978102189781,0.9057634027778375,1.0,7/10,32.66%,RYR3;P2RY6;TRPM2;CASQ2;SLC8A1;CACNA1S;RYR1
prerank,mitochondrion disassembly (GO:0061726),0.3495469286952462,0.9221011473575452,0.6089965397923875,0.8295220031700973,1.0,15/34,29.95%,ATG7;SQSTM1;WDR45;MAP1LC3B;FBXO7;ATG2B;MARK2;MAP1LC3A;GABARAP;BNIP3;ATG3;AMBRA1;USP30;FIS1;BECN1
prerank,receptor signaling pathway via STAT (GO:0097696),0.36097782079889373,0.9217349891851695,0.6037959667852907,0.8299240878974666,1.0,11/25,28.15%,STAT4;CCR2;GHR;IL31RA;PIAS1;STAT5B;SOCS2;JAK2;IFNAR2;STAMBP;CTR9
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.34419232982572,-0.9217232078234128,0.549618320610687,0.9044626284909143,1.0,3/12,6.14%,PARP8;PARP12;PARP11
prerank,dopamine metabolic process (GO:0042417),0.3916157403839625,0.9214248524051971,0.6005089058524173,0.8302036373733389,1.0,2/18,3.80%,ATP7A;TH
prerank,regulation of inclusion body assembly (GO:0090083),-0.3600486341769538,-0.9211815716921165,0.5304659498207885,0.9031957864954168,1.0,2/11,10.41%,SNCAIP;DNAJA4
prerank,circulatory system development (GO:0072359),0.30928673801776274,0.9206286760360147,0.667005076142132,0.8314271126927766,1.0,20/118,17.70%,SH3PXD2B;FN1;MICAL2;HDAC9;AKAP13;PDLIM1;ID2;TH;FBXW7;SOX9;SMG9;MTHFD1;RBP4;TCF25;SRF;NF1;HSPG2;PKP2;STK11;MKKS
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.38472923409643295,0.9201374382499666,0.5943517329910141,0.8320982085157962,1.0,6/18,20.90%,MMP9;CAV1;CAB39;ATP1A2;SLC43A2;EPO
prerank,histone acetylation (GO:0016573),0.3175181286661482,0.9197878026756118,0.6545842217484008,0.8324510012124466,1.0,19/69,20.47%,LEF1;CPA4;MSL3;ING4;TRIM16;TADA1;WDR5;MRGBP;ING3;CHD5;ING5;JADE3;KAT7;EP400;DR1;PHF20L1;TAF6;MORF4L1;YEATS2
prerank,positive regulation of neurogenesis (GO:0050769),0.31705151410241206,0.919001336817202,0.6272251308900524,0.8337130807913495,1.0,11/68,12.09%,PLXNC1;CTNNB1;PLXNA2;NPTN;AMIGO1;CUX1;VEGFA;SS18L2;PLXND1;CHODL;RHOA
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.4357286673524207,0.9189385829322372,0.6080536912751678,0.8334800146619902,1.0,5/10,23.93%,PDGFA;SOX9;CHRD;TGFBR2;FGFR2
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.39599573006516015,0.9188548218868452,0.6131479140328698,0.8332971828332376,1.0,6/17,29.97%,SRD5A3;MPDU1;DPAGT1;NUS1;ALG1;DOLPP1
prerank,axonal fasciculation (GO:0007413),-0.33802312946388324,-0.9185877887930095,0.5783582089552238,0.9077054236214367,1.0,2/12,2.75%,EPHA4;CNTN4
prerank,ceramide catabolic process (GO:0046514),0.41194635457112866,0.9182653573525337,0.5984251968503937,0.8341464899703015,1.0,4/14,18.83%,HEXA;GLA;NEU1;ASAH1
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.37823600294587356,0.9180189753342948,0.5994962216624685,0.8342686389550815,1.0,7/20,31.26%,SLC9A1;ATP1A2;ATP2A2;CALM3;FKBP1B;GSTO1;CALM1
prerank,negative regulation of JNK cascade (GO:0046329),0.3524162949353394,0.9177276840786431,0.6198830409356725,0.8344791037661582,1.0,4/31,6.11%,SIRPA;NPPA;TAOK3;PTPN22
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.325907490893298,-0.9174582448777503,0.5675675675675675,0.9081260948294525,1.0,5/14,10.88%,MEF2C;AIF1;NDRG4;IGFBP5;IGFBP3
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.30233175554984826,0.9173061256624564,0.6812182741116751,0.8349780187045431,1.0,48/138,32.07%,HDAC9;HDAC7;NPPA;NR4A3;VDR;NCOR2;PPARG;TAF4B;HDAC1;POLR2H;GTF2A2;NRBF2;PPARD;E2F3;MAML2;MED17;TAF15;GTF2F1;POLR2D;NR4A2;TBP;GTF2H1;DR1;TAF7;TAF6;NR3C1;RXRB;TEAD1;GTF2E2;MED7;RXRA;POLR2F;GTF2H5;NOTCH4;HDAC3;NR6A1;SNW1;NR2C2AP;MNAT1;MED1;RXRG;MAZ;MED27;CCN2;ERCC2;NR4A1;RARG;CREBBP
prerank,regulation of exit from mitosis (GO:0007096),0.3401777774196171,0.9170133447643605,0.6122905027932961,0.8352323952747489,1.0,9/38,20.01%,UBA52;PPP1R9B;RPS27A;ANAPC15;ANAPC1;CDC26;MAD2L1BP;BUB1B;UBC
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.3885003940159451,0.9169562624526093,0.5866495507060334,0.8349844449634545,1.0,5/17,25.96%,CHAMP1;IK;KNL1;SPDL1;CENPA
prerank,regulation of actin filament-based process (GO:0032970),0.3175557346520082,0.9167766243302801,0.6520811099252934,0.8349895729736181,1.0,22/70,24.26%,IQGAP1;LRP1;PDGFA;HRG;PRKCD;DLC1;RHOD;RHOQ;RHOG;RHOA;IQGAP2;CELSR1;ROCK1;HIP1R;TESK1;ARHGAP17;BST2;BAIAP2;TAOK1;ARHGEF5;RHOF;CCDC88A
prerank,membrane depolarization during action potential (GO:0086010),0.36132041269579535,0.9167637502696903,0.6258907363420427,0.8346643548227587,1.0,6/26,16.28%,SCN4A;KCNJ2;SCN1B;CACNA1D;ATP1A2;SCN3B
prerank,DNA modification (GO:0006304),0.3739039475629773,0.9166798609872424,0.6101694915254238,0.8344787334576704,1.0,9/22,27.17%,EXOSC4;NEIL2;MBD4;PARP3;EXOSC5;TERF1;ACD;PARP2;TERF2IP
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.4078390424124034,0.9166587678566522,0.594147582697201,0.8341731660893305,1.0,3/14,6.49%,AK8;AK4;AK3
prerank,positive regulation of catalytic activity (GO:0043085),0.34048831684381076,0.9161518879448469,0.6104783599088838,0.8348576368910277,1.0,8/37,17.97%,ABL2;ATP7A;CAV1;PSEN2;MID1IP1;CHTOP;SLC5A3;YWHAB
prerank,cellular response to estrogen stimulus (GO:0071391),0.4017800986911936,0.9155281388940888,0.5936675461741425,0.8357347285586089,1.0,4/14,25.22%,SERPINB9;WBP2;TRIM24;SFRP1
prerank,neural tube closure (GO:0001843),0.3446195088245944,0.9154027575240423,0.5917901938426454,0.8356608392088531,1.0,9/34,21.28%,DEAF1;LMO4;PRICKLE1;DLC1;CELSR1;MTHFD1;LRP6;VASP;IFT122
prerank,negative regulation of myoblast differentiation (GO:0045662),0.41548204684477535,0.9151813778481344,0.6007751937984496,0.8357668625870542,1.0,2/13,6.78%,PRICKLE1;SOX9
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.3853627390024614,0.9146287934696402,0.6075,0.8365630011579798,1.0,3/18,8.78%,HDAC4;HDAC1;BHLHE41
prerank,purine-containing compound biosynthetic process (GO:0072522),0.3596782575376825,0.913941705040798,0.6045130641330166,0.8375734368836194,1.0,12/25,30.71%,AMPD2;GART;SHMT1;PRPSAP1;MTHFD1;APRT;PRPS2;PPAT;ADSL;HPRT1;GMPS;SHMT2
prerank,protein import into peroxisome membrane (GO:0045046),0.3709923082095319,0.9139217817931554,0.5845588235294118,0.8372632244834473,1.0,9/22,23.23%,PEX2;RAB8B;ABCD2;ABCD3;PXMP2;ALDH3A2;PEX16;ACBD5;PEX14
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.33187820016491676,0.9136743566017158,0.6339285714285714,0.8373968426871042,1.0,10/43,22.66%,TAOK3;FZR1;FOXN3;BRCA1;ABRAXAS1;BLM;UIMC1;ATM;TAOK1;TOPBP1
prerank,regulation of interferon-beta production (GO:0032648),0.33428352630114533,0.913508718710072,0.6224719101123596,0.8373831195461485,1.0,10/46,18.62%,SIRPA;NLRC3;TRAF3;LILRB1;POLR3D;RIOK3;IRF5;YY1;TIRAP;DHX9
prerank,phosphate-containing compound metabolic process (GO:0006796),0.2961392899642018,0.9129763150233536,0.7183098591549296,0.8381349394210202,1.0,25/198,10.19%,LPL;PTPRC;PLAAT3;GPD2;ACYP1;CERK;ITPKB;ALDOA;GCK;GK;SPHK2;PLCB4;PIK3CB;SPHK1;CDK5;NUDT5;PLPP3;PFKFB3;INPPL1;PLCB2;HK1;PFKL;PGK1;PLAA;INPP5A
prerank,regulation of TOR signaling (GO:0032006),0.3173681638814401,0.9128633081036371,0.640807651434644,0.8380179028435693,1.0,22/67,30.28%,RRAGD;SMCR8;TREM2;NPRL2;GAS6;UBR2;FAM83D;NPRL3;LARS1;GOLPH3;RRAGC;HDAC3;LAMTOR3;PIH1D1;GSK3A;FNIP1;RICTOR;LAMTOR1;GNA12;TMEM127;SIRT1;RRAGB
prerank,protein export from nucleus (GO:0006611),0.3589353458047212,0.9120545436093976,0.6364705882352941,0.8392959955253532,1.0,12/27,29.50%,EGR2;CCHCR1;XPO1;TPR;CHP1;DESI1;XPO6;CALR;DUSP16;NUP42;NUTF2;NUP214
prerank,double-strand break repair via break-induced replication (GO:0000727),0.41791041187445993,0.911837698362894,0.6134889753566797,0.839368340752404,1.0,4/12,20.26%,MCM7;MCM2;CDC7;MCM6
prerank,cell junction assembly (GO:0034329),0.308253030486415,0.911261767737116,0.6550665301944729,0.8401578854553269,1.0,17/100,14.04%,FBLIM1;FN1;TLN1;FLNA;PKP4;PCDHB10;PKP1;CDK5;LIMS2;ACTG1;CDH1;ILK;PLXND1;RHOA;CDC42;PCDHB11;ACTB
prerank,protein localization to microtubule organizing center (GO:1905508),-0.3212625798979719,-0.9107379350328751,0.5622317596566524,0.923784860941815,1.0,5/15,12.97%,CEP192;CCDC14;C2CD3;STIL;CEP131
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.32677305182673444,-0.9101146572167327,0.5601659751037344,0.9227530038045748,1.0,2/13,3.33%,MEF2C;RBPJ
prerank,cellular response to metal ion (GO:0071248),0.29954722333369543,0.9100784084662836,0.6741803278688525,0.8421415686420353,1.0,30/123,21.41%,IQGAP1;P2RX4;SLC25A24;ADCY8;ITPKB;ATP13A2;ADCY7;MMP9;DAXX;CLIC4;CDH1;B2M;JUN;CPNE3;RASGRP2;MAPK9;SMPD1;BMP6;SYT8;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;SLC13A5;CPNE6;HSF1
prerank,response to sterol (GO:0036314),-0.3506219666290331,-0.9096154405994858,0.5815899581589958,0.9215660688066613,1.0,2/11,6.37%,CCR5;INSIG1
prerank,protein destabilization (GO:0031648),0.3503642651647701,0.9095794316321826,0.62877030162413,0.8427596580885464,1.0,14/32,32.07%,CCDC88C;HTT;PEX2;GSN;DERL1;CUL3;FBXW11;TRIM21;MDM2;BTRC;SIRT1;MUL1;EP300;CREBBP
prerank,regulation of ossification (GO:0030278),0.3405942385996151,0.909517272675251,0.6338983050847458,0.8425259680305213,1.0,8/36,17.04%,ANKH;CYP27B1;LRP4;SOX9;ECM1;ZBTB16;LRP6;DDR2
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.4389060041593405,0.9093519599690426,0.5967741935483871,0.8425148168044096,1.0,3/10,15.85%,RNF125;RIOK3;C1QBP
prerank,cGMP metabolic process (GO:0046068),0.41640775904167454,0.9086160188905157,0.6171352074966533,0.8435828250879135,1.0,3/12,20.18%,NPPA;NPR2;NPPC
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.3112539077130602,0.9085678412857751,0.670846394984326,0.8433300782725214,1.0,8/76,6.11%,MMP8;NLRC3;TMSB4X;SASH1;HDAC7;TRIM6;SPHK1;PTPN22
prerank,thymus development (GO:0048538),-0.32368471925082737,-0.908363016537986,0.5662650602409639,0.922284012425762,1.0,6/13,28.79%,FGF10;SOD1;FOXE1;SHH;FADD;TGFBR1
prerank,smooth muscle cell differentiation (GO:0051145),0.41867656605882964,0.9075980115962482,0.5986666666666667,0.8448857509140029,1.0,3/12,11.91%,MRTFA;TBX18;MRTFB
prerank,protein localization to cell junction (GO:1902414),0.36948771385660467,0.9063820082396569,0.6154791154791155,0.846913627189154,1.0,6/22,13.46%,NECTIN1;TJP2;JAK1;ARHGEF18;PAK2;MPP4
prerank,mitochondrial transcription (GO:0006390),0.43470224844455574,0.9063533940867,0.6065573770491803,0.8466176313652636,1.0,3/10,15.05%,SLC25A33;MRPL12;TWNK
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.35320300947020344,0.9049458329553756,0.5997610513739546,0.8490263987459115,1.0,11/26,29.44%,NFE2L2;HSPB1;FYN;PPIA;FBXO7;SOD2;MAPK7;ATF4;TXN;NOL3;SIRT1
prerank,monocarboxylic acid transport (GO:0015718),-0.23032608997239712,-0.9048700309277755,0.6777777777777778,0.9292825996401276,1.0,8/51,9.48%,SLCO2B1;SLC16A7;NCOA1;SLC16A6;SLCO1B1;NCOA2;SLC6A11;SLC27A4
prerank,regulation of erythrocyte differentiation (GO:0045646),0.33841917780000874,0.9048538393646044,0.637400228050171,0.8488591690614294,1.0,2/35,0.60%,HIF1A;CDK6
prerank,7-methylguanosine mRNA capping (GO:0006370),-0.2548920559049828,-0.9038076918016127,0.62,0.9267419944206128,1.0,8/31,11.99%,GTF2H2;RAMAC;GTF2H3;POLR2C;CMTR1;POLR2L;POLR2J;ERCC3
prerank,7-methylguanosine RNA capping (GO:0009452),-0.2548920559049828,-0.9038076918016127,0.62,0.9267419944206128,1.0,8/31,11.99%,GTF2H2;RAMAC;GTF2H3;POLR2C;CMTR1;POLR2L;POLR2J;ERCC3
prerank,inorganic ion transmembrane transport (GO:0098660),-0.33044153592273645,-0.9036704452515325,0.549800796812749,0.9244469186099888,1.0,3/12,19.48%,ABCC9;TRPM4;P2RX3
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.4010544565568355,0.9036141261864488,0.625503355704698,0.8509191206184293,1.0,1/14,0.86%,BCL2L1
prerank,N-glycan processing (GO:0006491),0.37725174911835135,0.9032725495102011,0.6218274111675127,0.8512355522256699,1.0,3/18,8.84%,GNPTAB;MAN1C1;ST8SIA6
prerank,rRNA methylation (GO:0031167),0.3620355620727127,0.9029826526562281,0.6148148148148148,0.8514123840120338,1.0,10/22,27.49%,MRM2;MRM1;FTSJ3;MRM3;METTL15;NSUN3;TRMT112;DIMT1;FDXACB1;NSUN4
prerank,acute-phase response (GO:0006953),-0.33568284579414837,-0.9027781209148421,0.5806451612903226,0.9242683899410866,1.0,1/12,0.20%,IL6R
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.4118276112673972,0.9024460404294153,0.6197368421052631,0.8521125291514904,1.0,3/12,12.99%,SDE2;FBXO31;CDK2
prerank,positive regulation of cell division (GO:0051781),0.33441259057379974,0.9022140176515392,0.6496018202502845,0.8521736045010866,1.0,13/38,25.34%,MAP10;PKP4;RHOA;CDC42;PKN2;RACGAP1;SVIL;CUL3;HTR2B;FGFR2;GIPC1;CDC25B;FGF1
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.33463017023059244,0.90205158761352,0.6325369738339022,0.8521606319936833,1.0,18/39,33.26%,TTC7B;ITPKB;PIK3CB;PI4K2A;EFR3B;SOCS5;PIK3R2;PI4KA;TTC7A;SOCS2;PIK3C2A;PI4K2B;SMG1;ITPKC;SOCS4;SOCS7;IP6K2;SOCS6
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.41376017071639865,0.9020345306032065,0.6345381526104418,0.8518429770656367,1.0,3/12,9.98%,ERN1;BCL2L11;BAX
prerank,visual perception (GO:0007601),0.3035487866533356,0.901791385231903,0.6743215031315241,0.8519498781660308,1.0,11/84,13.66%,CHRNB2;EYA4;RDH12;DHRS3;TH;COL18A1;SFRP5;ABLIM1;RABGGTB;CNGB1;CEP250
prerank,endothelial cell migration (GO:0043542),0.33437507183998305,0.9017394055741821,0.6330690826727067,0.8517047983311151,1.0,16/37,36.76%,NRP1;VEGFA;PLXND1;RHOA;FSTL1;CYP1B1;ID1;GIPC1;CORO1B;TNFSF12;NR4A1;LGALS8;DPP4;CDH5;MYH9;LPXN
prerank,heart looping (GO:0001947),0.3319793779492087,0.901693486857938,0.6294642857142857,0.8514410319399269,1.0,3/39,3.32%,MICAL2;TBX21;EOMES
prerank,RNA interference (GO:0016246),0.38386183264448587,0.9011079040880817,0.6307884856070087,0.852236067435676,1.0,7/17,30.68%,AGO2;CELF1;DHX9;AGO3;TERT;TARBP2;CLP1
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.3899450944626674,0.9008478806345533,0.6073697585768743,0.8523807960076727,1.0,11/15,39.56%,VCP;SEC61B;DERL1;OS9;HSP90B1;HERPUD1;SYVN1;FAF2;TMEM129;AUP1;NPLOC4
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.4188282174972117,0.9004478661633242,0.625,0.8528180267393968,1.0,2/11,3.09%,ANXA1;PIK3CB
prerank,negative regulation of interleukin-2 production (GO:0032703),0.3752828331455006,0.9004308761455057,0.6240409207161125,0.8525010163338812,1.0,3/18,2.23%,PTPRC;HDAC7;TBX21
prerank,synaptic vesicle localization (GO:0097479),0.39749759125873263,0.9000317645616663,0.5912806539509536,0.8529432833835988,1.0,3/13,10.79%,CDK5;TMEM230;DNM2
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.3834142438374756,0.899614973262608,0.6125786163522012,0.8533830931712512,1.0,12/17,39.56%,VCP;SEC61B;DERL1;HM13;OS9;HSP90B1;HERPUD1;SYVN1;FAF2;TMEM129;AUP1;NPLOC4
prerank,regulation of sodium ion transport (GO:0002028),0.3384519741125961,0.8995276768009063,0.6397727272727273,0.8532031036644107,1.0,9/34,16.83%,P2RX4;PRSS8;SIK1;ATP1A1;RANGRF;SCN1B;CNKSR3;SCN3B;PKP2
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.38407868875292606,0.8991080826957811,0.6127770534550195,0.853625292267491,1.0,5/16,21.09%,CAV1;PPP2R1A;PTPN2;ADIPOR1;VHL
prerank,mitotic chromosome condensation (GO:0007076),0.34723907545922084,0.898973691126418,0.6451990632318502,0.8535515727252753,1.0,5/26,12.06%,NCAPG;NCAPG2;KMT5A;CCNB1;NCAPH
prerank,peptidyl-serine modification (GO:0018209),0.29470424847143084,0.8988281508282255,0.7398785425101214,0.8534712253308047,1.0,44/166,21.47%,PRKCH;PRKCQ;SGK1;SGK3;SGK2;MAPK13;DYRK2;CDK5;PRKCD;PDPK1;IKBKE;SBK1;PLK2;PRKCB;MAPKAPK3;MAPKAPK2;CSNK1G1;STK32A;HIPK1;HPF1;MAP3K12;GAS6;CDK2;PKN2;PAK2;ROCK1;CAB39;PRKD2;CSNK1D;MAPK9;STK38;CDC7;TLK1;RPS6KA2;CAMK4;NEK6;ATM;CSNK2A2;TOP1;PDK3;MARK2;LMTK2;GSK3B;SRPK2
prerank,neuromuscular junction development (GO:0007528),-0.2684971927942643,-0.8988252704686407,0.5904255319148937,0.9320690841451125,1.0,3/24,5.23%,CACNB2;LRRK2;UNC13B
prerank,CENP-A containing chromatin organization (GO:0061641),0.3453156843767828,0.8987300934566581,0.6207302709069493,0.8529536113153722,1.0,14/29,33.44%,CENPO;CENPT;CENPX;KNL1;NPM1;RBBP7;CENPK;CENPA;CENPS;RSF1;NASP;CENPH;CENPC;CENPW
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.3453156843767828,0.8987300934566581,0.6207302709069493,0.8529536113153722,1.0,14/29,33.44%,CENPO;CENPT;CENPX;KNL1;NPM1;RBBP7;CENPK;CENPA;CENPS;RSF1;NASP;CENPH;CENPC;CENPW
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.3112647352146072,0.8984465012625257,0.6708333333333333,0.8531424839752235,1.0,6/69,4.87%,BCL2;APOE;HIF1A;ADAM8;PTK2B;CPEB4
prerank,L-serine metabolic process (GO:0006563),-0.3574939162362276,-0.8982969488021931,0.5607142857142857,0.9308826530787797,1.0,1/10,0.23%,SERINC3
prerank,protein insertion into membrane (GO:0051205),0.33755598841629575,0.8978542959274735,0.6476744186046511,0.8538979472309258,1.0,11/32,27.38%,TRAM1L1;SEC61B;HMOX1;GET1;VAMP2;ALDH3A2;REEP1;GRIN3B;WDR83OS;RTP4;STX5
prerank,negative regulation of catabolic process (GO:0009895),0.3243098321257869,0.8973679994446343,0.6379498364231189,0.8544817529034917,1.0,6/47,6.52%,FLNA;APOA2;AZIN1;HDAC4;ADGRB1;SF3B3
prerank,C21-steroid hormone metabolic process (GO:0008207),-0.288217026825197,-0.8973452040253196,0.572139303482587,0.9307610090344023,1.0,5/20,16.32%,FDXR;TSPOAP1;STAR;STARD3;CYP46A1
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.3200392754000922,-0.8973157130281173,0.6111111111111112,0.9282444219990309,1.0,4/14,9.03%,IL18;CD81;LGALS9;EBI3
prerank,epithelial tube morphogenesis (GO:0060562),0.3416446590341563,0.897257882168603,0.6403712296983759,0.8543482634583315,1.0,4/32,6.77%,CTNNB1;GATA3;MTSS1;COL4A1
prerank,covalent chromatin modification (GO:0016569),0.3981619452887961,0.8967806059475397,0.6141025641025641,0.8548859728470373,1.0,5/14,29.44%,HDAC1;PARP2;HLCS;UFL1;SIRT1
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.3417269368061561,0.8965451996568652,0.6358381502890174,0.8549995038151204,1.0,7/31,12.86%,ANK1;RAP2A;MSN;ERBIN;PDCD6IP;RHOA;CDC42
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.31618388234883554,0.8964320603109762,0.6537216828478964,0.8548418102805554,1.0,17/54,27.90%,CTNNB1;GTPBP4;SQSTM1;CAV1;ADGRB1;RPL11;OGT;SMAD7;CHP1;RPS3;PRMT3;TRIM21;DNAJA1;DCUN1D3;VPS28;UFL1;TNFAIP3
prerank,determination of bilateral symmetry (GO:0009855),0.3580002727411186,0.8962373245005057,0.6156670746634026,0.8548678404131618,1.0,7/24,28.50%,ODAD2;FOXJ1;MKKS;BBS7;ARL6;DNAH5;DNAH11
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.3710744426558117,0.8960929435383638,0.6402439024390244,0.8548031297823603,1.0,5/20,12.36%,BCL2L1;DAB2;RHOQ;PKDCC;TMBIM1
prerank,coenzyme A metabolic process (GO:0015936),-0.32102882244247855,-0.8955741582916835,0.6053811659192825,0.9303158499775286,1.0,3/14,5.58%,PANK4;PANK1;PPCDC
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.3646377609479785,0.8954547024776536,0.6404907975460122,0.8557027007900853,1.0,4/21,12.47%,FLNA;NPPA;SCN1B;CACNA1D
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.38739593971911923,0.895396257371727,0.6121134020618557,0.855456827109363,1.0,2/15,7.29%,NLRC3;TREM2
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.39287855696823243,0.8952960313099206,0.6085319949811794,0.8553067501635546,1.0,5/15,18.66%,AK8;AK4;ENTPD5;AK5;ENTPD6
prerank,neuron migration (GO:0001764),0.3233128281441735,0.8952168224241659,0.6478405315614618,0.8551019542600459,1.0,9/48,13.42%,FGF13;LRP12;CDK5;NRP1;VEGFA;USP9X;NAV1;CELSR1;DCX
prerank,regulation of protein polymerization (GO:0032271),-0.2398134903743218,-0.8948972479288979,0.6893939393939394,0.9294913882823388,1.0,9/35,16.73%,FCHSD2;MAP2;TPPP3;DBN1;PAK3;ARHGAP28;TPPP;ESAM;CAMSAP3
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.3236434761460408,0.8947789138633405,0.6426155580608793,0.8556236778595576,1.0,11/41,20.79%,FLNA;KCNN4;KCNJ2;AMIGO1;KCNMA1;KCNMB4;KCNJ10;GNB1;ACTN2;KCNJ6;KCNJ15
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.4070515336800351,0.8947595495734958,0.637466307277628,0.8553097414469293,1.0,2/13,9.62%,NIBAN2;CADM4
prerank,immunoglobulin mediated immune response (GO:0016064),-0.3468476268849029,-0.8947029642228133,0.5723270440251572,0.9274072837628635,1.0,5/10,27.05%,CD81;FCGR2B;TLR8;GAPT;CD19
prerank,rRNA transcription (GO:0009303),-0.298158359827196,-0.8945296790004166,0.6130653266331658,0.9253122253881182,1.0,4/17,7.22%,GTF3C2;GTF3C1;BRF1;GTF3C6
prerank,negative regulation of cell aging (GO:0090344),0.3848157358720596,0.8941306419699425,0.6280254777070063,0.85615752664125,1.0,3/16,12.28%,CDK6;FBXO5;ZKSCAN3
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.3611463604123992,0.8939574107086582,0.6166868198307134,0.856142276154094,1.0,5/22,14.90%,MALT1;TRAF2;IL12RB1;B2M;HSPD1
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.3925381236224146,0.8933149684333305,0.6353092783505154,0.8569770080246748,1.0,5/13,32.32%,NAMPT;PTGIS;PARP16;PARP9;NAXD
prerank,protein processing (GO:0016485),0.29556441011943524,0.8932885679480125,0.7139917695473251,0.8566771232199984,1.0,23/102,15.94%,TMPRSS2;ADAMTS13;ECEL1;CPXM2;KLK1;KLK6;SDE2;HPR;HP;PSEN2;ADAM17;AEBP1;CD5L;CLN3;DDI2;SPCS3;AFG3L2;OGT;KLKB1;CPD;SPPL3;CASP4;FURIN
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.41898123162779966,0.8930867129711975,0.6130374479889042,0.8567321079163837,1.0,3/10,8.96%,PTPRC;KLRC1;LILRB1
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.3375788264336587,0.8928634476807976,0.6387921022067363,0.8568176923011803,1.0,10/31,23.23%,PEX2;DNAJC15;TIMM44;TOMM40;HSPD1;TIMM21;PEX16;TIMM17A;TIMM23;PEX14
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.3274015405673598,0.8927620786909028,0.6596685082872928,0.8566552538678956,1.0,18/42,33.78%,UBA52;RPS27A;POLE;VCP;UBE2L6;RFC1;UBC;REV1;RFC2;POLD4;SIRT1;ZBTB1;RFC4;UBB;POLA1;RFC5;PCLAF;PCNA
prerank,response to purine-containing compound (GO:0014074),0.3777362913720042,0.8925001479665623,0.6134020618556701,0.8567859016330971,1.0,2/17,9.15%,P2RX4;P2RY1
prerank,metanephric mesenchyme development (GO:0072075),-0.34044941164133125,-0.8923744548537016,0.6007604562737643,0.928314951232561,1.0,7/10,32.69%,PAX2;OSR1;STAT1;SHH;WT1;WNT4;SIX4
prerank,protein autoubiquitination (GO:0051865),0.3107030547261523,0.8922820887749272,0.6723768736616702,0.8568626740921051,1.0,20/61,30.60%,TRAF2;CNOT4;NFX1;DDB2;BRCA1;OBI1;BFAR;KLHL24;RNF157;RNFT1;CUL3;RNF41;TRIM21;MDM2;RNF13;WWP2;ERCC8;TRIM68;RNF19B;TRIM37
prerank,negative regulation of protein localization to cell surface (GO:2000009),-0.33083761852748916,-0.8917393351118025,0.5754385964912281,0.9274255983777361,1.0,4/11,15.71%,PICALM;COMMD1;TAX1BP3;NEDD4L
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.387646452139347,0.8916023759178509,0.6241956241956242,0.8577145862876964,1.0,3/14,13.97%,WDR12;FTSJ3;DDX18
prerank,tetrapyrrole metabolic process (GO:0033013),0.3741381286060878,0.8913537049891277,0.6183879093198993,0.8578314203150444,1.0,4/18,16.98%,ABCD4;MMUT;MMAB;MTRR
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.30672608050396793,0.8911871777522227,0.6971904266389178,0.8578002677222495,1.0,13/75,15.64%,PLEK;RGS3;PPP1R9B;MGLL;KLK6;SAG;C3;CCL5;PDE6B;CNGB1;ROCK1;GIT1;RNF157
prerank,regulation of protein localization to cell surface (GO:2000008),0.3365286714400193,0.8911788363841332,0.6397228637413395,0.8574689343687303,1.0,11/33,29.78%,CTNNB1;SNX33;RANGRF;ABCA7;STX3;ACTN2;HSP90AB1;TNF;STX4;RAB11B;LEPROT
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.27169487673267284,-0.8906722435334133,0.5974842767295597,0.9275859707321417,1.0,1/26,0.04%,NAV3
prerank,tRNA processing (GO:0008033),0.31106649509978834,0.8905041240257704,0.6884368308351178,0.8584009481329327,1.0,24/61,33.40%,AARS1;THG1L;METTL1;TRMT10C;ANKRD16;DDX1;QTRT1;SARS1;FARS2;NSUN2;TSEN15;ELP5;CSTF2;TRMT6;CDKAL1;WDR4;POP1;RTRAF;TSEN2;CLP1;LCMT2;NSUN6;RTCB;TRMT10A
prerank,interstrand cross-link repair (GO:0036297),0.31593629913644594,0.8903183907426286,0.6512875536480687,0.8584021983198781,1.0,18/53,27.61%,UBA52;RPS27A;ERCC1;VCP;FANCF;XPA;CENPX;ERCC4;SLX4;FANCA;RAD51AP1;UBC;DCLRE1A;MCM8;WDR48;USP1;CENPS;ATR
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.389328172418271,0.8901955768794111,0.6212710765239948,0.8582850782499901,1.0,5/15,27.91%,CCT2;CCT8;CCT5;DKC1;RUVBL2
prerank,cellular senescence (GO:0090398),0.35338183833671866,0.8901319353114189,0.6452380952380953,0.8580691083551939,1.0,3/27,4.64%,NSMCE2;ID2;PRKCD
prerank,regulation of striated muscle contraction (GO:0006942),0.3492093267680865,0.889864622579361,0.6542056074766355,0.8582250297814924,1.0,5/27,15.42%,P2RX4;TNNT3;SRI;SMAD7;ATP1A2
prerank,inner mitochondrial membrane organization (GO:0007007),0.31908867753134984,0.8896104227449727,0.6711560044893379,0.8583503418040495,1.0,16/47,29.24%,IMMT;SAMM50;ATP5MG;TIMM9;AFG3L2;MTX3;CHCHD6;GHITM;HSPA9;TMEM11;ATP5PD;ATP5F1B;ATP5MF;ATP5F1C;ATP5MC1;SPG7
prerank,cobalamin metabolic process (GO:0009235),0.3787278412046062,0.8890538340023072,0.6195372750642674,0.8590384410988223,1.0,4/17,16.98%,ABCD4;MMUT;MMAB;MTRR
prerank,spliceosomal complex assembly (GO:0000245),0.3223836879186424,0.888977339818479,0.6655480984340044,0.858833217549375,1.0,17/46,28.52%,SRPK1;LUC7L2;ZRSR2;CELF1;DDX1;DDX39B;PUF60;PRPF6;CELF6;GCFC2;SRPK2;SF3A3;SNRPG;SF3B1;NOL3;SRSF1;SRSF10
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.2966756087218222,-0.8884439322108115,0.6136363636363636,0.9307381223608338,1.0,2/17,5.81%,PDE3B;SORL1
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.3135523843921048,-0.8884313335267082,0.6278026905829597,0.928226675780519,1.0,4/14,13.64%,ALDH9A1;NOS1;DAGLB;ACHE
prerank,regulation of hormone secretion (GO:0046883),0.38585130765450054,0.8883262469562487,0.6291989664082688,0.8597456214930564,1.0,1/15,1.53%,ANXA1
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.37692826689745346,0.8880907257734382,0.6568123393316195,0.8598195306844426,1.0,5/18,21.95%,CCT2;EXOSC10;CCT8;CCT5;DKC1
prerank,regulation of brown fat cell differentiation (GO:0090335),0.3792196308166866,0.8878764721525337,0.6419597989949749,0.8598609029566433,1.0,5/16,21.50%,ZBTB7B;NAPEPLD;PIM1;HNRNPU;METRNL
prerank,arachidonic acid metabolic process (GO:0019369),-0.24170736083740016,-0.8877132911947619,0.696969696969697,0.927563337294884,1.0,10/35,15.56%,PTGS1;ALOX5;HPGDS;PNPLA8;CYP2U1;EPHX1;DAGLB;PLA2G4C;EPHX2;ALOXE3
prerank,polarized epithelial cell differentiation (GO:0030859),0.3968586454382837,0.8876970441459028,0.6388888888888888,0.8598438885790276,1.0,4/13,12.86%,RAP2A;MSN;RHOA;CDC42
prerank,response to alcohol (GO:0097305),-0.26393221547567497,-0.8874635889341588,0.6153846153846154,0.9256447499999458,1.0,8/27,16.91%,GRIN2A;CCR5;GRIN2B;SDF4;GRIN1;SOD1;GLRA1;GRIN3A
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.2697009124151198,-0.8873269063325011,0.6052631578947368,0.9235020540339023,1.0,4/23,7.72%,GRK4;CAMKMT;FNTA;METAP2
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.30055945968030456,0.8868033537983835,0.7138397502601457,0.8611257511103364,1.0,29/87,25.39%,IQGAP1;LRP1;ABL2;PDGFA;HRG;PTK2B;PRKCD;DLC1;RHOD;RHOQ;RHOG;PHPT1;RHOA;IQGAP2;CELSR1;ROCK1;HIP1R;DAPK3;TESK1;ARHGAP17;BST2;ARHGDIB;BAIAP2;TAOK1;ARHGEF5;RHOF;CCDC88A;PDGFRA;MDK
prerank,regulation of fibroblast migration (GO:0010762),0.3647519267663877,0.8863177008301024,0.6413708690330477,0.8616683084313054,1.0,6/20,18.68%,CORO1C;FGF2;CLN3;APPL2;DDR2;ITGB1BP1
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.3918715552034794,0.8861762670307312,0.630012936610608,0.8615840945998344,1.0,7/15,25.98%,RIOK2;ANAPC1;TACC3;TPR;NEK6;ANAPC7;UBE2C
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.31182559260185616,-0.8861277058037836,0.6428571428571429,0.9240284871774754,1.0,10/14,34.10%,ENPEP;AVPR2;ACE;OXTR;EDN3;EDN2;AVPR1A;ACE2;AGTR1;EDN1
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.32916459027067807,-0.8860113874137836,0.5660377358490566,0.9218069107489372,1.0,3/12,8.24%,INSIG1;INSIG2;TAPT1
prerank,adherens junction organization (GO:0034332),0.32250834955123997,0.8859675604742379,0.6685267857142857,0.8616238520307081,1.0,10/48,14.04%,CTNNB1;NECTIN1;CADM1;NECTIN3;CDH1;JUP;PIP5K1C;SMAD7;PAK2;ACTB
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),-0.22795849616323705,-0.8859098895351222,0.7171717171717171,0.9195681720683738,1.0,7/46,10.46%,PLCL1;ADAMTS5;ACVR2B;RBPJ;IP6K1;MAP2K6;PCTP
prerank,renal system development (GO:0072001),-0.21924526995646995,-0.8858526499541035,0.7272727272727273,0.9172544158979018,1.0,18/52,21.52%,SALL1;PCSK5;ITGA8;PAX8;AGT;PAX2;GREB1L;SULF2;IFT27;STAT1;SULF1;PYGO2;TFAP2B;CENPF;BAG6;PKD1;MME;HYAL2
prerank,negative regulation of interleukin-1 production (GO:0032692),0.35729379600395106,0.8857010918143204,0.6568986568986569,0.8617722568353302,1.0,1/23,0.06%,IGF1
prerank,regulation of heart contraction (GO:0008016),0.29952565727773595,0.8854981141960359,0.7048503611971104,0.8618012479140459,1.0,28/90,30.03%,ASPH;P2RX4;ATP1B3;ATP2B1;NPPA;TH;ATP1A4;ATP1A3;ATP1A1;SRI;NPR2;SMAD7;ATP1A2;FXYD4;ITPR3;NPPC;ATP2A2;FXYD1;CALM3;CORIN;ATP1B2;GSK3A;FKBP1B;HCN4;ITPR1;SCN10A;STIM1;NPR1
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.41553774688754114,0.8853484383153036,0.6251728907330567,0.861724901977692,1.0,4/10,14.76%,MUC1;HRG;SERPINE1;CYP1B1
prerank,protein K63-linked deubiquitination (GO:0070536),0.33681411569627695,0.8852869008207099,0.6775320139697323,0.8614876383625667,1.0,16/31,31.16%,OTUD4;ATXN3;ABRAXAS1;PSMD14;UIMC1;USP33;OTUD1;USP50;USP8;OTUD5;BRCC3;TNFAIP3;STAMBP;USP13;SHMT2;STAMBPL1
prerank,positive regulation of interferon-beta production (GO:0032728),-0.24124728351720448,-0.8848995426187006,0.6666666666666666,0.9171918222245892,1.0,9/33,16.99%,OAS2;POLR3F;DHX58;TRIM56;TLR2;TLR8;FLOT1;OAS3;TOMM70
prerank,regulation of BMP signaling pathway (GO:0030510),-0.21295526982581514,-0.8848644435021451,0.7894736842105263,0.9148197807736697,1.0,21/73,19.73%,CRIM1;BMPER;ACVR2B;BMPR1B;RBPJ;PCSK6;SMURF1;SORL1;SMURF2;UBE2O;VWC2;XIAP;BMP2;ENG;LRP2;SFRP4;SULF1;ACVR2A;FOXD1;FBXL15;TFAP2B
prerank,negative regulation of cell cycle (GO:0045786),0.3062809872251415,0.8847369731613842,0.7,0.8621554529817127,1.0,18/73,22.43%,CDK6;IPO5;GATA3;NUDT6;BRINP2;GMNN;LILRB1;CEBPA;TFAP4;NUPR2;RPS6KA2;PDCD4;RNF167;TAF6;NPPC;RUNX3;BMP4;LATS1
prerank,negative regulation of blood pressure (GO:0045776),0.40302377612502754,0.8846267986877334,0.6454545454545455,0.8620197101573746,1.0,2/13,10.13%,NPPA;SCPEP1
prerank,cell chemotaxis (GO:0060326),0.3073659658937857,0.8845598783197655,0.6816720257234726,0.86180307018833,1.0,11/60,12.41%,PRKCQ;LEF1;CXCR2;NRP1;PRKCD;VEGFA;DEFB130A;RHOG;CCR2;PARVA;CCL28
prerank,negative regulation of cell growth (GO:0030308),0.2959034925273878,0.8840469108808189,0.7275510204081632,0.8624000217121374,1.0,19/121,19.32%,APBB2;FGF13;PPP1R9B;SPHK2;HRG;CYP27B1;PPP2R1A;BCL6;RNF6;DCBLD2;RACK1;ENO1;ADAM15;OSGIN2;SERTAD3;STK11;NME6;CCAR2;BST2
prerank,positive regulation of hydrolase activity (GO:0051345),0.29006864413613587,0.8839880132458652,0.7580645161290323,0.8621584665829239,1.0,36/137,25.35%,BCAR3;RGS1;RGP1;CCL4;ALS2;PKP4;PSAP;TBC1D2;RAPGEF6;RASGRP1;RIC1;CCL13;RACK1;MMUT;CCL7;CCL5;RHOA;CCL14;RCN3;RASGRP2;NF1;AFDN;RIPK3;TBC1D20;PIN1;FERMT2;RPS3;GSK3B;F2R;LARS1;CALM3;DOCK11;RAB3GAP1;SFRP1;CX3CL1;MAPK12
prerank,cAMP-mediated signaling (GO:0019933),-0.2668847149387472,-0.8836664145934493,0.64,0.9152817598695699,1.0,10/24,17.56%,ADGRG6;ADCY2;RAPGEF2;RIMS2;EPHA5;AKAP6;PDE7B;PDE4D;PDE2A;RAPGEF3
prerank,RNA biosynthetic process (GO:0032774),0.336691583838886,0.8835593077888744,0.6552941176470588,0.8625835805134707,1.0,8/31,23.62%,TTF1;PRMT5;TBPL1;TBP;TAF7;TAF6;TERT;POLA2
prerank,mRNA splice site selection (GO:0006376),-0.25026461468913086,-0.8825735008650536,0.7115384615384616,0.915545248958192,1.0,9/30,14.46%,CELF2;LUC7L;SRSF9;ISY1;CELF4;CELF5;SETX;SF3A1;LUC7L3
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.31295952404340177,0.8824499252346772,0.6825749167591565,0.8642680621839365,1.0,14/52,18.02%,MBNL3;RBM25;CELF1;DDX17;RBM11;MBNL2;RBM15;RBFOX2;PUF60;NOVA2;FXR2;RBM15B;HNRNPU;CELF6
prerank,positive regulation of double-strand break repair (GO:2000781),0.3258156292139956,0.88225701064684,0.6689576174112256,0.8642775627007744,1.0,15/39,31.01%,ERCC6;MGMT;KMT5B;ARID2;KDM4D;PARP3;RAD51AP1;SETMAR;WAS;WDR48;SMCHD1;FUS;ACTR2;PNKP;PARP9
prerank,maintenance of protein localization in organelle (GO:0072595),-0.2927765529771179,-0.8822197231318111,0.6538461538461539,0.9140452074875776,1.0,9/19,23.63%,MORC3;SUPT7L;TAPT1;HK2;BCL3;TAF3;PML;BBS4;TAF8
prerank,organic anion transport (GO:0015711),0.30258751188240096,0.8821512726454065,0.6865828092243187,0.8641140048964743,1.0,17/76,21.90%,LRRC8C;SLC25A24;SLC23A1;SLC22A3;SLCO5A1;CYB5R4;CYB5R1;SLC52A2;SLC2A8;SLC4A9;SLC35B1;SLC4A2;SLC19A1;SLC16A2;SLC17A9;SLC2A6;SLC26A6
prerank,macrophage activation involved in immune response (GO:0002281),-0.31546842610857606,-0.8818911975070027,0.6039215686274509,0.9125031183996795,1.0,2/13,3.58%,CX3CR1;PLCG2
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.3054428131233407,0.8818590567725944,0.6817691477885652,0.8642891973477614,1.0,14/57,24.48%,IGF1;PPP2R1A;VEGFA;PTPN2;ARL2BP;CCL5;GHR;IL31RA;IL6;IL2;EPO;FGFR3;TNF;JAK2
prerank,positive regulation of signaling (GO:0023056),-0.23711325867272873,-0.8816408794724165,0.7545454545454545,0.9106465355735548,1.0,6/37,7.80%,GRIK2;RIMS1;CLSTN2;CLSTN3;SYT1;RIMS2
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.39303058328418694,0.8814616299598594,0.6464237516869096,0.8646416475023877,1.0,2/13,9.82%,CAV1;SRI
prerank,phosphatidylinositol dephosphorylation (GO:0046856),-0.26115683827389197,-0.8804474438019307,0.6981132075471698,0.9112671673598348,1.0,10/23,24.55%,MTMR9;SACM1L;MTMR7;INPP5J;INPP5K;INPP5B;PIP4P1;MTMR4;TPTE;MTMR2
prerank,regulation of double-strand break repair (GO:2000779),0.32596273193844166,0.8803164913003256,0.6748329621380846,0.8663732973118372,1.0,17/39,33.99%,FIGNL1;PPP4C;TRIP12;MGMT;DEK;RTEL1;RAD51AP1;WAS;TERF2IP;KDM1A;ACTR2;RNF169;PPP4R2;UBR5;SLF2;SETD2;RAD51
prerank,regulation of smooth muscle contraction (GO:0006940),0.35953987106693397,0.8801476874605804,0.6425061425061425,0.86632448097955,1.0,3/20,5.32%,ATP2B1;SPHK1;CAV1
prerank,regulation of neutrophil migration (GO:1902622),0.4137673362804034,0.8801357134268848,0.6241519674355496,0.8659995392626683,1.0,8/10,40.16%,RHOG;NCKAP1L;OLFM4;RAC2;MPP1;JAM3;RAC1;RHOH
prerank,regulation of astrocyte differentiation (GO:0048710),-0.3195288317875266,-0.8798613048744873,0.5907473309608541,0.9103461059631022,1.0,2/12,1.99%,BIN1;EPHA4
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.31520270904476466,0.8797781422579581,0.6790393013100436,0.8662766388638448,1.0,17/50,30.14%,GTPBP4;CCNB1;BCCIP;BLM;ACTB;STOX1;CCND2;CDKN3;GTF2H1;CCNT2;HSP90AB1;SERTAD1;GADD45A;MNAT1;CNPPD1;CDC25A;CCND1
prerank,cellular response to drug (GO:0035690),-0.2638301246996607,-0.879733975443246,0.691358024691358,0.9082719470024033,1.0,2/25,0.59%,MEF2C;PPM1E
prerank,hippo signaling (GO:0035329),0.346539296010857,0.8796218133554259,0.6477541371158393,0.8662112328369339,1.0,9/26,25.59%,TJP2;STK3;FAT4;SAV1;YWHAB;AMOTL1;TEAD1;LATS1;MOB1A
prerank,receptor catabolic process (GO:0032801),0.3525333570323596,0.8789269515546191,0.6502994011976048,0.8671609298488995,1.0,4/24,14.78%,MYLIP;SNX25;ZNRF3;MVB12A
prerank,ERAD pathway (GO:0036503),0.29642741695742214,0.8788417095615321,0.703239289446186,0.8669764748324033,1.0,34/83,34.34%,DERL3;EDEM1;DNAJB14;STT3B;ATXN3;VCP;SEC61B;UBE4A;DNAJB9;UBXN4;UBQLN1;RCN3;DERL1;PSMC6;RNF121;WFS1;UBE4B;UBXN6;DNAJC10;HSPA5;USP19;ECPAS;ERLIN1;DNAJB12;OS9;HSP90B1;USP13;HERPUD1;SYVN1;FAF2;UBQLN2;BRSK2;ERLIN2;UGGT1
prerank,modulation by symbiont of entry into host (GO:0052372),0.37022828942313885,0.8786857019096369,0.6299615877080665,0.8669084287054607,1.0,3/16,11.79%,TRIM6;CAV1;EXOC2
prerank,signal transduction in response to DNA damage (GO:0042770),0.3157541067601203,0.878387892256758,0.6905027932960894,0.8670923719920798,1.0,17/49,28.92%,ERCC6;DOT1L;BID;GRB2;TRIAP1;NDRG1;ATRX;ATM;RAD1;CASP9;USP28;INTS7;GADD45A;SESN2;ATR;RAD9A;HINFP
prerank,regulation of protein targeting to membrane (GO:0090313),-0.25585205746936784,-0.8783461309098443,0.6223776223776224,0.9093328615037932,1.0,6/28,14.28%,ITGAM;KCNB1;C2CD5;DMTN;INPP5K;HRAS
prerank,positive regulation of mitochondrial fission (GO:0090141),0.3744505697772477,0.8779767157908094,0.6699875466998755,0.8674881970328253,1.0,11/18,35.25%,DDHD1;DCN;KDR;VPS35;BNIP3;FIS1;MUL1;MFF;RALA;RALBP1;MCU
prerank,nuclear membrane organization (GO:0071763),0.36610286545843473,0.8771490018619262,0.6433041301627034,0.8686571800598144,1.0,5/19,22.65%,CHMP4B;DCTN1;CHMP7;TARDBP;TOR1B
prerank,RNA polyadenylation (GO:0043631),0.3403765701988772,0.8770466961106935,0.6722288438617402,0.8681548902549636,1.0,15/26,35.35%,GRSF1;PAPOLA;PABPC1;SYMPK;PAF1;SSU72;MTPAP;PAPOLG;TENT4B;LEO1;CLP1;AHCYL1;TUT1;WDR33;CSTF3
prerank,mRNA polyadenylation (GO:0006378),0.3403765701988772,0.8770466961106935,0.6722288438617402,0.8681548902549636,1.0,15/26,35.35%,GRSF1;PAPOLA;PABPC1;SYMPK;PAF1;SSU72;MTPAP;PAPOLG;TENT4B;LEO1;CLP1;AHCYL1;TUT1;WDR33;CSTF3
prerank,tryptophan metabolic process (GO:0006568),0.4064912197333479,0.8769893494509079,0.6621067031463749,0.8679141838515116,1.0,3/11,24.61%,ATP7A;IDO2;KYNU
prerank,muscle cell migration (GO:0014812),0.4166125862892375,0.8768707369676266,0.6408544726301736,0.8677916336177848,1.0,3/10,18.68%,ROCK1;AAMP;ITGB1BP1
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.31556953006556315,0.8767532846945384,0.6993534482758621,0.8676651287664617,1.0,16/51,22.74%,CSF1;FPR2;VEGFA;MOSPD2;ADAM17;CCR2;SERPINE1;CCL5;GAS6;C1QBP;AKIRIN1;ANO6;IL6;HMGB1;CALR;IL34
prerank,negative regulation of ion transport (GO:0043271),-0.25995178747758374,-0.8757273439947919,0.7039473684210527,0.9134365873434286,1.0,6/24,12.05%,WNK1;CD33;PXK;WNK3;NOS1;INPP5K
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.3022352147894529,0.875705441516661,0.7122002085505735,0.869216457716968,1.0,17/75,17.80%,CTNNB1;NIBAN2;HRG;PPARG;ANGPT4;ADGRB1;PGK1;CCR2;ROCK1;DCN;HSPG2;APOH;CCN6;SARS1;SPINK5;KLK3;KRIT1
prerank,plasma membrane tubulation (GO:0097320),0.3919996502730498,0.875515047206635,0.6605019815059445,0.8692056911755263,1.0,5/13,27.65%,SNX33;CHMP4A;CAVIN2;BIN3;PACSIN2
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.37309318347986725,0.8752491905394392,0.649810366624526,0.8693483265808659,1.0,8/18,18.25%,RIPOR2;PTK2B;RACK1;RUFY3;ROCK1;LLGL2;KRIT1;ARFGEF1
prerank,Notch signaling pathway (GO:0007219),-0.21400408948234645,-0.8752221071906878,0.6857142857142857,0.912281249735516,1.0,9/59,6.05%,SORBS2;ITCH;RBPJ;DTX3L;NOTCH2;WWC1;PSEN1;KAT2B;APH1B
prerank,axonemal dynein complex assembly (GO:0070286),0.339791082085266,0.8751413990529275,0.6491841491841492,0.8691975346039867,1.0,10/27,28.87%,ODAD2;DNAH8;DNAAF5;TTC12;CCDC65;DNAI3;CCDC40;CCDC39;DNAH5;DNAH17
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.2599858126517874,-0.8749561666746797,0.6687898089171974,0.9105588886264115,1.0,1/28,0.04%,NAV3
prerank,nucleoside salvage (GO:0043174),0.4217768760153246,0.8748546365033827,0.6473829201101928,0.8693501702166241,1.0,7/10,38.82%,UCKL1;HPRT1;TK1;TK2;DCK;UPP2;UCK2
prerank,peroxisomal membrane transport (GO:0015919),0.34356938241875035,0.8747016271706167,0.6599045346062052,0.8693001554517414,1.0,10/27,23.23%,ABCD4;PEX2;RAB8B;ABCD2;ABCD3;PXMP2;ALDH3A2;PEX16;ACBD5;PEX14
prerank,barbed-end actin filament capping (GO:0051016),0.3676518417399376,0.8743873644046948,0.6658259773013872,0.8691812602863175,1.0,6/18,25.85%,CAPG;SCIN;GSN;SVIL;TRIOBP;ADD3
prerank,actin filament capping (GO:0051693),0.3676518417399376,0.8743873644046948,0.6658259773013872,0.8691812602863175,1.0,6/18,25.85%,CAPG;SCIN;GSN;SVIL;TRIOBP;ADD3
prerank,protein import into mitochondrial matrix (GO:0030150),0.36626739122699115,0.8742866002229692,0.6403061224489796,0.8690199317428511,1.0,6/18,22.35%,DNAJC15;TIMM44;TOMM40;TIMM21;TIMM17A;TIMM23
prerank,retinal metabolic process (GO:0042574),0.3982715643074744,0.8735083091503948,0.6653116531165312,0.8700586605738477,1.0,4/12,22.05%,ABCA4;CYP1B1;RDH13;RDH10
prerank,nucleoside phosphate catabolic process (GO:1901292),0.4022588504612855,0.873052866520429,0.6493333333333333,0.8705212479518477,1.0,5/13,21.01%,DCTPP1;ITPA;ENTPD5;ENTPD6;NUDT15
prerank,embryonic appendage morphogenesis (GO:0035113),0.3981553458037742,0.8723422625262911,0.6440217391304348,0.8714218443785096,1.0,5/12,36.93%,FBXW4;LRP6;MEGF8;SKI;TGFB2
prerank,negative regulation of biomineral tissue development (GO:0070168),0.35726199165706235,0.8720970725714688,0.6686674669867947,0.8715263529813635,1.0,5/21,13.60%,PTK2B;SOX9;ECM1;GAS6;ROCK1
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.26806473674658193,-0.8718339611275844,0.6818181818181818,0.9157336551315958,1.0,11/24,23.39%,CPOX;PGRMC1;UROS;SLC25A38;ALAS2;RSAD1;ALAD;FECH;PPOX;COX15;ABCB10
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.30592287979440524,0.8717268701945572,0.7101293103448276,0.8718608747990746,1.0,14/57,22.66%,TAOK3;SDE2;FZR1;FBXO31;MDC1;FOXN3;BRCA1;ABRAXAS1;BLM;CDK2;UIMC1;ATM;TAOK1;TOPBP1
prerank,organonitrogen compound catabolic process (GO:1901565),0.3017486800914452,0.8713660252981512,0.6970998925886144,0.8721391412762038,1.0,15/57,25.24%,ANPEP;RENBP;ADAMTS13;GNPDA1;NAGK;NPL;TST;GNPDA2;MPST;TRIM24;TPP1;CLPX;AMDHD2;PDXDC1;PLA2G5
prerank,regulation of lipid kinase activity (GO:0043550),-0.3280619330692053,-0.8708354494029851,0.6507936507936508,0.9157816439944365,1.0,2/11,4.52%,PIK3R1;RBL2
prerank,neural crest cell differentiation (GO:0014033),0.3688499195162676,0.8708142008818648,0.6521212121212121,0.8727678970822281,1.0,5/18,16.51%,FBXL17;NRG1;NOLC1;LRP6;TCOF1
prerank,positive regulation of cyclase activity (GO:0031281),-0.3092692134288463,-0.8706901914109588,0.6310679611650486,0.9137723202869016,1.0,4/14,14.09%,MAPK14;MAPK8;NOS1;CACNA1C
prerank,regulation of mitochondrial fission (GO:0090140),-0.2634395654675604,-0.8706455469829264,0.6521739130434783,0.9115196525645115,1.0,3/24,3.51%,CYRIB;SPIRE1;LRRK2
prerank,apical junction assembly (GO:0043297),0.3071205558582681,0.8703203080618688,0.6918103448275862,0.8733096200095725,1.0,11/53,20.55%,POF1B;CLDN19;PDCD6IP;CLDN18;RHOA;PKN2;PAK2;MICALL2;AFDN;PATJ;MARVELD2
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.37818901400637794,0.8702998828640912,0.6531942633637549,0.8730048080478381,1.0,8/15,33.80%,RNASEH1;ZC3H12B;ZC3H12D;POP1;ZC3H12C;NYNRIN;ZC3H12A;NUDT16
prerank,regulation of axon regeneration (GO:0048679),-0.3205856966694075,-0.8702399518857266,0.6307692307692307,0.9102488584581627,1.0,2/12,3.20%,EPHA4;RTN4RL1
prerank,actin filament bundle organization (GO:0061572),0.3243355459198798,0.8694154186447108,0.6812428078250863,0.8741657601771846,1.0,12/33,28.94%,LCP1;MICAL1;NEDD9;RHOD;ESPN;PLS1;BAIAP2;BAIAP2L2;RFLNA;BAIAP2L1;CORO1B;PAWR
prerank,regulation of adenylate cyclase activity (GO:0045761),0.35233721842557647,0.8693253858882529,0.6731707317073171,0.8739629628493625,1.0,8/22,29.77%,CAP1;CCR2;CACNA1D;NF1;CAP2;ORAI1;DRD3;STIM1
prerank,lipid modification (GO:0030258),0.32300115137059565,0.8692454291962982,0.6809954751131222,0.8737663534364515,1.0,7/37,17.10%,DGKZ;PLPP6;PLPP3;LPCAT3;DGKA;DGKH;DGKD
prerank,muscle tissue development (GO:0060537),0.38138529831322976,0.8692147686871919,0.6533333333333333,0.8734815254910491,1.0,4/13,21.85%,CSRP3;NF1;CSRP2;BMP4
prerank,chromatin remodeling at centromere (GO:0031055),0.3297298710113746,0.8691552269652489,0.6647196261682243,0.8732435008137571,1.0,14/31,33.44%,CENPO;CENPT;CENPX;KNL1;NPM1;RBBP7;CENPK;CENPA;CENPS;RSF1;NASP;CENPH;CENPC;CENPW
prerank,cellular response to virus (GO:0098586),0.33423801615127025,0.8686302303359281,0.6655132641291811,0.8738465585031063,1.0,8/30,20.83%,HIF1A;BAX;POU2AF1;RIOK3;CCL5;IL6;VWCE;EIF5A
prerank,regulation of cell aging (GO:0090342),0.4024139207439722,0.8680104032329237,0.6492434662998624,0.874582347198585,1.0,5/11,23.58%,LMNA;NEK4;ING2;NEK6;MIF
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.2888073630577343,0.8676627518148536,0.7410071942446043,0.8748811969789527,1.0,22/95,18.40%,STAP1;SIRPA;VIM;AXL;CD274;TNIP3;LILRB1;PABPN1;PLAA;TICAM1;SERPINE1;TNFRSF1B;TNIP2;RHOA;GIT1;NFKB1;ACOD1;TIRAP;PDCD4;SBNO2;PAF1;IL6
prerank,cellular response to organic cyclic compound (GO:0071407),0.28572093841854557,0.8674396005484366,0.7754279959718026,0.8749039869765659,1.0,26/141,15.42%,CTNNB1;SPP1;P2RX4;MSN;ADCY8;ADCY3;MGARP;NR4A3;TFPI;ATP1A3;ATP1A1;UBE2L3;CDH1;P2RY1;BRCA1;JUP;RIOK3;DIAPH1;CCL5;LARP1;BLM;TIPARP;ACTB;CASP7;CYP1B1;ATP1A2
prerank,glycerol metabolic process (GO:0006071),0.4148065923043176,0.8671420018484963,0.6599462365591398,0.8750626132461505,1.0,2/10,16.88%,GK;COQ3
prerank,carbohydrate derivative catabolic process (GO:1901136),0.3596694992221466,0.8671192913571965,0.6480304955527318,0.8747608342391896,1.0,4/18,11.51%,DERA;STT3B;OGA;FUCA1
prerank,glutamine family amino acid metabolic process (GO:0009064),0.32625163986402683,0.8671159836371387,0.6850574712643678,0.8744248551887503,1.0,9/33,17.97%,MTHFS;PYCR3;ART4;GLS2;GLS;FPGS;CAD;SIRT4;OAT
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.40432528012353985,0.866902388432862,0.6566757493188011,0.8744517915056581,1.0,6/12,30.25%,FZR1;RAB1A;GOLGA2;UBE2C;BTRC;PTEN
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.3371030595078284,0.866216808938193,0.67561260210035,0.875339364815612,1.0,4/29,5.52%,DEDD2;TRAF2;CAV1;BID
prerank,protein localization to lysosome (GO:0061462),0.336147787171619,0.8661338754226494,0.6881720430107527,0.8751415416121252,1.0,4/28,12.03%,ATP13A2;RNF128;RAB7A;GCC2
prerank,negative regulation of protein localization to membrane (GO:1905476),0.34866046733737566,0.865984542974339,0.6738351254480287,0.8750714118065616,1.0,8/24,20.50%,BCL2L1;DAB2;GDI1;RHOQ;TMBIM1;LZTFL1;ITGB1BP1;PPFIA1
prerank,B cell activation involved in immune response (GO:0002312),-0.3052533342238714,-0.8657580409655843,0.652,0.9185584712016491,1.0,5/13,28.92%,FCGR2B;RNF168;GAPT;CD19;RNF8
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.3315179435098233,0.8652643317661557,0.6736596736596736,0.8759892691786068,1.0,12/31,26.11%,EXOSC4;PATL1;EXOSC9;NT5C3B;DCP1A;LSM6;EDC4;EXOSC5;CNOT6;LSM4;EDC3;LSM3
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.3026753466878349,0.8647895417422382,0.7226435536294691,0.8764577767140412,1.0,12/63,13.12%,MUC1;CNOT4;SDE2;PLK2;FBXO31;CCNB1;BAX;CNOT10;TRIAP1;CARM1;CDK2;PCBP4
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.3923745915057777,0.8647737296867837,0.6823529411764706,0.8761400245875489,1.0,2/13,4.39%,ADCY8;SQSTM1
prerank,positive regulation of interferon-alpha production (GO:0032727),0.3599100590954928,0.8647134387658597,0.6646039603960396,0.8759099417662297,1.0,11/19,39.51%,IRF5;HSPD1;DHX36;DHX9;TLR9;TBK1;MAVS;SETD2;DDX3X;IRF3;CHUK
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.35008721385816244,0.8645093122413504,0.6835599505562423,0.8758919202140516,1.0,6/22,19.07%,NES;ID2;DLL4;APPL2;TOX;SLC16A2
prerank,inorganic cation import across plasma membrane (GO:0098659),0.2979461344162593,0.8645076454793525,0.7328482328482329,0.8755504322789088,1.0,13/75,15.42%,SLC9A1;ATP1B3;SLC5A1;KCNJ2;ATP1A4;ATP1A3;ATP1A1;SLC12A4;SLC39A6;KCNJ10;SLC9A7;SLC9A6;ATP1A2
prerank,production of siRNA involved in RNA interference (GO:0030422),0.41856108652321367,0.8644177187313797,0.665742024965326,0.875371885455316,1.0,1/10,2.20%,AGO2
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.35466667797930246,0.864312394337396,0.6550435865504358,0.8752086234460846,1.0,3/20,7.65%,AGO2;EIF6;CELF1
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.38017768182173417,0.8634380207025757,0.6640625,0.8763956602198423,1.0,5/15,17.90%,PIK3CB;DAB2;SCYL2;DGKD;HIP1R
prerank,regulation of chemokine production (GO:0032642),0.31783014320100744,0.8626085810684747,0.6786516853932584,0.877497739417064,1.0,5/36,10.16%,LPL;HIF1A;TREM2;ADAM17;HMOX1
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.40822381989391093,0.8622725771788402,0.6698369565217391,0.8777084372824212,1.0,4/10,29.18%,ATP5MG;ATP5PD;ATP5F1C;ATP5MC1
prerank,nuclear body organization (GO:0030575),0.3908369385179282,0.8621849797158925,0.6804260985352862,0.8775262125711869,1.0,6/12,33.84%,USPL1;SRPK2;USP50;ZPR1;ETS1;HIPK2
prerank,protein secretion (GO:0009306),0.3042754752557456,0.8619359870155047,0.7318376068376068,0.8776106398521336,1.0,16/56,24.07%,ABCA1;ANXA1;SNX19;CYB5R4;RAB8A;RAB8B;MON1A;WLS;RCN3;VIP;TMEM167A;LTBP2;ARFGAP3;RAB3D;CANX;GOLPH3
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.39596572258458085,0.8615619203320681,0.6434210526315789,0.877902956588393,1.0,6/11,36.82%,IL6;BMP4;MAP2K2;RIPK1;MAP2K1;TGFB1
prerank,tight junction assembly (GO:0120192),0.30685746955002635,0.8613509033786028,0.7138193688792165,0.8779017159263156,1.0,10/49,20.55%,POF1B;CLDN19;ACTG1;PDCD6IP;CLDN18;PAK2;MICALL2;AFDN;PATJ;MARVELD2
prerank,regulation of dendrite extension (GO:1903859),-0.28474824578814256,-0.8612722937799274,0.7090909090909091,0.926448505521479,1.0,7/18,15.71%,RIMS1;SYT1;SMURF1;SYT2;RIMS2;CPNE5;NEDD4L
prerank,I-kappaB phosphorylation (GO:0007252),-0.33748203417280453,-0.8611833855453794,0.6509090909090909,0.9243120984967508,1.0,3/10,18.21%,MAP3K7;TLR2;PRDX4
prerank,angiogenesis involved in wound healing (GO:0060055),0.40119850150510866,0.8610905880720763,0.6549865229110512,0.8779942413848756,1.0,6/11,31.58%,VEGFA;SRF;KDR;HPSE;NDNF;MCAM
prerank,cellular glucan metabolic process (GO:0006073),0.4002737619431114,0.86098988203983,0.6639004149377593,0.8778213951232402,1.0,4/11,27.68%,PHKB;GSK3B;PYGM;GBE1
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.34767991427579353,0.860819512462942,0.6646778042959427,0.8777800906924076,1.0,9/22,30.44%,MGAT5;CCL5;GHR;CYP1B1;IL6;F2R;TNF;HES1;CRLF2
prerank,cellular response to retinoic acid (GO:0071300),0.31518106263166096,0.8606643675446322,0.7093922651933702,0.8777019118274917,1.0,5/42,9.08%,ABL2;PTK2B;SOX9;BRINP2;WNT6
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.2978184004110604,0.8606536875404192,0.7305644302449414,0.8773762587739526,1.0,13/69,16.66%,IGF1;PLCB4;PIK3CB;PIK3R5;GATA3;IGF1R;PLCB2;PLEKHA1;RHOA;OGT;C1QBP;NF1;PIK3R2
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.2764899241876974,0.8603522585161607,0.854,0.8775286856938046,1.0,83/259,29.65%,SDCBP;FLNA;RAP2A;ASAP1;CFAP44;PPP1R9B;TEKT2;PTPN23;NRP1;ATP6V0D1;RILPL2;FOXJ1;SPAG16;FGD6;FXYD5;MTSS1;RAPGEF6;IFT43;RHOD;TEKT5;WDR35;SNX10;ARMC9;RAB8A;ABLIM1;RAB8B;CEP41;TCTN3;PARVA;EXOC2;GSN;CNGB1;CEP250;ACTR3;IFT88;TMEM216;PLK4;MINK1;RAB1A;LZTFL1;IFT74;MKKS;EHD4;NTN1;RAB11A;CFAP70;PMP22;ANO6;RILPL1;PARVB;BBIP1;ACTN2;MAK;FGD5;IFT122;DYNC2I1;EHD1;GOLPH3;CCDC88A;CYS1;CCDC65;TRAF3IP1;RILP;BBS7;TMEM107;MKS1;SCLT1;CYFIP1;S1PR2;DYNLT2B;ARL6;EXOC4;ACTR2;TMEM237;ARL3;DNAH5;ITGB1;TMEM17;CEP83;IQCB1;RAP2B;CFAP410;PIBF1
prerank,positive regulation of stress fiber assembly (GO:0051496),0.31261015332750697,0.8601067776401797,0.6798679867986799,0.8776104379450345,1.0,20/44,30.62%,NRP1;MYOC;RHOA;LIMK1;CDC42;LPAR1;SERPINF2;TESK1;ITGB1BP1;FERMT2;EVL;CD47;GPR65;ARHGEF5;CCDC88A;SFRP1;S100A10;CCN2;SORBS3;RHOC
prerank,negative regulation of lymphocyte migration (GO:2000402),0.41042877540324135,0.8600741990930851,0.6581196581196581,0.8773295781379101,1.0,2/10,6.20%,RIPOR2;CD200R1
prerank,DNA damage checkpoint signaling (GO:0000077),0.33344248956255884,0.8600158119081063,0.6894484412470024,0.8770996342456185,1.0,12/28,34.13%,ERCC6;DOT1L;ATM;RAD1;USP28;INTS7;ATR;RAD9A;HINFP;MAP3K20;HUS1;CHEK2
prerank,embryonic heart tube morphogenesis (GO:0003143),0.31421960819865297,0.8595080897983388,0.6822222222222222,0.8776549779086753,1.0,3/43,3.32%,MICAL2;TBX21;EOMES
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.32325445038124184,0.8589677999479371,0.7194982896237172,0.8782253247684554,1.0,7/36,15.88%,SIRPA;TAOK3;PTPN22;TREM2;PPIA;DUSP3;FOXO1
prerank,regulation of cilium movement (GO:0003352),0.4135178631910128,0.8588863236341896,0.6570644718792867,0.8780186419898054,1.0,6/10,32.29%,ODAD2;CCDC65;CCDC40;CCDC39;DNAH11;CFAP298
prerank,regulation of GTPase activity (GO:0043087),0.27875046571691015,0.8581816102414281,0.8258258258258259,0.8788719483248648,1.0,55/177,28.06%,BCAR3;PLXNC1;RGS1;GPR137B;PLXNA2;RGP1;CCL4;ALS2;PKP4;TBC1D2;CPEB2;FGD6;RAPGEF6;RASGRP1;RIC1;CCL13;KLRK1;RACK1;MMUT;PLXND1;CCL7;CCL5;CCL14;ARHGAP12;RASGRP2;NF1;AFDN;ARHGAP9;RAB3GAP2;TBC1D20;ARFGEF1;PIN1;ITGB1BP1;FERMT2;GMIP;FGD5;GSK3B;ARHGEF5;F2R;LARS1;VAV3;DOCK11;RRP1B;RAB3GAP1;VAV1;SFRP1;CX3CL1;SNX18;PLXNA1;TBC1D15;LIMS1;TMED2;S100A10;ADAP1;ITGB1
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.2881079741250022,-0.8580205223037973,0.6868686868686869,0.9291612816103197,1.0,3/16,8.73%,DPYD;DPYSL2;CRMP1
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.32598313759975694,-0.8574697816339724,0.6466165413533834,0.9280324260639603,1.0,6/11,29.91%,TIMM10B;TOMM70;TIMM29;NDUFA13;TIMM8B;TIMM13
prerank,mitotic sister chromatid segregation (GO:0000070),0.28807208231194514,0.8574107423989688,0.7764102564102564,0.8798242089923687,1.0,30/98,29.95%,NCAPG;EML4;NCAPG2;CHMP4A;CHMP4B;KMT5A;PDCD6IP;CCNB1;VPS4B;NCAPH;CHMP7;INO80;KIFC1;TEX14;RAB11A;CUL3;CSNK2A2;CHMP6;SPDL1;NIPBL;MCPH1;EML3;CENPK;ESPL1;PDS5A;PHF13;KIF22;NUDC;PIBF1;BECN1
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.30052463891480635,-0.8566040378818877,0.6652360515021459,0.9276158993534751,1.0,6/14,20.07%,GPS2;CCDC3;PELI3;RFFL;CARD16;NLRP2B
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.30550806614658726,0.8558020386031298,0.7166123778501629,0.8822251463630644,1.0,18/53,28.62%,APOE;FBXW7;TREM2;RHBDF1;PSMC3;XPO1;PSMD14;PSME3IP1;PSMC6;DESI1;TMF1;NUDT15;HSP90AB1;USP14;USP19;GPX1;UFL1;GNA12
prerank,positive regulation of cytokinesis (GO:0032467),0.3250823526986396,0.855243455057142,0.7064327485380117,0.8828435690568691,1.0,10/32,25.05%,MAP10;PKP4;RHOA;CDC42;PKN2;RACGAP1;SVIL;CUL3;GIPC1;CDC25B
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.29385933141510673,0.8550694042483307,0.751311647429171,0.882798962131389,1.0,25/78,30.67%,CCNY;GTPBP4;IPO5;ADAM17;CCNB1;BCCIP;CEBPA;TFAP4;BLM;ACTB;CCND2;CDKN3;GTF2H1;CCNT2;SERTAD1;LATS1;GADD45A;PSMD10;CDK5RAP1;MNAT1;CNPPD1;CDC25A;CCND1;PTEN;HEXIM1
prerank,ncRNA catabolic process (GO:0034661),0.3321157412636459,0.8550659961635277,0.6949152542372882,0.8824599495273028,1.0,11/28,29.33%,DEDD2;EXOSC4;ERN2;EXOSC9;EXOSC10;EXOSC5;SND1;XRN1;TRIR;TENT4B;POP1
prerank,negative regulation of angiogenesis (GO:0016525),0.2909930268364768,0.854949026950259,0.7430626927029804,0.882307816621936,1.0,19/84,17.80%,CTNNB1;NIBAN2;PIK3CB;HRG;PPARG;ANGPT4;ADGRB1;PGK1;CCR2;SERPINE1;ROCK1;DCN;HSPG2;APOH;CCN6;SARS1;SPINK5;KLK3;KRIT1
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.39022061932622315,0.8546746190076289,0.6653386454183267,0.882441337245073,1.0,4/12,24.29%,NCOR2;IL6;TERT;TNF
prerank,protein insertion into ER membrane (GO:0045048),0.3195127778586005,0.8544598093226051,0.7024504084014003,0.8824568786307428,1.0,10/37,19.51%,TRAM1L1;UBL4A;SEC61B;HMOX1;EMC9;EMC3;GET1;VAMP2;ALDH3A2;GET3
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.3477522928617406,0.8543928677259136,0.6744186046511628,0.882224136922222,1.0,7/23,24.51%,PLK2;WEE1;PRCC;BUB1B;SETMAR;ZFYVE19;PLK3
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.34330794561918854,0.8543478693197488,0.6901072705601907,0.8819628184963588,1.0,8/25,25.17%,SDCBP;NRP1;ILK;CCL5;PTGES3;DSCAM;MIF;NCKAP1L
prerank,anterior/posterior axis specification (GO:0009948),0.3744438471012274,0.854031425972966,0.6790757381258024,0.8821387938387848,1.0,2/15,14.31%,WLS;DDIT3
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.3170910891136501,0.8535627210659258,0.7074285714285714,0.8825819038734852,1.0,8/38,13.52%,PTPRC;NEDD9;CAV1;NCK2;MVP;GAS6;EFNA1;GPRC5B
prerank,response to acidic pH (GO:0010447),0.3916850836265215,0.8534630840902581,0.6977660972404731,0.8824045596550708,1.0,2/13,3.44%,SLC9A1;GPR151
prerank,regulation of cellular senescence (GO:2000772),0.33145988462409925,0.8524348467878999,0.7008244994110718,0.8837530406678463,1.0,7/28,17.88%,CDK6;FBXO5;NEK4;B2M;ZKSCAN3;ING2;NEK6
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.3994427883745571,0.8521686880795252,0.6745152354570637,0.8838321200052536,1.0,3/10,25.29%,CAV1;SUMO1;KCNAB1
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.36869425865546473,0.8519225462693619,0.6830530401034929,0.8839028849570583,1.0,7/14,33.38%,GART;ATIC;ADSS1;PPAT;ADSL;GMPS;ADSS2
prerank,ruffle organization (GO:0031529),-0.28319170103897784,-0.8518401746125268,0.6310679611650486,0.9362793501850717,1.0,3/16,5.50%,CSF1R;CARMIL1;AIF1
prerank,odontogenesis (GO:0042476),0.3214874973319898,0.8517704427732922,0.6967963386727689,0.8838101635676128,1.0,9/35,25.54%,HDAC1;WNT6;ANKRD11;TUFT1;LRP6;BMP4;FGFR2;HDAC2;COL1A2
prerank,histone H3-K36 demethylation (GO:0070544),-0.33002735310424214,-0.8509213830820158,0.6679841897233202,0.9359953310875077,1.0,3/10,9.95%,PHF8;KDM4A;KDM7A
prerank,sensory perception of mechanical stimulus (GO:0050954),0.2875718044147481,0.8509065608581968,0.7667009249743063,0.8849211797958818,1.0,19/85,23.02%,P2RX4;CHRNB2;MYO1A;GRXCR1;RIPOR2;PIEZO2;TPRN;TIMM9;CACNA1D;BIRC5;HOMER2;SLC26A4;WFS1;USP53;MYO3B;ATP6V0A4;MARVELD2;NIPBL;CLIC5
prerank,regulation of viral life cycle (GO:1903900),0.3489613856736617,0.8508514662924986,0.6934487021013597,0.8846711125962977,1.0,4/21,14.16%,AXL;TRIM6;KPNA6;PPIA
prerank,positive regulation of histone acetylation (GO:0035066),0.34611055753598163,0.8508246229560844,0.6828087167070218,0.8843717943939683,1.0,10/23,28.29%,SPHK2;MUC1;BRCA1;SMARCB1;WBP2;KAT7;GLYR1;PIH1D1;RUVBL2;MAPK3
prerank,actin filament bundle assembly (GO:0051017),0.3182235832019564,0.8507165074273441,0.6991963260619977,0.8842135279221672,1.0,4/33,7.79%,LCP1;MICAL1;NEDD9;RHOD
prerank,cell junction maintenance (GO:0034331),-0.3048350995406652,-0.8501245143559826,0.6313725490196078,0.9354924145019318,1.0,1/14,0.16%,CSF1R
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.26265975525585705,-0.849906295631827,0.6868686868686869,0.9336173485229379,1.0,7/20,20.81%,PRKCE;HECW1;HECW2;OSR1;NEDD4L;PLN;ADRA2A
prerank,rRNA modification (GO:0000154),0.34137631140416375,0.8496382802811514,0.6978776529338327,0.8857171386256086,1.0,9/21,27.49%,MRM2;FTSJ3;GAR1;NSUN3;DKC1;TRMT112;DIMT1;NAT10;NSUN4
prerank,inner dynein arm assembly (GO:0036159),0.40341630306413057,0.8495905923211464,0.6810228802153432,0.8854557833012976,1.0,4/10,27.39%,DNAAF5;DNAI3;CCDC40;CCDC39
prerank,determination of heart left/right asymmetry (GO:0061371),0.311453672331248,0.8493180809963686,0.7048997772828508,0.8855527403627764,1.0,3/42,3.32%,MICAL2;TBX21;EOMES
prerank,diacylglycerol metabolic process (GO:0046339),0.33646919205857173,0.8492472915656443,0.6904761904761905,0.8853268983458829,1.0,5/23,17.10%,DGKZ;APOA2;DGKA;DGKH;DGKD
prerank,negative regulation of nuclear division (GO:0051784),0.39475119758779037,0.848773255167386,0.6706827309236948,0.8857707041571852,1.0,3/11,21.85%,FBXO5;NME6;BMP4
prerank,histone mRNA metabolic process (GO:0008334),0.32461882140503834,0.8485300119287233,0.7082352941176471,0.8858008980678944,1.0,13/27,33.96%,EXOSC4;EXOSC10;ATM;XRN1;SNRPG;SNRPF;MTPAP;TENT4B;LSM11;DCP2;TUT1;SLBP;ERI1
prerank,regulation of fat cell differentiation (GO:0045598),0.29235104036519594,0.8483410214948371,0.7550158394931362,0.8857794297784363,1.0,30/74,33.16%,LPL;ID2;PPARG;GATA3;NOCT;PPARD;ASXL2;CARM1;ZBTB16;ASXL1;FOXO1;ANKRD26;IL6;FERMT2;SYAP1;ADIG;LMO3;TRIB2;TNF;CCDC85B;SFRP1;CREBL2;SIRT1;RARRES2;FRZB;SIRT2;XBP1;ZC3H12A;CEBPB;TMEM64
prerank,response to retinoic acid (GO:0032526),0.29745508298891,0.8483404155042691,0.7388059701492538,0.8854400508157323,1.0,9/59,15.51%,ABL2;PTK2B;SOX9;BRINP2;TRIM16;WNT6;FZD4;RBP4;ASXL1
prerank,regulation of Golgi organization (GO:1903358),0.36166069621001046,0.8480240316301614,0.6965428937259923,0.8856349075538771,1.0,1/17,0.41%,MYO5A
prerank,positive regulation of cellular senescence (GO:2000774),-0.33124572202291314,-0.8478337703256791,0.6227106227106227,0.9358921363087365,1.0,4/10,20.81%,ABI3;HMGA2;ARG2;HMGA1
prerank,regulation of protein localization to membrane (GO:1905475),0.32873389622317695,0.8477724615131977,0.7174163783160323,0.8857127792411364,1.0,7/28,17.43%,CDK5;FYN;CLN3;GSN;CRIPT;ACTB;SLC5A3
prerank,regulation of epidermal cell differentiation (GO:0045604),0.3447289634512632,0.8471276607991669,0.6988984088127295,0.8864468064367469,1.0,6/21,21.85%,MAFF;RUNX1;MAFG;ROCK1;SULT2B1;BMP4
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.3517842833064695,0.8470570591616372,0.689156626506024,0.8862158480064258,1.0,4/20,14.57%,NPTN;FGF2;SPRY4;PRKD2
prerank,negative regulation of ATPase activity (GO:0032780),0.36573523219212273,0.847049494056015,0.6863979848866498,0.8858874904019808,1.0,5/16,33.06%,LTF;THADA;TLR9;SIRT1;PAM16
prerank,female gonad development (GO:0008585),0.3568984473056215,0.8469512086876696,0.6825,0.8857138859288974,1.0,5/19,24.02%,CYP19A1;VEGFA;COL9A3;EIF2B2;EIF2B4
prerank,piRNA metabolic process (GO:0034587),0.3525253642917143,0.8469070475453466,0.6982543640897756,0.8854487630446786,1.0,1/19,6.26%,PIWIL2
prerank,mitotic nuclear division (GO:0140014),0.29317766009420226,0.8465462603810308,0.7383474576271186,0.885698843737553,1.0,20/71,26.58%,FLNA;NCAPG2;CHMP4B;LSM14A;BCCIP;ABRAXAS1;RHOA;CHMP7;PPP2R2D;INO80;SMC3;TOGARAM2;KIFC1;RAB11A;AAAS;STAG1;GOLGA2;CENPK;UBE2C;ESPL1
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),-0.2896312186707716,-0.8465187207545846,0.683982683982684,0.9365379153019288,1.0,4/16,15.42%,PDK1;FOXK2;PRKN;PDK2
prerank,embryonic digestive tract development (GO:0048566),-0.27174344233818665,-0.8448345430061308,0.7219512195121951,0.9379017105741783,1.0,2/18,1.29%,SALL1;PCSK5
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.33891693441763415,0.8444979684983516,0.6990521327014217,0.8886825304620134,1.0,10/23,29.65%,PTK2B;CCL5;GHR;CYP1B1;IL6;F2R;TNF;JAK2;HES1;PIBF1
prerank,hematopoietic stem cell proliferation (GO:0071425),0.38898376715037897,0.8443286124859303,0.6945945945945946,0.8886125240142004,1.0,3/11,15.48%,RUNX1;ETV6;YTHDF2
prerank,organelle disassembly (GO:1903008),0.321110520661071,0.8442921483976229,0.7335640138408305,0.8883256701010055,1.0,13/33,27.69%,DENR;KLC1;UFM1;VCP;RETREG1;ATG2B;GFM2;PLK3;GOLGA2;STX5;ZFAND1;EIF2D;UFL1
prerank,positive regulation of protein targeting to membrane (GO:0090314),-0.25399584124719293,-0.844291365033338,0.6951219512195121,0.9367496967921701,1.0,3/24,8.81%,ITGAM;KCNB1;C2CD5
prerank,regulation of phosphate metabolic process (GO:0019220),0.36417034788225255,0.8442378049389602,0.6914357682619647,0.8880756259813866,1.0,2/16,4.33%,CD24;MCM7
prerank,regulation of intracellular transport (GO:0032386),0.31562892505644,0.843972916038921,0.725,0.8881794755342991,1.0,3/38,4.91%,LCP1;ATP13A2;DYNC1H1
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.2960833717244774,0.8438344560288493,0.752411575562701,0.8880592029949663,1.0,16/59,23.00%,DYRK2;CDK5;PRKCD;PDPK1;SBK1;HIPK1;MAP3K12;ROCK1;PRKD2;CAD;NLK;CSNK2A2;MARK2;LMTK2;GSK3B;TGFBR2
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.3744899782097157,0.843691151747423,0.6956521739130435,0.8879580742173976,1.0,3/14,16.06%,CD226;KMT5B;TFRC
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.37697195210860296,0.8434319674115314,0.6974025974025974,0.8880101571208604,1.0,3/13,15.18%,ANAPC15;CCNB1;TPR
prerank,neuromuscular synaptic transmission (GO:0007274),0.35505879622795045,0.8432855630441285,0.6787048567870486,0.8879029079374359,1.0,4/18,14.92%,CHRNB2;ERC2;DTNA;TBC1D24
prerank,negative regulation of viral release from host cell (GO:1902187),0.3793222944966042,0.842540168173969,0.6924083769633508,0.8887600626164205,1.0,6/13,37.66%,TRIM28;TRIM21;TRIM8;TRIM11;TRIM35;CHMP3
prerank,mitochondrial RNA metabolic process (GO:0000959),0.36974469748693717,0.8417649558933009,0.6968152866242038,0.8896779027515701,1.0,4/14,15.05%,SLC25A33;MRPL12;EARS2;TWNK
prerank,regulation of protein localization to cell periphery (GO:1904375),0.3525287454285634,0.8413704808958559,0.7036569987389659,0.8899783941679341,1.0,3/18,14.04%,CDK5;CLN3;ACTB
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.3232607915521459,0.8409293621998384,0.704093567251462,0.8903760260356374,1.0,14/29,33.26%,STAT4;CCR2;GHR;IL31RA;PIAS1;STAT5B;SOCS2;JAK2;IFNAR2;STAMBP;CTR9;JAK3;IFNAR1;SOCS6
prerank,regulation of catecholamine secretion (GO:0050433),-0.24082707587122162,-0.8408557663428637,0.76875,0.9417898438833899,1.0,7/29,13.86%,SYT10;KCNB1;SYT1;SYT2;PRKN;STX1A;SYT9
prerank,eye development (GO:0001654),0.2989451444408773,0.8406703761523565,0.761437908496732,0.8904394780651919,1.0,13/54,25.14%,SH3PXD2B;BLOC1S3;HIPK1;SMG9;SMOC1;RBP4;CPAMD8;MEIS3;PBX1;NIPBL;PBX2;SIPA1L3;RAB3GAP1
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.3957404412683975,0.8406180764168975,0.6885245901639344,0.890184637107552,1.0,7/10,40.78%,PIH1D1;RUVBL2;ZNHIT6;NAF1;RUVBL1;SHQ1;TAF9
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.29892362720041926,0.8405540571874762,0.7133258678611423,0.8899493642451731,1.0,16/45,29.57%,CD44;IRF6;PRKCD;IRF8;B2M;JAK1;IRF5;SP100;GBP2;TRIM21;JAK2;MT2A;IFNGR2;TRIM8;OASL;TRIM68
prerank,central nervous system neuron differentiation (GO:0021953),0.32077510607645,0.8401635269270594,0.7044673539518901,0.8902429835406727,1.0,8/33,19.29%,CTNNB1;ATP7A;LRP6;NR4A2;CHD5;TOX;GBA2;AGTPBP1
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.4005421979617194,0.8399798067647087,0.7085714285714285,0.8902041719184957,1.0,2/10,9.58%,PPP2R1A;PTPN2
prerank,cilium assembly (GO:0060271),0.27000213223147845,0.8397230661521683,0.899,0.8902656334755021,1.0,86/296,29.65%,FLNA;ASAP1;CFAP44;ODF2;TEKT2;PTPN23;BBS10;ATP6V0D1;DYNC1H1;PPP2R1A;RILPL2;FOXJ1;SPAG16;NINL;IFT43;TEKT5;WDR35;HAUS8;SNX10;ARMC9;RAB8A;ABLIM1;RAB8B;CEP41;DCTN1;TCTN3;PARVA;YWHAG;EXOC2;GSN;TBC1D32;CNGB1;DCX;CEP250;ACTR3;IFT88;CSNK1D;TMEM216;SPATA6;PLK4;RAB1A;LZTFL1;IFT74;TUBB;MKKS;EHD4;RAB11A;CFAP70;HAUS2;RILPL1;BBIP1;MAK;IFT122;MARK4;DYNC2I1;EHD1;CYS1;CCDC65;TNPO1;CETN2;TRAF3IP1;RILP;BBS7;TMEM107;MKS1;SCLT1;MAPRE1;CCDC40;CCDC39;DYNLT2B;ARL6;EXOC4;ACTR2;TMEM237;ARL3;DNAH5;CEP97;TMEM17;CEP83;IQCB1;RPGRIP1;ALMS1;CSNK1E;CFAP410;GORAB;PIBF1
prerank,sensory perception (GO:0007600),0.3051445709638759,0.8395882019004239,0.7311111111111112,0.8901428867055151,1.0,8/45,16.70%,P2RX4;PTGES;CHRNB2;ASIC3;CCR2;ADORA2A;RETREG1;C5AR1
prerank,positive regulation of neuron projection development (GO:0010976),0.2832058204325921,0.8385730173458594,0.7784743991640544,0.8914071087286213,1.0,7/85,4.41%,S100A9;APOE;ABL2;ALKAL2;ZDHHC15;PTK2B;NPTN
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.2827738703751186,0.8381546973101777,0.764033264033264,0.8917502618786406,1.0,18/86,24.48%,SDCBP;BMP8B;GDF6;DAB2;ADAM17;RNF111;RBPMS;NUMA1;ING2;SH2B1;BMP6;STK11;BMP5;NUP93;HSP90AB1;BMP4;GIPC1;JAK2
prerank,epithelial cell development (GO:0002064),0.3427345816370793,0.838040762844755,0.6953405017921147,0.8915861273418054,1.0,6/20,24.09%,POF1B;RILPL2;ACTA2;RILPL1;TMEM79;SIPA1L3
prerank,neural tube development (GO:0021915),-0.28782838563997803,-0.8374629602229732,0.6954545454545454,0.9468583749637107,1.0,7/15,30.47%,STIL;PKD1;ARL13B;ALDH1A2;GRHL2;HES5;SOX4
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.2905386747917058,-0.83678272539849,0.717391304347826,0.9460654551323561,1.0,3/15,9.61%,PNP;EBI3;NKAP
prerank,regulation of vesicle-mediated transport (GO:0060627),0.2807296793888131,0.8367320948567682,0.7816683831101957,0.8933536527109137,1.0,35/91,30.95%,ABL2;PTPRC;FGR;SPHK1;NRP1;CD22;BET1L;RAB5C;RAB8A;RAB8B;HIP1;RAB5A;CPLX2;RUFY2;SYK;VAMP2;HIP1R;RAB11A;ARFGAP1;RAB3D;SNX12;MAP2K2;STON1;STX4;RAB5B;PACSIN2;MAPK3;SNX17;RAB11B;RUFY1;FES;PTPN1;MAPK1;RALA;OLFM4
prerank,positive regulation of dendrite extension (GO:1903861),-0.2847580924025753,-0.8366208353441151,0.7432432432432432,0.9441439918200283,1.0,7/17,15.71%,RIMS1;SYT1;SMURF1;SYT2;RIMS2;CPNE5;NEDD4L
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.39140495419685595,0.8366166668476028,0.6894664842681258,0.8932102734558057,1.0,1/11,4.62%,NRP1
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.33451906505047063,0.8365483739939423,0.7144549763033176,0.8929786056528511,1.0,6/23,21.31%,SLC9A1;SLC12A4;SLC9A7;SLC26A4;ATP6V0A4;SLC12A7
prerank,hemidesmosome assembly (GO:0031581),0.3831624591218719,0.8360307716206961,0.6939597315436241,0.8934524799854194,1.0,4/11,21.56%,PLEC;LAMC1;DST;LAMA3
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.3869761771980483,0.8358999273513184,0.6830238726790451,0.8933254265406643,1.0,5/11,23.93%,PDGFA;SOX9;CHRD;TGFBR2;FGFR2
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.3345837864812693,-0.835745442633562,0.7148148148148148,0.9435742790965468,1.0,4/10,14.35%,EMC2;MMGT1;EMC10;EMC6
prerank,ERBB2 signaling pathway (GO:0038128),0.3167183605603282,0.8357067183432114,0.7111622554660529,0.8933041170564566,1.0,6/31,13.73%,NRG1;GRB2;ERBIN;MYOC;PTPN12;CPNE3
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.3999626546321925,0.8354444654756885,0.696551724137931,0.8933811082945657,1.0,4/10,27.10%,CD274;CRTAM;PRKAR1A;RC3H1
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.3521725065826816,0.8347800867073629,0.7133917396745932,0.894064092906935,1.0,9/17,30.80%,CD44;CD74;MIF;MDM2;PSMD10;KDM1A;PTTG1IP;SIRT1;RNF34
prerank,retrograde axonal transport (GO:0008090),0.3585156485063437,0.8347780887813342,0.7069182389937106,0.8937290257173292,1.0,5/16,20.19%,MGARP;DYNC1H1;KIF1A;DST;FBXW11
prerank,phosphatidylcholine metabolic process (GO:0046470),0.2835513278898756,0.8347772417062599,0.7740899357601713,0.8933919019310076,1.0,7/70,7.62%,SLC27A1;PLAAT3;PEMT;APOA2;PON1;STARD10;CHKB
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.3285731403316583,0.8342473998723073,0.7110834371108343,0.8938886117989708,1.0,8/24,31.26%,SELENON;SRI;JPH1;CALM3;FKBP1B;GSTO1;FKBP1A;CALM1
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.37296099455413523,0.8340578831655565,0.6912928759894459,0.8938559815038971,1.0,7/13,31.55%,RHOA;ITGB2;IL6;TNF;MDK;ZDHHC21;ETS1
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.3226491104977176,0.8335089001360765,0.7318501170960188,0.8944271294621806,1.0,9/29,25.22%,GATA3;NKX2-1;SMAD7;EFNA1;ADIPOR1;BMP5;SPRED2;SPRED3;SFRP1
prerank,skeletal muscle contraction (GO:0003009),0.34956316762781364,0.8334962835206554,0.7267156862745098,0.8941083185288168,1.0,2/19,7.68%,TNNT3;STAC2
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.322517004966527,0.8331233436874534,0.7245508982035929,0.8943903562890478,1.0,14/27,35.35%,ERN1;RNASEH1;ZC3H12B;RNASE6;ZC3H12D;XRN1;TRIR;POP1;ZC3H12C;NYNRIN;ZC3H12A;TOE1;NUDT16;CSTF3
prerank,gas transport (GO:0015669),0.40682721091775614,0.8329801839432357,0.7188365650969529,0.8942642444974372,1.0,1/10,3.86%,NGB
prerank,phosphatidylinositol metabolic process (GO:0046488),0.27579029106267133,0.8328110257614995,0.8085539714867617,0.8941869928172728,1.0,19/109,14.39%,PLEK;SLC27A1;PLAAT3;ARF3;PIK3CB;FGF2;PIK3R5;PI4K2A;INPPL1;VAC14;PLCB2;PGAP1;PLEKHA1;PIP5K1C;LPGAT1;MTMR14;RAB5A;PTPN13;MTMR12
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.33521878585571296,0.83227680390678,0.6911057692307693,0.8943419158705277,1.0,3/22,13.22%,ZDHHC15;ZDHHC18;ZDHHC1
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.33521878585571296,0.83227680390678,0.6911057692307693,0.8943419158705277,1.0,3/22,13.22%,ZDHHC15;ZDHHC18;ZDHHC1
prerank,establishment of mitotic spindle orientation (GO:0000132),0.3370413487499804,0.8317595674194493,0.7239336492890995,0.8948304474748644,1.0,7/23,28.06%,HTT;DCTN1;NUMA1;FBXW11;SPDL1;CENPA;ITGB1
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.30117815245654,-0.8315316915078477,0.6866359447004609,0.9501627086985827,1.0,4/14,7.79%,WNK1;GLRX;WNK3;DMD
prerank,regulation of acrosome reaction (GO:0060046),0.3975682566632174,0.8312083581268584,0.6990424076607387,0.8953193780052885,1.0,1/10,3.39%,SERPINA10
prerank,regulation of kinase activity (GO:0043549),0.28365370670654816,0.8310815346697902,0.7932843651626443,0.8951794042087415,1.0,11/89,10.83%,FLT1;CD4;FGR;AXL;LMO4;EEF1A1;TREM2;IGF1R;VAC14;RAD50;NPRL2
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.37668034816875373,0.8309754063214914,0.6934210526315789,0.8950280424453528,1.0,2/13,14.31%,TMSB4X;DDIT3
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.37818147731595525,0.8309628303732948,0.7022696929238985,0.894718629750507,1.0,1/12,2.03%,ADCY8
prerank,nucleotide metabolic process (GO:0009117),0.33441335022379026,0.8309141247485592,0.7127139364303179,0.8944595993260208,1.0,9/23,25.95%,AK8;NUDT5;AK4;AK5;RNASEH2B;NMNAT3;AK7;GUK1;ME1
prerank,bicellular tight junction assembly (GO:0070830),0.2969683720032466,0.8300460337702916,0.7428571428571429,0.8954907702273801,1.0,9/46,20.55%,POF1B;CLDN19;PDCD6IP;CLDN18;PAK2;MICALL2;AFDN;PATJ;MARVELD2
prerank,positive regulation of DNA repair (GO:0045739),0.3004969233812522,0.8300055449603833,0.7416851441241685,0.8952102224532509,1.0,11/46,20.16%,ERCC6;EYA4;TRIM28;BRCA1;ABRAXAS1;MGMT;CEBPG;UIMC1;DHX9;HMGB1;RPS3
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.39349765814212867,0.8298065618295013,0.7062841530054644,0.8951830277780779,1.0,6/10,36.49%,RTEL1;DCLRE1A;ACD;TERF2IP;TERF2;RIF1
prerank,maintenance of blood-brain barrier (GO:0035633),-0.23684307058382487,-0.8297925818258637,0.75,0.9514192163963819,1.0,12/30,20.25%,F11R;JAM2;TJP1;SLC12A2;WNK3;DMD;CLDN12;ESAM;TJP3;SLC1A1;OCLN;CLDN5
prerank,embryonic organ development (GO:0048568),0.2921656163427955,0.8287776864876553,0.7840425531914894,0.8964604618136472,1.0,17/61,24.57%,KMT2A;PDGFA;NES;GATA3;KITLG;TBC1D23;PKDCC;RBP4;KDR;IFT122;PBX1;TEAD1;TGFBR2;PBX2;FGFR2;TNF;ATF4
prerank,double-strand break repair (GO:0006302),0.2702986397204698,0.8287443339277011,0.84375,0.8961775733712423,1.0,64/158,34.21%,RAD51B;NSMCE2;ERCC1;CYREN;AP5Z1;RMI1;MDC1;BRCA1;VCP;ABRAXAS1;RAD50;DDX1;BAP1;HPF1;BLM;YY1;PSMD14;INO80;ERCC4;SLX4;SEM1;BARD1;KDM4D;POLB;UBE2V2;UIMC1;PARP3;BAZ1B;ATM;MORF4L1;HMGB1;RAD51AP1;RECQL5;TRIP13;DCLRE1A;MCM8;SETMAR;NSMCE1;PARP2;SUMO1;GEN1;SMC6;PALB2;PIAS4;LIG3;BRCC3;APTX;XRCC5;HMGB2;MMS22L;TDP2;NABP1;PARP9;ACTR8;HUS1;POLA1;EYA3;BABAM2;KDM4B;SMARCAL1;RAD51;CHEK2;POLM;REV3L
prerank,inositol phosphate catabolic process (GO:0071545),-0.3164674251356331,-0.8278015367168432,0.703862660944206,0.9532445669558108,1.0,5/12,16.93%,INPP5J;INPP5K;INPP1;INPP5B;IMPA2
prerank,positive regulation of chemokine production (GO:0032722),0.2984007418270105,0.827585816427566,0.7455947136563876,0.8975843063752124,1.0,14/44,25.90%,LPL;HIF1A;ADAM17;HMOX1;MBP;SYK;TIRAP;IL6;HMGB1;IL17RA;EGR1;CD74;TNF;TLR9
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.38534158797708107,0.8274552422866585,0.7160664819944599,0.8974577535781948,1.0,2/11,7.31%,KCNJ2;ATP1A1
prerank,positive regulation of isotype switching (GO:0045830),-0.2899888941312377,-0.827413287003363,0.6651162790697674,0.9517525607077894,1.0,5/15,18.31%,PAXIP1;CD40;SHLD3;MAD2L2;SHLD2
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.31924054300699006,0.8269230321053169,0.7400468384074942,0.8975757803231704,1.0,12/29,37.07%,ACOT9;ACOT6;ACAT1;GLYAT;ACOT1;ACOT8;DBI;ACLY;ACOT13;ACOT4;ACSF2;ACSL6
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.31924054300699006,0.8269230321053169,0.7400468384074942,0.8975757803231704,1.0,12/29,37.07%,ACOT9;ACOT6;ACAT1;GLYAT;ACOT1;ACOT8;DBI;ACLY;ACOT13;ACOT4;ACSF2;ACSL6
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.3686937111799005,0.8267608454608473,0.6973684210526315,0.8974802653260703,1.0,5/13,25.17%,RUNX1;ZBTB7B;RUNX3;TGFBR2;NCKAP1L
prerank,embryonic limb morphogenesis (GO:0030326),0.3117547366188746,0.8267399344011727,0.7213872832369942,0.8971770433130615,1.0,12/34,32.12%,CTNNB1;HDAC1;FBXW4;LRP6;NIPBL;ECE1;HDAC2;GLI3;MAP3K20;RARG;CREBBP;MEGF8
prerank,regulation of lysosomal lumen pH (GO:0035751),0.37305386210200914,0.8265743311120682,0.7127371273712737,0.8970836545488383,1.0,3/12,18.81%,TMEM199;CLN3;TMEM165
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.2829700804186187,0.8262895644644366,0.7872340425531915,0.8971876728178747,1.0,22/72,26.37%,MUC1;CNOT4;ING4;PLK2;CCNB1;BAX;CNOT10;TRIAP1;NDRG1;CARM1;TFAP4;SP100;PCBP4;ATRX;ATM;CRADD;CNOT6;MDM2;PLK3;GADD45A;CNOT6L;SESN2
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.3694856461332107,0.8258152467483317,0.6987951807228916,0.8975939822199136,1.0,3/13,17.73%,NRROS;FSTL1;DAND5
prerank,mesonephros development (GO:0001823),-0.31320488192946383,-0.8256683720741743,0.6505576208178439,0.9530872386212139,1.0,4/11,13.14%,FGF10;PAX8;PAX2;OSR1
prerank,digestive tract development (GO:0048565),-0.22851821715299214,-0.8255714439133333,0.7952755905511811,0.951019003190005,1.0,2/32,1.29%,SALL1;PCSK5
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.2771347999962538,-0.8255464351173109,0.6905829596412556,0.9488182874965514,1.0,4/15,8.44%,DAAM2;TIAM1;WNT5B;RSPO3
prerank,cellular response to sterol (GO:0036315),-0.29157171656759084,-0.8252100144020946,0.696969696969697,0.9471423126742775,1.0,3/13,7.97%,INSIG1;INSIG2;OSBPL7
prerank,electron transport chain (GO:0022900),0.36330636369054514,0.824866053240165,0.7282321899736148,0.8987183214397849,1.0,2/15,6.23%,POR;SDHB
prerank,limb morphogenesis (GO:0035108),-0.2656470272811136,-0.8246958834303584,0.7355769230769231,0.9459444072804656,1.0,2/20,3.29%,PCSK5;BMPR1B
prerank,protein acylation (GO:0043543),0.30703071270037946,0.824580558157532,0.7275822928490352,0.8988197095709509,1.0,7/38,16.57%,SPHK1;ZDHHC15;ZDHHC18;ING4;ZDHHC1;FOXO1;ING5
prerank,cardiolipin metabolic process (GO:0032048),0.37576258347707203,0.8245443502366088,0.7040417209908736,0.8985410118151492,1.0,5/13,25.24%,SLC27A1;TAMM41;PTPMT1;HADHA;PLA2G5
prerank,positive regulation of tissue remodeling (GO:0034105),0.3972669313139362,0.8244938680532692,0.7158469945355191,0.8982845766103298,1.0,4/10,19.64%,HRG;TMBIM1;ROCK1;IL2
prerank,transport along microtubule (GO:0010970),0.36642560258247725,0.8244580504037411,0.712998712998713,0.8980043861338223,1.0,3/13,14.53%,ARHGAP21;CDC42;BORCS5
prerank,regulation of small molecule metabolic process (GO:0062012),0.32648965343301456,0.8238074843676928,0.7438882421420256,0.8986670972240783,1.0,6/28,21.69%,APOE;NCOR2;ARV1;ADIPOR1;PDK3;ACADL
prerank,gonad development (GO:0008406),0.30629154043358653,0.8236697702769468,0.7525195968645016,0.8985400417554502,1.0,9/41,20.89%,CYP19A1;GATA3;SOX9;KITLG;BASP1;IRX5;COL9A3;MKKS;BIK
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.33917873107371144,0.8236134251825092,0.724907063197026,0.8982862674542736,1.0,7/21,20.66%,FBXO5;TPR;TEX14;ATM;IK;BUB1B;TRIP13
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.28186374068826875,0.8230046186500516,0.8116545265348595,0.898882472075205,1.0,15/82,18.44%,ODF2;DYNC1H1;PPP2R1A;NINL;HAUS8;CEP41;DCTN1;ATF5;YWHAG;CDK2;CEP250;CSNK1D;PLK4;TUBB;HAUS2
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.30222030590991444,0.8227964434076641,0.7460850111856824,0.8988746094912321,1.0,8/41,13.52%,STAP1;FBXW7;NEDD9;ADAM17;FYN;GAS6;EFNA1;GPRC5B
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.2693931127563835,0.8225822339104312,0.8676028084252758,0.8988675112782332,1.0,26/159,15.59%,ALCAM;CD84;ITGAL;NECTIN1;PCDHB10;CD6;CLDN19;NPTN;MILR1;AMIGO1;SELL;CADM1;FAT4;NECTIN3;CDH1;JAML;CRTAM;CLDN18;MPZ;PCDHGC3;EMB;PALLD;PCDHB11;SLITRK2;ITGB2;TRO
prerank,defense response to tumor cell (GO:0002357),0.39367135324076186,0.8223918444447507,0.7091633466135459,0.8988274352627019,1.0,3/10,20.98%,PRF1;DAPK1;LAPTM5
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.26335687794369345,-0.8221176900037338,0.766497461928934,0.9488360636714013,1.0,6/19,16.15%,DENND6A;TJP1;NEXMIF;PTPRU;FLOT1;MAD2L2
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.3140410556408297,0.8220850862233112,0.7105575326215896,0.898956411864255,1.0,5/29,12.82%,APOE;MCTP1;SYNGR1;CLN3;RAB5A
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.28239446769024373,0.821408443338369,0.8064516129032258,0.8996622564885064,1.0,20/75,24.55%,APOE;PIK3CB;PRKCD;IPO5;CD300A;CEBPA;PAQR3;TFAP4;PKIB;SPRY4;LRP6;STK38;SMPD1;NF1;TESK1;PRKAR1A;BMP4;LATS1;HEG1;GADD45A
prerank,DNA strand elongation (GO:0022616),0.345321338516104,0.8212099712985342,0.7202970297029703,0.8996408642793219,1.0,8/18,33.56%,MCM7;RAD50;GINS1;TERT;RFC4;GINS3;GINS2;POLA1
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.33490672162539653,0.8208648453143073,0.7281437125748503,0.8998428337798368,1.0,2/22,4.08%,CYP27B1;VDR
prerank,vasculature development (GO:0001944),0.35605028574507613,0.820802968799566,0.7382198952879581,0.8996083446697105,1.0,7/16,34.17%,FBXW7;STK11;PDGFRA;NOTCH4;APLNR;ERRFI1;CDH5
prerank,nucleoside catabolic process (GO:0009164),0.38844016143997345,0.8206559385281439,0.7177835051546392,0.8995033984428089,1.0,2/11,12.19%,DERA;UPB1
prerank,C-terminal protein amino acid modification (GO:0018410),0.37399681501219395,0.8206252753941563,0.6902536715620827,0.8992204306883038,1.0,1/11,1.07%,ATG7
prerank,oxoacid metabolic process (GO:0043436),0.31742082502774494,0.8203960352533343,0.7332549941245593,0.8992309933583058,1.0,9/27,30.31%,GNMT;SULT6B1;TPST1;BPNT1;SULT2B1;MIF;LIPT2;BPNT2;PPA1
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.31051169929728206,0.8201174154412912,0.754524886877828,0.8993118282687897,1.0,4/35,6.78%,APOE;NPPA;CAP1;SOX9
prerank,regulation of interleukin-10 production (GO:0032653),0.30023426231289435,0.8201145805561298,0.760655737704918,0.8989812773100807,1.0,10/44,22.10%,MMP8;CD28;CD274;LILRB1;HSPD1;SYK;IL6;HMGB1;CD47;TRIB2
prerank,cellular response to UV-A (GO:0071492),0.3826605698048026,0.8199566003847728,0.7056451612903226,0.8988895955191252,1.0,1/11,4.42%,MMP9
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.35320752359192786,0.8199291367486686,0.7146464646464646,0.8986020956539514,1.0,9/17,32.46%,EIF4G1;CADM4;SMAD7;SPRED2;CALM3;SPRED3;SIRT2;CALM1;DGKQ
prerank,regulation of lipid metabolic process (GO:0019216),0.27581858918310453,0.8183216860375438,0.8155440414507772,0.9007358781390512,1.0,27/88,25.77%,NFYA;ACACA;ID2;NCOR2;PSAP;CAV1;PPARG;PPARD;APOC1;CARM1;MID1IP1;ABCA7;NFYB;HELZ2;ADIPOR1;SP1;ACACB;NPC2;SREBF1;TM6SF2;PMVK;RXRA;MBOAT7;EDF1;FASN;LACTB;HDAC3
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.29818646754967765,-0.8182674031257926,0.7171314741035857,0.9543418941890733,1.0,4/13,13.06%,CNOT8;PNPT1;GTPBP1;MOV10
prerank,ganglioside biosynthetic process (GO:0001574),0.3528188093639286,0.8181377995629324,0.7080103359173127,0.9006885292343649,1.0,3/15,14.06%,B4GALT5;ST8SIA6;B4GALNT1
prerank,renal absorption (GO:0070293),0.3944200263115515,0.8180202371413725,0.7286501377410468,0.9005209490300514,1.0,2/10,11.96%,SGK1;GSN
prerank,glutamate metabolic process (GO:0006536),0.34327513082686467,0.8177696465369343,0.731457800511509,0.9005573800796611,1.0,5/19,17.97%,MTHFS;GLS2;GLS;FPGS;OAT
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.3008573981358037,0.8173342558716248,0.7393258426966293,0.900907978307233,1.0,10/39,17.55%,SH3KBP1;GRB2;MVP;PTPN2;PTPN12;CDC42;STAM2;CBL;DUSP3;EPS15L1
prerank,heart contraction (GO:0060047),-0.20819980703493968,-0.8169403493893438,0.8288288288288288,0.954702079237445,1.0,21/41,33.99%,SGCZ;SGCD;DMD;SOD1;KCNH2;SCN2B;TNNI2;MYL2;KCNQ1;MYBPC3;SCN4B;GRK2;ACE;TPM1;CASQ2;SLC8A1;TNNC1;TNNT2;MYH6;MYL3;MYH7
prerank,neuron projection development (GO:0031175),0.2650026291898221,0.816669069546409,0.8597194388777555,0.9015912247670927,1.0,37/168,21.76%,APOE;ERCC6;GAS7;BLOC1S3;LRP12;SGK1;ATP7A;PPP1R9B;ATXN10;ALS2;GPRIN1;GRXCR1;CDK5;TAOK3;DTNBP1;FRYL;TBC1D23;DIP2A;DNM2;MYOC;CDC42;ROCK1;STX3;SLC9A6;TBC1D24;IFT88;DOCK7;MINK1;MICALL2;RAB11A;IL6;CDK16;HMGB1;GPRIN3;MARK2;GSK3B;TAOK1
prerank,regulation of cellular respiration (GO:0043457),-0.2656422840258338,-0.8164612484145114,0.7323943661971831,0.9534083514906775,1.0,5/17,15.96%,CBFA2T3;IL10RB;PNPT1;PRDM16;IFNLR1
prerank,response to light stimulus (GO:0009416),0.2922033102444467,0.8163443239597112,0.7874865156418555,0.9017401556561455,1.0,9/55,18.89%,ERCC6;COPS3;MAP4K3;DDB2;ZRANB3;RRH;ERCC4;UBE4B;CCAR2
prerank,protein maturation (GO:0051604),0.27285436082405384,0.8161883268587238,0.8250517598343685,0.9016413619158722,1.0,20/95,15.94%,ADAMTS13;ECEL1;CPXM2;TSPAN17;SDE2;NFU1;PSEN2;NAA16;ADAM17;AEBP1;ISCA1;TASP1;CLN3;DDI2;AFG3L2;TSPAN5;OGT;CPD;HSPD1;FURIN
prerank,intracellular protein transmembrane transport (GO:0065002),0.29630179851275257,0.8159576097964195,0.7662921348314606,0.9016645218338284,1.0,13/42,24.88%,PEX2;DNAJC15;TIMM44;SEC61B;SEC63;TOMM40;HSPD1;TIMM21;PEX16;TIMM17A;TIMM23;PEX14;HSPA5
prerank,protein acetylation (GO:0006473),0.31815484115100884,0.8155107596467894,0.7447795823665894,0.9020072952346031,1.0,14/30,32.51%,SPHK1;ING4;NAA16;FOXO1;ING5;NAA80;NAT10;HAT1;NAA15;SIRT1;AANAT;EP300;CREBBP;NAA50
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.28496805943263087,0.8154269509919302,0.8019271948608137,0.9017991262104983,1.0,9/59,13.14%,CD84;NECTIN1;NPTN;AMIGO1;CADM1;NECTIN3;CDH1;EMB;PALLD
prerank,protein K48-linked deubiquitination (GO:0071108),0.32586346701767777,0.8153863297876219,0.74875,0.9015227227754723,1.0,11/23,30.57%,OTUD4;ATXN3;USP5;BAP1;USP33;USP50;USP8;OTUD5;TNFAIP3;USP34;MINDY2
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.33242034023463324,0.8147142604795826,0.7515375153751538,0.9021754311741809,1.0,10/20,29.29%,NKTR;PPIA;PPIE;PIN1;PPIG;PPIL6;PPIH;FKBP1B;PPIL3;FKBP1A
prerank,cellular response to leucine (GO:0071233),0.393270628202421,0.8134366395397182,0.7233748271092669,0.90335854402584,1.0,4/10,26.37%,RRAGD;UBR2;LARS1;SESN2
prerank,response to leucine (GO:0043201),0.393270628202421,0.8134366395397182,0.7233748271092669,0.90335854402584,1.0,4/10,26.37%,RRAGD;UBR2;LARS1;SESN2
prerank,signal transduction by p53 class mediator (GO:0072331),-0.232461843609873,-0.8134013779597317,0.8231292517006803,0.9573945349727315,1.0,7/30,17.33%,FHIT;PAXIP1;MYO6;PDK2;PMAIP1;BCL3;E2F7
prerank,cellular response to oxygen-containing compound (GO:1901701),0.26019688330197255,0.8132658118413727,0.9279279279279279,0.9032759541917167,1.0,51/291,18.40%,LPL;STAP1;ABL2;RRAGD;P2RX4;SIRPA;VIM;PRDX5;AXL;NR4A3;PTK2B;MMP9;PRKCD;CPEB4;IPO5;CD274;SOX9;BRINP2;TNIP3;LILRB1;AGAP3;WNT6;P2RY1;PABPN1;PLAA;TICAM1;VCP;CPEB3;JUN;SHMT1;SERPINE1;TNFRSF1B;TNIP2;RHOA;CDK2;FZD4;ACTB;GIT1;NFKB1;DAPK1;ACOD1;MAPK9;FOXO1;TIRAP;DHX36;PDCD4;SBNO2;P2RY2;PAF1;ATM;IL6
prerank,steroid metabolic process (GO:0008202),0.2773870381809693,0.813124252115079,0.7976939203354297,0.9031495424210124,1.0,12/72,19.63%,LIPA;CYP19A1;CYP27B1;VDR;DHRS9;ARV1;CYP2A6;NPC1;CYP1B1;DHRS11;GBA2;SULT2B1
prerank,heme biosynthetic process (GO:0006783),-0.25662666968202325,-0.8124915988060973,0.78125,0.9569153933011211,1.0,10/22,23.39%,CPOX;PGRMC1;UROS;SLC25A38;ALAS2;ALAD;FECH;PPOX;COX15;ABCB10
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.273338825459056,0.812385273540268,0.8280123583934088,0.9039350495290022,1.0,28/94,30.94%,ODF2;DYNC1H1;PPP2R1A;NINL;HAUS8;CEP41;DCTN1;TCTN3;YWHAG;CEP250;CSNK1D;TMEM216;PLK4;TUBB;RAB11A;HAUS2;MARK4;CETN2;MKS1;SCLT1;MAPRE1;CEP97;CEP83;IQCB1;ALMS1;CSNK1E;CEP57;TTBK2
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.28454325279445897,0.8118734812793935,0.7680355160932297,0.9043463124167237,1.0,13/48,29.29%,SELENON;PTK2B;PDPK1;SRI;DIAPH1;JPH1;F2R;CALM3;CX3CL1;FKBP1B;APLNR;GSTO1;FKBP1A
prerank,ubiquinone biosynthetic process (GO:0006744),0.3502736503219469,0.8112957735838375,0.7266922094508301,0.90489327153405,1.0,4/15,17.06%,COQ10B;COQ5;COQ3;NDUFA9
prerank,regulation of pseudopodium assembly (GO:0031272),-0.31296304673715347,-0.8107059385426748,0.7037037037037037,0.9558332032917952,1.0,3/10,11.92%,CDC42EP4;APC;WASHC1
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.31296304673715347,-0.8107059385426748,0.7037037037037037,0.9558332032917952,1.0,3/10,11.92%,CDC42EP4;APC;WASHC1
prerank,regulation of muscle cell differentiation (GO:0051147),0.3105014206949744,0.8105471229837817,0.7793103448275862,0.9056679077753048,1.0,6/31,15.51%,CTNNB1;HDAC9;ID2;SPAG9;CDC42;SRF
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.2663327594653524,0.8100269925654304,0.8533604887983707,0.9061222564703888,1.0,27/124,21.48%,APOE;ERCC6;PLEK;BLOC1S3;LRP12;PPP1R9B;ATXN10;ODF2;GPRIN1;CDK5;DTNBP1;FRYL;TBC1D23;PLEKHA1;MYOC;ROCK1;STX3;TBC1D24;DOCK7;MICALL2;RAB11A;IL6;CDK16;HMGB1;GPRIN3;GSK3B;MARK4
prerank,central nervous system projection neuron axonogenesis (GO:0021952),-0.2992732510103433,-0.8099409252534802,0.6972111553784861,0.9551340539479397,1.0,5/12,18.62%,EPHA4;EPHB1;NFIB;EPHB6;MYCBP2
prerank,potassium ion transport (GO:0006813),0.26694437816980787,0.8097841816595731,0.8529411764705882,0.9061619881757669,1.0,20/120,16.30%,SLC9A1;SLC24A4;KCNN4;ATP1B3;KCNK13;LRRC52;KCNA3;KCNJ2;CCDC51;KCNMA1;SLC9A8;ATP1A4;KCNA4;KCNMB4;KCNJ10;SLC9A7;SLC9A6;ATP1A2;KCNH8;CHP1
prerank,apical protein localization (GO:0045176),-0.3102897256474359,-0.8095290371674052,0.6959706959706959,0.9536602344479199,1.0,2/10,4.87%,INSC;VANGL2
prerank,regulation of lamellipodium organization (GO:1902743),0.3624839304172903,0.8094133109739517,0.7296248382923674,0.9063775185943816,1.0,3/14,12.86%,PDPN;CD44;CDC42
prerank,rRNA pseudouridine synthesis (GO:0031118),0.3789493931029062,0.8092153444612514,0.7349228611500701,0.9063427084305694,1.0,4/10,24.52%,GAR1;DKC1;RPUSD1;RPUSD4
prerank,negative regulation of neuron differentiation (GO:0045665),0.3303029648644988,0.8085650256643493,0.745049504950495,0.9069531496707983,1.0,8/22,29.06%,SOX3;SOX9;B2M;NEPRO;GSK3B;CALR;HES1;MED1
prerank,substantia nigra development (GO:0021762),0.2995702065058829,0.8085437110018742,0.770193401592719,0.9066554496937332,1.0,13/37,26.01%,BASP1;SUDS3;ZNF148;RHOA;CDC42;MBP;ACTB;RAD1;INA;CNP;CALM3;HSPA5;MAPKAP1
prerank,response to growth factor (GO:0070848),0.29819419323512264,0.8085145660642803,0.7846836847946725,0.9063631978737607,1.0,9/41,25.22%,CTNNB1;SPHK1;RACK1;CPNE3;MAPK7;TGFBR2;STAT5B;MAP2K5;SFRP1
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.3570883632872474,0.8084995750268035,0.7390728476821192,0.9060562237529799,1.0,6/13,32.25%,EAPP;HNRNPU;RECQL5;SUPT4H1;HEXIM1;NELFA
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.3036817646716123,0.8083429711393753,0.7724687144482366,0.9059551514835261,1.0,14/34,31.19%,DUSP9;PTPN22;PTPN2;DUSP6;PTPN12;PTPN13;DUSP3;DUSP16;PTPN9;PTPN18;PTPN6;DUSP5;PTPN1;PTPRZ1
prerank,development of primary male sexual characteristics (GO:0046546),0.30826691045672194,0.808188192604237,0.755656108597285,0.9058407201625475,1.0,4/34,8.39%,LHFPL2;GATA3;SOX9;KITLG
prerank,regulation of establishment of endothelial barrier (GO:1903140),-0.2700537912538745,-0.8078053327976583,0.7608695652173914,0.9547224066837389,1.0,2/17,1.24%,F11R;ROCK2
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.23592476490478104,-0.8077889890884387,0.8,0.9525696830388879,1.0,11/29,25.33%,LPCAT2;PNPLA8;PLA2G4C;PLA2G4E;NR1H3;PLBD1;PLA2G3;PLA2G4F;PLA2G2D;LPCAT4;MBOAT2
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.28233786394983484,0.8076526160068842,0.7861020629750272,0.9063190786659152,1.0,11/54,14.07%,FLNA;KCNN4;KCNJ2;CAV1;AMIGO1;KCNMA1;CD63;KCNMB4;CACNA1D;KCNJ10;CAB39
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.3023607853399117,0.8069121142417315,0.7738636363636363,0.907062196765382,1.0,8/35,15.73%,ACACA;SLC27A5;SLC25A1;SCD5;HSD17B8;AACS;ACAT1;BDH1
prerank,spliceosomal snRNP assembly (GO:0000387),0.29708222039021076,0.8066607006453578,0.7730900798175598,0.907079060492733,1.0,17/38,32.91%,CD2BP2;PRMT5;PRMT7;SART1;PRPF6;PRPF8;LSM4;GEMIN8;SNRPG;GEMIN2;SNRPF;GEMIN5;SRSF10;PRPF31;SNRPD2;SNRPD1;SART3
prerank,regulation of stress fiber assembly (GO:0051492),0.27708373131366076,0.8066433067804103,0.8082627118644068,0.9067736161555058,1.0,25/74,22.64%,SLC9A1;NRP1;DLC1;ACTG1;ARHGAP6;MYOC;ARHGEF18;RHOA;LIMK1;CDC42;PAK2;ROCK1;LPAR1;SERPINF2;TESK1;ITGB1BP1;FERMT2;EVL;PPFIA1;CD47;GPR65;PTGER4;WAS;PFN1;ARHGEF5
prerank,ventricular septum development (GO:0003281),-0.2142528439495303,-0.8065678946528785,0.8538461538461538,0.9526570342794166,1.0,13/37,26.64%,SALL1;ROBO1;ZFPM1;ROBO2;PDE2A;MATR3;HEY1;SLIT2;HEYL;CITED2;BMPR2;GJA5;ZFPM2
prerank,macromolecule catabolic process (GO:0009057),-0.23777834415055804,-0.8062906510409735,0.75,0.9510217168929982,1.0,3/26,5.61%,CAPN3;LGMN;SMURF1
prerank,cellular response to misfolded protein (GO:0071218),0.336658267255453,0.8055032337729422,0.7544303797468355,0.9080993972930729,1.0,5/20,19.05%,DNAJB14;ATXN3;VCP;DERL1;CUL3
prerank,anterograde axonal transport (GO:0008089),0.29522083215177886,0.804915404836745,0.7885714285714286,0.9086054690179366,1.0,6/37,12.09%,BLOC1S3;MGARP;HSPB1;TRAK1;DTNBP1;KIF1A
prerank,DNA biosynthetic process (GO:0071897),-0.2694927742289423,-0.8043000334094355,0.7357512953367875,0.9525818036502294,1.0,6/16,15.47%,WRN;WRNIP1;CDKN2D;POLD1;POLH;POLD2
prerank,mitotic spindle organization (GO:0007052),0.26578632081517467,0.8029873526156864,0.863773965691221,0.9110532460378803,1.0,42/153,26.78%,FLNA;PTPA;DYNC1H1;EML4;LSM14A;PLK2;AHCTF1;CENPO;VCP;CCNB1;BCCIP;ABRAXAS1;RHOA;XPO1;CENPT;BIRC5;RANBP2;DYNC1LI2;RPS27;RCC1;SMC3;TOGARAM2;KIFC1;NEK6;RAB11A;KNL1;BUB1B;ERCC6L;AAAS;TAOK1;SPDL1;DCTN6;EFHC1;STAG1;NUP98;GOLGA2;CENPK;CENPA;NUP133;MAP4;CENPS;MAPRE1
prerank,receptor recycling (GO:0001881),0.383192767891481,0.8027159705197388,0.7359550561797753,0.9111181036478598,1.0,5/10,29.41%,REP15;ARFGEF2;LMTK2;PLEKHJ1;RAB11B
prerank,skeletal system morphogenesis (GO:0048705),0.297199282869148,0.8026232964146188,0.7779030439684329,0.9109095557721054,1.0,12/42,24.96%,LTF;HOXA4;ANKRD11;LRP6;HOXB4;HHIP;HOXC9;FGFR3;DYNC2I1;WWOX;FGFR2;PDGFRA
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.27799993454244104,-0.8020297346319891,0.7430830039525692,0.9547034546627949,1.0,4/14,11.54%,PKIG;RAPGEF2;PRKAR2A;PRKAR2B
prerank,T cell migration (GO:0072678),0.36061714816924323,0.8018499043667086,0.7428571428571429,0.9116822876242089,1.0,4/13,26.14%,MSN;CXCL16;MYO1G;GPR183
prerank,regulation of cilium assembly (GO:1902017),0.277159016510082,0.8015251305583977,0.797427652733119,0.9118297213293057,1.0,21/62,28.21%,TBC1D10C;TBC1D22A;KCTD17;TBC1D2;HTT;TBC1D24;IFT88;TBC1D22B;TBC1D20;TESK1;TBC1D19;MARK4;CEP120;TBC1D10A;CCDC88A;TBC1D16;MAPK15;TBC1D15;ATG3;DYNLT2B;CEP97
prerank,regulation of axon guidance (GO:1902667),0.3780497107166063,0.8013777062788102,0.7088948787061995,0.9117114187107404,1.0,4/10,22.69%,NRP1;VEGFA;ZSWIM8;ZSWIM5
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.36367504996249156,0.8012213126591685,0.7473821989528796,0.9115969161139558,1.0,3/13,15.79%,SRD5A3;MPDU1;DPAGT1
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.2884580599928304,0.8010920480328324,0.7751937984496124,0.9114409183640362,1.0,12/46,25.24%,DGKZ;SLC27A1;DDHD1;ABHD5;DGKA;DGKH;DGKD;AGPAT2;PLA2G12A;AGPAT1;ABHD4;PLA2G5
prerank,miRNA metabolic process (GO:0010586),0.3308712910615788,0.8007791373945505,0.7546699875466999,0.9115581658056866,1.0,6/20,29.19%,AGO2;DDX17;SND1;KHSRP;TARBP2;TENT4B
prerank,negative regulation of fat cell differentiation (GO:0045599),0.3034700984217417,0.8000323257729081,0.7929864253393665,0.9122803756122847,1.0,9/34,24.40%,GATA3;ASXL1;FOXO1;ANKRD26;IL6;FERMT2;TRIB2;TNF;CCDC85B
prerank,microtubule polymerization or depolymerization (GO:0031109),0.3188106762217447,0.7995937798954068,0.7467144563918757,0.912577827278748,1.0,1/24,0.26%,FGF13
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.34360412270859475,0.7991242013068861,0.7557544757033248,0.9129236237251288,1.0,6/17,21.23%,LTF;SASH1;SIGIRR;BMP6;SCIMP;CD55
prerank,respiratory electron transport chain (GO:0022904),0.35603567367528566,0.7984276725712673,0.7449933244325768,0.9136000807147068,1.0,2/14,6.23%,GPD2;SDHB
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.31674912806544675,-0.7979707623167882,0.7428571428571429,0.9577917082960107,1.0,5/11,16.93%,INPP5J;INPP5K;INPP1;INPP5B;IMPA2
prerank,inositol phosphate dephosphorylation (GO:0046855),-0.31674912806544675,-0.7979707623167882,0.7428571428571429,0.9577917082960107,1.0,5/11,16.93%,INPP5J;INPP5K;INPP1;INPP5B;IMPA2
prerank,negative regulation of hydrolase activity (GO:0051346),0.28737843567586807,0.7978262618500651,0.7836065573770492,0.914126022382109,1.0,13/49,20.84%,CST7;APOA2;CPEB2;ZCCHC9;CSTB;KLRK1;PPP1R35;ECM1;SH2D4A;CHP1;ARFGEF1;EGLN1;GMIP
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.33378236196885425,0.7974852880214041,0.770012706480305,0.9142720313338207,1.0,2/19,2.89%,PTPRC;PTGFR
prerank,sister chromatid segregation (GO:0000819),0.310603295099796,0.7973305987601748,0.7721518987341772,0.9141606741260707,1.0,7/31,26.58%,CHAMP1;NCAPG2;INO80;KIFC1;LATS1;CENPK;ESPL1
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.3165411375687739,0.7971717381644319,0.7699530516431925,0.9140464376562664,1.0,3/25,10.77%,B4GAT1;B3GNT3;NDST1
prerank,response to UV-B (GO:0010224),-0.29605056822568665,-0.7971554723404336,0.7370517928286853,0.9570875662397145,1.0,6/12,32.84%,RELA;MME;HYAL2;MFAP4;IL12A;IL12B
prerank,cilium movement (GO:0003341),0.28952125987970984,0.7968547250974439,0.802801724137931,0.9141597661424474,1.0,13/47,28.87%,ODAD2;TEKT2;CFAP251;TEKT5;DNAAF5;CFAP70;ADCY10;DNAI3;CCDC40;CCDC39;DNAH5;DNAH11;DNAH17
prerank,heart development (GO:0007507),0.26581763839688055,0.7966192197002874,0.8869828456104945,0.9141506234011564,1.0,32/150,24.63%,SH3PXD2B;FN1;MICAL2;HDAC9;AKAP13;PDLIM1;ID2;TH;MEF2D;CSRP3;SOX9;VEGFA;DLC1;SMG9;MTHFD1;RBP4;TCF25;SRF;NF1;PKP2;MKKS;DAND5;BMP5;ALPK3;IFT122;BMP4;HTR2B;NIPBL;TGFBR2;ECE1;HEG1;FLRT2
prerank,protein depolymerization (GO:0051261),0.3103502447006357,0.7960800294560747,0.7634032634032634,0.9145846626991946,1.0,4/27,11.96%,MICAL2;MICAL1;VPS4B;GSN
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.283402864108479,0.7960086591510411,0.7971334068357222,0.9143525719185062,1.0,12/49,24.48%,IGF1;VEGFA;ARL2BP;CCL5;GHR;IL31RA;IL6;IL2;EPO;FGFR3;TNF;JAK2
prerank,purine nucleotide catabolic process (GO:0006195),0.3654913564663849,0.7957635094551158,0.7439678284182306,0.9143688545302803,1.0,4/13,26.30%,XDH;ITPA;NUDT15;GPX1
prerank,termination of RNA polymerase II transcription (GO:0006369),0.2971892710668738,0.7955229110400832,0.7745664739884393,0.9143600184561486,1.0,17/33,37.91%,PAPOLA;PABPN1;SYMPK;SSU72;CPSF7;SNRPG;SNRPF;CSTF2;NUDT21;MAZ;LSM11;CLP1;WDR33;SLBP;CSTF3;SNRPB;SNRPD3
prerank,mRNA metabolic process (GO:0016071),0.26633240592749585,0.7954169800182644,0.8305613305613305,0.9141710753190349,1.0,28/90,28.75%,ERN1;CELF1;SON;METTL3;SRSF11;CNOT10;RNH1;DXO;SRSF7;HNRNPA2B1;LSM6;YTHDF2;KIN;AGO3;SRSF2;ZC3H12D;PRPF8;HSF1;SF3A3;SNRPG;SF3B2;GEMIN2;SNRPF;LSM3;SUPT4H1;SRSF1;RIDA;NUDT21
prerank,N-terminal protein amino acid modification (GO:0031365),-0.27497642355812046,-0.7952332119760948,0.7522522522522522,0.9585383383774515,1.0,3/14,7.72%,NAA60;NAA10;METAP2
prerank,positive regulation of RNA metabolic process (GO:0051254),0.28563004950301596,0.7948315105888916,0.7802690582959642,0.9146736837387862,1.0,17/45,28.03%,ERN1;GRSF1;RIOK2;HNRNPLL;WDR43;DXO;NFKB1;IL6;SLC38A2;BMP4;MAP2K2;RBM22;TRMT112;DIMT1;ZPR1;SUPV3L1;RIPK1
prerank,response to amino acid (GO:0043200),0.2997221176389877,0.7948133658648285,0.766743648960739,0.9143733809405042,1.0,13/31,31.66%,RRAGD;CPEB4;IPO5;CPEB3;NSMF;LARS1;CPEB1;RRAGC;SESN2;LAMTOR3;LAMTOR1;RRAGB;XBP1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.28264001133613986,0.7940400114549828,0.8083700440528634,0.9151122473528478,1.0,16/54,26.22%,MUC1;CNOT4;PLK2;CCNB1;BAX;CNOT10;TRIAP1;CARM1;PCBP4;ATM;CRADD;CNOT6;MDM2;PLK3;GADD45A;CNOT6L
prerank,regulation of microtubule-based process (GO:0032886),0.30007651674632196,0.793964784275975,0.7885514018691588,0.914884607679921,1.0,11/36,21.76%,MAP10;MACF1;ATF5;PHLDB1;DIAPH1;MEMO1;ROCK1;MARK2;GSK3B;MARK4;TAOK1
prerank,mitochondrial fission (GO:0000266),0.34149020274685143,0.7938223793038811,0.7435233160621761,0.914754394894757,1.0,7/16,29.88%,DNM2;MTFP1;MTFR2;MTFR1;FIS1;MUL1;MFF
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.2979697413922235,-0.7935168479617726,0.7439024390243902,0.9594857028913464,1.0,4/12,24.71%,PLCB1;DUSP1;SLIT2;SLAMF8
prerank,protein heterooligomerization (GO:0051291),0.3379158343769268,0.7934914785206201,0.7557544757033248,0.9148894408251664,1.0,5/17,21.01%,TMEM120B;HSD17B8;FARSA;FARSB;CPSF7
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.29664273321478885,0.793336203604416,0.7927519818799547,0.9147641064070511,1.0,8/39,16.28%,SPHK2;FXYD5;RANGRF;SCN1B;CACNA1D;UTRN;FXYD4;SCN3B
prerank,negative regulation of developmental process (GO:0051093),0.27709258427618944,0.7930340294228369,0.8310598111227702,0.914858569250103,1.0,19/69,25.48%,CDK6;FOXJ1;SOX9;VAT1;SFRP5;HUWE1;GAS6;ROCK1;TFRC;SINHCAF;PARP3;BMP4;FGFR3;BNIP3;MIF;IL17D;ANP32B;SFRP1;NOTCH4
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.3222457985400512,0.7928424651211591,0.7838509316770186,0.914800291599349,1.0,5/22,14.78%,PTPN23;PLAA;VPS4B;UBAP1;MVB12A
prerank,glycerolipid metabolic process (GO:0046486),0.366979323455572,0.7924992740144038,0.764,0.9149855079039125,1.0,1/11,0.75%,DGKZ
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.3612078018539251,0.7924383876160356,0.7589403973509934,0.9147441520954852,1.0,4/13,21.92%,HACD2;HACD1;ELOVL2;ELOVL1
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.26803479692161614,0.7922349801680437,0.8341915550978373,0.9146889187224994,1.0,29/86,30.84%,APOE;PLEK;COLGALT1;PTK2B;NCK2;NCK1;DCTN1;DRG1;LIMK1;EFEMP2;NUMA1;CLU;EVL;RPS3;VASP;SLAIN2;BAIAP2;PFN1;BAIAP2L2;NCKAP1L;CX3CL1;GPX1;STMN2;MAPRE1;BAIAP2L1;CDC42EP3;SYNPO;FES;ARF6
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.28611256189419354,0.7921446066901788,0.7838427947598253,0.9144860488691419,1.0,16/47,32.14%,RAP2A;TAOK3;RASGRP1;IGF1R;PPIA;FOXO1;ARL6IP5;SCIMP;TAOK1;MAP2K2;MAPK3;MAPK8IP3;AGER;QARS1;MAPK1;PHLPP1
prerank,mammary gland epithelium development (GO:0061180),0.3475673472611096,0.791989501865519,0.7581081081081081,0.9143541990991907,1.0,2/14,3.51%,ID2;IRF6
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.3065469696313188,-0.791711488038832,0.7,0.9605593507601807,1.0,3/10,11.70%,WHRN;ADGRV1;SOD1
prerank,positive regulation of developmental growth (GO:0048639),0.283451072496106,0.7914988770506381,0.8131147540983606,0.91470333124604,1.0,10/49,18.05%,MACF1;GOLGA4;ITSN2;PLAA;RUFY3;RASAL1;LIMK1;GHR;RNF157;NTN1
prerank,endothelial cell differentiation (GO:0045446),0.35624445167415775,0.7913005445035594,0.7456724367509987,0.9146342478360432,1.0,4/12,24.55%,JAG1;FSTL1;KDR;EDF1
prerank,chloride transport (GO:0006821),0.2696243621974177,0.7898934538202401,0.8331584470094439,0.9162214278508457,1.0,17/74,23.02%,PACC1;SLC26A1;SLC5A1;GABRP;ANO9;ANO8;CLIC4;SLC12A4;CLCN1;GABRA4;ANO5;ANO6;CLCN4;SLC12A7;SLC26A6;FXYD1;CLIC5
prerank,negative regulation of interleukin-17 production (GO:0032700),-0.3036940591680884,-0.789679833888223,0.7355072463768116,0.961909049174464,1.0,1/10,1.69%,VSIR
prerank,cellular polysaccharide catabolic process (GO:0044247),-0.2715263631187925,-0.7895007371892281,0.7797356828193832,0.9600297422339722,1.0,3/16,3.11%,PHKA2;AOAH;PHKG1
prerank,heterochromatin organization (GO:0070828),0.3490368844515705,0.7893705745402434,0.7689295039164491,0.9166113133991889,1.0,5/14,32.42%,HP1BP3;SMCHD1;SETDB1;SIRT1;BAHD1
prerank,dendritic cell chemotaxis (GO:0002407),0.3469271141106855,0.7889503832766953,0.7606727037516171,0.9168700561051104,1.0,6/14,26.67%,CXCR2;CCR2;CCL5;HMGB1;GPR183;CXCR4
prerank,fatty acid elongation (GO:0030497),0.35987165475108657,0.7889222706829427,0.7651715039577837,0.9165745723541435,1.0,4/13,21.92%,HACD2;HACD1;ELOVL2;ELOVL1
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.32287621484627915,0.7887201551680991,0.7655502392344498,0.9165258190112374,1.0,5/21,25.70%,LTF;FYN;USP50;BIRC2;AIM2
prerank,smooth muscle tissue development (GO:0048745),0.3722452477931074,0.7878684025085368,0.7513888888888889,0.9173383213036388,1.0,3/10,21.85%,EFEMP2;NF1;BMP4
prerank,peroxisome organization (GO:0007031),0.31303343979279835,0.7872225647033306,0.7752403846153846,0.9178885254650793,1.0,11/25,29.88%,PLAAT3;ABCD4;PEX2;ABCD2;ABCD3;PEX16;PEX14;ACOT8;PEX19;FIS1;MFF
prerank,RNA 3'-end processing (GO:0031123),0.2717615799313828,0.786491311646177,0.8178913738019169,0.9185181008731859,1.0,25/69,31.28%,THOC1;PAPOLA;PABPN1;SRSF11;SRSF7;DDX39B;EIF4A3;SYMPK;CHTOP;THOC2;RPRD1A;SRSF2;CPSF7;UPF3B;POLDIP3;SRRM1;MTPAP;THOC6;SUPV3L1;CSTF2;SRSF1;NUDT21;TENT4B;CLP1;CDC40
prerank,sulfur amino acid catabolic process (GO:0000098),0.36924667716463844,0.7863803195376968,0.7604456824512534,0.9183443574556852,1.0,4/10,19.67%,BLMH;MTRR;TST;MPST
prerank,stem cell differentiation (GO:0048863),0.29175736310724615,0.7860131360688606,0.798876404494382,0.918515171028998,1.0,10/39,25.22%,PTPRC;FBXL17;MTF2;LRP6;SP7;PUM1;HOXB4;HTR2B;FGFR2;SFRP1
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.3276801075574279,0.7858527129297979,0.7710109622411693,0.9183974761220197,1.0,6/20,20.50%,BCL2L1;DAB2;RHOQ;TMBIM1;LZTFL1;PPFIA1
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.27339619944725235,0.785761231970885,0.8278775079197466,0.9181866945628782,1.0,14/67,18.94%,MYO10;TBC1D10C;P2RX4;TBC1D22A;CAV1;TBC1D2;RAB5A;CDC42;TBC1D24;IFT88;FXR2;TBC1D22B;TBC1D20;TBC1D19
prerank,regulation of membrane repolarization (GO:0060306),0.3464040604692452,0.7850651700381991,0.7440944881889764,0.918817955909812,1.0,2/13,5.32%,KCNJ2;CAV1
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.3670288040095316,0.7843925052508196,0.7496503496503496,0.9193669788404031,1.0,3/11,21.09%,CAV1;ADIPOR1;VHL
prerank,ceramide biosynthetic process (GO:0046513),0.2894604866701843,0.7843385341317652,0.7903587443946188,0.9191068035917985,1.0,16/40,33.92%,SGMS1;CERS6;SPTSSA;SMPD4;ST8SIA6;B4GALNT1;SMPD1;ASAH1;SAMD8;SPTLC3;B3GALT4;SPTLC2;ST6GALNAC3;SPTSSB;CLN8;SGMS2
prerank,cell part morphogenesis (GO:0032990),-0.2895196139669475,-0.7842917216504318,0.7476635514018691,0.9669934616474486,1.0,3/13,8.10%,SLIRP;PNPT1;MYH14
prerank,mRNA methylation (GO:0080009),0.3391524633534218,0.783930432363728,0.7612137203166227,0.9193160160742564,1.0,7/15,29.64%,TRMT10C;METTL3;NSUN2;CBLL1;METTL8;TRMT6;PCIF1
prerank,regulation of feeding behavior (GO:0060259),0.3612078314112883,0.7839283428710226,0.748993288590604,0.9189896659408446,1.0,2/11,13.24%,NR4A3;AGRP
prerank,chemical homeostasis (GO:0048878),0.2743658893514889,0.7838649674498144,0.8226495726495726,0.9187492286182771,1.0,15/61,21.77%,ATP13A2;FBXW7;PPARG;TLCD1;TREM2;TLCD2;ABHD5;CEBPA;SLC4A9;THADA;AQP4;SLC4A2;USF2;TM6SF2;ACOX3
prerank,placenta development (GO:0001890),0.35403335940262726,0.7838241369917089,0.7483870967741936,0.9184805354079695,1.0,1/12,5.42%,PPARG
prerank,regulation of osteoblast proliferation (GO:0033688),0.3329071217867998,0.7833891069504716,0.7792041078305519,0.9187333922811557,1.0,3/17,12.09%,LTF;NELL1;RHOA
prerank,mitochondrial genome maintenance (GO:0000002),0.36294850148966346,0.7832808291815282,0.738191632928475,0.918534823487475,1.0,3/11,14.25%,SLC25A33;LONP1;SLC25A36
prerank,positive regulation of cation channel activity (GO:2001259),0.2813255254025891,0.7821289827299723,0.7946127946127947,0.9197664659700483,1.0,5/40,11.26%,TMSB4X;LRRC52;HTT;STAC2;CCR2
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.3638200732796428,0.7817226488701069,0.7541899441340782,0.9199920244876487,1.0,6/11,32.85%,UQCRH;UQCR10;UQCRB;UQCR11;CYCS;UQCRQ
prerank,epithelial structure maintenance (GO:0010669),0.3625535987367089,0.7807032780011821,0.747638326585695,0.9210498201432835,1.0,2/11,25.90%,RBP4;TLR9
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.32085473979286766,0.7806403146053257,0.7755856966707768,0.9208107028667336,1.0,4/19,14.22%,FGF2;RUNX1;PIM1;RBP4
prerank,protein prenylation (GO:0018342),0.3649042671566868,0.7805887886570247,0.7370572207084468,0.9205517610399806,1.0,2/10,10.58%,PTAR1;RABGGTB
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.3391605536292664,0.7805136149200796,0.7739816031537451,0.9203224411350652,1.0,3/14,16.15%,NRP1;VEGFA;KDR
prerank,tRNA 5'-end processing (GO:0099116),0.3373309415111456,0.7804647467336363,0.7746113989637305,0.9200642215526338,1.0,5/15,29.33%,TRMT10C;PRORP;RPP25L;RPP38;POP1
prerank,negative regulation of cellular protein localization (GO:1903828),0.29421673484402266,0.7800406366671371,0.7897727272727273,0.9203258705636792,1.0,10/34,23.70%,RIPOR2;MFHAS1;SNX33;ILRUN;ANKRD13A;LZTFL1;ACTN2;GSK3B;LATS1;DNAJA1
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.30174936417422227,0.7799666750379659,0.7619047619047619,0.9201019589034953,1.0,12/26,31.23%,NLRC3;LTF;ILRUN;ACOD1;C1QBP;SIGIRR;LYAR;TRIM21;TRAF3IP1;TNFAIP3;MUL1;SIRT2
prerank,ubiquinone metabolic process (GO:0006743),0.3347190099511931,0.7795532024905222,0.767948717948718,0.9203060693200107,1.0,5/15,24.86%,COQ10B;COQ5;COQ3;AIFM2;COQ8B
prerank,megakaryocyte differentiation (GO:0030219),-0.290691105392003,-0.7795230057432059,0.754863813229572,0.9728787564135306,1.0,11/11,70.96%,ZFPM1;KIT;TAL1;SH2B3;IL11;CDKN2B;MPIG6B;GATA1;THPO;UBA5;MED1
prerank,artery development (GO:0060840),0.31254290948332164,0.7793570551400091,0.7830750893921334,0.9202194526666434,1.0,6/23,19.16%,NRP1;VEGFA;SMAD7;EFEMP2;NF1;HECTD1
prerank,heart morphogenesis (GO:0003007),0.2817321529949285,0.7793287503111791,0.8257080610021786,0.9199283662697922,1.0,4/50,7.58%,TH;SOX9;VEGFA;DLC1
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.33596051148616357,0.7789743003512395,0.7843388960205392,0.9197472518529876,1.0,3/16,10.17%,CORO1C;DLC1;ARHGAP6
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.33596051148616357,0.7789743003512395,0.7843388960205392,0.9197472518529876,1.0,3/16,10.17%,CORO1C;DLC1;ARHGAP6
prerank,nucleotide biosynthetic process (GO:0009165),0.32805151745848093,0.7789506417174109,0.7761194029850746,0.9194559195824641,1.0,9/18,25.97%,GART;PRPSAP1;MTHFD1;PRPS2;PPAT;NMNAT3;ADSL;ME1;HPRT1
prerank,centromere complex assembly (GO:0034508),0.28908075237106834,0.7786718637442569,0.8020361990950227,0.9194852782744408,1.0,14/36,33.44%,CENPO;CENPT;CENPX;KNL1;NPM1;RBBP7;CENPK;CENPA;CENPS;RSF1;NASP;CENPH;CENPC;CENPW
prerank,cellular response to fluid shear stress (GO:0071498),0.3579648592662059,0.7785028807470298,0.765625,0.9193745221686955,1.0,2/12,6.71%,NFE2L2;MTSS1
prerank,regulation of transposition (GO:0010528),0.3515499772397504,0.7783261219461496,0.7779255319148937,0.9192830239524271,1.0,3/13,24.28%,PIWIL2;UBR2;SMYD5
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.31836419882379624,0.7782109519745424,0.7783251231527094,0.9191156247955643,1.0,2/19,5.86%,PRKCH;RUNX1
prerank,cellular response to gamma radiation (GO:0071480),0.32620408380522686,0.7776852348650952,0.7767857142857143,0.9194708769780262,1.0,8/17,31.65%,ATM;TMEM109;HSF1;MDM2;KDM1A;ATR;XRCC5;MAP3K20
prerank,positive regulation of dendritic spine development (GO:0060999),0.3169101691948755,0.7762484149561357,0.7898009950248757,0.9210292631093772,1.0,3/20,10.21%,APOE;LLPH;CPEB3
prerank,negative regulation of protein ubiquitination (GO:0031397),0.27810675978198235,0.7757927234406896,0.8195819581958196,0.9213080603658504,1.0,15/50,27.90%,GTPBP4;SQSTM1;CAV1;ADGRB1;FBXO5;LIMK1;OGT;SMAD7;CHP1;RPS3;PRMT3;DNAJA1;VPS28;UFL1;TNFAIP3
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.3624144070555688,0.7753854098751949,0.772,0.9215292243620047,1.0,2/12,11.44%,NR4A3;ABCD2
prerank,response to nutrient levels (GO:0031667),0.3276308009198181,0.7753574251667504,0.7764857881136951,0.9212399954762927,1.0,2/17,6.45%,EIF4G1;SCTR
prerank,negative regulation of mRNA processing (GO:0050686),0.3387023826310202,0.7749918109865348,0.7786357786357786,0.9214122954176209,1.0,4/15,15.90%,SRSF7;PCBP4;C1QBP;BARD1
prerank,generation of neurons (GO:0048699),0.2533351207414337,0.7745657866859058,0.9197592778335005,0.9216133408713537,1.0,25/190,16.00%,FGF13;CTNNB1;CDK6;ERCC6;LRP12;CDK5;NRP1;RUNX1;HES7;BHLHE40;BHLHE41;USP9X;WNT6;OTP;NAV1;IRX5;FZD1;PRUNE1;CELSR1;DCX;FZD4;YTHDF2;DOCK7;RACGAP1;NR4A2
prerank,activation of phospholipase C activity (GO:0007202),0.2959017935589979,0.7745175278311613,0.7810304449648712,0.9213377360989062,1.0,8/29,16.70%,ITK;GNAQ;EDNRA;TXK;PLCB2;ARHGAP6;LPAR1;C5AR1
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.2762085169809486,0.7741142876424775,0.834619625137817,0.9215523679816254,1.0,8/51,13.40%,FSTL3;PPARG;BAMBI;LEMD2;CHRD;SMAD7;FSTL1;SMAD1
prerank,metanephros development (GO:0001656),-0.22620458338747754,-0.7740057099882508,0.8531468531468531,0.9799965342137874,1.0,9/26,22.18%,FGF10;PAX8;PAX2;ROBO2;OSR1;WNT7B;FOXD1;PKD1;SHH
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.3644631443003238,0.7739473297973316,0.7726027397260274,0.9214373855479608,1.0,1/10,1.37%,NFE2L2
prerank,erythrocyte development (GO:0048821),0.36837335632441814,0.7735402788899491,0.7768707482993197,0.9216439029108343,1.0,4/10,29.06%,ALAS1;LYAR;NCKAP1L;MED1
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.3289124409315996,0.7735385826386502,0.7934093789607097,0.9213200493309903,1.0,3/17,8.30%,CD8A;JAG1;BTN3A3
prerank,microtubule nucleation (GO:0007020),0.32650548718648903,0.7735125372842101,0.807061790668348,0.9210295521190495,1.0,5/19,25.42%,TUBGCP4;RANBP9;CSNK1D;SLAIN2;GOLGA2
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.24979132301835602,-0.7734587552900745,0.8081395348837209,0.9786934836626151,1.0,4/19,8.58%,CSF1R;CAMK1D;PTK2;THBS1
prerank,histone H2A monoubiquitination (GO:0035518),0.3331975494606845,0.7731456372654638,0.7929736511919699,0.9211787622055051,1.0,7/17,30.66%,DDB2;DDB1;RNF2;BMI1;PCGF6;TRIM37;PCGF2
prerank,regulation of neurogenesis (GO:0050767),0.2723912128607152,0.7725837938084693,0.8447537473233405,0.9215829829431562,1.0,11/55,18.40%,CTNNB1;HES7;BHLHE40;BHLHE41;B2M;PRUNE1;YTHDF2;DOCK7;APPL2;HOOK3;IL6
prerank,spermatid development (GO:0007286),0.29221650607206523,0.772490594733829,0.7962962962962963,0.9213754312667863,1.0,9/32,30.28%,SOX30;TTC21A;SYCP3;ING2;MKKS;CDYL;IQCG;TDRD5;CEP57
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.3162529664926698,0.7724861871562572,0.7784577723378213,0.9210547612595706,1.0,7/20,24.29%,CD6;PTPN22;TICAM1;CCL5;MTDH;LBP;TNF
prerank,negative regulation of defense response to virus (GO:0050687),0.36205508570820366,0.772311723962848,0.7622377622377622,0.9209507030490619,1.0,5/10,29.83%,ILRUN;C1QBP;TRAF3IP1;TARBP2;MUL1
prerank,somite development (GO:0061053),-0.2891181876920976,-0.7720098243763234,0.8046875,0.9788321394651116,1.0,4/11,22.36%,PPP2R3A;MEOX2;SHH;SFRP2
prerank,dorsal/ventral pattern formation (GO:0009953),-0.2412997018593721,-0.7713907323283702,0.8548387096774194,0.9777037662601675,1.0,2/20,4.30%,BMPR1B;DSCAML1
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.3521371298752377,0.77130840871999,0.7789336801040312,0.9219573682888141,1.0,5/13,23.46%,VDAC2;BCL2L11;BAX;RHOT2;BNIP3
prerank,negative regulation of chemokine production (GO:0032682),0.34355116889677684,0.7709180508079064,0.7735602094240838,0.9221188661775486,1.0,4/14,23.96%,SIRPA;SIGIRR;IL6;MAP2K5
prerank,cellular modified amino acid catabolic process (GO:0042219),0.33468938027421496,0.7697414749666782,0.7698309492847855,0.923312559118802,1.0,1/15,4.27%,ABHD12
prerank,phosphatidic acid metabolic process (GO:0046473),0.27659585465894543,0.7695362504441013,0.8251670378619154,0.9232728194564707,1.0,12/48,25.24%,DGKZ;SLC27A1;DDHD1;ABHD5;DGKA;DGKH;DGKD;AGPAT2;PLA2G12A;AGPAT1;ABHD4;PLA2G5
prerank,potassium ion transmembrane transport (GO:0071805),0.25274029586570057,0.7693189021556628,0.9082661290322581,0.9232219846603894,1.0,15/135,9.54%,SLC9A1;SLC24A4;KCNN4;ATP1B3;KCNK13;LRRC52;KCNA3;KCNJ2;CCDC51;SLC9A8;ATP1A4;ATP1A3;ATP1A1;KCNA4;SLC12A4
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.31557848655577,0.7691081551724055,0.7884378843788438,0.9231726204142857,1.0,8/19,28.38%,GATA3;NFKB1;TMEM106A;WFS1;MAPK7;MAP2K5;TNF;MTPN
prerank,positive regulation of histone modification (GO:0031058),0.29017090632667103,0.7683966157739766,0.7995337995337995,0.9237762255169113,1.0,13/33,28.29%,FAM47E;ZBTB7B;BRCA1;SAP30BP;ING2;CHTOP;PAF1;GLYR1;NIPBL;KDM1A;RUVBL2;APLNR;MAPK3
prerank,regulation of microtubule-based movement (GO:0060632),-0.2915250550718191,-0.7679829701140506,0.7624521072796935,0.9810190240860763,1.0,5/11,23.90%,MAP2;HAP1;TTC21B;DRC1;HDAC6
prerank,blood vessel diameter maintenance (GO:0097746),0.29348126569701594,0.7677605420609154,0.8056818181818182,0.9242238461862748,1.0,8/34,23.72%,EDNRA;SCPEP1;KCNMB4;ROCK1;SERPINF2;ITGB1BP1;HTR2B;ECE1
prerank,regulation of cell size (GO:0008361),0.30864845451209233,0.7660560907784687,0.7896009673518742,0.9260703365021687,1.0,2/23,1.76%,PLEK;MSN
prerank,regulation of membrane depolarization (GO:0003254),0.3178174933164286,0.7652654570215804,0.7839195979899497,0.92677615759097,1.0,4/18,16.28%,RANGRF;SCN1B;SMAD7;SCN3B
prerank,epithelial cell migration (GO:0010631),0.28273388163302915,0.7650723431918462,0.8181818181818182,0.9267016408073291,1.0,8/37,18.30%,NRP1;PLXND1;RHOA;FSTL1;PKN2;ROCK1;CYP1B1;TESK1
prerank,cellular response to interleukin-7 (GO:0098761),-0.2608689222239422,-0.7649817176334809,0.8256880733944955,0.9814827056174704,1.0,3/17,6.01%,STAT5A;STAT3;IRS2
prerank,interleukin-7-mediated signaling pathway (GO:0038111),-0.2608689222239422,-0.7649817176334809,0.8256880733944955,0.9814827056174704,1.0,3/17,6.01%,STAT5A;STAT3;IRS2
prerank,bile acid biosynthetic process (GO:0006699),-0.2303714658827682,-0.764932027277666,0.8098159509202454,0.9794030627189763,1.0,6/24,11.75%,CYP27A1;OSBPL9;OSBPL7;SLC27A2;CYP7B1;CYP39A1
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.28384988384651694,-0.7646879735872458,0.7511111111111111,0.9776357638222191,1.0,4/12,18.57%,IL18;IL1B;CD80;PAEP
prerank,positive regulation of protein deacetylation (GO:0090312),0.34227704581822,0.764648604949378,0.7958115183246073,0.9269228250198603,1.0,5/14,28.23%,ZBTB7B;SAP30BP;ING2;NIPBL;APLNR
prerank,calcineurin-mediated signaling (GO:0097720),-0.2938803011716189,-0.7642820213915441,0.7659574468085106,0.9739822484658364,1.0,4/10,17.91%,NFATC2;NFATC1;PPP3CB;ADGRB2
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.2938803011716189,-0.7642820213915441,0.7659574468085106,0.9739822484658364,1.0,4/10,17.91%,NFATC2;NFATC1;PPP3CB;ADGRB2
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.3612060142368765,0.7642362769133937,0.7864214992927864,0.9271041377379364,1.0,4/10,25.90%,NAMPT;KDR;JAK2;TLR9
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.34741758059577865,0.7642047533939135,0.7737127371273713,0.9268203434280482,1.0,3/12,17.48%,NINL;DCTN1;HOOK3
prerank,negative regulation of cell projection organization (GO:0031345),0.27345245205323765,0.763932394004658,0.8436123348017621,0.9268231468193353,1.0,8/48,16.08%,APOE;MYLIP;GAK;FYN;PAQR3;CBFA2T2;LPAR1;EFNB2
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.31228038897959864,0.7638757784908076,0.7744733581164808,0.9265650275766244,1.0,5/20,21.40%,CCNY;ADAM17;STOX1;CCND2;HSP90AB1
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.36045614968660245,0.7638520036839963,0.7644628099173554,0.9262731459552712,1.0,2/10,13.02%,GNMT;OGT
prerank,peptidyl-threonine modification (GO:0018210),0.26419007695436986,0.7637809691841543,0.8640674394099052,0.9260368311903807,1.0,16/66,23.00%,DYRK2;CDK5;PRKCD;PDPK1;SBK1;HIPK1;MAP3K12;ROCK1;PRKD2;CAD;NLK;CSNK2A2;MARK2;LMTK2;GSK3B;TGFBR2
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.31963101138218397,0.7634385202245342,0.7950310559006211,0.9261380940126064,1.0,4/18,14.57%,ADCY8;VEGFA;CRTC1;PRKD2
prerank,positive regulation of heart contraction (GO:0045823),0.31908502729963534,0.7633597010465447,0.7881040892193308,0.9259130569029488,1.0,5/19,27.44%,NPPA;ATP1A2;SCN3B;ATP2A2;GSK3A
prerank,cognition (GO:0050890),0.27547132022777465,0.7632880399515334,0.8305647840531561,0.9256863934958053,1.0,11/42,27.17%,CHRNB2;MAGT1;PTCHD1;DOP1B;NF1;TUSC3;C5AR1;NIPBL;TNF;CYFIP1;CHD7
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.3454443149203061,0.7630228677088015,0.7878395860284605,0.9257027841472646,1.0,5/13,27.61%,PLA2R1;ATM;SPRED2;SPRED3;ATR
prerank,"base-excision repair, gap-filling (GO:0006287)",0.2869215266729407,0.7629639083892906,0.8168373151308305,0.925450324977454,1.0,15/35,33.78%,LIG1;POLE;MBD4;ADPRS;POLB;RFC1;POLG;RFC2;LIG3;POLD4;PARG;PNKP;RFC4;RFC5;PCNA
prerank,positive regulation of type I interferon production (GO:0032481),0.2592205236517095,0.7628991864435407,0.8664563617245006,0.9252041017582789,1.0,13/73,18.62%,CTNNB1;PTPN22;POLR2H;LRRFIP1;POLR3E;POLR3D;RIOK3;IRF5;NFKB1;HSPD1;DHX36;DHX33;DHX9
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.24725491404391786,0.7628874597134205,0.9295774647887324,0.9248971235407584,1.0,50/172,27.39%,DGKZ;SLC27A1;DDHD1;ARF3;PEMT;PIK3CB;APOA2;FGF2;PIK3R5;PI4K2A;STARD10;CHKB;INPPL1;VAC14;PLEKHA1;ABHD5;PIP5K1C;CLN3;MTMR14;RAB5A;LPCAT3;PTPN13;CPNE3;MTMR12;TAMM41;DGKA;DGKH;PIK3R2;DGKD;CSNK2A2;PIKFYVE;AGPAT2;PLA2G12A;HDHD5;PI4KA;CPNE6;PIP5K1B;AGPAT1;ABHD4;MBOAT7;LPIN3;PIK3C2A;SYNJ2;PLA2G5;SLC44A2;PI4K2B;MTMR6;MTMR1;PCYT1A;PITPNM1
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.30176748335504955,0.7628603598677887,0.7834549878345499,0.9246099497150208,1.0,5/24,17.22%,BCL2L1;RACK1;LPCAT3;CLU;WFS1
prerank,positive regulation of blood coagulation (GO:0030194),0.323900866491251,0.7628026372289864,0.8040455120101138,0.9243518168294887,1.0,6/17,22.71%,HRG;SERPINE1;APOH;SERPINF2;ANO6;F2R
prerank,vasodilation (GO:0042311),-0.27660044482398466,-0.7627437430324694,0.8161434977578476,0.9742032676605735,1.0,3/13,11.70%,ADRB1;NOS1;SOD1
prerank,pulmonary valve development (GO:0003177),-0.25275007390016646,-0.7624932931278432,0.78,0.972523543536729,1.0,7/18,21.74%,ROBO1;NOTCH2;ROBO2;NFATC1;HEY1;SLIT2;HEYL
prerank,response to calcium ion (GO:0051592),0.25380239732516385,0.7622300801695661,0.8880903490759754,0.9247259896910671,1.0,8/102,6.55%,IQGAP1;SLC25A24;ADCY8;ITPKB;ANXA11;CAV1;CLIC4;KCNMA1
prerank,negative regulation of cilium assembly (GO:1902018),-0.2851459423678155,-0.7608976864762659,0.7560975609756098,0.972862428909585,1.0,3/12,12.94%,TBC1D30;TCHP;ODF2L
prerank,brain morphogenesis (GO:0048854),-0.2755478754632813,-0.7607348097881783,0.7723214285714286,0.9710246531222885,1.0,3/12,8.53%,CTNNA2;SHANK3;PAX2
prerank,nucleotide-sugar metabolic process (GO:0009225),0.3500400155166942,0.7597366190752648,0.7924528301886793,0.9274905350066673,1.0,4/12,29.85%,EXTL2;GALT;GFUS;PARG
prerank,regulation of peptide hormone secretion (GO:0090276),0.2609646698508822,0.7590214064053183,0.8645502645502645,0.9280653751511321,1.0,10/67,19.10%,CACNA1A;GCK;SLC2A1;CCL5;CACNA1D;SLC8B1;GIPR;GLP1R;IL6;ITPR3
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.20809013864255066,-0.7589769102795656,0.8993288590604027,0.9715526929283358,1.0,4/32,10.24%,CAPN3;HAP1;P2RY6;AKAP6
prerank,positive regulation of vasculogenesis (GO:2001214),-0.3034493819680752,-0.7586451259190383,0.7566539923954373,0.9699554873365184,1.0,5/10,20.46%,TMEM100;RAPGEF2;CD34;ASB4;RRAS
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.27781285713491255,-0.758583464834397,0.8017241379310345,0.9679473011477112,1.0,3/13,17.04%,PTS;PRKG2;QDPR
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.2314061676595614,-0.7579253762735833,0.8465909090909091,0.9668068521811062,1.0,5/24,7.65%,ABCA3;PLA2G15;PNPLA8;CRLS1;GPAM
prerank,inositol lipid-mediated signaling (GO:0048017),0.2671957811202954,0.7574463763567107,0.8516902944383861,0.9297078968204924,1.0,7/50,13.02%,IGF1;PLCB4;PIK3CB;IGF1R;PLCB2;RHOA;OGT
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.3506982099627902,0.7571813955616372,0.7883870967741935,0.9297022116863117,1.0,3/12,16.43%,PTGIR;CBL;CBLB
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.3449387088544362,0.7568492563360795,0.7945383615084526,0.9297569324476406,1.0,4/13,25.90%,IRAK2;TNIP2;IRAK4;TLR9
prerank,neurotransmitter uptake (GO:0001504),0.3458884520609644,0.7563835206097679,0.7979002624671916,0.929979971081698,1.0,3/12,15.42%,SLC38A1;SLC22A3;ATP1A2
prerank,negative regulation of insulin secretion (GO:0046676),-0.25568540331891126,-0.756090553565462,0.8354978354978355,0.9674690570089919,1.0,6/17,20.81%,KCNB1;PRKN;REST;KLF7;MIDN;ADRA2A
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.3391789226616362,0.756068691042515,0.7928759894459103,0.9300192893551582,1.0,2/13,9.00%,ASPH;CYFIP2
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.3054369477145556,0.7560337991654498,0.8175355450236966,0.9297316860689436,1.0,13/23,38.32%,RIPOR2;MOSPD2;C1QBP;TIRAP;CD74;NCKAP1L;MDK;DPP4;MCU;RAC2;MPP1;JAM3;RAC1
prerank,positive regulation of rRNA processing (GO:2000234),0.35606246779887385,0.7556844704339252,0.7960618846694796,0.9298249946130144,1.0,4/10,24.18%,RIOK2;WDR43;TRMT112;DIMT1
prerank,response to prostaglandin E (GO:0034695),0.35923283537627143,0.7540423194002395,0.8017118402282454,0.9314987219874117,1.0,3/10,25.22%,GNB1;PTGER4;SFRP1
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.33461933115667514,0.7540223372226232,0.8074866310160428,0.9311984942884274,1.0,5/14,23.96%,CARD10;DLL4;RHOA;ITGB1BP1;MAP2K5
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.33145769383725887,0.7539015835984667,0.8087071240105541,0.931007643036908,1.0,7/14,33.32%,DDX1;TSEN15;CSTF2;RTRAF;TSEN2;CLP1;RTCB
prerank,axon guidance (GO:0007411),0.2426616923609403,0.7535535972305023,0.9479479479479479,0.9311191565210037,1.0,25/201,13.34%,PLXNC1;ALCAM;NRP2;NIBAN2;PTPRA;PLXNA2;PRKCQ;DAG1;PIK3CB;LRTM1;NPTN;NRP1;SH3KBP1;GRB2;VEGFA;DOK2;RANBP9;PLXND1;FYN;RHOG;DOK1;SCN1B;EMB;PALLD;EFNA1
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.3178939050306371,0.7534847383783713,0.7924050632911392,0.9308802953561837,1.0,5/17,19.51%,UBL4A;EMC9;EMC3;GET1;GET3
prerank,positive regulation of insulin secretion (GO:0032024),0.28110256863198874,0.7530191935856684,0.8268348623853211,0.9311302169595822,1.0,3/36,3.43%,ADCY8;GCK;TRH
prerank,establishment of endothelial barrier (GO:0061028),0.291236681130224,0.752646352202676,0.8108108108108109,0.9312589149597035,1.0,7/29,20.55%,MSN;TJP2;RAPGEF6;MYADM;RAB1A;AFDN;MARVELD2
prerank,regulation of glucose metabolic process (GO:0010906),-0.2111800461331818,-0.7501603317782668,0.9343065693430657,0.9740142158911131,1.0,8/34,15.81%,PDK1;IRS2;FOXK2;KHK;PRKN;ZNF692;PDK2;PMAIP1
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.2889247265092374,0.7494525075142394,0.8286713286713286,0.9347375290791203,1.0,9/31,24.96%,HOXA4;IRX5;EIF4A3;HOXB4;HOXC9;TGFBR2;DYNC2I1;FGFR2;PDGFRA
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.30127696963847983,0.7488483337916609,0.8266666666666667,0.9350859478841236,1.0,6/22,17.73%,ABCG1;GSAP;RANBP9;EFNA1;CLU;SP1
prerank,mesenchyme development (GO:0060485),-0.25430597981476044,-0.7485070747789362,0.8181818181818182,0.974357630696448,1.0,8/15,33.18%,BMP2;HMGA2;SFRP2;BMPR2;ISL1;TGFBR1;BMP7;WNT11
prerank,positive regulation of protein export from nucleus (GO:0046827),0.3246904713769935,0.748415290898273,0.7882653061224489,0.9352774895532451,1.0,6/15,24.06%,GAS6;TPR;GSK3B;BAG3;RBM22;ANP32B
prerank,myelination in peripheral nervous system (GO:0022011),0.33621497076176743,0.7474413782846048,0.7976031957390146,0.9361295066823087,1.0,3/13,16.05%,MYOC;NCMAP;NF1
prerank,regulation of hydrolase activity (GO:0051336),0.2579410660549648,0.7473885421172731,0.8747368421052631,0.9358583938861617,1.0,20/71,26.60%,PLXNC1;GPR137B;PLXNA2;CAV1;FGD6;RAPGEF6;PLXND1;ARHGAP12;NF1;ARHGAP9;RAB3GAP2;ITGB1BP1;FBXW11;FGD5;ARHGEF5;VAV3;RAB3GAP1;VAV1;PLXNA1;TBC1D15
prerank,replication fork processing (GO:0031297),0.27553178331849437,0.7469395707302704,0.8331441543700341,0.9360664224059676,1.0,16/38,33.99%,THOC1;ZRANB3;BOD1L1;BLM;CENPX;ATRX;RTEL1;ZGRF1;SETMAR;GEN1;CENPS;ATR;MMS22L;SMARCAL1;PCNA;RAD51
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.32103647339412533,0.7466043276990229,0.7946428571428571,0.9358167068487937,1.0,3/15,16.15%,BLOC1S3;DTNBP1;AP3D1
prerank,anterograde synaptic vesicle transport (GO:0048490),0.32103647339412533,0.7466043276990229,0.7946428571428571,0.9358167068487937,1.0,3/15,16.15%,BLOC1S3;DTNBP1;AP3D1
prerank,protein import into peroxisome matrix (GO:0016558),-0.27615735453249934,-0.7460519757750372,0.7628458498023716,0.9759186484520318,1.0,3/12,10.01%,PEX7;PEX12;PEX5L
prerank,lipid biosynthetic process (GO:0008610),0.254763662539662,0.7457710248331363,0.8705636743215032,0.9364627648102619,1.0,6/77,8.47%,LPL;ACACA;CYP19A1;ACSL1;FADS1;SCD5
prerank,histone H3 acetylation (GO:0043966),0.27429831338441996,0.7456998347456418,0.8382022471910112,0.9362269254970608,1.0,10/40,20.47%,LEF1;ING4;TRIM16;TADA1;WDR5;ING5;JADE3;KAT7;DR1;YEATS2
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.34253193856873987,0.7455622980419174,0.803840877914952,0.9354291269209766,1.0,4/12,26.58%,NSMCE2;CUL3;ANAPC7;ESPL1
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.34253193856873987,0.7455622980419174,0.803840877914952,0.9354291269209766,1.0,4/12,26.58%,NSMCE2;CUL3;ANAPC7;ESPL1
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.34253193856873987,0.7455622980419174,0.803840877914952,0.9354291269209766,1.0,4/12,26.58%,NSMCE2;CUL3;ANAPC7;ESPL1
prerank,amide biosynthetic process (GO:0043604),0.2737621482798376,0.7455038419263383,0.8604395604395605,0.9351668495156271,1.0,20/47,37.02%,SGMS1;CERS6;SPTSSA;SMPD4;FURIN;SMPD1;NANP;ASAH1;SAMD8;SPTLC3;ASL;SPTLC2;AANAT;SPTSSB;CLN8;PM20D1;SGMS2;CERS5;NMRAL1;SPTLC1
prerank,neuron projection organization (GO:0106027),0.31787317324472486,0.7454381926999074,0.8045977011494253,0.9349255280495166,1.0,5/15,21.45%,ATP1A3;DCTN1;ABCD2;PLS1;GSK3B
prerank,cellular response to organonitrogen compound (GO:0071417),0.2501469314415717,0.745350665250011,0.9004149377593361,0.9347114766015442,1.0,14/99,12.42%,CTNNB1;RRAGD;P2RX4;MAPK13;CPEB4;IPO5;SOX9;CDH1;P2RY1;BRCA1;JUP;CPEB3;DIAPH1;LARP1
prerank,action potential (GO:0001508),0.26965615294267425,0.744946477185973,0.850613154960981,0.9348617562669774,1.0,8/44,16.28%,GNAQ;SCN4A;KCNJ2;SRI;CLN3;KCNMB4;GNA11;SCN3B
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.32812619984483715,0.7444961500165193,0.7952755905511811,0.9350773569182858,1.0,6/13,28.67%,IL27;IL27RA;JAK1;CANX;JAK2;OASL
prerank,protein dephosphorylation (GO:0006470),0.24761539114556116,0.7437598048902196,0.9300202839756593,0.9356029417561829,1.0,31/135,21.07%,PTPRA;PTPRC;EYA4;DUSP9;PPM1J;PPP2R5C;PPP2R1A;PPM1H;PTPN22;CTDNEP1;NCK1;PPP1R12A;TAB1;PTPN2;DUSP6;PTPN12;PHPT1;PPP2R2D;PTPN13;PPP1R15B;DUSP3;DUSP11;PPP6C;PPP2R2C;STK11;RPRD1A;PPP3CC;PTPN21;FBXW11;SSU72;DUSP12
prerank,pharyngeal system development (GO:0060037),0.3296906185495262,0.7436190184773093,0.8143790849673203,0.9354539801598075,1.0,4/15,27.42%,GATA3;BMP5;BMP4;HES1
prerank,cellular amino acid catabolic process (GO:0009063),-0.17314636430284397,-0.7435962623519278,1.0,0.9773636699621647,1.0,23/87,21.45%,HMGCLL1;MCCC2;GLUD1;HNMT;KMO;BCKDHB;GLUL;ASPA;DLD;ALDH6A1;NOS1;GAD1;PRODH;HAL;HAAO;HYKK;BCKDHA;QDPR;IVD;ALDH4A1;DAO;CARNMT1;AUH
prerank,cyclooxygenase pathway (GO:0019371),0.353109301047533,0.7411191068523495,0.8087201125175809,0.9380360633769936,1.0,5/10,25.23%,PTGES;CBR1;PTGES3;PTGIS;TBXAS1
prerank,DNA conformation change (GO:0071103),-0.2382549338828156,-0.7407889517329969,0.8254716981132075,0.9793022965395349,1.0,5/17,17.30%,NAA10;TOP2A;TOP3B;ERCC3;TOP3A
prerank,vasculogenesis (GO:0001570),0.2835791846822905,0.7406393356168555,0.8433874709976799,0.9382885590211207,1.0,5/32,16.40%,CAV1;VEGFA;EGFL7;KDR;RASA1
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.33901900358666437,0.7400052360168528,0.8185430463576159,0.9387006491438081,1.0,3/12,20.33%,LPCAT3;MBTPS2;SREBF1
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.3209514327802525,0.739929472009016,0.8109517601043025,0.9384672826671262,1.0,2/15,7.31%,KCNJ2;ATP1A1
prerank,prostaglandin biosynthetic process (GO:0001516),0.30629973019339407,0.7393130431741459,0.8193224592220828,0.9388204272647249,1.0,7/18,25.23%,PTGES;CBR1;PTGES3;PTGIS;CD74;MIF;TBXAS1
prerank,regulation of DNA metabolic process (GO:0051052),0.2671882796505721,0.7386247459267647,0.8612334801762115,0.9392838233012188,1.0,17/44,36.41%,PDGFA;THOC1;WDR70;STOX1;UBE2V2;KAT7;USP1;TERF2IP;SMG1;TICRR;XRCC5;PARG;TERF2;MPHOSPH8;IL7R;MYC;MPV17
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.3290618818597618,0.738330768637856,0.8157216494845361,0.9392899952359233,1.0,3/14,14.12%,FGF2;GATA3;SPRY4
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.30101698629402246,0.7379179259347554,0.818069306930693,0.9394265621045379,1.0,8/20,31.56%,PMPCA;AFG3L2;SLC8B1;STOML2;PARL;SLC25A23;SPG7;SMDT1
prerank,modulation by host of viral genome replication (GO:0044827),-0.2650883410535178,-0.7378579511463661,0.8243243243243243,0.9813626480493897,1.0,4/13,20.62%,YTHDC2;PRKN;NUCKS1;FBXL2
prerank,regulation of rRNA processing (GO:2000232),0.31576304087614543,0.7378428963759684,0.8199233716475096,0.9391929969403041,1.0,6/16,24.18%,RIOK2;WDR43;YTHDF2;USP36;TRMT112;DIMT1
prerank,sensory perception of light stimulus (GO:0050953),0.2486872058808848,0.7369444413555509,0.8940809968847352,0.9399243028926062,1.0,10/87,12.94%,CHRNB2;EYA4;RDH12;DHRS3;TH;COL18A1;SFRP5;ABLIM1;RABGGTB;CNGB1
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.2853219108353607,0.7355940838774265,0.8450536352800954,0.9411096314929055,1.0,3/29,7.60%,GOSR2;VTI1A;NAPA
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.30557857983565195,0.7352985350440241,0.828641370869033,0.9411046635749721,1.0,6/20,21.40%,P2RX4;C3AR1;C3;ENTPD5;ANO6;HSP90AB1
prerank,linoleic acid metabolic process (GO:0043651),0.31043983505251505,0.7346361955428317,0.8141592920353983,0.9415252177743348,1.0,4/17,21.92%,ACSL1;FADS1;ELOVL2;ELOVL1
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.2825948470675005,0.7345222972902905,0.8451834862385321,0.9413291126439727,1.0,8/30,24.63%,SDCBP;RPL11;OGT;CCAR2;HSP90AB1;USP14;GIPC1;EIF3H
prerank,positive regulation of peptidase activity (GO:0010952),0.30291681146410954,0.733246177692791,0.8106435643564357,0.9424210608025697,1.0,6/20,28.64%,TANK;VCP;RCN3;PRELID1;MAPK12;APH1A
prerank,ribosomal large subunit assembly (GO:0000027),0.29455846902494554,0.7329548558473158,0.8387096774193549,0.9424355751547815,1.0,4/24,15.19%,BRIX1;PPAN;RPL11;MDN1
prerank,secretion (GO:0046903),0.3225797954140739,0.7328184356230228,0.8108448928121059,0.9422666168270963,1.0,6/14,30.03%,TPD52;VIP;ABCB11;DRD3;FBLN5;NPR1
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.34303202882837847,0.7327297627314097,0.8186738836265224,0.9420366411625848,1.0,4/11,17.18%,TJP2;RAPGEF6;RAB1A;AFDN
prerank,regulation of catabolic process (GO:0009894),0.30578350750002636,0.7324702993996397,0.8327183271832719,0.9420023825771351,1.0,12/18,36.38%,FURIN;ODC1;FAM83D;CHMP6;MDM2;ITGB1;FAF1;SNF8;RARRES2;CHEK2;CENATAC;ZDHHC2
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.32643131732276115,0.7323141157944859,0.8048162230671736,0.9418536448453124,1.0,8/14,30.69%,CSF1;CCL5;AKIRIN1;IL34;MDK;MAPK3;RARRES2;MAPK1
prerank,positive regulation of filopodium assembly (GO:0051491),0.2930707308922974,0.7322955519249104,0.8361244019138756,0.9415486688113965,1.0,4/24,12.86%,RIPOR2;NRP1;RHOQ;CDC42
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.3019185466990874,0.7321204718979252,0.8391521197007481,0.9414294921782077,1.0,3/18,16.80%,FAM3D;CRH;SIRT4
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.2723923717604534,0.7315813895320116,0.8629671574178935,0.9417083035142371,1.0,7/37,14.21%,EIF4G1;TRIM6;SPHK1;CADM4;SMAD7;CAB39;STOX1
prerank,determination of left/right symmetry (GO:0007368),0.2741407615380055,0.7305731324473246,0.8470319634703196,0.9424983426730744,1.0,10/36,28.50%,ODAD2;FOXJ1;MKKS;DAND5;BBS7;CCDC40;CCDC39;ARL6;DNAH5;DNAH11
prerank,prostanoid biosynthetic process (GO:0046457),0.3164597791791205,0.7305271402463843,0.8322411533420708,0.9422294585856039,1.0,6/15,25.23%,PTGES;PTGES3;PTGIS;CD74;MIF;TBXAS1
prerank,regulation of lipid catabolic process (GO:0050994),-0.23560699807993174,-0.7304115393134307,0.8780487804878049,0.9892084271950495,1.0,1/19,0.18%,PDE3B
prerank,response to organonitrogen compound (GO:0010243),-0.19508331964854725,-0.7301328386144379,0.9147286821705426,0.9874759567880903,1.0,13/38,22.13%,GLRA3;SEL1L;CCDC47;PRKN;GLRA2;MEAK7;GLRA1;INAVA;IRAK3;TRPM2;MTOR;RNF139;NR1H4
prerank,regulation of protein localization to centrosome (GO:1904779),-0.28988266528416085,-0.729198930763274,0.8028673835125448,0.9866317054809035,1.0,2/10,7.55%,BICD1;APC
prerank,histone ubiquitination (GO:0016574),0.29902702966161643,0.7286409183728352,0.8517156862745098,0.9439712411118995,1.0,9/21,35.29%,HUWE1;PAF1;UBR2;RNF20;CTR9;LEO1;UHRF1;USP22;UBE2A
prerank,metal ion homeostasis (GO:0055065),0.26926453285819596,0.7286028091096264,0.8795454545454545,0.9436919377397937,1.0,7/40,17.22%,SELENON;CYP27B1;CAV1;SLC12A4;CNNM2;SLC7A8;WFS1
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.26207952063066736,0.728475947776384,0.8918918918918919,0.9435155262357497,1.0,18/50,31.31%,MMP8;SASH1;SPHK1;ILK;RHOA;PDCD4;RPS3;LAPTM5;ACTN4;TNF;TCIM;TLR9;TERF2IP;LIMS1;TRIP6;AGER;EP300;NOD1
prerank,cardiac muscle cell development (GO:0055013),0.30210849058745265,0.7284029258913587,0.8236009732360098,0.9432772878189095,1.0,5/20,24.96%,CSRP3;VEGFA;MYH11;ALPK3;PDGFRA
prerank,serine family amino acid catabolic process (GO:0009071),0.3449373598598187,0.7283863061484531,0.8358413132694938,0.9429751984537573,1.0,5/10,31.60%,SHMT1;AMT;GCSH;SHMT2;CBS
prerank,nerve growth factor signaling pathway (GO:0038180),-0.28182367883737436,-0.7283659909906065,0.7852112676056338,0.9857227885217823,1.0,5/10,34.41%,RAPGEF2;BDNF;NTRK1;NGF;NTF4
prerank,regulation of bone mineralization (GO:0030500),0.25896891156878293,0.7280735263459386,0.8856526429341963,0.9429974481790507,1.0,5/55,4.61%,ANKH;ATP2B1;CYP27B1;PTK2B;NELL1
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.259975715667573,-0.7274464642326341,0.8447488584474886,0.9847930963290155,1.0,7/14,22.67%,THBS1;TLR8;SLAMF1;LILRA5;IRAK3;CMKLR1;MEFV
prerank,protein complex oligomerization (GO:0051259),0.24518567547598433,0.726799537336709,0.9161490683229814,0.9441103021012726,1.0,22/85,29.37%,LRRC8C;SLC9A1;ADCY8;ALS2;TMEM120B;PDCD6IP;PRF1;UPB1;BLM;TWNK;NINJ1;EHD4;STOML2;CPSF7;EHD1;TRIM72;NOL3;ARC;FUS;NUDT21;ZNHIT6;CLDN1
prerank,aromatic amino acid family catabolic process (GO:0009074),-0.2519730726104669,-0.7267884285802584,0.8391304347826087,0.9835465492695168,1.0,4/15,24.06%,KMO;HAAO;QDPR;FAH
prerank,ribosomal subunit export from nucleus (GO:0000054),0.32804820940511303,0.726512117367137,0.8485639686684073,0.94410121776922,1.0,3/13,21.52%,EIF6;XPO1;NPM1
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.28783110778025295,0.7257965554354678,0.8564476885644768,0.9445806205164557,1.0,5/23,25.24%,PLAAT3;LPCAT3;PLA2G12A;ABHD4;PLA2G5
prerank,mismatch repair (GO:0006298),0.28669746256059814,0.7257853972943685,0.836104513064133,0.944270266411659,1.0,11/27,36.75%,ERCC1;LIG1;RNASEH2A;PMS1;XPC;POLD4;MLH3;SETD2;PCNA;MCM9;PMS2
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.3285962461748254,0.725436616094921,0.8194070080862533,0.9443218949136298,1.0,5/12,32.25%,EAPP;HNRNPU;RECQL5;HEXIM1;NELFA
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.28660891475188577,0.7254194171420767,0.8446833930704899,0.9440177407496778,1.0,2/24,4.90%,NR4A3;COQ10B
prerank,glutathione derivative metabolic process (GO:1901685),0.2972372643500847,0.7250576076890644,0.838909541511772,0.9437742299851297,1.0,9/20,38.47%,GSTA2;AKR1A1;GSTO2;GSTO1;GSTK1;ESD;GSTT1;MGST3;GSTP1
prerank,glutathione derivative biosynthetic process (GO:1901687),0.2972372643500847,0.7250576076890644,0.838909541511772,0.9437742299851297,1.0,9/20,38.47%,GSTA2;AKR1A1;GSTO2;GSTO1;GSTK1;ESD;GSTT1;MGST3;GSTP1
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.2661105740040285,-0.7249625381549627,0.8472222222222222,0.9838735316585893,1.0,3/13,13.17%,SESN1;RNF152;CASTOR1
prerank,regulation of histone acetylation (GO:0035065),0.274383436659949,0.7249095161159245,0.8576349024110218,0.9436120331757737,1.0,4/33,9.47%,KMT2A;NOC2L;THAP7;BRCA1
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.28558806857957103,0.7242354226966357,0.8660287081339713,0.9440259929522549,1.0,7/28,22.96%,FBXW7;TREM2;PSMC3;CLU;PSMC6;LAPTM5;CCDC22
prerank,embryonic eye morphogenesis (GO:0048048),0.3376559494450181,0.7241917901906865,0.8191632928475033,0.9437505218145424,1.0,2/11,14.85%,TH;LRP6
prerank,long-chain fatty acid metabolic process (GO:0001676),0.24812272034522515,0.724153609857374,0.8846153846153846,0.9434793944209314,1.0,6/64,8.37%,AIG1;ACSBG1;ACSBG2;MGLL;ACSL1;FADS1
prerank,endocrine system development (GO:0035270),-0.23060091648698172,-0.7240773445907378,0.8944444444444445,0.9829572402535949,1.0,3/21,8.84%,SALL1;PAX8;TG
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.3090103581305781,0.7232641599798745,0.8196078431372549,0.9441131886158874,1.0,3/16,14.63%,DDX17;PPARGC1B;RBFOX2
prerank,protein targeting to peroxisome (GO:0006625),0.27943730998418415,0.7226852682607355,0.8571428571428571,0.9444218848845432,1.0,12/29,29.68%,PEX2;RAB8B;ABCD2;ABCD3;PXMP2;ALDH3A2;PEX16;ACBD5;PEX14;ZFAND6;PEX19;FIS1
prerank,regulation of vasculogenesis (GO:2001212),0.32146017153101186,0.7220998812697241,0.8296774193548387,0.9447258732485542,1.0,3/14,16.15%,XDH;RIN2;KDR
prerank,pancreas development (GO:0031016),-0.2699139872103218,-0.722086397303653,0.8314606741573034,0.9834828325068206,1.0,6/12,34.16%,SELENOT;TCF7L2;DNAAF1;ISL1;NPHP3;NKX6-1
prerank,anterior/posterior pattern specification (GO:0009952),0.25577696870089095,0.7210935011436963,0.8866090712742981,0.9454727424899182,1.0,11/53,21.26%,HOXA4;HES7;BHLHE40;BHLHE41;BASP1;HOXA7;WLS;DDIT3;HOXC5;HOXB4;HOXC9
prerank,response to gamma radiation (GO:0010332),0.2831334018914101,0.7188495738415324,0.8444976076555024,0.9475448033616539,1.0,9/24,31.65%,ATM;TMEM109;HSF1;MDM2;DCUN1D3;KDM1A;ATR;XRCC5;MAP3K20
prerank,microtubule bundle formation (GO:0001578),0.26444965517777164,0.7186517487663484,0.878619153674833,0.9474322880843424,1.0,9/42,21.48%,FOXJ1;SPAG16;NAV1;KIF20A;DCX;NUMA1;CHP1;AAAS;MARK4
prerank,cellular response to glucose starvation (GO:0042149),0.2610560757547898,0.7184883347656732,0.8888888888888888,0.9472866773565692,1.0,14/41,35.32%,CPEB4;SIK1;MYBBP1A;PRKAG1;NIM1K;ATF4;HSPA5;SESN2;BECN1;ASNS;XBP1;ZC3H12A;BRSK2;IMPACT
prerank,alpha-amino acid metabolic process (GO:1901605),0.25885425614328145,0.7177833513842731,0.8882743362831859,0.9477218205909907,1.0,18/45,32.91%,ATP7A;GNMT;MMUT;PYCR3;GLS2;GLS;MTHFD1;MTRR;OAT;MTHFR;PYCR2;NOX4;SRR;DDAH1;ASNS;CBS;KYAT1;SLC25A13
prerank,signal peptide processing (GO:0006465),-0.2776373768719674,-0.7175700569859877,0.8388429752066116,0.986947557183363,1.0,3/11,10.24%,PCSK5;SEC11C;SPCS2
prerank,aminoglycan catabolic process (GO:0006026),0.27861988142198185,0.7168620975588729,0.8558030480656507,0.9483648878332238,1.0,8/28,24.77%,GNS;GLB1;FUCA1;GUSB;HSPG2;IDUA;SDC3;SDC4
prerank,positive regulation of response to wounding (GO:1903036),-0.216173194211568,-0.7166729672602491,0.9263803680981595,0.9860119220207341,1.0,9/24,20.81%,PRKCE;KANK1;PTK2;HBEGF;DMTN;HRAS;OCLN;MYLK;ADRA2A
prerank,response to cholesterol (GO:0070723),0.3086572997935765,0.7162489069164815,0.8539603960396039,0.9486816613541138,1.0,5/17,23.10%,LRP6;GRAMD1B;MLC1;TGFBR2;PMVK
prerank,protein hydroxylation (GO:0018126),0.30861995833335765,0.7162382851676282,0.8333333333333334,0.9483715706792407,1.0,4/15,16.42%,ASPH;P3H1;OGFOD1;VIPAS39
prerank,establishment of protein localization to extracellular region (GO:0035592),0.26449567290432463,0.7158811666280384,0.881489841986456,0.9484252720518518,1.0,17/39,32.43%,ABCA1;RAB8A;RAB8B;MON1A;RCN3;TMEM167A;LTBP2;ARFGAP3;RAB3D;CANX;GOLPH3;AFM;TANGO2;COPG1;COPG2;STEAP3;MIA3
prerank,cellular response to catecholamine stimulus (GO:0071870),0.2917210783476311,0.7155469450731986,0.8733252131546894,0.9484589364726292,1.0,2/23,3.93%,SLC9A1;NR4A3
prerank,atrioventricular valve development (GO:0003171),-0.24466764967620536,-0.714393111203385,0.8930232558139535,0.986649082355357,1.0,5/14,26.28%,ZFPM1;BMP2;HEYL;BMPR2;GJA5
prerank,establishment of mitotic spindle localization (GO:0040001),0.27963083628305174,0.713981912179443,0.8779342723004695,0.9497518434373776,1.0,8/28,28.06%,HTT;DCTN1;NUMA1;FBXW11;SPDL1;CENPA;ESPL1;ITGB1
prerank,glucan catabolic process (GO:0009251),0.31030295784826784,0.7139101585906884,0.8382541720154044,0.9495121096126332,1.0,6/15,25.69%,GAA;MGAM;PHKB;PYGM;PGM2;STBD1
prerank,isotype switching (GO:0045190),-0.27787644131762673,-0.7138863139393274,0.8402777777777778,0.9852344386189329,1.0,2/10,12.06%,RNF168;CCR6
prerank,ameboidal-type cell migration (GO:0001667),0.2542870312355692,0.7138250331490633,0.8875413450937155,0.9492849395442484,1.0,4/51,7.35%,CORO1C;PDLIM1;ITGA4;ANXA6
prerank,indolalkylamine catabolic process (GO:0046218),-0.2734113694183619,-0.7137116403853685,0.8526315789473684,0.983413640548873,1.0,2/10,15.22%,KMO;HAAO
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.2967870511775128,0.7135547350873278,0.8460591133004927,0.9492442279093534,1.0,7/20,30.67%,IPO5;CEBPA;TFAP4;LATS1;CDK5RAP1;PTEN;HEXIM1
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.303166822377554,0.7129532121186852,0.841025641025641,0.949566388271109,1.0,2/16,4.35%,PRDX6;NCL
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.32902165752526236,0.7128205182349467,0.8554216867469879,0.9493783178131462,1.0,5/12,26.14%,PTK2B;POU2AF1;IL6;DOCK11;GPR183
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.24446982808321915,0.7126453208513,0.9113924050632911,0.9492264967514734,1.0,11/79,14.12%,NIBAN2;FSTL3;FGF2;PPARG;CADM4;BAMBI;LEMD2;CHRD;SMAD7;SMAD1;SPRY4
prerank,Golgi to lysosome transport (GO:0090160),0.3358039621889625,0.7122292163610036,0.8360655737704918,0.9493433687656125,1.0,5/11,26.70%,GAK;CLN3;AP1G1;LAPTM5;LAMP1
prerank,cellular biogenic amine catabolic process (GO:0042402),-0.282612482124514,-0.7120746600336164,0.8178807947019867,0.9832744141012941,1.0,1/10,3.61%,HNMT
prerank,positive regulation of cilium assembly (GO:0045724),0.296712527439176,0.7120285363754683,0.86489898989899,0.9492356671126473,1.0,5/18,24.26%,KCTD17;HTT;MARK4;CEP120;CCDC88A
prerank,regulation of DNA damage checkpoint (GO:2000001),0.33288249005818127,0.7118363572090387,0.8315508021390374,0.9491063867084314,1.0,3/10,18.89%,THOC1;DDX39B;CCAR2
prerank,protein K48-linked ubiquitination (GO:0070936),-0.17506619636109613,-0.7110189150538306,0.9420289855072463,0.9824575030072017,1.0,12/54,16.56%,ITCH;KLHL3;DTX3L;UBE3A;UBE2G1;PRKN;UBE2E3;RNF152;UBE2Q2;RFFL;NEDD4L;UBE2T
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.287488847835168,0.7105019011344668,0.8527227722772277,0.9501373883759854,1.0,8/21,31.04%,CNOT4;CNOT10;CNOT6;SAMD4A;PAN2;CNOT6L;CNOT9;SAMD4B
prerank,negative regulation of lyase activity (GO:0051350),0.307165466196927,0.7101872254570379,0.8463508322663252,0.9501359949100064,1.0,3/16,16.98%,CCR2;PHPT1;MTRR
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.2735375007484122,-0.7099078624164009,0.8188976377952756,0.9816863458828529,1.0,1/10,0.62%,BIN1
prerank,myeloid cell development (GO:0061515),-0.23475738082969327,-0.709550078070405,0.8704663212435233,0.9800827084956859,1.0,5/18,13.05%,APP;DMTN;TLR2;ALAS2;SRC
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.3084750760321952,0.7092017403162986,0.8302631578947368,0.9508205680904306,1.0,6/16,28.79%,PRPF39;SART1;WBP11;RBM22;SRSF1;WBP4
prerank,positive regulation of cell aging (GO:0090343),0.3265239625756243,0.7089482711952289,0.824468085106383,0.9507578538416296,1.0,2/11,10.02%,LMNA;B2M
prerank,endothelial cell development (GO:0001885),0.279325148223436,0.7078999948814518,0.875453446191052,0.9514877309050793,1.0,9/25,34.46%,MSN;COL18A1;MYADM;MARVELD2;PECAM1;RAP1B;RDX;PPP1R16B;COL22A1
prerank,intraciliary transport involved in cilium assembly (GO:0035735),-0.19112929825686953,-0.707548768687471,0.9568965517241379,0.9804271243796572,1.0,9/37,17.44%,IFT81;KIF3C;IFT46;KIFAP3;IFT80;DYNC2LI1;CEP131;IFT27;TTC21B
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.2829258520613936,0.7074402070943073,0.8582089552238806,0.9516254770648713,1.0,1/21,0.26%,FGF13
prerank,positive regulation of dendrite development (GO:1900006),0.3378468181324044,0.7068042361011614,0.8372739916550765,0.9519427910909081,1.0,1/10,4.23%,ZDHHC15
prerank,regulation of chromosome segregation (GO:0051983),-0.24295170433301405,-0.7068013901574288,0.8778280542986425,0.9792963234004527,1.0,6/16,20.40%,BUB1;IHO1;AURKB;KIF2C;MKI67;HORMAD1
prerank,protein localization to centrosome (GO:0071539),0.29365491182185677,0.7052916407306316,0.8513853904282116,0.9531890823781695,1.0,4/17,17.48%,GOLGB1;SNX10;CSNK1D;HOOK3
prerank,V(D)J recombination (GO:0033151),0.32850093838504263,0.7051861737537076,0.8358620689655173,0.952974575516355,1.0,4/11,29.81%,LIG1;HMGB1;LIG3;HMGB2
prerank,regulation of ERAD pathway (GO:1904292),0.3328386969321776,0.7048074267826681,0.8366197183098592,0.9530523806496223,1.0,7/11,37.19%,ATXN3;RNFT1;USP19;USP13;HERPUD1;AQP11;RNF185
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.2479160923858068,0.7045335650311084,0.9213362068965517,0.9529948844168967,1.0,7/59,15.91%,LPL;ACACA;SLC27A5;OSBPL2;HSD17B8;CH25H;ABCD3
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.31908624576129246,0.7043367821310703,0.8509803921568627,0.9528905334433334,1.0,1/12,0.83%,CSF1
prerank,SNARE complex assembly (GO:0035493),-0.27314367848808485,-0.7041252080102541,0.8237547892720306,0.9801037745195966,1.0,5/10,22.11%,STXBP1;VAMP1;UVRAG;STXBP6;VAMP8
prerank,vascular process in circulatory system (GO:0003018),0.31922282258977996,0.7037708387337934,0.8390052356020943,0.9528328892082231,1.0,3/13,18.68%,SCPEP1;ROCK1;ITGB1BP1
prerank,regulation of tube diameter (GO:0035296),0.31922282258977996,0.7037708387337934,0.8390052356020943,0.9528328892082231,1.0,3/13,18.68%,SCPEP1;ROCK1;ITGB1BP1
prerank,membrane lipid catabolic process (GO:0046466),0.3327026271398897,0.7033454509039349,0.8456090651558074,0.9529598510390191,1.0,3/10,24.16%,FUCA1;CYP1B1;PDXDC1
prerank,positive regulation of mRNA processing (GO:0050685),0.28453682475208697,0.7025209139283927,0.8720787207872078,0.9534682076187154,1.0,10/21,33.47%,PRDX6;NCL;DHX36;PAF1;NUP98;SNW1;TRA2B;LEO1;CIRBP;DAZAP1
prerank,protein heterotetramerization (GO:0051290),0.31498018713379494,0.7020902900227157,0.8492597577388964,0.9535835945092845,1.0,4/13,21.01%,HSD17B8;FARSA;FARSB;CPSF7
prerank,negative regulation of ossification (GO:0030279),0.2806067557275732,0.701617278855648,0.8850710900473934,0.9537566341496129,1.0,4/23,12.14%,PTK2B;LRP4;SOX9;ECM1
prerank,respiratory chain complex IV assembly (GO:0008535),0.28787300189876913,0.7006631151198852,0.8633004926108374,0.9543509490563027,1.0,6/21,20.67%,PET100;SURF1;COX10;TIMM21;SMIM20;FASTKD3
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.28794809094683743,0.7005730795751733,0.8659286592865929,0.9541180683792448,1.0,5/20,18.99%,CHRNB2;GNAQ;LY6G6D;GNA11;GNB1
prerank,positive regulation of interleukin-10 production (GO:0032733),0.269792858660908,0.7001737277617879,0.8820160366552119,0.9541781407304214,1.0,6/30,19.98%,CD28;CD274;HSPD1;SYK;IL6;HMGB1
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.26596961802288366,0.7001647367020873,0.8861047835990888,0.9538666704423263,1.0,11/33,30.25%,PTGIR;PPARG;HMOX1;EFEMP2;VIP;PDCD4;SOD2;OGN;TNFAIP3;PRKG1;PTEN
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.240022832537992,0.6999483186099482,0.9290254237288136,0.953756273446194,1.0,18/72,22.64%,FGF13;APOE;PRKCD;TREM2;IAPP;MID1IP1;HSPA8;PFDN1;CLU;MYADM;HIP1R;ARFGEF1;PFDN2;ARHGEF2;EMILIN1;PLEKHH2;TAOK1;PFN1
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.2512836811745788,-0.699900279865536,0.8492063492063492,0.9827592255470854,1.0,2/13,8.79%,GRM3;ADGRV1
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.29667284822619744,0.6996637339038642,0.8738853503184714,0.9537114055562292,1.0,3/17,16.11%,CCNY;ADAM17;CCND2
prerank,oligodendrocyte differentiation (GO:0048709),0.28989354610518064,0.6993841451846478,0.8395378690629012,0.9536727020684919,1.0,6/19,25.80%,CDK5;SOX9;EIF2B2;EIF2B4;SOX10;MYRF
prerank,establishment of skin barrier (GO:0061436),0.30504241523211995,0.6992263105293475,0.8671775223499362,0.9531754494752257,1.0,2/15,11.37%,UGCG;HRNR
prerank,regulation of water loss via skin (GO:0033561),0.30504241523211995,0.6992263105293475,0.8671775223499362,0.9531754494752257,1.0,2/15,11.37%,UGCG;HRNR
prerank,DNA integrity checkpoint signaling (GO:0031570),0.25871476011408057,0.6990331745248255,0.8914285714285715,0.9530453811933963,1.0,12/36,32.37%,ERCC6;DOT1L;ATM;RAD1;USP28;SETMAR;INTS7;ATR;RAD9A;HINFP;MAP3K20;HUS1
prerank,peptidyl-threonine dephosphorylation (GO:0035970),-0.2141357241037649,-0.6985424815024746,0.88,0.9822409395259002,1.0,6/22,16.44%,PPM1E;PDP1;PPM1G;DUSP1;PPP1CA;DUSP7
prerank,ncRNA 3'-end processing (GO:0043628),0.3051665795352376,0.6983405431290248,0.8537234042553191,0.953426934979016,1.0,6/14,33.96%,INTS14;INTS2;INTS6;INTS7;TOE1;ERI1
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.2253461723897436,-0.6981284135813229,0.9009009009009009,0.9807337353549036,1.0,9/17,27.27%,NOS1AP;AKAP6;RNF207;ANK3;KCNG1;KCNE3;KCNRG;KCNE4;KCNS1
prerank,mesenchymal cell development (GO:0014031),0.2985726990694916,0.6980598762692164,0.8609022556390977,0.9533662763071346,1.0,3/18,16.51%,NRG1;NOLC1;TCOF1
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.3056807721943373,0.6980263011765262,0.8517555266579974,0.9530832226966961,1.0,3/14,18.37%,ITGA4;PDCD4;ANO6
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.31367140441318975,0.6972081576144964,0.8738255033557047,0.953573182238807,1.0,6/13,32.91%,CD2BP2;PRPF6;PRPF8;SRSF10;PRPF31;SART3
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.32873842135346265,0.6966086768516373,0.8556005398110661,0.9538265923130074,1.0,4/11,29.44%,DAB2;CSNK1D;SFRP1;CSNK1E
prerank,Notch signaling involved in heart development (GO:0061314),0.32550160256212246,0.6964562728294873,0.8561827956989247,0.9536707442690023,1.0,2/11,11.73%,JAG1;DLL4
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.26938451319841544,0.6949440421895592,0.8978622327790974,0.9547904294656834,1.0,9/28,24.14%,COTL1;RASA1;HAX1;GBA2;PLEKHG2;LATS1;WAS;PFN1;NAA80
prerank,positive regulation of vasoconstriction (GO:0045907),0.3047657914253145,0.6948220618537203,0.8459563543003851,0.9546004091356081,1.0,1/13,5.32%,CAV1
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.3290317286823907,0.6946162970373727,0.8444444444444444,0.9544760264696128,1.0,3/10,25.48%,VEGFA;BMP6;NOTCH4
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.27596469459390827,0.6939491538192367,0.8722157092614302,0.9547857195897188,1.0,7/25,21.40%,RPS7;RPL23;RPL11;EFNA1;PSME3IP1;CSNK2A2;HSP90AB1
prerank,exit from mitosis (GO:0010458),0.31621247054577367,0.6935563256263325,0.8565459610027855,0.9548421564636905,1.0,3/12,12.87%,CHMP4B;CHMP7;PPP2R2D
prerank,positive regulation of vacuole organization (GO:0044090),0.32512886733618174,0.6931225574931967,0.8482384823848238,0.9549127977849128,1.0,5/10,36.86%,RALB;RAB3GAP2;RAB3GAP1;GRN;LRSAM1
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.30948431487141015,0.6929997614063339,0.8430079155672823,0.9547179682509769,1.0,2/13,10.22%,NFU1;ISCA1
prerank,sensory perception of sound (GO:0007605),0.23386241943891717,0.6928557987711834,0.9456410256410256,0.9545327567575164,1.0,18/88,23.02%,CHRNB2;MYO1A;GRXCR1;RIPOR2;TPRN;TIMM9;CACNA1D;BIRC5;HOMER2;SLC26A4;WFS1;USP53;MKKS;MYO3B;ATP6V0A4;MARVELD2;NIPBL;CLIC5
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.3340764021689687,0.6927120357879417,0.8575342465753425,0.954339877066341,1.0,3/10,15.61%,CCNB1;CDC42;RACGAP1
prerank,acidic amino acid transport (GO:0015800),-0.2300756861413209,-0.6916355394046806,0.8957345971563981,0.985442502307582,1.0,4/17,10.17%,SLC1A3;SLC25A12;SLC6A1;PRAF2
prerank,histone H2A ubiquitination (GO:0033522),0.29602247255933367,0.691597844863158,0.8611111111111112,0.9550689172921819,1.0,4/17,18.54%,DDB2;DDB1;RNF2;UBR2
prerank,glutathione metabolic process (GO:0006749),0.25326483322032634,0.691149151905295,0.8883878241262683,0.9551630630728347,1.0,4/38,10.36%,GSTA2;CNDP2;GSR;NAT8
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.26066265999186095,0.6909922531399195,0.8936416184971099,0.9550029929400748,1.0,8/33,26.46%,ID2;FBXW7;INO80;APPL2;PAF1;FAM83D;TCIM;PTPN6
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.31418200505941163,0.6908757689758737,0.8626666666666667,0.9547885616654681,1.0,3/12,16.83%,CAV1;JUP;PKP2
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.2797796380215751,0.690730813570246,0.8814180929095354,0.9546101215034821,1.0,6/23,29.29%,ID2;SMAD7;PKP2;FGFR2;ADAMTS9;FKBP1A
prerank,positive regulation of cell cycle phase transition (GO:1901989),-0.24229956146188864,-0.6906360994702125,0.902542372881356,0.984534386457254,1.0,5/15,17.98%,PLCG2;ATAD5;STXBP4;EZH2;CRNN
prerank,negative regulation of TOR signaling (GO:0032007),0.25963881862137994,0.6897480112182707,0.9006849315068494,0.9552090522268388,1.0,10/36,29.44%,NPRL2;STK11;ATM;UBR2;NPRL3;SESN2;GSK3A;FNIP1;TMEM127;SIRT1
prerank,positive regulation of coagulation (GO:0050820),0.32838169155834623,0.6880417192624004,0.8612637362637363,0.9561290152837902,1.0,4/10,28.47%,SERPINE1;APOH;F2R;HPSE
prerank,positive regulation of hemostasis (GO:1900048),0.32838169155834623,0.6880417192624004,0.8612637362637363,0.9561290152837902,1.0,4/10,28.47%,SERPINE1;APOH;F2R;HPSE
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.2941248586796608,0.6877281968274963,0.8540332906530089,0.9561020154048723,1.0,2/16,6.13%,NPPA;KLK1
prerank,cardiac muscle cell action potential (GO:0086001),0.26578589642589884,0.6875211238395171,0.8908246225319396,0.9559737431006156,1.0,7/30,16.83%,KCNJ2;ATP1A1;SCN1B;CACNA1D;ATP1A2;SCN3B;PKP2
prerank,quinone biosynthetic process (GO:1901663),0.2997818642365385,0.6873085198179735,0.8595360824742269,0.955855681505032,1.0,3/14,16.88%,COQ10B;COQ5;COQ3
prerank,cellular response to organic substance (GO:0071310),0.22820062185977433,0.6869751613285588,0.9673135852911133,0.9558527551914772,1.0,31/116,27.24%,CTNNB1;IL18R1;LEF1;SPHK1;PTPN23;RACK1;PTPN2;PTPN12;CCL5;RHOA;TIPARP;PTPN13;GHR;CPNE3;CYP1B1;SIGIRR;HAX1;ARL6IP5;MAPK7;TGFBR2;STAT5B;PTPN9;SOCS2;MAP2K5;TNF;PTPN18;KHSRP;SFRP1;PTPN6;CXCR4;TBK1
prerank,amyloid-beta metabolic process (GO:0050435),0.29370430338191866,0.686930052695986,0.884318766066838,0.9555712219061054,1.0,3/16,13.05%,PSEN2;NAT8;ABCA7
prerank,protein K11-linked ubiquitination (GO:0070979),0.2663716807339471,0.6857907330599585,0.9028436018957346,0.9562771592896303,1.0,7/27,25.98%,UBE2H;UBE2L3;FZR1;ANAPC1;CDC26;ANAPC7;UBE2C
prerank,cell-cell junction organization (GO:0045216),0.2338611396711327,0.6849823270775856,0.9345114345114345,0.9566809466396355,1.0,10/79,10.08%,TLN1;NECTIN1;PKP4;PKP1;TJP2;CADM1;LIMS2;NECTIN3;CDH1;JUP
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.2993285843600621,0.6848243130870716,0.871927554980595,0.9565058994330743,1.0,3/15,13.52%,PPARG;PPARD;SLC45A3
prerank,heart trabecula morphogenesis (GO:0061384),0.28960031929702446,0.6847606467178949,0.862547288776797,0.9562548393462714,1.0,4/18,19.77%,NRG1;DLL4;RBP4;BMP5
prerank,neural crest cell development (GO:0014032),0.2533535574979811,0.6847074322088696,0.9114349775784754,0.9559884552083898,1.0,4/44,9.52%,CORO1C;NRG1;ANXA6;NOLC1
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.2390648958243785,0.6835523723928166,0.9289558665231432,0.9567116024694199,1.0,21/62,32.25%,POLR2H;CDK13;AFF4;GTF2F1;POLR2D;ELOF1;EAF1;ELOB;PAF1;GTF2H1;CCNT2;MLLT1;POLR2F;GTF2H5;SUPT4H1;CTR9;MNAT1;LEO1;TCEA1;ERCC2;NELFA
prerank,early endosome to Golgi transport (GO:0034498),0.3158380200658262,0.6831889120266964,0.8661311914323963,0.956727919118708,1.0,5/11,27.38%,SNX8;LMAN1;SNX1;SURF4;STX5
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.309159179630678,0.6828830953308742,0.8694516971279374,0.9566903997901058,1.0,4/13,17.49%,LPCAT3;CLU;WFS1;MBTPS2
prerank,mitochondrial protein processing (GO:0034982),0.3188145787364734,0.6828765845230012,0.86468200270636,0.9563815140617803,1.0,3/11,19.56%,PMPCA;AFG3L2;STOML2
prerank,positive regulation of neuron migration (GO:2001224),0.31817700636860813,0.682469534545454,0.850828729281768,0.9564228012431438,1.0,6/11,31.09%,PLAA;ARHGEF2;NSMF;NIPBL;MDK;SEMA3A
prerank,purine-containing compound catabolic process (GO:0072523),0.3123072151616211,0.6823259117883181,0.8632707774798928,0.9562462849574925,1.0,4/13,26.30%,XDH;ITPA;NUDT15;GPX1
prerank,regulation of protein export from nucleus (GO:0046825),0.2770431258869659,0.6816971015835354,0.8754623921085081,0.9565220920523708,1.0,8/23,24.06%,GAS6;SP100;TPR;BARD1;GSK3B;BAG3;RBM22;ANP32B
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.2601806275559071,0.6816875253654449,0.9059633027522935,0.9562146768936355,1.0,8/32,22.39%,DYRK2;AEN;HIPK1;MYBBP1A;STK11;TMEM109;USP28;CDIP1
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.22458715654565792,-0.6813526626993367,0.8762376237623762,0.9916694205522861,1.0,7/17,22.39%,RBPJ;WWC1;KAT2B;NOTCH3;STAT1;HEYL;MAML3
prerank,positive regulation of protein acetylation (GO:1901985),-0.25140701454276554,-0.6808190600261363,0.8388625592417062,0.9901897035423468,1.0,4/12,17.56%,DIP2B;CAMK1;KAT5;RAPGEF3
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.26509724402335644,0.6803473884027412,0.8979833926453143,0.9570748393396131,1.0,6/27,16.28%,FXYD5;RANGRF;SCN1B;UTRN;FXYD4;SCN3B
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.3249039758996154,0.6801606904991956,0.8561827956989247,0.9569342534132387,1.0,5/10,24.31%,DGKH;DGKD;F2R;HTR2B;PRKD3
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.22724573288569594,0.6798191672365927,0.9651639344262295,0.9569165607211445,1.0,31/104,30.14%,SLC27A1;LTF;GTPBP4;HTT;CCNB1;BCCIP;RHOA;BLM;ACTB;CAB39;LRP6;CCND2;CDKN3;RALB;GTF2H1;TESK1;CCNT2;SYAP1;SERTAD1;TRIB2;MAP2K2;CALM3;GADD45A;PARP16;PIH1D1;MNAT1;CNPPD1;SIRT1;CDC25A;SNF8;CCND1
prerank,monocarboxylic acid catabolic process (GO:0072329),0.2769751108953693,0.6797048796220557,0.893848009650181,0.9567073604448059,1.0,2/21,8.86%,CEL;PPARD
prerank,regulation of histone modification (GO:0031056),0.3085768996053431,0.6794471994099702,0.872,0.9566183352593961,1.0,5/13,37.15%,HPF1;MTHFR;PARG;AKAP8;FLCN
prerank,osteoclast differentiation (GO:0030316),0.2725084015386854,0.6793476950461967,0.8667496886674969,0.956385907611304,1.0,3/22,9.30%,CSF1;TREM2;SNX10
prerank,positive regulation of RNA splicing (GO:0033120),0.2575944337257935,0.678272776523632,0.8905882352941177,0.9570144511882023,1.0,4/29,9.07%,PRDX6;NCL;ERN1;HNRNPLL
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.27120065154187784,-0.6778670985061396,0.8489932885906041,0.9910021923331095,1.0,2/10,9.74%,CORO2B;NDFIP1
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.29804902041770887,0.6778667248609563,0.8938401048492791,0.9570583954922355,1.0,5/15,29.29%,FSTL3;SMAD7;FST;DACT1;FKBP1A
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.28797978208705943,0.6772610161975923,0.8878980891719745,0.9572724191383536,1.0,5/18,20.67%,PET100;SURF1;TIMM21;SMIM20;FASTKD3
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.28755751353019554,0.6768411532549727,0.8933823529411765,0.9573353304226668,1.0,8/18,34.71%,RNF125;C1QBP;PUM1;BIRC2;OASL;USP15;GPATCH3;PUM2
prerank,peptidyl-lysine acetylation (GO:0018394),-0.2672850836134534,-0.6765419323048252,0.8783269961977186,0.9903256081967441,1.0,4/10,21.56%,KAT2B;KAT5;BAG6;ESCO1
prerank,negative regulation of cyclase activity (GO:0031280),-0.23652322048187724,-0.675512327049534,0.8713692946058091,0.9893074335890989,1.0,2/14,8.79%,GRM3;ADGRV1
prerank,motor neuron axon guidance (GO:0008045),-0.22496579229400882,-0.6753379200380186,0.9126637554585153,0.9874808356664496,1.0,2/15,8.04%,EPHA4;TMEFF1
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.2884984207380918,0.6751888062157804,0.8907242693773825,0.9584958151702845,1.0,4/16,15.62%,RMI1;CENPX;ERCC4;SLX4
prerank,myelin maintenance (GO:0043217),0.3237134992385297,0.6742333610701815,0.848605577689243,0.9590182602171543,1.0,5/10,30.25%,ABCD2;CLU;MYRF;CXCR4;PTEN
prerank,glycogen catabolic process (GO:0005980),-0.23410775881713797,-0.6739630245602138,0.8868778280542986,0.9867509256219589,1.0,4/15,13.04%,PHKA2;PHKG1;RB1CC1;PGM2L1
prerank,negative regulation of protein depolymerization (GO:1901880),0.26271365552729353,0.6738130784402661,0.9,0.9590664905806885,1.0,1/24,0.26%,FGF13
prerank,negative regulation of bone mineralization (GO:0030502),0.29998665489309806,0.6731939195130839,0.8839050131926122,0.9592902015416575,1.0,4/13,27.30%,PTK2B;ECM1;SRGN;RFLNA
prerank,embryonic digit morphogenesis (GO:0042733),-0.22092720831129742,-0.6730365260931365,0.9045226130653267,0.9856139220670683,1.0,3/18,13.14%,SALL1;INTU;OSR1
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.22931056134622632,-0.6728442647670209,0.9069767441860465,0.9838640882303666,1.0,16/16,77.10%,SGO1;DSCC1;BOD1;CDCA5;HASPIN;RAD21;SMC1A;RAD21L1;REC8;POGZ;RB1;MAU2;NAA50;PDS5B;PDS5A;NIPBL
prerank,negative regulation of centrosome duplication (GO:0010826),0.31394433640219,0.6718240904978181,0.8878248974008208,0.9601063011269926,1.0,5/11,34.93%,BRCA1;MDM1;NPM1;TRIM37;CENATAC
prerank,regulation of steroid biosynthetic process (GO:0050810),0.3171923577095675,0.6717799011555341,0.87716955941255,0.9598280554899253,1.0,7/11,37.26%,ASAH1;BMP5;EGR1;SIRT1;DGKQ;NR5A1;FGFR4
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.22559656144952395,0.6716520464948574,0.9673802242609582,0.9596194602380934,1.0,32/125,26.78%,PTPA;DYNC1H1;EML4;PLK2;AHCTF1;CENPO;CCNB1;BCCIP;XPO1;CENPT;BIRC5;RANBP2;DYNC1LI2;RPS27;TACC3;RCC1;NEK6;KNL1;BUB1B;ERCC6L;TAOK1;SPDL1;DCTN6;EFHC1;NUP98;CENPK;CENPA;NUP133;MAP4;CENPS;ESPL1;MAPRE1
prerank,negative regulation of cartilage development (GO:0061037),0.299327938398964,0.6716471343381651,0.8835341365461847,0.9593078357426177,1.0,1/13,6.78%,SOX9
prerank,negative regulation of cell division (GO:0051782),-0.2548556211459285,-0.6696340746237756,0.8835341365461847,0.9847293199547129,1.0,4/11,17.33%,TXNIP;AURKB;CHMP4C;E2F7
prerank,negative regulation of nervous system development (GO:0051961),0.28231265861229604,0.6677977950056965,0.8915816326530612,0.9621931803837102,1.0,5/17,24.29%,B2M;APPL2;HOOK3;IL6;TNF
prerank,negative regulation of hormone secretion (GO:0046888),0.31306141034401963,0.6676404711741013,0.8790322580645161,0.9620143775488783,1.0,1/10,7.19%,RAB11FIP1
prerank,regulation of neuron projection arborization (GO:0150011),0.29460419464050935,0.6675189658499143,0.8678237650200267,0.9618043388455568,1.0,9/15,37.75%,MACF1;FZD4;MYO9A;DLG4;MFSD2A;NTNG2;DVL2;SPRY3;DVL3
prerank,regulation of insulin secretion (GO:0050796),0.22129978065573014,0.6674727155571335,0.9652351738241309,0.9615264172888931,1.0,16/101,19.92%,CACNA1A;GCK;FAM3D;TRH;SLC2A1;CCL5;CACNA1D;RBP4;SLC8B1;GIPR;AACS;GLP1R;SIRT4;IL6;ITPR3;CDK16
prerank,spindle assembly checkpoint signaling (GO:0071173),0.27811658564865543,0.6672601481032899,0.9035087719298246,0.9607553682115321,1.0,6/20,20.66%,TPR;TEX14;ATM;IK;BUB1B;TRIP13
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.27811658564865543,0.6672601481032899,0.9035087719298246,0.9607553682115321,1.0,6/20,20.66%,TPR;TEX14;ATM;IK;BUB1B;TRIP13
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.27811658564865543,0.6672601481032899,0.9035087719298246,0.9607553682115321,1.0,6/20,20.66%,TPR;TEX14;ATM;IK;BUB1B;TRIP13
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.23228953081038906,0.6669430335497917,0.9411134903640257,0.9607149142254421,1.0,21/64,32.25%,POLR2H;CDK13;AFF4;GTF2F1;POLR2D;ELOF1;EAF1;ELOB;PAF1;GTF2H1;CCNT2;MLLT1;POLR2F;GTF2H5;SUPT4H1;CTR9;MNAT1;LEO1;TCEA1;ERCC2;NELFA
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.26846815895671505,0.6659684926962951,0.8977832512315271,0.9612204235749761,1.0,4/21,16.40%,ARHGAP25;SPRY4;ARHGAP12;SYNGAP1
prerank,regulation of dopamine secretion (GO:0014059),0.25962002898725955,0.6657169921721376,0.9066666666666666,0.961112622579733,1.0,3/25,11.67%,CHRNB2;DTNBP1;FGF20
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.2668436093220534,0.6653140623049089,0.9010989010989011,0.9611399563816547,1.0,7/22,21.48%,NPPA;STAC2;SRI;CACNB3;CACNB1;AHNAK;CACNB4
prerank,regulation of vasoconstriction (GO:0019229),0.2582269105926547,0.664891410799528,0.9052132701421801,0.9611759189471493,1.0,3/27,11.99%,ATP2B1;CAV1;KCNMB4
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.2713888588284802,0.6647225073584185,0.9015795868772782,0.9610037420624465,1.0,7/22,30.67%,IPO5;CEBPA;TFAP4;LATS1;CDK5RAP1;PTEN;HEXIM1
prerank,pre-miRNA processing (GO:0031054),0.29144415558637393,0.6630801009352244,0.8894736842105263,0.962030446413666,1.0,3/14,19.31%,AGO2;ADAR;AGO3
prerank,dendritic spine organization (GO:0097061),0.2585675003962976,0.6629129325012505,0.8921800947867299,0.9618461425567458,1.0,6/26,17.16%,TREM2;IGF1R;DIP2A;FYN;CDC42;ITGA3
prerank,snRNA processing (GO:0016180),0.28463345759618136,0.6623257169070315,0.8865979381443299,0.9619944193788085,1.0,6/16,32.76%,INTS14;INTS2;INTS6;INTS7;TOE1;TUT1
prerank,autophagy of nucleus (GO:0044804),0.2870154874478912,0.6620855576081799,0.8894668400520156,0.9618587223788313,1.0,2/16,8.76%,ATG7;WDR45
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.2785597581782192,0.6615453631341809,0.8871989860583016,0.9619903028495588,1.0,5/17,27.63%,TAOK3;ARL6IP5;SCIMP;TAOK1;RNF13
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.29474970968399417,0.6610668071099509,0.905608755129959,0.9620736860407202,1.0,4/13,25.90%,NAMPT;KDR;JAK2;TLR9
prerank,ureteric bud morphogenesis (GO:0060675),0.28390970146968053,0.6609346276526169,0.899874843554443,0.9618710933155707,1.0,2/16,6.39%,FGF2;GATA3
prerank,regulation of Notch signaling pathway (GO:0008593),0.2250742469726843,0.6609102622718589,0.9544041450777202,0.9615757880081494,1.0,16/76,21.45%,ZMIZ1;NIBAN2;FBXW7;JAG1;METTL3;MAML2;DLL4;DLK2;TSPAN5;EGFL7;LLGL2;YTHDF2;ITGB1BP1;NEPRO;ENHO;PRAG1
prerank,regulation of macrophage cytokine production (GO:0010935),0.29888258483169444,0.6609001217420825,0.897503285151117,0.9612730509251084,1.0,8/13,36.93%,LILRB1;GPRC5B;LAPTM5;CD74;SIRT1;CUEDC2;TGFB1;TGFB2
prerank,regulation of microtubule depolymerization (GO:0031114),0.25614660405481077,0.6601006088188184,0.904126213592233,0.9615802349288192,1.0,1/25,0.26%,FGF13
prerank,positive regulation of interleukin-12 production (GO:0032735),0.2535764112874829,0.659531563476771,0.9224629418472063,0.9617076740004714,1.0,10/31,25.90%,LTB;IRF5;HSPD1;SYK;TIRAP;SCIMP;HMGB1;LAPTM5;MDK;TLR9
prerank,ventricular septum morphogenesis (GO:0060412),-0.19258310431573483,-0.6594313053559976,0.9647058823529412,0.9912261356890105,1.0,11/27,30.47%,ROBO1;ZFPM1;ROBO2;HEY1;SLIT2;HEYL;CITED2;BMPR2;ZFPM2;TGFBR1;SOX4
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.2817501458614678,0.6587464802516958,0.8997395833333334,0.9620333927747471,1.0,2/15,9.47%,CELF1;BRCA1
prerank,response to UV-A (GO:0070141),0.29307020566328873,0.6585626131334267,0.8911917098445595,0.9618739135907178,1.0,1/14,4.42%,MMP9
prerank,BMP signaling pathway (GO:0030509),0.22991395936277814,0.6568258149033389,0.9472551130247578,0.9628840835499178,1.0,11/62,23.57%,BMP8B;GDF6;USP9X;CHRD;SMAD7;SMAD1;BMP6;PDCD4;BMP5;BMP4;AMH
prerank,lung epithelium development (GO:0060428),0.3097230284809058,0.6563367984689285,0.8962131837307152,0.9629623008847761,1.0,3/10,21.85%,FOXJ1;RCN3;BMP4
prerank,zinc ion transport (GO:0006829),0.2694908894202828,0.6551570173312677,0.9098557692307693,0.963548793321884,1.0,5/21,22.42%,SLC39A6;SLC39A7;SLC30A9;SLC39A11;SLC39A1
prerank,regulation of cellular component size (GO:0032535),0.2490160641629393,0.6550549169305301,0.9220023282887078,0.9633186074676073,1.0,14/30,32.07%,MSN;ATP13A2;HP1BP3;RAB22A;PPP1R15A;LARS1;VAV3;VAV1;MTPN;PTEN;RIN3;RDX;RARG;PEX11G
prerank,histone H2B ubiquitination (GO:0033523),0.30651021871975276,0.65489440014799,0.8915343915343915,0.9631335205788346,1.0,4/10,29.68%,PAF1;RNF20;CTR9;LEO1
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.2554181029033333,0.6534999722847631,0.9036427732079906,0.9639017696384672,1.0,4/23,14.21%,TRIM6;SPHK1;CAB39;STOX1
prerank,embryonic organ morphogenesis (GO:0048562),0.23833466830888086,0.6532971404300872,0.9276974416017798,0.9637522857338189,1.0,10/42,27.42%,ID2;HOXA4;RBP4;HOXB4;HOXC9;NIPBL;DYNC2I1;FGFR2;PDGFRA;HES1
prerank,male gonad development (GO:0008584),0.2501997897383902,0.6532572567885326,0.919908466819222,0.9634704926472384,1.0,6/34,20.89%,GATA3;SOX9;KITLG;ING2;COL9A3;BIK
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.24050175014898312,0.6530476492109475,0.9295302013422819,0.9633034209794057,1.0,5/39,15.13%,GCK;TRH;CRH;RBP4;AACS
prerank,reticulophagy (GO:0061709),0.3023770627130651,0.6511986038721204,0.8911022576361222,0.9644217134935651,1.0,7/12,34.08%,UFM1;RETREG1;ATG2B;UFL1;UBA5;TEX264;ATG2A
prerank,dendrite self-avoidance (GO:0070593),0.27657439462318395,0.6510823756874826,0.907035175879397,0.9642046317187518,1.0,5/16,22.02%,NPTN;EMB;PALLD;DSCAM;IGSF9
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.2665018826272644,0.6498713340442799,0.9051186017478152,0.9647830767915971,1.0,4/20,17.49%,PSEN2;ADAM17;NFKB1;MBTPS2
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.2557059011115927,0.6497352547728225,0.9179734620024126,0.964574919279446,1.0,1/25,0.52%,HIF1A
prerank,triglyceride biosynthetic process (GO:0019432),0.2738735135562789,0.6493479001820014,0.9157372986369269,0.9645715462328629,1.0,3/18,11.69%,GK;LPGAT1;PCK2
prerank,camera-type eye development (GO:0043010),0.2578367690460699,0.6492045203512795,0.904993909866017,0.9643632623991765,1.0,6/25,25.14%,NES;VEGFA;CYP1B1;NF1;IFT122;RAB3GAP1
prerank,glycine transport (GO:0015816),0.31013513037046625,0.6489380562195495,0.9064245810055865,0.9642605006583812,1.0,2/10,16.59%,SLC36A3;SLC7A8
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.29657090698333266,0.6487703304514687,0.8994778067885117,0.9640761565613716,1.0,2/12,15.08%,ZBTB7B;SORBS1
prerank,extracellular transport (GO:0006858),-0.2352165725047081,-0.6482681151455945,0.9141630901287554,0.9980211659628038,1.0,12/12,76.50%,TSG101;SPAG17;DNAAF2;DNAAF4;ROPN1L;SPEF2;CABYR;ARRDC1;SPA17;WWP2;CCDC40;ADCY10
prerank,basement membrane organization (GO:0071711),-0.2294396958310344,-0.647320107062704,0.930327868852459,0.996737342342614,1.0,3/14,14.70%,CTSS;NTN4;HPN
prerank,bone morphogenesis (GO:0060349),0.2854815105692048,0.6471098307001123,0.8915032679738563,0.9649869226504258,1.0,4/14,23.93%,LTF;LRP6;FGFR3;FGFR2
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.26083197714773304,0.6457394717213233,0.8991282689912827,0.965663498626174,1.0,4/22,19.64%,RUNX1;BCL6;FANCA;IL2
prerank,cardiac myofibril assembly (GO:0055003),0.28284049221003876,0.6447218178847969,0.8990825688073395,0.9660988753963903,1.0,3/15,24.96%,CSRP3;NEBL;PDGFRA
prerank,ganglioside metabolic process (GO:0001573),0.25887847274661685,0.6428386434097861,0.9221260815822002,0.9671514645911881,1.0,4/20,14.06%,HEXA;ST8SIA6;NEU1;B4GALNT1
prerank,peripheral nervous system development (GO:0007422),0.258342860158865,0.6426694218899708,0.9130434782608695,0.9669602395881193,1.0,5/23,18.45%,ADGRB1;EGR2;NF1;PMP22;ALDH3A2
prerank,regulation of ion transport (GO:0043269),0.21838526683266327,0.6423689733967182,0.9572025052192067,0.9668568719599397,1.0,9/76,13.27%,P2RX4;CHRNB2;KCNJ2;SIK1;ATP1A1;DTNBP1;B2M;FGF20;KCNJ10
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.2805261368483249,0.6417225894993738,0.8915343915343915,0.9670025631270166,1.0,5/14,32.76%,ERN1;CPSF7;CSTF2;NUDT21;TUT1
prerank,regulation of cytoplasmic transport (GO:1903649),-0.23738153260675904,-0.6412398159410074,0.9191176470588235,0.999082223050681,1.0,2/11,13.05%,LRRK2;SRC
prerank,organic cation transport (GO:0015695),-0.204405880769649,-0.6411843401087794,0.9562841530054644,0.9971789222723454,1.0,7/20,28.10%,SLC22A5;SEC14L1;SLC25A29;PDZK1;SLC22A18;SLC5A7;SLC47A1
prerank,rRNA 3'-end processing (GO:0031125),0.3016566851672193,0.6410595049317631,0.896032831737346,0.9671688482511807,1.0,5/10,33.96%,EXOSC9;EXOSC10;ERI2;ERI3;ERI1
prerank,clathrin coat assembly (GO:0048268),-0.21535493986331772,-0.6406838900013914,0.9490740740740741,0.9955585167784871,1.0,6/15,23.33%,PICALM;SGIP1;FCHO2;CLTB;AP2S1;EPS15
prerank,positive regulation of wound healing (GO:0090303),0.23925023829711325,0.6406255725807489,0.926052332195677,0.9671771264472259,1.0,9/36,22.74%,ANXA1;PLPP3;ACTG1;SERPINE1;APOH;ARFGEF1;FERMT2;F2R;INSL3
prerank,cardiac atrium morphogenesis (GO:0003209),0.2752521801640372,0.640150500178764,0.9116094986807388,0.9671913063325019,1.0,2/16,11.73%,SHOX2;DLL4
prerank,regulation of RNA export from nucleus (GO:0046831),0.2973176901536431,0.6397213280511167,0.9108108108108108,0.967194651024616,1.0,3/11,19.19%,TPR;DHX9;NSUN2
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.26062403999941075,-0.6369761739646822,0.9354838709677419,0.9961423997494394,1.0,2/10,10.41%,SORL1;DNAJA4
prerank,protein monoubiquitination (GO:0006513),0.23780333415041105,0.6368068676467493,0.9351535836177475,0.9689105832733157,1.0,10/36,30.33%,OBI1;HUWE1;UBE2R2;PAF1;CUL3;RNF20;TRIM21;CTR9;LEO1;KBTBD8
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.27219730864472097,0.636695079406766,0.9062901155327343,0.9686701067776688,1.0,7/16,31.01%,KMT5B;KDM4D;PARP3;SETMAR;SMCHD1;PNKP;PARP9
prerank,motile cilium assembly (GO:0044458),-0.23277286245401788,-0.6346563762300773,0.9493670886075949,0.9957311525822357,1.0,5/12,29.40%,E2F4;RSPH9;DNAAF3;DNAAF1;BBOF1
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.2728396832918677,0.6339540088539912,0.9060913705583756,0.9702432012508305,1.0,4/17,25.24%,LPGAT1;PLA2G12A;SERAC1;PLA2G5
prerank,myofibril assembly (GO:0030239),0.2296656790885134,0.6335604616137043,0.9551569506726457,0.9701947754737621,1.0,2/42,4.82%,TNNT3;CSRP3
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.3042641224183308,0.6330234916419697,0.9241379310344827,0.9702714991122351,1.0,7/10,37.52%,TNFRSF1B;EMILIN1;DPP4;ADTRP;NOTCH1;TGFB1;TNFRSF1A
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.27235600487924944,0.6320761613019136,0.9164619164619164,0.9706117540815267,1.0,4/17,20.57%,PPARG;EFEMP2;PDCD4;SOD2
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.2987558953624819,0.6302050028024095,0.9067567567567567,0.971535736601561,1.0,4/10,32.35%,PRKCB;APPL2;GSK3A;PID1
prerank,inner ear morphogenesis (GO:0042472),0.2557514599601639,0.6287378321498144,0.9234507897934386,0.9721672459772541,1.0,2/22,6.78%,TBX18;SOX9
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.28923531624342247,0.6273452384884526,0.9163237311385459,0.9727761058864339,1.0,3/11,19.96%,CAV1;CAB39;ACTN2
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.2721703433471045,0.6272989170716639,0.9235668789808917,0.9724947837643179,1.0,8/16,32.51%,NAA16;NAA20;NAA80;NAA15;AANAT;EP300;CREBBP;NAA50
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.29122919199064196,0.6259038397949637,0.9320905459387483,0.973076995296774,1.0,3/12,18.23%,GMNN;BLM;KAT7
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),-0.23653712910197253,-0.6252396862830849,0.9149797570850202,1.0,1.0,4/12,18.76%,RAD17;CLSPN;ORC1;STK33
prerank,negative regulation of heart contraction (GO:0045822),0.29318570682307804,0.6245736154196166,0.9055330634278003,0.9736460879795643,1.0,5/11,35.68%,SRI;ATP1A2;FKBP1B;ZC3H12A;SPTBN4
prerank,negative regulation of vascular permeability (GO:0043116),0.28421674989421436,0.6242261243433598,0.9195250659630607,0.9735388854559006,1.0,2/12,7.25%,VEGFA;ANGPT1
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.2115508802002916,0.6232479333409954,0.9779874213836478,0.9738465201114441,1.0,16/87,22.82%,NDUFS7;SLC25A33;NDUFA1;SAMM50;PET100;NDUFAF1;SURF1;NDUFAF8;NDUFA9;TIMM21;NDUFA2;SMIM20;FASTKD3;TTC19;NDUFAF4;NDUFAF2
prerank,cellular response to BMP stimulus (GO:0071773),0.21599847527529722,0.6221765917828421,0.9680851063829787,0.9742058685525008,1.0,12/66,25.22%,BMP8B;GDF6;SOX9;USP9X;SMAD7;SMAD1;BMP6;PDCD4;BMP5;BMP4;AMH;SFRP1
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.26341085264549735,0.6218525892380927,0.9147286821705426,0.9740874927729863,1.0,3/16,14.06%,LARGE1;ST8SIA6;B4GALNT1
prerank,negative regulation of cell communication (GO:0010648),0.2572754093021599,0.6206784585464009,0.9423312883435583,0.9745006954386263,1.0,2/21,10.69%,BRAP;SOCS5
prerank,negative regulation of ATP metabolic process (GO:1903579),0.26437275103112967,0.6196732804910847,0.9222082810539524,0.9748340477087537,1.0,2/17,14.17%,HDAC4;GIT1
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.27430128551156907,0.6189659123707153,0.9384010484927916,0.9749555693862842,1.0,3/14,15.85%,SRSF7;PCBP4;C1QBP
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.1896404471121939,-0.6171140285610764,0.9712643678160919,1.0,1.0,4/23,15.55%,NREP;SMURF2;LATS2;ENG
prerank,UV protection (GO:0009650),-0.228995374958787,-0.6169608132208153,0.9548611111111112,1.0,1.0,5/10,23.01%,SDF4;FEN1;SCARA3;ERCC5;MFAP4
prerank,protein palmitoylation (GO:0018345),0.23765058308443426,0.615312781116175,0.9380841121495327,0.9768913180431824,1.0,2/30,5.02%,ZDHHC15;ZDHHC18
prerank,peptidyl-proline modification (GO:0018208),0.23992854023957277,0.6148894928651163,0.9511059371362048,0.9768237578445593,1.0,12/25,29.29%,OGFOD1;NKTR;PPIA;PPIE;PIN1;PPIG;PPIL6;NTMT1;PPIH;FKBP1B;PPIL3;FKBP1A
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.23718942629588002,0.6116834056221097,0.9607843137254902,0.9783999930438974,1.0,6/30,22.71%,AKAP13;GPR174;LPAR1;PRAG1;GPR65;F2R
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.22592728913537985,0.6113907179088147,0.9584736251402918,0.9782593737887854,1.0,12/40,27.61%,THOC1;POLE;ZRANB3;BOD1L1;BLM;CENPX;ATRX;RTEL1;SETMAR;GEN1;CENPS;ATR
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.23769771528998243,-0.6108932742727162,0.9368029739776952,1.0,1.0,10/10,76.25%,GNB5;CRHR1;CBARP;DRD2;DRD4;GPR35;FMR1;CALM1;DRD3;CALM3
prerank,negative regulation of transposition (GO:0010529),0.2653895549278057,0.6105990219129755,0.9481865284974094,0.9784294145836968,1.0,3/16,24.28%,PIWIL2;UBR2;SMYD5
prerank,"base-excision repair, AP site formation (GO:0006285)",-0.20571782118518078,-0.6100093816439975,0.9569377990430622,1.0,1.0,8/17,21.57%,TDG;NEIL1;NEIL3;UNG;NTHL1;MUTYH;ERCC5;OGG1
prerank,purine-containing compound salvage (GO:0043101),0.278774519740618,0.609713514684001,0.9273670557717251,0.9786247311035686,1.0,2/12,14.61%,AMPD2;APRT
prerank,negative regulation of viral transcription (GO:0032897),-0.22142005147843558,-0.6081969790622439,0.9730941704035875,1.0,1.0,13/13,77.88%,TRIM27;LARP7;TRIM62;TRIM13;TRIM32;TRIM14;MID2;ZFP36;IFITM3;TRIM11;HEXIM1;UBP1;TRIM21
prerank,embryonic heart tube development (GO:0035050),-0.21289552988448018,-0.6080647894031103,0.9539170506912442,0.9984704791528227,1.0,14/14,78.74%,NDRG4;TBX2;CITED2;PITX2;SOX17;RYR2;APELA;FGF8;SOX18;TBX20;ACVR1;MEGF8;HES1;IFT122
prerank,ovarian follicle development (GO:0001541),0.27299872951011095,0.6073171363800373,0.9150326797385621,0.9797025626550725,1.0,3/13,24.02%,VEGFA;EIF2B2;EIF2B4
prerank,steroid hormone biosynthetic process (GO:0120178),0.23490892919573217,0.6056681355996358,0.9495798319327731,0.9803204763028638,1.0,3/29,12.85%,CYP19A1;SRD5A3;HSD17B8
prerank,histone monoubiquitination (GO:0010390),0.2442033296555045,0.6045600102467898,0.9455205811138014,0.9806070135860416,1.0,9/24,33.35%,DDB2;DDB1;RNF2;PAF1;RNF20;CTR9;LEO1;TRIM37;UHRF1
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.22277309537218148,-0.6027445345074649,0.9585062240663901,0.9992350430439265,1.0,3/12,10.74%,PTPN14;UHMK1;RBM4
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),-0.18916208465766807,-0.602656319181642,0.9842931937172775,0.9973903359804075,1.0,5/20,21.74%,RBPJ;BMP2;ENG;HEY1;HEYL
prerank,neuromuscular process (GO:0050905),0.2570058239356194,0.6011098268049847,0.9303225806451613,0.9821690937390514,1.0,4/16,21.79%,DCTN1;CLN3;AGTPBP1;TPP1
prerank,regulation of interleukin-12 production (GO:0032655),0.2165639395556434,0.6001932088244274,0.9783549783549783,0.9823278138166119,1.0,16/47,30.83%,LTB;LILRB1;IRF5;HSPD1;C1QBP;SYK;TIRAP;SCIMP;HMGB1;LAPTM5;CD47;MDK;TLR9;PIBF1;AGER;JAK3
prerank,aerobic electron transport chain (GO:0019646),0.20647126941643673,0.6001282983978132,0.9874081846799581,0.9820560483568365,1.0,15/68,24.68%,NDUFS7;NDUFA1;COX6A2;COX5B;AFG1L;NDUFAF1;NDUFA9;COX10;UQCRH;NDUFA2;COX7A2L;SDHC;UQCR10;UQCRB;UQCR11
prerank,regulation of stem cell population maintenance (GO:2000036),-0.19601425730076827,-0.599234828959367,0.9701492537313433,0.9972503251697753,1.0,7/18,31.06%,REST;CNOT2;HMGA2;ESRRB;KAT2A;NCOA3;PTN
prerank,response to progesterone (GO:0032570),0.24999989067050954,0.5990330912865753,0.944233206590621,0.9823254309864378,1.0,3/18,17.93%,CAV1;ACOD1;WBP2
prerank,chondrocyte differentiation (GO:0002062),0.22457070085155223,0.5971366814116134,0.96,0.982998133637508,1.0,4/32,10.63%,SNX19;RUNX1;SOX9;CREB3L2
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.19358572813737504,-0.5970926576850266,0.965,0.9963971091312158,1.0,13/19,36.85%,NFATC2;NFATC1;PPP3CB;PLCE1;ADGRB2;GPR62;EDN3;NFATC4;NMUR1;EDN2;EDN1;NFAT5;NMUR2
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.2610036546407727,0.5965631830998609,0.9373333333333334,0.982978232423963,1.0,1/14,6.78%,SOX9
prerank,mesoderm formation (GO:0001707),0.2527673642337792,0.5963376581661477,0.9492574257425742,0.9827792726550821,1.0,4/17,28.06%,EOMES;ITGA3;ITGA2;ITGB1
prerank,heterocycle biosynthetic process (GO:0018130),0.258368384968698,0.5928938223207314,0.949468085106383,0.9842612922045529,1.0,7/14,33.66%,MOCOS;PYCR3;PYCR2;MOCS3;MOCS2;MOCS1;GPHN
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.2101826856676502,-0.591900693942824,0.9718875502008032,0.9968505979727607,1.0,13/13,79.01%,CPSF6;CPSF4L;CSTF2T;NCBP1;CPSF4;CPSF1;FIP1L1;NCBP2;CPSF2;TUT1;NUDT21;CSTF2;CPSF7
prerank,C4-dicarboxylate transport (GO:0015740),-0.20751105073058201,-0.5917901311374208,0.9623430962343096,0.9950311327286366,1.0,2/14,6.57%,SLC25A12;SLC25A11
prerank,amino sugar metabolic process (GO:0006040),0.28473834314294755,0.5904430215484983,0.9355281207133059,0.9851698346889731,1.0,2/10,16.48%,EXTL2;ST6GAL1
prerank,dephosphorylation (GO:0016311),0.194742060656268,0.5895842650790011,0.9908722109533469,0.9852934897543681,1.0,27/147,21.24%,PTPRA;PTPRC;PLPP6;DUSP9;PPM1J;PPP2R5C;PPP2R1A;PPM1H;PTPN22;CTDNEP1;PLPP3;PPP1R12A;TAB1;DUSP6;PTPN12;PHPT1;PTPN13;ACP3;DUSP3;DUSP11;PPP6C;STK11;PPP3CC;PTPN21;FBXW11;DUSP12;DUSP15
prerank,detection of calcium ion (GO:0005513),-0.20948672675873128,-0.5875444908317754,0.9710743801652892,0.9950923410543984,1.0,6/13,28.32%,SYT1;KCNMB2;KCNIP2;KCNMB3;CASQ2;KCNMB1
prerank,regulation of fatty acid beta-oxidation (GO:0031998),-0.2088592363623143,-0.5874096051418479,0.966804979253112,0.9932915145341451,1.0,5/14,25.72%,IRS2;MTLN;PPARA;TYSND1;ABCD1
prerank,cardiac ventricle development (GO:0003231),0.2415331631213954,0.5867053186603651,0.9479695431472082,0.986396816587638,1.0,4/20,19.16%,GATA3;DLL4;DAND5;HECTD1
prerank,iron ion transmembrane transport (GO:0034755),-0.2264569938145255,-0.585582473109905,0.9507042253521126,0.9921519237176685,1.0,1/10,4.25%,SLC40A1
prerank,axoneme assembly (GO:0035082),0.22555867935907387,0.5843409353456952,0.9703087885985748,0.9871927191481698,1.0,8/30,27.39%,FOXJ1;SPAG16;DNAJB13;DCX;TTC12;CCDC65;CCDC40;CCDC39
prerank,heterochromatin assembly (GO:0031507),0.24105240141846468,0.5840561965038695,0.9547123623011016,0.9870148163085078,1.0,6/20,32.42%,HDAC1;SMCHD1;H3-3A;SIRT1;SIRT2;BAHD1
prerank,cellular response to mechanical stimulus (GO:0071260),0.2129805577845301,0.5837886620847842,0.9791208791208791,0.9868321713276984,1.0,13/46,29.34%,SLC9A1;PIEZO1;SOX9;PIEZO2;MAP3K1;NFKB1;CRADD;PTGER4;BNIP3;GADD45A;CASP8AP2;MAPK3;TNFRSF8
prerank,NAD biosynthetic process (GO:0009435),0.2389550898754203,0.5836484436529827,0.9533169533169533,0.9865858972132977,1.0,8/20,34.58%,NAMPT;PTGIS;NMNAT3;KYNU;PARP16;PARP9;NAXD;NADSYN1
prerank,regulation of protein acetylation (GO:1901983),0.26657859224104025,0.5819351938913022,0.9502617801047121,0.9870692200921685,1.0,5/12,29.44%,GSK3B;TAOK1;CEP295;TERF2IP;SIRT1
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.22443241138450715,0.5801792211083785,0.9670975323149236,0.9875490022596249,1.0,4/31,16.83%,NRG1;DLL4;SMAD7;PKP2
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.19948344548869662,0.5800336728615306,0.9947423764458465,0.9872985325962018,1.0,15/69,24.68%,NDUFS7;NDUFA1;COX6A2;COX5B;AFG1L;NDUFAF1;NDUFA9;COX10;UQCRH;NDUFA2;COX7A2L;SDHC;UQCR10;UQCRB;UQCR11
prerank,bile acid metabolic process (GO:0008206),0.22800887796181946,0.5789753545225469,0.9692671394799054,0.9874634940469571,1.0,10/27,29.93%,SLC27A5;OSBPL2;NPC1;CH25H;GBA2;OSBP;ABCB11;ACOT8;OSBPL1A;SCP2
prerank,phasic smooth muscle contraction (GO:0014821),-0.2276550338940497,-0.5767675204516648,0.9481481481481482,0.9938157722104818,1.0,10/10,77.26%,TIFAB;EDNRB;EDN3;EDN2;EDN1;DRD2;GDNF;HTR1D;PTGER3;HTR2B
prerank,positive regulation of lyase activity (GO:0051349),0.2547897636451827,0.576274023826133,0.9457755359394704,0.9883378047496861,1.0,4/14,29.77%,CACNA1D;NF1;ORAI1;STIM1
prerank,negative regulation of secretion (GO:0051048),0.2723643253189711,0.5750345704288764,0.9560439560439561,0.988567893638123,1.0,4/10,27.82%,NRG1;CD74;PTGER3;VAMP3
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.2631022643611007,0.574786685246081,0.9614873837981408,0.9883542248017182,1.0,1/12,8.20%,CNDP2
prerank,negative chemotaxis (GO:0050919),0.21700603417397474,0.5743155353069315,0.966743119266055,0.9882339688376802,1.0,2/33,3.61%,PDGFA;LRTM1
prerank,regulation of isotype switching (GO:0045191),0.25357037414133116,0.5740253652576631,0.9493506493506494,0.9880405459455992,1.0,3/14,17.95%,KMT5B;TFRC;PARP3
prerank,alpha-amino acid catabolic process (GO:1901606),0.22225556939129457,0.573910560127892,0.973715651135006,0.9877801541946255,1.0,10/29,36.70%,BLMH;ACAT1;MTRR;IDO2;KYNU;CBS;KYAT1;HOGA1;SARDH;ACADSB
prerank,negative regulation of B cell proliferation (GO:0030889),0.2689525254169129,0.5715283140527234,0.953519256308101,0.9884772892518822,1.0,3/11,27.10%,CD300A;ATM;RC3H1
prerank,cytosolic calcium ion transport (GO:0060401),0.2208997115121614,0.5714729231841887,0.9672897196261683,0.9881843666968207,1.0,6/28,22.34%,ATP2B1;AFG3L2;JPH1;CACNB3;ITPR3;ATP2A2
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.21507620221102583,0.5695293583708668,0.9780346820809248,0.9886482691539177,1.0,12/31,33.66%,CYP19A1;MOCOS;PYCR3;DHRS11;PYCR2;MOCS3;SCP2;SRD5A1;MOCS2;MOCS1;SRD5A2;GPHN
prerank,glutathione biosynthetic process (GO:0006750),0.26310741447429087,0.5686668154656743,0.9587765957446809,0.9886818123643224,1.0,1/11,8.20%,CNDP2
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.2638252463749923,0.5677526827270513,0.9559834938101788,0.9887211311634856,1.0,11/11,73.64%,RTP4;PKD2L1;PKD1L3;RTP3;PIGR;TAS1R2;GNAT2;GNAT3;TAS1R3;RTP2;LPO
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.21180128600401163,0.5665531813644826,0.9750849377123443,0.9888853389529928,1.0,5/38,19.50%,NDUFS7;NDUFA1;NDUFAF1;NDUFA9;NDUFA2
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.27171907178071153,0.5657917066831918,0.9436038514442916,0.9888708210978884,1.0,7/10,38.47%,MAP2K2;RNF13;MAPK3;MAPK1;MAP2K1;GREM1;GSTP1
prerank,B cell mediated immunity (GO:0019724),-0.22127297878040592,-0.5645978158840793,0.9423728813559322,0.9961609056707641,1.0,2/10,14.03%,FCGR2B;TLR8
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.22281602965915706,0.5642608026814588,0.9726516052318668,0.9891642170974503,1.0,7/27,28.97%,C3AR1;GPR174;LPAR1;GPR65;F2R;OPRL1;DRD3
prerank,positive regulation of heart rate (GO:0010460),0.23991441197656,0.5612728327329997,0.9694267515923567,0.9899919898700923,1.0,3/17,22.34%,NPPA;SCN3B;ATP2A2
prerank,homologous chromosome pairing at meiosis (GO:0007129),-0.16110123646085622,-0.5611253232035361,1.0,0.9953814684449958,1.0,11/29,28.35%,ZCWPW1;IHO1;MAJIN;HORMAD1;BAG6;TEX12;KASH5;RAD21;TERB1;MEIOB;SIRT7
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.21954724737417652,0.5606993136283042,0.9703087885985748,0.9898957876525478,1.0,3/26,8.64%,TREM2;OTUD4;FLOT2
prerank,eye morphogenesis (GO:0048592),0.22889458270007831,0.5599004698215297,0.9673366834170855,0.9898710046944807,1.0,5/19,22.91%,VEGFA;NF1;AGTPBP1;IFT122;NIPBL
prerank,synaptonemal complex assembly (GO:0007130),0.23904706709968,0.5577843490159431,0.9487516425755584,0.9900078002477268,1.0,4/15,29.92%,TRIP13;SYCE2;TEX11;SYCP2
prerank,synaptonemal complex organization (GO:0070193),0.23904706709968,0.5577843490159431,0.9487516425755584,0.9900078002477268,1.0,4/15,29.92%,TRIP13;SYCE2;TEX11;SYCP2
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.20312347601914696,0.5574750470484704,0.9831838565022422,0.989811521618492,1.0,4/41,8.47%,MGLL;ACSL1;FADS1;SCD5
prerank,zinc ion transmembrane transport (GO:0071577),-0.16948044684243793,-0.557299498658838,0.9939024390243902,0.994613348701805,1.0,6/22,19.24%,SLC30A1;SLC30A4;SLC39A10;SLC39A12;SLC30A3;TRPM2
prerank,2-oxoglutarate metabolic process (GO:0006103),0.24855847433859296,0.5563177620475228,0.9629139072847682,0.9899097507615218,1.0,5/13,38.30%,DLST;IDH2;IDH1;L2HGDH;PHYH
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.22164570338738618,0.55586319317955,0.9679715302491103,0.9897659380619643,1.0,2/24,7.03%,NRP1;VEGFA
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.23848096565054142,0.5548413929095217,0.9666666666666667,0.9898192038661368,1.0,5/16,25.39%,RHOA;ITGB2;IL6;TNF;MDK
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.2594497229455148,0.5543715687120487,0.9515235457063712,0.9896825662507253,1.0,2/11,15.12%,VCP;DERL1
prerank,tRNA 5'-leader removal (GO:0001682),0.24639607825926463,0.5528074983266329,0.9630606860158312,0.9899028704613597,1.0,4/13,29.33%,PRORP;RPP25L;RPP38;POP1
prerank,protein localization to mitochondrion (GO:0070585),0.2561716354004785,0.5524425447207693,0.9511533242876526,0.9897073160710327,1.0,3/11,23.70%,HK1;MTCH2;DNAJA1
prerank,mesenchyme morphogenesis (GO:0072132),0.23735894970133647,0.5507556915269476,0.9704069050554871,0.9899710514279124,1.0,1/17,6.78%,SOX9
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.2350784036820459,0.5467071989669348,0.963963963963964,0.9909671985778815,1.0,5/17,22.06%,COX6A2;COX5B;AFG1L;COX10;COX7A2L
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.15642747743388463,-0.5453856713185664,0.9929577464788732,0.9960401999869923,1.0,12/29,33.99%,ZFPM1;BMP2;ENG;MYL2;MYBPC3;ISL1;TPM1;TNNC1;TNNT2;MYH6;MYL3;MYH7
prerank,purine ribonucleotide catabolic process (GO:0009154),0.22447477273987682,0.5444326016237306,0.9758454106280193,0.9913840783568073,1.0,1/21,2.50%,XDH
prerank,kinetochore organization (GO:0051383),0.24425556930459955,0.5398205029251673,0.9636363636363636,0.9924511822514184,1.0,5/13,33.44%,CENPT;CENPA;CENPH;CENPC;CENPW
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.2580732074468265,0.5353853934967272,0.963855421686747,0.9934129687074746,1.0,1/10,9.10%,DIP2A
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.1726953026877669,-0.5339339022242943,0.9887640449438202,0.9968916905418078,1.0,18/18,82.76%,ODAD4;CFAP53;SPAG17;DNAAF2;DNAAF1;OFD1;NPHP3;DNAAF4;ROPN1L;SPEF2;CABYR;RFX3;SPA17;NEK10;CCDC39;CCDC40;ADCY10;AQP4
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.20533666142624074,0.5331107666362329,0.9842615012106537,0.9937362303010058,1.0,6/27,21.48%,SELENON;JPH1;CACNB3;CACNB1;AHNAK;CACNB4
prerank,synaptic vesicle membrane organization (GO:0048499),0.22626686014843583,0.5326435651600377,0.9705128205128205,0.9935536541315276,1.0,5/17,26.71%,SYNGR1;STX3;AP3D1;SYNGR2;STX4
prerank,Golgi inheritance (GO:0048313),0.24819341384788063,0.5324110400634646,0.9731543624161074,0.9933088473780187,1.0,4/11,27.38%,PLK3;YWHAZ;GOLGA2;STX5
prerank,regulation of viral release from host cell (GO:1902186),0.2164887709791877,0.5297645553359568,0.9829268292682927,0.9936995964453891,1.0,2/21,9.85%,TRIM28;DDB1
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.22713663730756362,0.5288585313867282,0.9731113956466069,0.9936156153309885,1.0,2/17,11.73%,JAG1;DLL4
prerank,energy reserve metabolic process (GO:0006112),0.21790116063150203,0.5281993050653869,0.9763092269326683,0.9934773857962513,1.0,8/19,39.27%,PHKB;GSK3B;PYGM;GBE1;PID1;MYC;UGP2;PHKG2
prerank,proteasome assembly (GO:0043248),0.24926220782158473,0.5276794596215264,0.9648648648648649,0.9932923031909987,1.0,3/11,29.76%,PSMD5;PSMD10;POMP
prerank,bicarbonate transport (GO:0015701),0.20987619834298088,0.527350572214873,0.9846878680800942,0.9930664767198492,1.0,5/25,21.90%,CYB5R4;CYB5R1;SLC4A9;SLC4A2;SLC26A6
prerank,T cell homeostasis (GO:0043029),-0.2086067905691012,-0.5268267262044921,0.9812734082397003,0.9964882040789759,1.0,5/10,28.82%,FAS;PMAIP1;FOXP3;FADD;ZC3H8
prerank,endocardial cushion morphogenesis (GO:0003203),0.22184484698922075,0.5237823467390331,0.9878640776699029,0.9936564573247139,1.0,3/18,23.00%,SOX9;BMP4;TGFBR2
prerank,neuronal action potential (GO:0019228),0.21514099146710502,0.5233058692544458,0.9851668726823238,0.9934523514893142,1.0,2/22,11.99%,SCN4A;KCNMB4
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.18390272680235542,0.5179801016397386,0.9956521739130435,0.9941084196923365,1.0,9/56,22.82%,NDUFS7;NDUFA1;NDUFAF1;NDUFAF8;NDUFA9;TIMM21;NDUFA2;NDUFAF4;NDUFAF2
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.18390272680235542,0.5179801016397386,0.9956521739130435,0.9941084196923365,1.0,9/56,22.82%,NDUFS7;NDUFA1;NDUFAF1;NDUFAF8;NDUFA9;TIMM21;NDUFA2;NDUFAF4;NDUFAF2
prerank,response to ketone (GO:1901654),-0.15978855922780832,-0.5150322266299077,0.9945054945054945,0.9967978282622421,1.0,11/24,33.41%,UBE3A;THBS1;NR1H3;SLIT2;CATSPERB;CATSPER3;HSD3B2;CCL19;ABCB4;CCR7;CATSPER4
prerank,regulation of endocytic recycling (GO:2001135),-0.199673592367083,-0.5091465945456092,0.9889705882352942,0.9958907861636734,1.0,11/11,80.05%,SORL1;PLA2G4E;PLA2G3;EHD2;INPP5F;EIPR1;ATP9A;RAB11B;ARHGAP1;EHD1;ACTN2
prerank,regulation of chromosome organization (GO:0033044),0.20667167844647344,0.5079046595603967,0.9903730445246691,0.995917071059766,1.0,8/22,36.58%,WAPL;SETMAR;TERF2IP;SMG1;XRCC5;TERF2;MYC;CENPV
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.2369593873579814,0.5033771992917918,0.9816901408450704,0.9964921733727794,1.0,11/11,76.32%,SLC19A2;NT5C3A;SLC25A19;DCK;ERH;DCTD;CTPS2;THTPA;SLC19A3;TPK1;ENPP3
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.20105762093951507,0.49844098641551177,0.9837702871410736,0.9970987678159878,1.0,6/21,31.26%,SRI;ATP1A2;CALM3;FKBP1B;GSTO1;CALM1
prerank,cardiac ventricle morphogenesis (GO:0003208),0.18198446515421082,0.49675928293772603,0.9966178128523112,0.997084701783037,1.0,8/41,23.93%,JAG1;GATA3;DLL4;SMAD7;PKP2;BMP4;TGFBR2;FGFR2
prerank,nitric oxide metabolic process (GO:0046209),0.21576122715349522,0.48669460600383685,0.9856209150326798,0.9983566570518697,1.0,3/14,27.93%,CYP1B1;CYB5R3;NQO1
prerank,nitric oxide biosynthetic process (GO:0006809),0.21577876637252902,0.4859911422265061,0.9856020942408377,0.9981592299595082,1.0,3/13,27.93%,CYP1B1;CYB5R3;NQO1
prerank,calcium import into the mitochondrion (GO:0036444),0.2287919043886129,0.481623132075686,0.9917355371900827,0.9984877802994238,1.0,4/10,35.25%,AFG3L2;SLC25A23;SMDT1;MCU
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.21718047110981453,0.47157981136964966,0.9850136239782016,0.9994664797779105,1.0,2/11,18.62%,PUM1;DHX9
prerank,epithelial cell-cell adhesion (GO:0090136),0.21980733773582473,0.46887583487699963,0.9892328398384926,0.9994529681751805,1.0,3/11,31.22%,JUP;SERPINB8;VCL
prerank,xenobiotic transport (GO:0042908),0.19523467280417206,0.4620356718559454,0.9887920298879203,0.9998491390775847,1.0,1/17,6.72%,SLC22A3
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.1975234025834075,0.4615387046041271,0.9920948616600791,0.9995851499929234,1.0,6/16,35.95%,ATP1A2;CALM3;FKBP1B;GSTO1;CALM1;CAMK2D
prerank,muscle tissue morphogenesis (GO:0060415),0.1976511231278705,0.4583763504298649,0.993581514762516,0.9995865423891571,1.0,2/16,21.85%,EFEMP2;BMP4
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.2195915520401922,0.4553167053645938,0.9908256880733946,0.9995625318478542,1.0,3/10,29.75%,UPB1;NT5M;NT5C3A
prerank,positive regulation of cellular respiration (GO:1901857),0.21046047234155388,0.44804135075606594,0.9918809201623816,0.9998635814064413,1.0,2/11,23.27%,VCP;PRELID1
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.16929249220062975,0.44653059272839374,0.9964953271028038,0.99966877705109,1.0,4/30,17.16%,FSTL3;SMAD7;FSTL1;ITGA3
prerank,nucleic acid-templated transcription (GO:0097659),0.16271909138217,0.44557726196871555,0.9988662131519275,0.9994319025973111,1.0,8/42,25.07%,POLR2H;DRG1;PWP1;POLR2D;NR4A2;TERT;POLR2F;RRAGC
prerank,spinal cord development (GO:0021510),0.2053358443188953,0.4448002887135446,0.9933510638297872,0.9991732936910109,1.0,12/12,79.48%,NF1;ZPR1;LOXL3;SOX11;PKD2;GLI2;VIT;SOX4;DLL1;SOX12;RELN;PKD1
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.1863844108908953,0.4397425180782099,0.9938650306748467,0.9992147576901238,1.0,4/19,25.97%,AMPD2;APRT;TERT;HPRT1
prerank,histone deubiquitination (GO:0016578),0.1840028534109311,0.4378476157520974,0.9949558638083228,0.9990343428401806,1.0,6/18,34.22%,UIMC1;USP36;BRCC3;USP15;USP22;TRRAP
prerank,microtubule-based transport (GO:0099111),0.19559658350100723,0.4268817817084737,0.9961240310077519,0.9993714306745128,1.0,4/12,32.39%,HTT;ADCY10;CCDC40;DYNC1I2
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.1334547509891352,-0.42038422252855384,1.0,0.9996887732005433,1.0,19/19,86.68%,ZFPM1;BMP2;HEY1;HEYL;BMPR2;SOX4;BMPR1A;SMAD4;SLIT3;MDM4;GATA4;ACVR1;SMAD6;TGFB2;HEY2;NOTCH1;OLFM1;TGFBR2;EFNA1
prerank,endocardial cushion development (GO:0003197),0.1686292491940664,0.4110823773011706,0.9975728155339806,0.9997583530610101,1.0,1/21,6.78%,SOX9
prerank,phosphate ion homeostasis (GO:0055062),0.188466562039302,0.39311888549167334,1.0,0.9999718342394361,1.0,1/10,18.13%,XPR1
prerank,snRNA metabolic process (GO:0016073),0.16342649562622974,0.3868908895842897,1.0,0.9997945737685222,1.0,3/17,23.74%,INTS2;INTS6;INTS7
prerank,in utero embryonic development (GO:0001701),0.14417724495788334,0.36503522435386265,0.9975874547647768,0.9997753272627392,1.0,8/25,33.74%,VEGFA;ARNT2;ZNF568;FGFR2;CHD7;HINFP;EGFL8;LMX1B
